BB-cat+ner-1016123/text	DOCUMENT	BB-cat+ner-1016123/text
An	DT	An
evaluation	NN	evaluation
of	IN	of
selective	JJ	selective
broths	NNS	broth
based	VBN	base
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bi-selenite	JJ	bi-selenite
ion	NN	ion
and	CC	and
on	IN	on
hypertonic	JJ	hypertonic
strontium	NN	strontium
chloride	NN	chloride
in	IN	in
Salmonellae	NP	Salmonellae
detection	NN	detection
in	IN	in
egg	NN	egg
products	NNS	product
.	SENT	.
.	SENT	.
Of	IN	Of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
104	CD	104
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
isolations	NNS	isolation
of	IN	of
Salmonella	NN	Salmonella
sp	NN	sp
.	SENT	.
from	IN	from
egg	NN	egg
pulp	NN	pulp
,	,	,
97	CD	97
were	VVD	be
obtained	VBN	obtain
from	IN	from
strontium	NN	strontium
chloride	NN	chloride
M	NN	M
broth	NN	broth
,	,	,
42	CD	42
from	IN	from
strontium	NN	strontium
selenite	NN	selenite
broth	NN	broth
and	CC	and
57	CD	57
from	IN	from
strontium	NN	strontium
selenite	NN	selenite
A	NN	A
broth	NN	broth
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
results	NNS	result
suggest	VBP	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
first	JJ	first
medium	NN	medium
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
be	VV	be
used	VBN	use
<FORBIDDEN ID=82 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
successfully	RB	successfully
than	IN	than
bi-selenite	JJ	bi-selenite
based	VBN	base
media	NNS	medium
for	IN	for
enrichment	NN	enrichment
and	CC	and
subsequent	JJ	subsequent
detection	NN	detection
of	IN	of
salmonellae	NN	salmonellae
in	IN	in
egg	NN	egg
products	NNS	product
;	COLUMN	;
however	RB	however
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
growth	NN	growth
of	IN	of
S	NN	S
.	SENT	.
pullorum	NN	pullorum
was	VVD	be
not	RB	not
satisfactory	JJ	satisfactory
in	IN	in
strontium	NN	strontium
chloride	NN	chloride
M	NN	M
broth	NN	broth
.	SENT	.
.	SENT	.
BB-cat+ner-10492485/text	DOCUMENT	BB-cat+ner-10492485/text
Application	NN	Application
of	IN	of
ozone	NN	ozone
for	IN	for
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
enhancing	VBG	enhance
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
microbiological	JJ	microbiological
safety	NN	safety
and	CC	and
quality	NN	quality
of	IN	of
foods	NNS	food
:	COLUMN	:
a	DT	a
review	NN	review
.	SENT	.
.	SENT	.
Ozone	NN	Ozone
(	(	(
O3	NN	O3
)	)	)
is	VVZ	be
a	DT	a
strong	JJ	strong
antimicrobial	JJ	antimicrobial
agent	NN	agent
with	IN	with
numerous	JJ	numerous
potential	JJ	potential
applications	NNS	application
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
food	NN	food
industry	NN	industry
.	SENT	.
.	SENT	.
High	JJ	High
reactivity	NN	reactivity
,	,	,
penetrability	NN	penetrability
,	,	,
and	CC	and
spontaneous	JJ	spontaneous
decomposition	NN	decomposition
to	TO	to
a	DT	a
nontoxic	JJ	nontoxic
product	NN	product
(	(	(
<FORBIDDEN ID=71 ACTION=delete>
i.e.	FW	i.e.
</FORBIDDEN ID=71 ACTION=delete>
,	,	,
O2	NN	O2
)	)	)
make	VBP	make
<FORBIDDEN ID=0 ACTION=split SPLIT_AFTER=0>
ozone	NN	ozone
a	DT	a
</FORBIDDEN ID=0 ACTION=split SPLIT_AFTER=0>
viable	JJ	viable
disinfectant	NN	disinfectant
for	IN	for
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
ensuring	VBG	ensure
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
microbiological	JJ	microbiological
safety	NN	safety
of	IN	of
food	NN	food
products	NNS	product
.	SENT	.
.	SENT	.
Ozone	NN	Ozone
has	VHZ	have
been	VVN	be
used	VBN	use
for	IN	for
decades	NNS	decade
in	IN	in
<FORBIDDEN ID=28 ACTION=delete>
many	JJ	many
</FORBIDDEN ID=28 ACTION=delete>
countries	NNS	country
and	CC	and
recently	RB	recently
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=161 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
generally	RB	generally
</FORBIDDEN ID=161 ACTION=delete>
recognized	VBN	recognize
as	IN	as
safe	JJ	safe
(	(	(
GRAS	NN	GRAS
)	)	)
status	NN	status
of	IN	of
this	DT	this
gas	NN	gas
has	VHZ	have
been	VVN	be
reaffirmed	VBN	reaffirm
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
United	NP	United
States	NPS	State
.	SENT	.
.	SENT	.
Ozone	NN	Ozone
,	,	,
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
gaseous	JJ	gaseous
or	CC	or
aqueous	JJ	aqueous
phases	NNS	phase
,	,	,
is	VVZ	be
effective	JJ	effective
against	IN	against
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
majority	NN	majority
of	IN	of
microorganisms	NNS	microorganism
tested	VBN	test
by	IN	by
numerous	JJ	numerous
research	NN	research
groups	NNS	group
.	SENT	.
.	SENT	.
Relatively	RB	Relatively
low	JJ	low
concentrations	NNS	concentration
of	IN	of
ozone	NN	ozone
and	CC	and
short	JJ	short
contact	NN	contact
time	NN	time
are	VVP	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
sufficient	JJ	sufficient
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
inactivate	VB	inactivate
bacteria	NNS	bacteria
,	,	,
molds	NNS	mold
,	,	,
yeasts	NNS	yeast
,	,	,
parasites	NNS	parasite
,	,	,
and	CC	and
viruses	NNS	virus
.	SENT	.
.	SENT	.
However	RB	However
,	,	,
rates	NNS	rate
of	IN	of
inactivation	NN	inactivation
are	VVP	be
greater	JJR	great
in	IN	in
ozone	NN	ozone
demand	NN	demand
-	HYPH	-
free	JJ	free
systems	NNS	system
than	IN	than
when	WRB	when
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
medium	NN	medium
contains	VBZ	contain
oxidizable	JJ	oxidizable
organic	JJ	organic
substances	NNS	substance
.	SENT	.
.	SENT	.
Susceptibility	NN	Susceptibility
of	IN	of
microorganisms	NNS	microorganism
to	TO	to
ozone	NN	ozone
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
varies	VBZ	vary
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
physiological	JJ	physiological
state	NN	state
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
culture	NN	culture
,	,	,
pH	NN	pH
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
medium	NN	medium
,	,	,
temperature	NN	temperature
,	,	,
humidity	NN	humidity
,	,	,
and	CC	and
presence	NN	presence
of	IN	of
additives	NNS	additive
(	(	(
<FORBIDDEN ID=67 ACTION=delete>
e.g.	FW	e.g.
</FORBIDDEN ID=67 ACTION=delete>
,	,	,
acids	NNS	acid
,	,	,
surfactants	NNS	surfactant
,	,	,
and	CC	and
sugars	NNS	sugar
)	)	)
.	SENT	.
.	SENT	.
Ozone	NN	Ozone
applications	NNS	application
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
food	NN	food
industry	NN	industry
are	VVP	be
mostly	RB	mostly
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
related	JJ	related
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
decontamination	NN	decontamination
of	IN	of
product	NN	product
surface	NN	surface
and	CC	and
water	NN	water
treatment	NN	treatment
.	SENT	.
.	SENT	.
Ozone	NN	Ozone
has	VHZ	have
been	VVN	be
used	VBN	use
with	IN	with
mixed	VBN	mix
success	NN	success
to	TO	to
inactivate	VB	inactivate
contaminant	JJ	contaminant
microflora	NN	microflora
on	IN	on
meat	NN	meat
,	,	,
poultry	NN	poultry
,	,	,
eggs	NNS	egg
,	,	,
fish	NNS	fish
,	,	,
fruits	NNS	fruit
,	,	,
vegetables	NNS	vegetable
,	,	,
and	CC	and
dry	JJ	dry
foods	NNS	food
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
gas	NN	gas
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
is	VVZ	be
useful	JJ	useful
in	IN	in
detoxification	NN	detoxification
and	CC	and
elimination	NN	elimination
of	IN	of
mycotoxins	NNS	mycotoxin
and	CC	and
pesticide	NN	pesticide
residues	NNS	residue
from	IN	from
some	DT	some
agricultural	JJ	agricultural
products	NNS	product
.	SENT	.
.	SENT	.
Excessive	JJ	Excessive
use	NN	use
of	IN	of
ozone	NN	ozone
,	,	,
however	RB	however
,	,	,
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
cause	VB	cause
oxidation	NN	oxidation
of	IN	of
some	DT	some
ingredients	NNS	ingredient
on	IN	on
food	NN	food
surface	NN	surface
.	SENT	.
.	SENT	.
This	DT	This
usually	RB	usually
results	VBZ	result
in	IN	in
discoloration	NN	discoloration
and	CC	and
deterioration	NN	deterioration
of	IN	of
food	NN	food
flavor	NN	flavor
.	SENT	.
.	SENT	.
Additional	JJ	Additional
research	NN	research
is	VVZ	be
needed	VBN	need
to	TO	to
elucidate	VB	elucidate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
kinetics	NNS	kinetic
and	CC	and
mechanisms	NNS	mechanism
of	IN	of
microbial	JJ	microbial
inactivation	NN	inactivation
by	IN	by
ozone	NN	ozone
and	CC	and
to	TO	to
optimize	VB	optimize
its	PP$	its
use	NN	use
in	IN	in
food	NN	food
applications	NNS	application
.	SENT	.
.	SENT	.
BB-cat+ner-10496597/text	DOCUMENT	BB-cat+ner-10496597/text
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
differential	JJ	differential
diagnosis	NN	diagnosis
of	IN	of
<FORBIDDEN ID=45 ACTION=delete>
early	JJ	early
</FORBIDDEN ID=45 ACTION=delete>
gastric	JJ	gastric
mucosa	NN	mucosa
-	HYPH	-
associated	VBN	associate
lymphoma	NN	lymphoma
:	COLUMN	:
polymerase	NN	polymerase
chain	NN	chain
reaction	NN	reaction
and	CC	and
paraffin	NN	paraffin
section	NN	section
immunophenotyping	NN	immunophenotyping
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
distinction	NN	distinction
between	IN	between
benign	JJ	benign
florid	NN	florid
lymphoid	JJ	lymphoid
hyperplasia	NN	hyperplasia
and	CC	and
low-grade	JJ	low-grade
gastric	JJ	gastric
mucosal	NN	mucosal
-	HYPH	-
associated	VBN	associate
lymphoid	JJ	lymphoid
tissue	NN	tissue
(	(	(
MALT	NN	MALT
)	)	)
lymphoma	NN	lymphoma
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
be	VV	be
a	DT	a
challenge	NN	challenge
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
monoclonal	JJ	monoclonal
B	NN	B
cells	NNS	cell
in	IN	in
Helicobacter	NN	Helicobacter
pylori	NNS	pylorus
-	HYPH	-
chronic	JJ	chronic
active	JJ	active
gastritis	NN	gastritis
has	VHZ	have
suggested	VBN	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
polymerase	NN	polymerase
chain	NN	chain
reaction	NN	reaction
(	(	(
PCR	NN	PCR
)	)	)
data	NNS	datum
should	MD	should
be	VV	be
viewed	VBN	view
with	IN	with
caution	NN	caution
.	SENT	.
.	SENT	.
We	PP	We
investigated	VBD	investigate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
reliability	NN	reliability
of	IN	of
PCR	NN	PCR
<FORBIDDEN ID=23 ACTION=delete>
versus	CC	versus
</FORBIDDEN ID=23 ACTION=delete>
immunophenotyping	NN	immunophenotyping
in	IN	in
diagnosing	VBG	diagnose
<FORBIDDEN ID=45 ACTION=delete>
early	JJ	early
</FORBIDDEN ID=45 ACTION=delete>
gastric	JJ	gastric
MALT	NN	MALT
lymphoma	NN	lymphoma
.	SENT	.
.	SENT	.
We	PP	We
studied	VBD	study
1511	CD	1511
biopsies	NNS	biopsy
from	IN	from
eight	CD	eight
patients	NNS	patient
with	IN	with
high	JJ	high
-	HYPH	-
grade	NN	grade
primary	JJ	primary
gastric	JJ	gastric
lymphoma	NN	lymphoma
,	,	,
25	CD	25
with	IN	with
low-grade	JJ	low-grade
MALT	NN	MALT
lymphoma	NN	lymphoma
,	,	,
32	CD	32
with	IN	with
atypical	JJ	atypical
lymphoid	JJ	lymphoid
infiltrates	NNS	infiltrate
,	,	,
and	CC	and
39	CD	39
with	IN	with
Helicobacter	NN	Helicobacter
pylori	NNS	pylorus
-	HYPH	-
chronic	JJ	chronic
active	JJ	active
gastritis	NN	gastritis
.	SENT	.
.	SENT	.
Paraffin	NN	Paraffin
sections	NNS	section
from	IN	from
all	DT	all
cases	NNS	case
were	VVD	be
stained	VBN	stain
with	IN	with
antibodies	NNS	antibody
to	TO	to
CD20	NN	CD20
,	,	,
CD3	NN	CD3
,	,	,
AE1	NN	AE1
/	SYM	/
AE3	NN	AE3
,	,	,
kappa	NN	kappa
and	CC	and
lambda	NN	lambda
.	SENT	.
.	SENT	.
PCR	NN	PCR
was	VVD	be
performed	VBN	perform
on	IN	on
paraffin	NN	paraffin
sections	NNS	section
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
using	VBG	use
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
primer	NN	primer
set	NN	set
VH	NN	VH
-	HYPH	-
FR3	NN	FR3
/	SYM	/
J(H)	NN	J(H)
.	SENT	.
.	SENT	.
Using	VBG	Use
histopathology	NN	histopathology
as	IN	as
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
gold	JJ	gold
standard	NN	standard
in	IN	in
diagnosis	NN	diagnosis
,	,	,
we	PP	we
confirmed	VBD	confirm
monoclonality	NN	monoclonality
in	IN	in
22	CD	22
of	IN	of
25	CD	25
MALT	NN	MALT
lymphomas	NNS	lymphoma
(	(	(
88%	NN	88%
)	)	)
;	COLUMN	;
a	DT	a
clonal	JJ	clonal
band	NN	band
was	VVD	be
found	VBN	find
in	IN	in
38%	CD	38%
(	(	(
15	CD	15
of	IN	of
39	CD	39
)	)	)
of	IN	of
patients	NNS	patient
with	IN	with
chronic	JJ	chronic
active	JJ	active
gastritis	NN	gastritis
.	SENT	.
.	SENT	.
An	DT	An
immunophenotype	NN	immunophenotype
pattern	NN	pattern
with	IN	with
predominance	NN	predominance
of	IN	of
CD20	NN	CD20
-	HYPH	-
positive	JJ	positive
cells	NNS	cell
in	IN	in
lymphocytic	JJ	lymphocytic
infiltrates	NNS	infiltrate
was	VVD	be
associated	VBN	associate
with	IN	with
monoclonality	NN	monoclonality
in	IN	in
92%	CD	92%
of	IN	of
cases	NNS	case
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
an	DT	an
enlarged	JJ	enlarged
irregular	JJ	irregular
mantle	NN	mantle
zone	NN	zone
was	VVD	be
found	VBN	find
in	IN	in
<FORBIDDEN ID=30 ACTION=delete>
both	CC	both
</FORBIDDEN ID=30 ACTION=delete>
monoclonal	JJ	monoclonal
and	CC	and
polyclonal	JJ	polyclonal
areas	NNS	area
.	SENT	.
.	SENT	.
An	DT	An
equal	JJ	equal
prevalence	NN	prevalence
of	IN	of
B	NN	B
and	CC	and
T	NN	T
cells	NNS	cell
in	IN	in
lymphocytic	JJ	lymphocytic
infiltrates	NNS	infiltrate
was	VVD	be
associated	VBN	associate
with	IN	with
a	DT	a
polyclonal	JJ	polyclonal
pattern	NN	pattern
in	IN	in
24	CD	24
of	IN	of
31	CD	31
cases	NNS	case
(	(	(
77%	CD	77%
)	)	)
.	SENT	.
.	SENT	.
Immunostaining	NN	Immunostaining
of	IN	of
sIg	NN	sIg
(	(	(
kappa	NN	kappa
and	CC	and
lambda	NN	lambda
)	)	)
was	VVD	be
difficult	JJ	difficult
in	IN	in
paraffin	NN	paraffin
sections	NNS	section
and	CC	and
convincing	VBG	convince
proof	NN	proof
of	IN	of
monoclonality	NN	monoclonality
was	VVD	be
not	RB	not
obtained	VBN	obtain
.	SENT	.
.	SENT	.
Lymphoepithelial	JJ	Lymphoepithelial
lesions	NNS	lesion
were	VVD	be
infrequent	JJ	infrequent
in	IN	in
gastric	JJ	gastric
biopsies	NNS	biopsy
and	CC	and
their	PP$	their
presence	NN	presence
was	VVD	be
highlighted	VBN	highlight
with	IN	with
keratin	NN	keratin
stains	NNS	stain
.	SENT	.
.	SENT	.
Because	IN	Because
monoclonal	JJ	monoclonal
B	NN	B
cells	NNS	cell
are	VVP	be
observed	VBN	observe
in	IN	in
Helicobacter	NN	Helicobacter
pylori	NNS	pylorus
-	HYPH	-
associated	VBN	associate
gastritis	NN	gastritis
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
correct	JJ	correct
interpretation	NN	interpretation
of	IN	of
clonality	NN	clonality
by	IN	by
PCR	NN	PCR
remains	VBZ	remain
unclear	JJ	unclear
.	SENT	.
.	SENT	.
Paraffin	NN	Paraffin
section	NN	section
IHC	NN	IHC
using	VBG	use
CD20	NN	CD20
and	CC	and
CD3	NN	CD3
is	VVZ	be
especially	RB	especially
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
useful	JJ	useful
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
confirm	VB	confirm
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
diagnosis	NN	diagnosis
of	IN	of
gastric	JJ	gastric
MALT	NN	MALT
lymphoma	NN	lymphoma
.	SENT	.
.	SENT	.
BB-cat+ner-10618167/text	DOCUMENT	BB-cat+ner-10618167/text
Listeria	NN	Listeria
monocytogenes	NNS	monocytogene
ActA	NN	ActA
protein	NN	protein
interacts	VBZ	interact
with	IN	with
phosphatidylinositol	NN	phosphatidylinositol
4	CD	4
,	,	,
5-bisphosphate	NN	5-bisphosphate
in vitro	FW	in_vitro
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
N-terminal	JJ	N-terminal
region	NN	region
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Listeria	NP	Listeria
monocytogenes	NNS	monocytogene
ActA	NN	ActA
protein	NN	protein
,	,	,
in	IN	in
conjunction	NN	conjunction
with	IN	with
host	NN	host
cell	NN	cell
factors	NNS	factor
,	,	,
is	VVZ	be
sufficient	JJ	sufficient
for	IN	for
actin	NN	actin
polymerization	NN	polymerization
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bacterial	JJ	bacterial
surface	NN	surface
.	SENT	.
.	SENT	.
Previous	JJ	Previous
data	NNS	datum
suggested	VBD	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
ActA	NN	ActA
could	MD	could
protect	VB	protect
barbed	JJ	barbed
ends	NNS	end
from	IN	from
capping	VBG	cap
proteins	NNS	protein
.	SENT	.
.	SENT	.
We	PP	We
tested	VBD	test
this	DT	this
hypothesis	NN	hypothesis
by	IN	by
actin	NN	actin
polymerization	NN	polymerization
experiments	NNS	experiment
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
ActA	NN	ActA
N-terminal	JJ	N-terminal
fragment	NN	fragment
and	CC	and
capping	VBG	cap
protein	NN	protein
.	SENT	.
.	SENT	.
ActA	NN	ActA
does	VBZ	do
not	RB	not
protect	VB	protect
barbed	VBN	barb
ends	NNS	end
from	IN	from
capping	VBG	cap
protein	NN	protein
.	SENT	.
.	SENT	.
In	IN	In
contrast	NN	contrast
,	,	,
this	DT	this
polypeptide	NN	polypeptide
prevents	VBZ	prevent
PIP(2)	NN	PIP(2)
from	IN	from
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
inhibiting	VBG	inhibit
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
capping	NN	capping
activity	NN	activity
of	IN	of
capping	VBG	cap
protein	NN	protein
.	SENT	.
.	SENT	.
Gel	NN	Gel
filtration	NN	filtration
and	CC	and
tryptophan	NN	tryptophan
fluorescence	NN	fluorescence
experiments	NNS	experiment
showed	VBD	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
purified	VBN	purify
ActA	NN	ActA
N-terminal	JJ	N-terminal
fragment	NN	fragment
binds	VBZ	bind
to	TO	to
PIP(2)	NN	PIP(2)
and	CC	and
PIP	NN	PIP
,	,	,
defining	VBG	define
phosphoinositides	NNS	phosphoinositide
as	IN	as
novels	NNS	novel
ligands	NNS	ligand
for	IN	for
this	DT	this
functional	JJ	functional
domain	NN	domain
of	IN	of
ActA	NN	ActA
.	SENT	.
.	SENT	.
Phosphoinositide	NN	Phosphoinositide
binding	NN	binding
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
N-terminal	JJ	N-terminal
region	NN	region
of	IN	of
ActA	NN	ActA
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
induce	VB	induce
conformational	JJ	conformational
changes	NNS	change
in	IN	in
ActA	NN	ActA
and	CC	and
/	SYM	/
or	CC	or
facilitate	VB	facilitate
binding	NN	binding
of	IN	of
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
cell	NN	cell
components	NNS	component
,	,	,
important	JJ	important
for	IN	for
ActA	NN	ActA
-	HYPH	-
induced	VBN	induce
actin	NN	actin
polymerization	NN	polymerization
.	SENT	.
.	SENT	.
BB-cat+ner-10645449/text	DOCUMENT	BB-cat+ner-10645449/text
Genotypic	JJ	Genotypic
characterization	NN	characterization
of	IN	of
drug	NN	drug
-	HYPH	-
resistant	JJ	resistant
Mycobacterium	NN	Mycobacterium
tuberculosis	NN	tuberculosis
isolates	NNS	isolate
from	IN	from
Peru	NP	Peru
.	SENT	.
.	SENT	.
Twenty	CD	Twenty
-	HYPH	-
nine	CD	nine
epidemiological	JJ	epidemiological
unrelated	JJ	unrelated
and	CC	and
mostly	RB	mostly
multidrug	JJ	multidrug
-	HYPH	-
resistant	JJ	resistant
Mycobacterium	NN	Mycobacterium
tuberculosis	NN	tuberculosis
(	(	(
MDR	NN	MDR
-	HYPH	-
TB	NN	TB
)	)	)
strains	NNS	strain
from	IN	from
Peruvian	JJ	Peruvian
patients	NNS	patient
.	SENT	.
.	SENT	.
To	TO	To
investigate	VB	investigate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
molecular	JJ	molecular
genetics	NNS	genetic
of	IN	of
MDR	NN	MDR
-	HYPH	-
TB	NN	TB
strains	NNS	strain
recovered	VBN	recover
in	IN	in
a	DT	a
Latin	JJ	Latin
American	JJ	American
country	NN	country
.	SENT	.
.	SENT	.
Antimicrobial	JJ	Antimicrobial
agent	NN	agent
susceptibility	NN	susceptibility
testing	NN	testing
,	,	,
major	JJ	major
genetic	JJ	genetic
group	NN	group
designation	NN	designation
,	,	,
IS6110	NN	IS6110
fingerprinting	NN	fingerprinting
,	,	,
spoligotyping	NN	spoligotyping
,	,	,
and	CC	and
automated	VBN	automate
deoxyribonucleic	JJ	deoxyribonucleic
acid	NN	acid
sequencing	NN	sequencing
of	IN	of
regions	NNS	region
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
katG	NN	katG
,	,	,
rpoB	NN	rpoB
,	,	,
embB	NN	embB
,	,	,
gyrA	NN	gyrA
,	,	,
and	CC	and
pncA	NN	pncA
genes	NNS	gene
with	IN	with
mutations	NNS	mutation
commonly	RB	commonly
associated	VBN	associate
with	IN	with
drug	NN	drug
resistance	NN	resistance
.	SENT	.
.	SENT	.
Nineteen	CD	Nineteen
isolates	NNS	isolate
were	VVD	be
found	VBN	find
to	TO	to
be	VV	be
multidrug	JJ	multidrug
-	HYPH	-
resistant	JJ	resistant
by	IN	by
susceptibility	NN	susceptibility
testing	NN	testing
.	SENT	.
.	SENT	.
IS6110	NN	IS6110
typing	NN	typing
showed	VBD	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
virtually	RB	virtually
all	DT	all
isolates	NNS	isolate
were	VVD	be
unique	JJ	unique
and	CC	and
<FORBIDDEN ID=162 ACTION=delete>
therefore	RB	therefore
</FORBIDDEN ID=162 ACTION=delete>
had	VHD	have
independently	RB	independently
acquired	VBN	acquire
drug	NN	drug
resistance	NN	resistance
.	SENT	.
.	SENT	.
Seventy	CD	Seventy
-	HYPH	-
nine	CD	nine
percent	NN	percent
of	IN	of
isoniazid	NN	isoniazid
-	HYPH	-
resistant	JJ	resistant
strains	NNS	strain
had	VHD	have
a	DT	a
Ser315Thr	NN	Ser315Thr
amino	JJ	amino
acid	NN	acid
change	NN	change
in	IN	in
KatG	NP	KatG
.	SENT	.
.	SENT	.
Ninety	CD	Ninety
-	HYPH	-
five	CD	five
percent	NN	percent
of	IN	of
rifampin	NN	rifampin
-	HYPH	-
resistant	JJ	resistant
isolates	NNS	isolate
had	VHD	have
amino	JJ	amino
acid	NN	acid
replacements	NNS	replacement
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
rifampin	NN	rifampin
-	HYPH	-
resistance	NN	resistance
determining	VBG	determine
region	NN	region
of	IN	of
RpoB	NN	RpoB
.	SENT	.
.	SENT	.
Six	CD	Six
of	IN	of
11	CD	11
ethambutol	NN	ethambutol
-	HYPH	-
resistant	JJ	resistant
strains	NNS	strain
had	VHD	have
EmbB	NN	EmbB
alterations	NNS	alteration
.	SENT	.
.	SENT	.
Eleven	CD	Eleven
pyrazinamide	NN	pyrazinamide
-	HYPH	-
resistant	JJ	resistant
strains	NNS	strain
had	VHD	have
distinct	JJ	distinct
mutations	NNS	mutation
in	IN	in
pncA	NN	pncA
.	SENT	.
.	SENT	.
Virtually	RB	Virtually
all	DT	all
organisms	NNS	organism
evolved	VBD	evolve
drug	NN	drug
resistance	NN	resistance
independently	RB	independently
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
types	NNS	type
of	IN	of
drug	NN	drug
resistance	NN	resistance
-	HYPH	-
associated	VBN	associate
mutations	NNS	mutation
identified	VBN	identify
were	VVD	be
very	RB	very
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
similar	JJ	similar
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
changes	NNS	change
occurring	VBG	occur
in	IN	in
isolates	NNS	isolate
from	IN	from
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
areas	NNS	area
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
world	NN	world
.	SENT	.
.	SENT	.
Nucleotide	NN	Nucleotide
sequence	NN	sequence
-	HYPH	-
based	VBN	base
strategies	NNS	strategy
for	IN	for
rapid	JJ	rapid
detection	NN	detection
of	IN	of
drug	NN	drug
resistance	NN	resistance
-	HYPH	-
conferring	VBG	confer
mutants	NNS	mutant
will	MD	will
be	VV	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
applicable	JJ	applicable
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
organisms	NNS	organism
recovered	VBN	recover
in	IN	in
Peru	NP	Peru
,	,	,
and	CC	and
potentially	RB	potentially
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
areas	NNS	area
of	IN	of
Latin	NP	Latin
America	NP	America
.	SENT	.
.	SENT	.
BB-cat+ner-10656819/text	DOCUMENT	BB-cat+ner-10656819/text
Display	NN	Display
of	IN	of
active	JJ	active
subtilisin	NN	subtilisin
309	CD	309
on	IN	on
phage	NN	phage
:	COLUMN	:
analysis	NN	analysis
of	IN	of
parameters	NNS	parameter
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
influencing	VBG	influence
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
selection	NN	selection
of	IN	of
subtilisin	NN	subtilisin
variants	NNS	variant
with	IN	with
changed	VBN	change
substrate	NN	substrate
specificity	NN	specificity
from	IN	from
libraries	NNS	library
using	VBG	use
phosphonylating	VBG	phosphonylate
inhibitors	NNS	inhibitor
.	SENT	.
.	SENT	.
<FORBIDDEN ID=28 ACTION=delete>
Many	JJ	Many
</FORBIDDEN ID=28 ACTION=delete>
attempts	NNS	attempt
have	VHP	have
been	VVN	be
made	VBN	make
to	TO	to
endow	VB	endow
enzymes	NNS	enzyme
with	IN	with
<FORBIDDEN ID=38 ACTION=delete>
<FORBIDDEN ID=37 ACTION=delete>
new	JJ	new
</FORBIDDEN ID=37 ACTION=delete>
</FORBIDDEN ID=38 ACTION=delete>
catalytic	JJ	catalytic
activities	NNS	activity
.	SENT	.
.	SENT	.
One	CD	One
general	JJ	general
strategy	NN	strategy
involves	VBZ	involve
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
creation	NN	creation
of	IN	of
random	JJ	random
combinatorial	JJ	combinatorial
libraries	NNS	library
of	IN	of
mutants	NNS	mutant
associated	VBN	associate
with	IN	with
an	DT	an
efficient	JJ	efficient
screening	NN	screening
or	CC	or
selection	NN	selection
scheme	NN	scheme
.	SENT	.
.	SENT	.
Phage	NN	Phage
display	NN	display
has	VHZ	have
been	VVN	be
shown	VBN	show
to	TO	to
greatly	RB	greatly
facilitate	VB	facilitate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
selection	NN	selection
of	IN	of
polypeptides	NNS	polypeptide
with	IN	with
desired	VBN	desire
properties	NNS	property
by	IN	by
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
establishing	VBG	establish
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
close	JJ	close
link	NN	link
between	IN	between
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
polypeptide	NN	polypeptide
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
gene	NN	gene
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
encodes	VBZ	encode
it	PP	it
.	SENT	.
.	SENT	.
Selection	NN	Selection
of	IN	of
phage	NN	phage
displayed	VBD	display
enzymes	NNS	enzyme
for	IN	for
<FORBIDDEN ID=38 ACTION=delete>
<FORBIDDEN ID=37 ACTION=delete>
new	JJ	new
</FORBIDDEN ID=37 ACTION=delete>
</FORBIDDEN ID=38 ACTION=delete>
catalytic	JJ	catalytic
activities	NNS	activity
remains	VBZ	remain
a	DT	a
challenge	NN	challenge
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
aim	NN	aim
of	IN	of
this	DT	this
study	NN	study
was	VVD	be
to	TO	to
display	VB	display
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
serine	NN	serine
protease	NN	protease
subtilisin	NN	subtilisin
309	CD	309
(	(	(
savinase	NN	savinase
)	)	)
from	IN	from
Bacillus	NN	Bacillus
lentus	NN	lentus
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
surface	NN	surface
of	IN	of
filamentous	JJ	filamentous
fd	NN	fd
phage	NN	phage
and	CC	and
to	TO	to
develop	VB	develop
selection	NN	selection
schemes	NNS	scheme
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
allow	VBP	allow
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
extraction	NN	extraction
of	IN	of
subtilisin	NN	subtilisin
variants	NNS	variant
with	IN	with
a	DT	a
changed	VBN	change
substrate	NN	substrate
specificity	NN	specificity
from	IN	from
libraries	NNS	library
.	SENT	.
.	SENT	.
Subtilisins	NNS	Subtilisin
are	VVP	be
produced	VBN	produce
as	IN	as
secreted	VBN	secrete
preproenzyme	NN	preproenzyme
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
mature	VBP	mature
in	IN	in
active	JJ	active
enzyme	NN	enzyme
autocatalytically	RB	autocatalytically
.	SENT	.
.	SENT	.
They	PP	They
have	VHP	have
a	DT	a
broad	JJ	broad
substrate	NN	substrate
specificity	NN	specificity
but	CC	but
exhibit	VBP	exhibit
a	DT	a
significant	JJ	significant
preference	NN	preference
for	IN	for
hydrophobic	JJ	hydrophobic
residues	NNS	residue
and	CC	and
very	RB	very
limited	JJ	limited
reactivity	NN	reactivity
toward	IN	toward
charged	VBN	charge
residues	NNS	residue
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
P4	NN	P4
site	NN	site
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
substrate	NN	substrate
.	SENT	.
.	SENT	.
Here	RB	Here
,	,	,
we	PP	we
show	VBP	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
savinase	NN	savinase
can	MD	can
be	VV	be
functionally	RB	functionally
displayed	VBN	display
on	IN	on
phage	NN	phage
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
proteic	JJ	proteic
inhibitor	NN	inhibitor
CI2	NN	CI2
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
free	JJ	free
enzyme	NN	enzyme
is	VVZ	be
released	VBN	release
from	IN	from
its	PP$	its
complex	NN	complex
with	IN	with
CI2	NN	CI2
upon	IN	upon
addition	NN	addition
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
anionic	JJ	anionic
detergent	NN	detergent
LAS	NN	LAS
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
phage	NN	phage
-	HYPH	-
enzyme	NN	enzyme
can	MD	can
be	VV	be
panned	VBN	pan
on	IN	on
streptavidin	NN	streptavidin
beads	VBZ	bead
after	IN	after
labelling	NN	labelling
by	IN	by
reaction	NN	reaction
with	IN	with
(	(	(
biotin	NN	biotin
-	HYPH	-
N-epsilon	NN	N-epsilon
-	HYPH	-
aminocaproyl	NN	aminocaproyl
-	HYPH	-
cystamine	NN	cystamine
-	HYPH	-
N'	NN	N'
-	HYPH	-
glutaryl	NN	glutaryl
)-l	JJ	)-l
-	HYPH	-
Ala-l	NN	Ala-l
-	HYPH	-
Ala-l	NN	Ala-l
-	HYPH	-
P	NN	P
ro-Phe(P)	NN	ro-Phe(P)
-	HYPH	-
diphenyl	NN	diphenyl
ester	NN	ester
.	SENT	.
.	SENT	.
Reactions	NNS	Reaction
of	IN	of
libraries	NNS	library
,	,	,
in	IN	in
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
residues	NNS	residue
104	CD	104
and	CC	and
107	CD	107
forming	VBG	form
part	NN	part
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
S4	NN	S4
pocket	NN	pocket
have	VHP	have
been	VVN	be
randomised	VBN	randomise
,	,	,
with	IN	with
(	(	(
biotin	NN	biotin
-	HYPH	-
N-epsilon	NN	N-epsilon
-	HYPH	-
aminocaproyl	NN	aminocaproyl
-	HYPH	-
cystamine	NN	cystamine
-	HYPH	-
N'	NN	N'
-	HYPH	-
glutaryl	NN	glutaryl
)	)	)
-	HYPH	-
alpha-l	NN	alpha-l
-	HYPH	-
Lys-l	NN	Lys-l
-	HYPH	-
A	NN	A
la-l	NN	la-l
-	HYPH	-
Pro-Phe(P)	NN	Pro-Phe(P)
-	HYPH	-
diphenylester	NN	diphenylester
allowed	VBD	allow
us	PP	us
to	TO	to
select	VB	select
enzymes	NNS	enzyme
with	IN	with
increased	VBN	increase
specific	JJ	specific
activity	NN	activity
for	IN	for
a	DT	a
substrate	NN	substrate
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
containing	VBG	contain
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
lysine	NN	lysine
in	IN	in
P4	NN	P4
.	SENT	.
.	SENT	.
Parameters	NNS	Parameter
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
influencing	VBG	influence
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
selection	NN	selection
as	IN	as
for	IN	for
<FORBIDDEN ID=0 ACTION=split SPLIT_AFTER=0>
instance	NN	instance
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=0 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
efficiency	NN	efficiency
of	IN	of
maturation	NN	maturation
of	IN	of
mutant	JJ	mutant
enzymes	NNS	enzyme
in	IN	in
libraries	NNS	library
have	VHP	have
been	VVN	be
investigated	VBN	investigate
.	SENT	.
.	SENT	.
BB-cat+ner-10658649/text	DOCUMENT	BB-cat+ner-10658649/text
Identification	NN	Identification
of	IN	of
a	DT	a
novel	JJ	novel
glycoprotein	NN	glycoprotein
-	HYPH	-
binding	NN	binding
activity	NN	activity
in	IN	in
Streptococcus	NP	Streptococcus
pyogenes	NNS	pyogene
regulated	VBN	regulate
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
mga	NN	mga
gene	NN	gene
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
interaction	NN	interaction
between	IN	between
Streptococcus	NP	Streptococcus
pyogenes	NNS	pyogene
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
host	NN	host
cell	NN	cell
surface	NN	surface
is	VVZ	be
not	RB	not
completely	RB	completely
understood	VBN	understand
.	SENT	.
.	SENT	.
Characterization	NN	Characterization
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
adhesion	NN	adhesion
mechanisms	NNS	mechanism
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bacterium	NN	bacterium
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
host	NN	host
cell	NN	cell
surface	NN	surface
is	VVZ	be
needed	VBN	need
<FORBIDDEN ID=27 ACTION=delete>
<FORBIDDEN ID=26 ACTION=delete>
in	IN	in
order	NN	order
to	TO	to
</FORBIDDEN ID=26 ACTION=delete>
</FORBIDDEN ID=27 ACTION=delete>
develop	VB	develop
<FORBIDDEN ID=38 ACTION=delete>
<FORBIDDEN ID=37 ACTION=delete>
new	JJ	new
</FORBIDDEN ID=37 ACTION=delete>
</FORBIDDEN ID=38 ACTION=delete>
vaccines	NNS	vaccine
and	CC	and
anti	AFX	anti
-	HYPH	-
adhesion	NN	adhesion
drugs	NNS	drug
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
glycoprotein	NN	glycoprotein
-	HYPH	-
binding	VBG	bind
activities	NNS	activity
among	IN	among
streptococcal	JJ	streptococcal
strains	NNS	strain
was	VVD	be
investigated	VBN	investigate
.	SENT	.
.	SENT	.
An	DT	An
activity	NN	activity
<FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
binding	VBG	bind
to	TO	to
</FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
thyroglobulin	NN	thyroglobulin
,	,	,
fetuin	NN	fetuin
,	,	,
asialofetuin	NN	asialofetuin
and	CC	and
mucin	NN	mucin
but	CC	but
not	RB	not
non-glycosylated	JJ	non-glycosylated
proteins	NNS	protein
was	VVD	be
found	VBN	find
to	TO	to
be	VV	be
present	JJ	present
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
majority	NN	majority
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
S	NN	S
.	SENT	.
pyogenes	NNS	pyogene
strains	NNS	strain
studied	VBN	study
.	SENT	.
.	SENT	.
Cross	AFX	Cross
-	HYPH	-
inhibition	NN	inhibition
experiments	NNS	experiment
suggested	VBD	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
glycoproteins	NNS	glycoprotein
share	VBP	share
a	DT	a
common	JJ	common
structure	NN	structure
recognized	VBN	recognize
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bacteria	NNS	bacteria
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
glycoprotein	NN	glycoprotein
-	HYPH	-
binding	NN	binding
activity	NN	activity
was	VVD	be
found	VBN	find
to	TO	to
be	VV	be
proteinaceous	JJ	proteinaceous
,	,	,
tightly	RB	tightly
attached	VBN	attach
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bacterial	JJ	bacterial
surface	NN	surface
and	CC	and
it	PP	it
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
mediated	VBD	mediate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
adherence	NN	adherence
of	IN	of
bacteria	NNS	bacteria
to	TO	to
solid	JJ	solid
surfaces	NNS	surface
coated	VBN	coat
with	IN	with
glycoproteins	NNS	glycoprotein
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
activity	NN	activity
was	VVD	be
found	VBN	find
by	IN	by
transposon	NN	transposon
mutagenesis	NN	mutagenesis
and	CC	and
complementation	NN	complementation
to	TO	to
be	VV	be
regulated	VBN	regulate
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
multiple	JJ	multiple
-	HYPH	-
gene	NN	gene
regulator	NN	regulator
Mga	NN	Mga
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
has	VHZ	have
been	VVN	be
implicated	VBN	implicate
as	IN	as
a	DT	a
regulator	NN	regulator
of	IN	of
S	NN	S
.	SENT	.
pyogenes	NNS	pyogene
virulence	NN	virulence
factors	NNS	factor
.	SENT	.
.	SENT	.
BB-cat+ner-10665543/text	DOCUMENT	BB-cat+ner-10665543/text
Evaluation	NN	Evaluation
of	IN	of
three	CD	three
Brucella	NN	Brucella
soluble	JJ	soluble
antigens	NNS	antigen
used	VBN	use
in	IN	in
an	DT	an
indirect	JJ	indirect
Elisa	NP	Elisa
to	TO	to
discriminate	VB	discriminate
S19	NN	S19
vaccinated	VBN	vaccinate
from	IN	from
naturally	RB	naturally
infected	JJ	infected
cattle	NNS	cattle
.	SENT	.
.	SENT	.
An	DT	An
O-polysaccharide	NN	O-polysaccharide
(	(	(
O-chain	NN	O-chain
)	)	)
and	CC	and
a	DT	a
hot-water	JJ	hot-water
extracted	VBN	extract
polysaccharide	NN	polysaccharide
(	(	(
PS	NN	PS
)	)	)
,	,	,
<FORBIDDEN ID=30 ACTION=delete>
both	DT	both
</FORBIDDEN ID=30 ACTION=delete>
obtained	VBN	obtain
from	IN	from
Brucella	NP	Brucella
abortus	IN	abortus
1119-3	CD	1119-3
,	,	,
and	CC	and
a	DT	a
B	NN	B
.	SENT	.
melitensis	NN	melitensis
16M	NN	16M
native	JJ	native
hapten	NN	hapten
(	(	(
NH	NN	NH
)	)	)
were	VVD	be
evaluated	VBN	evaluate
by	IN	by
indirect	JJ	indirect
enzyme	NN	enzyme
linked	VBD	link
immunosorbent	JJ	immunosorbent
assay	NN	assay
(	(	(
ELISA	NN	ELISA
)	)	)
on	IN	on
three	CD	three
groups	NNS	group
of	IN	of
cattle	NNS	cattle
sera	NNS	serum
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
sera	NNS	serum
tested	VBN	test
were	VVD	be
:	COLUMN	:
(	(	(
a	DT	a
)	)	)
75	CD	75
sera	NNS	serum
from	IN	from
cows	NNS	cow
naturally	RB	naturally
infected	VBN	infect
with	IN	with
B	NN	B
.	SENT	.
abortus	NN	abortus
;	COLUMN	;
(	(	(
b	NN	b
)	)	)
130	CD	130
sera	NNS	serum
from	IN	from
non-infected	JJ	non-infected
and	CC	and
non-vaccinated	JJ	non-vaccinated
cattle	NNS	cattle
;	COLUMN	;
and	CC	and
(	(	(
c	NN	c
)	)	)
61	CD	61
sera	NNS	serum
from	IN	from
non-infected	JJ	non-infected
heifers	NNS	heifer
recently	RB	recently
vaccinated	VBN	vaccinate
with	IN	with
B	NN	B
.	SENT	.
abortus	IN	abortus
Strain	NP	Strain
19	CD	19
(	(	(
S19	NN	S19
)	)	)
.	SENT	.
.	SENT	.
Sensitivity	NN	Sensitivity
(	(	(
Se	NN	Se
)	)	)
,	,	,
specificity	NN	specificity
(	(	(
Sp	NN	Sp
)	)	)
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
capability	NN	capability
to	TO	to
discriminate	VB	discriminate
vaccinated	VBN	vaccinate
cattle	NNS	cattle
(	(	(
ADV	NN	ADV
)	)	)
were	VVD	be
determined	VBN	determine
.	SENT	.
.	SENT	.
Using	VBG	Use
PS	NN	PS
antigen	NN	antigen
,	,	,
Se	NN	Se
was	VVD	be
100%	CD	100%
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Sp	NN	Sp
was	VVD	be
97.7	CD	97.7
%	NN	%
,	,	,
while	IN	while
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
highest	JJS	high
Sp	NN	Sp
was	VVD	be
obtained	VBN	obtain
by	IN	by
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
using	VBG	use
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
O-chain	NN	O-chain
(	(	(
99.2	CD	99.2
%	NN	%
)	)	)
.	SENT	.
.	SENT	.
For	IN	For
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
NH	NN	NH
antigen	NN	antigen
,	,	,
Se	NP	Se
was	VVD	be
94.7	CD	94.7
%	NN	%
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Sp	NN	Sp
was	VVD	be
90.0	CD	90.0
%	NN	%
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
ADV	NN	ADV
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
three	CD	three
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
antigens	NNS	antigen
was	VVD	be
approximately	RB	approximately
85%	CD	85%
.	SENT	.
.	SENT	.
Statistical	JJ	Statistical
analysis	NN	analysis
showed	VBD	show
significant	JJ	significant
differences	NNS	difference
between	IN	between
O-chain	NN	O-chain
/	SYM	/
PS	NN	PS
and	CC	and
O-chain	NN	O-chain
/	SYM	/
NH	NN	NH
antigens	NNS	antigen
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
agreement	NN	agreement
among	IN	among
antigens	NNS	antigen
determined	VBN	determine
by	IN	by
kappa	NN	kappa
coefficient	NN	coefficient
was	VVD	be
0.899	CD	0.899
for	IN	for
O-chain	NN	O-chain
/	SYM	/
PS	NN	PS
,	,	,
0.845	CD	0.845
for	IN	for
O-chain	NN	O-chain
/	SYM	/
NH	NN	NH
and	CC	and
0.795	CD	0.795
for	IN	for
PS	NN	PS
/	SYM	/
NH	NN	NH
.	SENT	.
.	SENT	.
BB-cat+ner-10738994/text	DOCUMENT	BB-cat+ner-10738994/text
Genotyping	NN	Genotyping
by	IN	by
restriction	NN	restriction
endonuclease	NN	endonuclease
analysis	NN	analysis
compared	VBN	compare
to	TO	to
phenotyping	NN	phenotyping
by	IN	by
antibiogram	NN	antibiogram
for	IN	for
typing	VBG	type
methicillin	NN	methicillin
-	HYPH	-
resistant	JJ	resistant
Staphylococcus	NP	Staphylococcus
aureus	NN	aureus
strains	NNS	strain
colonizing	VBG	colonize
patients	NNS	patient
in	IN	in
a	DT	a
nursing	NN	nursing
home	NN	home
.	SENT	.
.	SENT	.
To	TO	To
assist	VB	assist
in	IN	in
defining	VBG	define
patterns	NNS	pattern
of	IN	of
methicillin	NN	methicillin
-	HYPH	-
resistant	JJ	resistant
Staphylococcus	NN	Staphylococcus
aureus	NN	aureus
(	(	(
MRSA	NN	MRSA
)	)	)
colonization	NN	colonization
in	IN	in
a	DT	a
skilled	JJ	skilled
nursing	NN	nursing
facility	NN	facility
(	(	(
SNF	NN	SNF
)	)	)
,	,	,
we	PP	we
compared	VBD	compare
genotyping	NN	genotyping
by	IN	by
field	NN	field
-	HYPH	-
inversion	NN	inversion
gel	NN	gel
electrophoresis	NN	electrophoresis
(	(	(
FIGE	NN	FIGE
)	)	)
restriction	NN	restriction
endonuclease	NN	endonuclease
digestion	NN	digestion
analysis	NN	analysis
(	(	(
REA	NN	REA
)	)	)
with	IN	with
phenotyping	NN	phenotyping
by	IN	by
antibiogram	NN	antibiogram
for	IN	for
defining	VBG	define
strain	NN	strain
relatedness	NN	relatedness
among	IN	among
MRSA	NN	MRSA
isolates	NNS	isolate
from	IN	from
SNF	NN	SNF
patients	NNS	patient
.	SENT	.
.	SENT	.
Prospective	JJ	Prospective
screening	NN	screening
culture	NN	culture
surveillance	NN	surveillance
for	IN	for
MRSA	NN	MRSA
among	IN	among
patients	NNS	patient
in	IN	in
a	DT	a
community	NN	community
SNF	NN	SNF
.	SENT	.
.	SENT	.
Nares	NNS	Nare
and	CC	and
stool	NN	stool
swab	NN	swab
cultures	NNS	culture
were	VVD	be
obtained	VBN	obtain
from	IN	from
newly	RB	newly
admitted	VBN	admit
patients	NNS	patient
and	CC	and
from	IN	from
all	DT	all
patients	NNS	patient
quarterly	RB	quarterly
.	SENT	.
.	SENT	.
MRSA	NN	MRSA
were	VVD	be
isolated	VBN	isolate
by	IN	by
oxacillin	NN	oxacillin
screening	NN	screening
agar	NN	agar
.	SENT	.
.	SENT	.
Antibiograms	NNS	Antibiogram
were	VVD	be
determined	VBN	determine
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
disk	NN	disk
-	HYPH	-
diffusion	NN	diffusion
method	NN	method
,	,	,
and	CC	and
genotyping	NN	genotyping
was	VVD	be
by	IN	by
FIGE	NN	FIGE
REA	NN	REA
.	SENT	.
.	SENT	.
It	PP	It
was	VVD	be
shown	VBN	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
,	,	,
among	IN	among
isolates	NNS	isolate
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=16 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
same	JJ	same
</FORBIDDEN ID=16 ACTION=delete>
genotypes	NNS	genotype
,	,	,
<FORBIDDEN ID=28 ACTION=delete>
many	JJ	many
</FORBIDDEN ID=28 ACTION=delete>
had	VHD	have
different	JJ	different
antibiograms	NNS	antibiogram
;	COLUMN	;
among	IN	among
isolates	NNS	isolate
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=16 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
same	JJ	same
</FORBIDDEN ID=16 ACTION=delete>
antibiograms	NNS	antibiogram
,	,	,
<FORBIDDEN ID=28 ACTION=delete>
many	JJ	many
</FORBIDDEN ID=28 ACTION=delete>
had	VHD	have
different	JJ	different
genotypes	NNS	genotype
;	COLUMN	;
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
discriminatory	JJ	discriminatory
indices	NNS	index
for	IN	for
isolates	NNS	isolate
of	IN	of
MRSA	NN	MRSA
by	IN	by
FIGE	NN	FIGE
REA	NN	REA
and	CC	and
by	IN	by
antibiogram	NN	antibiogram
were	VVD	be
0.56	CD	0.56
and	CC	and
0.78	CD	0.78
,	,	,
respectively	RB	respectively
.	SENT	.
.	SENT	.
Our	PP$	Our
study	NN	study
demonstrated	VBD	demonstrate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
,	,	,
in	IN	in
patients	NNS	patient
from	IN	from
one	CD	one
SNF	NN	SNF
,	,	,
genotyping	NN	genotyping
by	IN	by
FIGE	NN	FIGE
REA	NN	REA
identified	VBD	identify
two	CD	two
prevalent	JJ	prevalent
REA	NN	REA
DNA	NN	DNA
types	NNS	type
,	,	,
but	CC	but
with	IN	with
variability	NN	variability
of	IN	of
antibiogram	NN	antibiogram
patterns	NNS	pattern
within	IN	within
each	DT	each
DNA	NN	DNA
type	NN	type
;	COLUMN	;
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
antibiogram	NN	antibiogram
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
identified	VBD	identify
prevalent	JJ	prevalent
patterns	NNS	pattern
with	IN	with
variability	NN	variability
of	IN	of
REA	NN	REA
DNA	NN	DNA
type	NN	type
within	IN	within
each	DT	each
antibiogram	NN	antibiogram
pattern	NN	pattern
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
discriminatory	JJ	discriminatory
index	NN	index
of	IN	of
antibiograms	NNS	antibiogram
alone	RB	alone
,	,	,
or	CC	or
of	IN	of
genotypes	NNS	genotype
alone	RB	alone
as	IN	as
determined	VBN	determine
by	IN	by
FIGE	NN	FIGE
REA	NN	REA
,	,	,
was	VVD	be
poor	JJ	poor
for	IN	for
strains	NNS	strain
of	IN	of
MRSA	NN	MRSA
isolated	VBN	isolate
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
SNF	NN	SNF
patients	NNS	patient
in	IN	in
our	PP$	our
study	NN	study
.	SENT	.
.	SENT	.
BB-cat+ner-10770276/text	DOCUMENT	BB-cat+ner-10770276/text
Immune	JJ	Immune
response	NN	response
to	TO	to
infection	NN	infection
with	IN	with
Salmonella	NP	Salmonella
typhimurium	NP	typhimurium
in	IN	in
mice	NNS	mouse
.	SENT	.
.	SENT	.
Infection	NN	Infection
of	IN	of
mice	NNS	mouse
with	IN	with
Salmonella	NP	Salmonella
typhimurium	NP	typhimurium
results	VBZ	result
in	IN	in
systemic	JJ	systemic
infection	NN	infection
and	CC	and
a	DT	a
disease	NN	disease
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
similar	JJ	similar
to	TO	to
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
that	DT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
seen	VBN	see
in	IN	in
humans	NNS	human
after	IN	after
infection	NN	infection
with	IN	with
S	NN	S
.	SENT	.
typhi	NN	typhi
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
innate	JJ	innate
immune	JJ	immune
system	NN	system
can	MD	can
restrict	VB	restrict
replication	NN	replication
of	IN	of
S	NP	S
.	SENT	.
typhimurium	NP	typhimurium
to	TO	to
a	DT	a
<FORBIDDEN ID=87 ACTION=delete>
certain	JJ	certain
</FORBIDDEN ID=87 ACTION=delete>
degree	NN	degree
,	,	,
but	CC	but
for	IN	for
effective	JJ	effective
control	NN	control
and	CC	and
eradication	NN	eradication
of	IN	of
bacteria	NNS	bacteria
,	,	,
acquired	VBN	acquire
immunity	NN	immunity
is	VVZ	be
essential	JJ	essential
.	SENT	.
.	SENT	.
Salmonella	NN	Salmonella
infection	NN	infection
induces	VBZ	induce
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
generation	NN	generation
of	IN	of
specific	JJ	specific
CD4+	JJ	CD4+
and	CC	and
CD8+	JJ	CD8+
T	NN	T
cells	NNS	cell
,	,	,
and	CC	and
<FORBIDDEN ID=30 ACTION=delete>
both	CC	both
</FORBIDDEN ID=30 ACTION=delete>
T	NN	T
cell	NN	cell
populations	NNS	population
are	VVP	be
important	JJ	important
for	IN	for
protection	NN	protection
during	IN	during
primary	JJ	primary
and	CC	and
secondary	JJ	secondary
responses	NNS	response
,	,	,
although	IN	although
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
mechanisms	NNS	mechanism
underlying	VBG	underlie
T	NN	T
cell	NN	cell
-	HYPH	-
mediated	VBN	mediate
protection	NN	protection
are	VVP	be
not	RB	not
yet	RB	yet
completely	RB	completely
understood	VBN	understand
.	SENT	.
.	SENT	.
Infection	NN	Infection
with	IN	with
S	NN	S
.	SENT	.
typhimurium	NP	typhimurium
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
results	VBZ	result
in	IN	in
a	DT	a
strong	JJ	strong
antibody	NN	antibody
response	NN	response
to	TO	to
Salmonella	NN	Salmonella
antigens	NNS	antigen
and	CC	and
,	,	,
<FORBIDDEN ID=27 ACTION=delete>
<FORBIDDEN ID=26 ACTION=delete>
in	IN	in
contrast	NN	contrast
to	TO	to
</FORBIDDEN ID=26 ACTION=delete>
</FORBIDDEN ID=27 ACTION=delete>
most	RBS	most
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
intracellular	JJ	intracellular
bacteria	NNS	bacteria
,	,	,
this	DT	this
antibody	NN	antibody
response	NN	response
participates	VBZ	participate
in	IN	in
protection	NN	protection
.	SENT	.
.	SENT	.
In	IN	In
summary	NN	summary
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
response	NN	response
to	TO	to
S	NN	S
.	SENT	.
typhimurium	NN	typhimurium
involves	VBZ	involve
<FORBIDDEN ID=30 ACTION=delete>
both	CC	both
</FORBIDDEN ID=30 ACTION=delete>
T	NN	T
and	CC	and
B	NN	B
cell	NN	cell
-	HYPH	-
mediated	VBN	mediate
immunity	NN	immunity
,	,	,
and	CC	and
mechanisms	NNS	mechanism
mediated	VBN	mediate
by	IN	by
<FORBIDDEN ID=30 ACTION=delete>
both	CC	both
</FORBIDDEN ID=30 ACTION=delete>
lymphocyte	NN	lymphocyte
populations	NNS	population
are	VVP	be
important	JJ	important
for	IN	for
control	NN	control
of	IN	of
primary	JJ	primary
infection	NN	infection
and	CC	and
protection	NN	protection
against	IN	against
secondary	JJ	secondary
infection	NN	infection
.	SENT	.
.	SENT	.
BB-cat+ner-10792385/text	DOCUMENT	BB-cat+ner-10792385/text
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
role	NN	role
of	IN	of
Fcgamma	NN	Fcgamma
receptor	NN	receptor
polymorphisms	NNS	polymorphism
and	CC	and
C3	NN	C3
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
immune	JJ	immune
defence	NN	defence
against	IN	against
Neisseria	NP	Neisseria
meningitidis	NNS	meningitidi
in	IN	in
complement	NN	complement
-	HYPH	-
deficient	JJ	deficient
individuals	NNS	individual
.	SENT	.
.	SENT	.
Individuals	NNS	Individual
with	IN	with
either	CC	either
a	DT	a
late	JJ	late
(	(	(
C	NN	C
5-9	CD	5-9
)	)	)
complement	NN	complement
component	NN	component
deficiency	NN	deficiency
(	(	(
LCCD	NN	LCCD
)	)	)
or	CC	or
properdin	NN	properdin
deficiency	NN	deficiency
are	VVP	be
at	IN	at
increased	VBN	increase
risk	NN	risk
to	TO	to
develop	VB	develop
meningococcal	JJ	meningococcal
disease	NN	disease
,	,	,
often	RB	often
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
due	JJ	due
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
serogroups	NNS	serogroup
W135	NN	W135
and	CC	and
Y	NN	Y
.	SENT	.
.	SENT	.
Anti	AFX	Anti
-	HYPH	-
meningococcal	JJ	meningococcal
defence	NN	defence
in	IN	in
<FORBIDDEN ID=30 ACTION=delete>
both	DT	both
</FORBIDDEN ID=30 ACTION=delete>
LCCD	NN	LCCD
persons	NNS	person
and	CC	and
properdin	NN	properdin
-	HYPH	-
deficient	JJ	deficient
individuals	NNS	individual
without	IN	without
bactericidal	JJ	bactericidal
antibodies	NNS	antibody
depends	VBZ	depend
mainly	RB	mainly
on	IN	on
phagocytosis	NN	phagocytosis
.	SENT	.
.	SENT	.
Three	CD	Three
types	NNS	type
of	IN	of
opsonin	NN	opsonin
receptors	NNS	receptor
are	VVP	be
involved	VBN	involve
in	IN	in
phagocytosis	NN	phagocytosis
by	IN	by
polymorphonuclear	JJ	polymorphonuclear
cells	NNS	cell
(	(	(
PMN	NN	PMN
)	)	)
.	SENT	.
.	SENT	.
These	DT	These
represent	VBP	represent
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
polymorphic	JJ	polymorphic
FcgammaRIIa	NN	FcgammaRIIa
(	(	(
CD32	NN	CD32
)	)	)
and	CC	and
FcgammaRIIIb	NN	FcgammaRIIIb
(	(	(
CD16b	NN	CD16b
)	)	)
receptors	NNS	receptor
,	,	,
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
C3	NN	C3
receptor	NN	receptor
CR3	NN	CR3
(	(	(
CD11b	NN	CD11b
/	SYM	/
CD18	NN	CD18
)	)	)
.	SENT	.
.	SENT	.
When	WRB	When
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
distribution	NN	distribution
of	IN	of
FcgammaRIIa	NN	FcgammaRIIa
and	CC	and
FcgammaRIIIb	NN	FcgammaRIIIb
allotypes	NNS	allotype
was	VVD	be
assessed	VBN	assess
in	IN	in
15	CD	15
LCCD	NN	LCCD
and	CC	and
in	IN	in
15	CD	15
properdin	NN	properdin
-	HYPH	-
deficient	JJ	deficient
patients	NNS	patient
with	IN	with
/	SYM	/
without	IN	without
previous	JJ	previous
meningococcal	JJ	meningococcal
disease	NN	disease
,	,	,
we	PP	we
found	VBD	find
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
combination	NN	combination
of	IN	of
FcgammaRIIa	NN	FcgammaRIIa
-	HYPH	-
R	NN	R
/	SYM	/
R131	NN	R131
with	IN	with
FcgammaRIIIb	NN	FcgammaRIIIb
-	HYPH	-
NA2	NN	NA2
/	SYM	/
NA2	NN	NA2
allotypes	NNS	allotype
to	TO	to
be	VV	be
associated	VBN	associate
with	IN	with
previous	JJ	previous
meningococcal	JJ	meningococcal
disease	NN	disease
(	(	(
odds	NNS	odd
ratio	NN	ratio
13.9	CD	13.9
,	,	,
Fisher's	NP	Fisher's
test	NN	test
P	NN	P
=	SYM	=
0.036	CD	0.036
)	)	)
.	SENT	.
.	SENT	.
No	DT	No
<FORBIDDEN ID=17 ACTION=delete>
such	JJ	such
</FORBIDDEN ID=17 ACTION=delete>
relation	NN	relation
was	VVD	be
observed	VBN	observe
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
properdin	NN	properdin
-	HYPH	-
deficient	JJ	deficient
patients	NNS	patient
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
importance	NN	importance
of	IN	of
FcgammaRIIa	NN	FcgammaRIIa
allotypes	NNS	allotype
was	VVD	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
demonstrated	VBN	demonstrate
using	VBG	use
in vitro	FW	in_vitro
phagocytosis	NN	phagocytosis
assays	NNS	assay
.	SENT	.
.	SENT	.
PMN	NN	PMN
from	IN	from
FcgammaRIIa	NN	FcgammaRIIa
-	HYPH	-
R	NN	R
/	SYM	/
R131	NN	R131
homozygous	JJ	homozygous
donors	NNS	donor
internalized	VBD	internalize
IgG2	NN	IgG2
opsonized	JJ	opsonized
meningococci	NNS	meningococci
<FORBIDDEN ID=165 ACTION=delete>
W135	NN	W135
significantly	RB	significantly
</FORBIDDEN ID=165 ACTION=delete>
(	(	(
P	NN	P
INF	SYM	INF
0.05	CD	0.05
)	)	)
less	JJR	less
than	IN	than
PMN	NN	PMN
from	IN	from
FcgammaRIIa	NN	FcgammaRIIa
-	HYPH	-
H	NN	H
/	SYM	/
H131	NN	H131
donors	NNS	donor
.	SENT	.
.	SENT	.
When	WRB	When
properdin	NN	properdin
-	HYPH	-
deficient	JJ	deficient
serum	NN	serum
was	VVD	be
tested	VBN	test
,	,	,
it	PP	it
was	VVD	be
observed	VBN	observe
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
reconstitution	NN	reconstitution
with	IN	with
properdin	NN	properdin
resulted	VBD	result
in	IN	in
enhanced	VBN	enhance
PMN	NN	PMN
phagocytosis	NN	phagocytosis
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
W135	NN	W135
meningococci	NNS	meningococci
(	(	(
P	NN	P
=	SYM	=
0.001	CD	0.001
)	)	)
.	SENT	.
.	SENT	.
This	DT	This
enhanced	VBN	enhance
phagocytosis	NN	phagocytosis
was	VVD	be
parallelled	VBN	parallel
by	IN	by
an	DT	an
increase	NN	increase
in	IN	in
C3	NN	C3
deposition	NN	deposition
onto	IN	onto
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
opsonized	VBN	opsonize
meningococci	NNS	meningococci
W135	NN	W135
(	(	(
r	NN	r
=	SYM	=
0.6568	CD	0.6568
,	,	,
P	NN	P
=	SYM	=
0	CD	0
.	SYM	.
01	CD	01
)	)	)
.	SENT	.
.	SENT	.
We	PP	We
conclude	VBP	conclude
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
occurrence	NN	occurrence
of	IN	of
meningococcal	JJ	meningococcal
disease	NN	disease
in	IN	in
LCCD	NN	LCCD
patients	NNS	patient
is	VVZ	be
associated	VBN	associate
with	IN	with
<FORBIDDEN ID=87 ACTION=delete>
certain	JJ	certain
</FORBIDDEN ID=87 ACTION=delete>
FcgammaR	NN	FcgammaR
allotypes	NNS	allotype
.	SENT	.
.	SENT	.
Properdin	NN	Properdin
-	HYPH	-
deficient	JJ	deficient
individuals	NNS	individual
are	VVP	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
susceptible	JJ	susceptible
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
meningococcal	JJ	meningococcal
disease	NN	disease
because	IN	because
of	IN	of
an	DT	an
insufficient	JJ	insufficient
C3	NN	C3
deposition	NN	deposition
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
surface	NN	surface
of	IN	of
meningococci	NNS	meningococci
,	,	,
resulting	VBG	result
in	IN	in
insufficient	JJ	insufficient
phagocytosis	NN	phagocytosis
.	SENT	.
.	SENT	.
BB-cat+ner-10796014/text	DOCUMENT	BB-cat+ner-10796014/text
Symbiotic	JJ	Symbiotic
induction	NN	induction
of	IN	of
pyruvate	NN	pyruvate
dehydrogenase	NN	dehydrogenase
genes	NNS	gene
from	IN	from
Sinorhizobium	NP	Sinorhizobium
meliloti	NP	meliloti
.	SENT	.
.	SENT	.
Genes	NNS	Gene
coding	VBG	cod
for	IN	for
components	NNS	component
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
pyruvate	NN	pyruvate
dehydrogenase	NN	dehydrogenase
(	(	(
PDH	NN	PDH
)	)	)
multienzyme	NN	multienzyme
complex	NN	complex
(	(	(
PDHc	NN	PDHc
)	)	)
from	IN	from
Sinorhizobium	NP	Sinorhizobium
meliloti	NP	meliloti
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
alfalfa	NN	alfalfa
symbiont	NN	symbiont
,	,	,
have	VHP	have
been	VVN	be
isolated	VBN	isolate
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
basis	NN	basis
of	IN	of
their	PP$	their
high	JJ	high
expression	NN	expression
in	IN	in
symbiotic	JJ	symbiotic
bacteria	NNS	bacteria
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Elp	NN	Elp
component	NN	component
,	,	,
PDH	NN	PDH
,	,	,
is	VVZ	be
encoded	VBN	encode
by	IN	by
two	CD	two
genes	NNS	gene
,	,	,
pdhAalpha	NN	pdhAalpha
(	(	(
1	CD	1
,	,	,
047	CD	047
bp	NN	bp
)	)	)
and	CC	and
pdhAbeta	NN	pdhAbeta
(	(	(
1	CD	1
,	,	,
383	CD	383
bp	NN	bp
)	)	)
,	,	,
a	DT	a
situation	NN	situation
encountered	VBN	encounter
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
alpha	SYM	alpha
-	HYPH	-
proteobacteria	NNS	proteobacteria
Rickettsia	NP	Rickettsia
prowazekii	NN	prowazekii
and	CC	and
Zymomonas	NP	Zymomonas
mobilis	NN	mobilis
as	RB	as
well	RB	well
as	IN	as
in	IN	in
some	DT	some
gram	NN	gram
-	HYPH	-
positive	JJ	positive
bacteria	NNS	bacteria
and	CC	and
in	IN	in
mitochondria	NNS	mitochondrion
.	SENT	.
pdhAalpha	NN	pdhAalpha
and	CC	and
pdhAbeta	NN	pdhAbeta
precede	VBP	precede
pdhB	NN	pdhB
(	(	(
1	CD	1
,	,	,
344	CD	344
bp	NN	bp
)	)	)
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
encodes	VBZ	encode
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
E2p	NN	E2p
component	NN	component
,	,	,
dihydrolipoamide	NN	dihydrolipoamide
acetyltransferase	NN	acetyltransferase
,	,	,
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
PDHc	NN	PDHc
.	SENT	.
.	SENT	.
No	DT	No
gene	NN	gene
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
encoding	VBG	encode
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
E3	NN	E3
component	NN	component
,	,	,
lipoamide	NN	lipoamide
dehydrogenase	NN	dehydrogenase
,	,	,
was	VVD	be
found	VBN	find
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
immediate	JJ	immediate
vicinity	NN	vicinity
of	IN	of
pdhA	NN	pdhA
and	CC	and
pdhB	NN	pdhB
genes	NNS	gene
.	SENT	.
pdhAalpha	NN	pdhAalpha
,	,	,
pdhAbeta	NN	pdhAbeta
and	CC	and
pdhB	NN	pdhB
likely	RB	likely
constitute	VBP	constitute
an	DT	an
operon	NN	operon
.	SENT	.
.	SENT	.
Here	RB	Here
,	,	,
we	PP	we
provide	VBP	provide
evidence	NN	evidence
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
pdhA	NN	pdhA
expression	NN	expression
is	VVZ	be
induced	VBN	induce
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
symbiotic	JJ	symbiotic
stage	NN	stage
,	,	,
compared	VBN	compare
with	IN	with
free	JJ	free
-	HYPH	-
living	NN	living
conditions	NNS	condition
.	SENT	.
.	SENT	.
We	PP	We
demonstrate	VBP	demonstrate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
symbiotic	JJ	symbiotic
expression	NN	expression
of	IN	of
pdhA	NN	pdhA
genes	NNS	gene
does	VBZ	do
not	RB	not
depend	VB	depend
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
fix	NN	fix
LJ	NN	LJ
regulatory	JJ	regulatory
cascade	NN	cascade
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
regulates	VBZ	regulate
nitrogen	NN	nitrogen
fixation	NN	fixation
and	CC	and
respiration	NN	respiration
gene	NN	gene
expression	NN	expression
in	IN	in
symbiotic	JJ	symbiotic
S	NN	S
.	SENT	.
meliloti	NN	meliloti
cells	NNS	cell
.	SENT	.
.	SENT	.
Induction	NN	Induction
of	IN	of
pdhA	NN	pdhA
expression	NN	expression
could	MD	could
be	VV	be
obtained	VBN	obtain
under	IN	under
free	JJ	free
-	HYPH	-
living	NN	living
conditions	NNS	condition
upon	IN	upon
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
addition	NN	addition
of	IN	of
pyruvate	NN	pyruvate
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
culture	NN	culture
medium	NN	medium
.	SENT	.
.	SENT	.
Induction	NN	Induction
by	IN	by
pyruvate	NN	pyruvate
and	CC	and
symbiotic	JJ	symbiotic
activation	NN	activation
of	IN	of
pdh	NN	pdh
gene	NN	gene
expression	NN	expression
take	VBP	take
place	NN	place
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=16 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
same	JJ	same
</FORBIDDEN ID=16 ACTION=delete>
promoter	NN	promoter
.	SENT	.
.	SENT	.
BB-cat+ner-11162736/text	DOCUMENT	BB-cat+ner-11162736/text
A	DT	A
<FORBIDDEN ID=38 ACTION=delete>
<FORBIDDEN ID=37 ACTION=delete>
new	JJ	new
</FORBIDDEN ID=37 ACTION=delete>
</FORBIDDEN ID=38 ACTION=delete>
purification	NN	purification
method	NN	method
for	IN	for
overproduced	VBN	overproduce
proteins	NNS	protein
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
sensitive	JJ	sensitive
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
endogenous	JJ	endogenous
proteases	NNS	protease
.	SENT	.
.	SENT	.
<FORBIDDEN ID=0 ACTION=split SPLIT_AFTER=0>
Proteolysisis	NN	Proteolysisis
a	DT	a
</FORBIDDEN ID=0 ACTION=split SPLIT_AFTER=0>
major	JJ	major
problem	NN	problem
in	IN	in
purification	NN	purification
of	IN	of
overproduced	VBN	overproduce
proteins	NNS	protein
for	IN	for
structural	JJ	structural
studies	NNS	study
.	SENT	.
.	SENT	.
We	PP	We
developed	VBD	develop
a	DT	a
<FORBIDDEN ID=38 ACTION=delete>
<FORBIDDEN ID=37 ACTION=delete>
new	JJ	new
</FORBIDDEN ID=37 ACTION=delete>
</FORBIDDEN ID=38 ACTION=delete>
method	NN	method
to	TO	to
avoid	VB	avoid
proteolysis	NN	proteolysis
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
products	NNS	product
<FORBIDDEN ID=157 ACTION=delete>
even	RB	even
</FORBIDDEN ID=157 ACTION=delete>
in	IN	in
cases	NNS	case
where	WRB	where
popular	JJ	popular
protease	NN	protease
inhibitors	NNS	inhibitor
do	VBP	do
not	RB	not
work	VB	work
effectively	RB	effectively
.	SENT	.
.	SENT	.
When	WRB	When
we	PP	we
cloned	VBD	clone
FlgF	NP	FlgF
,	,	,
a	DT	a
flagellar	JJ	flagellar
rod	NN	rod
protein	NN	protein
,	,	,
from	IN	from
Salmonella	NP	Salmonella
typhimurium	NP	typhimurium
and	CC	and
overproduced	VBD	overproduce
it	PP	it
in	IN	in
Escherichia	NP	Escherichia
coli	NP	coli
,	,	,
FlgF	NN	FlgF
was	VVD	be
highly	RB	highly
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
susceptible	JJ	susceptible
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
cleavage	NN	cleavage
by	IN	by
endogenous	JJ	endogenous
proteases	NNS	protease
after	IN	after
cell	NN	cell
disruption	NN	disruption
<FORBIDDEN ID=157 ACTION=delete>
even	RB	even
</FORBIDDEN ID=157 ACTION=delete>
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
<FORBIDDEN ID=54 ACTION=delete>
various	JJ	various
</FORBIDDEN ID=54 ACTION=delete>
protease	NN	protease
inhibitors	NNS	inhibitor
.	SENT	.
.	SENT	.
However	RB	However
,	,	,
FlgF	NN	FlgF
was	VVD	be
not	RB	not
digested	VBN	digest
when	WRB	when
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cells	NNS	cell
were	VVD	be
disrupted	VBN	disrupt
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
urea	NN	urea
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
allowed	VBD	allow
us	PP	us
to	TO	to
develop	VB	develop
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
following	VBG	follow
<FORBIDDEN ID=38 ACTION=delete>
<FORBIDDEN ID=37 ACTION=delete>
new	JJ	new
</FORBIDDEN ID=37 ACTION=delete>
</FORBIDDEN ID=38 ACTION=delete>
purification	NN	purification
procedure	NN	procedure
.	SENT	.
.	SENT	.
After	IN	After
cell	NN	cell
disruption	NN	disruption
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
urea	NN	urea
and	CC	and
removal	NN	removal
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cell	NN	cell
debris	NN	debris
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
supernatant	NN	supernatant
was	VVD	be
passed	VBN	pass
through	IN	through
tandem	NN	tandem
-	HYPH	-
connected	VBN	connect
cation	NN	cation
-	HYPH	-
and	CC	and
anion	NN	anion
-	HYPH	-
exchange	NN	exchange
columns	NNS	column
.	SENT	.
.	SENT	.
Proteases	NNS	Protease
were	VVD	be
trapped	VBN	trap
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cation	NN	cation
-	HYPH	-
exchange	NN	exchange
column	NN	column
,	,	,
and	CC	and
protease	NN	protease
-	HYPH	-
free	JJ	free
FlgF	NN	FlgF
was	VVD	be
eluted	VBN	elute
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
disconnected	VBN	disconnect
anion	NN	anion
-	HYPH	-
exchange	NN	exchange
column	NN	column
.	SENT	.
.	SENT	.
This	DT	This
gave	VBD	give
a	DT	a
stable	JJ	stable
full	JJ	full
-	HYPH	-
length	NN	length
product	NN	product
suitable	JJ	suitable
for	IN	for
crystallization	NN	crystallization
trials	NNS	trial
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
key	JJ	key
procedures	NNS	procedure
are	VVP	be
cell	NN	cell
disruption	NN	disruption
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
urea	NN	urea
and	CC	and
linked	VBN	link
ion-exchange	NN	ion-exchange
chromatography	NN	chromatography
to	TO	to
quickly	RB	quickly
remove	VB	remove
proteases	NNS	protease
as	RB	as
well	RB	well
as	IN	as
urea	NN	urea
.	SENT	.
.	SENT	.
This	DT	This
fast	JJ	fast
and	CC	and
simple	JJ	simple
method	NN	method
can	MD	can
be	VV	be
applied	VBN	apply
to	TO	to
purification	NN	purification
of	IN	of
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
overproduced	JJ	overproduced
proteins	NNS	protein
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
are	VVP	be
very	RB	very
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
sensitive	JJ	sensitive
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
proteolysis	NN	proteolysis
.	SENT	.
.	SENT	.
BB-cat+ner-11410343/text	DOCUMENT	BB-cat+ner-11410343/text
Effects	NNS	Effect
of	IN	of
2	CD	2
,	,	,
2'	CD	2'
,	,	,
5	CD	5
,	,	,
5'	JJ	5'
-	HYPH	-
tetrachlorobiphenyl	NN	tetrachlorobiphenyl
and	CC	and
biphenyl	NN	biphenyl
on	IN	on
cell	NN	cell
membranes	NNS	membrane
of	IN	of
Ralstonia	NP	Ralstonia
eutropha	NN	eutropha
H850	NN	H850
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
effects	NNS	effect
of	IN	of
2	CD	2
,	,	,
2'	CD	2'
,	,	,
5	CD	5
,	,	,
5'	JJ	5'
-	HYPH	-
tetrachlorobiphenyl	NN	tetrachlorobiphenyl
(	(	(
TeCB	NN	TeCB
)	)	)
,	,	,
a	DT	a
PCB	NN	PCB
congener	NN	congener
,	,	,
and	CC	and
biphenyl	NN	biphenyl
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cytoplasmic	JJ	cytoplasmic
membranes	NNS	membrane
of	IN	of
Ralstonia	NP	Ralstonia
eutropha	NN	eutropha
H850	NN	H850
were	VVD	be
investigated	VBN	investigate
by	IN	by
measuring	VBG	measure
fluorescence	NN	fluorescence
polarization	NN	polarization
using	VBG	use
1	CD	1
,	,	,
6-diphenyl	NN	6-diphenyl
-1	NN	-1
,	,	,
3	CD	3
,	,	,
5-hexatriene	NN	5-hexatriene
(	(	(
DPH	NN	DPH
)	)	)
as	IN	as
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
probe	NN	probe
,	,	,
and	CC	and
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
determining	VBG	determine
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cellular	JJ	cellular
fatty	JJ	fatty
acid	NN	acid
compositions	NNS	composition
.	SENT	.
.	SENT	.
<FORBIDDEN ID=165 ACTION=delete>
TeCB	NN	TeCB
significantly	RB	significantly
</FORBIDDEN ID=165 ACTION=delete>
affected	VBD	affect
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
membrane	NN	membrane
of	IN	of
R	NN	R
.	SENT	.
eutropha	NN	eutropha
H850	NN	H850
cells	NNS	cell
grown	VBN	grow
on	IN	on
fructose	NN	fructose
by	IN	by
decreasing	VBG	decrease
DPH	NN	DPH
fluorescence	NN	fluorescence
polarization	NN	polarization
.	SENT	.
.	SENT	.
In	IN	In
contrast	NN	contrast
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
membrane	NN	membrane
of	IN	of
cells	NNS	cell
grown	VBN	grow
on	IN	on
biphenyl	NN	biphenyl
showed	VBD	show
a	DT	a
considerably	RB	considerably
less	RBR	less
significant	JJ	significant
effect	NN	effect
of	IN	of
TeCB	NN	TeCB
on	IN	on
membrane	NN	membrane
polarization	NN	polarization
than	IN	than
in	IN	in
fructose	NN	fructose
-	HYPH	-
grown	VBN	grow
cells	NNS	cell
.	SENT	.
.	SENT	.
An	DT	An
increase	NN	increase
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
ratio	NN	ratio
of	IN	of
total	JJ	total
saturated	VBN	saturate
to	TO	to
unsaturated	JJ	unsaturated
fatty	JJ	fatty
acids	NNS	acid
in	IN	in
cells	NNS	cell
grown	VBN	grow
on	IN	on
biphenyl	NN	biphenyl
suggested	VBD	suggest
less	JJR	less
of	IN	of
a	DT	a
fluidizing	JJ	fluidizing
effect	NN	effect
of	IN	of
TeCB	NN	TeCB
on	IN	on
membranes	NNS	membrane
in	IN	in
those	DT	those
cells	NNS	cell
.	SENT	.
.	SENT	.
When	WRB	When
biphenyl	NN	biphenyl
-	HYPH	-
grown	VBN	grow
cells	NNS	cell
were	VVD	be
transferred	VBN	transfer
back	RB	back
to	TO	to
a	DT	a
fructose	NN	fructose
medium	NN	medium
,	,	,
they	PP	they
required	VBD	require
25	CD	25
generations	NNS	generation
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
membrane	NN	membrane
polarization	NN	polarization
and	CC	and
fatty	JJ	fatty
acid	NN	acid
compositions	NNS	composition
of	IN	of
these	DT	these
cells	NNS	cell
to	TO	to
revert	VB	revert
back	RB	back
to	TO	to
those	DT	those
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
initial	JJ	initial
fructose	NN	fructose
-	HYPH	-
grown	VBN	grow
cells	NNS	cell
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
re-adaptation	NN	re-adaptation
to	TO	to
a	DT	a
change	NN	change
in	IN	in
temperature	NN	temperature
required	VBD	require
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
five	CD	five
generations	NNS	generation
to	TO	to
return	VB	return
to	TO	to
normal	JJ	normal
.	SENT	.
.	SENT	.
These	DT	These
results	NNS	result
show	VBP	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
biphenyl	NN	biphenyl
affects	VBZ	affect
cells	NNS	cell
in	IN	in
<FORBIDDEN ID=82 ACTION=delete>
more	JJR	more
</FORBIDDEN ID=82 ACTION=delete>
ways	NNS	way
than	IN	than
simply	RB	simply
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
fluidizing	VBG	fluidize
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cytoplasmic	JJ	cytoplasmic
membrane	NN	membrane
.	SENT	.
.	SENT	.
BB-cat+ner-11437594/text	DOCUMENT	BB-cat+ner-11437594/text
Optimization	NN	Optimization
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
production	NN	production
of	IN	of
Chondrus	NP	Chondrus
crispus	NN	crispus
hexose	NN	hexose
oxidase	NN	oxidase
in	IN	in
Pichia	NP	Pichia
pastoris	NP	pastoris
.	SENT	.
.	SENT	.
Hexose	NN	Hexose
oxidase	NN	oxidase
(	(	(
D-hexose	NN	D-hexose
:	COLUMN	:
O(2)	NN	O(2)
-	HYPH	-
oxidoreductase	NN	oxidoreductase
,	,	,
EC	NP	EC
1.1	CD	1.1
.	SENT	.
3.5	CD	3.5
,	,	,
HOX	NN	HOX
)	)	)
normally	RB	normally
found	VBN	find
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
red	JJ	red
alga	NN	alga
Chondrus	NN	Chondrus
crispus	NN	crispus
was	VVD	be
produced	VBN	produce
heterologously	RB	heterologously
in	IN	in
different	JJ	different
host	NN	host
systems	NNS	system
.	SENT	.
.	SENT	.
Full	JJ	Full
-	HYPH	-
length	NN	length
HOX	NN	HOX
polypeptide	NN	polypeptide
was	VVD	be
produced	VBN	produce
in	IN	in
Escherichia	NP	Escherichia
coli	NP	coli
,	,	,
but	CC	but
no	DT	no
HOX	NN	HOX
activity	NN	activity
could	MD	could
be	VV	be
detected	VBN	detect
.	SENT	.
.	SENT	.
In	IN	In
contrast	NN	contrast
,	,	,
active	JJ	active
HOX	NN	HOX
could	MD	could
be	VV	be
produced	VBN	produce
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
methylotrophic	JJ	methylotrophic
yeast	NN	yeast
Pichia	NP	Pichia
pastoris	NP	pastoris
.	SENT	.
.	SENT	.
Several	JJ	Several
growth	NN	growth
physiological	JJ	physiological
and	CC	and
genetic	JJ	genetic
approaches	NNS	approach
for	IN	for
optimization	NN	optimization
of	IN	of
hexose	NN	hexose
oxidase	NN	oxidase
production	NN	production
in	IN	in
P	NN	P
.	SENT	.
pastoris	NN	pastoris
were	VVD	be
investigated	VBN	investigate
.	SENT	.
.	SENT	.
Our	PP$	Our
results	NNS	result
indicate	VBP	indicate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
specific	JJ	specific
growth	NN	growth
conditions	NNS	condition
are	VVP	be
essential	JJ	essential
<FORBIDDEN ID=27 ACTION=delete>
<FORBIDDEN ID=26 ACTION=delete>
in	IN	in
order	NN	order
to	TO	to
</FORBIDDEN ID=26 ACTION=delete>
</FORBIDDEN ID=27 ACTION=delete>
produce	VB	produce
active	JJ	active
HOX	NN	HOX
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
correct	JJ	correct
conformation	NN	conformation
.	SENT	.
.	SENT	.
Furthermore	RB	Furthermore
,	,	,
HOX	NN	HOX
seems	VBZ	seem
to	TO	to
be	VV	be
activated	VBN	activate
by	IN	by
proteolytic	JJ	proteolytic
cleavage	NN	cleavage
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
full	JJ	full
-	HYPH	-
length	NN	length
polypeptide	NN	polypeptide
chain	NN	chain
into	IN	into
two	CD	two
fragments	NNS	fragment
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
remain	VBP	remain
physically	RB	physically
associated	VBN	associate
.	SENT	.
.	SENT	.
Attempts	NNS	Attempt
to	TO	to
direct	VB	direct
HOX	NN	HOX
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
extracellular	JJ	extracellular
compartment	NN	compartment
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
using	VBG	use
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
widely	RB	widely
used	VBN	use
secretion	NN	secretion
signals	NNS	signal
from	IN	from
Saccharomyces	NP	Saccharomyces
cerevisiae	NP	cerevisiae
invertase	NN	invertase
or	CC	or
alpha	SYM	alpha
-	HYPH	-
mating	VBG	mat
factor	NN	factor
failed	VBD	fail
.	SENT	.
.	SENT	.
However	RB	However
,	,	,
we	PP	we
show	VBP	show
in	IN	in
this	DT	this
study	NN	study
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
HOX	NN	HOX
is	VVZ	be
transported	VBN	transport
out	IN	out
of	IN	of
P	NN	P
.	SENT	.
pastoris	NN	pastoris
via	IN	via
a	DT	a
hitherto	RB	hitherto
unknown	JJ	unknown
mechanism	NN	mechanism
and	CC	and
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
it	PP	it
is	VVZ	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
possible	JJ	possible
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
enhance	VB	enhance
this	DT	this
secretion	NN	secretion
by	IN	by
mutagenesis	NN	mutagenesis
from	IN	from
below	IN	below
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
detection	NN	detection
limit	NN	limit
to	TO	to
at	IN	at
<FORBIDDEN ID=18 ACTION=delete>
least	JJS	least
</FORBIDDEN ID=18 ACTION=delete>
250	CD	250
mg	NN	mg
extracellular	JJ	extracellular
enzyme	NN	enzyme
per	IN	per
liter	NN	liter
.	SENT	.
.	SENT	.
BB-cat+ner-11551069/text	DOCUMENT	BB-cat+ner-11551069/text
Cloning	NN	Cloning
and	CC	and
expression	NN	expression
analysis	NN	analysis
of	IN	of
Phytoplasma	NN	Phytoplasma
protein	NN	protein
translocation	NN	translocation
genes	NNS	gene
.	SENT	.
.	SENT	.
Genes	NNS	Gene
encoding	VBG	encode
SecA	NN	SecA
and	CC	and
SecY	NN	SecY
proteins	NNS	protein
,	,	,
essential	JJ	essential
components	NNS	component
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Sec	NP	Sec
protein	NN	protein
translocation	NN	translocation
system	NN	system
,	,	,
were	VVD	be
cloned	VBN	clone
from	IN	from
onion	NN	onion
yellows	VBZ	yellow
phytoplasma	NN	phytoplasma
,	,	,
an	DT	an
unculturable	JJ	unculturable
plant	NN	plant
pathogenic	JJ	pathogenic
bacterium	NN	bacterium
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
secA	NN	secA
gene	NN	gene
consists	VBZ	consist
of	IN	of
2	CD	2
,	,	,
505	CD	505
nucleotides	NNS	nucleotide
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
encoding	VBG	encode
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
an	DT	an
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
835	CD	835
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
amino	NN	amino
acid	NN	acid
protein	NN	protein
(	(	(
95.7	CD	95.7
kDa	NN	kDa
)	)	)
and	CC	and
shows	VBZ	show
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
highest	JJS	high
similarity	NN	similarity
with	IN	with
SecA	NN	SecA
of	IN	of
Bacillus	NN	Bacillus
subtilis	NN	subtilis
.	SENT	.
.	SENT	.
Anti	AFX	Anti
-	HYPH	-
SecA	NN	SecA
rabbit	NN	rabbit
antibody	NN	antibody
was	VVD	be
prepared	VBN	prepare
from	IN	from
a	DT	a
purified	VBN	purify
partial	JJ	partial
SecA	NN	SecA
protein	NN	protein
,	,	,
with	IN	with
a	DT	a
histidine	NN	histidine
tag	NN	tag
expressed	VBN	express
in	IN	in
Escherichia	NP	Escherichia
coli	NP	coli
.	SENT	.
.	SENT	.
Western	NN	Western
blot	NN	blot
analysis	NN	analysis
confirmed	VBD	confirm
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
SecA	NN	SecA
protein	NN	protein
(	(	(
approximately	RB	approximately
96	CD	96
kDa	NN	kDa
)	)	)
is	VVZ	be
produced	VBN	produce
in	IN	in
phytoplasma	NN	phytoplasma
-	HYPH	-
infected	VBN	infect
plants	NNS	plant
.	SENT	.
.	SENT	.
Immunohistochemical	JJ	Immunohistochemical
thin	JJ	thin
sections	NNS	section
observed	VBN	observe
by	IN	by
optical	JJ	optical
microscopy	NN	microscopy
showed	VBD	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
SecA	NN	SecA
is	VVZ	be
characteristically	RB	characteristically
present	JJ	present
in	IN	in
plant	NN	plant
phloem	NN	phloem
tissues	NNS	tissue
infected	VBN	infect
with	IN	with
phytoplasma	NN	phytoplasma
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
secY	NN	secY
gene	NN	gene
consists	VBZ	consist
of	IN	of
1	CD	1
,	,	,
239	CD	239
nucleotides	NNS	nucleotide
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
encoding	VBG	encode
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
413	CD	413
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
amino	NN	amino
acid	NN	acid
protein	NN	protein
(	(	(
45.9	CD	45.9
kDa	NN	kDa
)	)	)
and	CC	and
shows	VBZ	show
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
highest	JJS	high
similarity	NN	similarity
with	IN	with
SecY	NN	SecY
of	IN	of
B	NN	B
.	SENT	.
subtilis	NN	subtilis
.	SENT	.
.	SENT	.
These	DT	These
results	NNS	result
suggest	VBP	suggest
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
a	DT	a
functional	JJ	functional
Sec	NP	Sec
system	NN	system
in	IN	in
phytoplasmas	NNS	phytoplasma
.	SENT	.
.	SENT	.
Because	IN	Because
phytoplasmas	NNS	phytoplasma
are	VVP	be
endocellular	JJ	endocellular
bacteria	NNS	bacteria
lacking	VBG	lack
cell	NN	cell
walls	NNS	wall
,	,	,
this	DT	this
system	NN	system
might	MD	might
secrete	VB	secrete
bacterial	JJ	bacterial
proteins	NNS	protein
directly	RB	directly
into	IN	into
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
host	NN	host
cytoplasm	NN	cytoplasm
.	SENT	.
.	SENT	.
This	DT	This
study	NN	study
is	VVZ	be
what	WP	what
we	PP	we
believe	VBP	believe
to	TO	to
be	VV	be
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
first	JJ	first
report	NN	report
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
sequence	NN	sequence
and	CC	and
expression	NN	expression
analysis	NN	analysis
of	IN	of
phytoplasma	NN	phytoplasma
genes	NNS	gene
encoding	VBG	encode
membrane	NN	membrane
proteins	NNS	protein
with	IN	with
a	DT	a
predicted	VBN	predict
function	NN	function
.	SENT	.
.	SENT	.
BB-cat+ner-11989773/text	DOCUMENT	BB-cat+ner-11989773/text
Evaluation	NN	Evaluation
of	IN	of
two	CD	two
commercial	JJ	commercial
methods	NNS	method
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
detection	NN	detection
of	IN	of
Listeria	NP	Listeria
sp	NN	sp
.	SENT	.
and	CC	and
Listeria	NP	Listeria
monocytogenes	NNS	monocytogene
in	IN	in
a	DT	a
chicken	NN	chicken
nugget	NN	nugget
processing	NN	processing
plant	NN	plant
.	SENT	.
.	SENT	.
This	DT	This
study	NN	study
measures	VBZ	measure
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
detection	NN	detection
performances	NNS	performance
of	IN	of
two	CD	two
rapid	JJ	rapid
test	NN	test
systems	NNS	system
(	(	(
Listeria	NP	Listeria
Rapid	NP	Rapid
Test	NP	Test
Clearview	NN	Clearview
and	CC	and
Bax	NN	Bax
system	NN	system
)	)	)
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
screening	NN	screening
of	IN	of
Listeria	NP	Listeria
sp	NN	sp
.	SENT	.
and	CC	and
Listeria	NP	Listeria
monocytogenes	NNS	monocytogene
,	,	,
respectively	RB	respectively
.	SENT	.
.	SENT	.
A	DT	A
total	NN	total
of	IN	of
413	CD	413
samples	NNS	sample
from	IN	from
different	JJ	different
sources	NNS	source
(	(	(
product	NN	product
from	IN	from
(	(	(
i	LS	i
)	)	)
different	JJ	different
stages	NNS	stage
of	IN	of
processing	NN	processing
,	,	,
(	(	(
ii	LS	ii
)	)	)
different	JJ	different
environments	NNS	environment
,	,	,
and	CC	and
(	(	(
iii	LS	iii
)	)	)
different	JJ	different
food	NN	food
handlers	NNS	handler
)	)	)
,	,	,
collected	VBN	collect
from	IN	from
a	DT	a
chicken	NN	chicken
nugget	NN	nugget
processing	NN	processing
plant	NN	plant
,	,	,
were	VVD	be
analysed	VBN	analyse
by	IN	by
<FORBIDDEN ID=30 ACTION=delete>
both	DT	both
</FORBIDDEN ID=30 ACTION=delete>
rapid	JJ	rapid
methods	NNS	method
and	CC	and
a	DT	a
cultural	JJ	cultural
method	NN	method
consisting	VBG	consist
of	IN	of
pre-enrichment	NN	pre-enrichment
,	,	,
enrichment	NN	enrichment
,	,	,
and	CC	and
isolation	NN	isolation
onto	IN	onto
selective	JJ	selective
agars	NNS	agar
(	(	(
PALCAM	NN	PALCAM
,	,	,
LPM	NN	LPM
,	,	,
and	CC	and
HCLA	NN	HCLA
)	)	)
.	SENT	.
.	SENT	.
Overall	RB	Overall
,	,	,
results	NNS	result
showed	VBD	show
an	DT	an
excellent	JJ	excellent
correlation	NN	correlation
between	IN	between
data	NNS	datum
obtained	VBN	obtain
using	VBG	use
Clearview	NN	Clearview
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cultural	JJ	cultural
method	NN	method
,	,	,
with	IN	with
Clearview	NN	Clearview
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
presenting	VBG	present
an	DT	an
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
efficiency	NN	efficiency
of	IN	of
99%	CD	99%
.	SENT	.
.	SENT	.
Bax	NN	Bax
showed	VBD	show
a	DT	a
lower	JJR	low
correlation	NN	correlation
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
using	VBG	use
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cultural	JJ	cultural
method	NN	method
,	,	,
with	IN	with
an	DT	an
efficiency	NN	efficiency
of	IN	of
71.1	CD	71.1
%	NN	%
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
type	NN	type
of	IN	of
sample	NN	sample
did	VBD	do
not	RB	not
affect	VB	affect
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
efficiency	NN	efficiency
of	IN	of
Clearview	NP	Clearview
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
varied	VBD	vary
from	IN	from
98.1	CD	98.1
%	NN	%
for	IN	for
product	NN	product
samples	NNS	sample
to	TO	to
100%	CD	100%
for	IN	for
environmental	JJ	environmental
and	CC	and
food	NN	food
handler	NN	handler
samples	NNS	sample
,	,	,
while	IN	while
for	IN	for
Bax	NN	Bax
it	PP	it
had	VHD	have
a	DT	a
marked	JJ	marked
influence	NN	influence
.	SENT	.
.	SENT	.
Efficiency	NN	Efficiency
of	IN	of
Bax	NN	Bax
varied	VBD	vary
from	IN	from
as	RB	as
high	JJ	high
as	IN	as
100%	CD	100%
for	IN	for
food	NN	food
handlers	NNS	handler
to	TO	to
37.9	CD	37.9
%	NN	%
for	IN	for
product	NN	product
samples	NNS	sample
.	SENT	.
.	SENT	.
BB-cat+ner-12109661/text	DOCUMENT	BB-cat+ner-12109661/text
Long	JJ	Long
-	HYPH	-
term	NN	term
Helicobacter	NN	Helicobacter
pylori	NN	pylori
infection	NN	infection
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
development	NN	development
of	IN	of
atrophic	JJ	atrophic
gastritis	NN	gastritis
and	CC	and
gastric	JJ	gastric
cancer	NN	cancer
in	IN	in
Japan	NP	Japan
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
incidence	NN	incidence
of	IN	of
gastric	JJ	gastric
cancer	NN	cancer
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
prevalence	NN	prevalence
of	IN	of
Helicobacter	NN	Helicobacter
pylori	NNS	pylorus
are	VVP	be
high	JJ	high
in	IN	in
Japan	NP	Japan
,	,	,
so	IN	so
it	PP	it
is	VVZ	be
an	DT	an
important	JJ	important
issue	NN	issue
whether	IN	whether
long	JJ	long
-	HYPH	-
term	NN	term
H	NN	H
.	VBD	.
pylori	NN	pylori
infection	NN	infection
leads	VBZ	lead
to	TO	to
chronic	JJ	chronic
atrophic	JJ	atrophic
gastritis	NN	gastritis
,	,	,
considered	VBD	consider
<FORBIDDEN ID=55 ACTION=delete>
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
one	CD	one
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=55 ACTION=delete>
the	DT	the
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
precursors	NNS	precursor
of	IN	of
gastric	JJ	gastric
cancer	NN	cancer
.	SENT	.
.	SENT	.
We	PP	We
have	VHP	have
reported	VBN	report
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
grade	NN	grade
of	IN	of
atrophy	NN	atrophy
was	VVD	be
higher	JJR	high
in	IN	in
H	NN	H
.	SYM	.
pylori	NN	pylori
-	HYPH	-
positive	JJ	positive
subjects	NNS	subject
than	IN	than
in	IN	in
H	NN	H
.	SYM	.
pylori	NN	pylori
-	HYPH	-
negative	JJ	negative
subjects	NNS	subject
.	SENT	.
.	SENT	.
It	PP	It
has	VHZ	have
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
been	VVN	be
reported	VBN	report
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
atrophy	NN	atrophy
of	IN	of
gastric	JJ	gastric
mucosa	NN	mucosa
increased	VBD	increase
in	IN	in
H	NN	H
.	NN	.
pylori	NNS	pylorus
-	HYPH	-
infected	VBN	infect
monkeys	NNS	monkey
compared	VBN	compare
with	IN	with
control	NN	control
monkeys	NNS	monkey
in	IN	in
a	DT	a
5-year	JJ	5-year
follow-up	JJ	follow-up
study	NN	study
.	SENT	.
.	SENT	.
Most	JJS	Most
H	NN	H
.	VBD	.
pylori	NN	pylori
infections	NNS	infection
occur	VBP	occur
in	IN	in
children	NNS	child
,	,	,
and	CC	and
atrophy	NN	atrophy
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
gastric	JJ	gastric
mucosa	NN	mucosa
progresses	NNS	progress
during	IN	during
aging	NN	aging
.	SENT	.
.	SENT	.
Long	JJ	Long
-	HYPH	-
term	NN	term
data	NNS	datum
show	VBP	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
H	NN	H
.	SYM	.
pylori	NN	pylori
infection	NN	infection
can	MD	can
lead	VB	lead
to	TO	to
gastric	JJ	gastric
atrophy	NN	atrophy
and	CC	and
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
play	VB	play
an	DT	an
important	JJ	important
role	NN	role
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
development	NN	development
of	IN	of
gastric	JJ	gastric
cancer	NN	cancer
.	SENT	.
.	SENT	.
Interestingly	RB	Interestingly
,	,	,
there	EX	there
was	VVD	be
no	DT	no
difference	NN	difference
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
prevalence	NN	prevalence
of	IN	of
H	NN	H
.	SYM	.
pylori	NN	pylori
between	IN	between
patients	NNS	patient
with	IN	with
chronic	JJ	chronic
gastritis	NN	gastritis
and	CC	and
gastric	JJ	gastric
cancer	NN	cancer
in	IN	in
Japan	NP	Japan
,	,	,
but	CC	but
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
prevalence	NN	prevalence
of	IN	of
H	NN	H
.	NN	.
pylori	NN	pylori
in	IN	in
young	JJ	young
Japanese	JJ	Japanese
gastric	JJ	gastric
cancer	NN	cancer
patients	NNS	patient
was	VVD	be
significantly	RB	significantly
higher	JJR	high
than	IN	than
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
control	NN	control
group	NN	group
.	SENT	.
.	SENT	.
These	DT	These
data	NNS	datum
clearly	RB	clearly
show	VBP	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
H	NN	H
.	SYM	.
pylori	NN	pylori
infection	NN	infection
is	VVZ	be
<FORBIDDEN ID=55 ACTION=delete>
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
one	CD	one
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=55 ACTION=delete>
the	DT	the
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
risk	NN	risk
factors	NNS	factor
of	IN	of
gastric	JJ	gastric
cancer	NN	cancer
in	IN	in
young	JJ	young
Japanese	JJ	Japanese
people	NNS	people
,	,	,
There	EX	There
is	VVZ	be
no	DT	no
answer	NN	answer
to	TO	to
whether	IN	whether
curing	VBG	cure
H	NN	H
.	NN	.
pylori	NN	pylori
infection	NN	infection
can	MD	can
reverse	VB	reverse
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
atrophy	NN	atrophy
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
gastric	JJ	gastric
mucosa	NN	mucosa
and	CC	and
decrease	VB	decrease
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
risk	NN	risk
of	IN	of
gastric	JJ	gastric
cancer	NN	cancer
development	NN	development
.	SENT	.
.	SENT	.
To	TO	To
clarify	VB	clarify
this	DT	this
issue	NN	issue
,	,	,
an	DT	an
intervention	NN	intervention
study	NN	study
must	MD	must
be	VV	be
done	VBN	do
.	SENT	.
.	SENT	.
A	DT	A
large	JJ	large
clinical	JJ	clinical
trial	NN	trial
called	VBD	call
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Japanese	JJ	Japanese
Intervention	NN	Intervention
Trial	NN	Trial
of	IN	of
H	NN	H
.	NN	.
pylori	NN	pylori
is	VVZ	be
in	IN	in
progress	NN	progress
.	SENT	.
.	SENT	.
BB-cat+ner-1214327/text	DOCUMENT	BB-cat+ner-1214327/text
Serotypes	NNS	Serotype
of	IN	of
Vibrio	NP	Vibrio
parahaemolyticus	NN	parahaemolyticus
from	IN	from
clinical	JJ	clinical
and	CC	and
environmental	JJ	environmental
sources	NNS	source
in	IN	in
Togo	NP	Togo
(	(	(
West	NP	West
Africa	NP	Africa
)	)	)
.	SENT	.
.	SENT	.
Serological	JJ	Serological
analysis	NN	analysis
of	IN	of
O	NN	O
and	CC	and
K	NN	K
antigens	NNS	antigen
was	VVD	be
performed	VBN	perform
on	IN	on
343	CD	343
strains	NNS	strain
of	IN	of
Vibro	NN	Vibro
parahaemolyticus	NN	parahaemolyticus
isolated	VBN	isolate
from	IN	from
clinical	JJ	clinical
and	CC	and
environmental	JJ	environmental
sources	NNS	source
in	IN	in
Togo	NP	Togo
.	SENT	.
.	SENT	.
<FORBIDDEN ID=156 ACTION=delete>
Only	RB	Only
</FORBIDDEN ID=156 ACTION=delete>
two	CD	two
strains	NNS	strain
were	VVD	be
not	RB	not
typable	JJ	typable
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
available	JJ	available
O	NN	O
antisera	NNS	antiserum
.	SENT	.
.	SENT	.
K	NN	K
untypable	JJ	untypable
strains	NNS	strain
were	VVD	be
found	VBN	find
in	IN	in
4.8	CD	4.8
%	NN	%
of	IN	of
isolates	NNS	isolate
from	IN	from
gastroenteritis	NN	gastroenteritis
patients	NNS	patient
,	,	,
in	IN	in
11%	NN	11%
from	IN	from
healthy	JJ	healthy
carriers	NNS	carrier
,	,	,
and	CC	and
in	IN	in
47%	CD	47%
and	CC	and
46%	CD	46%
of	IN	of
isolates	NNS	isolate
,	,	,
respectively	RB	respectively
,	,	,
from	IN	from
water	NN	water
and	CC	and
fish	NN	fish
samples	NNS	sample
.	SENT	.
.	SENT	.
Thirteen	CD	Thirteen
serotypes	NNS	serotype
identified	VBN	identify
in	IN	in
Togo	NP	Togo
are	VVP	be
not	RB	not
considered	VBN	consider
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Japanese	JJ	Japanese
antigenic	JJ	antigenic
scheme	NN	scheme
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
suitability	NN	suitability
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Japanese	JJ	Japanese
typing	NN	typing
scheme	NN	scheme
for	IN	for
geographic	JJ	geographic
areas	NNS	area
outside	JJ	outside
of	IN	of
Japan	NP	Japan
is	VVZ	be
discussed	VBN	discuss
and	CC	and
its	PP$	its
extension	NN	extension
is	VVZ	be
suggested	VBN	suggest
.	SENT	.
.	SENT	.
BB-cat+ner-12417169/text	DOCUMENT	BB-cat+ner-12417169/text
Emergence	NN	Emergence
of	IN	of
resistance	NN	resistance
of	IN	of
vancomycin	NN	vancomycin
-	HYPH	-
resistant	JJ	resistant
Enterococcus	NN	Enterococcus
faecium	NN	faecium
in	IN	in
a	DT	a
thermal	JJ	thermal
injury	NN	injury
patient	NN	patient
treated	VBN	treat
with	IN	with
quinupristin	NN	quinupristin
-	HYPH	-
dalfopristin	NN	dalfopristin
and	CC	and
cultured	VBN	culture
epithelial	JJ	epithelial
autografts	NNS	autograft
for	IN	for
wound	NN	wound
closure	NN	closure
.	SENT	.
.	SENT	.
Vancomycin	NN	Vancomycin
-	HYPH	-
resistant	JJ	resistant
Enterococcus	NN	Enterococcus
faecium	NN	faecium
and	CC	and
faecalis	NN	faecalis
(	(	(
VRE	NN	VRE
)	)	)
remains	VBZ	remain
a	DT	a
major	JJ	major
complication	NN	complication
among	IN	among
critically	RB	critically
ill	JJ	ill
patients	NNS	patient
.	SENT	.
.	SENT	.
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
A	DT	A
26	CD	26
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
-	HYPH	-
year-old	JJ	year-old
patient	NN	patient
with	IN	with
65%	CD	65%
total	JJ	total
body	NN	body
surface	NN	surface
area	NN	area
burns	NNS	burn
(	(	(
TBSA	NN	TBSA
)	)	)
was	VVD	be
infected	VBN	infect
with	IN	with
several	JJ	several
E	NN	E
.	SENT	.
faecium	NN	faecium
strains	NNS	strain
during	IN	during
his	PP$	his
admission	NN	admission
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
were	VVD	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
resistant	JJ	resistant
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
vancomycin	NN	vancomycin
.	SENT	.
.	SENT	.
Because	IN	Because
chloramphenicol	NN	chloramphenicol
was	VVD	be
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
standard	JJ	standard
treatment	NN	treatment
at	IN	at
this	DT	this
time	NN	time
,	,	,
this	DT	this
drug	NN	drug
was	VVD	be
initiated	VBN	initiate
until	IN	until
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
organism	NN	organism
was	VVD	be
identified	VBN	identify
as	IN	as
E	NN	E
.	SENT	.
faecium	NN	faecium
and	CC	and
reported	VBD	report
as	RB	as
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
susceptible	JJ	susceptible
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
quinupristin	NN	quinupristin
-	HYPH	-
dalfopristin	NN	dalfopristin
.	SENT	.
.	SENT	.
Given	VBN	Give
these	DT	these
data	NNS	datum
,	,	,
it	PP	it
was	VVD	be
then	RB	then
decided	VBN	decide
to	TO	to
discontinue	VB	discontinue
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
chloramphenicol	NN	chloramphenicol
therapy	NN	therapy
.	SENT	.
.	SENT	.
Quinupristin	NN	Quinupristin
-	HYPH	-
dalfopristin	NN	dalfopristin
therapy	NN	therapy
resulted	VBD	result
in	IN	in
initial	JJ	initial
reduction	NN	reduction
of	IN	of
fever	NN	fever
and	CC	and
white	JJ	white
blood	NN	blood
cell	NN	cell
counts	NNS	count
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
continued	VBD	continue
over	IN	over
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=80 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
next	JJ	next
</FORBIDDEN ID=80 ACTION=delete>
5	CD	5
days	NNS	day
.	SENT	.
.	SENT	.
However	RB	However
,	,	,
on	IN	on
day	NN	day
7	CD	7
of	IN	of
quinupristin	NN	quinupristin
-	HYPH	-
dalfopristin	NN	dalfopristin
therapy	NN	therapy
,	,	,
a	DT	a
return	NN	return
of	IN	of
fever	NN	fever
and	CC	and
elevation	NN	elevation
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
white	JJ	white
blood	NN	blood
cell	NN	cell
count	NN	count
was	VVD	be
noted	VBN	note
and	CC	and
a	DT	a
repeated	VBN	repeat
E	NN	E
.	SENT	.
faecium	NN	faecium
blood	NN	blood
culture	NN	culture
demonstrated	VBD	demonstrate
sudden	JJ	sudden
resistance	NN	resistance
to	TO	to
quinupristin	NN	quinupristin
-	HYPH	-
dalfopristin	NN	dalfopristin
(	(	(
Bauer	NN	Bauer
-	HYPH	-
Kirby	NN	Kirby
zone	NN	zone
size	NN	size
INF14	CD	INF14
mm	NN	mm
)	)	)
.	SENT	.
.	SENT	.
Chloramphenicol	NN	Chloramphenicol
was	VVD	be
restarted	VBN	restart
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
patient	NN	patient
improved	VBD	improve
slowly	RB	slowly
over	IN	over
a	DT	a
period	NN	period
of	IN	of
16	CD	16
days	NNS	day
.	SENT	.
.	SENT	.
Our	PP$	Our
indigenous	JJ	indigenous
VRE	NN	VRE
had	VHD	have
limited	VBN	limit
exposure	NN	exposure
to	TO	to
quinupristin	NN	quinupristin
-	HYPH	-
dalfopristin	NN	dalfopristin
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
recent	JJ	recent
past	NN	past
;	COLUMN	;
however	RB	however
,	,	,
resistance	NN	resistance
emerged	VBD	emerge
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
first	JJ	first
commercial	JJ	commercial
use	NN	use
of	IN	of
this	DT	this
agent	NN	agent
in	IN	in
our	PP$	our
burn	NN	burn
treatment	NN	treatment
center	NN	center
.	SENT	.
.	SENT	.
High	JJ	High
-	HYPH	-
dose	NN	dose
chloramphenicol	NN	chloramphenicol
treatment	NN	treatment
did	VBD	do
not	RB	not
appear	VB	appear
to	TO	to
impair	VB	impair
engraftment	NN	engraftment
of	IN	of
cultured	VBN	culture
epithelial	JJ	epithelial
autografts	NNS	autograft
(	(	(
CEA	NN	CEA
)	)	)
in	IN	in
this	DT	this
patient	NN	patient
.	SENT	.
.	SENT	.
BB-cat+ner-12438382/text	DOCUMENT	BB-cat+ner-12438382/text
Pathological	JJ	Pathological
and	CC	and
therapeutic	JJ	therapeutic
significance	NN	significance
of	IN	of
cellular	JJ	cellular
invasion	NN	invasion
by	IN	by
Proteus	NP	Proteus
mirabilis	NN	mirabilis
in	IN	in
an	DT	an
enterocystoplasty	JJ	enterocystoplasty
infection	NN	infection
stone	NN	stone
model	NN	model
.	SENT	.
.	SENT	.
Proteus	NP	Proteus
mirabilis	NN	mirabilis
infection	NN	infection
often	RB	often
leads	VBZ	lead
to	TO	to
stone	NN	stone
formation	NN	formation
.	SENT	.
.	SENT	.
We	PP	We
evaluated	VBD	evaluate
how	WRB	how
bacterium	NN	bacterium
-	HYPH	-
mucin	NN	mucin
adhesion	NN	adhesion
,	,	,
invasion	NN	invasion
,	,	,
and	CC	and
intracellular	JJ	intracellular
crystal	NN	crystal
formation	NN	formation
are	VVP	be
related	VBN	relate
to	TO	to
antibiotic	JJ	antibiotic
sensitivity	NN	sensitivity
and	CC	and
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
cause	VB	cause
frequent	JJ	frequent
stone	NN	stone
formation	NN	formation
in	IN	in
enterocystoplasties	NNS	enterocystoplasty
.	SENT	.
.	SENT	.
Five	CD	Five
intestinal	JJ	intestinal
(	(	(
Caco	NP	Caco
-2	CD	-2
,	,	,
HT29	NN	HT29
,	,	,
HT	NN	HT
29-18	CD	29-18
N2	NN	N2
,	,	,
HT29	NN	HT29
-	HYPH	-
FU	NN	FU
,	,	,
and	CC	and
HT29	NN	HT29
-	HYPH	-
MTX	NN	MTX
)	)	)
and	CC	and
one	CD	one
ureter	NN	ureter
cell	NN	cell
line	NN	line
(	(	(
SV	NN	SV
-	HYPH	-
HUC	NN	HUC
-1	NN	-1
)	)	)
were	VVD	be
incubated	VBN	incubate
in	IN	in
artificial	JJ	artificial
urine	NN	urine
with	IN	with
five	CD	five
Proteus	NP	Proteus
mirabilis	NN	mirabilis
strains	NNS	strain
.	SENT	.
.	SENT	.
Fluorescence	NN	Fluorescence
-	HYPH	-
activated	VBN	activate
cell	NN	cell
sorting	NN	sorting
(	(	(
FACS	NN	FACS
)	)	)
,	,	,
laser	NN	laser
scanning	NN	scanning
microscopy	NN	microscopy
,	,	,
and	CC	and
electron	NN	electron
microscopy	NN	microscopy
evaluated	VBD	evaluate
cellular	JJ	cellular
adhesion	NN	adhesion
and	CC	and
/	SYM	/
or	CC	or
invasion	NN	invasion
,	,	,
pathologic	JJ	pathologic
changes	NNS	change
to	TO	to
mitochondria	NNS	mitochondrion
,	,	,
and	CC	and
P	NN	P
.	SENT	.
mirabilis	AFX	mirabilis
-	HYPH	-
mucin	NN	mucin
colocalization	NN	colocalization
(	(	(
MUC2	NN	MUC2
and	CC	and
MUC5AC	NN	MUC5AC
)	)	)
.	SENT	.
.	SENT	.
An	DT	An
MTT	NN	MTT
(	(	(
thiazolyl	NN	thiazolyl
blue	JJ	blue
tetrazolium	NN	tetrazolium
bromide	NN	bromide
)	)	)
assay	NN	assay
and	CC	and
FACS	NN	FACS
analysis	NN	analysis
of	IN	of
caspase	NN	caspase
-3	CD	-3
evaluated	VBD	evaluate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cellular	JJ	cellular
response	NN	response
.	SENT	.
.	SENT	.
Infected	JJ	Infected
cells	NNS	cell
were	VVD	be
incubated	VBN	incubate
with	IN	with
antibiotics	NNS	antibiotic
at	IN	at
dosages	NNS	dosage
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
representing	VBG	represent
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
expected	VBN	expect
urinary	JJ	urinary
concentrations	NNS	concentration
in	IN	in
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
a	DT	a
10	CD	10
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
-	HYPH	-
year-old	JJ	year-old
,	,	,
30-kg	JJ	30-kg
child	NN	child
to	TO	to
evaluate	VB	evaluate
bacterial	JJ	bacterial
invasion	NN	invasion
and	CC	and
survival	NN	survival
.	SENT	.
.	SENT	.
All	DT	All
cell	NN	cell
lines	NNS	line
showed	VBD	show
colocalization	NN	colocalization
of	IN	of
P	NN	P
.	SENT	.
mirabilis	NN	mirabilis
with	IN	with
human	JJ	human
colonic	JJ	colonic
mucin	NN	mucin
(	(	(
<FORBIDDEN ID=71 ACTION=delete>
i.e.	FW	i.e.
</FORBIDDEN ID=71 ACTION=delete>
,	,	,
MUC2	NN	MUC2
)	)	)
and	CC	and
human	JJ	human
gastric	JJ	gastric
mucin	NN	mucin
(	(	(
<FORBIDDEN ID=71 ACTION=delete>
i.e.	FW	i.e.
</FORBIDDEN ID=71 ACTION=delete>
,	,	,
MUC5AC	NN	MUC5AC
)	)	)
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
correlation	NN	correlation
between	IN	between
membrane	NN	membrane
mucin	NN	mucin
expression	NN	expression
and	CC	and
invasion	NN	invasion
was	VVD	be
significant	JJ	significant
and	CC	and
opposite	JJ	opposite
for	IN	for
SV	NN	SV
-	HYPH	-
HUC	NN	HUC
-1	NN	-1
and	CC	and
HT29	NN	HT29
-	HYPH	-
MTX	NN	MTX
.	SENT	.
.	SENT	.
Microscopically	RB	Microscopically
,	,	,
invasion	NN	invasion
by	IN	by
P	NN	P
.	SENT	.
mirabilis	NN	mirabilis
with	IN	with
intracellular	JJ	intracellular
crystal	NN	crystal
formation	NN	formation
and	CC	and
mitochondrial	JJ	mitochondrial
damage	NN	damage
was	VVD	be
found	VBN	find
.	SENT	.
.	SENT	.
Double	JJ	Double
membranes	NNS	membrane
surrounded	VBD	surround
bacteria	NNS	bacteria
in	IN	in
intestinal	JJ	intestinal
cells	NNS	cell
.	SENT	.
.	SENT	.
Relative	JJ	Relative
resistance	NN	resistance
to	TO	to
cotrimoxazole	NN	cotrimoxazole
and	CC	and
augmentin	NN	augmentin
was	VVD	be
found	VBN	find
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
epithelial	JJ	epithelial
cells	NNS	cell
.	SENT	.
.	SENT	.
Ciprofloxacin	NN	Ciprofloxacin
and	CC	and
gentamicin	NN	gentamicin
remained	VBD	remain
effective	JJ	effective
.	SENT	.
.	SENT	.
Membrane	NN	Membrane
mucin	NN	mucin
expression	NN	expression
was	VVD	be
correlated	VBN	correlate
with	IN	with
relative	JJ	relative
antibiotic	JJ	antibiotic
resistance	NN	resistance
.	SENT	.
.	SENT	.
Cell	NN	Cell
invasion	NN	invasion
by	IN	by
P	NN	P
.	SENT	.
mirabilis	NN	mirabilis
and	CC	and
mucin	NN	mucin
-	HYPH	-
and	CC	and
cell	NN	cell
type	NN	type
-	HYPH	-
related	VBN	relate
distribution	NN	distribution
and	CC	and
response	NN	response
differences	NNS	difference
indicate	VBP	indicate
bacterial	JJ	bacterial
tropism	NN	tropism
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
affects	VBZ	affect
crystal	NN	crystal
formation	NN	formation
and	CC	and
mucosal	JJ	mucosal
presence	NN	presence
.	SENT	.
.	SENT	.
Bacterial	JJ	Bacterial
invasion	NN	invasion
seems	VBZ	seem
to	TO	to
have	VH	have
cell	NN	cell
type	NN	type
-	HYPH	-
dependent	JJ	dependent
mechanisms	NNS	mechanism
and	CC	and
prolong	VB	prolong
bacterial	JJ	bacterial
survival	NN	survival
in	IN	in
antibiotic	JJ	antibiotic
therapy	NN	therapy
,	,	,
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
giving	VBG	give
a	DT	a
<FORBIDDEN ID=38 ACTION=delete>
<FORBIDDEN ID=37 ACTION=delete>
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
new	JJ	new
</FORBIDDEN ID=37 ACTION=delete>
</FORBIDDEN ID=38 ACTION=delete>
target	NN	target
for	IN	for
therapeutic	JJ	therapeutic
optimalization	NN	optimalization
of	IN	of
antibiotic	JJ	antibiotic
treatment	NN	treatment
.	SENT	.
.	SENT	.
BB-cat+ner-12728302/text	DOCUMENT	BB-cat+ner-12728302/text
Heat	NN	Heat
-	HYPH	-
shock	NN	shock
response	NN	response
and	CC	and
its	PP$	its
contribution	NN	contribution
to	TO	to
thermotolerance	NN	thermotolerance
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
nitrogen	NN	nitrogen
-	HYPH	-
fixing	VBG	fix
cyanobacterium	NN	cyanobacterium
Anabaena	NP	Anabaena
sp	NN	sp
.	SENT	.
strain	NN	strain
L	NN	L
-31	CD	-31
.	SENT	.
.	SENT	.
Compared	VBN	Compare
to	TO	to
Escherichia	NP	Escherichia
coli	NP	coli
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
nitrogen	NN	nitrogen
-	HYPH	-
fixing	VBG	fix
soil	NN	soil
cyanobacterium	NN	cyanobacterium
Anabaena	NP	Anabaena
sp	NN	sp
.	SENT	.
strain	NN	strain
L	NN	L
-31	CD	-31
exhibited	VBD	exhibit
significantly	RB	significantly
superior	JJ	superior
abilities	NNS	ability
to	TO	to
survive	VB	survive
prolonged	JJ	prolonged
and	CC	and
continuous	JJ	continuous
heat	NN	heat
stress	NN	stress
and	CC	and
recover	VB	recover
therefrom	RB	therefrom
.	SENT	.
.	SENT	.
Temperature	NN	Temperature
upshift	NN	upshift
induced	VBD	induce
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
synthesis	NN	synthesis
of	IN	of
heat	NN	heat
-	HYPH	-
shock	NN	shock
proteins	NNS	protein
of	IN	of
similar	JJ	similar
molecular	JJ	molecular
mass	NN	mass
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
two	CD	two
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
microbes	NNS	microbe
.	SENT	.
.	SENT	.
However	RB	However
,	,	,
in	IN	in
Anabaena	NP	Anabaena
sp	NN	sp
.	SENT	.
strain	NN	strain
L	NN	L
<FORBIDDEN ID=11 ACTION=delete>
-31	CD	-31
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=11 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
heat	NN	heat
-	HYPH	-
shock	NN	shock
proteins	NNS	protein
(	(	(
particularly	RB	particularly
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
GroEL	NN	GroEL
proteins	NNS	protein
)	)	)
were	VVD	be
synthesised	VBN	synthesise
throughout	IN	throughout
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
stress	NN	stress
period	NN	period
,	,	,
were	VVD	be
<FORBIDDEN ID=83 ACTION=delete>
much	RB	much
<FORBIDDEN ID=82 ACTION=delete>
</FORBIDDEN ID=83 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
stable	JJ	stable
and	CC	and
accumulated	VBN	accumulate
during	IN	during
heat	NN	heat
stress	NN	stress
.	SENT	.
.	SENT	.
In	IN	In
contrast	NN	contrast
,	,	,
in	IN	in
E	NN	E
.	SENT	.
coli	''	coli
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
heat	NN	heat
-	HYPH	-
shock	NN	shock
proteins	NNS	protein
were	VVD	be
transiently	RB	transiently
synthesised	VBN	synthesise
,	,	,
quickly	RB	quickly
turned	VBD	turn
over	RB	over
and	CC	and
did	VBD	do
not	RB	not
accumulate	VB	accumulate
.	SENT	.
.	SENT	.
Nitrogenase	NN	Nitrogenase
activity	NN	activity
of	IN	of
Anabaena	NN	Anabaena
cells	NNS	cell
of	IN	of
sp	NN	sp
.	SENT	.
strain	NN	strain
L	NN	L
-31	CD	-31
continuously	RB	continuously
exposed	VBN	expose
to	TO	to
heat	NN	heat
stress	NN	stress
for	IN	for
7	CD	7
days	NNS	day
rapidly	RB	rapidly
recovered	VBD	recover
from	IN	from
thermal	JJ	thermal
injury	NN	injury
,	,	,
although	IN	although
growth	NN	growth
recovery	NN	recovery
was	VVD	be
delayed	VBN	delay
.	SENT	.
.	SENT	.
Exposure	NN	Exposure
of	IN	of
E	NN	E
.	SENT	.
coli	NN	coli
cells	NNS	cell
to	TO	to
SUP	SYM	SUP
4.5	CD	4.5
h	NN	h
of	IN	of
heat	NN	heat
stress	NN	stress
resulted	VBD	result
in	IN	in
a	DT	a
complete	JJ	complete
loss	NN	loss
of	IN	of
viability	NN	viability
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
ability	NN	ability
to	TO	to
recover	VB	recover
.	SENT	.
.	SENT	.
Marked	JJ	Marked
differences	NNS	difference
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
synthesis	NN	synthesis
,	,	,
stability	NN	stability
and	CC	and
accumulation	NN	accumulation
of	IN	of
heat	NN	heat
-	HYPH	-
shock	NN	shock
proteins	NNS	protein
appear	VBP	appear
to	TO	to
distinguish	VB	distinguish
these	DT	these
bacteria	NNS	bacteria
in	IN	in
their	PP$	their
thermotolerance	NN	thermotolerance
and	CC	and
recovery	NN	recovery
from	IN	from
heat	NN	heat
stress	NN	stress
.	SENT	.
.	SENT	.
BB-cat+ner-12781527/text	DOCUMENT	BB-cat+ner-12781527/text
Campylobacter	NN	Campylobacter
--a	SYM	--a
tale	NN	tale
of	IN	of
two	CD	two
protein	NN	protein
glycosylation	NN	glycosylation
systems	NNS	system
.	SENT	.
.	SENT	.
Post	AFX	Post
-	HYPH	-
translational	JJ	translational
glycosylation	NN	glycosylation
is	VVZ	be
a	DT	a
universal	JJ	universal
modification	NN	modification
of	IN	of
proteins	NNS	protein
in	IN	in
eukarya	NN	eukarya
,	,	,
archaea	NN	archaea
and	CC	and
bacteria	NNS	bacteria
.	SENT	.
.	SENT	.
Two	CD	Two
recent	JJ	recent
publications	NNS	publication
describe	VBP	describe
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
first	JJ	first
confirmed	VBN	confirm
report	NN	report
of	IN	of
a	DT	a
bacterial	JJ	bacterial
N-linked	VBN	N-linke
glycosylation	NN	glycosylation
pathway	NN	pathway
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
human	JJ	human
gastrointestinal	JJ	gastrointestinal
pathogen	NN	pathogen
Campylobacter	NP	Campylobacter
jejuni	NP	jejuni
.	SENT	.
.	SENT	.
In	IN	In
addition	NN	addition
,	,	,
an	DT	an
O-linked	JJ	O-linked
glycosylation	NN	glycosylation
pathway	NN	pathway
has	VHZ	have
been	VVN	be
identified	VBN	identify
and	CC	and
characterized	VBN	characterize
in	IN	in
C	NN	C
.	SENT	.
jejuni	NNS	jejuni
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
related	VBN	relate
species	NNS	specie
Campylobacter	NP	Campylobacter
coli	NP	coli
.	SENT	.
.	SENT	.
<FORBIDDEN ID=30 ACTION=delete>
Both	DT	Both
</FORBIDDEN ID=30 ACTION=delete>
pathways	NNS	pathway
have	VHP	have
similarity	NN	similarity
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
respective	JJ	respective
N	NN	N
-	HYPH	-
and	CC	and
O-linked	JJ	O-linked
glycosylation	NN	glycosylation
processes	NNS	process
in	IN	in
eukaryotes	NNS	eukaryote
.	SENT	.
.	SENT	.
In	IN	In
bacteria	NNS	bacteria
,	,	,
homologues	NNS	homologue
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
genes	NNS	gene
in	IN	in
<FORBIDDEN ID=30 ACTION=delete>
both	DT	both
</FORBIDDEN ID=30 ACTION=delete>
pathways	NNS	pathway
are	VVP	be
found	VBN	find
in	IN	in
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
organisms	NNS	organism
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
complex	JJ	complex
glycans	NNS	glycan
linked	VBN	link
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
glycoproteins	NNS	glycoprotein
share	VBP	share
common	JJ	common
biosynthetic	JJ	biosynthetic
precursors	NNS	precursor
and	CC	and
these	DT	these
modifications	NNS	modification
could	MD	could
play	VB	play
similar	JJ	similar
biological	JJ	biological
roles	NNS	role
.	SENT	.
.	SENT	.
Thus	RB	Thus
,	,	,
Campylobacter	NP	Campylobacter
provides	VBZ	provide
a	DT	a
unique	JJ	unique
model	NN	model
system	NN	system
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
elucidation	NN	elucidation
and	CC	and
exploitation	NN	exploitation
of	IN	of
glycoprotein	NN	glycoprotein
biosynthesis	NN	biosynthesis
.	SENT	.
.	SENT	.
BB-cat+ner-12934822/text	DOCUMENT	BB-cat+ner-12934822/text
Detection	NN	Detection
of	IN	of
Cryptosporidium	NN	Cryptosporidium
parvum	NN	parvum
in	IN	in
secondary	JJ	secondary
effluents	NNS	effluent
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
using	VBG	use
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
most	RBS	most
probable	JJ	probable
number	NN	number
-	HYPH	-
polymerase	NN	polymerase
chain	NN	chain
reaction	NN	reaction
assay	NN	assay
.	SENT	.
.	SENT	.
Polymerase	NN	Polymerase
chain	NN	chain
reaction	NN	reaction
(	(	(
PCR	NN	PCR
)	)	)
was	VVD	be
used	VBN	use
to	TO	to
detect	VB	detect
Cryptosporidium	NN	Cryptosporidium
parvum	NN	parvum
oocysts	NNS	oocyst
in	IN	in
secondary	JJ	secondary
effluent	JJ	effluent
samples	NNS	sample
collected	VBN	collect
from	IN	from
activated	VBN	activate
-	HYPH	-
sludge	NN	sludge
facilities	NNS	facility
.	SENT	.
.	SENT	.
Serial	JJ	Serial
dilutions	NNS	dilution
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
purified	VBN	purify
nucleic	JJ	nucleic
acid	NN	acid
extracts	NNS	extract
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
samples	NNS	sample
were	VVD	be
made	VBN	make
and	CC	and
PCR	NN	PCR
was	VVD	be
conducted	VBN	conduct
to	TO	to
estimate	VB	estimate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
C	NN	C
.	SENT	.
parvum	NN	parvum
oocyst	NN	oocyst
concentration	NN	concentration
via	IN	via
a	DT	a
Poisson	NN	Poisson
distribution	NN	distribution
-	HYPH	-
based	VBN	base
most	RBS	most
probable	JJ	probable
number	NN	number
(	(	(
MPN	NN	MPN
)	)	)
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
degree	NN	degree
of	IN	of
oocysts	NNS	oocyst
associated	VBN	associate
with	IN	with
wastewater	NN	wastewater
particles	NNS	particle
was	VVD	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
evaluated	VBN	evaluate
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
sensitivity	NN	sensitivity
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MPN	NN	MPN
-	HYPH	-
PCR	NN	PCR
assay	NN	assay
was	VVD	be
20	CD	20
oocysts	NNS	oocyst
/	SYM	/
PCR	NN	PCR
unit	NN	unit
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
detection	NN	detection
limit	NN	limit
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
concentration	NN	concentration
,	,	,
extraction	NN	extraction
,	,	,
and	CC	and
purification	NN	purification
protocols	NNS	protocol
in	IN	in
phosphate	NN	phosphate
buffer	NN	buffer
saline	NN	saline
spiked	VBD	spike
with	IN	with
a	DT	a
known	JJ	known
concentration	NN	concentration
of	IN	of
oocysts	NNS	oocyst
ranged	VBD	range
from	IN	from
1.1	CD	1.1
to	TO	to
4.6	CD	4.6
oocysts	NNS	oocyst
/	SYM	/
L	NN	L
;	COLUMN	;
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
detection	NN	detection
limit	NN	limit
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
wastewater	NN	wastewater
samples	NNS	sample
ranged	VBD	range
from	IN	from
11	CD	11
to	TO	to
4200	CD	4200
oocysts	NNS	oocyst
/	SYM	/
L	NN	L
depending	VBG	depend
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
extent	NN	extent
of	IN	of
inhibition	NN	inhibition
in	IN	in
each	DT	each
sample	NN	sample
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
recovery	NN	recovery
efficiency	NN	efficiency
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
oocysts	NNS	oocyst
ranged	VBD	range
from	IN	from
48	CD	48
to	TO	to
59%	CD	59%
in	IN	in
most	JJS	most
samples	NNS	sample
.	SENT	.
.	SENT	.
Oocysts	NNS	Oocyst
were	VVD	be
found	VBN	find
in	IN	in
two	CD	two
out	IN	out
of	IN	of
seven	CD	seven
samples	NNS	sample
with	IN	with
concentrations	NNS	concentration
of	IN	of
203	CD	203
and	CC	and
308	CD	308
oocysts	NNS	oocyst
/	SYM	/
L	NN	L
,	,	,
as	IN	as
estimated	VBN	estimate
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MPN	NN	MPN
-	HYPH	-
PCR	NN	PCR
method	NN	method
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
oocysts	NNS	oocyst
were	VVD	be
found	VBN	find
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
filtrate	NN	filtrate
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
grab	NN	grab
samples	NNS	sample
;	COLUMN	;
particle	NN	particle
-	HYPH	-
associated	VBN	associate
oocysts	NNS	oocyst
were	VVD	be
not	RB	not
detected	VBN	detect
.	SENT	.
.	SENT	.
Association	NN	Association
of	IN	of
spiked	VBN	spike
C	NN	C
.	SENT	.
parvum	NN	parvum
oocysts	NNS	oocyst
with	IN	with
particles	NNS	particle
in	IN	in
secondary	JJ	secondary
effluent	JJ	effluent
drawn	NN	drawn
from	IN	from
wastewater	NN	wastewater
plants	NNS	plant
with	IN	with
varying	VBG	vary
operating	NN	operating
conditions	NNS	condition
indicated	VBD	indicate
a	DT	a
weak	JJ	weak
correlation	NN	correlation
between	IN	between
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
degree	NN	degree
of	IN	of
association	NN	association
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
mean	JJ	mean
cell	NN	cell
residence	NN	residence
time	NN	time
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
system	NN	system
.	SENT	.
.	SENT	.
BB-cat+ner-12970344/text	DOCUMENT	BB-cat+ner-12970344/text
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
three	CD	three
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
-	HYPH	-
dimensional	JJ	dimensional
structures	NNS	structure
of	IN	of
two	CD	two
beta	SYM	beta
-	HYPH	-
agarases	NNS	agaras
.	SENT	.
.	SENT	.
Agars	NNS	Agar
are	VVP	be
important	JJ	important
gelifying	VBG	gelifye
agents	NNS	agent
for	IN	for
biochemical	JJ	biochemical
use	NN	use
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
food	NN	food
industry	NN	industry
.	SENT	.
.	SENT	.
To	TO	To
cleave	VB	cleave
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
beta	NN	beta
-1	NN	-1
,	,	,
4-linkages	NNS	4-linkage
between	IN	between
beta	SYM	beta
-	HYPH	-
d-galactose	NN	d-galactose
and	CC	and
alpha-l	NN	alpha-l
-3	CD	-3
,	,	,
6-anhydro	AFX	6-anhydro
-	HYPH	-
galactose	NN	galactose
residues	NNS	residue
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
red	JJ	red
algal	JJ	algal
galactans	NNS	galactan
known	VBN	know
as	IN	as
agars	NNS	agar
,	,	,
marine	JJ	marine
bacteria	NNS	bacteria
produce	VBP	produce
polysaccharide	NN	polysaccharide
hydrolases	NNS	hydrolas
called	VBN	call
beta	SYM	beta
-	HYPH	-
agarases	NNS	agaras
.	SENT	.
.	SENT	.
Beta	SYM	Beta
-	HYPH	-
agarases	NNS	agaras
A	NN	A
and	CC	and
B	NN	B
from	IN	from
Zobellia	NP	Zobellia
galactanivorans	NNS	galactanivoran
Dsij	NP	Dsij
have	VHP	have
recently	RB	recently
been	VVN	be
biochemically	RB	biochemically
characterized	VBN	characterize
.	SENT	.
.	SENT	.
Here	RB	Here
we	PP	we
report	VBP	report
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
first	JJ	first
crystal	JJ	crystal
structure	NN	structure
of	IN	of
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
these	DT	these
two	CD	two
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
beta	SYM	beta
-	HYPH	-
agarases	NNS	agaras
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
two	CD	two
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
proteins	NNS	protein
were	VVD	be
overproduced	VBN	overproduce
in	IN	in
Escherichia	FW	Escherichia
coli	FW	coli
and	CC	and
crystallized	VBN	crystallize
,	,	,
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
crystal	JJ	crystal
structures	NNS	structure
were	VVD	be
determined	VBN	determine
at	IN	at
1.48	CD	1.48
and	CC	and
2.3	CD	2.3
A	NN	A
for	IN	for
beta	SYM	beta
-	HYPH	-
agarases	NNS	agaras
A	NN	A
and	CC	and
B	NN	B
,	,	,
respectively	RB	respectively
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
structure	NN	structure
of	IN	of
beta	SYM	beta
-	HYPH	-
agarase	NN	agarase
A	NN	A
was	VVD	be
solved	VBN	solve
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
multiple	JJ	multiple
anomalous	JJ	anomalous
diffraction	NN	diffraction
method	NN	method
,	,	,
whereas	IN	whereas
beta	SYM	beta
-	HYPH	-
agarase	NN	agarase
B	NN	B
was	VVD	be
solved	VBN	solve
with	IN	with
molecular	JJ	molecular
replacement	NN	replacement
using	VBG	use
beta	SYM	beta
-	HYPH	-
agarase	NN	agarase
A	NN	A
as	IN	as
model	NN	model
.	SENT	.
.	SENT	.
Their	PP$	Their
structures	NNS	structure
adopt	VBP	adopt
a	DT	a
jelly	JJ	jelly
roll	NN	roll
fold	RB	fold
with	IN	with
a	DT	a
deep	JJ	deep
active	JJ	active
site	NN	site
channel	NN	channel
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
harboring	VBG	harbor
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
catalytic	JJ	catalytic
machinery	NN	machinery
,	,	,
namely	RB	namely
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
nucleophilic	JJ	nucleophilic
residues	NNS	residue
Glu	NN	Glu
-147	CD	-147
and	CC	and
Glu	NN	Glu
-184	CD	-184
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
acid	NN	acid
/	SYM	/
base	NN	base
residues	NNS	residue
Glu	NN	Glu
-152	CD	-152
and	CC	and
Glu	NN	Glu
-189	CD	-189
for	IN	for
beta	SYM	beta
-	HYPH	-
agarases	NNS	agaras
A	NN	A
and	CC	and
B	NN	B
,	,	,
respectively	RB	respectively
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
structures	NNS	structure
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
agarases	NNS	agaras
were	VVD	be
compared	VBN	compare
with	IN	with
those	DT	those
of	IN	of
two	CD	two
lichenases	NNS	lichenas
and	CC	and
of	IN	of
a	DT	a
kappa	NN	kappa
-	HYPH	-
carrageenase	NN	carrageenase
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
all	DT	all
belong	VBP	belong
to	TO	to
family	NN	family
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
16	CD	16
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
glycoside	NN	glycoside
hydrolases	NNS	hydrolas
<FORBIDDEN ID=27 ACTION=delete>
<FORBIDDEN ID=26 ACTION=delete>
in	IN	in
order	NN	order
to	TO	to
</FORBIDDEN ID=26 ACTION=delete>
</FORBIDDEN ID=27 ACTION=delete>
pinpoint	VB	pinpoint
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
residues	NNS	residue
responsible	JJ	responsible
for	IN	for
their	PP$	their
widely	RB	widely
differing	VBG	differ
substrate	NN	substrate
specificity	NN	specificity
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
relationship	NN	relationship
between	IN	between
structure	NN	structure
and	CC	and
enzymatic	JJ	enzymatic
activity	NN	activity
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
two	CD	two
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
beta	SYM	beta
-	HYPH	-
agarases	NNS	agaras
from	IN	from
Z	NN	Z
.	SENT	.
galactanivorans	NNS	galactanivoran
Dsij	NP	Dsij
was	VVD	be
studied	VBN	study
by	IN	by
analysis	NN	analysis
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
degradation	NN	degradation
products	NNS	product
starting	VBG	start
with	IN	with
different	JJ	different
oligosaccharides	NNS	oligosaccharide
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
combination	NN	combination
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
structural	JJ	structural
and	CC	and
biochemical	JJ	biochemical
results	NNS	result
allowed	VBD	allow
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
determination	NN	determination
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
number	NN	number
of	IN	of
subsites	NNS	subsite
present	JJ	present
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
catalytic	JJ	catalytic
cleft	NN	cleft
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
beta	SYM	beta
-	HYPH	-
agarases	NNS	agaras
.	SENT	.
.	SENT	.
BB-cat+ner-1356998/text	DOCUMENT	BB-cat+ner-1356998/text
Human	JJ	Human
and	CC	and
tick	VB	tick
spotted	VBD	spot
fever	NN	fever
group	NN	group
Rickettsia	NP	Rickettsia
isolates	VBZ	isolate
from	IN	from
Israel	NP	Israel
:	COLUMN	:
a	DT	a
genotypic	JJ	genotypic
analysis	NN	analysis
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
genomes	NNS	genome
of	IN	of
spotted	VBN	spot
fever	NN	fever
group	NN	group
rickettsiae	NN	rickettsiae
isolated	VBN	isolate
in	IN	in
different	JJ	different
geographical	JJ	geographical
areas	NNS	area
of	IN	of
Israel	NP	Israel
(	(	(
two	CD	two
from	IN	from
ticks	NNS	tick
and	CC	and
four	CD	four
from	IN	from
humans	NNS	human
,	,	,
obtained	VBN	obtain
over	IN	over
a	DT	a
span	NN	span
of	IN	of
20	CD	20
years	NNS	year
)	)	)
were	VVD	be
studied	VBN	study
by	IN	by
polymerase	NN	polymerase
chain	NN	chain
reaction	NN	reaction
(	(	(
PCR	NN	PCR
)	)	)
and	CC	and
restriction	NN	restriction
endonuclease	NN	endonuclease
fragment	NN	fragment
length	NN	length
polymorphism	NN	polymorphism
(	(	(
RFLP	NN	RFLP
)	)	)
analysis	NN	analysis
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
human	JJ	human
isolates	NNS	isolate
were	VVD	be
obtained	VBN	obtain
from	IN	from
patients	NNS	patient
suffering	VBG	suffer
from	IN	from
rickettsial	JJ	rickettsial
disease	NN	disease
of	IN	of
different	JJ	different
degrees	NNS	degree
of	IN	of
severity	NN	severity
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
PCR	NN	PCR
products	NNS	product
obtained	VBN	obtain
with	IN	with
five	CD	five
pairs	NNS	pair
of	IN	of
oligonucleotide	NN	oligonucleotide
primers	NNS	primer
(	(	(
two	CD	two
primer	NN	primer
sets	NNS	set
derived	VBN	derive
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
190-kDa	JJ	190-kDa
polypeptide	NN	polypeptide
gene	NN	gene
and	CC	and
three	CD	three
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
120-kDa	JJ	120-kDa
polypeptide	NN	polypeptide
gene	NN	gene
)	)	)
and	CC	and
cleaved	VBN	cleave
with	IN	with
restriction	NN	restriction
endonucleases	NNS	endonucleas
were	VVD	be
used	VBN	use
to	TO	to
study	VB	study
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Israeli	JJ	Israeli
isolates	NNS	isolate
and	CC	and
reference	NN	reference
Rickettsia	NN	Rickettsia
conorii	NN	conorii
isolates	NNS	isolate
.	SENT	.
.	SENT	.
Subtle	JJ	Subtle
differences	NNS	difference
between	IN	between
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
PCR	NN	PCR
-	HYPH	-
RFLP	NN	RFLP
patterns	NNS	pattern
of	IN	of
Israeli	JJ	Israeli
isolates	NNS	isolate
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
two	CD	two
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
R	NN	R
.	SENT	.
conorii	NN	conorii
reference	NN	reference
strains	NNS	strain
(	(	(
Moroccan	NN	Moroccan
and	CC	and
no	DT	no
.	SENT	.
7	CD	7
)	)	)
were	VVD	be
seen	VBN	see
when	WRB	when
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
PCR	NN	PCR
products	NNS	product
derived	VBN	derive
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
190-kDa	JJ	190-kDa
gene	NN	gene
-	HYPH	-
derived	VBN	derive
primer	NN	primer
sets	NNS	set
were	VVD	be
digested	VBN	digest
.	SENT	.
.	SENT	.
All	DT	All
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Israeli	JJ	Israeli
isolates	NNS	isolate
were	VVD	be
identical	JJ	identical
by	IN	by
RFLP	NN	RFLP
analysis	NN	analysis
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
using	VBG	use
all	DT	all
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
primer	NN	primer
sets	NNS	set
.	SENT	.
.	SENT	.
This	DT	This
study	NN	study
showed	VBD	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Israeli	JJ	Israeli
spotted	VBN	spot
fever	NN	fever
group	NN	group
isolates	NNS	isolate
(	(	(
from	IN	from
<FORBIDDEN ID=30 ACTION=delete>
both	DT	both
</FORBIDDEN ID=30 ACTION=delete>
ticks	NNS	tick
and	CC	and
humans	NNS	human
)	)	)
were	VVD	be
genetically	RB	genetically
homogeneous	JJ	homogeneous
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
criteria	NNS	criterion
used	VBN	use
in	IN	in
this	DT	this
study	NN	study
,	,	,
despite	IN	despite
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
time	NN	time
and	CC	and
location	NN	location
differences	NNS	difference
in	IN	in
their	PP$	their
original	JJ	original
isolation	NN	isolation
,	,	,
and	CC	and
different	JJ	different
as	IN	as
a	DT	a
group	NN	group
from	IN	from
R	NN	R
.	SENT	.
conorii	NN	conorii
.	SENT	.
.	SENT	.
BB-cat+ner-14633026/text	DOCUMENT	BB-cat+ner-14633026/text
Characterization	NN	Characterization
of	IN	of
a	DT	a
mosquitocidal	JJ	mosquitocidal
Bacillus	NN	Bacillus
thuringiensis	NN	thuringiensis
serovar	NN	serovar
sotto	NN	sotto
strain	NN	strain
isolated	VBN	isolate
from	IN	from
Okinawa	NP	Okinawa
,	,	,
Japan	NP	Japan
.	SENT	.
.	SENT	.
To	TO	To
characterize	VB	characterize
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
mosquitocidal	JJ	mosquitocidal
activity	NN	activity
of	IN	of
parasporal	JJ	parasporal
inclusions	NNS	inclusion
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Bacillus	NN	Bacillus
thuringiensis	NN	thuringiensis
serovar	NN	serovar
sotto	NN	sotto
strain	NN	strain
96-OK	NN	96-OK
-	HYPH	-
85-24	CD	85-24
,	,	,
for	IN	for
comparison	NN	comparison
with	IN	with
two	CD	two
well	RB	well
-	HYPH	-
characterized	VBN	characterize
mosquitocidal	JJ	mosquitocidal
strains	NNS	strain
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
strain	NN	strain
96-OK	NN	96-OK
-	HYPH	-
85-24	CD	85-24
significantly	RB	significantly
differed	VBN	differ
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
existing	VBG	exist
mosquitocidal	NN	mosquitocidal
B	NN	B
.	SENT	.
thuringiensis	NN	thuringiensis
strains	NNS	strain
in	IN	in
:	COLUMN	:
(	(	(
1	LS	1
)	)	)
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
lacking	VBG	lack
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
larvicidal	JJ	larvicidal
activity	NN	activity
against	IN	against
Culex	NP	Culex
pipiens	NNS	pipien
molestus	NN	molestus
and	CC	and
haemolytic	JJ	haemolytic
activity	NN	activity
,	,	,
and	CC	and
(	(	(
2	LS	2
)	)	)
SDS	NN	SDS
-	HYPH	-
PAGE	NN	PAGE
profiles	NNS	profile
,	,	,
immunological	JJ	immunological
properties	NNS	property
and	CC	and
N-terminal	JJ	N-terminal
amino	JJ	amino
acid	NN	acid
sequences	NNS	sequence
of	IN	of
parasporal	JJ	parasporal
inclusion	NN	inclusion
proteins	NNS	protein
.	SENT	.
.	SENT	.
It	PP	It
is	VVZ	be
clear	JJ	clear
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
results	NNS	result
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
strain	NN	strain
96-OK	NN	96-OK
-	HYPH	-
85-24	CD	85-24
synthesizes	VBZ	synthesize
a	DT	a
novel	JJ	novel
mosquitocidal	JJ	mosquitocidal
Cry	NN	Cry
protein	NN	protein
with	IN	with
a	DT	a
unique	JJ	unique
toxicity	NN	toxicity
spectrum	NN	spectrum
.	SENT	.
.	SENT	.
This	DT	This
is	VVZ	be
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
first	JJ	first
report	NN	report
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
occurrence	NN	occurrence
of	IN	of
a	DT	a
mosquitocidal	JJ	mosquitocidal
B	NN	B
.	SENT	.
thuringiensis	NN	thuringiensis
strain	NN	strain
with	IN	with
an	DT	an
unusual	JJ	unusual
toxicity	NN	toxicity
spectrum	NN	spectrum
,	,	,
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
lacking	VBG	lack
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
activity	NN	activity
against	IN	against
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
culicine	NN	culicine
mosquito	NN	mosquito
.	SENT	.
.	SENT	.
BB-cat+ner-14638480/text	DOCUMENT	BB-cat+ner-14638480/text
Efficacies	NNS	Efficacy
of	IN	of
vancomycin	NN	vancomycin
,	,	,
arbekacin	NN	arbekacin
,	,	,
and	CC	and
gentamicin	NN	gentamicin
alone	RB	alone
or	CC	or
in	IN	in
combination	NN	combination
against	IN	against
methicillin	NN	methicillin
-	HYPH	-
resistant	JJ	resistant
Staphylococcus	NP	Staphylococcus
aureus	NN	aureus
in	IN	in
an	DT	an
in vitro	FW	in_vitro
infective	JJ	infective
endocarditis	NN	endocarditis
model	NN	model
.	SENT	.
.	SENT	.
We	PP	We
adopted	VBD	adopt
an	DT	an
in vitro	FW	in_vitro
infective	JJ	infective
endocarditis	NN	endocarditis
model	NN	model
(	(	(
IVIEM	NN	IVIEM
)	)	)
to	TO	to
compare	VB	compare
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
efficacy	NN	efficacy
of	IN	of
vancomycin	NN	vancomycin
(	(	(
VAN	NN	VAN
)	)	)
,	,	,
arbekacin	NN	arbekacin
(	(	(
ABK	NN	ABK
)	)	)
,	,	,
and	CC	and
gentamicin	NN	gentamicin
(	(	(
GEN	NN	GEN
)	)	)
alone	RB	alone
or	CC	or
in	IN	in
combination	NN	combination
.	SENT	.
.	SENT	.
Using	VBG	Use
two	CD	two
strains	NNS	strain
of	IN	of
clinically	RB	clinically
isolated	VBN	isolate
methicillin	NN	methicillin
-	HYPH	-
resistant	JJ	resistant
Staphylococcus	NP	Staphylococcus
aureus	NN	aureus
,	,	,
one	CD	one
GEN	NN	GEN
susceptible	JJ	susceptible
(	(	(
GS171	NN	GS171
)	)	)
and	CC	and
one	CD	one
GEN	NN	GEN
resistant	JJ	resistant
(	(	(
GR153	NN	GR153
)	)	)
,	,	,
fibrin	NN	fibrin
clots	NNS	clot
were	VVD	be
prepared	VBN	prepare
and	CC	and
suspended	VBN	suspend
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
IVIEM	NN	IVIEM
.	SENT	.
.	SENT	.
Antibiotics	NNS	Antibiotic
were	VVD	be
given	VBN	give
as	IN	as
<FORBIDDEN ID=1 ACTION=split SPLIT_AFTER=0>
boluses	NNS	bolus
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
every	DT	every
</FORBIDDEN ID=1 ACTION=split SPLIT_AFTER=0>
6	CD	6
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
h	NN	h
(	(	(
q6h	NN	q6h
)	)	)
,	,	,
q12h	NN	q12h
,	,	,
or	CC	or
q24h	NN	q24h
or	CC	or
by	IN	by
continuous	JJ	continuous
infusion	NN	infusion
with	IN	with
VAN	NN	VAN
,	,	,
q12h	NN	q12h
or	CC	or
q24h	NN	q24h
with	IN	with
ABK	NN	ABK
,	,	,
and	CC	and
q8h	NN	q8h
or	CC	or
q24h	NN	q24h
with	IN	with
GEN	NN	GEN
.	SENT	.
.	SENT	.
For	IN	For
combination	NN	combination
treatment	NN	treatment
,	,	,
VAN	NN	VAN
q12h	NN	q12h
plus	CC	plus
ABK	NN	ABK
q24h	NN	q24h
and	CC	and
VAN	NN	VAN
q12h	NN	q12h
plus	CC	plus
GEN	NN	GEN
q24h	NN	q24h
were	VVD	be
given	VBN	give
.	SENT	.
.	SENT	.
Fibrin	NN	Fibrin
clots	NNS	clot
were	VVD	be
removed	VBN	remove
from	IN	from
each	DT	each
model	NN	model
at	IN	at
0	CD	0
,	,	,
8	CD	8
,	,	,
24	CD	24
,	,	,
32	CD	32
,	,	,
48	CD	48
,	,	,
and	CC	and
72	CD	72
h	NN	h
,	,	,
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bacterial	JJ	bacterial
densities	NNS	density
were	VVD	be
determined	VBN	determine
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
number	NN	number
of	IN	of
colonies	NNS	colony
within	IN	within
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
fibrin	NN	fibrin
clot	NN	clot
was	VVD	be
significantly	RB	significantly
decreased	VBN	decrease
in	IN	in
all	DT	all
study	NN	study
groups	NNS	group
compared	VBN	compare
with	IN	with
control	JJ	control
groups	NNS	group
(	(	(
PINF	NN	PINF
0.001	CD	0.001
)	)	)
.	SENT	.
.	SENT	.
When	WRB	When
VAN	NN	VAN
and	CC	and
ABK	NN	ABK
were	VVD	be
administered	VBN	administer
alone	RB	alone
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
number	NN	number
of	IN	of
colonies	NNS	colony
was	VVD	be
significantly	RB	significantly
lower	JJR	low
in	IN	in
GS171	NN	GS171
than	IN	than
in	IN	in
GR153	NN	GR153
by	IN	by
8	CD	8
h	NN	h
after	IN	after
administration	NN	administration
(	(	(
P=	NN	P=
0.02	CD	0.02
)	)	)
and	CC	and
was	VVD	be
lowest	JJS	low
in	IN	in
GS171	NN	GS171
when	WRB	when
ABK	NN	ABK
was	VVD	be
administered	VBN	administer
q12h	NN	q12h
(	(	(
P=	NN	P=
0.01	CD	0.01
)	)	)
.	SENT	.
.	SENT	.
At	IN	At
72	CD	72
h	NN	h
,	,	,
ABK	NN	ABK
or	CC	or
VAN	NN	VAN
alone	RB	alone
produced	VBD	produce
equivalent	JJ	equivalent
bacterial	JJ	bacterial
reductions	NNS	reduction
regardless	RB	regardless
of	IN	of
dosing	NN	dosing
frequency	NN	frequency
and	CC	and
GEN	NN	GEN
resistance	NN	resistance
.	SENT	.
.	SENT	.
In	IN	In
GR153	NN	GR153
,	,	,
VAN	NN	VAN
plus	CC	plus
ABK	NN	ABK
showed	VBD	show
an	DT	an
additive	JJ	additive
effect	NN	effect
till	RB	till
24	CD	24
h	NN	h
,	,	,
although	IN	although
VAN	NN	VAN
plus	CC	plus
GEN	NN	GEN
showed	VBD	show
indifference	NN	indifference
.	SENT	.
.	SENT	.
Our	PP$	Our
data	NNS	datum
suggest	VBP	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
ABK	NN	ABK
could	MD	could
be	VV	be
used	VBN	use
as	IN	as
an	DT	an
alternative	NN	alternative
to	TO	to
VAN	NN	VAN
in	IN	in
GEN	NN	GEN
-	HYPH	-
resistant	JJ	resistant
staphylococcal	JJ	staphylococcal
endocarditis	NN	endocarditis
.	SENT	.
.	SENT	.
An	DT	An
additive	JJ	additive
effect	NN	effect
was	VVD	be
seen	VBN	see
when	WRB	when
VAN	NN	VAN
and	CC	and
ABK	NN	ABK
were	VVD	be
used	VBN	use
<FORBIDDEN ID=158 ACTION=delete>
together	RB	together
</FORBIDDEN ID=158 ACTION=delete>
in	IN	in
GEN	NN	GEN
-	HYPH	-
resistant	JJ	resistant
strains	NNS	strain
until	IN	until
24	CD	24
h	NN	h
;	COLUMN	;
however	RB	however
,	,	,
<FORBIDDEN ID=79 ACTION=delete>
further	JJ	further
</FORBIDDEN ID=79 ACTION=delete>
studies	NNS	study
are	VVP	be
warranted	VBN	warrant
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
clinical	JJ	clinical
application	NN	application
of	IN	of
this	DT	this
combination	NN	combination
.	SENT	.
.	SENT	.
BB-cat+ner-14645268/text	DOCUMENT	BB-cat+ner-14645268/text
XopC	NN	XopC
and	CC	and
XopJ	NN	XopJ
,	,	,
two	CD	two
novel	JJ	novel
type	NN	type
III	CD	III
effector	NN	effector
proteins	NNS	protein
from	IN	from
Xanthomonas	NN	Xanthomonas
campestris	NN	campestris
pv	NN	pv
.	SENT	.
vesicatoria	NN	vesicatoria
.	SENT	.
.	SENT	.
Pathogenicity	NN	Pathogenicity
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
gram	NN	gram
-	HYPH	-
negative	JJ	negative
plant	NN	plant
pathogen	NN	pathogen
Xanthomonas	NN	Xanthomonas
campestris	NN	campestris
pv	NN	pv
.	SENT	.
vesicatoria	NN	vesicatoria
depends	VBZ	depend
on	IN	on
a	DT	a
type	NN	type
III	CD	III
secretion	NN	secretion
(	(	(
TTS	NN	TTS
)	)	)
system	NN	system
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
translocates	VBZ	translocate
bacterial	JJ	bacterial
effector	NN	effector
proteins	NNS	protein
into	IN	into
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
plant	NN	plant
cell	NN	cell
.	SENT	.
.	SENT	.
Previous	JJ	Previous
transcriptome	NN	transcriptome
analysis	NN	analysis
identified	VBD	identify
a	DT	a
genome	NN	genome
-	HYPH	-
wide	JJ	wide
regulon	NN	regulon
of	IN	of
putative	JJ	putative
virulence	NN	virulence
genes	NNS	gene
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
are	VVP	be
coexpressed	VBN	coexpresse
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
TTS	NN	TTS
system	NN	system
.	SENT	.
.	SENT	.
In	IN	In
this	DT	this
study	NN	study
,	,	,
we	PP	we
characterized	VBD	characterize
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
two	CD	two
of	IN	of
these	DT	these
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
genes	NNS	gene
,	,	,
xopC	NN	xopC
and	CC	and
xopJ	NN	xopJ
.	SENT	.
.	SENT	.
<FORBIDDEN ID=30 ACTION=delete>
Both	DT	Both
</FORBIDDEN ID=30 ACTION=delete>
genes	NNS	gene
encode	VBP	encode
Xanthomonas	NP	Xanthomonas
outer	JJ	outer
proteins	NNS	protein
(	(	(
Xops	NNS	Xop
)	)	)
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
were	VVD	be
shown	VBN	show
to	TO	to
be	VV	be
secreted	VBN	secrete
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
TTS	NN	TTS
system	NN	system
.	SENT	.
.	SENT	.
In	IN	In
addition	NN	addition
,	,	,
type	NN	type
III	CD	III
-	HYPH	-
dependent	JJ	dependent
translocation	NN	translocation
of	IN	of
<FORBIDDEN ID=30 ACTION=delete>
both	DT	both
</FORBIDDEN ID=30 ACTION=delete>
proteins	NNS	protein
into	IN	into
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
plant	NN	plant
cell	NN	cell
was	VVD	be
demonstrated	VBN	demonstrate
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
using	VBG	use
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
AvrBs3	NN	AvrBs3
effector	NN	effector
domain	NN	domain
as	IN	as
a	DT	a
reporter	NN	reporter
.	SENT	.
.	SENT	.
XopJ	NN	XopJ
belongs	VBZ	belong
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
AvrRxv	NN	AvrRxv
/	SYM	/
YopJ	NN	YopJ
family	NN	family
of	IN	of
effector	NN	effector
proteins	NNS	protein
from	IN	from
plant	NN	plant
and	CC	and
animal	JJ	animal
pathogenic	JJ	pathogenic
bacteria	NNS	bacteria
.	SENT	.
.	SENT	.
By	IN	By
contrast	NN	contrast
,	,	,
XopC	NN	XopC
does	VBZ	do
not	RB	not
share	VB	share
significant	JJ	significant
homology	NN	homology
to	TO	to
proteins	NNS	protein
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
database	NN	database
.	SENT	.
.	SENT	.
Sequence	NN	Sequence
analysis	NN	analysis
revealed	VBD	reveal
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
xopC	NN	xopC
locus	NN	locus
contains	VBZ	contain
several	JJ	several
features	NNS	feature
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
are	VVP	be
reminiscent	JJ	reminiscent
of	IN	of
pathogenicity	NN	pathogenicity
islands	NNS	island
.	SENT	.
.	SENT	.
Interestingly	RB	Interestingly
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
xopC	NN	xopC
region	NN	region
is	VVZ	be
flanked	VBN	flank
by	IN	by
62-bp	JJ	62-bp
inverted	VBN	invert
repeats	NNS	repeat
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
are	VVP	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
associated	VBN	associate
with	IN	with
members	NNS	member
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Xanthomonas	NP	Xanthomonas
avrBs3	NN	avrBs3
effector	NN	effector
family	NN	family
.	SENT	.
.	SENT	.
Besides	IN	Besides
xopC	NN	xopC
,	,	,
a	DT	a
second	JJ	second
gene	NN	gene
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
locus	NN	locus
,	,	,
designated	VBN	designate
hpaJ	NN	hpaJ
,	,	,
was	VVD	be
shown	VBN	show
to	TO	to
be	VV	be
coexpressed	VBN	coexpresse
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
TTS	NN	TTS
system	NN	system
.	SENT	.
hpaJ	NN	hpaJ
encodes	VBZ	encode
a	DT	a
protein	NN	protein
with	IN	with
similarity	NN	similarity
to	TO	to
transglycosylases	NNS	transglycosylas
and	CC	and
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Pseudomonas	NP	Pseudomonas
syringae	JJ	syringae
pv	NN	pv
.	SENT	.
maculicola	NN	maculicola
protein	NN	protein
HopPmaG	NP	HopPmaG
.	SENT	.
.	SENT	.
HpaJ	NN	HpaJ
secretion	NN	secretion
and	CC	and
translocation	NN	translocation
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
X	NN	X
.	SENT	.
campestris	NN	campestris
pv	NN	pv
.	SENT	.
vesicatoria	NN	vesicatoria
TTS	NN	TTS
system	NN	system
was	VVD	be
not	RB	not
detectable	JJ	detectable
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
is	VVZ	be
consistent	JJ	consistent
with	IN	with
its	PP$	its
predicted	VBN	predict
Sec	NP	Sec
signal	NN	signal
and	CC	and
a	DT	a
putative	JJ	putative
function	NN	function
as	IN	as
transglycosylase	NN	transglycosylase
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bacterial	JJ	bacterial
periplasm	NN	periplasm
.	SENT	.
.	SENT	.
BB-cat+ner-14657131/text	DOCUMENT	BB-cat+ner-14657131/text
Mesonia	NP	Mesonia
algae	JJ	algae
gen	NN	gen
.	SENT	.
nov	NN	nov
.	NN	.
,	,	,
sp	NN	sp
.	SENT	.
nov	NN	nov
.	NN	.
,	,	,
a	DT	a
novel	JJ	novel
marine	JJ	marine
bacterium	NN	bacterium
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
family	NN	family
Flavobacteriaceae	NP	Flavobacteriaceae
isolated	VBN	isolate
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
green	JJ	green
alga	NN	alga
Acrosiphonia	NP	Acrosiphonia
sonderi	NP	sonderi
(	(	(
Kütz	NP	Kütz
)	)	)
Kornm	NP	Kornm
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
taxonomic	JJ	taxonomic
position	NN	position
of	IN	of
four	CD	four
heterotrophic	JJ	heterotrophic
,	,	,
aerobic	JJ	aerobic
,	,	,
Gram	NN	Gram
-	HYPH	-
negative	JJ	negative
,	,	,
non-motile	JJ	non-motile
and	CC	and
moderately	RB	moderately
halophilic	JJ	halophilic
marine	JJ	marine
bacteria	NNS	bacteria
,	,	,
isolated	VBN	isolate
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
green	JJ	green
alga	NN	alga
Acrosiphonia	NP	Acrosiphonia
sonderi	NP	sonderi
(	(	(
Kütz	NP	Kütz
)	)	)
Kornm	NP	Kornm
,	,	,
was	VVD	be
established	VBN	establish
.	SENT	.
16S	NN	16S
rDNA	NN	rDNA
sequence	NN	sequence
analysis	NN	analysis
indicated	VBD	indicate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
strains	NNS	strain
studied	VBN	study
are	VVP	be
members	NNS	member
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
family	NN	family
Flavobacteriaceae	NP	Flavobacteriaceae
,	,	,
in	IN	in
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
they	PP	they
form	VBP	form
a	DT	a
distinct	JJ	distinct
lineage	NN	lineage
.	SENT	.
.	SENT	.
On	IN	On
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
basis	NN	basis
of	IN	of
phenotypic	JJ	phenotypic
,	,	,
chemotaxonomic	JJ	chemotaxonomic
,	,	,
genotypic	JJ	genotypic
and	CC	and
phylogenetic	JJ	phylogenetic
data	NNS	datum
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
novel	JJ	novel
bacteria	NNS	bacteria
were	VVD	be
classified	VBN	classify
as	IN	as
Mesonia	NP	Mesonia
algae	NP	algae
gen	NN	gen
.	SENT	.
nov	NN	nov
.	NN	.
,	,	,
sp	NN	sp
.	SENT	.
nov	NN	nov
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
type	NN	type
strain	NN	strain
is	VVZ	be
KMM	NN	KMM
3909(T)	NN	3909(T)
(	(	(
=KCTC	NN	=KCTC
12089(T)=CCUG	NN	12089(T)=CCUG
47092(T))	NN	47092(T))
.	SENT	.
.	SENT	.
BB-cat+ner-15273106/text	DOCUMENT	BB-cat+ner-15273106/text
Modulation	NN	Modulation
of	IN	of
fibronectin	NN	fibronectin
adhesins	NNS	adhesin
and	CC	and
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
virulence	NN	virulence
factors	NNS	factor
in	IN	in
a	DT	a
teicoplanin	NN	teicoplanin
-	HYPH	-
resistant	JJ	resistant
derivative	NN	derivative
of	IN	of
methicillin	NN	methicillin
-	HYPH	-
resistant	JJ	resistant
Staphylococcus	NP	Staphylococcus
aureus	NN	aureus
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
impact	NN	impact
of	IN	of
glycopeptide	NN	glycopeptide
resistance	NN	resistance
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
molecular	JJ	molecular
regulation	NN	regulation
of	IN	of
Staphylococcus	FW	Staphylococcus
aureus	FW	aureus
virulence	NN	virulence
and	CC	and
attachment	NN	attachment
to	TO	to
host	NN	host
tissues	NNS	tissue
is	VVZ	be
poorly	RB	poorly
<FORBIDDEN ID=106 ACTION=delete>
documented	VBN	document
</FORBIDDEN ID=106 ACTION=delete>
.	SENT	.
.	SENT	.
We	PP	We
compared	VBD	compare
stable	JJ	stable
teicoplanin	NN	teicoplanin
-	HYPH	-
resistant	JJ	resistant
methicillin	NN	methicillin
-	HYPH	-
resistant	JJ	resistant
S	NN	S
.	SENT	.
aureus	NN	aureus
(	(	(
MRSA	NN	MRSA
)	)	)
strain	NN	strain
14-4	CD	14-4
with	IN	with
its	PP$	its
teicoplanin	NN	teicoplanin
-	HYPH	-
susceptible	JJ	susceptible
MRSA	NN	MRSA
parent	NN	parent
,	,	,
strain	NN	strain
MRGR3	NN	MRGR3
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
exhibits	VBZ	exhibit
a	DT	a
high	JJ	high
degree	NN	degree
of	IN	of
virulence	NN	virulence
in	IN	in
a	DT	a
rat	NN	rat
model	NN	model
of	IN	of
chronic	JJ	chronic
foreign	JJ	foreign
body	NN	body
MRSA	NN	MRSA
infection	NN	infection
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
levels	NNS	level
of	IN	of
fibronectin	NN	fibronectin
-	HYPH	-
mediated	VBN	mediate
adhesion	NN	adhesion
and	CC	and
surface	NN	surface
display	NN	display
of	IN	of
fibronectin	NN	fibronectin
-	HYPH	-
binding	VBG	bind
proteins	NNS	protein
were	VVD	be
higher	JJR	high
in	IN	in
teicoplanin	NN	teicoplanin
-	HYPH	-
resistant	JJ	resistant
strain	NN	strain
14-4	CD	14-4
than	IN	than
in	IN	in
its	PP$	its
teicoplanin	NN	teicoplanin
-	HYPH	-
susceptible	JJ	susceptible
parent	NN	parent
or	CC	or
a	DT	a
teicoplanin	NN	teicoplanin
-	HYPH	-
susceptible	JJ	susceptible
revertant	NN	revertant
(	(	(
strain	NN	strain
14-4	CD	14-4
rev	NN	rev
)	)	)
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
spontaneously	RB	spontaneously
emerged	VBD	emerge
during	IN	during
tissue	NN	tissue
cage	NN	cage
infection	NN	infection
.	SENT	.
.	SENT	.
Quantitative	JJ	Quantitative
reverse	JJ	reverse
transcription	NN	transcription
-	HYPH	-
PCR	NN	PCR
(	(	(
qRT	NN	qRT
-	HYPH	-
PCR	NN	PCR
)	)	)
showed	VBD	show
four	CD	four
-	HYPH	-
and	CC	and
twofold	RB	twofold
higher	JJR	high
steady	JJ	steady
-	HYPH	-
state	NN	state
levels	NNS	level
of	IN	of
fnbA	NN	fnbA
and	CC	and
fnbB	NN	fnbB
transcripts	NNS	transcript
,	,	,
respectively	RB	respectively
,	,	,
in	IN	in
strain	NN	strain
14-4	CD	14-4
than	IN	than
in	IN	in
its	PP$	its
teicoplanin	NN	teicoplanin
-	HYPH	-
susceptible	JJ	susceptible
counterparts	NNS	counterpart
.	SENT	.
.	SENT	.
Analysis	NN	Analysis
of	IN	of
global	JJ	global
regulatory	JJ	regulatory
activities	NNS	activity
by	IN	by
qRT	NN	qRT
-	HYPH	-
PCR	NN	PCR
revealed	VBD	reveal
a	DT	a
strong	JJ	strong
reduction	NN	reduction
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
steady	JJ	steady
-	HYPH	-
state	NN	state
levels	NNS	level
of	IN	of
RNAIII	NN	RNAIII
and	CC	and
RNAII	NN	RNAII
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
teicoplanin	NN	teicoplanin
-	HYPH	-
resistant	JJ	resistant
strain	NN	strain
compared	VBN	compare
to	TO	to
in	IN	in
its	PP$	its
teicoplanin	NN	teicoplanin
-	HYPH	-
susceptible	JJ	susceptible
counterparts	NNS	counterpart
.	SENT	.
.	SENT	.
In	IN	In
contrast	NN	contrast
,	,	,
sarA	NN	sarA
mRNA	NN	mRNA
levels	NNS	level
were	VVD	be
<FORBIDDEN ID=82 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
than	IN	than
fivefold	RB	fivefold
higher	JJR	high
in	IN	in
strain	NN	strain
14-4	CD	14-4
than	IN	than
in	IN	in
MRGR3	NN	MRGR3
and	CC	and
14-4	CD	14-4
rev	NN	rev
.	SENT	.
.	SENT	.
Furthermore	RB	Furthermore
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
alternative	JJ	alternative
transcription	NN	transcription
factor	NN	factor
sigma	NN	sigma
B	NN	B
had	VHD	have
a	DT	a
higher	JJR	high
level	NN	level
of	IN	of
functional	JJ	functional
activity	NN	activity
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
teicoplanin	NN	teicoplanin
-	HYPH	-
resistant	JJ	resistant
strain	NN	strain
than	IN	than
in	IN	in
its	PP$	its
teicoplanin	NN	teicoplanin
-	HYPH	-
susceptible	JJ	susceptible
counterparts	NNS	counterpart
,	,	,
as	IN	as
evidenced	VBN	evidence
by	IN	by
significant	JJ	significant
increases	NNS	increase
in	IN	in
<FORBIDDEN ID=30 ACTION=delete>
both	CC	both
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=30 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
sigma	NN	sigma
B-dependent	JJ	B-dependent
asp23	NN	asp23
mRNA	NN	mRNA
levels	NNS	level
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
sarA	NN	sarA
P3	NN	P3
promoter	NN	promoter
-	HYPH	-
derived	VBN	derive
transcript	NN	transcript
levels	NNS	level
,	,	,
as	IN	as
assayed	VBN	assay
by	IN	by
qRT	NN	qRT
-	HYPH	-
PCR	NN	PCR
and	CC	and
Northern	NN	Northern
blotting	NN	blotting
,	,	,
respectively	RB	respectively
.	SENT	.
.	SENT	.
These	DT	These
data	NNS	datum
provide	VBP	provide
<FORBIDDEN ID=79 ACTION=delete>
further	JJ	further
</FORBIDDEN ID=79 ACTION=delete>
evidence	NN	evidence
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
emergence	NN	emergence
of	IN	of
glycopeptide	NN	glycopeptide
resistance	NN	resistance
is	VVZ	be
linked	VBN	link
by	IN	by
still	RB	still
poorly	RB	poorly
understood	VBN	understand
molecular	JJ	molecular
pathways	NNS	pathway
with	IN	with
significant	JJ	significant
pleiotropic	JJ	pleiotropic
changes	NNS	change
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
expression	NN	expression
and	CC	and
regulation	NN	regulation
of	IN	of
some	DT	some
major	JJ	major
virulence	NN	virulence
genes	NNS	gene
.	SENT	.
.	SENT	.
These	DT	These
molecular	JJ	molecular
and	CC	and
phenotypic	JJ	phenotypic
changes	NNS	change
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
have	VH	have
a	DT	a
profound	JJ	profound
impact	NN	impact
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bacterial	JJ	bacterial
adhesion	NN	adhesion
and	CC	and
colonization	NN	colonization
properties	NNS	property
of	IN	of
<FORBIDDEN ID=17 ACTION=delete>
such	JJ	such
</FORBIDDEN ID=17 ACTION=delete>
multiresistant	JJ	multiresistant
organisms	NNS	organism
.	SENT	.
.	SENT	.
BB-cat+ner-15293611/text	DOCUMENT	BB-cat+ner-15293611/text
Clonal	JJ	Clonal
strains	NNS	strain
of	IN	of
Pseudomonas	NN	Pseudomonas
aeruginosa	NN	aeruginosa
in	IN	in
paediatric	JJ	paediatric
and	CC	and
adult	JJ	adult
cystic	JJ	cystic
fibrosis	NN	fibrosis
units	NNS	unit
.	SENT	.
.	SENT	.
Despite	IN	Despite
recent	JJ	recent
reports	NNS	report
of	IN	of
clonal	JJ	clonal
strains	NNS	strain
of	IN	of
Pseudomonas	NN	Pseudomonas
aeruginosa	NN	aeruginosa
in	IN	in
cystic	JJ	cystic
fibrosis	NN	fibrosis
(	(	(
CF	NN	CF
)	)	)
units	NNS	unit
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
need	NN	need
for	IN	for
routine	JJ	routine
microbiological	JJ	microbiological
surveillance	NN	surveillance
remains	VBZ	remain
contentious	JJ	contentious
.	SENT	.
.	SENT	.
Sputum	NP	Sputum
was	VVD	be
collected	VBN	collect
prospectively	RB	prospectively
from	IN	from
productive	JJ	productive
patients	NNS	patient
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
attending	VBG	attend
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
regional	JJ	regional
paediatric	JJ	paediatric
and	CC	and
adult	JJ	adult
CF	NN	CF
units	NNS	unit
in	IN	in
Brisbane	NP	Brisbane
,	,	,
Australia	NP	Australia
.	SENT	.
.	SENT	.
All	DT	All
P	NN	P
.	SENT	.
aeruginosa	NN	aeruginosa
isolates	NNS	isolate
were	VVD	be
typed	VBN	type
using	VBG	use
pulsed	JJ	pulsed
-	HYPH	-
field	NN	field
gel	NN	gel
electrophoresis	NN	electrophoresis
.	SENT	.
.	SENT	.
Spirometry	NN	Spirometry
,	,	,
anthropometrics	NNS	anthropometric
,	,	,
hospitalisations	NNS	hospitalisation
and	CC	and
antibiotic	JJ	antibiotic
sensitivity	NN	sensitivity
data	NNS	datum
were	VVD	be
recorded	VBN	record
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
first	JJ	first
100	CD	100
sputum	NN	sputum
samples	NNS	sample
(	(	(
first	JJ	first
50	CD	50
patients	NNS	patient
at	IN	at
each	DT	each
clinic	NN	clinic
)	)	)
harboured	VBD	harbour
163	CD	163
isolates	NNS	isolate
of	IN	of
P	NN	P
.	SENT	.
aeruginosa	NN	aeruginosa
.	SENT	.
.	SENT	.
A	DT	A
total	NN	total
of	IN	of
39	CD	39
patients	NNS	patient
shared	VBD	share
a	DT	a
common	JJ	common
strain	NN	strain
(	(	(
pulsotype	NN	pulsotype
2	CD	2
)	)	)
,	,	,
20	CD	20
patients	NNS	patient
shared	VBD	share
a	DT	a
strain	NN	strain
with	IN	with
at	IN	at
<FORBIDDEN ID=18 ACTION=delete>
least	JJS	least
</FORBIDDEN ID=18 ACTION=delete>
one	CD	one
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
patient	NN	patient
and	CC	and
41	CD	41
patients	NNS	patient
harboured	VBD	harbour
unique	JJ	unique
strains	NNS	strain
.	SENT	.
.	SENT	.
Eight	CD	Eight
patients	NNS	patient
shared	VBD	share
a	DT	a
strain	NN	strain
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
identical	JJ	identical
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
a	DT	a
previously	RB	previously
reported	VBN	report
Australian	JJ	Australian
transmissible	JJ	transmissible
strain	NN	strain
(	(	(
pulsotype	NN	pulsotype
1	CD	1
)	)	)
.	SENT	.
.	SENT	.
Compared	VBN	Compare
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
unique	JJ	unique
strain	NN	strain
group	NN	group
,	,	,
patients	NNS	patient
harbouring	VBG	harbour
pulsotype	NN	pulsotype
2	CD	2
were	VVD	be
younger	JJR	young
and	CC	and
had	VHD	have
poorer	JJR	poor
lung	NN	lung
function	NN	function
.	SENT	.
.	SENT	.
Treatment	NN	Treatment
requirements	NNS	requirement
were	VVD	be
similar	JJ	similar
in	IN	in
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
these	DT	these
two	CD	two
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
groups	NNS	group
,	,	,
as	IN	as
were	VVD	be
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
rates	NNS	rate
of	IN	of
multiresistance	NN	multiresistance
.	SENT	.
.	SENT	.
In	IN	In
conclusion	NN	conclusion
,	,	,
59%	CD	59%
of	IN	of
patients	NNS	patient
harboured	VBD	harbour
a	DT	a
clonal	JJ	clonal
strain	NN	strain
,	,	,
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
supporting	VBG	support
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
need	NN	need
for	IN	for
routine	JJ	routine
microbiological	JJ	microbiological
surveillance	NN	surveillance
.	SENT	.
.	SENT	.
<FORBIDDEN ID=27 ACTION=delete>
<FORBIDDEN ID=26 ACTION=delete>
In	IN	In
contrast	NN	contrast
to	TO	to
</FORBIDDEN ID=26 ACTION=delete>
</FORBIDDEN ID=27 ACTION=delete>
previously	RB	previously
described	VBN	describe
clonal	JJ	clonal
strains	NNS	strain
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
dominant	JJ	dominant
pulsotype	NN	pulsotype
was	VVD	be
indistinguishable	JJ	indistinguishable
from	IN	from
nonclonal	JJ	nonclonal
strains	NNS	strain
with	IN	with
<FORBIDDEN ID=58 ACTION=delete>
respect	NN	respect
to	TO	to
<FORBIDDEN ID=30 ACTION=delete>
</FORBIDDEN ID=58 ACTION=delete>
both	CC	both
</FORBIDDEN ID=30 ACTION=delete>
colonial	NN	colonial
morphology	NN	morphology
and	CC	and
multiresistance	NN	multiresistance
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
clinical	JJ	clinical
significance	NN	significance
of	IN	of
clonal	JJ	clonal
strains	NNS	strain
remains	VBZ	remain
uncertain	JJ	uncertain
and	CC	and
requires	VBZ	require
longitudinal	JJ	longitudinal
study	NN	study
.	SENT	.
.	SENT	.
BB-cat+ner-15358511/text	DOCUMENT	BB-cat+ner-15358511/text
Attachment	NN	Attachment
of	IN	of
Escherichia	FW	Escherichia
coli	FW	coli
O157	NN	O157
:	COLUMN	:
H7	NN	H7
grown	VBN	grow
in	IN	in
tryptic	JJ	tryptic
soy	NN	soy
broth	NN	broth
and	CC	and
nutrient	NN	nutrient
broth	NN	broth
to	TO	to
apple	VB	apple
and	CC	and
lettuce	VB	lettuce
surfaces	NNS	surface
as	IN	as
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
related	JJ	related
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
cell	NN	cell
hydrophobicity	NN	hydrophobicity
,	,	,
surface	NN	surface
charge	NN	charge
,	,	,
and	CC	and
capsule	NN	capsule
production	NN	production
.	SENT	.
.	SENT	.
This	DT	This
study	NN	study
investigated	VBD	investigate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
effect	NN	effect
of	IN	of
growth	NN	growth
in	IN	in
tryptic	JJ	tryptic
soy	NN	soy
broth	NN	broth
(	(	(
TSB	NN	TSB
)	)	)
and	CC	and
nutrient	NN	nutrient
broth	NN	broth
(	(	(
NB	NN	NB
)	)	)
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
ability	NN	ability
Escherichia	FW	Escherichia
coli	FW	coli
O157	NN	O157
:	COLUMN	:
H7	NN	H7
to	TO	to
attach	VB	attach
to	TO	to
lettuce	VB	lettuce
and	CC	and
apple	VB	apple
surfaces	NNS	surface
.	SENT	.
.	SENT	.
In	IN	In
addition	NN	addition
,	,	,
cell	NN	cell
surface	NN	surface
hydrophobicity	NN	hydrophobicity
,	,	,
charge	NN	charge
and	CC	and
capsule	NN	capsule
production	NN	production
were	VVD	be
determined	VBN	determine
on	IN	on
cells	NNS	cell
grown	VBN	grow
in	IN	in
these	DT	these
media	NNS	medium
.	SENT	.
.	SENT	.
Cells	NNS	Cell
grown	VBN	grow
in	IN	in
NB	NN	NB
attached	VBD	attach
less	JJR	less
to	TO	to
lettuce	VB	lettuce
and	CC	and
apple	VB	apple
surfaces	NNS	surface
than	IN	than
did	VBD	do
those	DT	those
grown	VBN	grow
in	IN	in
TSB	NN	TSB
.	SENT	.
.	SENT	.
TSB	NN	TSB
,	,	,
but	CC	but
not	RB	not
NB	NN	NB
,	,	,
supported	VBD	support
capsule	NN	capsule
production	NN	production
by	IN	by
E	NN	E
.	SENT	.
coli	NN	coli
O157	NN	O157
:	COLUMN	:
H7	NN	H7
.	SENT	.
.	SENT	.
Cells	NNS	Cell
grown	VBN	grow
in	IN	in
TSB	NN	TSB
were	VVD	be
<FORBIDDEN ID=82 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
hydrophilic	JJ	hydrophilic
than	IN	than
those	DT	those
grown	VBN	grow
in	IN	in
NB	NN	NB
.	SENT	.
.	SENT	.
No	DT	No
difference	NN	difference
was	VVD	be
found	VBN	find
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
electrokinetic	JJ	electrokinetic
properties	NNS	property
of	IN	of
cells	NNS	cell
grown	VBN	grow
in	IN	in
these	DT	these
media	NNS	medium
.	SENT	.
.	SENT	.
Electrostatic	JJ	Electrostatic
and	CC	and
hydrophobic	JJ	hydrophobic
interactions	NNS	interaction
and	CC	and
surface	NN	surface
proteins	NNS	protein
did	VBD	do
not	RB	not
appear	VB	appear
to	TO	to
play	VB	play
an	DT	an
important	JJ	important
role	NN	role
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
attachment	NN	attachment
of	IN	of
E	NN	E
.	SENT	.
coli	NN	coli
O157	NN	O157
:	COLUMN	:
H7	NN	H7
to	TO	to
these	DT	these
surfaces	NNS	surface
.	SENT	.
.	SENT	.
Of	IN	Of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
factors	NNS	factor
studied	VBN	study
,	,	,
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
capsule	NN	capsule
production	NN	production
was	VVD	be
associated	VBN	associate
with	IN	with
attachment	NN	attachment
ability	NN	ability
.	SENT	.
.	SENT	.
BB-cat+ner-15460321/text	DOCUMENT	BB-cat+ner-15460321/text
Mycoplasma	NN	Mycoplasma
otitis	NN	otitis
in	IN	in
California	NP	California
calves	NNS	calf
.	SENT	.
.	SENT	.
A	DT	A
retrospective	JJ	retrospective
study	NN	study
of	IN	of
Mycoplasma	NN	Mycoplasma
otitis	NN	otitis
in	IN	in
California	NP	California
calves	NNS	calf
submitted	VBN	submit
for	IN	for
necropsy	NN	necropsy
between	IN	between
1993	CD	1993
and	CC	and
2002	CD	2002
was	VVD	be
conducted	VBN	conduct
to	TO	to
characterize	VB	characterize
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
demographic	JJ	demographic
features	NNS	feature
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
disease	NN	disease
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
pathologic	JJ	pathologic
findings	NNS	finding
associated	VBN	associate
with	IN	with
infection	NN	infection
.	SENT	.
.	SENT	.
Sixty-one	CD	Sixty-one
confirmed	VBN	confirm
cases	NNS	case
of	IN	of
Mycoplasma	NN	Mycoplasma
otitis	NN	otitis
were	VVD	be
identified	VBN	identify
among	IN	among
20	CD	20
,	,	,
525	CD	525
necropsied	JJ	necropsied
cattle	NNS	cattle
.	SENT	.
.	SENT	.
All	DT	All
affected	VBN	affect
animals	NNS	animal
were	VVD	be
calves	NNS	calf
,	,	,
ranging	VBG	range
in	IN	in
age	NN	age
from	IN	from
2	CD	2
weeks	NNS	week
to	TO	to
4	CD	4
months	NNS	month
and	CC	and
with	IN	with
a	DT	a
median	JJ	median
age	NN	age
of	IN	of
1.5	CD	1.5
months	NNS	month
.	SENT	.
.	SENT	.
Ninety-two	CD	Ninety-two
percent	NN	percent
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cases	NNS	case
were	VVD	be
dairy	JJ	dairy
breeds	NNS	breed
.	SENT	.
.	SENT	.
A	DT	A
higher	JJR	high
percent	NN	percent
of	IN	of
necropsied	JJ	necropsied
calves	NNS	calf
with	IN	with
Mycoplasma	NN	Mycoplasma
otitis	NN	otitis
were	VVD	be
males	NNS	male
(	(	(
0.45	CD	0.45
%	NN	%
)	)	)
than	IN	than
females	NNS	female
(	(	(
0.23	CD	0.23
%	NN	%
)	)	)
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
proportion	NN	proportion
of	IN	of
cases	NNS	case
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
had	VHD	have
Mycoplasma	NN	Mycoplasma
otitis	NN	otitis
increased	VBD	increase
from	IN	from
1993	CD	1993
to	TO	to
2002	CD	2002
,	,	,
and	CC	and
there	EX	there
was	VVD	be
a	DT	a
significant	JJ	significant
(	(	(
P	NN	P
INF	SYM	INF
0.05	CD	0.05
)	)	)
seasonal	JJ	seasonal
distribution	NN	distribution
,	,	,
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
highest	JJS	high
proportion	NN	proportion
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
spring	NN	spring
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
lowest	JJS	low
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
summer	NN	summer
months	NNS	month
.	SENT	.
.	SENT	.
Infections	NNS	Infection
involved	VBD	involve
<FORBIDDEN ID=30 ACTION=delete>
both	CC	both
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=30 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
middle	JJ	middle
and	CC	and
inner	JJ	inner
ear	NN	ear
and	CC	and
were	VVD	be
characterized	VBN	characterize
by	IN	by
a	DT	a
suppurative	JJ	suppurative
inflammatory	JJ	inflammatory
response	NN	response
with	IN	with
extensive	JJ	extensive
bony	NN	bony
involvement	NN	involvement
.	SENT	.
.	SENT	.
Three	CD	Three
species	NNS	specie
of	IN	of
Mycoplasma	NN	Mycoplasma
were	VVD	be
isolated	VBN	isolate
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
ears	NNS	ear
:	COLUMN	:
M	NN	M
.	SENT	.
bovis	NN	bovis
,	,	,
M	NN	M
.	SENT	.
bovirhinis	NN	bovirhinis
,	,	,
and	CC	and
M	NN	M
.	SENT	.
alkalescens	NNS	alkalescen
.	SENT	.
.	SENT	.
Concurrent	JJ	Concurrent
pneumonia	NN	pneumonia
occurred	VBD	occur
in	IN	in
47	CD	47
cases	NNS	case
(	(	(
77%	NN	77%
)	)	)
,	,	,
and	CC	and
Mycoplasma	NN	Mycoplasma
was	VVD	be
isolated	VBN	isolate
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
lungs	NNS	lung
of	IN	of
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
30	CD	30
of	IN	of
those	DT	those
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
cases	NNS	case
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
increasing	VBG	increase
proportion	NN	proportion
of	IN	of
Mycoplasma	NN	Mycoplasma
otitis	NN	otitis
cases	NNS	case
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
past	JJ	past
10	CD	10
years	NNS	year
emphasizes	VBZ	emphasize
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
importance	NN	importance
of	IN	of
identifying	VBG	identify
risk	NN	risk
factors	NNS	factor
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
could	MD	could
be	VV	be
modified	VBN	modify
to	TO	to
lower	VB	lower
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
incidence	NN	incidence
of	IN	of
this	DT	this
disease	NN	disease
in	IN	in
calves	NNS	calf
.	SENT	.
.	SENT	.
BB-cat+ner-15612668/text	DOCUMENT	BB-cat+ner-15612668/text
Diagnosis	NN	Diagnosis
of	IN	of
atrophic	JJ	atrophic
body	NN	body
gastritis	NN	gastritis
in	IN	in
Chinese	JJ	Chinese
patients	NNS	patient
by	IN	by
measuring	VBG	measure
serum	NN	serum
pepsinogen	NN	pepsinogen
.	SENT	.
.	SENT	.
Atrophic	JJ	Atrophic
body	NN	body
gastritis	NN	gastritis
(	(	(
ABG	NN	ABG
)	)	)
is	VVZ	be
common	JJ	common
in	IN	in
China	NP	China
.	SENT	.
.	SENT	.
Although	IN	Although
histology	NN	histology
via	IN	via
endoscopy	NN	endoscopy
is	VVZ	be
an	DT	an
efficient	JJ	efficient
and	CC	and
reliable	JJ	reliable
<FORBIDDEN ID=19 ACTION=delete>
means	NNS	mean
of	IN	of
</FORBIDDEN ID=19 ACTION=delete>
diagnosing	VBG	diagnose
ABG	NP	ABG
,	,	,
it	PP	it
is	VVZ	be
an	DT	an
invasive	JJ	invasive
procedure	NN	procedure
.	SENT	.
.	SENT	.
<FORBIDDEN ID=162 ACTION=delete>
Therefore	RB	Therefore
</FORBIDDEN ID=162 ACTION=delete>
,	,	,
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
present	JJ	present
study	NN	study
serum	NN	serum
pepsinogen	NN	pepsinogen
(	(	(
PG	NN	PG
)	)	)
was	VVD	be
used	VBN	use
as	IN	as
a	DT	a
biomarker	NN	biomarker
to	TO	to
develop	VB	develop
a	DT	a
novel	JJ	novel
noninvasive	JJ	noninvasive
test	NN	test
as	IN	as
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
first	JJ	first
option	NN	option
for	IN	for
screening	NN	screening
of	IN	of
ABG	NN	ABG
in	IN	in
<FORBIDDEN ID=87 ACTION=delete>
certain	JJ	certain
</FORBIDDEN ID=87 ACTION=delete>
groups	NNS	group
of	IN	of
Chinese	JJ	Chinese
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
study	NN	study
population	NN	population
consisted	VBD	consist
of	IN	of
81	CD	81
selected	VBN	select
dyspeptic	JJ	dyspeptic
patients	NNS	patient
(	(	(
mean	JJ	mean
age	NN	age
,	,	,
64.8	CD	64.8
+	SYM	+
/	SYM	/
-	SYM	-
0.7	CD	0.7
years	NNS	year
;	COLUMN	;
M	NN	M
:	COLUMN	:
F	NN	F
,	,	,
43	CD	43
:	COLUMN	:
38	CD	38
)	)	)
who	WP	who
underwent	VBD	undergo
diagnostic	JJ	diagnostic
gastroscopy	NN	gastroscopy
.	SENT	.
.	SENT	.
At	IN	At
<FORBIDDEN ID=18 ACTION=delete>
least	JJS	least
</FORBIDDEN ID=18 ACTION=delete>
four	CD	four
biopsy	NN	biopsy
specimens	NNS	specimen
were	VVD	be
taken	VBN	take
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
antrum	NN	antrum
and	CC	and
corpus	NN	corpus
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
stomach	NN	stomach
(	(	(
two	CD	two
specimens	NNS	specimen
from	IN	from
each	DT	each
site	NN	site
)	)	)
for	IN	for
histological	JJ	histological
diagnosis	NN	diagnosis
.	SENT	.
.	SENT	.
Blood	NN	Blood
samples	NNS	sample
for	IN	for
ELISA	NN	ELISA
assays	NNS	assay
of	IN	of
serum	NN	serum
pepsinogen	NN	pepsinogen
I	CD	I
(	(	(
PGI	NN	PGI
)	)	)
,	,	,
pepsinogen	NN	pepsinogen
II	CD	II
(	(	(
PGII	NN	PGII
)	)	)
and	CC	and
IgG	NN	IgG
antibodies	NNS	antibody
against	IN	against
Helicobacter	NN	Helicobacter
pylori	NN	pylori
(	(	(
Hp	NN	Hp
IgG	NN	IgG
)	)	)
were	VVD	be
drawn	VBN	draw
after	IN	after
endoscopy	NN	endoscopy
.	SENT	.
.	SENT	.
Cut-off	JJ	Cut-off
points	NNS	point
were	VVD	be
calculated	VBN	calculate
using	VBG	use
receiver	NN	receiver
operating	NN	operating
curves	NNS	curve
(	(	(
ROC	NN	ROC
)	)	)
.	SENT	.
.	SENT	.
There	EX	There
was	VVD	be
no	DT	no
correlation	NN	correlation
between	IN	between
serum	NN	serum
PG	NN	PG
and	CC	and
atrophy	NN	atrophy
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
antral	JJ	antral
mucosa	NN	mucosa
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
mean	JJ	mean
serum	NN	serum
concentration	NN	concentration
of	IN	of
PGI	NN	PGI
was	VVD	be
lower	JJR	low
(	(	(
P	NN	P
INF	SYM	INF
0.05	CD	0.05
)	)	)
in	IN	in
patients	NNS	patient
with	IN	with
ABG	NN	ABG
(	(	(
89.9	CD	89.9
microg	NN	microg
/	SYM	/
L	NN	L
)	)	)
than	IN	than
in	IN	in
those	DT	those
with	IN	with
normal	JJ	normal
mucosa	NN	mucosa
(	(	(
NM	NN	NM
)	)	)
and	CC	and
non-ABG	JJ	non-ABG
(	(	(
123.7	CD	123.7
microg	NN	microg
/	SYM	/
L	NN	L
and	CC	and
139.1	CD	139.1
microg	NN	microg
/	SYM	/
L	NN	L
)	)	)
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
mean	JJ	mean
ratio	NN	ratio
of	IN	of
PGI	NN	PGI
:	COLUMN	:
PGII	NN	PGII
was	VVD	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
lower	JJR	low
(	(	(
P	NN	P
INF	SYM	INF
0.01	CD	0.01
)	)	)
in	IN	in
patients	NNS	patient
with	IN	with
ABG	NN	ABG
(	(	(
6.2	CD	6.2
)	)	)
than	IN	than
in	IN	in
those	DT	those
with	IN	with
NM	NN	NM
and	CC	and
non-ABG	JJ	non-ABG
(	(	(
11.6	CD	11.6
and	CC	and
11.7	CD	11.7
)	)	)
.	SENT	.
.	SENT	.
There	EX	There
was	VVD	be
no	DT	no
difference	NN	difference
in	IN	in
serum	NN	serum
PGI	NN	PGI
or	CC	or
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
PGI	NN	PGI
:	COLUMN	:
PGII	NN	PGII
ratio	NN	ratio
between	IN	between
patients	NNS	patient
with	IN	with
and	CC	and
without	IN	without
H	NN	H
.	SYM	.
pylori	NN	pylori
infection	NN	infection
.	SENT	.
.	SENT	.
For	IN	For
diagnosing	VBG	diagnose
ABG	NP	ABG
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
area	NN	area
under	IN	under
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
ROC	NN	ROC
of	IN	of
PGI	NN	PGI
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
PGI	NN	PGI
:	COLUMN	:
PGII	NN	PGII
ratio	NN	ratio
was	VVD	be
0.741	CD	0.741
(	(	(
95%	CD	95%
CI	NP	CI
:	COLUMN	:
0.627-0.856	CD	0.627-0.856
)	)	)
and	CC	and
0.874	CD	0.874
(	(	(
95%	CD	95%
CI	NP	CI
:	COLUMN	:
0.788-0.961	CD	0.788-0.961
)	)	)
,	,	,
respectively	RB	respectively
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
maximum	NN	maximum
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Youden's	NNS	Youden'
index	NN	index
(	(	(
YI	NN	YI
)	)	)
of	IN	of
PGI	NN	PGI
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
PGI	NN	PGI
:	COLUMN	:
PGII	NN	PGII
ratio	NN	ratio
was	VVD	be
0.426	CD	0.426
and	CC	and
0.722	CD	0.722
,	,	,
respectively	RB	respectively
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
best	RBS	well
cut-off	JJ	cut-off
point	NN	point
for	IN	for
PGI	NN	PGI
was	VVD	be
97.1	CD	97.1
microg	NN	microg
/	SYM	/
L	NN	L
with	IN	with
sensitivity	NN	sensitivity
of	IN	of
67%	NN	67%
and	CC	and
specificity	NN	specificity
of	IN	of
76%	NN	76%
,	,	,
and	CC	and
for	IN	for
PGI	NN	PGI
:	COLUMN	:
PGII	NN	PGII
ratio	NN	ratio
was	VVD	be
8.1	CD	8.1
microg	NN	microg
/	SYM	/
L	NN	L
,	,	,
with	IN	with
sensitivity	NN	sensitivity
of	IN	of
89%	NN	89%
and	CC	and
specificity	NN	specificity
of	IN	of
83%	NN	83%
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
serum	NN	serum
PGI	NN	PGI
:	COLUMN	:
PGII	NN	PGII
ratio	NN	ratio
appears	VBZ	appear
to	TO	to
be	VV	be
a	DT	a
sensitive	JJ	sensitive
and	CC	and
specific	JJ	specific
assay	NN	assay
for	IN	for
corpus	NN	corpus
atrophy	NN	atrophy
,	,	,
thus	RB	thus
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
providing	VBG	provide
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
noninvasive	JJ	noninvasive
and	CC	and
indicative	JJ	indicative
test	NN	test
for	IN	for
diagnosis	NN	diagnosis
of	IN	of
atrophic	JJ	atrophic
gastritis	NN	gastritis
.	SENT	.
.	SENT	.
BB-cat+ner-15618837/text	DOCUMENT	BB-cat+ner-15618837/text
Recurrence	NN	Recurrence
of	IN	of
Helicobacter	NN	Helicobacter
pylori	NN	pylori
infection	NN	infection
1	CD	1
year	NN	year
after	IN	after
successful	JJ	successful
treatment	NN	treatment
:	COLUMN	:
prospective	JJ	prospective
cohort	JJ	cohort
study	NN	study
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Republic	NP	Republic
of	IN	of
Yemen	NP	Yemen
.	SENT	.
.	SENT	.
To	TO	To
investigate	VB	investigate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
prevalence	NN	prevalence
of	IN	of
Helicobacter	NN	Helicobacter
pylori	NN	pylori
infection	NN	infection
in	IN	in
dyspeptic	JJ	dyspeptic
patients	NNS	patient
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Republic	NP	Republic
of	IN	of
Yemen	NP	Yemen
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
recurrence	NN	recurrence
rate	NN	rate
1	CD	1
year	NN	year
after	IN	after
apparently	RB	apparently
successful	JJ	successful
eradication	NN	eradication
.	SENT	.
.	SENT	.
A	DT	A
total	NN	total
of	IN	of
275	CD	275
patients	NNS	patient
with	IN	with
chronic	JJ	chronic
dyspepsia	NN	dyspepsia
seen	VBN	see
in	IN	in
one	CD	one
clinic	NN	clinic
were	VVD	be
enrolled	VBN	enrol
.	SENT	.
.	SENT	.
Gastric	JJ	Gastric
biopsies	NNS	biopsy
were	VVD	be
obtained	VBN	obtain
at	IN	at
endoscopy	NN	endoscopy
and	CC	and
H	NN	H
.	VBD	.
pylori	NN	pylori
infection	NN	infection
was	VVD	be
diagnosed	VBN	diagnose
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
using	VBG	use
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
rapid	JJ	rapid
urease	NN	urease
test	NN	test
.	SENT	.
.	SENT	.
Patients	NNS	Patient
with	IN	with
H	NN	H
.	SYM	.
pylori	NN	pylori
infection	NN	infection
were	VVD	be
given	VBN	give
either	CC	either
clarithromycin	NN	clarithromycin
or	CC	or
metronidazole	NN	metronidazole
-	HYPH	-
based	VBN	base
triple	JJ	triple
therapy	NN	therapy
.	SENT	.
.	SENT	.
Six	CD	Six
weeks	NNS	week
later	RB	later
H	NN	H
.	VBD	.
pylori	NN	pylori
status	NN	status
was	VVD	be
assessed	VBN	assess
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
using	VBG	use
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
C-urea	NN	C-urea
breath	NN	breath
test	NN	test
(	(	(
C-UBT	NN	C-UBT
)	)	)
.	SENT	.
.	SENT	.
Those	DT	Those
who	WP	who
were	VVD	be
negative	JJ	negative
for	IN	for
H	NN	H
.	NN	.
pylori	NNS	pylorus
had	VHD	have
a	DT	a
<FORBIDDEN ID=79 ACTION=delete>
further	JJ	further
</FORBIDDEN ID=79 ACTION=delete>
C-UBT	NN	C-UBT
after	IN	after
1	CD	1
year	NN	year
to	TO	to
establish	VB	establish
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
recurrence	NN	recurrence
rate	NN	rate
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
prevalence	NN	prevalence
of	IN	of
H	NN	H
.	SYM	.
pylori	NN	pylori
infection	NN	infection
at	IN	at
entry	NN	entry
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
study	NN	study
was	VVD	be
82.2	CD	82.2
%	NN	%
[	(	[
95%	CD	95%
confidence	NN	confidence
interval	NN	interval
(	(	(
CI	NN	CI
)	)	)
78-87	CD	78-87
%	NN	%
]	)	]
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
overall	JJ	overall
eradication	NN	eradication
rate	NN	rate
6	CD	6
weeks	NNS	week
after	IN	after
treatment	NN	treatment
was	VVD	be
49.1	CD	49.1
%	NN	%
(	(	(
95%	CD	95%
CI	NN	CI
42.6-55.6	CD	42.6-55.6
%	NN	%
)	)	)
by	IN	by
intention-to	AFX	intention-to
-	HYPH	-
treat	NN	treat
analysis	NN	analysis
,	,	,
and	CC	and
60%	CD	60%
(	(	(
95%	CD	95%
CI	NN	CI
53-67	CD	53-67
%	NN	%
)	)	)
by	IN	by
per-protocol	JJ	per-protocol
analysis	NN	analysis
.	SENT	.
.	SENT	.
Recurrence	NN	Recurrence
rate	NN	rate
of	IN	of
H	NN	H
.	SYM	.
pylori	NN	pylori
infection	NN	infection
at	IN	at
1	CD	1
year	NN	year
was	VVD	be
34%	CD	34%
(	(	(
95%	CD	95%
CI	NN	CI
14-45	CD	14-45
%	NN	%
)	)	)
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=156 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
only	JJ	only
</FORBIDDEN ID=156 ACTION=delete>
predictor	NN	predictor
of	IN	of
recurrence	NN	recurrence
was	VVD	be
an	DT	an
excess	JJ	excess
delta	NN	delta
C-UBT	NN	C-UBT
value	NN	value
less	JJR	less
than	IN	than
3.5	CD	3.5
per	IN	per
million	CD	million
but	CC	but
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
equal	JJ	equal
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
or	CC	or
greater	JJR	great
than	IN	than
2.5	CD	2.5
per	IN	per
million	CD	million
at	IN	at
6	CD	6
weeks	NNS	week
after	IN	after
treatment	NN	treatment
(	(	(
odds	NNS	odd
ratio	NN	ratio
2.28	CD	2.28
;	COLUMN	;
95%	CD	95%
CI	NN	CI
1.17-4.44	CD	1.17-4.44
;	COLUMN	;
P	NN	P
=	SYM	=
0.028	CD	0.028
)	)	)
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
prevalence	NN	prevalence
of	IN	of
H	NN	H
.	SYM	.
pylori	NN	pylori
infection	NN	infection
in	IN	in
dyspeptic	JJ	dyspeptic
patients	NNS	patient
in	IN	in
Yemen	NN	Yemen
is	VVZ	be
very	RB	very
high	JJ	high
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
eradication	NN	eradication
rate	NN	rate
with	IN	with
standard	JJ	standard
triple	JJ	triple
therapy	NN	therapy
was	VVD	be
unsatisfactory	JJ	unsatisfactory
<FORBIDDEN ID=163 ACTION=delete>
probably	RB	probably
</FORBIDDEN ID=163 ACTION=delete>
because	IN	because
of	IN	of
widespread	JJ	widespread
bacterial	JJ	bacterial
resistance	NN	resistance
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
due	JJ	due
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
unrestricted	JJ	unrestricted
antibiotic	JJ	antibiotic
use	NN	use
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
recurrence	NN	recurrence
rate	NN	rate
of	IN	of
infection	NN	infection
at	IN	at
1	CD	1
year	NN	year
was	VVD	be
high	JJ	high
,	,	,
as	IN	as
a	DT	a
result	NN	result
of	IN	of
recrudescence	NN	recrudescence
of	IN	of
incompletely	RB	incompletely
eradicated	VBN	eradicate
organisms	NNS	organism
rather	RB	rather
than	IN	than
reinfection	NN	reinfection
.	SENT	.
.	SENT	.
BB-cat+ner-15626953/text	DOCUMENT	BB-cat+ner-15626953/text
Haemophilus	NP	Haemophilus
influenzae	NNS	influenzae
:	COLUMN	:
a	DT	a
significant	JJ	significant
pathogen	NN	pathogen
in	IN	in
acute	JJ	acute
otitis	NN	otitis
media	NNS	medium
.	SENT	.
.	SENT	.
Haemophilus	NP	Haemophilus
influenzae	NN	influenzae
is	VVZ	be
a	DT	a
major	JJ	major
pathogen	NN	pathogen
in	IN	in
acute	JJ	acute
otitis	NN	otitis
media	NNS	medium
(	(	(
AOM	NN	AOM
)	)	)
causing	VBG	cause
disease	NN	disease
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
is	VVZ	be
not	RB	not
clinically	RB	clinically
distinguishable	JJ	distinguishable
from	IN	from
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	DT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
caused	VBN	cause
by	IN	by
Streptococcus	NP	Streptococcus
pneumoniae	NP	pneumoniae
.	SENT	.
.	SENT	.
AOM	NN	AOM
caused	VBN	cause
by	IN	by
H	NN	H
.	SYM	.
influenzae	NN	influenzae
is	VVZ	be
particularly	RB	particularly
associated	VBN	associate
with	IN	with
older	JJR	old
age	NN	age
and	CC	and
recurrent	JJ	recurrent
disease	NN	disease
.	SENT	.
.	SENT	.
Antibiotics	NNS	Antibiotic
differ	VBP	differ
in	IN	in
their	PP$	their
ability	NN	ability
to	TO	to
eradicate	VB	eradicate
H	NN	H
.	SYM	.
influenzae	NN	influenzae
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
middle	JJ	middle
ear	JJ	ear
space	NN	space
.	SENT	.
.	SENT	.
In	IN	In
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
United	NP	United
States	NPS	State
,	,	,
widespread	JJ	widespread
pneumococcal	JJ	pneumococcal
vaccination	NN	vaccination
has	VHZ	have
increased	VBN	increase
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
importance	NN	importance
of	IN	of
H	NN	H
.	VBD	.
influenzae	NNS	influenzae
as	IN	as
a	DT	a
major	JJ	major
therapeutic	JJ	therapeutic
challenge	NN	challenge
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
treatment	NN	treatment
of	IN	of
AOM	NN	AOM
.	SENT	.
.	SENT	.
BB-cat+ner-16263187/text	DOCUMENT	BB-cat+ner-16263187/text
Ability	NN	Ability
of	IN	of
Lactobacillus	NN	Lactobacillus
gasseri	NN	gasseri
K	NN	K
7	CD	7
to	TO	to
inhibit	VB	inhibit
Escherichia	FW	Escherichia
coli	FW	coli
adhesion	NN	adhesion
in vitro	FW	in_vitro
on	IN	on
Caco	NP	Caco
-2	CD	-2
cells	NNS	cell
and	CC	and
ex vivo	NN	ex_vivo
on	IN	on
pigs'	NN	pigs'
jejunal	JJ	jejunal
tissue	NN	tissue
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
ability	NN	ability
of	IN	of
Lactobacillus	NN	Lactobacillus
(	(	(
Lb	NN	Lb
.	SENT	.
)	)	)
gasseri	JJ	gasseri
K	NN	K
7	CD	7
to	TO	to
inhibit	VB	inhibit
adhesion	NN	adhesion
of	IN	of
Escherichia	FW	Escherichia
coli	FW	coli
O8	NN	O8
:	COLUMN	:
K88	NN	K88
to	TO	to
intestinal	JJ	intestinal
mucosa	NN	mucosa
was	VVD	be
studied	VBN	study
on	IN	on
cultured	VBN	culture
Caco	NP	Caco
-2	CD	-2
cells	NNS	cell
and	CC	and
ex vivo	NN	ex_vivo
on	IN	on
pigs'	NN	pigs'
small	JJ	small
intestinal	JJ	intestinal
tissue	NN	tissue
.	SENT	.
.	SENT	.
Lactobacilli	NNS	Lactobacillus
were	VVD	be
added	VBN	add
simultaneously	RB	simultaneously
with	IN	with
E	NN	E
.	SENT	.
coli	NN	coli
,	,	,
before	IN	before
E	NN	E
.	SENT	.
coli	NN	coli
and	CC	and
after	IN	after
E	NN	E
.	SENT	.
coli	NN	coli
for	IN	for
competition	NN	competition
,	,	,
exclusion	NN	exclusion
and	CC	and
displacement	NN	displacement
assays	NNS	assay
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
concentration	NN	concentration
of	IN	of
lactobacilli	NN	lactobacilli
on	IN	on
fully	RB	fully
differentiated	VBN	differentiate
Caco	NP	Caco
-2	CD	-2
cells	NNS	cell
was	VVD	be
4.5	CD	4.5
+	SYM	+
/	SYM	/
-0.3	CD	-0.3
x	SYM	x
10(8)	CD	10(8)
cfu	NN	cfu
/	SYM	/
well	NN	well
,	,	,
while	IN	while
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
concentration	NN	concentration
of	IN	of
E	NN	E
.	SENT	.
coli	NN	coli
varied	VBD	vary
from	IN	from
1.5	CD	1.5
x	SYM	x
10(6)	CD	10(6)
to	TO	to
4.3	CD	4.3
x	SYM	x
10(8)	CD	10(8)
cfu	NN	cfu
/	SYM	/
well	RB	well
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
number	NN	number
of	IN	of
E	NN	E
.	SENT	.
coli	NNS	coli
adhered	VBD	adhere
to	TO	to
Caco	NP	Caco
-2	CD	-2
monolayer	NN	monolayer
(	(	(
cfu	NN	cfu
/	SYM	/
well	NN	well
)	)	)
was	VVD	be
lineary	JJ	lineary
correlated	VBN	correlate
(R(2)=	NN	(R(2)=
0.97	CD	0.97
)	)	)
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
concentration	NN	concentration
of	IN	of
added	VBN	add
cells	NNS	cell
.	SENT	.
.	SENT	.
In	IN	In
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
assay	NN	assay
simulating	VBG	simulate
exclusion	NN	exclusion
,	,	,
E	NN	E
.	SENT	.
coli	NN	coli
adhesion	NN	adhesion
was	VVD	be
reduced	VBN	reduce
by	IN	by
Lb	NN	Lb
.	SENT	.
gasseri	NP	gasseri
K	NP	K
7	CD	7
strain	NN	strain
by	IN	by
0.1	CD	0.1
to	TO	to
0.6	CD	0.6
log	NN	log
cfu	NN	cfu
/	SYM	/
well	RB	well
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
binding	NN	binding
of	IN	of
E	NN	E
.	SENT	.
coli	NN	coli
was	VVD	be
inhibited	VBN	inhibit
<FORBIDDEN ID=157 ACTION=delete>
even	RB	even
<FORBIDDEN ID=82 ACTION=delete>
</FORBIDDEN ID=157 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
when	WRB	when
incubated	VBN	incubate
simultaneously	RB	simultaneously
with	IN	with
lactobacilli	NN	lactobacilli
,	,	,
particularly	RB	particularly
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
lowest	JJS	low
concentration	NN	concentration
of	IN	of
E	NN	E
.	SENT	.
coli	NN	coli
(	(	(
ratio	NN	ratio
E	NN	E
.	SENT	.
coli	NN	coli
/	SYM	/
lactobacilli	NN	lactobacilli
1	CD	1
:	COLUMN	:
248	CD	248
)	)	)
,	,	,
where	WRB	where
five	CD	five
-	HYPH	-
times	NNS	time
reduction	NN	reduction
(	(	(
or	CC	or
0.7	CD	0.7
log	NN	log
)	)	)
was	VVD	be
observed	VBN	observe
.	SENT	.
.	SENT	.
When	WRB	When
adhesion	NN	adhesion
to	TO	to
tissue	NN	tissue
derived	VBN	derive
from	IN	from
pigs'	NN	pigs'
jejunum	NN	jejunum
was	VVD	be
tested	VBN	test
,	,	,
concentration	NN	concentration
of	IN	of
E	NN	E
.	SENT	.
coli	NN	coli
was	VVD	be
constant	JJ	constant
(	(	(
6.9	CD	6.9
+	SYM	+
/	SYM	/
-0.14	CD	-0.14
x	SYM	x
10(7)	CD	10(7)
cfu	NN	cfu
/	SYM	/
ml	NN	ml
)	)	)
,	,	,
while	IN	while
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
concentration	NN	concentration
of	IN	of
Lb	NP	Lb
.	SENT	.
gasseri	NP	gasseri
K	NP	K
7	NP	7
was	VVD	be
5.9	CD	5.9
x	SYM	x
10(7)	CD	10(7)
and	CC	and
1.3	CD	1.3
x	SYM	x
10(7)	CD	10(7)
cfu	NN	cfu
/	SYM	/
ml	NN	ml
in	IN	in
two	CD	two
independent	JJ	independent
experiments	NNS	experiment
,	,	,
respectively	RB	respectively
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
adhesion	NN	adhesion
of	IN	of
E	NN	E
.	SENT	.
coli	NN	coli
and	CC	and
Lb	NN	Lb
.	SENT	.
gasseri	NP	gasseri
K	NP	K
7	CD	7
cells	NNS	cell
to	TO	to
jejunal	JJ	jejunal
mucosa	NN	mucosa
was	VVD	be
similar	JJ	similar
(	(	(
1.0	CD	1.0
+	SYM	+
/	SYM	/
-0.17	CD	-0.17
x	SYM	x
10(6)	CD	10(6)
and	CC	and
1.54	CD	1.54
+	SYM	+
/	SYM	/
-0.10	CD	-0.10
x	SYM	x
10(6)	CD	10(6)
cfu	NN	cfu
/	SYM	/
cm(2))	NN	cm(2))
when	WRB	when
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
concentrations	NNS	concentration
of	IN	of
single	JJ	single
strains	NNS	strain
in	IN	in
suspensions	NNS	suspension
were	VVD	be
approximately	RB	approximately
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=16 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
same	JJ	same
</FORBIDDEN ID=16 ACTION=delete>
.	SENT	.
.	SENT	.
No	DT	No
significant	JJ	significant
competition	NN	competition
,	,	,
exclusion	NN	exclusion
or	CC	or
displacement	NN	displacement
of	IN	of
E	NN	E
.	SENT	.
coli	NN	coli
by	IN	by
lactobacilli	NN	lactobacilli
was	VVD	be
observed	VBN	observe
on	IN	on
jejunal	JJ	jejunal
tissue	NN	tissue
.	SENT	.
.	SENT	.
In	IN	In
conclusion	NN	conclusion
,	,	,
Lb	NP	Lb
.	SENT	.
gasseri	NP	gasseri
K	NP	K
7	NP	7
was	VVD	be
found	VBN	find
to	TO	to
be	VV	be
effective	JJ	effective
in	IN	in
reducing	VBG	reduce
E	NN	E
.	SENT	.
coli	NN	coli
adhesion	NN	adhesion
to	TO	to
Caco	NP	Caco
-2	CD	-2
enterocytes	NNS	enterocyte
,	,	,
but	CC	but
it	PP	it
was	VVD	be
not	RB	not
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
able	JJ	able
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
do	VB	do
so	RB	so
in	IN	in
ex vivo	NN	ex_vivo
conditions	NNS	condition
tested	VBN	test
for	IN	for
pig	NN	pig
jejunal	JJ	jejunal
tissue	NN	tissue
.	SENT	.
.	SENT	.
BB-cat+ner-16273411/text	DOCUMENT	BB-cat+ner-16273411/text
<FORBIDDEN ID=45 ACTION=delete>
Early	JJ	Early
</FORBIDDEN ID=45 ACTION=delete>
pregnancy	NN	pregnancy
loss	NN	loss
and	CC	and
neonatal	JJ	neonatal
deaths	NNS	death
associated	VBN	associate
with	IN	with
Klebsiella	NN	Klebsiella
pneumonia	NN	pneumonia
infection	NN	infection
:	COLUMN	:
a	DT	a
mini	NN	mini
review	NN	review
of	IN	of
possible	JJ	possible
occupational	JJ	occupational
health	NN	health
risk	NN	risk
.	SENT	.
.	SENT	.
Recurrent	JJ	Recurrent
pregnancy	NN	pregnancy
loss	NN	loss
is	VVZ	be
a	DT	a
disease	NN	disease
of	IN	of
grave	NN	grave
psychological	JJ	psychological
and	CC	and
economic	JJ	economic
concern	NN	concern
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
etiology	NN	etiology
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
vast	JJ	vast
majority	NN	majority
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cases	NNS	case
is	VVZ	be
unknown	JJ	unknown
or	CC	or
at	IN	at
best	RB	best
poorly	RB	poorly
understood	VBN	understand
.	SENT	.
.	SENT	.
Although	IN	Although
Klebsiella	NN	Klebsiella
pneumonia	NN	pneumonia
infections	NNS	infection
have	VHP	have
been	VVN	be
reported	VBN	report
in	IN	in
humans	NNS	human
and	CC	and
animals	NNS	animal
during	IN	during
pregnancy	NN	pregnancy
,	,	,
there	EX	there
is	VVZ	be
hardly	RB	hardly
any	DT	any
information	NN	information
to	TO	to
indicate	VB	indicate
whether	IN	whether
or	CC	or
not	RB	not
these	DT	these
infections	NNS	infection
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
be	VV	be
responsible	JJ	responsible
for	IN	for
<FORBIDDEN ID=45 ACTION=delete>
early	JJ	early
</FORBIDDEN ID=45 ACTION=delete>
pregnancy	NN	pregnancy
loss	NN	loss
.	SENT	.
.	SENT	.
We	PP	We
present	VBP	present
a	DT	a
review	NN	review
of	IN	of
literature	NN	literature
and	CC	and
report	NN	report
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
first	JJ	first
time	NN	time
in	IN	in
humans	NNS	human
,	,	,
Klebsiella	NN	Klebsiella
pneumonia	NN	pneumonia
infection	NN	infection
in	IN	in
placenta	NN	placenta
of	IN	of
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
a	DT	a
38	CD	38
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
-	HYPH	-
year-old	JJ	year-old
secondary	JJ	secondary
recurrent	JJ	recurrent
aborter	NN	aborter
(	(	(
parity	NN	parity
2	CD	2
+	SYM	+
3	CD	3
)	)	)
.	SENT	.
.	SENT	.
BB-cat+ner-16432479/text	DOCUMENT	BB-cat+ner-16432479/text
Challenges	NNS	Challenge
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
control	NN	control
of	IN	of
gonorrhea	NN	gonorrhea
in	IN	in
South	NP	South
America	NP	America
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Caribbean	NP	Caribbean
:	COLUMN	:
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
monitoring	VBG	monitor
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
development	NN	development
of	IN	of
resistance	NN	resistance
to	TO	to
antibiotics	NNS	antibiotic
.	SENT	.
:	COLUMN	:
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
objective	NN	objective
of	IN	of
this	DT	this
study	NN	study
was	VVD	be
to	TO	to
ascertain	VB	ascertain
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
antimicrobial	JJ	antimicrobial
susceptibility	NN	susceptibility
of	IN	of
Neisseria	NP	Neisseria
gonorrhoeae	NP	gonorrhoeae
isolates	NNS	isolate
from	IN	from
6	CD	6
South	JJ	South
American	JJ	American
and	CC	and
13	CD	13
Caribbean	JJ	Caribbean
countries	NNS	country
participating	VBG	participate
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Gonococcal	NP	Gonococcal
Antimicrobial	NP	Antimicrobial
Surveillance	NP	Surveillance
Program	NP	Program
(	(	(
GASP	NN	GASP
)	)	)
from	IN	from
1990	CD	1990
to	TO	to
1999	CD	1999
.	SENT	.
:	COLUMN	:
A	DT	A
GASP	NN	GASP
network	NN	network
of	IN	of
laboratories	NNS	laboratory
was	VVD	be
launched	VBN	launch
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Americas	NP	Americas
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Caribbean	NP	Caribbean
during	IN	during
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
1990s	CD	1990s
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
.	SENT	.
.	SENT	.
Standardized	JJ	Standardized
methods	NNS	method
and	CC	and
interpretative	JJ	interpretative
criteria	NNS	criterion
were	VVD	be
established	VBN	establish
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
isolation	NN	isolation
of	IN	of
N	NN	N
.	SENT	.
gonorrhoeae	NNS	gonorrhoeae
,	,	,
strain	NN	strain
identification	NN	identification
,	,	,
and	CC	and
determination	NN	determination
,	,	,
and	CC	and
quality	NN	quality
control	NN	control
of	IN	of
antimicrobial	JJ	antimicrobial
susceptibility	NN	susceptibility
.	SENT	.
:	COLUMN	:
Two	CD	Two
countries	NNS	country
(	(	(
Argentina	NP	Argentina
and	CC	and
Uruguay	NP	Uruguay
)	)	)
maintained	VBD	maintain
continuous	JJ	continuous
surveillance	NN	surveillance
during	IN	during
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
study	NN	study
period	NN	period
.	SENT	.
.	SENT	.
Some	DT	Some
countries	NNS	country
gathered	VBD	gather
data	NNS	datum
periodically	RB	periodically
and	CC	and
several	JJ	several
<FORBIDDEN ID=22 ACTION=delete>
others	NNS	other
</FORBIDDEN ID=22 ACTION=delete>
were	VVD	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
unable	JJ	unable
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
initiate	VB	initiate
antimicrobial	JJ	antimicrobial
surveillance	NN	surveillance
as	IN	as
a	DT	a
result	NN	result
of	IN	of
lack	NN	lack
of	IN	of
resources	NNS	resource
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
percentage	NN	percentage
of	IN	of
penicillin	NN	penicillin
-	HYPH	-
resistant	JJ	resistant
N	NN	N
.	SENT	.
gonorrhoeae	NNS	gonorrhoeae
isolated	VBN	isolate
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
region	NN	region
over	IN	over
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
decade	NN	decade
varied	VBD	vary
considerably	RB	considerably
(	(	(
1.0-11.9	CD	1.0-11.9
%	NN	%
carried	VBD	carry
chromosomal	JJ	chromosomal
resistance	NN	resistance
and	CC	and
17.9-38.8	CD	17.9-38.8
%	NN	%
produced	VBN	produce
beta	SYM	beta
-	HYPH	-
lactamase	NN	lactamase
)	)	)
with	IN	with
an	DT	an
overall	JJ	overall
trend	NN	trend
to	TO	to
declining	VBG	decline
numbers	NNS	number
of	IN	of
penicillin	NN	penicillin
-	HYPH	-
resistant	JJ	resistant
isolates	NNS	isolate
.	SENT	.
.	SENT	.
For	IN	For
tetracycline	NN	tetracycline
,	,	,
7.4	CD	7.4
%	NN	%
to	TO	to
36.3	CD	36.3
%	NN	%
carried	VBD	carry
chromosomal	JJ	chromosomal
resistance	NN	resistance
,	,	,
whereas	IN	whereas
12.0	CD	12.0
%	NN	%
to	TO	to
27.4	CD	27.4
%	NN	%
carried	VBD	carry
plasmid	NN	plasmid
-	HYPH	-
mediated	VBN	mediate
resistance	NN	resistance
.	SENT	.
.	SENT	.
There	EX	There
were	VVD	be
no	DT	no
reports	NNS	report
of	IN	of
ciprofloxacin	NN	ciprofloxacin
-	HYPH	-
resistant	JJ	resistant
isolates	NNS	isolate
,	,	,
although	IN	although
N	NN	N
.	SENT	.
gonorrhoeae	NNS	gonorrhoeae
with	IN	with
decreased	VBN	decrease
susceptibility	NN	susceptibility
to	TO	to
ciprofloxacin	NN	ciprofloxacin
and	CC	and
azithromycin	NN	azithromycin
as	RB	as
well	RB	well
as	IN	as
spectinomycin	NN	spectinomycin
-	HYPH	-
resistant	JJ	resistant
isolates	NNS	isolate
were	VVD	be
identified	VBN	identify
in	IN	in
some	DT	some
countries	NNS	country
.	SENT	.
.	SENT	.
BB-cat+ner-16436701/text	DOCUMENT	BB-cat+ner-16436701/text
Antibacterial	JJ	Antibacterial
properties	NNS	property
of	IN	of
dermaseptin	NN	dermaseptin
S4	NN	S4
derivatives	NNS	derivative
under	IN	under
extreme	JJ	extreme
incubation	NN	incubation
conditions	NNS	condition
.	SENT	.
.	SENT	.
Antibacterial	JJ	Antibacterial
properties	NNS	property
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
frog	NN	frog
-	HYPH	-
derived	VBN	derive
peptide	NN	peptide
dermaseptin	NN	dermaseptin
S4	NN	S4
and	CC	and
a	DT	a
series	NN	series
of	IN	of
synthetic	JJ	synthetic
derivatives	NNS	derivative
against	IN	against
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
food	NN	food
pathogen	NN	pathogen
Escherichia	FW	Escherichia
coli	FW	coli
O157	NN	O157
:	COLUMN	:
H7	NN	H7
were	VVD	be
investigated	VBN	investigate
under	IN	under
extreme	JJ	extreme
incubation	NN	incubation
conditions	NNS	condition
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
28-mer	JJ	28-mer
analog	NN	analog
K4K20S4	NN	K4K20S4
(	(	(
P28	NN	P28
)	)	)
displayed	VBD	display
an	DT	an
MIC	NN	MIC
of	IN	of
8	CD	8
microM	NN	microM
and	CC	and
rapid	JJ	rapid
bactericidal	JJ	bactericidal
kinetics	NNS	kinetic
under	IN	under
standard	JJ	standard
culture	NN	culture
conditions	NNS	condition
.	SENT	.
.	SENT	.
Potent	JJ	Potent
bactericidal	JJ	bactericidal
properties	NNS	property
were	VVD	be
maintained	VBN	maintain
at	IN	at
high	JJ	high
salt	NN	salt
concentrations	NNS	concentration
,	,	,
under	IN	under
acidic	JJ	acidic
or	CC	or
basic	JJ	basic
conditions	NNS	condition
,	,	,
and	CC	and
at	IN	at
extreme	JJ	extreme
temperatures	NNS	temperature
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
N-terminal	JJ	N-terminal
14-mer	NN	14-mer
sequence	NN	sequence
(	(	(
P14	NN	P14
)	)	)
displayed	VBD	display
higher	JJR	high
potency	NN	potency
(	(	(
MIC	NN	MIC
,	,	,
4	CD	4
microM	NN	microM
)	)	)
but	CC	but
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
within	IN	within
a	DT	a
narrow	JJ	narrow
range	NN	range
of	IN	of
incubation	NN	incubation
conditions	NNS	condition
,	,	,
<FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
pointing	VBG	point
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
importance	NN	importance
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
C-terminal	JJ	C-terminal
domain	NN	domain
of	IN	of
P28	NN	P28
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
potency	NN	potency
range	NN	range
was	VVD	be
reextended	VBN	reextende
upon	IN	upon
conjugation	NN	conjugation
of	IN	of
aminododecanoic	JJ	aminododecanoic
acid	NN	acid
to	TO	to
P14	NN	P14
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
resulting	VBG	result
lipopeptide	NN	lipopeptide
was	VVD	be
<FORBIDDEN ID=157 ACTION=delete>
even	RB	even
<FORBIDDEN ID=82 ACTION=delete>
</FORBIDDEN ID=157 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
potent	JJ	potent
(	(	(
MIC	NN	MIC
,	,	,
2	CD	2
microM	NN	microM
)	)	)
and	CC	and
affected	VBN	affect
bacterial	JJ	bacterial
viability	NN	viability
under	IN	under
most	JJS	most
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
conditions	NNS	condition
tested	VBN	test
,	,	,
including	VBG	include
in	IN	in
commercial	JJ	commercial
apple	NN	apple
juice	NN	juice
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
mechanistic	JJ	mechanistic
implications	NNS	implication
of	IN	of
peptides'	NN	peptides'
hydrophobicity	NN	hydrophobicity
,	,	,
charge	NN	charge
,	,	,
structure	NN	structure
,	,	,
and	CC	and
binding	NN	binding
to	TO	to
an	DT	an
idealized	VBN	idealize
membrane	NN	membrane
were	VVD	be
probed	VBN	probe
and	CC	and
are	VVP	be
discussed	VBN	discuss
here	RB	here
.	SENT	.
.	SENT	.
Collectively	RB	Collectively
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
data	NNS	datum
indicate	VBP	indicate
interest	NN	interest
in	IN	in
simple	JJ	simple
peptide	NN	peptide
-	HYPH	-
based	VBN	base
compounds	NNS	compound
for	IN	for
design	NN	design
of	IN	of
antimicrobials	NNS	antimicrobial
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
affect	VBP	affect
pathogens	NNS	pathogen
under	IN	under
a	DT	a
variable	JJ	variable
range	NN	range
of	IN	of
incubation	NN	incubation
conditions	NNS	condition
.	SENT	.
.	SENT	.
BB-cat+ner-16458564/text	DOCUMENT	BB-cat+ner-16458564/text
Etiology	NN	Etiology
and	CC	and
epidemiology	NN	epidemiology
of	IN	of
diarrhea	NN	diarrhea
in	IN	in
children	NNS	child
in	IN	in
Hanoi	NP	Hanoi
,	,	,
Vietnam	NP	Vietnam
.	SENT	.
.	SENT	.
This	DT	This
paper	NN	paper
provides	VBZ	provide
a	DT	a
preliminary	JJ	preliminary
picture	NN	picture
of	IN	of
diarrhea	NN	diarrhea
with	IN	with
<FORBIDDEN ID=150 ACTION=delete>
regards	NNS	regard
</FORBIDDEN ID=150 ACTION=delete>
to	TO	to
etiology	NN	etiology
,	,	,
clinical	JJ	clinical
symptoms	NNS	symptom
,	,	,
and	CC	and
some	DT	some
related	VBN	relate
epidemiologic	JJ	epidemiologic
factors	NNS	factor
in	IN	in
children	NNS	child
less	JJR	less
than	IN	than
five	CD	five
years	NNS	year
of	IN	of
age	NN	age
living	NN	living
in	IN	in
Hanoi	NP	Hanoi
,	,	,
Vietnam	NP	Vietnam
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
study	NN	study
population	NN	population
included	VBD	include
587	CD	587
children	NNS	child
with	IN	with
diarrhea	NN	diarrhea
and	CC	and
249	CD	249
age-matched	JJ	age-matched
healthy	JJ	healthy
controls	NNS	control
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
identification	NN	identification
of	IN	of
pathogens	NNS	pathogen
was	VVD	be
carried	VBN	carry
out	RP	out
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
conventional	JJ	conventional
methods	NNS	method
in	IN	in
combination	NN	combination
with	IN	with
ELISA	NN	ELISA
,	,	,
immunoseparation	NN	immunoseparation
,	,	,
and	CC	and
PCR	NN	PCR
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
antibiotic	JJ	antibiotic
susceptibility	NN	susceptibility
was	VVD	be
determined	VBN	determine
by	IN	by
MIC	NN	MIC
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
following	VBG	follow
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
NCCLS	NN	NCCLS
recommendations	NNS	recommendation
.	SENT	.
.	SENT	.
Of	IN	Of
those	DT	those
with	IN	with
diarrhea	NN	diarrhea
,	,	,
40.9	CD	40.9
%	NN	%
were	VVD	be
less	JJR	less
than	IN	than
one	CD	one
year	NN	year
old	JJ	old
and	CC	and
71.0	CD	71.0
%	NN	%
were	VVD	be
less	JJR	less
than	IN	than
two	CD	two
years	NNS	year
old	JJ	old
.	SENT	.
.	SENT	.
A	DT	A
potential	JJ	potential
pathogen	NN	pathogen
was	VVD	be
identified	VBN	identify
in	IN	in
67.3	CD	67.3
%	NN	%
of	IN	of
children	NNS	child
with	IN	with
diarrhea	NN	diarrhea
.	SENT	.
.	SENT	.
They	PP	They
were	VVD	be
group	NN	group
A	NN	A
rotavirus	NN	rotavirus
,	,	,
diarrheagenic	JJ	diarrheagenic
Escherichia	NP	Escherichia
coli	NP	coli
,	,	,
Shigella	NP	Shigella
spp	NN	spp
,	,	,
and	CC	and
enterotoxigenic	JJ	enterotoxigenic
Bacteroides	NNS	Bacteroide
fragilis	NN	fragilis
,	,	,
with	IN	with
prevalences	NNS	prevalence
of	IN	of
46.7	CD	46.7
%	NN	%
,	,	,
22.5	CD	22.5
%	NN	%
,	,	,
4.7	CD	4.7
%	NN	%
,	,	,
and	CC	and
7.3	CD	7.3
%	NN	%
,	,	,
respectively	RB	respectively
.	SENT	.
.	SENT	.
No	DT	No
Salmonella	NP	Salmonella
spp	NN	spp
or	CC	or
Vibrio	NP	Vibrio
cholerae	NNS	cholerae
were	VVD	be
isolated	VBN	isolate
.	SENT	.
.	SENT	.
Rotavirus	NN	Rotavirus
and	CC	and
diarrheagenic	JJ	diarrheagenic
E	NN	E
.	SENT	.
coli	NNS	coli
were	VVD	be
predominant	JJ	predominant
in	IN	in
children	NNS	child
less	JJR	less
than	IN	than
two	CD	two
years	NNS	year
of	IN	of
age	NN	age
,	,	,
while	IN	while
Shigella	NN	Shigella
spp	NN	spp
,	,	,
and	CC	and
enterotoxigenic	JJ	enterotoxigenic
B	NN	B
.	SENT	.
fragilis	NN	fragilis
were	VVD	be
mostly	RB	mostly
seen	VBN	see
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
older	JJR	old
children	NNS	child
.	SENT	.
.	SENT	.
Diarrheagenic	JJ	Diarrheagenic
E	NN	E
.	SENT	.
coli	NN	coli
and	CC	and
Shigella	NN	Shigella
spp	NN	spp
showed	VBD	show
high	JJ	high
prevalence	NN	prevalence
of	IN	of
resistance	NN	resistance
to	TO	to
ampicillin	NN	ampicillin
,	,	,
chloramphenicol	NN	chloramphenicol
,	,	,
and	CC	and
to	TO	to
trimethoprim	VB	trimethoprim
/	SYM	/
sulfamethoxazole	NN	sulfamethoxazole
.	SENT	.
.	SENT	.
Children	NNS	Child
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
attending	VBG	attend
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
hospitals	NNS	hospital
had	VHD	have
fever	NN	fever
(	(	(
43.6	CD	43.6
%	NN	%
)	)	)
,	,	,
vomiting	VBG	vomit
(	(	(
53.8	CD	53.8
%	NN	%
)	)	)
,	,	,
and	CC	and
dehydration	NN	dehydration
(	(	(
82.6	CD	82.6
%	NN	%
)	)	)
.	SENT	.
.	SENT	.
Watery	NN	Watery
stool	NN	stool
was	VVD	be
predominant	JJ	predominant
with	IN	with
a	DT	a
prevalence	NN	prevalence
of	IN	of
66.4	CD	66.4
%	NN	%
,	,	,
followed	VBN	follow
by	IN	by
mucous	JJ	mucous
stool	NN	stool
(	(	(
21.0	CD	21.0
%	NN	%
)	)	)
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
mean	JJ	mean
episodes	NNS	episode
of	IN	of
stools	NNS	stool
per	IN	per
day	NN	day
was	VVD	be
seven	CD	seven
,	,	,
ranging	VBG	range
from	IN	from
two	CD	two
to	TO	to
23	CD	23
episodes	NNS	episode
.	SENT	.
.	SENT	.
Before	IN	Before
attending	VBG	attend
hospitals	NNS	hospital
,	,	,
162/587	CD	162/587
(	(	(
27.6	CD	27.6
%	NN	%
)	)	)
children	NNS	child
had	VHD	have
been	VVN	be
given	VBN	give
antibiotics	NNS	antibiotic
.	SENT	.
.	SENT	.
Overall	RB	Overall
,	,	,
<FORBIDDEN ID=82 ACTION=delete>
more	JJR	more
</FORBIDDEN ID=82 ACTION=delete>
children	NNS	child
got	VBD	get
diarrhea	NN	diarrhea
in	IN	in
(	(	(
i	LS	i
)	)	)
poor	JJ	poor
families	NNS	family
;	COLUMN	;
(	(	(
ii	LS	ii
)	)	)
families	NNS	family
where	WRB	where
piped	JJ	piped
water	NN	water
and	CC	and
a	DT	a
latrine	NN	latrine
were	VVD	be
lacking	VBG	lack
;	COLUMN	;
(	(	(
iii	LS	iii
)	)	)
families	NNS	family
where	WRB	where
mothers	NNS	mother
washed	VBD	wash
their	PP$	their
hands	NNS	hand
less	RBR	less
often	RB	often
before	IN	before
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
feeding	VBG	feed
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
children	NNS	child
;	COLUMN	;
(	(	(
iv	LS	iv
)	)	)
families	NNS	family
where	WRB	where
mothers	NNS	mother
had	VHD	have
a	DT	a
low	JJ	low
level	NN	level
of	IN	of
education	NN	education
;	COLUMN	;
(	(	(
v	LS	v
)	)	)
families	NNS	family
where	WRB	where
information	NN	information
on	IN	on
health	NN	health
and	CC	and
sanitation	NN	sanitation
less	RBR	less
often	RB	often
reached	VBN	reach
their	PP$	their
households	NNS	household
.	SENT	.
.	SENT	.
Group	NN	Group
A	NN	A
rotavirus	NN	rotavirus
,	,	,
diarrheagenic	JJ	diarrheagenic
Escherichia	NP	Escherichia
coli	NP	coli
,	,	,
Shigella	NP	Shigella
spp	NN	spp
,	,	,
and	CC	and
enterotoxigenic	JJ	enterotoxigenic
Bacteroides	NNS	Bacteroide
fragilis	NNS	fragili
play	VBP	play
an	DT	an
important	JJ	important
role	NN	role
in	IN	in
causing	VBG	cause
diarrhea	NN	diarrhea
in	IN	in
children	NNS	child
in	IN	in
Hanoi	NP	Hanoi
,	,	,
Vietnam	NP	Vietnam
.	SENT	.
.	SENT	.
Epidemiological	JJ	Epidemiological
factors	NNS	factor
<FORBIDDEN ID=17 ACTION=delete>
such	JJ	such
</FORBIDDEN ID=17 ACTION=delete>
as	IN	as
lack	NN	lack
of	IN	of
fresh	JJ	fresh
water	NN	water
supply	NN	supply
,	,	,
unhygienic	JJ	unhygienic
septic	JJ	septic
tank	NN	tank
,	,	,
low	JJ	low
family	NN	family
income	NN	income
,	,	,
lack	NN	lack
of	IN	of
health	NN	health
information	NN	information
,	,	,
and	CC	and
low	JJ	low
educational	JJ	educational
level	NN	level
of	IN	of
parents	NNS	parent
could	MD	could
contribute	VB	contribute
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
morbidity	NN	morbidity
of	IN	of
diarrhea	NN	diarrhea
in	IN	in
children	NNS	child
.	SENT	.
.	SENT	.
BB-cat+ner-1649682/text	DOCUMENT	BB-cat+ner-1649682/text
[	(	[
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
use	NN	use
of	IN	of
rifampin	NN	rifampin
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
treatment	NN	treatment
of	IN	of
infection	NN	infection
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
due	JJ	due
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
Staphylococcus	FW	Staphylococcus
aureus	FW	aureus
]	)	]
.	SENT	.
.	SENT	.
Infection	NN	Infection
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
due	JJ	due
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
Staphylococcus	FW	Staphylococcus
aureus	FW	aureus
continues	VBZ	continue
to	TO	to
be	VV	be
a	DT	a
source	NN	source
of	IN	of
significant	JJ	significant
morbidity	NN	morbidity
and	CC	and
mortality	NN	mortality
.	SENT	.
.	SENT	.
However	RB	However
,	,	,
its	PP$	its
treatment	NN	treatment
is	VVZ	be
increasingly	RB	increasingly
complicated	VBN	complicate
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
rising	VBG	rise
prevalence	NN	prevalence
of	IN	of
resistance	NN	resistance
to	TO	to
antibiotics	NNS	antibiotic
.	SENT	.
.	SENT	.
Apart	RB	Apart
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
two	CD	two
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
recognized	VBN	recognize
modes	NNS	mode
of	IN	of
staphylococcal	JJ	staphylococcal
resistance	NN	resistance
,	,	,
namely	RB	namely
,	,	,
penicillinase	NN	penicillinase
production	NN	production
and	CC	and
intrinsic	JJ	intrinsic
resistance	NN	resistance
,	,	,
Sabath	NN	Sabath
and	CC	and
associates	NNS	associate
have	VHP	have
described	VBN	describe
a	DT	a
third	JJ	third
type	NN	type
in	IN	in
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
resistance	NN	resistance
is	VVZ	be
manifested	VBN	manifest
by	IN	by
susceptibility	NN	susceptibility
to	TO	to
growth	NN	growth
inhibition	NN	inhibition
but	CC	but
tolerance	NN	tolerance
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
lethal	JJ	lethal
action	NN	action
of	IN	of
bactericidal	JJ	bactericidal
agents	NNS	agent
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
mechanism	NN	mechanism
of	IN	of
tolerance	NN	tolerance
is	VVZ	be
attributed	VBN	attribute
to	TO	to
a	DT	a
deficiency	NN	deficiency
of	IN	of
autolytic	JJ	autolytic
enzyme	NN	enzyme
activity	NN	activity
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
part	NN	part
of	IN	of
bacteria	NNS	bacteria
,	,	,
possibly	RB	possibly
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
secondary	JJ	secondary
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
an	DT	an
inhibition	NN	inhibition
of	IN	of
autolysins	NNS	autolysin
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
tolerant	JJ	tolerant
staphylococcal	JJ	staphylococcal
strains	NNS	strain
.	SENT	.
.	SENT	.
These	DT	These
strains	NNS	strain
are	VVP	be
found	VBN	find
in	IN	in
patients	NNS	patient
with	IN	with
infections	NNS	infection
responding	VBG	respond
poorly	RB	poorly
to	TO	to
treatment	NN	treatment
with	IN	with
cell	NN	cell
-	HYPH	-
wall	NN	wall
active	JJ	active
antibiotics	NNS	antibiotic
including	VBG	include
vancomycin	NN	vancomycin
.	SENT	.
.	SENT	.
Because	IN	Because
of	IN	of
its	PP$	its
unique	JJ	unique
mechanism	NN	mechanism
of	IN	of
action	NN	action
and	CC	and
pharmacokinetic	JJ	pharmacokinetic
properties	NNS	property
,	,	,
rifampin	NN	rifampin
has	VHZ	have
been	VVN	be
reported	VBN	report
to	TO	to
be	VV	be
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
most	RBS	most
active	JJ	active
among	IN	among
65	CD	65
antistaphylococcal	JJ	antistaphylococcal
agents	NNS	agent
tested	VBN	test
and	CC	and
have	VHP	have
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
capacity	NN	capacity
to	TO	to
kill	VB	kill
intraleukocytic	JJ	intraleukocytic
staphylococci	NNS	staphylococci
.	SENT	.
.	SENT	.
We	PP	We
present	VBP	present
2	CD	2
cases	NNS	case
who	WP	who
were	VVD	be
cured	VBN	cure
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
following	VBG	follow
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
addition	NN	addition
of	IN	of
rifampin	NN	rifampin
to	TO	to
previously	RB	previously
established	VBN	establish
regimens	NNS	regimen
.	SENT	.
.	SENT	.
Case	NN	Case
1	CD	1
was	VVD	be
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
a	DT	a
40	CD	40
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
-	HYPH	-
year-old	JJ	year-old
male	NN	male
who	WP	who
had	VHD	have
fever	NN	fever
,	,	,
cough	NN	cough
,	,	,
dyspnea	NN	dyspnea
,	,	,
a	DT	a
right	JJ	right
elbow	NN	elbow
abscess	NN	abscess
and	CC	and
left	VBD	leave
leg	NN	leg
swelling	VBG	swell
for	IN	for
2	CD	2
weeks	NNS	week
<FORBIDDEN ID=149 ACTION=delete>
prior	RB	prior
</FORBIDDEN ID=149 ACTION=delete>
to	TO	to
admission	NN	admission
.	SENT	.
.	SENT	.
Culture	NN	Culture
of	IN	of
purulent	JJ	purulent
material	NN	material
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
elbow	NN	elbow
abscess	NN	abscess
grew	VBD	grow
staphylococcus	NN	staphylococcus
aureus	NN	aureus
.	SENT	.
.	SENT	.
Chest	JJS	Ch
X-ray	NN	X-ray
showed	VBD	show
bilateral	JJ	bilateral
septic	JJ	septic
embolism	NN	embolism
and	CC	and
phleborheography	NN	phleborheography
showed	VBD	show
partial	JJ	partial
deep	JJ	deep
vein	NN	vein
occlusion	NN	occlusion
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
left	JJ	left
ileofemoral	JJ	ileofemoral
vein	NN	vein
.	SENT	.
.	SENT	.
Case	NN	Case
2	CD	2
was	VVD	be
22	CD	22
-	HYPH	-
year-old	JJ	year-old
female	NN	female
with	IN	with
fever	NN	fever
,	,	,
chills	NNS	chill
and	CC	and
cough	NN	cough
for	IN	for
3	CD	3
weeks	NNS	week
.	SENT	.
.	SENT	.
Blood	NN	Blood
culture	NN	culture
grew	VBD	grow
staphylococcus	NN	staphylococcus
aureus	NN	aureus
,	,	,
and	CC	and
Chest	NP	Chest
X-ray	NP	X-ray
revealed	VBD	reveal
bilateral	JJ	bilateral
septic	JJ	septic
embolism	NN	embolism
with	IN	with
pneumonia	NN	pneumonia
.	SENT	.
.	SENT	.
Neither	DT	Neither
of	IN	of
them	PP	them
responded	VBD	respond
to	TO	to
standard	JJ	standard
antibiotics	NNS	antibiotic
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
were	VVD	be
judged	VBN	judge
adequate	JJ	adequate
by	IN	by
in vitro	FW	in_vitro
sensitivity	NN	sensitivity
tests	NNS	test
.	SENT	.
.	SENT	.
Clinical	JJ	Clinical
cure	NN	cure
was	VVD	be
later	RB	later
obtained	VBN	obtain
after	IN	after
rifampin	NN	rifampin
was	VVD	be
added	VBN	add
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
regimens	NNS	regimen
.	SENT	.
.	SENT	.
These	DT	These
results	NNS	result
suggest	VBP	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
rifampin	NN	rifampin
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
be	VV	be
a	DT	a
useful	JJ	useful
adjunct	NN	adjunct
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
therapy	NN	therapy
of	IN	of
staphylococcal	JJ	staphylococcal
infections	NNS	infection
.	SENT	.
.	SENT	.
BB-cat+ner-16510930/text	DOCUMENT	BB-cat+ner-16510930/text
[	(	[
Results	NNS	Result
of	IN	of
serotyping	NN	serotyping
of	IN	of
strains	NNS	strain
isolated	VBN	isolate
from	IN	from
patients	NNS	patient
with	IN	with
ulcerative	JJ	ulcerative
colitis	NN	colitis
(	(	(
colitis	NN	colitis
gravis	NN	gravis
)	)	)
,	,	,
adaptive	JJ	adaptive
colitis	NN	colitis
and	CC	and
chronic	JJ	chronic
catarrhal	JJ	catarrhal
colitis	NN	colitis
]	)	]
.	SENT	.
.	SENT	.
Serotyping	NN	Serotyping
of	IN	of
565	CD	565
E	NN	E
.	SENT	.
coli	NN	coli
strains	NNS	strain
isolated	VBN	isolate
from	IN	from
273	CD	273
patients	NNS	patient
with	IN	with
ulcerative	JJ	ulcerative
colitis	NN	colitis
(	(	(
70	CD	70
patients	NNS	patient
)	)	)
;	COLUMN	;
chronic	JJ	chronic
catarrhal	JJ	catarrhal
colitis	NN	colitis
(	(	(
96	CD	96
patients	NNS	patient
)	)	)
,	,	,
adaptive	JJ	adaptive
colitis	NN	colitis
(	(	(
107	CD	107
patient	NN	patient
)	)	)
and	CC	and
of	IN	of
72	CD	72
E	NN	E
.	SENT	.
coli	NN	coli
strains	NNS	strain
isolated	VBN	isolate
from	IN	from
50	CD	50
practically	RB	practically
healthy	JJ	healthy
persons	NNS	person
(	(	(
control	NN	control
group	NN	group
)	)	)
was	VVD	be
performed	VBN	perform
.	SENT	.
.	SENT	.
Serotyping	NN	Serotyping
was	VVD	be
performed	VBN	perform
in	IN	in
reaction	NN	reaction
of	IN	of
agglutination	NN	agglutination
,	,	,
on	IN	on
stage	NN	stage
-	HYPH	-
glass	NN	glass
,	,	,
by	IN	by
use	NN	use
of	IN	of
commercial	JJ	commercial
set	NN	set
consisting	VBG	consist
of	IN	of
O	NN	O
and	CC	and
H	NN	H
monovalent	JJ	monovalent
serum	NN	serum
.	SENT	.
.	SENT	.
As	IN	As
a	DT	a
result	NN	result
of	IN	of
performed	VBN	perform
investigation	NN	investigation
it	PP	it
was	VVD	be
determined	VBN	determine
,	,	,
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
in	IN	in
patients	NNS	patient
with	IN	with
different	JJ	different
intestinal	JJ	intestinal
inflammatory	JJ	inflammatory
pathologies	NNS	pathology
,	,	,
there	EX	there
were	VVD	be
found	VBN	find
significant	JJ	significant
pathologic	JJ	pathologic
changes	NNS	change
in	IN	in
intestinal	JJ	intestinal
microbiocenosis	NN	microbiocenosis
,	,	,
in	IN	in
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
main	JJ	main
role	NN	role
are	VVP	be
playing	VBG	play
by	IN	by
strains	NNS	strain
of	IN	of
E	NN	E
.	SENT	.
coli	NN	coli
.	SENT	.
.	SENT	.
<FORBIDDEN ID=17 ACTION=delete>
Such	JJ	Such
</FORBIDDEN ID=17 ACTION=delete>
violations	NNS	violation
of	IN	of
intestinal	JJ	intestinal
microbiocenosis	NN	microbiocenosis
often	RB	often
are	VVP	be
<FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
leading	VBG	lead
to	TO	to
</FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
complications	NNS	complication
of	IN	of
basic	JJ	basic
disease	NN	disease
.	SENT	.
.	SENT	.
Serotyping	NN	Serotyping
of	IN	of
E	NN	E
.	SENT	.
coli	NN	coli
strains	NNS	strain
has	VHZ	have
shown	VBN	show
,	,	,
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
in	IN	in
formation	NN	formation
of	IN	of
pathologic	JJ	pathologic
microbiocenosis	NN	microbiocenosis
with	IN	with
<FORBIDDEN ID=82 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
or	CC	or
less	RBR	less
equal	JJ	equal
frequency	NN	frequency
are	VVP	be
taking	VBG	take
part	NN	part
enteropathogenic	JJ	enteropathogenic
,	,	,
enteroinvasive	JJ	enteroinvasive
,	,	,
enterotoxic	JJ	enterotoxic
strains	NNS	strain
of	IN	of
E	NN	E
.	SENT	.
coli	NN	coli
and	CC	and
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
some	DT	some
definite	JJ	definite
serotypes	NNS	serotype
of	IN	of
E	NN	E
.	SENT	.
coli	AFX	coli
-	HYPH	-
representatives	NNS	representative
of	IN	of
normal	JJ	normal
intestinal	JJ	intestinal
microflora	NN	microflora
with	IN	with
ability	NN	ability
of	IN	of
synthesis	NN	synthesis
of	IN	of
thermolabile	JJ	thermolabile
enterotoxin	NN	enterotoxin
.	SENT	.
.	SENT	.
BB-cat+ner-16514151/text	DOCUMENT	BB-cat+ner-16514151/text
Hg(II)	NN	Hg(II)
sequestration	NN	sequestration
and	CC	and
protection	NN	protection
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MerR	NN	MerR
metal	NN	metal
-	HYPH	-
binding	VBG	bind
domain	NN	domain
(	(	(
MBD	NN	MBD
)	)	)
.	SENT	.
.	SENT	.
MerR	NN	MerR
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
metalloregulator	NN	metalloregulator
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bacterial	JJ	bacterial
mercury	NN	mercury
resistance	NN	resistance
(	(	(
mer	NN	mer
)	)	)
operon	NN	operon
,	,	,
binds	VBZ	bind
Hg(II)	NN	Hg(II)
with	IN	with
high	JJ	high
affinity	NN	affinity
.	SENT	.
.	SENT	.
To	TO	To
study	VB	study
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
mechanism	NN	mechanism
of	IN	of
metal	NN	metal
-	HYPH	-
induced	VBN	induce
activation	NN	activation
,	,	,
a	DT	a
small	JJ	small
protein	NN	protein
was	VVD	be
previously	RB	previously
engineered	VBN	engineer
embodying	VBG	embody
in	IN	in
a	DT	a
single	JJ	single
<FORBIDDEN ID=0 ACTION=split SPLIT_AFTER=0>
polypeptide	NN	polypeptide
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=0 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
metal	NN	metal
-	HYPH	-
binding	VBG	bind
domain	NN	domain
(	(	(
MBD	NN	MBD
)	)	)
ordinarily	RB	ordinarily
formed	VBD	form
between	IN	between
two	CD	two
monomers	NNS	monomer
of	IN	of
MerR	NP	MerR
.	SENT	.
.	SENT	.
Here	RB	Here
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
physiological	JJ	physiological
and	CC	and
biochemical	JJ	biochemical
properties	NNS	property
of	IN	of
MBD	NN	MBD
expressed	VBN	express
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cell	NN	cell
surface	NN	surface
or	CC	or
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cytosol	NN	cytosol
were	VVD	be
examined	VBN	examine
,	,	,
to	TO	to
better	RBR	well
understand	VB	understand
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
environments	NNS	environment
in	IN	in
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
specific	JJ	specific
metal	NN	metal
binding	NN	binding
can	MD	can
occur	VB	occur
with	IN	with
this	DT	this
small	JJ	small
derivative	NN	derivative
.	SENT	.
.	SENT	.
Over	IN	Over
20	CD	20
000	CD	000
surface	NN	surface
copies	NNS	copy
of	IN	of
MBD	NN	MBD
were	VVD	be
expressed	VBN	express
per	IN	per
Escherichia	FW	Escherichia
coli	FW	coli
cell	NN	cell
,	,	,
with	IN	with
metal	NN	metal
stoichiometries	NNS	stoichiometry
of	IN	of
approximately	RB	approximately
1.0	CD	1.0
Hg(II)	NN	Hg(II)
per	IN	per
MBD	NN	MBD
monomer	NN	monomer
.	SENT	.
.	SENT	.
Cells	NNS	Cell
expressing	VBG	express
MBD	NN	MBD
on	IN	on
their	PP$	their
surface	NN	surface
in	IN	in
rich	JJ	rich
medium	NN	medium
bound	VBD	bind
6.1	CD	6.1
-	HYPH	-
fold	RB	fold
<FORBIDDEN ID=82 ACTION=delete>
more	JJR	more
</FORBIDDEN ID=82 ACTION=delete>
Hg(II)	NN	Hg(II)
than	IN	than
those	DT	those
not	RB	not
expressing	VBG	express
MBD	NN	MBD
.	SENT	.
.	SENT	.
Although	IN	Although
in	IN	in
nature	NN	nature
cells	NNS	cell
use	VBP	use
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
entire	JJ	entire
mer	NN	mer
operon	NN	operon
to	TO	to
detoxify	VB	detoxify
mercury	NN	mercury
,	,	,
it	PP	it
was	VVD	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
interesting	JJ	interesting
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
note	VB	note
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
cells	NNS	cell
expressing	VBG	express
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
MBD	NN	MBD
survived	VBD	survive
Hg(II)	NN	Hg(II)
challenge	NN	challenge
and	CC	and
recovered	VBD	recover
<FORBIDDEN ID=82 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
quickly	RB	quickly
than	IN	than
cells	NNS	cell
without	IN	without
MBD	NN	MBD
.	SENT	.
.	SENT	.
Cell	NN	Cell
-	HYPH	-
surface	NN	surface
-	HYPH	-
expressed	VBN	express
MBD	NN	MBD
bound	VBD	bind
Hg(II)	NN	Hg(II)
preferentially	RB	preferentially
<FORBIDDEN ID=157 ACTION=delete>
even	RB	even
</FORBIDDEN ID=157 ACTION=delete>
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
a	DT	a
22-fold	JJ	22-fold
molar	JJ	molar
excess	NN	excess
of	IN	of
Zn(II)	NN	Zn(II)
and	CC	and
when	WRB	when
exposed	VBN	expose
to	TO	to
equimolar	JJ	equimolar
Cd(II)	NN	Cd(II)
in	IN	in
addition	NN	addition
.	SENT	.
.	SENT	.
MBD	NN	MBD
expressed	VBN	express
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cystosol	NN	cystosol
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
afforded	VBD	afford
improved	JJ	improved
survival	NN	survival
from	IN	from
Hg(II)	NN	Hg(II)
exposure	NN	exposure
for	IN	for
E	NN	E
.	SENT	.
coli	NN	coli
and	CC	and
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
completely	RB	completely
unrelated	JJ	unrelated
bacterium	NN	bacterium
Deinococcus	NN	Deinococcus
radiodurans	NNS	radioduran
.	SENT	.
.	SENT	.
BB-cat+ner-16728960/text	DOCUMENT	BB-cat+ner-16728960/text
Swarming	JJ	Swarming
differentiation	NN	differentiation
of	IN	of
vibrio	NN	vibrio
vulnificus	NN	vulnificus
downregulates	VBZ	downregulate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
expression	NN	expression
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
vvhBA	NN	vvhBA
hemolysin	NN	hemolysin
gene	NN	gene
via	IN	via
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
LuxS	NN	LuxS
quorum	NN	quorum
-	HYPH	-
sensing	VBG	sense
system	NN	system
.	SENT	.
.	SENT	.
Swarming	NP	Swarming
has	VHZ	have
proven	VBN	prove
to	TO	to
be	VV	be
a	DT	a
good	JJ	good
in vitro	NN	in_vitro
model	NN	model
for	IN	for
bacterial	JJ	bacterial
surface	NN	surface
adherence	NN	adherence
and	CC	and
colonization	NN	colonization
,	,	,
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
swarming	JJ	swarming
differentiation	NN	differentiation
of	IN	of
a	DT	a
bacterium	NN	bacterium
has	VHZ	have
been	VVN	be
shown	VBN	show
to	TO	to
be	VV	be
coupled	VBN	couple
with	IN	with
changes	NNS	change
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
expression	NN	expression
of	IN	of
virulence	NN	virulence
factors	NNS	factor
associated	VBN	associate
with	IN	with
its	PP$	its
invasiveness	NN	invasiveness
,	,	,
particularly	RB	particularly
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=45 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
early	JJ	early
</FORBIDDEN ID=45 ACTION=delete>
stages	NNS	stage
of	IN	of
infection	NN	infection
.	SENT	.
.	SENT	.
In	IN	In
this	DT	this
study	NN	study
,	,	,
we	PP	we
attempted	VBD	attempt
to	TO	to
determine	VB	determine
whether	IN	whether
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
expression	NN	expression
of	IN	of
vvhA	NN	vvhA
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
encodes	VBZ	encode
for	IN	for
hemolysin	NN	hemolysin
/	SYM	/
cytolysin	NN	cytolysin
(	(	(
VvhA	NN	VvhA
)	)	)
,	,	,
is	VVZ	be
either	RB	either
upregulated	VBN	upregulate
or	CC	or
downregulated	VBN	downregulate
during	IN	during
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
swarming	JJ	swarming
differentiation	NN	differentiation
of	IN	of
V	NN	V
.	SENT	.
vulnificus	NN	vulnificus
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
insertional	JJ	insertional
inactivation	NN	inactivation
of	IN	of
vvhA	NN	vvhA
itself	PP	itself
exerted	VBD	exert
no	DT	no
detectable	JJ	detectable
effect	NN	effect
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
expression	NN	expression
of	IN	of
V	NN	V
.	SENT	.
vulnificus	CC	vulnificus
swarming	JJ	swarming
motility	NN	motility
.	SENT	.
.	SENT	.
However	RB	However
,	,	,
in	IN	in
our	PP$	our
lacZ	NN	lacZ
-	HYPH	-
fused	VBN	fuse
vvhA	NN	vvhA
transcriptional	JJ	transcriptional
reporter	NN	reporter
assay	NN	assay
,	,	,
vvhA	NN	vvhA
expression	NN	expression
decreased	VBD	decrease
in	IN	in
swarming	VBG	swarm
V	NN	V
.	SENT	.
vulnificus	NN	vulnificus
as	IN	as
compared	VBN	compare
to	TO	to
non-swarming	JJ	non-swarming
or	CC	or
planktonic	JJ	planktonic
V	NN	V
.	SENT	.
vulnificus	NN	vulnificus
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
reduced	VBN	reduce
expression	NN	expression
of	IN	of
vvhA	NN	vvhA
in	IN	in
swarming	VBG	swarm
V	NN	V
.	SENT	.
vulnificus	''	vulnificus
increased	VBD	increase
as	IN	as
a	DT	a
result	NN	result
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
deletional	JJ	deletional
inactivation	NN	inactivation
of	IN	of
luxS	NN	luxS
,	,	,
a	DT	a
gene	NN	gene
associated	VBN	associate
with	IN	with
quorum	NN	quorum
sensing	NN	sensing
.	SENT	.
.	SENT	.
These	DT	These
results	NNS	result
show	VBP	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
vvhA	NN	vvhA
expression	NN	expression
in	IN	in
swarming	VBG	swarm
V	NN	V
.	SENT	.
vulnificus	NN	vulnificus
is	VVZ	be
downregulated	VBN	downregulate
via	IN	via
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
activity	NN	activity
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
LuxS	NN	LuxS
quorum	NN	quorum
-	HYPH	-
sensing	VBG	sense
system	NN	system
,	,	,
suggesting	VBG	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
VvhA	NN	VvhA
performs	VBZ	perform
no	DT	no
essential	JJ	essential
role	NN	role
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
invasiveness	NN	invasiveness
of	IN	of
V	NN	V
.	SENT	.
vulnificus	NN	vulnificus
via	IN	via
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
adherence	NN	adherence
to	TO	to
and	CC	and
colonization	NN	colonization
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
body	NN	body
surfaces	NNS	surface
required	VBN	require
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=45 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
early	JJ	early
</FORBIDDEN ID=45 ACTION=delete>
stages	NNS	stage
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
infection	NN	infection
.	SENT	.
.	SENT	.
However	RB	However
,	,	,
VvhA	NN	VvhA
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
play	VB	play
a	DT	a
significant	JJ	significant
role	NN	role
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
pathophysiological	JJ	pathophysiological
deterioration	NN	deterioration
occurring	VBG	occur
after	IN	after
swarming	VBG	swarm
V	NN	V
.	SENT	.
vulnificus	NN	vulnificus
is	VVZ	be
differentiated	VBN	differentiate
into	IN	into
planktonic	JJ	planktonic
V	NN	V
.	SENT	.
vulnificus	NN	vulnificus
.	SENT	.
.	SENT	.
BB-cat+ner-16990433/text	DOCUMENT	BB-cat+ner-16990433/text
An	DT	An
extensive	JJ	extensive
repertoire	NN	repertoire
of	IN	of
type	NN	type
III	CD	III
secretion	NN	secretion
effectors	NNS	effector
in	IN	in
Escherichia	FW	Escherichia
coli	FW	coli
O157	NN	O157
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
role	NN	role
of	IN	of
lambdoid	JJ	lambdoid
phages	NNS	phage
in	IN	in
their	PP$	their
dissemination	NN	dissemination
.	SENT	.
.	SENT	.
Several	JJ	Several
pathogenic	JJ	pathogenic
strains	NNS	strain
of	IN	of
Escherichia	FW	Escherichia
coli	FW	coli
exploit	NN	exploit
type	NN	type
III	CD	III
secretion	NN	secretion
to	TO	to
inject	VB	inject
"	``	"
effector	NN	effector
proteins	NNS	protein
"	''	"
into	IN	into
human	JJ	human
cells	NNS	cell
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
then	RB	then
subvert	VBP	subvert
eukaryotic	JJ	eukaryotic
cell	NN	cell
biology	NN	biology
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bacterium's	NNS	bacterium'
advantage	NN	advantage
.	SENT	.
.	SENT	.
We	PP	We
have	VHP	have
exploited	VBN	exploit
bioinformatics	NNS	bioinformatic
and	CC	and
experimental	JJ	experimental
approaches	NNS	approach
to	TO	to
establish	VB	establish
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
effector	NN	effector
repertoire	NN	repertoire
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Sakai	NP	Sakai
strain	NN	strain
of	IN	of
enterohemorrhagic	JJ	enterohemorrhagic
E	NN	E
.	SENT	.
coli	NN	coli
(	(	(
EHEC	NN	EHEC
)	)	)
O157	NN	O157
:	COLUMN	:
H7	NN	H7
is	VVZ	be
<FORBIDDEN ID=83 ACTION=delete>
much	RB	much
</FORBIDDEN ID=83 ACTION=delete>
larger	JJR	large
than	IN	than
previously	RB	previously
thought	VBN	think
.	SENT	.
.	SENT	.
Homology	NN	Homology
searches	NNS	search
led	VBD	lead
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
identification	NN	identification
of	IN	of
SUP60	CD	SUP60
putative	JJ	putative
effector	NN	effector
genes	NNS	gene
.	SENT	.
.	SENT	.
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
Thirteen	CD	Thirteen
of	IN	of
these	DT	these
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
were	VVD	be
judged	VBN	judge
to	TO	to
be	VV	be
likely	JJ	likely
pseudogenes	NNS	pseudogene
,	,	,
whereas	IN	whereas
49	CD	49
were	VVD	be
judged	VBN	judge
to	TO	to
be	VV	be
potentially	RB	potentially
functional	JJ	functional
.	SENT	.
.	SENT	.
In	IN	In
total	NN	total
,	,	,
39	CD	39
proteins	NNS	protein
were	VVD	be
confirmed	VBN	confirm
experimentally	RB	experimentally
as	IN	as
effectors	NNS	effector
:	COLUMN	:
31	CD	31
through	IN	through
proteomics	NNS	proteomic
and	CC	and
28	CD	28
through	IN	through
translocation	NN	translocation
assays	NNS	assay
.	SENT	.
.	SENT	.
At	IN	At
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
protein	NN	protein
level	NN	level
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
EHEC	NP	EHEC
effector	NN	effector
sequences	NNS	sequence
fall	VBP	fall
into	IN	into
SUP20	CD	SUP20
families	NNS	family
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
largest	JJS	large
family	NN	family
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
NleG	NN	NleG
family	NN	family
,	,	,
contains	VBZ	contain
14	CD	14
members	NNS	member
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Sakai	NP	Sakai
strain	NN	strain
alone	RB	alone
.	SENT	.
.	SENT	.
EHEC	NN	EHEC
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
harbors	VBZ	harbor
functional	JJ	functional
homologs	NNS	homolog
of	IN	of
effectors	NNS	effector
from	IN	from
plant	NN	plant
pathogens	NNS	pathogen
(	(	(
HopPtoH	NP	HopPtoH
,	,	,
HopW	NP	HopW
,	,	,
AvrA	NP	AvrA
)	)	)
and	CC	and
from	IN	from
Shigella	NN	Shigella
(	(	(
OspD	NN	OspD
,	,	,
OspE	NN	OspE
,	,	,
OspG	NN	OspG
)	)	)
,	,	,
and	CC	and
two	CD	two
additional	JJ	additional
members	NNS	member
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Map	NN	Map
/	SYM	/
IpgB	NN	IpgB
family	NN	family
.	SENT	.
.	SENT	.
Genes	NNS	Gene
encoding	VBG	encode
proven	VBN	prove
or	CC	or
predicted	VBN	predict
effectors	NNS	effector
occur	VBP	occur
in	IN	in
SUP20	CD	SUP20
exchangeable	JJ	exchangeable
effector	NN	effector
loci	NNS	locus
scattered	VBN	scatter
throughout	IN	throughout
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
chromosome	NN	chromosome
.	SENT	.
.	SENT	.
Crucially	RB	Crucially
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
majority	NN	majority
of	IN	of
functional	JJ	functional
effector	NN	effector
genes	NNS	gene
are	VVP	be
encoded	VBN	encode
by	IN	by
nine	CD	nine
exchangeable	JJ	exchangeable
effector	NN	effector
loci	NNS	locus
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
lie	VBP	lie
within	IN	within
lambdoid	JJ	lambdoid
prophages	NNS	prophage
.	SENT	.
.	SENT	.
Thus	RB	Thus
,	,	,
type	NN	type
III	CD	III
secretion	NN	secretion
in	IN	in
E	NN	E
.	SENT	.
coli	NN	coli
is	VVZ	be
linked	VBN	link
to	TO	to
a	DT	a
vast	JJ	vast
phage	NN	phage
"	''	"
metagenome	NN	metagenome
,	,	,
"	''	"
acting	VBG	act
as	IN	as
a	DT	a
crucible	JJ	crucible
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
evolution	NN	evolution
of	IN	of
pathogenicity	NN	pathogenicity
.	SENT	.
.	SENT	.
BB-cat+ner-17237163/text	DOCUMENT	BB-cat+ner-17237163/text
Quorum	NN	Quorum
-	HYPH	-
sensing	VBG	sense
regulation	NN	regulation
of	IN	of
adhesion	NN	adhesion
in	IN	in
Serratia	NP	Serratia
marcescens	NP	marcescens
MG1	NN	MG1
is	VVZ	be
surface	NN	surface
dependent	JJ	dependent
.	SENT	.
.	SENT	.
Serratia	NP	Serratia
marcescens	NP	marcescens
is	VVZ	be
an	DT	an
opportunistic	JJ	opportunistic
pathogen	NN	pathogen
and	CC	and
a	DT	a
major	JJ	major
cause	NN	cause
of	IN	of
ocular	JJ	ocular
infections	NNS	infection
.	SENT	.
.	SENT	.
In	IN	In
previous	JJ	previous
studies	NNS	study
of	IN	of
S	NN	S
.	SENT	.
marcescens	NNS	marcescen
MG1	NN	MG1
,	,	,
we	PP	we
showed	VBD	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
biofilm	NN	biofilm
maturation	NN	maturation
and	CC	and
sloughing	NN	sloughing
were	VVD	be
regulated	VBN	regulate
by	IN	by
N-acyl	NN	N-acyl
homoserine	NN	homoserine
lactone	NN	lactone
(	(	(
AHL	NN	AHL
)	)	)
-	HYPH	-
based	VBN	base
quorum	NN	quorum
sensing	VBG	sense
(	(	(
QS	NN	QS
)	)	)
.	SENT	.
.	SENT	.
Because	IN	Because
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
importance	NN	importance
of	IN	of
adhesion	NN	adhesion
in	IN	in
initiating	VBG	initiate
biofilm	NN	biofilm
formation	NN	formation
and	CC	and
infection	NN	infection
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
primary	JJ	primary
goal	NN	goal
of	IN	of
this	DT	this
study	NN	study
was	VVD	be
to	TO	to
determine	VB	determine
whether	IN	whether
QS	NN	QS
is	VVZ	be
important	JJ	important
<FORBIDDEN ID=27 ACTION=delete>
<FORBIDDEN ID=26 ACTION=delete>
in	IN	in
adhesion	NN	adhesion
to	TO	to
<FORBIDDEN ID=30 ACTION=delete>
</FORBIDDEN ID=26 ACTION=delete>
</FORBIDDEN ID=27 ACTION=delete>
both	CC	both
</FORBIDDEN ID=30 ACTION=delete>
abiotic	JJ	abiotic
and	CC	and
biotic	JJ	biotic
surfaces	NNS	surface
,	,	,
as	IN	as
assessed	VBN	assess
by	IN	by
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
determining	VBG	determine
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
degree	NN	degree
of	IN	of
attachment	NN	attachment
to	TO	to
hydrophilic	JJ	hydrophilic
tissue	NN	tissue
culture	NN	culture
plates	NNS	plate
and	CC	and
human	JJ	human
corneal	NN	corneal
epithelial	JJ	epithelial
(	(	(
HCE	NN	HCE
)	)	)
cells	NNS	cell
.	SENT	.
.	SENT	.
Our	PP$	Our
results	NNS	result
demonstrate	VBP	demonstrate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
while	IN	while
adhesion	NN	adhesion
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
abiotic	JJ	abiotic
surface	NN	surface
was	VVD	be
AHL	NN	AHL
regulated	VBN	regulate
,	,	,
adhesion	NN	adhesion
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
HCE	NN	HCE
cell	NN	cell
biotic	JJ	biotic
surface	NN	surface
was	VVD	be
not	RB	not
.	SENT	.
.	SENT	.
Type	NN	Type
I	CD	I
fimbriae	NNS	fimbria
were	VVD	be
identified	VBN	identify
as	IN	as
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
critical	JJ	critical
adhesin	NN	adhesin
for	IN	for
non-QS	NN	non-QS
-	HYPH	-
mediated	VBN	mediate
attachment	NN	attachment
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
biotic	JJ	biotic
HCE	NN	HCE
cell	NN	cell
surface	NN	surface
but	CC	but
played	VBD	play
no	DT	no
role	NN	role
<FORBIDDEN ID=27 ACTION=delete>
<FORBIDDEN ID=26 ACTION=delete>
in	IN	in
adhesion	NN	adhesion
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=26 ACTION=delete>
</FORBIDDEN ID=27 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
abiotic	JJ	abiotic
surface	NN	surface
.	SENT	.
.	SENT	.
While	IN	While
we	PP	we
were	VVD	be
not	RB	not
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
able	JJ	able
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
identify	VB	identify
a	DT	a
single	JJ	single
QS	NN	QS
-	HYPH	-
regulated	VBN	regulate
adhesin	NN	adhesin
essential	JJ	essential
for	IN	for
attachment	NN	attachment
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
abiotic	JJ	abiotic
surface	NN	surface
,	,	,
four	CD	four
AHL	NN	AHL
-	HYPH	-
regulated	VBN	regulate
genes	NNS	gene
involved	VBN	involve
<FORBIDDEN ID=27 ACTION=delete>
<FORBIDDEN ID=26 ACTION=delete>
in	IN	in
adhesion	NN	adhesion
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=26 ACTION=delete>
</FORBIDDEN ID=27 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
abiotic	JJ	abiotic
surface	NN	surface
were	VVD	be
identified	VBN	identify
.	SENT	.
.	SENT	.
Interestingly	RB	Interestingly
,	,	,
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
two	CD	two
of	IN	of
these	DT	these
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
genes	NNS	gene
,	,	,
bsmA	NN	bsmA
and	CC	and
bsmB	NN	bsmB
,	,	,
were	VVD	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
shown	VBN	show
to	TO	to
be	VV	be
involved	VBN	involve
<FORBIDDEN ID=27 ACTION=delete>
<FORBIDDEN ID=26 ACTION=delete>
in	IN	in
adhesion	NN	adhesion
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=26 ACTION=delete>
</FORBIDDEN ID=27 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
biotic	JJ	biotic
surface	NN	surface
in	IN	in
a	DT	a
non-QS	JJ	non-QS
-	HYPH	-
controlled	JJ	controlled
fashion	NN	fashion
.	SENT	.
.	SENT	.
<FORBIDDEN ID=162 ACTION=delete>
Therefore	RB	Therefore
</FORBIDDEN ID=162 ACTION=delete>
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
expression	NN	expression
of	IN	of
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
these	DT	these
two	CD	two
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
genes	NNS	gene
appears	VBZ	appear
to	TO	to
be	VV	be
cocontrolled	VBN	cocontrolle
by	IN	by
regulators	NNS	regulator
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
than	IN	than
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
QS	NN	QS
system	NN	system
for	IN	for
mediation	NN	mediation
of	IN	of
attachment	NN	attachment
to	TO	to
HCE	NN	HCE
cells	NNS	cell
.	SENT	.
.	SENT	.
We	PP	We
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
found	VBD	find
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
QS	NN	QS
in	IN	in
S	NN	S
.	SENT	.
marcescens	NNS	marcescen
regulates	VBZ	regulate
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
potential	JJ	potential
cell	NN	cell
surface	NN	surface
adhesins	NNS	adhesin
,	,	,
including	VBG	include
exopolysaccharide	NN	exopolysaccharide
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
outer	JJ	outer
membrane	NN	membrane
protein	NN	protein
OmpX	NN	OmpX
.	SENT	.
.	SENT	.
We	PP	We
concluded	VBD	conclude
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
S	NN	S
.	SENT	.
marcescens	NNS	marcescen
MG1	NN	MG1
utilizes	VBZ	utilize
different	JJ	different
regulatory	JJ	regulatory
systems	NNS	system
and	CC	and
adhesins	NNS	adhesin
<FORBIDDEN ID=27 ACTION=delete>
<FORBIDDEN ID=26 ACTION=delete>
in	IN	in
attachment	NN	attachment
to	TO	to
</FORBIDDEN ID=26 ACTION=delete>
</FORBIDDEN ID=27 ACTION=delete>
biotic	JJ	biotic
and	CC	and
abiotic	JJ	abiotic
surfaces	NNS	surface
and	CC	and
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
QS	NN	QS
is	VVZ	be
a	DT	a
main	JJ	main
regulatory	JJ	regulatory
pathway	NN	pathway
<FORBIDDEN ID=27 ACTION=delete>
<FORBIDDEN ID=26 ACTION=delete>
in	IN	in
adhesion	NN	adhesion
to	TO	to
</FORBIDDEN ID=26 ACTION=delete>
</FORBIDDEN ID=27 ACTION=delete>
an	DT	an
abiotic	JJ	abiotic
surface	NN	surface
but	CC	but
not	RB	not
<FORBIDDEN ID=27 ACTION=delete>
<FORBIDDEN ID=26 ACTION=delete>
in	IN	in
adhesion	NN	adhesion
to	TO	to
</FORBIDDEN ID=26 ACTION=delete>
</FORBIDDEN ID=27 ACTION=delete>
a	DT	a
biotic	JJ	biotic
surface	NN	surface
.	SENT	.
.	SENT	.
BB-cat+ner-17261513/text	DOCUMENT	BB-cat+ner-17261513/text
Use	NN	Use
of	IN	of
transposon	NN	transposon
promoter	NN	promoter
-	HYPH	-
probe	NN	probe
vectors	NNS	vector
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
metabolic	JJ	metabolic
engineering	NN	engineering
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
obligate	JJ	obligate
methanotroph	NN	methanotroph
Methylomonas	NN	Methylomonas
sp	NN	sp
.	SENT	.
strain	NN	strain
16a	NN	16a
for	IN	for
enhanced	VBN	enhance
C40	NN	C40
carotenoid	NN	carotenoid
synthesis	NN	synthesis
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
recent	JJ	recent
expansion	NN	expansion
of	IN	of
genetic	JJ	genetic
and	CC	and
genomic	JJ	genomic
tools	NNS	tool
for	IN	for
metabolic	JJ	metabolic
engineering	NN	engineering
has	VHZ	have
accelerated	VBN	accelerate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
development	NN	development
of	IN	of
microorganisms	NNS	microorganism
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
industrial	JJ	industrial
production	NN	production
of	IN	of
desired	VBN	desire
compounds	NNS	compound
.	SENT	.
.	SENT	.
We	PP	We
have	VHP	have
used	VBN	use
transposable	JJ	transposable
elements	NNS	element
to	TO	to
identify	VB	identify
chromosomal	JJ	chromosomal
locations	NNS	location
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
obligate	JJ	obligate
methanotroph	NN	methanotroph
Methylomonas	NN	Methylomonas
sp	NN	sp
.	SENT	.
strain	NN	strain
16a	NN	16a
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
support	VBP	support
high	JJ	high
-	HYPH	-
level	NN	level
expression	NN	expression
of	IN	of
genes	NNS	gene
involved	VBN	involve
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
synthesis	NN	synthesis
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
C(40)	NN	C(40)
carotenoids	NNS	carotenoid
canthaxanthin	NN	canthaxanthin
and	CC	and
astaxanthin	NN	astaxanthin
.	SENT	.
with	IN	with
three	CD	three
promoterless	JJ	promoterless
carotenoid	NN	carotenoid
transposons	NNS	transposon
,	,	,
five	CD	five
chromosomal	JJ	chromosomal
locations-the	JJ	locations-the
fliCS	NN	fliCS
,	,	,
hsdM	NN	hsdM
,	,	,
ccp	NN	ccp
-3	CD	-3
,	,	,
cysH	NN	cysH
,	,	,
and	CC	and
nirS	NN	nirS
regions	NNS	region
-	COLUMN	-
were	VVD	be
identified	VBN	identify
.	SENT	.
.	SENT	.
Total	JJ	Total
carotenoid	NN	carotenoid
synthesis	NN	synthesis
increased	VBD	increase
10- to	CD	10-_to
20-fold	RB	20-fold
when	WRB	when
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
carotenoid	NN	carotenoid
gene	NN	gene
clusters	NNS	cluster
were	VVD	be
inserted	VBN	insert
at	IN	at
these	DT	these
chromosomal	JJ	chromosomal
locations	NNS	location
compared	VBN	compare
to	TO	to
when	WRB	when
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=16 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
same	JJ	same
</FORBIDDEN ID=16 ACTION=delete>
carotenoid	NN	carotenoid
gene	NN	gene
clusters	NNS	cluster
were	VVD	be
integrated	VBN	integrate
at	IN	at
neutral	JJ	neutral
locations	NNS	location
under	IN	under
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
control	NN	control
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
promoter	NN	promoter
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
gene	NN	gene
conferring	VBG	confer
resistance	NN	resistance
to	TO	to
chloramphenicol	NN	chloramphenicol
.	SENT	.
.	SENT	.
A	DT	A
chromosomal	JJ	chromosomal
integration	NN	integration
system	NN	system
based	VBN	base
on	IN	on
sucrose	NN	sucrose
lethality	NN	lethality
was	VVD	be
used	VBN	use
to	TO	to
make	VB	make
targeted	VBN	target
gene	NN	gene
deletions	NNS	deletion
or	CC	or
site	NN	site
-	HYPH	-
specific	JJ	specific
integration	NN	integration
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
carotenoid	NN	carotenoid
gene	NN	gene
cluster	NN	cluster
into	IN	into
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Methylomonas	NP	Methylomonas
genome	NN	genome
without	IN	without
leaving	VBG	leave
genetic	JJ	genetic
scars	NNS	scar
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
chromosome	NN	chromosome
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
antibiotic	JJ	antibiotic
resistance	NN	resistance
genes	NNS	gene
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
are	VVP	be
present	JJ	present
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
integration	NN	integration
vector	NN	vector
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
genetic	JJ	genetic
approaches	NNS	approach
described	VBN	describe
in	IN	in
this	DT	this
work	NN	work
demonstrate	VBP	demonstrate
how	WRB	how
metabolic	JJ	metabolic
engineering	NN	engineering
of	IN	of
microorganisms	NNS	microorganism
,	,	,
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
including	VBG	include
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
less	JJR	less
-	HYPH	-
studied	VBN	study
environmental	JJ	environmental
isolates	NNS	isolate
,	,	,
can	MD	can
be	VV	be
greatly	RB	greatly
enhanced	VBN	enhance
by	IN	by
identifying	VBG	identify
integration	NN	integration
sites	NNS	site
within	IN	within
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
chromosome	NN	chromosome
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
host	NN	host
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
permit	VBP	permit
optimal	JJ	optimal
expression	NN	expression
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
target	NN	target
genes	NNS	gene
.	SENT	.
.	SENT	.
BB-cat+ner-17687514/text	DOCUMENT	BB-cat+ner-17687514/text
Unveiling	NN	Unveiling
molecular	JJ	molecular
mechanisms	NNS	mechanism
of	IN	of
bacterial	JJ	bacterial
surface	NN	surface
proteins	NNS	protein
:	COLUMN	:
Streptococcus	FW	Streptococcus
pneumoniae	FW	pneumoniae
as	IN	as
a	DT	a
model	NN	model
organism	NN	organism
for	IN	for
structural	JJ	structural
studies	NNS	study
.	SENT	.
.	SENT	.
Bacteria	NNS	Bacteria
present	VBP	present
a	DT	a
<FORBIDDEN ID=57 ACTION=delete>
variety	NN	variety
of	IN	of
</FORBIDDEN ID=57 ACTION=delete>
molecules	NNS	molecule
either	CC	either
on	IN	on
their	PP$	their
surface	NN	surface
or	CC	or
in	IN	in
a	DT	a
cell	NN	cell
-	HYPH	-
free	JJ	free
form	NN	form
.	SENT	.
.	SENT	.
These	DT	These
molecules	NNS	molecule
take	VBP	take
part	NN	part
in	IN	in
numerous	JJ	numerous
processes	NNS	process
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
interactions	NNS	interaction
with	IN	with
their	PP$	their
host	NN	host
,	,	,
with	IN	with
its	PP$	its
tissues	NNS	tissue
and	CC	and
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
molecules	NNS	molecule
.	SENT	.
.	SENT	.
These	DT	These
molecules	NNS	molecule
are	VVP	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
essential	JJ	essential
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
bacterial	JJ	bacterial
pathogenesis	NN	pathogenesis
either	CC	either
during	IN	during
colonization	NN	colonization
or	CC	or
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
spread	NN	spread
/	SYM	/
invasion	NN	invasion
stages	NNS	stage
,	,	,
and	CC	and
most	JJS	most
are	VVP	be
virulence	NN	virulence
factors	NNS	factor
.	SENT	.
.	SENT	.
This	DT	This
review	NN	review
is	VVZ	be
focused	VBN	focus
on	IN	on
<FORBIDDEN ID=17 ACTION=delete>
such	JJ	such
</FORBIDDEN ID=17 ACTION=delete>
molecules	NNS	molecule
using	VBG	use
Streptococcus	NP	Streptococcus
pneumoniae	NP	pneumoniae
,	,	,
a	DT	a
Gram	NN	Gram
-	HYPH	-
positive	JJ	positive
bacterium	NN	bacterium
,	,	,
as	IN	as
an	DT	an
<FORBIDDEN ID=134 ACTION=delete>
<FORBIDDEN ID=133 ACTION=delete>
<FORBIDDEN ID=131 ACTION=delete>
example	NN	example
</FORBIDDEN ID=131 ACTION=delete>
</FORBIDDEN ID=133 ACTION=delete>
</FORBIDDEN ID=134 ACTION=delete>
.	SENT	.
.	SENT	.
Selected	VBN	Select
surface	NN	surface
proteins	NNS	protein
are	VVP	be
introduced	VBN	introduce
,	,	,
their	PP$	their
structure	NN	structure
described	VBN	describe
,	,	,
and	CC	and
,	,	,
whenever	WRB	whenever
available	JJ	available
,	,	,
their	PP$	their
mechanisms	NNS	mechanism
of	IN	of
function	NN	function
on	IN	on
an	DT	an
atomic	JJ	atomic
level	NN	level
are	VVP	be
explained	VBN	explain
.	SENT	.
.	SENT	.
<FORBIDDEN ID=17 ACTION=delete>
Such	JJ	Such
</FORBIDDEN ID=17 ACTION=delete>
mechanisms	NNS	mechanism
for	IN	for
hyaluronate	NN	hyaluronate
lyase	NN	lyase
,	,	,
pneumococcal	JJ	pneumococcal
surface	NN	surface
protein	NN	protein
A	NN	A
,	,	,
pneumolysin	NN	pneumolysin
,	,	,
histidine	NN	histidine
-	HYPH	-
triad	NN	triad
and	CC	and
fibronectin	NN	fibronectin
-	HYPH	-
binding	VBG	bind
proteins	NNS	protein
are	VVP	be
discussed	VBN	discuss
.	SENT	.
.	SENT	.
Elucidation	NN	Elucidation
of	IN	of
molecular	JJ	molecular
mechanisms	NNS	mechanism
of	IN	of
virulence	NN	virulence
factors	NNS	factor
is	VVZ	be
essential	JJ	essential
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
understanding	NN	understanding
of	IN	of
bacteria	NNS	bacteria
and	CC	and
their	PP$	their
functional	JJ	functional
properties	NNS	property
.	SENT	.
.	SENT	.
Structural	JJ	Structural
biology	NN	biology
appears	VBZ	appear
pivotal	JJ	pivotal
for	IN	for
these	DT	these
studies	NNS	study
,	,	,
as	IN	as
structural	JJ	structural
and	CC	and
mechanistic	JJ	mechanistic
insights	NNS	insight
facilitate	VBP	facilitate
rational	JJ	rational
approach	NN	approach
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
development	NN	development
of	IN	of
<FORBIDDEN ID=38 ACTION=delete>
<FORBIDDEN ID=37 ACTION=delete>
new	JJ	new
</FORBIDDEN ID=37 ACTION=delete>
</FORBIDDEN ID=38 ACTION=delete>
treatments	NNS	treatment
.	SENT	.
.	SENT	.
BB-cat+ner-18094887/text	DOCUMENT	BB-cat+ner-18094887/text
Rickettsia	NN	Rickettsia
infection	NN	infection
in	IN	in
five	CD	five
areas	NNS	area
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
state	NN	state
of	IN	of
São	NP	São
Paulo	NP	Paulo
,	,	,
Brazil	NP	Brazil
.	SENT	.
.	SENT	.
This	DT	This
study	NN	study
investigated	VBD	investigate
rickettsial	JJ	rickettsial
infection	NN	infection
in	IN	in
animals	NNS	animal
,	,	,
humans	NNS	human
,	,	,
ticks	NNS	tick
,	,	,
and	CC	and
fleas	NNS	flea
collected	VBN	collect
in	IN	in
five	CD	five
areas	NNS	area
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
state	NN	state
of	IN	of
São	NP	São
Paulo	NP	Paulo
.	SENT	.
.	SENT	.
Eight	CD	Eight
flea	NN	flea
species	NNS	specie
(	(	(
Adoratopsylla	NN	Adoratopsylla
antiquorum	NN	antiquorum
antiquorum	NN	antiquorum
,	,	,
Ctenocephalides	NP	Ctenocephalides
felis	VBD	feli
felis	NN	felis
,	,	,
Polygenis	NP	Polygenis
atopus	NP	atopus
,	,	,
Polygenis	NP	Polygenis
rimatus	NP	rimatus
,	,	,
Polygenis	NP	Polygenis
roberti	NP	roberti
roberti	NP	roberti
,	,	,
Polygenis	NP	Polygenis
tripus	NP	tripus
,	,	,
Rhopalopsyllus	NP	Rhopalopsyllus
lugubris	NP	lugubris
,	,	,
and	CC	and
Rhopalopsyllus	NP	Rhopalopsyllus
lutzi	FW	lutzi
lutzi	FW	lutzi
)	)	)
,	,	,
and	CC	and
five	CD	five
tick	NN	tick
species	NNS	specie
(	(	(
Amblyomma	NP	Amblyomma
aureolatum	NP	aureolatum
,	,	,
Amblyomma	NP	Amblyomma
cajennense	NN	cajennense
,	,	,
Amblyomma	NP	Amblyomma
dubitatum	NP	dubitatum
,	,	,
Ixodes	NP	Ixodes
loricatus	NP	loricatus
,	,	,
and	CC	and
Rhipicephalus	NN	Rhipicephalus
sanguineus	NN	sanguineus
)	)	)
were	VVD	be
collected	VBN	collect
from	IN	from
dogs	NNS	dog
,	,	,
cats	NNS	cat
,	,	,
and	CC	and
opossums	NNS	opossum
.	SENT	.
.	SENT	.
Rickettsia	NP	Rickettsia
felis	NN	felis
was	VVD	be
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=156 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
only	JJ	only
</FORBIDDEN ID=156 ACTION=delete>
rickettsia	NN	rickettsia
found	VBD	find
infecting	VBG	infect
fleas	NNS	flea
,	,	,
whereas	IN	whereas
Rickettsia	NP	Rickettsia
bellii	NN	bellii
was	VVD	be
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=156 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
only	JJ	only
</FORBIDDEN ID=156 ACTION=delete>
agent	NN	agent
infecting	VBG	infect
ticks	NNS	tick
,	,	,
but	CC	but
no	DT	no
animal	NN	animal
or	CC	or
human	JJ	human
blood	NN	blood
was	VVD	be
shown	VBN	show
to	TO	to
contain	VB	contain
rickettsial	JJ	rickettsial
DNA	NN	DNA
.	SENT	.
.	SENT	.
Testing	JJ	Testing
animal	NN	animal
and	CC	and
human	JJ	human
sera	NNS	serum
by	IN	by
indirect	JJ	indirect
immunofluorescence	NN	immunofluorescence
assay	NN	assay
against	IN	against
four	CD	four
rickettsia	NN	rickettsia
antigens	NNS	antigen
(	(	(
R	NN	R
.	SENT	.
rickettsii	NN	rickettsii
,	,	,
R	NN	R
.	SENT	.
parkeri	NN	parkeri
,	,	,
R	NN	R
.	SENT	.
felis	NN	felis
,	,	,
and	CC	and
R	NN	R
.	SENT	.
bellii	NN	bellii
)	)	)
,	,	,
some	DT	some
opossum	NN	opossum
,	,	,
dog	NN	dog
,	,	,
horse	NN	horse
,	,	,
and	CC	and
human	JJ	human
sera	NNS	serum
reacted	VBD	react
to	TO	to
R	NN	R
.	SENT	.
rickettsii	NN	rickettsii
with	IN	with
titers	NNS	titer
at	IN	at
<FORBIDDEN ID=18 ACTION=delete>
least	JJS	least
</FORBIDDEN ID=18 ACTION=delete>
four	CD	four
-	HYPH	-
fold	RB	fold
higher	JJR	high
than	IN	than
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=22 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
three	CD	three
rickettsial	JJ	rickettsial
antigens	NNS	antigen
.	SENT	.
.	SENT	.
These	DT	These
sera	NNS	serum
were	VVD	be
considered	VBN	consider
to	TO	to
have	VH	have
a	DT	a
predominant	JJ	predominant
antibody	NN	antibody
response	NN	response
to	TO	to
R	NN	R
.	SENT	.
rickettsii	NN	rickettsii
.	SENT	.
.	SENT	.
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
Using	VBG	Use
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=16 ACTION=delete>
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
same	JJ	same
</FORBIDDEN ID=16 ACTION=delete>
criteria	NNS	criterion
,	,	,
opossum	NN	opossum
,	,	,
dog	NN	dog
,	,	,
and	CC	and
horse	NN	horse
sera	NNS	serum
showed	VBD	show
predominant	JJ	predominant
antibody	NN	antibody
response	NN	response
to	TO	to
R	NN	R
.	SENT	.
parkeri	NN	parkeri
or	CC	or
a	DT	a
very	RB	very
closely	RB	closely
related	JJ	related
genotype	NN	genotype
.	SENT	.
.	SENT	.
Our	PP$	Our
serological	JJ	serological
results	NNS	result
suggest	VBP	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=30 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
both	DT	both
</FORBIDDEN ID=30 ACTION=delete>
R	NN	R
.	SENT	.
rickettsii	NN	rickettsii
and	CC	and
R	NN	R
.	SENT	.
parkeri	NN	parkeri
infected	JJ	infected
animals	NNS	animal
and	CC	and
/	SYM	/
or	CC	or
humans	NNS	human
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
studied	VBN	study
areas	NNS	area
.	SENT	.
.	SENT	.
BB-cat+ner-18687046/text	DOCUMENT	BB-cat+ner-18687046/text
Impact	NN	Impact
of	IN	of
intracranial	JJ	intracranial
pressure	NN	pressure
monitor	NN	monitor
prophylaxis	NN	prophylaxis
on	IN	on
central	JJ	central
nervous	JJ	nervous
system	NN	system
infections	NNS	infection
and	CC	and
bacterial	JJ	bacterial
multi	AFX	multi
-	HYPH	-
drug	NN	drug
resistance	NN	resistance
.	SENT	.
.	SENT	.
Routine	NN	Routine
intracranial	JJ	intracranial
pressure	NN	pressure
monitor	NN	monitor
(	(	(
ICP	NN	ICP
)	)	)
prophylaxis	NN	prophylaxis
is	VVZ	be
not	RB	not
practiced	VBN	practice
at	IN	at
our	PP$	our
institution	NN	institution
.	SENT	.
.	SENT	.
Nevertheless	RB	Nevertheless
,	,	,
some	DT	some
patients	NNS	patient
receive	VBP	receive
de facto	NN	de_facto
prophylaxis	NN	prophylaxis
as	IN	as
a	DT	a
result	NN	result
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
use	NN	use
of	IN	of
antibiotics	NNS	antibiotic
for	IN	for
injuries	NNS	injury
<FORBIDDEN ID=17 ACTION=delete>
such	JJ	such
</FORBIDDEN ID=17 ACTION=delete>
as	IN	as
open	JJ	open
or	CC	or
facial	JJ	facial
fractures	NNS	fracture
.	SENT	.
.	SENT	.
We	PP	We
tested	VBD	test
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
hypothesis	NN	hypothesis
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
prophylactic	JJ	prophylactic
antibiotics	NNS	antibiotic
do	VBP	do
not	RB	not
reduce	VB	reduce
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
incidence	NN	incidence
of	IN	of
central	JJ	central
nervous	JJ	nervous
system	NN	system
(	(	(
CNS	NN	CNS
)	)	)
infections	NNS	infection
but	CC	but
instead	RB	instead
are	VVP	be
associated	VBN	associate
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
acquisition	NN	acquisition
of	IN	of
multi	AFX	multi
-	HYPH	-
drug	NN	drug
resistant	JJ	resistant
(	(	(
MDR	NN	MDR
)	)	)
bacterial	JJ	bacterial
infections	NNS	infection
.	SENT	.
.	SENT	.
Patients	NNS	Patient
admitted	VBN	admit
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
trauma	NN	trauma
intensive	JJ	intensive
care	NN	care
unit	NN	unit
(	(	(
TICU	NN	TICU
)	)	)
from	IN	from
<FORBIDDEN ID=119 ACTION=delete>
January	NP	January
</FORBIDDEN ID=119 ACTION=delete>
,	,	,
2001	CD	2001
through	IN	through
December	NP	December
,	,	,
2004	CD	2004
with	IN	with
blunt	NN	blunt
,	,	,
non-operative	JJ	non-operative
traumatic	JJ	traumatic
brain	NN	brain
injury	NN	injury
who	WP	who
were	VVD	be
managed	VBN	manage
solely	RB	solely
with	IN	with
an	DT	an
ICP	NN	ICP
monitor	NN	monitor
were	VVD	be
identified	VBN	identify
from	IN	from
our	PP$	our
trauma	NN	trauma
registry	NN	registry
and	CC	and
divided	VBN	divide
into	IN	into
two	CD	two
groups	NNS	group
:	COLUMN	:
(	(	(
1	LS	1
)	)	)
Those	DT	Those
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
receiving	VBG	receive
no	DT	no
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
antibiotics	NNS	antibiotic
<FORBIDDEN ID=149 ACTION=delete>
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
prior	JJ	prior
</FORBIDDEN ID=149 ACTION=delete>
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
or	CC	or
during	IN	during
ICP	NN	ICP
monitoring	NN	monitoring
(	(	(
NONE	NN	NONE
;	COLUMN	;
n	NN	n
=	SYM	=
71	CD	71
)	)	)
;	COLUMN	;
and	CC	and
(	(	(
2	LS	2
)	)	)
those	DT	those
already	RB	already
receiving	VBG	receive
antibiotics	NNS	antibiotic
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
time	NN	time
of	IN	of
ICP	NN	ICP
monitor	NN	monitor
insertion	NN	insertion
(	(	(
PRO	NN	PRO
;	COLUMN	;
n	NN	n
=	SYM	=
84	CD	84
)	)	)
.	SENT	.
.	SENT	.
Groups	NNS	Group
were	VVD	be
stratified	VBN	stratify
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
basis	NN	basis
of	IN	of
age	NN	age
,	,	,
Injury	NN	Injury
Severity	NN	Severity
Score	NN	Score
(	(	(
ISS	NN	ISS
)	)	)
,	,	,
Glasgow	NP	Glasgow
Coma	NP	Coma
Scale	NP	Scale
(	(	(
GCS	NN	GCS
)	)	)
Score	NN	Score
,	,	,
base	NN	base
excess	NN	excess
(	(	(
BE	NN	BE
)	)	)
,	,	,
ICP	NN	ICP
days	NNS	day
,	,	,
transfusions	NNS	transfusion
in	IN	in
24	CD	24
h	NN	h
,	,	,
ICU	NN	ICU
days	NNS	day
,	,	,
ventilator	NN	ventilator
days	NNS	day
,	,	,
head	NN	head
Abbreviated	VBD	Abbreviate
Injury	NN	Injury
Score	NN	Score
(	(	(
AIS	NN	AIS
)	)	)
,	,	,
and	CC	and
chest	NN	chest
AIS	NN	AIS
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
study	NN	study
groups	NNS	group
did	VBD	do
not	RB	not
differ	VB	differ
with	IN	with
<FORBIDDEN ID=58 ACTION=delete>
respect	NN	respect
to	TO	to
</FORBIDDEN ID=58 ACTION=delete>
age	NN	age
,	,	,
ISS	NN	ISS
,	,	,
GCS	NN	GCS
,	,	,
BE	NN	BE
,	,	,
ICP	NN	ICP
days	NNS	day
,	,	,
24-h	JJ	24-h
transfusions	NNS	transfusion
,	,	,
ICU	NN	ICU
days	NNS	day
,	,	,
ventilator	NN	ventilator
days	NNS	day
,	,	,
head	NN	head
AIS	NN	AIS
,	,	,
or	CC	or
length	NN	length
of	IN	of
stay	NN	stay
.	SENT	.
.	SENT	.
In	IN	In
all	DT	all
,	,	,
183	CD	183
patients	NNS	patient
were	VVD	be
identified	VBN	identify
,	,	,
of	IN	of
whom	WP	whom
28	CD	28
died	VBD	die
within	IN	within
seven	CD	seven
days	NNS	day
and	CC	and
were	VVD	be
excluded	VBN	exclude
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
analysis	NN	analysis
.	SENT	.
.	SENT	.
All	DT	All
patients	NNS	patient
were	VVD	be
followed	VBN	follow
until	IN	until
discharge	NN	discharge
for	IN	for
<FORBIDDEN ID=30 ACTION=delete>
both	DT	both
</FORBIDDEN ID=30 ACTION=delete>
CNS	NN	CNS
infections	NNS	infection
and	CC	and
subsequent	JJ	subsequent
infectious	JJ	infectious
complications	NNS	complication
.	SENT	.
.	SENT	.
<FORBIDDEN ID=156 ACTION=delete>
Only	RB	Only
</FORBIDDEN ID=156 ACTION=delete>
two	CD	two
patients	NNS	patient
,	,	,
<FORBIDDEN ID=30 ACTION=delete>
both	CC	both
</FORBIDDEN ID=30 ACTION=delete>
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
PRO	NN	PRO
group	NN	group
,	,	,
developed	VBD	develop
CNS	NN	CNS
infection	NN	infection
.	SENT	.
.	SENT	.
<FORBIDDEN ID=30 ACTION=delete>
Both	DT	Both
</FORBIDDEN ID=30 ACTION=delete>
infectious	JJ	infectious
complications	NNS	complication
(	(	(
0.7	CD	0.7
<FORBIDDEN ID=25 ACTION=delete>
vs	IN	vs
</FORBIDDEN ID=25 ACTION=delete>
1.4	CD	1.4
per	IN	per
patient	NN	patient
;	COLUMN	;
p	NN	p
INF	SYM	INF
0.05	CD	0.05
)	)	)
and	CC	and
infections	NNS	infection
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
secondary	JJ	secondary
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
MDR	NN	MDR
pathogens	NNS	pathogen
(	(	(
0.03	CD	0.03
vs	NNS	v
.	SENT	.
0.33	CD	0.33
per	IN	per
patient	NN	patient
;	COLUMN	;
p	NN	p
INF	SYM	INF
0.01	CD	0.01
)	)	)
were	VVD	be
significantly	RB	significantly
<FORBIDDEN ID=82 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
common	JJ	common
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
PRO	NN	PRO
group	NN	group
.	SENT	.
.	SENT	.
Twenty	CD	Twenty
-	HYPH	-
nine	CD	nine
percent	NN	percent
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
ventilator	NN	ventilator
-	HYPH	-
associated	VBN	associate
pneumonias	NNS	pneumonia
and	CC	and
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
33%	CD	33%
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
blood	NN	blood
stream	NN	stream
infections	NNS	infection
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
PRO	NN	PRO
group	NN	group
were	VVD	be
MDR	NN	MDR
,	,	,
whereas	IN	whereas
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
two	CD	two
blood	NN	blood
stream	NN	stream
infections	NNS	infection
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
NONE	NN	NONE
group	NN	group
(	(	(
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
4%	CD	4%
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
total	JJ	total
infections	NNS	infection
)	)	)
were	VVD	be
MDR	NN	MDR
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
routine	JJ	routine
use	NN	use
of	IN	of
prophylactic	JJ	prophylactic
antibiotics	NNS	antibiotic
for	IN	for
ICP	NN	ICP
monitor	NN	monitor
insertion	NN	insertion
is	VVZ	be
not	RB	not
warranted	VBN	warrant
.	SENT	.
.	SENT	.
This	DT	This
practice	NN	practice
does	VBZ	do
not	RB	not
reduce	VB	reduce
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
CNS	NN	CNS
infection	NN	infection
rate	NN	rate
and	CC	and
is	VVZ	be
associated	VBN	associate
with	IN	with
<FORBIDDEN ID=82 ACTION=delete>
more	JJR	more
</FORBIDDEN ID=82 ACTION=delete>
MDR	NN	MDR
pathogens	NNS	pathogen
in	IN	in
any	DT	any
subsequent	JJ	subsequent
infectious	JJ	infectious
complications	NNS	complication
.	SENT	.
.	SENT	.
BB-cat+ner-18694716/text	DOCUMENT	BB-cat+ner-18694716/text
Quantitative	JJ	Quantitative
metabolome	NN	metabolome
analysis	NN	analysis
using	VBG	use
liquid	NN	liquid
chromatography	NN	chromatography
-	HYPH	-
high	JJ	high
-	HYPH	-
resolution	NN	resolution
mass	NN	mass
spectrometry	NN	spectrometry
.	SENT	.
.	SENT	.
In	IN	In
this	DT	this
report	NN	report
,	,	,
we	PP	we
introduce	VBP	introduce
a	DT	a
liquid	JJ	liquid
chromatography	NN	chromatography
single	JJ	single
-	HYPH	-
mass	NN	mass
spectrometry	NN	spectrometry
method	NN	method
for	IN	for
metabolome	NN	metabolome
quantification	NN	quantification
,	,	,
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
using	VBG	use
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
LTQ	NN	LTQ
Orbitrap	NN	Orbitrap
high	JJ	high
-	HYPH	-
resolution	NN	resolution
mass	NN	mass
spectrometer	NN	spectrometer
.	SENT	.
.	SENT	.
Analytes	NNS	Analyte
were	VVD	be
separated	VBN	separate
with	IN	with
hydrophilic	JJ	hydrophilic
interaction	NN	interaction
liquid	NN	liquid
chromatography	NN	chromatography
.	SENT	.
.	SENT	.
At	IN	At
a	DT	a
working	NN	working
resolution	NN	resolution
of	IN	of
30	CD	30
,	,	,
000	CD	000
(	(	(
at	IN	at
m	NN	m
/	SYM	/
z	NN	z
400	CD	400
)	)	)
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
limit	NN	limit
of	IN	of
detection	NN	detection
varied	VBD	vary
from	IN	from
50	CD	50
fmol	NN	fmol
to	TO	to
5	CD	5
pmol	NN	pmol
for	IN	for
25	CD	25
metabolites	NNS	metabolite
tested	VBN	test
.	SENT	.
.	SENT	.
In	IN	In
terms	NNS	term
of	IN	of
metabolite	NN	metabolite
concentration	NN	concentration
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
linearity	NN	linearity
was	VVD	be
about	RB	about
2	CD	2
to	TO	to
3	CD	3
orders	NNS	order
of	IN	of
magnitude	NN	magnitude
for	IN	for
most	JJS	most
compounds	NNS	compound
(R(2)SUP	NN	(R(2)SUP
0.99	CD	0.99
)	)	)
.	SENT	.
.	SENT	.
To	TO	To
determine	VB	determine
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
accuracy	NN	accuracy
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
system	NN	system
in	IN	in
complex	JJ	complex
sample	NN	sample
matrices	NNS	matrix
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
isotope	NN	isotope
dilution	NN	dilution
method	NN	method
was	VVD	be
evaluated	VBN	evaluate
from	IN	from
mixtures	NNS	mixture
of	IN	of
pure	JJ	pure
compounds	NNS	compound
and	CC	and
uniformly	RB	uniformly
13C	NN	13C
-	HYPH	-
labeled	VBN	label
cell	NN	cell
extracts	NNS	extract
.	SENT	.
.	SENT	.
With	IN	With
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
application	NN	application
of	IN	of
this	DT	this
method	NN	method
,	,	,
quantification	NN	quantification
was	VVD	be
possible	JJ	possible
within	IN	within
single	JJ	single
runs	NNS	run
<FORBIDDEN ID=157 ACTION=delete>
even	RB	even
</FORBIDDEN ID=157 ACTION=delete>
when	WRB	when
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
pool	NN	pool
sizes	VBZ	size
of	IN	of
individual	JJ	individual
metabolites	NNS	metabolite
varied	VBD	vary
from	IN	from
0.13	CD	0.13
to	TO	to
55.6	CD	55.6
microM	NN	microM
.	SENT	.
.	SENT	.
As	IN	As
a	DT	a
case	NN	case
study	NN	study
,	,	,
intracellular	JJ	intracellular
concentrations	NNS	concentration
of	IN	of
central	JJ	central
metabolites	NNS	metabolite
were	VVD	be
determined	VBN	determine
for	IN	for
Methylobacterium	NN	Methylobacterium
extorquens	VBZ	extorquen
AM1	NN	AM1
during	IN	during
growth	NN	growth
on	IN	on
two	CD	two
different	JJ	different
carbon	NN	carbon
sources	NNS	source
,	,	,
methanol	NN	methanol
and	CC	and
succinate	NN	succinate
.	SENT	.
.	SENT	.
Reproducible	JJ	Reproducible
results	NNS	result
from	IN	from
technical	JJ	technical
and	CC	and
biological	JJ	biological
repetitions	NNS	repetition
were	VVD	be
obtained	VBN	obtain
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
revealed	VBD	reveal
significant	JJ	significant
variations	NNS	variation
of	IN	of
intracellular	JJ	intracellular
metabolite	NN	metabolite
pool	NN	pool
sizes	VBZ	size
,	,	,
depending	VBG	depend
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
carbon	NN	carbon
source	NN	source
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
LTQ	NN	LTQ
Obitrap	NN	Obitrap
offers	VBZ	offer
<FORBIDDEN ID=38 ACTION=delete>
<FORBIDDEN ID=37 ACTION=delete>
new	JJ	new
</FORBIDDEN ID=37 ACTION=delete>
</FORBIDDEN ID=38 ACTION=delete>
perspectives	NNS	perspective
and	CC	and
strategies	NNS	strategy
for	IN	for
metabolome	NN	metabolome
quantification	NN	quantification
.	SENT	.
.	SENT	.
BB-cat+ner-18789156/text	DOCUMENT	BB-cat+ner-18789156/text
A	DT	A
novel	JJ	novel
receptor	NN	receptor
-	HYPH	-
ligand	NN	ligand
pathway	NN	pathway
for	IN	for
entry	NN	entry
of	IN	of
Francisella	NP	Francisella
tularensis	NN	tularensis
in	IN	in
monocyte	NN	monocyte
-	HYPH	-
like	JJ	like
THP	NN	THP
-1	NN	-1
cells	NNS	cell
:	COLUMN	:
interaction	NN	interaction
between	IN	between
surface	NN	surface
nucleolin	NN	nucleolin
and	CC	and
bacterial	JJ	bacterial
elongation	NN	elongation
factor	NN	factor
Tu	NN	Tu
.	SENT	.
.	SENT	.
Francisella	NP	Francisella
tularensis	NP	tularensis
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
causative	JJ	causative
agent	NN	agent
of	IN	of
tularemia	NN	tularemia
,	,	,
is	VVZ	be
<FORBIDDEN ID=55 ACTION=delete>
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
one	CD	one
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=55 ACTION=delete>
the	DT	the
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
most	RBS	most
infectious	JJ	infectious
human	JJ	human
bacterial	JJ	bacterial
pathogens	NNS	pathogen
.	SENT	.
.	SENT	.
It	PP	It
is	VVZ	be
phagocytosed	VBN	phagocytose
by	IN	by
immune	JJ	immune
cells	NNS	cell
,	,	,
<FORBIDDEN ID=17 ACTION=delete>
such	JJ	such
</FORBIDDEN ID=17 ACTION=delete>
as	IN	as
monocytes	NNS	monocyte
and	CC	and
macrophages	NNS	macrophage
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
precise	JJ	precise
mechanisms	NNS	mechanism
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
initiate	VBP	initiate
bacterial	JJ	bacterial
uptake	NN	uptake
have	VHP	have
not	RB	not
yet	RB	yet
been	VVN	be
elucidated	VBN	elucidate
.	SENT	.
.	SENT	.
Participation	NN	Participation
of	IN	of
C3	NN	C3
,	,	,
CR3	NN	CR3
,	,	,
class	NN	class
A	NN	A
scavenger	NN	scavenger
receptors	NNS	receptor
and	CC	and
mannose	NN	mannose
receptor	NN	receptor
in	IN	in
bacterial	JJ	bacterial
uptake	NN	uptake
have	VHP	have
been	VVN	be
already	RB	already
reported	VBN	report
.	SENT	.
.	SENT	.
However	RB	However
,	,	,
contribution	NN	contribution
of	IN	of
an	DT	an
additional	JJ	additional
,	,	,
as-yet	RB	as-yet
-	HYPH	-
unidentified	JJ	unidentified
receptor	NN	receptor
for	IN	for
F	NN	F
.	SENT	.
tularensis	NN	tularensis
internalization	NN	internalization
has	VHZ	have
been	VVN	be
suggested	VBN	suggest
.	SENT	.
.	SENT	.
We	PP	We
show	VBP	show
here	RB	here
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
cell	NN	cell
-	HYPH	-
surface	NN	surface
expressed	VBN	express
nucleolin	NN	nucleolin
is	VVZ	be
a	DT	a
receptor	NN	receptor
for	IN	for
Francisella	NP	Francisella
tularensis	NP	tularensis
Live	NP	Live
Vaccine	NP	Vaccine
Strain	NP	Strain
(	(	(
LVS	NP	LVS
)	)	)
and	CC	and
promotes	VBZ	promote
LVS	NN	LVS
binding	NN	binding
and	CC	and
infection	NN	infection
of	IN	of
human	JJ	human
monocyte	NN	monocyte
-	HYPH	-
like	JJ	like
THP	NN	THP
-1	NN	-1
cells	NNS	cell
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
HB	NN	HB
-19	CD	-19
pseudopeptide	NN	pseudopeptide
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
binds	VBZ	bind
specifically	RB	specifically
carboxy	AFX	carboxy
-	HYPH	-
terminal	JJ	terminal
RGG	NN	RGG
domain	NN	domain
of	IN	of
nucleolin	NN	nucleolin
inhibits	VBZ	inhibit
LVS	NN	LVS
binding	NN	binding
and	CC	and
infection	NN	infection
of	IN	of
monocyte	NN	monocyte
-	HYPH	-
like	JJ	like
THP	NN	THP
-1	NN	-1
cells	NNS	cell
.	SENT	.
.	SENT	.
In	IN	In
a	DT	a
pull	VB	pull
-	HYPH	-
down	RP	down
assay	NN	assay
,	,	,
elongation	NN	elongation
factor	NN	factor
Tu	NN	Tu
(	(	(
EF	NN	EF
-	HYPH	-
Tu	NN	Tu
)	)	)
,	,	,
a	DT	a
GTP	NN	GTP
-	HYPH	-
binding	VBG	bind
protein	NN	protein
involved	VBN	involve
in	IN	in
protein	NN	protein
translation	NN	translation
,	,	,
usually	RB	usually
found	VBN	find
in	IN	in
cytoplasm	NN	cytoplasm
,	,	,
was	VVD	be
recovered	VBN	recover
among	IN	among
LVS	NN	LVS
bacterial	JJ	bacterial
membrane	NN	membrane
proteins	NNS	protein
bound	VBN	bind
on	IN	on
RGG	NN	RGG
domain	NN	domain
of	IN	of
nucleolin	NN	nucleolin
.	SENT	.
.	SENT	.
A	DT	A
specific	JJ	specific
polyclonal	JJ	polyclonal
murine	JJ	murine
antibody	NN	antibody
was	VVD	be
raised	VBN	raise
against	IN	against
recombinant	JJ	recombinant
LVS	NN	LVS
EF	NN	EF
-	HYPH	-
Tu	NN	Tu
.	SENT	.
.	SENT	.
By	IN	By
fluorescence	NN	fluorescence
and	CC	and
electron	NN	electron
microscopy	NN	microscopy
experiments	NNS	experiment
,	,	,
we	PP	we
found	VBD	find
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
a	DT	a
fraction	NN	fraction
of	IN	of
EF	NN	EF
-	HYPH	-
Tu	NN	Tu
could	MD	could
be	VV	be
detected	VBN	detect
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bacterial	JJ	bacterial
surface	NN	surface
.	SENT	.
.	SENT	.
Anti	AFX	Anti
-	HYPH	-
EF	NN	EF
-	HYPH	-
Tu	NN	Tu
antibodies	NNS	antibody
reduced	VBD	reduce
LVS	NN	LVS
binding	NN	binding
to	TO	to
monocyte	NN	monocyte
-	HYPH	-
like	JJ	like
THP	NN	THP
-1	NN	-1
cells	NNS	cell
and	CC	and
impaired	JJ	impaired
infection	NN	infection
,	,	,
<FORBIDDEN ID=157 ACTION=delete>
even	RB	even
</FORBIDDEN ID=157 ACTION=delete>
in	IN	in
absence	NN	absence
of	IN	of
complement	NN	complement
and	CC	and
complement	NN	complement
receptors	NNS	receptor
.	SENT	.
.	SENT	.
Interaction	NN	Interaction
between	IN	between
EF	NN	EF
-	HYPH	-
Tu	NN	Tu
and	CC	and
nucleolin	NN	nucleolin
was	VVD	be
illustrated	VBN	illustrate
by	IN	by
two	CD	two
different	JJ	different
pull	NN	pull
-	HYPH	-
down	RP	down
assays	NNS	assay
using	VBG	use
recombinant	JJ	recombinant
EF	NN	EF
-	HYPH	-
Tu	NN	Tu
proteins	NNS	protein
and	CC	and
either	CC	either
RGG	NN	RGG
domain	NN	domain
of	IN	of
nucleolin	NN	nucleolin
or	CC	or
cell	NN	cell
solubilized	VBD	solubilize
nucleolin	NN	nucleolin
.	SENT	.
.	SENT	.
Altogether	RB	Altogether
,	,	,
our	PP$	our
results	NNS	result
demonstrate	VBP	demonstrate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
interaction	NN	interaction
between	IN	between
surface	NN	surface
nucleolin	NN	nucleolin
and	CC	and
its	PP$	its
bacterial	JJ	bacterial
ligand	NN	ligand
EF	NN	EF
-	HYPH	-
Tu	NN	Tu
plays	VBZ	play
an	DT	an
important	JJ	important
role	NN	role
in	IN	in
Francisella	NP	Francisella
tularensis	NN	tularensis
adhesion	NN	adhesion
and	CC	and
entry	NN	entry
process	NN	process
and	CC	and
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
<FORBIDDEN ID=162 ACTION=delete>
</FORBIDDEN ID=123 ACTION=delete>
therefore	RB	therefore
</FORBIDDEN ID=162 ACTION=delete>
facilitate	VB	facilitate
invasion	NN	invasion
of	IN	of
host	NN	host
tissues	NNS	tissue
.	SENT	.
.	SENT	.
Since	IN	Since
phagosomal	JJ	phagosomal
escape	NN	escape
and	CC	and
intra	AFX	intra
-	HYPH	-
cytosolic	JJ	cytosolic
multiplication	NN	multiplication
of	IN	of
LVS	NN	LVS
in	IN	in
infected	JJ	infected
monocytes	NNS	monocyte
are	VVP	be
very	RB	very
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
similar	JJ	similar
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
those	DT	those
of	IN	of
human	JJ	human
pathogenic	JJ	pathogenic
F	NN	F
.	SENT	.
tularensis	NN	tularensis
ssp	NN	ssp
tularensis	NN	tularensis
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
mechanism	NN	mechanism
of	IN	of
entry	NN	entry
into	IN	into
monocyte	NN	monocyte
-	HYPH	-
like	JJ	like
THP	NN	THP
-1	NN	-1
cells	NNS	cell
,	,	,
involving	VBG	involve
interaction	NN	interaction
between	IN	between
EF	NN	EF
-	HYPH	-
Tu	NN	Tu
and	CC	and
nucleolin	NN	nucleolin
,	,	,
might	MD	might
be	VV	be
similar	JJ	similar
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
two	CD	two
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
subspecies	NNS	subspecy
.	SENT	.
.	SENT	.
Thus	RB	Thus
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
use	NN	use
of	IN	of
either	CC	either
nucleolin	NN	nucleolin
-	HYPH	-
specific	JJ	specific
pseudopeptide	NN	pseudopeptide
HB	NN	HB
-19	CD	-19
or	CC	or
recombinant	JJ	recombinant
EF	NN	EF
-	HYPH	-
Tu	NN	Tu
could	MD	could
provide	VB	provide
attractive	JJ	attractive
therapeutic	JJ	therapeutic
approaches	NNS	approach
for	IN	for
modulating	VBG	modulate
F	NN	F
.	SENT	.
tularensis	NN	tularensis
infection	NN	infection
.	SENT	.
.	SENT	.
BB-cat+ner-18845825/text	DOCUMENT	BB-cat+ner-18845825/text
High	JJ	High
genetic	JJ	genetic
diversity	NN	diversity
of	IN	of
nontypeable	JJ	nontypeable
Haemophilus	NPS	Haemophilu
influenzae	VBP	influenzae
isolates	NNS	isolate
from	IN	from
two	CD	two
children	NNS	child
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
attending	VBG	attend
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
day	NN	day
care	NN	care
center	NN	center
.	SENT	.
.	SENT	.
Twenty-one	CD	Twenty-one
nontypeable	JJ	nontypeable
Haemophilus	NN	Haemophilus
influenzae	NNS	influenzae
(	(	(
NTHi	NN	NTHi
)	)	)
isolates	VBZ	isolate
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
throats	NNS	throat
of	IN	of
two	CD	two
healthy	JJ	healthy
children	NNS	child
were	VVD	be
genotyped	VBN	genotype
by	IN	by
multilocus	JJ	multilocus
sequence	NN	sequence
typing	NN	typing
.	SENT	.
.	SENT	.
Nine	CD	Nine
unique	JJ	unique
sequence	NN	sequence
types	NNS	type
(	(	(
STs	NNS	ST
)	)	)
were	VVD	be
identified	VBN	identify
.	SENT	.
.	SENT	.
These	DT	These
STs	NNS	ST
were	VVD	be
scattered	VBN	scatter
throughout	IN	throughout
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
phylogenetic	JJ	phylogenetic
tree	NN	tree
of	IN	of
reported	VBN	report
NTHi	NP	NTHi
STs	NNS	ST
,	,	,
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
demonstrating	VBG	demonstrate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
high	JJ	high
level	NN	level
of	IN	of
NTHi	NN	NTHi
diversity	NN	diversity
found	VBN	find
in	IN	in
colonized	VBN	colonize
children	NNS	child
.	SENT	.
.	SENT	.
BB-cat+ner-19004249/text	DOCUMENT	BB-cat+ner-19004249/text
Evaluation	NN	Evaluation
of	IN	of
antibacterial	JJ	antibacterial
activity	NN	activity
of	IN	of
synthetic	JJ	synthetic
aliphatic	JJ	aliphatic
and	CC	and
aromatic	JJ	aromatic
monoacylglycerols	NNS	monoacylglycerol
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
antibacterial	JJ	antibacterial
activity	NN	activity
of	IN	of
synthetic	JJ	synthetic
aliphatic	JJ	aliphatic
and	CC	and
aromatic	JJ	aromatic
monoacylglycerols	NNS	monoacylglycerol
(	(	(
MAGs	NNS	MAG
)	)	)
was	VVD	be
studied	VBN	study
against	IN	against
two	CD	two
human	JJ	human
pathogens	NNS	pathogen
:	COLUMN	:
Staphylococcus	FW	Staphylococcus
aureus	FW	aureus
and	CC	and
Escherichia	FW	Escherichia
coli	FW	coli
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
active	JJ	active
compounds	NNS	compound
inhibited	VBD	inhibit
<FORBIDDEN ID=81 ACTION=delete>
selectively	RB	selectively
</FORBIDDEN ID=81 ACTION=delete>
S	NN	S
.	SENT	.
aureus	NN	aureus
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
most	RBS	most
active	JJ	active
compounds	NNS	compound
amongst	IN	amongst
them	PP	them
were	VVD	be
those	DT	those
with	IN	with
medium	NN	medium
size	NN	size
aliphatic	JJ	aliphatic
chain	NN	chain
and	CC	and
aromatic	JJ	aromatic
MAGs	NNS	MAG
with	IN	with
electron	NN	electron
withdrawing	VBG	withdraw
substituents	NNS	substituent
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
aryl	NN	aryl
ring	NN	ring
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
introduction	NN	introduction
of	IN	of
one	CD	one
or	CC	or
two-carbon	NN	two-carbon
spacer	NN	spacer
between	IN	between
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
aryl	NN	aryl
ring	NN	ring
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
carboxylic	JJ	carboxylic
function	NN	function
did	VBD	do
not	RB	not
influence	VB	influence
antibacterial	JJ	antibacterial
effectiveness	NN	effectiveness
.	SENT	.
.	SENT	.
BB-cat+ner-19049879/text	DOCUMENT	BB-cat+ner-19049879/text
Molecular	JJ	Molecular
cloning	NN	cloning
and	CC	and
expression	NN	expression
of	IN	of
MyD88	NN	MyD88
in	IN	in
large	JJ	large
yellow	JJ	yellow
croaker	NN	croaker
,	,	,
Pseudosciaena	NP	Pseudosciaena
crocea	NN	crocea
.	SENT	.
.	SENT	.
Myeloid	JJ	Myeloid
differentiation	NN	differentiation
factor	NN	factor
88	CD	88
(	(	(
MyD88	NN	MyD88
)	)	)
is	VVZ	be
an	DT	an
adaptor	NN	adaptor
protein	NN	protein
involved	VBN	involve
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
interleukin	NN	interleukin
-1	NN	-1
receptor	NN	receptor
and	CC	and
Toll	NN	Toll
-	HYPH	-
like	JJ	like
receptor	NN	receptor
-	HYPH	-
induced	VBN	induce
activation	NN	activation
of	IN	of
nuclear	JJ	nuclear
factor	NN	factor
-	HYPH	-
kappaB	NN	kappaB
(	(	(
NF	NN	NF
-	HYPH	-
kappaB	NN	kappaB
)	)	)
.	SENT	.
.	SENT	.
In	IN	In
this	DT	this
report	NN	report
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
full	JJ	full
-	HYPH	-
length	NN	length
cDNA	NN	cDNA
of	IN	of
MyD88	NN	MyD88
was	VVD	be
cloned	VBN	clone
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
large	JJ	large
yellow	JJ	yellow
croaker	NN	croaker
,	,	,
Pseudosciaena	NP	Pseudosciaena
crocea	NN	crocea
.	SENT	.
.	SENT	.
It	PP	It
was	VVD	be
of	IN	of
1574	CD	1574
bp	NN	bp
,	,	,
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
including	VBG	include
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
5'	NN	5'
-	HYPH	-
terminal	JJ	terminal
untranslated	JJ	untranslated
region	NN	region
(	(	(
UTR	NN	UTR
)	)	)
of	IN	of
89	CD	89
bp	NN	bp
,	,	,
a	DT	a
3'	JJ	3'
-	HYPH	-
terminal	JJ	terminal
UTR	NN	UTR
of	IN	of
621bp	NN	621bp
and	CC	and
an	DT	an
open	JJ	open
reading	NN	reading
frame	NN	frame
(	(	(
ORF	NN	ORF
)	)	)
of	IN	of
864	CD	864
bp	NN	bp
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
encoding	VBG	encode
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
polypeptide	NN	polypeptide
of	IN	of
287	CD	287
amino	NN	amino
acids	NNS	acid
.	SENT	.
.	SENT	.
It	PP	It
contained	VBD	contain
a	DT	a
typical	JJ	typical
death	NN	death
domain	NN	domain
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
N-terminal	JJ	N-terminal
and	CC	and
a	DT	a
conservative	JJ	conservative
Toll	NN	Toll
/	SYM	/
IL	NN	IL
-1	SYM	-1
R	NN	R
(	(	(
TIR	NN	TIR
)	)	)
domain	NN	domain
structure	NN	structure
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
C-terminal	JJ	C-terminal
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
quantitative	JJ	quantitative
real	JJ	real
-	HYPH	-
time	NN	time
reverse	JJ	reverse
transcription	NN	transcription
PCR	NN	PCR
analysis	NN	analysis
revealed	VBD	reveal
a	DT	a
broad	JJ	broad
expression	NN	expression
of	IN	of
MyD88	NN	MyD88
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
highest	JJS	high
expression	NN	expression
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
spleen	NN	spleen
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
weakest	JJS	weak
expression	NN	expression
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
muscle	NN	muscle
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
expression	NN	expression
of	IN	of
MyD88	NN	MyD88
after	IN	after
challenge	NN	challenge
with	IN	with
formalin	NN	formalin
-	HYPH	-
inactivated	VBN	inactivate
Gram	NN	Gram
-	HYPH	-
negative	JJ	negative
bacterium	NN	bacterium
Vibrio	NN	Vibrio
parahaemolyticus	NN	parahaemolyticus
was	VVD	be
tested	VBN	test
in	IN	in
blood	NN	blood
,	,	,
spleen	NN	spleen
and	CC	and
liver	NN	liver
.	SENT	.
.	SENT	.
It	PP	It
suggested	VBD	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
highest	JJS	high
expression	NN	expression
was	VVD	be
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
spleen	NN	spleen
(	(	(
pINF	NN	pINF
0.05	CD	0.05
)	)	)
with	IN	with
1.9	CD	1.9
times	NNS	time
(	(	(
at	IN	at
48	CD	48
h	NN	h
)	)	)
as	RB	as
<FORBIDDEN ID=83 ACTION=delete>
much	RB	much
</FORBIDDEN ID=83 ACTION=delete>
as	IN	as
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	DT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
control	NN	control
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
lowest	JJS	low
expression	NN	expression
of	IN	of
MyD88	NN	MyD88
was	VVD	be
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
liver	NN	liver
(	(	(
pINF	NN	pINF
0.05	CD	0.05
)	)	)
with	IN	with
0.29	CD	0.29
times	NNS	time
(	(	(
at	IN	at
3h	LS	3h
)	)	)
of	IN	of
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	DT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
control	NN	control
.	SENT	.
.	SENT	.
These	DT	These
results	NNS	result
indicated	VBD	indicate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
as	IN	as
a	DT	a
universal	JJ	universal
key	JJ	key
adaptor	NN	adaptor
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Toll	NN	Toll
-	HYPH	-
like	JJ	like
receptor	NN	receptor
pathway	NN	pathway
in	IN	in
mammals	NNS	mammal
,	,	,
MyD88	NN	MyD88
might	MD	might
play	VB	play
an	DT	an
important	JJ	important
role	NN	role
in	IN	in
large	JJ	large
yellow	JJ	yellow
croaker	NN	croaker
defense	NN	defense
against	IN	against
pathogenic	JJ	pathogenic
infection	NN	infection
.	SENT	.
.	SENT	.
BB-cat+ner-19075662/text	DOCUMENT	BB-cat+ner-19075662/text
Prevention	NN	Prevention
and	CC	and
treatment	NN	treatment
of	IN	of
Staphylococcus	NP	Staphylococcus
biofilms	NNS	biofilm
.	SENT	.
.	SENT	.
Staphylococcus	NN	Staphylococcus
growth	NN	growth
on	IN	on
medical	JJ	medical
devices	NNS	device
represents	VBZ	represent
a	DT	a
common	JJ	common
occurrence	NN	occurrence
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
can	MD	can
lead	VB	lead
to	TO	to
serious	JJ	serious
illness	NN	illness
and	CC	and
death	NN	death
.	SENT	.
.	SENT	.
Biomaterial	NN	Biomaterial
-	HYPH	-
associated	VBN	associate
infection	NN	infection
,	,	,
mostly	RB	mostly
caused	VBN	cause
by	IN	by
Staphylococcus	NN	Staphylococcus
epidermidis	NN	epidermidis
and	CC	and
Staphylococcus	FW	Staphylococcus
aureus	FW	aureus
,	,	,
is	VVZ	be
fairly	RB	fairly
complicated	VBN	complicate
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
organism'	NN	organism'
development	NN	development
of	IN	of
a	DT	a
biofilm	NN	biofilm
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
provides	VBZ	provide
a	DT	a
microenvironment	NN	microenvironment
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
protects	VBZ	protect
from	IN	from
attack	NN	attack
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
host	NN	host
immune	JJ	immune
system	NN	system
and	CC	and
antibiotics	NNS	antibiotic
.	SENT	.
.	SENT	.
In	IN	In
this	DT	this
review	NN	review
we	PP	we
present	VBP	present
recent	JJ	recent
insights	NNS	insight
<FORBIDDEN ID=150 ACTION=delete>
regarding	VBG	regard
</FORBIDDEN ID=150 ACTION=delete>
S	NN	S
.	SENT	.
aureus	NN	aureus
and	CC	and
S	NN	S
.	SENT	.
epidermidis	NN	epidermidis
structural	JJ	structural
and	CC	and
functional	JJ	functional
factors	NNS	factor
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
are	VVP	be
effective	JJ	effective
in	IN	in
biofilm	NN	biofilm
development	NN	development
and	CC	and
describe	VBP	describe
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
regulation	NN	regulation
of	IN	of
their	PP$	their
expression	NN	expression
.	SENT	.
.	SENT	.
On	IN	On
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
basis	NN	basis
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
knowledge	NN	knowledge
gained	VBD	gain
,	,	,
we	PP	we
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
present	VBP	present
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
potential	JJ	potential
and	CC	and
limits	NNS	limit
of	IN	of
current	JJ	current
biochemical	JJ	biochemical
and	CC	and
biophysical	JJ	biophysical
strategies	NNS	strategy
aimed	VBN	aim
at	IN	at
preventing	VBG	prevent
biofilm	NN	biofilm
formation	NN	formation
or	CC	or
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
treatment	NN	treatment
of	IN	of
established	JJ	established
mature	JJ	mature
biofilms	NNS	biofilm
.	SENT	.
.	SENT	.
BB-cat+ner-19099664/text	DOCUMENT	BB-cat+ner-19099664/text
[	(	[
Changes	NNS	Change
of	IN	of
pathogens	NNS	pathogen
and	CC	and
susceptibility	NN	susceptibility
to	TO	to
antibiotics	NNS	antibiotic
in	IN	in
hematology	NN	hematology
ward	NN	ward
from	IN	from
years	NNS	year
2001	CD	2001
to	TO	to
2005	CD	2005
]	)	]
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
<FORBIDDEN ID=138 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
purpose	NN	purpose
of	IN	of
</FORBIDDEN ID=138 ACTION=delete>
this	DT	this
study	NN	study
was	VVD	be
to	TO	to
determine	VB	determine
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
changes	NNS	change
of	IN	of
pathogens	NNS	pathogen
in	IN	in
hematological	JJ	hematological
ward	NN	ward
and	CC	and
susceptibility	NN	susceptibility
of	IN	of
patients	NNS	patient
received	VBD	receive
chemotherapy	NN	chemotherapy
to	TO	to
antibiotics	NNS	antibiotic
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
pathogens	NNS	pathogen
were	VVD	be
taken	VBN	take
from	IN	from
blood	NN	blood
,	,	,
urine	NN	urine
and	CC	and
sputum	NN	sputum
of	IN	of
patients	NNS	patient
who	WP	who
accepted	VBD	accept
chemotherapy	NN	chemotherapy
from	IN	from
years	NNS	year
2001	CD	2001
to	TO	to
2005	CD	2005
,	,	,
then	RB	then
were	VVD	be
isolated	VBN	isolate
and	CC	and
identified	VBN	identify
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
susceptibility	NN	susceptibility
test	NN	test
was	VVD	be
performed	VBN	perform
by	IN	by
disk	NN	disk
diffusion	NN	diffusion
method	NN	method
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
results	NNS	result
showed	VBD	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
total	NN	total
of	IN	of
418	CD	418
strains	NNS	strain
were	VVD	be
detected	VBN	detect
.	SENT	.
.	SENT	.
Gram	NN	Gram
-	HYPH	-
negative	JJ	negative
bacteria	NNS	bacteria
were	VVD	be
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
most	RBS	most
common	JJ	common
of	IN	of
nosocomial	JJ	nosocomial
infection	NN	infection
.	SENT	.
.	SENT	.
Pseudomonas	NP	Pseudomonas
aeruginosa	NP	aeruginosa
,	,	,
Enterobacter	NP	Enterobacter
cloacae	NNS	cloaca
,	,	,
E	NN	E
.	SENT	.
coli	NNS	coli
account	VBP	account
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
most	JJS	most
of	IN	of
Gram	NN	Gram
negative	JJ	negative
-	HYPH	-
bacteria	NNS	bacteria
infection	NN	infection
and	CC	and
most	RBS	most
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
resistant	JJ	resistant
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
broad	JJ	broad
-	HYPH	-
spectrum	NN	spectrum
penicillin	NN	penicillin
,	,	,
Acinetobacter	NP	Acinetobacter
baumannii	NN	baumannii
showed	VBD	show
a	DT	a
trend	NN	trend
of	IN	of
increase	NN	increase
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
ratios	NNS	ratio
of	IN	of
gram	NN	gram
positive	JJ	positive
bacteria	NNS	bacteria
and	CC	and
fungi	NNS	fungus
were	VVD	be
increased	VBN	increase
slowly	RB	slowly
,	,	,
mainly	RB	mainly
as	IN	as
Enterococcus	NP	Enterococcus
and	CC	and
Candida	NP	Candida
.	SENT	.
.	SENT	.
Enterococcus	NP	Enterococcus
is	VVZ	be
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
most	RBS	most
common	JJ	common
cause	NN	cause
of	IN	of
Gram	NN	Gram
-	HYPH	-
positive	JJ	positive
bacterial	JJ	bacterial
infection	NN	infection
.	SENT	.
.	SENT	.
Vancomycin	NN	Vancomycin
resistance	NN	resistance
did	VBD	do
not	RB	not
occur	VB	occur
.	SENT	.
.	SENT	.
It	PP	It
is	VVZ	be
concluded	VBN	conclude
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
Gram	NN	Gram
-	HYPH	-
negative	JJ	negative
bacteria	NNS	bacteria
are	VVP	be
main	JJ	main
cause	NN	cause
of	IN	of
nosocomial	JJ	nosocomial
infection	NN	infection
in	IN	in
patients	NNS	patient
with	IN	with
hematological	JJ	hematological
malignancies	NNS	malignancy
.	SENT	.
.	SENT	.
Gram	NN	Gram
positive	JJ	positive
bacteria	NNS	bacteria
and	CC	and
fungi	NNS	fungus
had	VHD	have
been	VVN	be
<FORBIDDEN ID=82 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
frequent	JJ	frequent
.	SENT	.
.	SENT	.
Strains	NNS	Strain
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
resistant	JJ	resistant
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
antimicrobial	JJ	antimicrobial
agents	NNS	agent
increase	VBP	increase
.	SENT	.
.	SENT	.
BB-cat+ner-19175621/text	DOCUMENT	BB-cat+ner-19175621/text
Occurrence	NN	Occurrence
of	IN	of
extended	VBN	extend
-	HYPH	-
spectrum	NN	spectrum
beta	SYM	beta
-	HYPH	-
lactamase	NN	lactamase
-	HYPH	-
producing	VBG	produce
Salmonella	NN	Salmonella
enterica	NN	enterica
in	IN	in
northern	JJ	northern
Spain	NN	Spain
with	IN	with
evidence	NN	evidence
of	IN	of
CTX	NN	CTX
-	HYPH	-
M	NN	M
-9	CD	-9
clonal	JJ	clonal
spread	NN	spread
among	IN	among
animals	NNS	animal
and	CC	and
humans	NNS	human
.	SENT	.
.	SENT	.
Among	IN	Among
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
1233	CD	1233
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
Salmonella	NP	Salmonella
enterica	NP	enterica
isolates	NNS	isolate
obtained	VBN	obtain
in	IN	in
two	CD	two
Spanish	JJ	Spanish
hospitals	NNS	hospital
,	,	,
five	CD	five
isolates	NNS	isolate
(	(	(
0.4	CD	0.4
%	NN	%
)	)	)
(	(	(
serovars	NNS	serovar
:	COLUMN	:
Virchow	NN	Virchow
,	,	,
four	CD	four
;	COLUMN	;
Livingstone	NN	Livingstone
,	,	,
one	CD	one
)	)	)
had	VHD	have
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
phenotype	NN	phenotype
of	IN	of
an	DT	an
extended	VBN	extend
-	HYPH	-
spectrum	NN	spectrum
beta	SYM	beta
-	HYPH	-
lactamase	NN	lactamase
(	(	(
ESBL	NN	ESBL
)	)	)
producer	NN	producer
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
genetic	JJ	genetic
characterization	NN	characterization
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
ESBL	NP	ESBL
of	IN	of
S	NP	S
.	SENT	.
enterica	NP	enterica
Livingstone	NP	Livingstone
revealed	VBD	reveal
a	DT	a
bla(SHV	NN	bla(SHV
-2	CD	-2
)	)	)
gene	NN	gene
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bla(CTX	NN	bla(CTX
-	HYPH	-
M	NN	M
-10	CD	-10
)	)	)
gene	NN	gene
in	IN	in
a	DT	a
phage	NN	phage
-	HYPH	-
related	VBN	relate
genetic	JJ	genetic
environment	NN	environment
was	VVD	be
found	VBN	find
in	IN	in
one	CD	one
S	NN	S
.	SENT	.
enterica	NP	enterica
Virchow	NP	Virchow
isolate	NN	isolate
,	,	,
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bla(CTX	NN	bla(CTX
-	HYPH	-
M	NN	M
-9	CD	-9
)	)	)
gene	NN	gene
within	IN	within
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
In60	NN	In60
integron	NN	integron
was	VVD	be
found	VBN	find
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
three	CD	three
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
remaining	VBG	remain
Virchow	NN	Virchow
isolates	NNS	isolate
.	SENT	.
.	SENT	.
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
These	DT	These
three	CD	three
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
isolates	NNS	isolate
presented	VBD	present
indistinguishable	JJ	indistinguishable
or	CC	or
closely	RB	closely
related	JJ	related
pulsed	JJ	pulsed
-	HYPH	-
field	NN	field
gel	NN	gel
electrophoresis	NN	electrophoresis
patterns	NNS	pattern
among	IN	among
themselves	PP	themselves
and	CC	and
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
as	IN	as
compared	VBN	compare
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
two	CD	two
<FORBIDDEN ID=22 ACTION=delete>
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
bla(CTX	NN	bla(CTX
-	HYPH	-
M	NN	M
-9	CD	-9
)	)	)
-	HYPH	-
containing	VBG	contain
isolates	NNS	isolate
previously	RB	previously
obtained	VBN	obtain
from	IN	from
animals	NNS	animal
.	SENT	.
.	SENT	.
ESBL	NN	ESBL
production	NN	production
is	VVZ	be
an	DT	an
emerging	VBG	emerge
mechanism	NN	mechanism
of	IN	of
resistance	NN	resistance
in	IN	in
S	NN	S
.	SENT	.
enterica	NN	enterica
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
two	CD	two
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
studied	VBN	study
hospitals	NNS	hospital
.	SENT	.
.	SENT	.
BB-cat+ner-19339076/text	DOCUMENT	BB-cat+ner-19339076/text
Bile	NN	Bile
resistance	NN	resistance
in	IN	in
Lactococcus	NN	Lactococcus
lactis	NN	lactis
strains	NNS	strain
varies	VBZ	vary
with	IN	with
cellular	JJ	cellular
fatty	JJ	fatty
acid	NN	acid
composition	NN	composition
:	COLUMN	:
analysis	NN	analysis
by	IN	by
using	VBG	use
different	JJ	different
growth	NN	growth
media	NNS	medium
.	SENT	.
.	SENT	.
Bile	NN	Bile
resistance	NN	resistance
is	VVZ	be
<FORBIDDEN ID=55 ACTION=delete>
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
one	CD	one
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=55 ACTION=delete>
the	DT	the
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
basic	JJ	basic
characteristics	NNS	characteristic
of	IN	of
probiotic	JJ	probiotic
bacteria	NNS	bacteria
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
aim	NN	aim
of	IN	of
this	DT	this
study	NN	study
was	VVD	be
to	TO	to
investigate	VB	investigate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
characteristics	NNS	characteristic
of	IN	of
bile	NN	bile
resistance	NN	resistance
in	IN	in
lactococci	NNS	lactococci
by	IN	by
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
studying	VBG	study
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
relationship	NN	relationship
between	IN	between
bile	NN	bile
resistance	NN	resistance
and	CC	and
cellular	JJ	cellular
fatty	JJ	fatty
acid	NN	acid
composition	NN	composition
in	IN	in
lactococcci	NNS	lactococcci
grown	VBN	grow
on	IN	on
different	JJ	different
media	NNS	medium
.	SENT	.
.	SENT	.
We	PP	We
determined	VBD	determine
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bile	NN	bile
resistance	NN	resistance
of	IN	of
14	CD	14
strains	NNS	strain
in	IN	in
lactose	NN	lactose
-	HYPH	-
free	JJ	free
M17	NN	M17
medium	NN	medium
supplemented	VBN	supplement
with	IN	with
either	DT	either
glucose	NN	glucose
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
(	(	(
GM17	NN	GM17
)	)	)
or	CC	or
lactose	NN	lactose
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
(	(	(
LM17	NN	LM17
)	)	)
.	SENT	.
.	SENT	.
Gas	IN	Gas
chromatographic	JJ	chromatographic
analyses	NNS	analysis
of	IN	of
free	JJ	free
lipids	NNS	lipid
extracted	VBN	extract
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
tested	VBN	test
strains	NNS	strain
were	VVD	be
used	VBN	use
for	IN	for
determining	VBG	determine
their	PP$	their
fatty	JJ	fatty
acid	NN	acid
composition	NN	composition
.	SENT	.
.	SENT	.
A	DT	A
correlation	NN	correlation
analysis	NN	analysis
of	IN	of
all	DT	all
strains	NNS	strain
grown	VBN	grow
in	IN	in
<FORBIDDEN ID=30 ACTION=delete>
both	DT	both
</FORBIDDEN ID=30 ACTION=delete>
media	NNS	medium
revealed	VBD	reveal
significant	JJ	significant
positive	JJ	positive
correlations	NNS	correlation
between	IN	between
bile	NN	bile
resistance	NN	resistance
and	CC	and
relative	JJ	relative
contents	NNS	content
of	IN	of
hexadecanoic	JJ	hexadecanoic
acid	NN	acid
and	CC	and
octadecenoic	JJ	octadecenoic
acid	NN	acid
,	,	,
and	CC	and
negative	JJ	negative
correlations	NNS	correlation
between	IN	between
bile	NN	bile
resistance	NN	resistance
and	CC	and
relative	JJ	relative
contents	NNS	content
of	IN	of
hexadecenoic	JJ	hexadecenoic
acid	NN	acid
and	CC	and
C	NN	C
-19	CD	-19
cyclopropane	NN	cyclopropane
fatty	JJ	fatty
acid	NN	acid
.	SENT	.
.	SENT	.
It	PP	It
is	VVZ	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
a	DT	a
fact	NN	fact
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
fatty	JJ	fatty
acids	NNS	acid
associated	VBN	associate
with	IN	with
bile	NN	bile
resistance	NN	resistance
depended	VBD	depend
on	IN	on
species	NNS	specie
,	,	,
strain	NN	strain
,	,	,
and	CC	and
/	SYM	/
or	CC	or
growth	NN	growth
medium	NN	medium
.	SENT	.
.	SENT	.
In	IN	In
L	NN	L
.	SENT	.
lactis	NN	lactis
subsp	NN	subsp
.	SENT	.
cremoris	NN	cremoris
strains	NNS	strain
grown	VBN	grow
in	IN	in
GM17	NN	GM17
medium	NN	medium
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bile	NN	bile
-	HYPH	-
resistant	JJ	resistant
strains	NNS	strain
had	VHD	have
significantly	RB	significantly
<FORBIDDEN ID=82 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
octadecenoic	JJ	octadecenoic
acid	NN	acid
than	IN	than
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bile	NN	bile
-	HYPH	-
sensitive	JJ	sensitive
strains	NNS	strain
.	SENT	.
.	SENT	.
In	IN	In
LM17	NN	LM17
medium	NN	medium
,	,	,
bile	NN	bile
-	HYPH	-
resistant	JJ	resistant
strains	NNS	strain
had	VHD	have
significantly	RB	significantly
<FORBIDDEN ID=82 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
octadecenoic	JJ	octadecenoic
acid	NN	acid
and	CC	and
significantly	RB	significantly
less	JJR	less
C	NN	C
-19	CD	-19
cyclopropane	NN	cyclopropane
fatty	JJ	fatty
acid	NN	acid
than	IN	than
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bile	NN	bile
-	HYPH	-
sensitive	JJ	sensitive
strains	NNS	strain
.	SENT	.
.	SENT	.
In	IN	In
L	NN	L
.	SENT	.
lactis	NN	lactis
subsp	NN	subsp
.	SENT	.
lactis	NN	lactis
strains	NNS	strain
,	,	,
bile	NN	bile
resistances	NNS	resistance
<FORBIDDEN ID=12 ACTION=split SPLIT_AFTER=0>
of	IN	of
some	DT	some
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=12 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
tested	VBN	test
strains	NNS	strain
were	VVD	be
altered	VBN	alter
by	IN	by
growth	NN	growth
medium	NN	medium
.	SENT	.
.	SENT	.
Some	DT	Some
strains	NNS	strain
were	VVD	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
resistant	JJ	resistant
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
bile	NN	bile
in	IN	in
GM17	NN	GM17
medium	NN	medium
but	CC	but
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
sensitive	JJ	sensitive
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
bile	NN	bile
in	IN	in
LM17	NN	LM17
medium	NN	medium
.	SENT	.
.	SENT	.
Some	DT	Some
strains	NNS	strain
were	VVD	be
resistant	JJ	resistant
in	IN	in
<FORBIDDEN ID=30 ACTION=delete>
both	DT	both
</FORBIDDEN ID=30 ACTION=delete>
media	NNS	medium
tested	VBN	test
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
strains	NNS	strain
grown	VBN	grow
in	IN	in
GM17	NN	GM17
medium	NN	medium
had	VHD	have
significantly	RB	significantly
<FORBIDDEN ID=82 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
hexadecanoic	JJ	hexadecanoic
acid	NN	acid
and	CC	and
octadecenoic	JJ	octadecenoic
acid	NN	acid
,	,	,
and	CC	and
significantly	RB	significantly
less	RBR	less
tetradecanoic	JJ	tetradecanoic
acid	NN	acid
,	,	,
octadecadienoic	JJ	octadecadienoic
acid	NN	acid
and	CC	and
C	NN	C
-19	CD	-19
cyclopropane	NN	cyclopropane
fatty	JJ	fatty
acid	NN	acid
than	IN	than
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
strains	NNS	strain
grown	VBN	grow
in	IN	in
LM17	NN	LM17
medium	NN	medium
.	SENT	.
.	SENT	.
In	IN	In
conclusion	NN	conclusion
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
fatty	JJ	fatty
acid	NN	acid
compositions	NNS	composition
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bile	NN	bile
-	HYPH	-
resistant	JJ	resistant
lactococci	NNS	lactococci
differed	VBD	differ
from	IN	from
those	DT	those
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bile	NN	bile
-	HYPH	-
sensitive	JJ	sensitive
ones	NNS	one
.	SENT	.
.	SENT	.
<FORBIDDEN ID=82 ACTION=delete>
More	RBR	More
</FORBIDDEN ID=82 ACTION=delete>
importantly	RB	importantly
,	,	,
our	PP$	our
data	NNS	datum
suggest	VBP	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
altering	VBG	alter
their	PP$	their
fatty	JJ	fatty
acid	NN	acid
composition	NN	composition
(	(	(
<FORBIDDEN ID=71 ACTION=delete>
i.e.	FW	i.e.
</FORBIDDEN ID=71 ACTION=delete>
increased	VBN	increase
hexadecanoic	JJ	hexadecanoic
acid	NN	acid
and	CC	and
octadecenoic	JJ	octadecenoic
acid	NN	acid
and	CC	and
decreased	VBD	decrease
hexadecenoic	JJ	hexadecenoic
acid	NN	acid
and	CC	and
C	NN	C
-19	CD	-19
cyclopropane	NN	cyclopropane
fatty	JJ	fatty
acid	NN	acid
)	)	)
by	IN	by
changing	VBG	change
growth	NN	growth
conditions	NNS	condition
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
be	VV	be
a	DT	a
useful	JJ	useful
way	NN	way
to	TO	to
enhance	VB	enhance
their	PP$	their
bile	NN	bile
resistance	NN	resistance
in	IN	in
lactococci	NNS	lactococci
.	SENT	.
.	SENT	.
BB-cat+ner-19396518/text	DOCUMENT	BB-cat+ner-19396518/text
Rapid	JJ	Rapid
detection	NN	detection
of	IN	of
eight	CD	eight
causative	JJ	causative
pathogens	NNS	pathogen
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
diagnosis	NN	diagnosis
of	IN	of
bacterial	JJ	bacterial
meningitis	NN	meningitis
by	IN	by
real	JJ	real
-	HYPH	-
time	NN	time
PCR	NN	PCR
.	SENT	.
.	SENT	.
We	PP	We
aimed	VBD	aim
to	TO	to
detect	VB	detect
causative	JJ	causative
pathogens	NNS	pathogen
in	IN	in
cerebrospinal	JJ	cerebrospinal
fluid	NN	fluid
(	(	(
CSF	NN	CSF
)	)	)
collected	VBN	collect
from	IN	from
patients	NNS	patient
diagnosed	VBN	diagnose
with	IN	with
bacterial	JJ	bacterial
meningitis	NN	meningitis
by	IN	by
real	JJ	real
-	HYPH	-
time	NN	time
polymerase	NN	polymerase
chain	NN	chain
reaction	NN	reaction
(	(	(
PCR	NN	PCR
)	)	)
.	SENT	.
.	SENT	.
<FORBIDDEN ID=27 ACTION=delete>
<FORBIDDEN ID=26 ACTION=delete>
In	IN	In
addition	NN	addition
to	TO	to
</FORBIDDEN ID=26 ACTION=delete>
</FORBIDDEN ID=27 ACTION=delete>
Streptococcus	NP	Streptococcus
pneumoniae	NP	pneumoniae
,	,	,
Haemophilus	NP	Haemophilus
influenzae	NP	influenzae
,	,	,
and	CC	and
Mycoplasma	NN	Mycoplasma
pneumoniae	NNS	pneumoniae
described	VBN	describe
previously	RB	previously
,	,	,
five	CD	five
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
pathogens	NNS	pathogen
,	,	,
Neisseria	NP	Neisseria
meningitidis	NP	meningitidis
,	,	,
Escherichia	NP	Escherichia
coli	NP	coli
,	,	,
Streptococcus	NP	Streptococcus
agalactiae	NP	agalactiae
,	,	,
Staphylococcus	NP	Staphylococcus
aureus	NP	aureus
,	,	,
and	CC	and
Listeria	NP	Listeria
monocytogenes	NNS	monocytogene
,	,	,
were	VVD	be
targeted	VBN	target
,	,	,
based	VBN	base
on	IN	on
a	DT	a
large	JJ	large
-	HYPH	-
scale	NN	scale
surveillance	NN	surveillance
in	IN	in
Japan	NP	Japan
.	SENT	.
.	SENT	.
Results	NNS	Result
in	IN	in
CSF	NN	CSF
from	IN	from
neonates	NNS	neonate
and	CC	and
children	NNS	child
(	(	(
n=150	NN	n=150
)	)	)
,	,	,
and	CC	and
from	IN	from
adults	NNS	adult
(	(	(
n=18	NN	n=18
)	)	)
analyzed	VBN	analyze
by	IN	by
real	JJ	real
-	HYPH	-
time	NN	time
PCR	NN	PCR
with	IN	with
molecular	JJ	molecular
beacon	NN	beacon
probes	NNS	probe
were	VVD	be
compared	VBN	compare
with	IN	with
those	DT	those
of	IN	of
conventional	JJ	conventional
culturing	NN	culturing
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
total	JJ	total
time	NN	time
from	IN	from
DNA	NN	DNA
extraction	NN	extraction
from	IN	from
CSF	NN	CSF
to	TO	to
PCR	NN	PCR
analysis	NN	analysis
was	VVD	be
1.5	CD	1.5
h	NN	h
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
limit	NN	limit
of	IN	of
detection	NN	detection
for	IN	for
these	DT	these
pathogens	NNS	pathogen
ranged	VBD	range
from	IN	from
5	CD	5
copies	NNS	copy
to	TO	to
28	CD	28
copies	NNS	copy
per	IN	per
tube	NN	tube
.	SENT	.
.	SENT	.
Nonspecific	JJ	Nonspecific
positive	JJ	positive
reactions	NNS	reaction
were	VVD	be
not	RB	not
recognized	VBN	recognize
for	IN	for
37	CD	37
microorganisms	NNS	microorganism
in	IN	in
clinical	JJ	clinical
isolates	NNS	isolate
as	IN	as
a	DT	a
negative	JJ	negative
control	NN	control
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
pathogens	NNS	pathogen
were	VVD	be
detected	VBN	detect
in	IN	in
72.0	CD	72.0
%	NN	%
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
samples	NNS	sample
by	IN	by
real	JJ	real
-	HYPH	-
time	NN	time
PCR	NN	PCR
,	,	,
but	CC	but
in	IN	in
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
48.2	CD	48.2
%	NN	%
by	IN	by
culture	NN	culture
,	,	,
although	IN	although
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
microorganisms	NNS	microorganism
were	VVD	be
completely	RB	completely
concordant	JJ	concordant
.	SENT	.
.	SENT	.
With	IN	With
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
real	JJ	real
-	HYPH	-
time	NN	time
PCR	NN	PCR
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
detection	NN	detection
rate	NN	rate
of	IN	of
H	NN	H
.	VBD	.
influenzae	NNS	influenzae
from	IN	from
CSF	NN	CSF
was	VVD	be
high	JJ	high
,	,	,
at	IN	at
45.2	CD	45.2
%	NN	%
,	,	,
followed	VBN	follow
by	IN	by
S	NN	S
.	SENT	.
pneumoniae	FW	pneumoniae
(	(	(
21.4	CD	21.4
%	NN	%
)	)	)
,	,	,
S	NN	S
.	SENT	.
agalactiae	FW	agalactiae
(	(	(
2.4	CD	2.4
%	NN	%
)	)	)
,	,	,
E	NN	E
.	SENT	.
coli	NN	coli
(	(	(
1.8	CD	1.8
%	NN	%
)	)	)
,	,	,
L	NN	L
.	SENT	.
monocytogenes	NNS	monocytogene
(	(	(
0.6	CD	0.6
%	NN	%
)	)	)
,	,	,
and	CC	and
M	NN	M
.	SENT	.
pneumoniae	FW	pneumoniae
(	(	(
0.6	CD	0.6
%	NN	%
)	)	)
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
detection	NN	detection
rate	NN	rate
with	IN	with
PCR	NN	PCR
was	VVD	be
significantly	RB	significantly
better	JJR	good
than	IN	than
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	DT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
with	IN	with
cultures	NNS	culture
in	IN	in
patients	NNS	patient
with	IN	with
antibiotic	JJ	antibiotic
administration	NN	administration
(	(	(
chi2=	NN	chi2=
18.3182	CD	18.3182
;	COLUMN	;
P=	NN	P=
0.0000	CD	0.0000
)	)	)
.	SENT	.
.	SENT	.
In	IN	In
conclusion	NN	conclusion
,	,	,
detection	NN	detection
with	IN	with
real	JJ	real
-	HYPH	-
time	NN	time
PCR	NN	PCR
is	VVZ	be
useful	JJ	useful
for	IN	for
rapidly	RB	rapidly
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
identifying	VBG	identify
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
causative	JJ	causative
pathogens	NNS	pathogen
of	IN	of
meningitis	NN	meningitis
and	CC	and
for	IN	for
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
examining	VBG	examine
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
clinical	JJ	clinical
course	NN	course
of	IN	of
chemotherapy	NN	chemotherapy
.	SENT	.
.	SENT	.
BB-cat+ner-19494280/text	DOCUMENT	BB-cat+ner-19494280/text
Involvement	NN	Involvement
of	IN	of
CD252	NN	CD252
(	(	(
CD134L	NN	CD134L
)	)	)
and	CC	and
IL	NN	IL
-2	CD	-2
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
expression	NN	expression
of	IN	of
cytotoxic	JJ	cytotoxic
proteins	NNS	protein
in	IN	in
bacterial	JJ	bacterial
-	HYPH	-
or	CC	or
viral	JJ	viral
-	HYPH	-
activated	VBN	activate
human	JJ	human
T	NN	T
cells	NNS	cell
.	SENT	.
.	SENT	.
Regulation	NN	Regulation
of	IN	of
cytotoxic	JJ	cytotoxic
effector	NN	effector
molecule	NN	molecule
expression	NN	expression
in	IN	in
human	JJ	human
CTLs	NNS	CTL
after	IN	after
viral	JJ	viral
or	CC	or
bacterial	JJ	bacterial
activation	NN	activation
is	VVZ	be
poorly	RB	poorly
understood	VBN	understand
.	SENT	.
.	SENT	.
By	IN	By
using	VBG	use
human	JJ	human
autologous	JJ	autologous
dendritic	JJ	dendritic
cells	NNS	cell
(	(	(
DCs	NNS	DC
)	)	)
to	TO	to
prime	JJ	prime
T	NN	T
lymphocytes	NNS	lymphocyte
,	,	,
we	PP	we
found	VBD	find
perforin	NN	perforin
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
highly	RB	highly
up-regulated	VBN	up-regulate
in	IN	in
virus	NN	virus
-	HYPH	-
(	(	(
HSV	NN	HSV
-1	NN	-1
,	,	,
vaccinia	NN	vaccinia
virus	NN	virus
)	)	)
but	CC	but
not	RB	not
in	IN	in
intracellular	JJ	intracellular
bacteria	NNS	bacteria
-	HYPH	-
(	(	(
Listeria	NN	Listeria
innocua	NN	innocua
,	,	,
Listeria	NP	Listeria
monocytogenes	NNS	monocytogene
,	,	,
Mycobacterium	NN	Mycobacterium
tuberculosis	NN	tuberculosis
,	,	,
Chlamydophila	NN	Chlamydophila
pneumoniae	NN	pneumoniae
)	)	)
activated	VBN	activate
CTLs	NNS	CTL
.	SENT	.
.	SENT	.
In	IN	In
contrast	NN	contrast
,	,	,
larger	JJR	large
quantities	NNS	quantity
of	IN	of
IFN	NN	IFN
-	HYPH	-
gamma	SYM	gamma
and	CC	and
TNF	NN	TNF
-	HYPH	-
alpha	SYM	alpha
were	VVD	be
produced	VBN	produce
in	IN	in
Listeria	NN	Listeria
-	HYPH	-
stimulated	VBN	stimulate
cultures	NNS	culture
.	SENT	.
.	SENT	.
Granzyme	NN	Granzyme
B	NN	B
and	CC	and
granulysin	NN	granulysin
were	VVD	be
similarly	RB	similarly
up-regulated	VBN	up-regulate
by	IN	by
all	DT	all
tested	VBN	test
viruses	NNS	virus
and	CC	and
intracellular	JJ	intracellular
bacteria	NNS	bacteria
.	SENT	.
.	SENT	.
DCs	NNS	DC
infected	VBN	infect
with	IN	with
HSV	NN	HSV
-1	NN	-1
showed	VBD	show
enhanced	VBN	enhance
surface	NN	surface
expression	NN	expression
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
costimulatory	JJ	costimulatory
molecule	NN	molecule
CD252	NN	CD252
(	(	(
CD134L	NN	CD134L
)	)	)
compared	VBN	compare
with	IN	with
Listeria	NN	Listeria
-	HYPH	-
infected	VBN	infect
DC	NN	DC
and	CC	and
induced	VBD	induce
enhanced	VBN	enhance
secretion	NN	secretion
of	IN	of
IL	NN	IL
-2	CD	-2
.	SENT	.
.	SENT	.
Adding	VBG	Add
blocking	VBG	block
CD134	NN	CD134
or	CC	or
neutralizing	VBG	neutralize
IL	NN	IL
-2	CD	-2
Abs	NNS	Ab
during	IN	during
T	NN	T
cell	NN	cell
activation	NN	activation
reduced	VBD	reduce
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
HSV	NN	HSV
-	HYPH	-
dependent	JJ	dependent
up-regulation	NN	up-regulation
of	IN	of
perforin	NN	perforin
.	SENT	.
.	SENT	.
These	DT	These
data	NNS	datum
indicate	VBP	indicate
a	DT	a
distinct	JJ	distinct
CTL	NN	CTL
effector	NN	effector
function	NN	function
<FORBIDDEN ID=27 ACTION=delete>
<FORBIDDEN ID=26 ACTION=delete>
in	IN	in
response	NN	response
to	TO	to
</FORBIDDEN ID=26 ACTION=delete>
</FORBIDDEN ID=27 ACTION=delete>
intracellular	JJ	intracellular
pathogens	NNS	pathogen
triggered	VBN	trigger
via	IN	via
differing	VBG	differ
endogenous	JJ	endogenous
IL	NN	IL
-2	CD	-2
production	NN	production
upon	IN	upon
costimulation	NN	costimulation
through	IN	through
CD252	NN	CD252
.	SENT	.
.	SENT	.
BB-cat+ner-19501788/text	DOCUMENT	BB-cat+ner-19501788/text
Construction	NN	Construction
of	IN	of
an	DT	an
attenuated	VBN	attenuate
Pseudomonas	NP	Pseudomonas
fluorescens	NNS	fluorescen
strain	NN	strain
and	CC	and
evaluation	NN	evaluation
of	IN	of
its	PP$	its
potential	NN	potential
as	IN	as
a	DT	a
cross	AFX	cross
-	HYPH	-
protective	JJ	protective
vaccine	NN	vaccine
.	SENT	.
.	SENT	.
Ferric	JJ	Ferric
uptake	NN	uptake
regulator	NN	regulator
(	(	(
Fur	NN	Fur
)	)	)
is	VVZ	be
a	DT	a
global	JJ	global
transcription	NN	transcription
regulator	NN	regulator
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
is	VVZ	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
ubiquitous	JJ	ubiquitous
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
Gram	NN	Gram
-	HYPH	-
negative	JJ	negative
bacteria	NNS	bacteria
and	CC	and
regulates	VBZ	regulate
diverse	JJ	diverse
biological	JJ	biological
processes	NNS	process
,	,	,
including	VBG	include
iron	NN	iron
uptake	NN	uptake
,	,	,
cellular	JJ	cellular
metabolism	NN	metabolism
,	,	,
stress	NN	stress
response	NN	response
,	,	,
and	CC	and
production	NN	production
of	IN	of
virulence	NN	virulence
determinants	NNS	determinant
.	SENT	.
.	SENT	.
As	IN	As
a	DT	a
result	NN	result
,	,	,
for	IN	for
<FORBIDDEN ID=28 ACTION=delete>
many	JJ	many
</FORBIDDEN ID=28 ACTION=delete>
pathogenic	JJ	pathogenic
bacteria	NNS	bacteria
,	,	,
Fur	NP	Fur
plays	VBZ	play
a	DT	a
crucial	JJ	crucial
role	NN	role
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
course	NN	course
of	IN	of
infection	NN	infection
and	CC	and
disease	NN	disease
development	NN	development
.	SENT	.
.	SENT	.
In	IN	In
this	DT	this
study	NN	study
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
fur	NN	fur
gene	NN	gene
was	VVD	be
cloned	VBN	clone
from	IN	from
a	DT	a
pathogenic	JJ	pathogenic
Pseudomonas	NP	Pseudomonas
fluorescens	NP	fluorescens
strain	NN	strain
,	,	,
TSS	NN	TSS
,	,	,
isolated	VBN	isolate
from	IN	from
diseased	JJ	diseased
Japanese	JJ	Japanese
flounder	NN	flounder
cultured	VBN	culture
in	IN	in
a	DT	a
local	JJ	local
farm	NN	farm
.	SENT	.
.	SENT	.
TSS	NN	TSS
Fur	NP	Fur
can	MD	can
partially	RB	partially
complement	VB	complement
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
defective	JJ	defective
phenotype	NN	phenotype
of	IN	of
an	DT	an
Escherichia	FW	Escherichia
coli	FW	coli
fur	NN	fur
mutant	NN	mutant
.	SENT	.
.	SENT	.
A	DT	A
TSS	NN	TSS
fur	NN	fur
null	JJ	null
mutant	NN	mutant
,	,	,
TFM	NN	TFM
,	,	,
was	VVD	be
constructed	VBN	construct
.	SENT	.
.	SENT	.
Compared	VBN	Compare
to	TO	to
TSS	NN	TSS
,	,	,
TFM	NN	TFM
exhibits	VBZ	exhibit
reduced	VBN	reduce
growth	NN	growth
ability	NN	ability
,	,	,
aberrant	JJ	aberrant
production	NN	production
of	IN	of
outer	JJ	outer
membrane	NN	membrane
proteins	NNS	protein
,	,	,
decreased	VBD	decrease
resistance	NN	resistance
against	IN	against
host	NN	host
serum	NN	serum
bactericidal	JJ	bactericidal
activity	NN	activity
,	,	,
impaired	VBD	impair
ability	NN	ability
to	TO	to
disseminate	VB	disseminate
in	IN	in
host	NN	host
blood	NN	blood
and	CC	and
tissues	NNS	tissue
,	,	,
and	CC	and
drastic	JJ	drastic
attenuation	NN	attenuation
in	IN	in
overall	JJ	overall
bacterial	JJ	bacterial
virulence	NN	virulence
in	IN	in
a	DT	a
Japanese	JJ	Japanese
flounder	NN	flounder
infection	NN	infection
model	NN	model
.	SENT	.
.	SENT	.
When	WRB	When
used	VBN	use
as	IN	as
a	DT	a
live	JJ	live
vaccine	NN	vaccine
administered	VBN	administer
via	IN	via
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
injection	NN	injection
,	,	,
immersion	NN	immersion
,	,	,
and	CC	and
oral	JJ	oral
routes	NNS	route
,	,	,
TFM	NN	TFM
affords	VBZ	afford
high	JJ	high
levels	NNS	level
of	IN	of
protection	NN	protection
upon	IN	upon
Japanese	JJ	Japanese
flounder	NN	flounder
against	IN	against
not	RB	not
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
P	NN	P
.	SENT	.
fluorescens	NNS	fluorescen
infection	NN	infection
but	CC	but
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
Aeromonas	NP	Aeromonas
hydrophila	NN	hydrophila
infection	NN	infection
.	SENT	.
.	SENT	.
Furthermore	RB	Furthermore
,	,	,
a	DT	a
plasmid	NN	plasmid
,	,	,
pJAQ	NN	pJAQ
,	,	,
was	VVD	be
constructed	VBN	construct
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
expresses	VBZ	express
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
coding	VBG	cod
element	NN	element
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Vibrio	NP	Vibrio
harveyi	NN	harveyi
antigen	NN	antigen
AgaV	NN	AgaV
-	HYPH	-
DegQ	NN	DegQ
.	SENT	.
.	SENT	.
TFM	NN	TFM
harboring	VBG	harbor
pJAQ	NN	pJAQ
can	MD	can
secret	VB	secret
AgaV	NN	AgaV
-	HYPH	-
DegQ	NN	DegQ
into	IN	into
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
extracellular	JJ	extracellular
milieu	NN	milieu
.	SENT	.
.	SENT	.
Vaccination	NN	Vaccination
of	IN	of
Japanese	JJ	Japanese
flounder	NN	flounder
with	IN	with
live	JJ	live
TFM	NN	TFM
/	SYM	/
pJAQ	NN	pJAQ
elicited	VBD	elicit
strong	JJ	strong
immunoprotection	NN	immunoprotection
against	IN	against
<FORBIDDEN ID=30 ACTION=delete>
both	DT	both
</FORBIDDEN ID=30 ACTION=delete>
V	NN	V
.	SENT	.
harveyi	NN	harveyi
and	CC	and
A	NN	A
.	SENT	.
hydrophila	NN	hydrophila
infections	NNS	infection
.	SENT	.
.	SENT	.
BB-cat+ner-19552770/text	DOCUMENT	BB-cat+ner-19552770/text
Prevalence	NN	Prevalence
of	IN	of
thermotolerant	JJ	thermotolerant
Campylobacter	NP	Campylobacter
in	IN	in
partridges	NNS	partridge
(	(	(
Perdix	NN	Perdix
perdix	NN	perdix
)	)	)
.	SENT	.
.	SENT	.
To	TO	To
estimate	VB	estimate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
prevalence	NN	prevalence
of	IN	of
thermotolerant	JJ	thermotolerant
Campylobacter	NP	Campylobacter
spp	NN	spp
.	SENT	.
in	IN	in
commercially	RB	commercially
reared	VBN	rear
partridges	NNS	partridge
(	(	(
Perdix	NN	Perdix
perdix	NN	perdix
)	)	)
in	IN	in
southern	JJ	southern
Italy	NP	Italy
.	SENT	.
.	SENT	.
Cloacal	JJ	Cloacal
swabs	NNS	swab
of	IN	of
partridges	NNS	partridge
(	(	(
n	NN	n
=	SYM	=
240	CD	240
)	)	)
,	,	,
equally	RB	equally
distributed	VBN	distribute
between	IN	between
male	JJ	male
and	CC	and
female	JJ	female
birds	NNS	bird
,	,	,
from	IN	from
a	DT	a
game	NN	game
bird	NN	bird
farm	NN	farm
located	JJ	located
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Southern	NP	Southern
Italy	NP	Italy
were	VVD	be
examined	VBN	examine
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
prevalence	NN	prevalence
of	IN	of
thermotolerant	JJ	thermotolerant
Campylobacter	NP	Campylobacter
spp	NN	spp
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
samples	NNS	sample
were	VVD	be
processed	VBN	process
<FORBIDDEN ID=27 ACTION=delete>
<FORBIDDEN ID=26 ACTION=delete>
in	IN	in
order	NN	order
to	TO	to
</FORBIDDEN ID=26 ACTION=delete>
</FORBIDDEN ID=27 ACTION=delete>
detect	VB	detect
thermotolerant	JJ	thermotolerant
Campylobacter	NP	Campylobacter
spp	NN	spp
.	SENT	.
by	IN	by
culture	NN	culture
methods	NNS	method
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
positive	JJ	positive
samples	NNS	sample
were	VVD	be
then	RB	then
confirmed	VBN	confirm
by	IN	by
multiplex	JJ	multiplex
polymerase	NN	polymerase
chain	NN	chain
reaction	NN	reaction
.	SENT	.
.	SENT	.
Thermotolerant	NP	Thermotolerant
Campylobacter	NP	Campylobacter
spp	NN	spp
.	SENT	.
were	VVD	be
isolated	VBN	isolate
from	IN	from
118	CD	118
(	(	(
49.2	CD	49.2
%	NN	%
)	)	)
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
240	CD	240
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
cloacal	JJ	cloacal
swabs	NNS	swab
examined	VBN	examine
.	SENT	.
.	SENT	.
As	IN	As
proved	VBN	prove
by	IN	by
PCR	NN	PCR
,	,	,
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
100%	CD	100%
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
strains	NNS	strain
were	VVD	be
identified	VBN	identify
as	IN	as
Campylobacter	FW	Campylobacter
coli	FW	coli
(	(	(
118/118	CD	118/118
)	)	)
,	,	,
and	CC	and
15	CD	15
(	(	(
12.7	CD	12.7
%	NN	%
)	)	)
out	IN	out
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
118	CD	118
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
positive	JJ	positive
samples	NNS	sample
were	VVD	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
positive	JJ	positive
for	IN	for
Campylobacter	NP	Campylobacter
jejuni	NP	jejuni
.	SENT	.
.	SENT	.
In	IN	In
contrast	NN	contrast
,	,	,
Campylobacter	NP	Campylobacter
lari	NP	lari
was	VVD	be
not	RB	not
identified	VBN	identify
.	SENT	.
.	SENT	.
Adult	JJ	Adult
partridges	NNS	partridge
showed	VBD	show
a	DT	a
significantly	RB	significantly
higher	JJR	high
prevalence	NN	prevalence
(	(	(
P	NN	P
INF	SYM	INF
0.05	CD	0.05
)	)	)
than	IN	than
younger	JJR	young
ones	NNS	one
.	SENT	.
.	SENT	.
These	DT	These
results	NNS	result
reinforce	VBP	reinforce
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
assumption	NN	assumption
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
game	NN	game
birds	NNS	bird
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
be	VV	be
considered	VBN	consider
as	IN	as
potential	JJ	potential
carriers	NNS	carrier
of	IN	of
Campylobacter	NN	Campylobacter
spp	NN	spp
.	SENT	.
for	IN	for
human	JJ	human
being	VVG	be
and	CC	and
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
animal	NN	animal
species	NNS	specie
.	SENT	.
.	SENT	.
Although	IN	Although
an	DT	an
<FORBIDDEN ID=45 ACTION=delete>
earlier	JJR	early
</FORBIDDEN ID=45 ACTION=delete>
1986	CD	1986
publication	NN	publication
described	VBD	describe
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
prevalence	NN	prevalence
of	IN	of
Campylobacter	NP	Campylobacter
coli	NP	coli
in	IN	in
commercially	RB	commercially
reared	VBN	rear
partridges	NNS	partridge
,	,	,
this	DT	this
is	VVZ	be
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
first	JJ	first
report	NN	report
to	TO	to
confirm	VB	confirm
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
species	NN	species
of	IN	of
Campylobacter	NP	Campylobacter
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
using	VBG	use
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
PCR	NN	PCR
test	NN	test
.	SENT	.
.	SENT	.
BB-cat+ner-19621381/text	DOCUMENT	BB-cat+ner-19621381/text
A	DT	A
general	JJ	general
strategy	NN	strategy
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bacterial	JJ	bacterial
expression	NN	expression
of	IN	of
amyloidogenic	JJ	amyloidogenic
peptides	NNS	peptide
using	VBG	use
BCL	NN	BCL
-	HYPH	-
XL	NN	XL
-1/2	CD	-1/2
fusions	NNS	fusion
.	SENT	.
.	SENT	.
Biophysical	JJ	Biophysical
studies	NNS	study
on	IN	on
amyloidogenic	JJ	amyloidogenic
and	CC	and
aggregation	NN	aggregation
-	HYPH	-
prone	NN	prone
peptides	NNS	peptide
often	RB	often
require	VBP	require
large	JJ	large
quantities	NNS	quantity
of	IN	of
material	NN	material
.	SENT	.
.	SENT	.
However	RB	However
,	,	,
solid	JJ	solid
-	HYPH	-
phase	NN	phase
synthesis	NN	synthesis
,	,	,
handling	NN	handling
,	,	,
and	CC	and
purification	NN	purification
of	IN	of
peptides	NNS	peptide
often	RB	often
present	VBP	present
challenges	NNS	challenge
on	IN	on
these	DT	these
scales	NNS	scale
.	SENT	.
.	SENT	.
Recombinant	JJ	Recombinant
expression	NN	expression
is	VVZ	be
an	DT	an
attractive	JJ	attractive
alternative	NN	alternative
because	IN	because
of	IN	of
its	PP$	its
low	JJ	low
cost	NN	cost
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
ability	NN	ability
to	TO	to
isotopically	RB	isotopically
label	VB	label
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
peptides	NNS	peptide
,	,	,
and	CC	and
access	NN	access
to	TO	to
sequences	NNS	sequence
exceeding	VBG	exceed
approximately	RB	approximately
50	CD	50
residues	NNS	residue
.	SENT	.
.	SENT	.
However	RB	However
,	,	,
expression	NN	expression
systems	NNS	system
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
seek	VBP	seek
to	TO	to
solubilize	VB	solubilize
amyloidogenic	JJ	amyloidogenic
peptides	NNS	peptide
suffer	VBP	suffer
from	IN	from
low	JJ	low
yields	NNS	yield
,	,	,
difficult	JJ	difficult
optimizations	NNS	optimization
,	,	,
and	CC	and
isolation	NN	isolation
challenges	NNS	challenge
.	SENT	.
.	SENT	.
We	PP	We
present	VBP	present
a	DT	a
general	JJ	general
strategy	NN	strategy
for	IN	for
expressing	VBG	express
and	CC	and
isolating	VBG	isolate
amyloidogenic	JJ	amyloidogenic
peptides	NNS	peptide
in	IN	in
Escherichia	FW	Escherichia
coli	FW	coli
by	IN	by
fusion	NN	fusion
to	TO	to
a	DT	a
polypeptide	NN	polypeptide
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
drives	VBZ	drive
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
expression	NN	expression
of	IN	of
attached	VBN	attach
peptides	NNS	peptide
into	IN	into
bacterial	JJ	bacterial
inclusion	NN	inclusion
bodies	NNS	body
.	SENT	.
.	SENT	.
This	DT	This
scheme	NN	scheme
minimizes	VBZ	minimize
toxicity	NN	toxicity
during	IN	during
bacterial	JJ	bacterial
growth	NN	growth
and	CC	and
enables	VBZ	enable
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
processing	NN	processing
and	CC	and
handling	NN	handling
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
peptides	NNS	peptide
in	IN	in
denaturing	VBG	denature
solutions	NNS	solution
.	SENT	.
.	SENT	.
Immobilized	VBN	Immobilize
metal	NN	metal
affinity	NN	affinity
chromatography	NN	chromatography
,	,	,
reverse	JJ	reverse
phase	NN	phase
HPLC	NN	HPLC
,	,	,
and	CC	and
cyanogen	NN	cyanogen
bromide	NN	bromide
cleavage	NN	cleavage
are	VVP	be
used	VBN	use
to	TO	to
isolate	VB	isolate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
peptide	NN	peptide
,	,	,
followed	VBN	follow
by	IN	by
<FORBIDDEN ID=79 ACTION=delete>
further	JJ	further
</FORBIDDEN ID=79 ACTION=delete>
reverse	JJ	reverse
phase	NN	phase
HPLC	NN	HPLC
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
yields	VBZ	yield
milligram	NN	milligram
quantities	NNS	quantity
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
purified	VBN	purify
peptide	NN	peptide
.	SENT	.
.	SENT	.
We	PP	We
demonstrate	VBP	demonstrate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
driving	VBG	drive
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
peptides	NNS	peptide
into	IN	into
inclusion	NN	inclusion
bodies	NNS	body
using	VBG	use
fusion	NN	fusion
to	TO	to
BCL	NN	BCL
-	HYPH	-
XL	NN	XL
-1/2	CD	-1/2
is	VVZ	be
a	DT	a
general	JJ	general
strategy	NN	strategy
for	IN	for
their	PP$	their
expression	NN	expression
and	CC	and
isolation	NN	isolation
,	,	,
as	IN	as
exemplified	VBN	exemplify
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
production	NN	production
of	IN	of
11	CD	11
peptides	NNS	peptide
species	NNS	specie
.	SENT	.
.	SENT	.
BB-cat+ner-19622846/text	DOCUMENT	BB-cat+ner-19622846/text
Detection	NN	Detection
of	IN	of
Staphylococcus	FW	Staphylococcus
aureus	FW	aureus
including	VBG	include
MRSA	NN	MRSA
on	IN	on
environmental	JJ	environmental
surfaces	NNS	surface
in	IN	in
a	DT	a
jail	NN	jail
setting	NN	setting
.	SENT	.
.	SENT	.
We	PP	We
examined	VBD	examine
jail	NN	jail
environmental	JJ	environmental
surfaces	NNS	surface
to	TO	to
explore	VB	explore
whether	IN	whether
they	PP	they
might	MD	might
serve	VB	serve
as	IN	as
reservoirs	NNS	reservoir
of	IN	of
viable	JJ	viable
methicillin	NN	methicillin
-	HYPH	-
resistant	JJ	resistant
Staphylococcus	NN	Staphylococcus
aureus	NN	aureus
(	(	(
MRSA	NN	MRSA
)	)	)
.	SENT	.
.	SENT	.
We	PP	We
swabbed	VBD	swab
132	CD	132
surfaces	NNS	surface
,	,	,
inoculated	VBN	inoculate
primary	JJ	primary
and	CC	and
secondary	JJ	secondary
mannitol	NN	mannitol
salts	NNS	salt
and	CC	and
oxacillin	NN	oxacillin
-	HYPH	-
resistant	JJ	resistant
screening	NN	screening
agar	NN	agar
,	,	,
and	CC	and
used	VBN	use
API	NN	API
tests	NNS	test
to	TO	to
identify	VB	identify
S	NN	S
.	SENT	.
aureus	NN	aureus
and	CC	and
E-tests	NNS	E-test
to	TO	to
determine	VB	determine
methicillin	NN	methicillin
/	SYM	/
oxacillin	NN	oxacillin
resistance	NN	resistance
.	SENT	.
.	SENT	.
We	PP	We
recovered	VBD	recover
S	NN	S
.	SENT	.
aureus	NN	aureus
from	IN	from
10	CD	10
(	(	(
7.6	CD	7.6
%	NN	%
)	)	)
surfaces	NNS	surface
;	COLUMN	;
eight	CD	eight
(	(	(
6.1	CD	6.1
%	NN	%
)	)	)
isolates	NNS	isolate
were	VVD	be
MRSA	NN	MRSA
.	SENT	.
.	SENT	.
We	PP	We
ran	VBD	run
pulsed	VBN	pulse
-	HYPH	-
field	NN	field
gel	NN	gel
electrophoresis	NN	electrophoresis
on	IN	on
six	CD	six
resistant	JJ	resistant
isolates	NNS	isolate
and	CC	and
observed	VBD	observe
three	CD	three
patterns	NNS	pattern
,	,	,
<FORBIDDEN ID=55 ACTION=delete>
one	CD	one
of	IN	of
<FORBIDDEN ID=36 ACTION=delete>
</FORBIDDEN ID=55 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
was	VVD	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
identical	JJ	identical
to	TO	to
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
that	DT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
identified	VBN	identify
in	IN	in
a	DT	a
previous	JJ	previous
study	NN	study
of	IN	of
inmates'	JJ	inmates'
nasal	JJ	nasal
specimens	NNS	specimen
.	SENT	.
.	SENT	.
Finding	VBG	Find
MRSA	NN	MRSA
-	HYPH	-
contaminated	VBN	contaminate
surfaces	NNS	surface
on	IN	on
a	DT	a
<FORBIDDEN ID=57 ACTION=delete>
variety	NN	variety
of	IN	of
</FORBIDDEN ID=57 ACTION=delete>
environmental	JJ	environmental
surfaces	NNS	surface
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
absence	NN	absence
of	IN	of
an	DT	an
overt	JJ	overt
outbreak	NN	outbreak
emphasizes	VBZ	emphasize
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
correctional	JJ	correctional
facilities	NNS	facility
should	MD	should
have	VH	have
protocols	NNS	protocol
for	IN	for
environmental	JJ	environmental
cleaning	NN	cleaning
as	IN	as
a	DT	a
component	NN	component
of	IN	of
MRSA	NN	MRSA
prevention	NN	prevention
.	SENT	.
.	SENT	.
BB-cat+ner-19656787/text	DOCUMENT	BB-cat+ner-19656787/text
Protection	NN	Protection
of	IN	of
Salmonella	NN	Salmonella
by	IN	by
ampicillin	NN	ampicillin
-	HYPH	-
resistant	JJ	resistant
Escherichia	NP	Escherichia
coli	NN	coli
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
otherwise	RB	otherwise
lethal	JJ	lethal
drug	NN	drug
concentrations	NNS	concentration
.	SENT	.
.	SENT	.
Microbial	JJ	Microbial
systems	NNS	system
have	VHP	have
become	VBN	become
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=78 ACTION=delete>
<FORBIDDEN ID=77 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
preferred	JJ	preferred
</FORBIDDEN ID=77 ACTION=delete>
</FORBIDDEN ID=78 ACTION=delete>
testing	NN	testing
grounds	NNS	ground
for	IN	for
experimental	JJ	experimental
work	NN	work
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
evolution	NN	evolution
of	IN	of
traits	NNS	trait
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
benefit	VBP	benefit
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
group	NN	group
members	NNS	member
.	SENT	.
.	SENT	.
This	DT	This
work	NN	work
,	,	,
based	VBN	base
on	IN	on
conceptual	JJ	conceptual
and	CC	and
theoretical	JJ	theoretical
models	NNS	model
of	IN	of
frequency	NN	frequency
-	HYPH	-
dependent	JJ	dependent
selection	NN	selection
within	IN	within
populations	NNS	population
,	,	,
has	VHZ	have
proven	VBN	prove
fruitful	JJ	fruitful
in	IN	in
terms	NNS	term
of	IN	of
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
understanding	VBG	understand
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
dynamics	NNS	dynamic
of	IN	of
group	NN	group
beneficial	JJ	beneficial
or	CC	or
'public	JJ	'public
goods'	NN	goods'
traits	NNS	trait
within	IN	within
species	NNS	specie
.	SENT	.
.	SENT	.
Here	RB	Here
,	,	,
we	PP	we
expand	VBP	expand
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
scope	NN	scope
of	IN	of
microbial	JJ	microbial
work	NN	work
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
evolution	NN	evolution
of	IN	of
group	NN	group
-	HYPH	-
beneficial	JJ	beneficial
traits	NNS	trait
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
case	NN	case
of	IN	of
multi	AFX	multi
-	HYPH	-
species	NN	species
communities	NNS	community
,	,	,
particularly	RB	particularly
those	DT	those
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
affect	VBP	affect
human	JJ	human
health	NN	health
.	SENT	.
.	SENT	.
We	PP	We
examined	VBD	examine
whether	IN	whether
beta	SYM	beta
-	HYPH	-
lactamase	NN	lactamase
-	HYPH	-
producing	VBG	produce
Escherichia	FW	Escherichia
coli	FW	coli
could	MD	could
protect	VB	protect
ampicillin	NN	ampicillin
-	HYPH	-
sensitive	JJ	sensitive
cohorts	NNS	cohort
of	IN	of
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
species	NNS	specie
,	,	,
particularly	RB	particularly
species	NNS	specie
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
could	MD	could
cause	VB	cause
human	JJ	human
disease	NN	disease
.	SENT	.
.	SENT	.
<FORBIDDEN ID=30 ACTION=delete>
Both	CC	Both
</FORBIDDEN ID=30 ACTION=delete>
beta	SYM	beta
-	HYPH	-
lactamase	NN	lactamase
-	HYPH	-
secreting	VBG	secrete
E	NN	E
.	SENT	.
coli	NN	coli
and	CC	and
,	,	,
surprisingly	RB	surprisingly
,	,	,
those	DT	those
engineered	VBN	engineer
to	TO	to
retain	VB	retain
it	PP	it
,	,	,
allowed	VBN	allow
for	IN	for
survival	NN	survival
of	IN	of
a	DT	a
large	JJ	large
number	NN	number
of	IN	of
ampicillin	NN	ampicillin
-	HYPH	-
sensitive	JJ	sensitive
cohorts	NNS	cohort
of	IN	of
Salmonella	NP	Salmonella
enterica	NP	enterica
serovar	NP	serovar
Typhimurium	NP	Typhimurium
,	,	,
including	VBG	include
<FORBIDDEN ID=30 ACTION=delete>
both	CC	both
</FORBIDDEN ID=30 ACTION=delete>
laboratory	NN	laboratory
and	CC	and
clinical	JJ	clinical
isolates	NNS	isolate
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Salmonella	NP	Salmonella
survivors	NNS	survivor
,	,	,
however	RB	however
,	,	,
remained	VBD	remain
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
sensitive	JJ	sensitive
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
ampicillin	VB	ampicillin
when	WRB	when
re-plated	JJ	re-plated
onto	IN	onto
solid	JJ	solid
medium	NN	medium
and	CC	and
there	EX	there
was	VVD	be
no	DT	no
evidence	NN	evidence
of	IN	of
gene	NN	gene
transfer	NN	transfer
.	SENT	.
.	SENT	.
Salmonella	NN	Salmonella
survival	NN	survival
did	VBD	do
not	RB	not
<FORBIDDEN ID=157 ACTION=delete>
even	RB	even
</FORBIDDEN ID=157 ACTION=delete>
require	VB	require
direct	JJ	direct
physical	JJ	physical
contact	NN	contact
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
resistant	JJ	resistant
E	NN	E
.	SENT	.
coli	NN	coli
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
observed	VBN	observe
phenomenon	NN	phenomenon
appears	VBZ	appear
to	TO	to
involve	VB	involve
increased	VBN	increase
release	NN	release
of	IN	of
beta	SYM	beta
-	HYPH	-
lactamase	NN	lactamase
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
E	NN	E
.	SENT	.
coli	NN	coli
when	WRB	when
present	JJ	present
with	IN	with
S	NN	S
.	SENT	.
enterica	NN	enterica
.	SENT	.
.	SENT	.
Significantly	RB	Significantly
,	,	,
these	DT	these
findings	NNS	finding
imply	VBP	imply
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
resistant	JJ	resistant
E	NN	E
.	SENT	.
coli	NN	coli
,	,	,
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
are	VVP	be
not	RB	not
themselves	PP	themselves
pathogenic	JJ	pathogenic
,	,	,
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
be	VV	be
exploited	VBN	exploit
,	,	,
<FORBIDDEN ID=157 ACTION=delete>
even	RB	even
</FORBIDDEN ID=157 ACTION=delete>
when	WRB	when
they	PP	they
are	VVP	be
normally	RB	normally
selfish	VB	selfish
with	IN	with
<FORBIDDEN ID=58 ACTION=delete>
respect	NN	respect
to	TO	to
<FORBIDDEN ID=22 ACTION=delete>
</FORBIDDEN ID=58 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
E	NN	E
.	SENT	.
coli	NN	coli
.	SENT	.
.	SENT	.
Thus	RB	Thus
,	,	,
Salmonella	NP	Salmonella
can	MD	can
gain	VB	gain
protection	NN	protection
against	IN	against
antibiotics	NNS	antibiotic
from	IN	from
E	NN	E
.	SENT	.
coli	NN	coli
without	IN	without
gene	NN	gene
transfer	NN	transfer
,	,	,
a	DT	a
phenomenon	NN	phenomenon
not	RB	not
previously	RB	previously
known	VBN	know
.	SENT	.
.	SENT	.
As	IN	As
a	DT	a
consequence	NN	consequence
,	,	,
antibiotic	JJ	antibiotic
-	HYPH	-
resistant	JJ	resistant
E	NN	E
.	SENT	.
coli	NN	coli
can	MD	can
play	VB	play
a	DT	a
decisive	JJ	decisive
role	NN	role
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
survival	NN	survival
of	IN	of
a	DT	a
species	NN	species
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
causes	VBZ	cause
disease	NN	disease
and	CC	and
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
thereby	RB	thereby
interfere	VB	interfere
with	IN	with
successful	JJ	successful
treatment	NN	treatment
.	SENT	.
.	SENT	.
BB-cat+ner-20005916/text	DOCUMENT	BB-cat+ner-20005916/text
Usage	NN	Usage
of	IN	of
signaling	NN	signaling
in	IN	in
neurodegeneration	NN	neurodegeneration
and	CC	and
regeneration	NN	regeneration
of	IN	of
peripheral	JJ	peripheral
nerves	NNS	nerve
by	IN	by
leprosy	JJ	leprosy
bacteria	NNS	bacteria
.	SENT	.
.	SENT	.
Multiple	JJ	Multiple
signaling	NN	signaling
pathways	NNS	pathway
play	VBP	play
key	JJ	key
regulatory	JJ	regulatory
roles	NNS	role
during	IN	during
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
development	NN	development
of	IN	of
peripheral	JJ	peripheral
nervous	JJ	nervous
system	NN	system
(	(	(
PNS	NN	PNS
)	)	)
and	CC	and
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
in	IN	in
neuroregeneration	NN	neuroregeneration
process	NN	process
following	VBG	follow
nerve	NN	nerve
degeneration	NN	degeneration
.	SENT	.
.	SENT	.
Schwann	NP	Schwann
cells	NNS	cell
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
glial	JJ	glial
cells	NNS	cell
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
PNS	NN	PNS
,	,	,
by	IN	by
interacting	VBG	interact
with	IN	with
neuronal	JJ	neuronal
(	(	(
axonal	JJ	axonal
)	)	)
ligands	NNS	ligand
,	,	,
mainly	RB	mainly
neuregulins	NNS	neuregulin
via	IN	via
receptor	NN	receptor
tyrosine	NN	tyrosine
kinase	NN	kinase
(	(	(
RTK	NN	RTK
)	)	)
complex	NN	complex
,	,	,
ErbB2	NN	ErbB2
/	SYM	/
ErbB3	NN	ErbB3
,	,	,
initiate	VBP	initiate
intracellular	JJ	intracellular
signaling	NN	signaling
pathways	NNS	pathway
to	TO	to
drive	VB	drive
proliferation	NN	proliferation
and	CC	and
differentiation	NN	differentiation
of	IN	of
Schwann	NP	Schwann
cells	NNS	cell
,	,	,
<FORBIDDEN ID=30 ACTION=delete>
both	CC	both
</FORBIDDEN ID=30 ACTION=delete>
during	IN	during
development	NN	development
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
process	NN	process
of	IN	of
regeneration	NN	regeneration
and	CC	and
re-myelination	NN	re-myelination
after	IN	after
nerve	NN	nerve
injury	NN	injury
.	SENT	.
.	SENT	.
<FORBIDDEN ID=55 ACTION=delete>
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
One	CD	One
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=55 ACTION=delete>
the	DT	the
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
major	JJ	major
signaling	NN	signaling
kinases	NNS	kinase
,	,	,
extracellular	JJ	extracellular
signal	NN	signal
-	HYPH	-
regulated	VBN	regulate
kinase	NN	kinase
-1/2	CD	-1/2
(	(	(
ERK	NN	ERK
1/2	CD	1/2
)	)	)
,	,	,
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
is	VVZ	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
a	DT	a
downstream	JJ	downstream
signaling	NN	signaling
pathway	NN	pathway
of	IN	of
neuregulin	NN	neuregulin
-	HYPH	-
ErbB2	NN	ErbB2
/	SYM	/
ErbB3	NN	ErbB3
activation	NN	activation
,	,	,
has	VHZ	have
been	VVN	be
identified	VBN	identify
as	IN	as
a	DT	a
key	JJ	key
regulator	NN	regulator
of	IN	of
Schwann	NP	Schwann
cell	NN	cell
proliferation	NN	proliferation
,	,	,
differentiation	NN	differentiation
,	,	,
demyelination	NN	demyelination
and	CC	and
nerve	NN	nerve
regeneration	NN	regeneration
.	SENT	.
.	SENT	.
Recent	JJ	Recent
studies	NNS	study
have	VHP	have
provided	VBN	provide
evidence	NN	evidence
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bacterium	NN	bacterium
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
causes	VBZ	cause
human	JJ	human
leprosy	NN	leprosy
,	,	,
Mycobacterium	NN	Mycobacterium
leprae	NNS	leprae
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
has	VHZ	have
a	DT	a
unique	JJ	unique
capacity	NN	capacity
to	TO	to
invade	VB	invade
Schwann	NP	Schwann
cells	NNS	cell
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
adult	JJ	adult
PNS	NN	PNS
,	,	,
utilizes	VBZ	utilize
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
neuregulin	NN	neuregulin
-	HYPH	-
ErbB2	NN	ErbB2
/	SYM	/
ErbB3	NN	ErbB3
associated	VBN	associate
signaling	NN	signaling
network	NN	network
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bacterial	JJ	bacterial
advantage	NN	advantage
.	SENT	.
.	SENT	.
M	NN	M
.	SENT	.
leprae	NNS	leprae
directly	RB	directly
bind	VB	bind
to	TO	to
ErbB2	NN	ErbB2
on	IN	on
myelinated	JJ	myelinated
Schwann	NP	Schwann
cells	NNS	cell
and	CC	and
activate	VBP	activate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
RTK	NN	RTK
by	IN	by
a	DT	a
novel	JJ	novel
route	NN	route
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
bypasses	VBZ	bypass
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
classical	JJ	classical
neuregulin	NN	neuregulin
/	SYM	/
growth	NN	growth
factor	NN	factor
-	HYPH	-
induced	VBN	induce
ErbB2	NN	ErbB2
-	HYPH	-
ErbB3	NN	ErbB3
heterodimerization	NN	heterodimerization
,	,	,
and	CC	and
subsequently	RB	subsequently
induce	VBP	induce
downstream	RB	downstream
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
canonical	JJ	canonical
Erk	NN	Erk
1/2	CD	1/2
signaling	NN	signaling
,	,	,
<FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
leading	VBG	lead
to	TO	to
</FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
myelin	NN	myelin
breakdown	NN	breakdown
and	CC	and
subsequent	JJ	subsequent
axonal	JJ	axonal
damage	NN	damage
.	SENT	.
.	SENT	.
This	DT	This
initial	JJ	initial
injury	NN	injury
provides	VBZ	provide
a	DT	a
survival	NN	survival
advantage	NN	advantage
for	IN	for
M	NN	M
.	SENT	.
leprae	NNS	leprae
as	IN	as
it	PP	it
induces	VBZ	induce
de-differentiation	NN	de-differentiation
and	CC	and
generates	VBZ	generate
myelin	NN	myelin
-	HYPH	-
free	JJ	free
cells	NNS	cell
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
are	VVP	be
highly	RB	highly
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
susceptible	JJ	susceptible
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
M	NN	M
.	SENT	.
leprae	JJ	leprae
invasion	NN	invasion
and	CC	and
promote	VB	promote
bacterial	JJ	bacterial
survival	NN	survival
.	SENT	.
.	SENT	.
Once	RB	Once
invaded	VBN	invade
M	NN	M
.	SENT	.
leprae	NNS	leprae
activate	VBP	activate
Erk	NN	Erk
1/2	CD	1/2
via	IN	via
a	DT	a
non-canonical	JJ	non-canonical
pathway	NN	pathway
and	CC	and
subsequently	RB	subsequently
increase	VB	increase
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cell	NN	cell
proliferation	NN	proliferation
and	CC	and
maintain	VB	maintain
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
infected	JJ	infected
cells	NNS	cell
in	IN	in
de-differentiated	JJ	de-differentiated
state	NN	state
,	,	,
thereby	RB	thereby
preventing	VBG	prevent
remyelination	NN	remyelination
.	SENT	.
.	SENT	.
<FORBIDDEN ID=162 ACTION=delete>
Therefore	RB	Therefore
</FORBIDDEN ID=162 ACTION=delete>
,	,	,
by	IN	by
subverting	VBG	subvert
major	JJ	major
RTKs	NNS	RTK
and	CC	and
signaling	NN	signaling
pathways	NNS	pathway
in	IN	in
adult	JJ	adult
Schwann	NP	Schwann
cells	NNS	cell
M	NN	M
.	SENT	.
leprae	NNS	leprae
appear	VBP	appear
to	TO	to
propagate	VB	propagate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bacterial	JJ	bacterial
niche	NN	niche
and	CC	and
maintain	VBP	maintain
survival	NN	survival
within	IN	within
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
PNS	NN	PNS
.	SENT	.
.	SENT	.
These	DT	These
studies	NNS	study
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
<FORBIDDEN ID=155 ACTION=delete>
</FORBIDDEN ID=123 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
provide	VB	provide
<FORBIDDEN ID=38 ACTION=delete>
<FORBIDDEN ID=37 ACTION=delete>
new	JJ	new
</FORBIDDEN ID=37 ACTION=delete>
</FORBIDDEN ID=38 ACTION=delete>
insights	NNS	insight
into	IN	into
our	PP$	our
understanding	NN	understanding
of	IN	of
signaling	NN	signaling
mechanisms	NNS	mechanism
involve	VBP	involve
in	IN	in
<FORBIDDEN ID=30 ACTION=delete>
both	CC	both
</FORBIDDEN ID=30 ACTION=delete>
neurodegeneration	NN	neurodegeneration
and	CC	and
neuroregeneration	NN	neuroregeneration
.	SENT	.
.	SENT	.
BB-cat+ner-20073421/text	DOCUMENT	BB-cat+ner-20073421/text
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
effect	NN	effect
of	IN	of
interferon	NN	interferon
-	HYPH	-
gamma	SYM	gamma
and	CC	and
lipopolysaccharide	NN	lipopolysaccharide
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
growth	NN	growth
of	IN	of
Francisella	NP	Francisella
tularensis	NP	tularensis
LVS	NP	LVS
in	IN	in
murine	JJ	murine
macrophage	NN	macrophage
-	HYPH	-
like	JJ	like
cell	NN	cell
line	NN	line
J774	NN	J774
.	SENT	.
.	SENT	.
Francisella	NP	Francisella
tularensis	NP	tularensis
,	,	,
a	DT	a
causative	JJ	causative
agent	NN	agent
of	IN	of
human	JJ	human
tularemia	NN	tularemia
,	,	,
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
displaying	VBG	display
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
ability	NN	ability
to	TO	to
proliferate	VB	proliferate
inside	IN	inside
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
human	JJ	human
cells	NNS	cell
.	SENT	.
.	SENT	.
To	TO	To
evaluate	VB	evaluate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
growth	NN	growth
potential	NN	potential
of	IN	of
F	NN	F
.	SENT	.
tularensis	NN	tularensis
LVS	NN	LVS
strain	NN	strain
in	IN	in
macrophage	NN	macrophage
-	HYPH	-
like	JJ	like
cell	NN	cell
line	NN	line
J774	NN	J774
modulated	VBN	modulate
by	IN	by
recombinant	JJ	recombinant
interferon	NN	interferon
gamma	NN	gamma
and	CC	and
E	NN	E
.	SENT	.
coli	NN	coli
derived	VBD	derive
lipopolysaccharide	NN	lipopolysaccharide
.	SENT	.
.	SENT	.
Stimulation	NN	Stimulation
of	IN	of
J774	NN	J774
cells	NNS	cell
either	CC	either
by	IN	by
interferon	NN	interferon
-	HYPH	-
gamma	NN	gamma
or	CC	or
lipopolysaccharide	NN	lipopolysaccharide
alone	RB	alone
,	,	,
or	CC	or
especially	RB	especially
in	IN	in
combination	NN	combination
before	IN	before
infection	NN	infection
F	NN	F
.	SENT	.
tularensis	NN	tularensis
,	,	,
revealed	VBD	reveal
protective	JJ	protective
effects	NNS	effect
.	SENT	.
.	SENT	.
Higher	JJR	High
concentrations	NNS	concentration
of	IN	of
stimulating	VBG	stimulate
agents	NNS	agent
were	VVD	be
needed	VBN	need
to	TO	to
inhibit	VB	inhibit
ongoing	JJ	ongoing
F	NN	F
.	SENT	.
tularensis	NN	tularensis
infection	NN	infection
.	SENT	.
.	SENT	.
Stimulation	NN	Stimulation
of	IN	of
J774	NN	J774
cell	NN	cell
line	NN	line
by	IN	by
combination	NN	combination
of	IN	of
interferon	NN	interferon
-	HYPH	-
gamma	NN	gamma
with	IN	with
lipopolysaccharide	NN	lipopolysaccharide
inhibits	VBZ	inhibit
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
intracellular	JJ	intracellular
growth	NN	growth
of	IN	of
F	NN	F
.	SENT	.
tularensis	NN	tularensis
.	SENT	.
.	SENT	.
BB-cat+ner-20148898/text	DOCUMENT	BB-cat+ner-20148898/text
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
professional	JJ	professional
phagocytes	NNS	phagocyte
dictates	VBZ	dictate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
number	NN	number
of	IN	of
host	NN	host
cells	NNS	cell
targeted	VBN	target
for	IN	for
Yop	NN	Yop
translocation	NN	translocation
during	IN	during
infection	NN	infection
.	SENT	.
.	SENT	.
Type	NN	Type
III	CD	III
secretion	NN	secretion
systems	NNS	system
deliver	VBP	deliver
effector	NN	effector
proteins	NNS	protein
from	IN	from
Gram	NN	Gram
-	HYPH	-
negative	JJ	negative
bacterial	JJ	bacterial
pathogens	NNS	pathogen
into	IN	into
host	NN	host
cells	NNS	cell
,	,	,
where	WRB	where
they	PP	they
disarm	VBP	disarm
host	NN	host
defences	NNS	defence
,	,	,
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
allowing	VBG	allow
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
pathogens	NNS	pathogen
to	TO	to
establish	VB	establish
infection	NN	infection
.	SENT	.
.	SENT	.
Although	IN	Although
Yersinia	NP	Yersinia
pseudotuberculosis	NN	pseudotuberculosis
delivers	VBZ	deliver
its	PP$	its
effector	NN	effector
proteins	NNS	protein
,	,	,
called	VBN	call
Yops	NP	Yops
,	,	,
into	IN	into
numerous	JJ	numerous
cell	NN	cell
types	NNS	type
grown	VBN	grow
in	IN	in
culture	NN	culture
,	,	,
we	PP	we
show	VBP	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
during	IN	during
infection	NN	infection
Y	NN	Y
.	SENT	.
pseudotuberculosis	NN	pseudotuberculosis
<FORBIDDEN ID=81 ACTION=delete>
selectively	RB	selectively
</FORBIDDEN ID=81 ACTION=delete>
targets	VBZ	target
Yops	NNS	Yop
to	TO	to
professional	JJ	professional
phagocytes	NNS	phagocyte
in	IN	in
Peyer's	NP	Peyer's
patches	NNS	patch
,	,	,
mesenteric	JJ	mesenteric
lymph	NN	lymph
nodes	NNS	node
and	CC	and
spleen	NN	spleen
,	,	,
although	IN	although
it	PP	it
colocalizes	VBZ	colocalize
with	IN	with
B	NN	B
and	CC	and
T	NN	T
cells	NNS	cell
as	RB	as
well	RB	well
as	IN	as
professional	JJ	professional
phagocytes	NNS	phagocyte
.	SENT	.
.	SENT	.
Strikingly	RB	Strikingly
,	,	,
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
absence	NN	absence
of	IN	of
neutrophils	NNS	neutrophil
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
number	NN	number
of	IN	of
cells	NNS	cell
with	IN	with
translocated	VBN	translocate
Yops	NNS	Yop
was	VVD	be
significantly	RB	significantly
reduced	VBN	reduce
although	IN	although
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bacterial	JJ	bacterial
loads	NNS	load
were	VVD	be
similar	JJ	similar
,	,	,
indicating	VBG	indicate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
Y	NN	Y
.	SENT	.
pseudotuberculosis	NN	pseudotuberculosis
did	VBD	do
not	RB	not
arbitrarily	RB	arbitrarily
deliver	VB	deliver
Yops	NNS	Yop
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
available	JJ	available
cells	NNS	cell
.	SENT	.
.	SENT	.
Using	VBG	Use
isolated	VBN	isolate
splenocytes	NNS	splenocyte
,	,	,
selective	JJ	selective
binding	NN	binding
and	CC	and
selective	JJ	selective
targeting	NN	targeting
to	TO	to
professional	JJ	professional
phagocytes	NNS	phagocyte
when	WRB	when
bacteria	NNS	bacteria
were	VVD	be
limiting	VBG	limit
was	VVD	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
observed	VBN	observe
,	,	,
indicating	VBG	indicate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
tissue	NN	tissue
architecture	NN	architecture
was	VVD	be
not	RB	not
required	VBN	require
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
tropism	NN	tropism
for	IN	for
professional	JJ	professional
phagocytes	NNS	phagocyte
.	SENT	.
.	SENT	.
In	IN	In
isolated	VBN	isolate
splenocytes	NNS	splenocyte
,	,	,
YadA	NN	YadA
and	CC	and
Invasin	NN	Invasin
increased	VBD	increase
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
number	NN	number
of	IN	of
all	DT	all
cells	NNS	cell
types	NNS	type
with	IN	with
translocated	VBN	translocate
Yops	NNS	Yop
,	,	,
but	CC	but
professional	JJ	professional
phagocytes	NNS	phagocyte
were	VVD	be
still	RB	still
preferentially	RB	preferentially
translocated	VBN	translocate
with	IN	with
Yops	NNS	Yop
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
absence	NN	absence
of	IN	of
these	DT	these
adhesins	NNS	adhesin
.	SENT	.
.	SENT	.
<FORBIDDEN ID=158 ACTION=delete>
Together	RB	Together
</FORBIDDEN ID=158 ACTION=delete>
these	DT	these
results	NNS	result
indicate	VBP	indicate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
Y	NN	Y
.	SENT	.
pseudotuberculosis	NN	pseudotuberculosis
discriminates	VBZ	discriminate
among	IN	among
cells	NNS	cell
it	PP	it
encounters	VBZ	encounter
during	IN	during
infection	NN	infection
and	CC	and
<FORBIDDEN ID=81 ACTION=delete>
selectively	RB	selectively
</FORBIDDEN ID=81 ACTION=delete>
delivers	VBZ	deliver
Yops	NNS	Yop
to	TO	to
phagocytes	NNS	phagocyte
while	IN	while
refraining	VBG	refrain
from	IN	from
translocation	NN	translocation
to	TO	to
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
cell	NN	cell
types	NNS	type
.	SENT	.
.	SENT	.
BB-cat+ner-20174624/text	DOCUMENT	BB-cat+ner-20174624/text
Neutrophils	NNS	Neutrophil
are	VVP	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
resistant	JJ	resistant
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
Yersinia	NP	Yersinia
YopJ	NP	YopJ
/	SYM	/
P-induced	JJ	P-induced
apoptosis	NN	apoptosis
and	CC	and
are	VVP	be
protected	VBN	protect
from	IN	from
ROS	NN	ROS
-	HYPH	-
mediated	VBN	mediate
cell	NN	cell
death	NN	death
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
type	NN	type
III	CD	III
secretion	NN	secretion
system	NN	system
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
human	JJ	human
innate	JJ	innate
immune	JJ	immune
system	NN	system
relies	VBZ	rely
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
coordinated	VBN	coordinate
activity	NN	activity
of	IN	of
macrophages	NNS	macrophage
and	CC	and
polymorphonuclear	JJ	polymorphonuclear
leukocytes	NNS	leukocyte
(	(	(
neutrophils	NNS	neutrophil
or	CC	or
PMNs	NNS	PMN
)	)	)
for	IN	for
defense	NN	defense
against	IN	against
bacterial	JJ	bacterial
pathogens	NNS	pathogen
.	SENT	.
.	SENT	.
Yersinia	NN	Yersinia
spp	NN	spp
.	SENT	.
subvert	VB	subvert
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
innate	JJ	innate
immune	JJ	immune
response	NN	response
to	TO	to
cause	VB	cause
disease	NN	disease
in	IN	in
humans	NNS	human
.	SENT	.
.	SENT	.
In	IN	In
particular	JJ	particular
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Yersinia	NP	Yersinia
outer	JJ	outer
protein	NN	protein
YopJ	NN	YopJ
(	(	(
Y	NN	Y
.	SENT	.
pestis	NN	pestis
and	CC	and
Y	NN	Y
.	SENT	.
pseudotuberculosis	NN	pseudotuberculosis
)	)	)
and	CC	and
YopP	NN	YopP
(	(	(
Y	NN	Y
.	SENT	.
enterocolitica	NN	enterocolitica
)	)	)
rapidly	RB	rapidly
induce	VBP	induce
apoptosis	NN	apoptosis
in	IN	in
murine	JJ	murine
macrophages	NNS	macrophage
and	CC	and
dendritic	JJ	dendritic
cells	NNS	cell
.	SENT	.
.	SENT	.
However	RB	However
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
effects	NNS	effect
of	IN	of
Yersinia	NP	Yersinia
Yop	NP	Yop
J	NP	J
/	SYM	/
P	NN	P
on	IN	on
neutrophil	NN	neutrophil
fate	NN	fate
are	VVP	be
not	RB	not
clearly	RB	clearly
defined	VBN	define
.	SENT	.
.	SENT	.
In	IN	In
this	DT	this
study	NN	study
,	,	,
we	PP	we
utilized	VBD	utilize
wild	JJ	wild
-	HYPH	-
type	NN	type
and	CC	and
mutant	JJ	mutant
strains	NNS	strain
of	IN	of
Yersinia	NP	Yersinia
to	TO	to
test	VB	test
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
contribution	NN	contribution
of	IN	of
YopJ	NN	YopJ
and	CC	and
YopP	NN	YopP
on	IN	on
induction	NN	induction
of	IN	of
apoptosis	NN	apoptosis
in	IN	in
human	JJ	human
monocyte	NN	monocyte
-	HYPH	-
derived	VBN	derive
macrophages	NNS	macrophage
(	(	(
HMDM	NN	HMDM
)	)	)
and	CC	and
neutrophils	NNS	neutrophil
.	SENT	.
.	SENT	.
Whereas	IN	Whereas
YopJ	NN	YopJ
and	CC	and
YopP	NN	YopP
similarly	RB	similarly
induced	VBD	induce
apoptosis	NN	apoptosis
in	IN	in
HMDMs	NNS	HMDM
,	,	,
interaction	NN	interaction
of	IN	of
human	JJ	human
neutrophils	NNS	neutrophil
with	IN	with
virulence	NN	virulence
plasmid	NN	plasmid
-	HYPH	-
containing	VBG	contain
Yersinia	NN	Yersinia
did	VBD	do
not	RB	not
result	VB	result
in	IN	in
PMN	NN	PMN
caspase	NN	caspase
activation	NN	activation
,	,	,
release	NN	release
of	IN	of
LDH	NN	LDH
,	,	,
or	CC	or
loss	NN	loss
of	IN	of
membrane	NN	membrane
integrity	NN	integrity
greater	JJR	great
than	IN	than
PMN	NN	PMN
controls	NNS	control
.	SENT	.
.	SENT	.
In	IN	In
contrast	NN	contrast
,	,	,
interaction	NN	interaction
of	IN	of
human	JJ	human
PMNs	NNS	PMN
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
virulence	NN	virulence
plasmid	NN	plasmid
-	HYPH	-
deficient	JJ	deficient
Y	NN	Y
.	SENT	.
pestis	NN	pestis
strain	NN	strain
KIM6	NN	KIM6
resulted	VBD	result
in	IN	in
increased	VBN	increase
surface	NN	surface
exposure	NN	exposure
of	IN	of
phosphatidylserine	NN	phosphatidylserine
(	(	(
PS	NN	PS
)	)	)
and	CC	and
cell	NN	cell
death	NN	death
.	SENT	.
.	SENT	.
PMN	NN	PMN
reactive	JJ	reactive
oxygen	NN	oxygen
species	NNS	specie
(	(	(
ROS	NN	ROS
)	)	)
production	NN	production
was	VVD	be
inhibited	VBN	inhibit
in	IN	in
a	DT	a
virulence	NN	virulence
plasmid	NN	plasmid
-	HYPH	-
dependent	JJ	dependent
but	CC	but
YopJ	NN	YopJ
/	SYM	/
YopP	NN	YopP
-	HYPH	-
independent	JJ	independent
manner	NN	manner
.	SENT	.
.	SENT	.
Following	VBG	Follow
phagocytic	JJ	phagocytic
interaction	NN	interaction
with	IN	with
Y	NN	Y
.	SENT	.
pestis	NN	pestis
strain	NN	strain
KIM6	NN	KIM6
,	,	,
inhibition	NN	inhibition
of	IN	of
PMN	NN	PMN
ROS	NN	ROS
production	NN	production
with	IN	with
diphenyleneiodonium	NN	diphenyleneiodonium
chloride	NN	chloride
resulted	VBD	result
in	IN	in
a	DT	a
reduction	NN	reduction
of	IN	of
PMN	NN	PMN
cell	NN	cell
death	NN	death
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
similar	JJ	similar
to	TO	to
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
that	DT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
induced	VBN	induce
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
virulence	NN	virulence
plasmid	NN	plasmid
-	HYPH	-
containing	VBG	contain
strain	NN	strain
Y	NN	Y
.	SENT	.
pestis	VBZ	pesti
KIM5	NP	KIM5
.	SENT	.
.	SENT	.
Our	PP$	Our
findings	NNS	finding
showed	VBD	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
Yersinia	NP	Yersinia
YopJ	NP	YopJ
and	CC	and
/	SYM	/
or	CC	or
YopP	NN	YopP
did	VBD	do
not	RB	not
induce	VB	induce
pronounced	JJ	pronounced
apoptosis	NN	apoptosis
in	IN	in
human	JJ	human
neutrophils	NNS	neutrophil
.	SENT	.
.	SENT	.
Furthermore	RB	Furthermore
,	,	,
robust	JJ	robust
PMN	NN	PMN
ROS	NN	ROS
production	NN	production
<FORBIDDEN ID=27 ACTION=delete>
<FORBIDDEN ID=26 ACTION=delete>
in	IN	in
response	NN	response
to	TO	to
</FORBIDDEN ID=26 ACTION=delete>
</FORBIDDEN ID=27 ACTION=delete>
virulence	NN	virulence
plasmid	NN	plasmid
-	HYPH	-
deficient	JJ	deficient
Yersinia	NN	Yersinia
was	VVD	be
associated	VBN	associate
with	IN	with
increased	VBN	increase
PMN	NN	PMN
cell	NN	cell
death	NN	death
,	,	,
suggesting	VBG	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
Yersinia	NP	Yersinia
inhibition	NN	inhibition
of	IN	of
PMN	NN	PMN
ROS	NN	ROS
production	NN	production
plays	VBZ	play
a	DT	a
role	NN	role
in	IN	in
evasion	NN	evasion
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
human	JJ	human
innate	JJ	innate
immune	JJ	immune
response	NN	response
in	IN	in
part	NN	part
by	IN	by
limiting	VBG	limit
PMN	NN	PMN
apoptosis	NN	apoptosis
.	SENT	.
.	SENT	.
BB-cat+ner-20400104/text	DOCUMENT	BB-cat+ner-20400104/text
Microbiota	NN	Microbiota
in	IN	in
pediatric	JJ	pediatric
inflammatory	JJ	inflammatory
bowel	NN	bowel
disease	NN	disease
.	SENT	.
.	SENT	.
To	TO	To
test	VB	test
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
hypothesis	NN	hypothesis
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
compared	VBN	compare
with	IN	with
controls	NNS	control
,	,	,
children	NNS	child
with	IN	with
inflammatory	JJ	inflammatory
bowel	NN	bowel
disease	NN	disease
(	(	(
IBD	NN	IBD
)	)	)
exhibit	VBP	exhibit
differences	NNS	difference
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
relationships	NNS	relationship
between	IN	between
gut	NN	gut
microbiota	NN	microbiota
and	CC	and
disease	NN	disease
activity	NN	activity
.	SENT	.
.	SENT	.
Children	NNS	Child
and	CC	and
adolescents	NNS	adolescent
(	(	(
n	NN	n
=	SYM	=
69	CD	69
;	COLUMN	;
median	JJ	median
age	NN	age
,	,	,
14	CD	14
years	NNS	year
)	)	)
with	IN	with
IBD	NN	IBD
and	CC	and
25	CD	25
healthy	JJ	healthy
controls	NNS	control
(	(	(
median	JJ	median
age	NN	age
,	,	,
14	CD	14
years	NNS	year
)	)	)
were	VVD	be
recruited	VBN	recruit
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
study	NN	study
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
disease	NN	disease
activity	NN	activity
was	VVD	be
determined	VBN	determine
<FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
according	VBG	accord
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Pediatric	NP	Pediatric
Ulcerative	NP	Ulcerative
Colitis	NP	Colitis
Activity	NP	Activity
Index	NP	Index
or	CC	or
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Pediatric	NP	Pediatric
Crohn	NP	Crohn
Disease	NP	Disease
Activity	NP	Activity
Index	NP	Index
.	SENT	.
.	SENT	.
Cell	NN	Cell
counts	NNS	count
of	IN	of
9	CD	9
bacterial	JJ	bacterial
groups	NNS	group
and	CC	and
species	NNS	specie
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
fecal	JJ	fecal
microbiota	NN	microbiota
were	VVD	be
monitored	VBN	monitor
by	IN	by
real	JJ	real
-	HYPH	-
time	NN	time
polymerase	NN	polymerase
chain	NN	chain
reaction	NN	reaction
analysis	NN	analysis
.	SENT	.
.	SENT	.
Although	IN	Although
no	DT	no
major	JJ	major
changes	NNS	change
were	VVD	be
observed	VBN	observe
in	IN	in
patients	NNS	patient
with	IN	with
ulcerative	JJ	ulcerative
colitis	NN	colitis
,	,	,
except	IN	except
for	IN	for
a	DT	a
decrease	NN	decrease
in	IN	in
bifidobacteria	NNS	bifidobacteria
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
active	JJ	active
state	NN	state
of	IN	of
IBD	NN	IBD
,	,	,
children	NNS	child
with	IN	with
active	JJ	active
and	CC	and
inactive	JJ	inactive
Crohn's	NNS	Crohn'
disease	NN	disease
(	(	(
CD	NN	CD
)	)	)
had	VHD	have
lower	JJR	low
numbers	NNS	number
of	IN	of
Faecalibacterium	NP	Faecalibacterium
prausnitzii	NNS	prausnitzii
and	CC	and
bifidobacteria	NNS	bifidobacteria
(	(	(
P	NN	P
INF	SYM	INF
.	SENT	.
05	CD	05
)	)	)
,	,	,
and	CC	and
patients	NNS	patient
with	IN	with
active	JJ	active
CD	NN	CD
had	VHD	have
higher	JJR	high
numbers	NNS	number
of	IN	of
Escherichia	FW	Escherichia
coli	FW	coli
(	(	(
P	NN	P
INF	SYM	INF
.	SENT	.
05	CD	05
)	)	)
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
microbiota	NN	microbiota
in	IN	in
children	NNS	child
with	IN	with
CD	NN	CD
is	VVZ	be
characterized	VBN	characterize
by	IN	by
decreased	VBN	decrease
numbers	NNS	number
of	IN	of
F	NN	F
praunsitzii	NN	praunsitzii
and	CC	and
increased	VBN	increase
numbers	NNS	number
of	IN	of
E	NN	E
coli	NN	coli
.	SENT	.
.	SENT	.
BB-cat+ner-20580604/text	DOCUMENT	BB-cat+ner-20580604/text
Effects	NNS	Effect
of	IN	of
a	DT	a
probiotic	JJ	probiotic
fermented	VBN	ferment
milk	NN	milk
beverage	NN	beverage
containing	VBG	contain
Lactobacillus	NN	Lactobacillus
casei	NN	casei
strain	NN	strain
Shirota	NN	Shirota
on	IN	on
defecation	NN	defecation
frequency	NN	frequency
,	,	,
intestinal	JJ	intestinal
microbiota	NNS	microbiota
,	,	,
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
intestinal	JJ	intestinal
environment	NN	environment
of	IN	of
healthy	JJ	healthy
individuals	NNS	individual
with	IN	with
soft	JJ	soft
stools	NNS	stool
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
effects	NNS	effect
of	IN	of
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
drinking	VBG	drink
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
fermented	VBN	ferment
milk	NN	milk
beverage	NN	beverage
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
contains	VBZ	contain
Lactobacillus	NN	Lactobacillus
casei	NN	casei
strain	NN	strain
Shirota	NN	Shirota
(	(	(
LcS	NN	LcS
)	)	)
at	IN	at
40	CD	40
billion	CD	billion
bacterial	JJ	bacterial
cells	NNS	cell
/	SYM	/
bottle	NN	bottle
for	IN	for
4	CD	4
weeks	NNS	week
(	(	(
probiotics	NNS	probiotic
,	,	,
1	CD	1
bottle	NN	bottle
/	SYM	/
day	NN	day
)	)	)
on	IN	on
defecation	NN	defecation
frequency	NN	frequency
,	,	,
intestinal	JJ	intestinal
microbiota	NN	microbiota
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
intestinal	JJ	intestinal
environment	NN	environment
of	IN	of
healthy	JJ	healthy
individuals	NNS	individual
with	IN	with
soft	JJ	soft
stools	NNS	stool
were	VVD	be
evaluated	VBN	evaluate
.	SENT	.
.	SENT	.
Thirty	CD	Thirty
-	HYPH	-
four	CD	four
healthy	JJ	healthy
adults	NNS	adult
who	WP	who
had	VHD	have
soft	JJ	soft
stools	NNS	stool
were	VVD	be
randomised	VBN	randomise
into	IN	into
2	CD	2
groups	NNS	group
,	,	,
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
effects	NNS	effect
of	IN	of
a	DT	a
regular	JJ	regular
4-week	JJ	4-week
intake	NN	intake
of	IN	of
probiotics	NNS	probiotic
were	VVD	be
evaluated	VBN	evaluate
by	IN	by
a	DT	a
placebo	NN	placebo
-	HYPH	-
controlled	VBN	control
,	,	,
double	JJ	double
-	HYPH	-
blind	JJ	blind
,	,	,
parallel	JJ	parallel
-	HYPH	-
group	NN	group
comparative	JJ	comparative
design	NN	design
.	SENT	.
.	SENT	.
Defecation	NN	Defecation
<FORBIDDEN ID=165 ACTION=delete>
frequency	NN	frequency
significantly	RB	significantly
</FORBIDDEN ID=165 ACTION=delete>
decreased	VBD	decrease
after	IN	after
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
4-week	JJ	4-week
intake	NN	intake
period	NN	period
compared	VBN	compare
with	IN	with
before	RB	before
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
probiotic	JJ	probiotic
treatment	NN	treatment
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
stool	NN	stool
<FORBIDDEN ID=165 ACTION=delete>
quality	NN	quality
significantly	RB	significantly
</FORBIDDEN ID=165 ACTION=delete>
improved	VBD	improve
(	(	(
hardened	VBN	harden
)	)	)
compared	VBN	compare
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
placebo	NN	placebo
.	SENT	.
.	SENT	.
<FORBIDDEN ID=155 ACTION=delete>
Also	RB	Also
</FORBIDDEN ID=155 ACTION=delete>
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
water	NN	water
content	NN	content
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
stools	NNS	stool
was	VVD	be
lower	JJR	low
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
probiotic	JJ	probiotic
group	NN	group
than	IN	than
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
placebo	NN	placebo
group	NN	group
.	SENT	.
.	SENT	.
Live	JJ	Live
LcS	NN	LcS
was	VVD	be
recovered	VBN	recover
at	IN	at
6.9	CD	6.9
±	NN	±
1.3	CD	1.3
and	CC	and
7.2	CD	7.2
±	HYPH	±
0.8	CD	0.8
log(10)	NN	log(10)
CFU	NN	CFU
per	IN	per
1g	NN	1g
of	IN	of
stool	NN	stool
after	IN	after
2	CD	2
and	CC	and
4	CD	4
weeks	NNS	week
,	,	,
respectively	RB	respectively
,	,	,
of	IN	of
probiotic	JJ	probiotic
treatment	NN	treatment
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
number	NN	number
of	IN	of
bifidobacteria	NNS	bifidobacteria
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
stools	NNS	stool
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
increased	VBD	increase
significantly	RB	significantly
compared	VBN	compare
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
level	NN	level
before	IN	before
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
starting	VBG	start
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
probiotics	NNS	probiotic
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
organic	JJ	organic
acid	NN	acid
levels	NNS	level
(	(	(
total	JJ	total
,	,	,
acetic	JJ	acetic
acid	NN	acid
,	,	,
propionic	JJ	propionic
acid	NN	acid
,	,	,
and	CC	and
butyric	JJ	butyric
acid	NN	acid
)	)	)
significantly	RB	significantly
increased	VBD	increase
compared	VBN	compare
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
level	NN	level
before	IN	before
intake	NN	intake
in	IN	in
<FORBIDDEN ID=30 ACTION=delete>
both	CC	both
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=30 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
probiotic	JJ	probiotic
and	CC	and
placebo	NN	placebo
groups	NNS	group
,	,	,
but	CC	but
they	PP	they
returned	VBD	return
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
original	JJ	original
levels	NNS	level
after	IN	after
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
end	NN	end
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
intake	JJ	intake
period	NN	period
.	SENT	.
.	SENT	.
These	DT	These
results	NNS	result
suggest	VBP	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
probiotic	JJ	probiotic
fermented	VBN	ferment
milk	NN	milk
beverage	NN	beverage
has	VHZ	have
an	DT	an
intestine	NN	intestine
-	HYPH	-
conditioning	VBG	condition
effect	NN	effect
by	IN	by
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
improving	VBG	improve
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
frequency	NN	frequency
of	IN	of
defecation	NN	defecation
and	CC	and
stool	NN	stool
quality	NN	quality
and	CC	and
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
increasing	VBG	increase
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
intrinsic	JJ	intrinsic
bifidobacteria	NNS	bifidobacteria
in	IN	in
healthy	JJ	healthy
individuals	NNS	individual
with	IN	with
soft	JJ	soft
stool	NN	stool
.	SENT	.
.	SENT	.
BB-cat+ner-20672296/text	DOCUMENT	BB-cat+ner-20672296/text
An	DT	An
18-month	JJ	18-month
study	NN	study
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
safety	NN	safety
and	CC	and
efficacy	NN	efficacy
of	IN	of
repeated	VBN	repeat
courses	NNS	course
of	IN	of
inhaled	VBN	inhale
aztreonam	NN	aztreonam
lysine	NN	lysine
in	IN	in
cystic	JJ	cystic
fibrosis	NN	fibrosis
.	SENT	.
.	SENT	.
Chronic	JJ	Chronic
airway	NN	airway
infection	NN	infection
with	IN	with
Pseudomonas	NN	Pseudomonas
aeruginosa	NN	aeruginosa
(	(	(
PA	NN	PA
)	)	)
causes	VBZ	cause
morbidity	NN	morbidity
and	CC	and
mortality	NN	mortality
in	IN	in
patients	NNS	patient
with	IN	with
cystic	JJ	cystic
fibrosis	NN	fibrosis
(	(	(
CF	NN	CF
)	)	)
.	SENT	.
.	SENT	.
Additional	JJ	Additional
anti	AFX	anti
-	HYPH	-
PA	NN	PA
therapies	NNS	therapy
are	VVP	be
needed	VBN	need
to	TO	to
improve	VB	improve
health	NN	health
status	NN	status
and	CC	and
health	NN	health
-	HYPH	-
related	VBN	relate
quality	NN	quality
of	IN	of
life	NN	life
.	SENT	.
.	SENT	.
AIR	NN	AIR
-	HYPH	-
CF3	NN	CF3
was	VVD	be
an	DT	an
international	JJ	international
18-month	JJ	18-month
,	,	,
open	JJ	open
-	HYPH	-
label	NN	label
study	NN	study
to	TO	to
evaluate	VB	evaluate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
safety	NN	safety
and	CC	and
efficacy	NN	efficacy
of	IN	of
repeated	VBN	repeat
courses	NNS	course
of	IN	of
aztreonam	NN	aztreonam
for	IN	for
inhalation	NN	inhalation
solution	NN	solution
(	(	(
AZLI	NN	AZLI
,	,	,
now	RB	now
marketed	VBN	market
as	IN	as
Cayston®	NN	Cayston®
)	)	)
in	IN	in
patients	NNS	patient
aged	VBN	age
≥	IN	≥
6	CD	6
years	NNS	year
with	IN	with
CF	NN	CF
and	CC	and
PA	NN	PA
infection	NN	infection
who	WP	who
previously	RB	previously
participated	VBD	participate
in	IN	in
<FORBIDDEN ID=55 ACTION=delete>
one	CD	one
of	IN	of
</FORBIDDEN ID=55 ACTION=delete>
two	CD	two
Phase	NN	Phase
3	CD	3
studies	NNS	study
:	COLUMN	:
AIR	NN	AIR
-	HYPH	-
CF1	NN	CF1
or	CC	or
AIR	NN	AIR
-	HYPH	-
CF2	NN	CF2
.	SENT	.
.	SENT	.
Patients	NNS	Patient
received	VBD	receive
up	RB	up
to	TO	to
nine	CD	nine
courses	NNS	course
(	(	(
28	CD	28
days	NNS	day
on	IN	on
/	SYM	/
28	CD	28
days	NNS	day
off	RB	off
)	)	)
of	IN	of
75	CD	75
mg	NN	mg
AZLI	NN	AZLI
two	CD	two
(	(	(
BID	NN	BID
)	)	)
or	CC	or
three	CD	three
times	NNS	time
daily	JJ	daily
(	(	(
TID	NN	TID
)	)	)
based	VBN	base
on	IN	on
randomization	NN	randomization
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
previous	JJ	previous
trials	NNS	trial
.	SENT	.
274	CD	274
patients	NNS	patient
,	,	,
mean	JJ	mean
age	NN	age
28.5	CD	28.5
years	NNS	year
(	(	(
range	NN	range
:	COLUMN	:
8-74	CD	8-74
years	NNS	year
)	)	)
,	,	,
participated	VBD	participate
.	SENT	.
.	SENT	.
Mean	NN	Mean
treatment	NN	treatment
adherence	NN	adherence
was	VVD	be
high	JJ	high
(	(	(
92.0	CD	92.0
%	NN	%
BID	NN	BID
group	NN	group
,	,	,
88.0	CD	88.0
%	NN	%
TID	NN	TID
group	NN	group
)	)	)
.	SENT	.
.	SENT	.
Hospitalization	NN	Hospitalization
rates	NNS	rate
were	VVD	be
low	JJ	low
and	CC	and
adverse	JJ	adverse
events	NNS	event
were	VVD	be
consistent	JJ	consistent
with	IN	with
CF	NN	CF
.	SENT	.
.	SENT	.
With	IN	With
each	DT	each
course	NN	course
of	IN	of
AZLI	NN	AZLI
,	,	,
FEV(1)	NN	FEV(1)
and	CC	and
scores	NNS	score
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Cystic	NP	Cystic
Fibrosis	NP	Fibrosis
Questionnaire	NP	Questionnaire
-	HYPH	-
Revised	NP	Revised
Respiratory	NP	Respiratory
Symptom	NP	Symptom
scale	NN	scale
improved	VBD	improve
and	CC	and
bacterial	JJ	bacterial
density	NN	density
in	IN	in
sputum	NN	sputum
was	VVD	be
reduced	VBN	reduce
.	SENT	.
.	SENT	.
Benefits	NNS	Benefit
waned	VBD	wan
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
28	CD	28
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
days	NNS	day
off	IN	off
therapy	NN	therapy
,	,	,
but	CC	but
weight	NN	weight
gain	NN	gain
was	VVD	be
sustained	JJ	sustained
over	IN	over
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
18	CD	18
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
months	NNS	month
.	SENT	.
.	SENT	.
There	EX	There
were	VVD	be
no	DT	no
sustained	JJ	sustained
decreases	NNS	decrease
in	IN	in
PA	NN	PA
susceptibility	NN	susceptibility
.	SENT	.
.	SENT	.
A	DT	A
dose	NN	dose
response	NN	response
was	VVD	be
observed	VBN	observe
;	COLUMN	;
AZLI	NN	AZLI
TID	NN	TID
-	HYPH	-
treated	VBN	treat
patients	NNS	patient
demonstrated	VBD	demonstrate
greater	JJR	great
improvements	NNS	improvement
in	IN	in
lung	NN	lung
function	NN	function
and	CC	and
respiratory	JJ	respiratory
symptoms	NNS	symptom
over	IN	over
18	CD	18
months	NNS	month
.	SENT	.
.	SENT	.
Repeated	VBN	Repeat
intermittent	JJ	intermittent
28-day	JJ	28-day
courses	NNS	course
of	IN	of
AZLI	NN	AZLI
treatment	NN	treatment
were	VVD	be
well	RB	well
tolerated	VBN	tolerate
.	SENT	.
.	SENT	.
Clinical	JJ	Clinical
benefits	NNS	benefit
in	IN	in
pulmonary	JJ	pulmonary
function	NN	function
,	,	,
health	NN	health
-	HYPH	-
related	VBN	relate
quality	NN	quality
of	IN	of
life	NN	life
,	,	,
and	CC	and
weight	NN	weight
were	VVD	be
observed	VBN	observe
with	IN	with
each	DT	each
course	NN	course
of	IN	of
therapy	NN	therapy
.	SENT	.
.	SENT	.
AZLI	NN	AZLI
is	VVZ	be
a	DT	a
safe	JJ	safe
and	CC	and
effective	JJ	effective
<FORBIDDEN ID=38 ACTION=delete>
<FORBIDDEN ID=37 ACTION=delete>
new	JJ	new
</FORBIDDEN ID=37 ACTION=delete>
</FORBIDDEN ID=38 ACTION=delete>
therapy	NN	therapy
in	IN	in
patients	NNS	patient
with	IN	with
CF	NN	CF
and	CC	and
PA	NN	PA
airway	NN	airway
infection	NN	infection
.	SENT	.
.	SENT	.
BB-cat+ner-21148810/text	DOCUMENT	BB-cat+ner-21148810/text
TLR2	NN	TLR2
-	HYPH	-
dependent	JJ	dependent
pathway	NN	pathway
of	IN	of
heterologous	JJ	heterologous
down	RB	down
-	HYPH	-
modulation	NN	modulation
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
CC	NN	CC
chemokine	NN	chemokine
receptors	NNS	receptor
1	CD	1
,	,	,
2	CD	2
,	,	,
and	CC	and
5	CD	5
in	IN	in
human	JJ	human
blood	NN	blood
monocytes	NNS	monocyte
.	SENT	.
.	SENT	.
During	IN	During
innate	JJ	innate
immune	JJ	immune
responses	NNS	response
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
inflammatory	JJ	inflammatory
CC	NN	CC
chemokine	NN	chemokine
receptors	NNS	receptor
CCR1	NN	CCR1
,	,	,
CCR2	NN	CCR2
,	,	,
and	CC	and
CCR5	NN	CCR5
mediate	VBP	mediate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
recruitment	NN	recruitment
of	IN	of
blood	NN	blood
monocytes	NNS	monocyte
to	TO	to
infected	JJ	infected
tissues	NNS	tissue
by	IN	by
promoting	VBG	promote
cell	NN	cell
migration	NN	migration
<FORBIDDEN ID=27 ACTION=delete>
<FORBIDDEN ID=26 ACTION=delete>
in	IN	in
response	NN	response
to	TO	to
</FORBIDDEN ID=26 ACTION=delete>
</FORBIDDEN ID=27 ACTION=delete>
chemokines	NNS	chemokine
CCL	NN	CCL
2-5	CD	2-5
.	SENT	.
.	SENT	.
Toll	NN	Toll
-	HYPH	-
like	JJ	like
receptors	NNS	receptor
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
play	VBP	play
an	DT	an
essential	JJ	essential
role	NN	role
,	,	,
allowing	VBG	allow
pathogen	NN	pathogen
recognition	NN	recognition
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
recruited	VBN	recruit
monocytes	NNS	monocyte
.	SENT	.
.	SENT	.
Here	RB	Here
,	,	,
we	PP	we
demonstrate	VBP	demonstrate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
Toll	NN	Toll
-	HYPH	-
like	JJ	like
receptor	NN	receptor
2	CD	2
(	(	(
TLR2	NN	TLR2
)	)	)
stimulation	NN	stimulation
by	IN	by
lipoteichoic	JJ	lipoteichoic
acid	NN	acid
(	(	(
LTA	NN	LTA
)	)	)
from	IN	from
Staphylococcus	FW	Staphylococcus
aureus	FW	aureus
leads	VBZ	lead
to	TO	to
gradual	JJ	gradual
down	RB	down
-	HYPH	-
modulation	NN	modulation
of	IN	of
CCR1	NN	CCR1
,	,	,
CCR2	NN	CCR2
,	,	,
and	CC	and
CCR5	NN	CCR5
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
plasma	NN	plasma
membrane	NN	membrane
of	IN	of
human	JJ	human
blood	NN	blood
-	HYPH	-
isolated	VBN	isolate
monocytes	NNS	monocyte
and	CC	and
inhibits	VBZ	inhibit
chemotaxis	NN	chemotaxis
.	SENT	.
.	SENT	.
Interestingly	RB	Interestingly
,	,	,
LTA	NN	LTA
does	VBZ	do
not	RB	not
promote	VB	promote
rapid	JJ	rapid
desensitization	NN	desensitization
of	IN	of
chemokine	NN	chemokine
-	HYPH	-
mediated	VBN	mediate
calcium	NN	calcium
responses	NNS	response
.	SENT	.
.	SENT	.
We	PP	We
found	VBD	find
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
TLR2	NN	TLR2
crosstalk	NN	crosstalk
with	IN	with
chemokine	NN	chemokine
receptors	NNS	receptor
is	VVZ	be
not	RB	not
dependent	JJ	dependent
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Toll	NN	Toll
/	SYM	/
interleukin	NN	interleukin
-1	NN	-1
receptor	NN	receptor
domain	NN	domain
-	HYPH	-
containing	VBG	contain
adaptor	NN	adaptor
protein	NN	protein
,	,	,
but	CC	but
instead	RB	instead
involves	VBZ	involve
phospholipase	NN	phospholipase
C	NN	C
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
small	JJ	small
G	NN	G
protein	NN	protein
Rac1	NN	Rac1
,	,	,
and	CC	and
is	VVZ	be
phorbol	NN	phorbol
ester	NN	ester
sensitive	JJ	sensitive
.	SENT	.
.	SENT	.
Activation	NN	Activation
of	IN	of
this	DT	this
pathway	NN	pathway
by	IN	by
LTA	NN	LTA
lead	VBP	lead
to	TO	to
β	AFX	β
-	HYPH	-
arrestin	NN	arrestin
-	HYPH	-
mediated	VBN	mediate
endocytosis	NN	endocytosis
of	IN	of
Ser349	NN	Ser349
-	HYPH	-
phosphorylated	VBN	phosphorylate
CCR5	NN	CCR5
into	IN	into
recycling	VBG	recycle
endosomes	NNS	endosome
,	,	,
as	IN	as
does	VBZ	do
CCL5	NN	CCL5
treatment	NN	treatment
.	SENT	.
.	SENT	.
However	RB	However
,	,	,
LTA	NN	LTA
-	HYPH	-
induced	VBN	induce
internalization	NN	internalization
of	IN	of
CCR5	NN	CCR5
is	VVZ	be
a	DT	a
slower	JJR	slow
process	NN	process
associated	VBN	associate
with	IN	with
phospholipase	NN	phospholipase
C-mediated	JJ	C-mediated
and	CC	and
phorbol	NN	phorbol
ester	NN	ester
-	HYPH	-
sensitive	JJ	sensitive
phosphorylation	NN	phosphorylation
.	SENT	.
.	SENT	.
Overall	RB	Overall
,	,	,
our	PP$	our
data	NNS	datum
indicate	VBP	indicate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
TLR2	NN	TLR2
negatively	RB	negatively
regulates	VBZ	regulate
CCR1	NN	CCR1
,	,	,
CCR2	NN	CCR2
,	,	,
and	CC	and
CCR5	NN	CCR5
on	IN	on
human	JJ	human
blood	NN	blood
monocytes	NNS	monocyte
by	IN	by
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
activating	VBG	activate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
machinery	NN	machinery
used	VBN	use
to	TO	to
support	VB	support
chemokine	NN	chemokine
-	HYPH	-
dependent	JJ	dependent
down	RB	down
-	HYPH	-
modulation	NN	modulation
and	CC	and
provide	VBP	provide
a	DT	a
molecular	JJ	molecular
mechanism	NN	mechanism
for	IN	for
inhibiting	VBG	inhibit
monocyte	NN	monocyte
migration	NN	migration
after	IN	after
pathogen	NN	pathogen
recognition	NN	recognition
.	SENT	.
.	SENT	.
BB-cat+ner-21270066/text	DOCUMENT	BB-cat+ner-21270066/text
Lymphogranuloma	NN	Lymphogranuloma
venereum	NN	venereum
presenting	VBG	present
as	IN	as
perianal	JJ	perianal
ulceration	NN	ulceration
:	COLUMN	:
an	DT	an
emerging	VBG	emerge
clinical	JJ	clinical
presentation	NN	presentation
?	SENT	?
.	SENT	.
An	DT	An
outbreak	NN	outbreak
of	IN	of
lymphogranuloma	NN	lymphogranuloma
venereum	NN	venereum
(	(	(
LGV	NN	LGV
)	)	)
infection	NN	infection
has	VHZ	have
been	VVN	be
recognised	VBN	recognise
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
UK	NN	UK
since	IN	since
2004	CD	2004
,	,	,
predominantly	RB	predominantly
affecting	VBG	affect
HIV	NN	HIV
-	HYPH	-
positive	JJ	positive
men	NNS	man
who	WP	who
have	VHP	have
sex	NN	sex
with	IN	with
men	NNS	man
(	(	(
MSM	NN	MSM
)	)	)
.	SENT	.
.	SENT	.
Patients	NNS	Patient
typically	RB	typically
present	VBP	present
with	IN	with
proctitis	NN	proctitis
symptoms	NNS	symptom
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
prevalence	NN	prevalence
of	IN	of
rectal	JJ	rectal
LGV	NN	LGV
in	IN	in
MSM	NN	MSM
attending	VBG	attend
sexually	RB	sexually
transmitted	VBN	transmit
infection	NN	infection
clinics	NNS	clinic
in	IN	in
London	NP	London
is	VVZ	be
estimated	VBN	estimate
at	IN	at
1%	NN	1%
.	SENT	.
.	SENT	.
Health	NP	Health
Protection	NP	Protection
Agency	NP	Agency
surveillance	NN	surveillance
has	VHZ	have
shown	VBN	show
a	DT	a
decrease	NN	decrease
in	IN	in
anorectal	JJ	anorectal
manifestations	NNS	manifestation
despite	IN	despite
little	JJ	little
demographic	JJ	demographic
change	NN	change
.	SENT	.
.	SENT	.
Two	CD	Two
cases	NNS	case
of	IN	of
HIV	NN	HIV
-	HYPH	-
infected	VBN	infect
patients	NNS	patient
presenting	VBG	present
with	IN	with
isolated	VBN	isolate
perianal	JJ	perianal
ulcer	NN	ulcer
disease	NN	disease
are	VVP	be
reported	VBN	report
here	RB	here
.	SENT	.
.	SENT	.
<FORBIDDEN ID=30 ACTION=delete>
Both	DT	Both
</FORBIDDEN ID=30 ACTION=delete>
cases	NNS	case
were	VVD	be
confirmed	VBN	confirm
to	TO	to
have	VH	have
rectal	JJ	rectal
Chlamydia	NP	Chlamydia
trachomatis	AFX	trachomatis
-	HYPH	-
specific	JJ	specific
DNA	NN	DNA
of	IN	of
an	DT	an
LGV	NN	LGV
associated	JJ	associated
serovar	NN	serovar
.	SENT	.
.	SENT	.
As	IN	As
presentations	NNS	presentation
of	IN	of
LGV	NN	LGV
diversify	VBP	diversify
,	,	,
<FORBIDDEN ID=79 ACTION=delete>
further	JJ	further
</FORBIDDEN ID=79 ACTION=delete>
education	NN	education
and	CC	and
surveillance	NN	surveillance
are	VVP	be
needed	VBN	need
<FORBIDDEN ID=27 ACTION=delete>
<FORBIDDEN ID=26 ACTION=delete>
in	IN	in
order	NN	order
to	TO	to
</FORBIDDEN ID=26 ACTION=delete>
</FORBIDDEN ID=27 ACTION=delete>
reduce	VB	reduce
transmission	NN	transmission
and	CC	and
prevent	VBP	prevent
long	JJ	long
-	HYPH	-
term	NN	term
complications	NNS	complication
.	SENT	.
.	SENT	.
A	DT	A
strong	JJ	strong
argument	NN	argument
already	RB	already
exists	VBZ	exist
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
incorporation	NN	incorporation
of	IN	of
chlamydia	NN	chlamydia
nucleic	JJ	nucleic
acid	NN	acid
amplification	NN	amplification
tests	NNS	test
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
management	NN	management
of	IN	of
MSM	NN	MSM
with	IN	with
proctitis	NN	proctitis
;	COLUMN	;
this	DT	this
paper	NN	paper
provides	VBZ	provide
evidence	NN	evidence
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
this	DT	this
should	MD	should
be	VV	be
extended	VBN	extend
to	TO	to
MSM	NN	MSM
with	IN	with
perianal	JJ	perianal
ulcer	NN	ulcer
disease	NN	disease
.	SENT	.
.	SENT	.
BB-cat+ner-21476570/text	DOCUMENT	BB-cat+ner-21476570/text
Absorption	NN	Absorption
linear	JJ	linear
dichroism	NN	dichroism
measured	VBN	measure
directly	RB	directly
on	IN	on
a	DT	a
single	JJ	single
light	NN	light
-	HYPH	-
harvesting	VBG	harvest
system	NN	system
:	COLUMN	:
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
role	NN	role
of	IN	of
disorder	NN	disorder
in	IN	in
chlorosomes	NNS	chlorosome
of	IN	of
green	JJ	green
photosynthetic	JJ	photosynthetic
bacteria	NNS	bacteria
.	SENT	.
.	SENT	.
Chlorosomes	NNS	Chlorosome
are	VVP	be
light	JJ	light
-	HYPH	-
harvesting	VBG	harvest
antennae	NNS	antenna
of	IN	of
photosynthetic	JJ	photosynthetic
bacteria	NNS	bacteria
containing	VBG	contain
large	JJ	large
numbers	NNS	number
of	IN	of
self	NN	self
-	HYPH	-
aggregated	VBN	aggregate
bacteriochlorophyll	NN	bacteriochlorophyll
(	(	(
BChl	NN	BChl
)	)	)
molecules	NNS	molecule
.	SENT	.
.	SENT	.
They	PP	They
have	VHP	have
developed	VBN	develop
unique	JJ	unique
photophysical	JJ	photophysical
properties	NNS	property
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
enable	VBP	enable
them	PP	them
to	TO	to
absorb	VB	absorb
light	NN	light
and	CC	and
transfer	VB	transfer
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
excitation	NN	excitation
energy	NN	energy
with	IN	with
very	RB	very
high	JJ	high
efficiency	NN	efficiency
.	SENT	.
.	SENT	.
However	RB	However
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
molecular	JJ	molecular
-	HYPH	-
level	NN	level
organization	NN	organization
,	,	,
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
produces	VBZ	produce
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
photophysical	JJ	photophysical
properties	NNS	property
of	IN	of
BChl	NN	BChl
molecules	NNS	molecule
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
aggregates	NNS	aggregate
,	,	,
is	VVZ	be
still	RB	still
not	RB	not
fully	RB	fully
understood	VBN	understand
.	SENT	.
.	SENT	.
<FORBIDDEN ID=55 ACTION=delete>
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
One	CD	One
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=55 ACTION=delete>
the	DT	the
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
reasons	NNS	reason
is	VVZ	be
heterogeneity	NN	heterogeneity
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
chlorosome	NN	chlorosome
structure	NN	structure
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
gives	VBZ	give
rise	NN	rise
to	TO	to
a	DT	a
hierarchy	NN	hierarchy
of	IN	of
structural	JJ	structural
and	CC	and
energy	NN	energy
disorder	NN	disorder
.	SENT	.
.	SENT	.
In	IN	In
this	DT	this
report	NN	report
,	,	,
we	PP	we
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
first	JJ	first
time	NN	time
directly	RB	directly
measure	VB	measure
absorption	NN	absorption
linear	JJ	linear
dichroism	NN	dichroism
(	(	(
LD	NN	LD
)	)	)
on	IN	on
individual	NN	individual
,	,	,
isolated	VBN	isolate
chlorosomes	NNS	chlorosome
.	SENT	.
.	SENT	.
<FORBIDDEN ID=158 ACTION=delete>
Together	RB	Together
</FORBIDDEN ID=158 ACTION=delete>
with	IN	with
fluorescence	NN	fluorescence
-	HYPH	-
detected	VBN	detect
three	CD	three
-	HYPH	-
dimensional	JJ	dimensional
LD	NN	LD
,	,	,
these	DT	these
experiments	NNS	experiment
reveal	VBP	reveal
a	DT	a
large	JJ	large
amount	NN	amount
of	IN	of
disorder	NN	disorder
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
single	JJ	single
-	HYPH	-
chlorosome	NN	chlorosome
level	NN	level
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
form	NN	form
of	IN	of
distributions	NNS	distribution
of	IN	of
LD	NN	LD
observables	NNS	observable
in	IN	in
chlorosomes	NNS	chlorosome
from	IN	from
wild	JJ	wild
-	HYPH	-
type	NN	type
bacterium	NN	bacterium
Chlorobaculum	NN	Chlorobaculum
tepidum	NN	tepidum
.	SENT	.
.	SENT	.
Fluorescence	NN	Fluorescence
spectral	JJ	spectral
parameters	NNS	parameter
,	,	,
<FORBIDDEN ID=17 ACTION=delete>
such	JJ	such
</FORBIDDEN ID=17 ACTION=delete>
as	IN	as
peak	JJ	peak
wavelength	NN	wavelength
and	CC	and
bandwidth	NN	bandwidth
,	,	,
are	VVP	be
measures	NNS	measure
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
aggregate	JJ	aggregate
excitonic	JJ	excitonic
properties	NNS	property
.	SENT	.
.	SENT	.
These	DT	These
parameters	NNS	parameter
obtained	VBN	obtain
on	IN	on
individual	JJ	individual
chlorosomes	NNS	chlorosome
are	VVP	be
uncorrelated	JJ	uncorrelated
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
observed	VBN	observe
LD	NN	LD
distributions	NNS	distribution
and	CC	and
indicate	VBP	indicate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
observed	VBN	observe
disorder	NN	disorder
is	VVZ	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
due	JJ	due
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
inner	JJ	inner
structural	JJ	structural
disorder	NN	disorder
along	IN	along
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
chlorosome	NN	chlorosome
long	JJ	long
axis	NN	axis
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
excitonic	JJ	excitonic
disorder	NN	disorder
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
is	VVZ	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
present	JJ	present
is	VVZ	be
not	RB	not
manifested	VBN	manifest
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
LD	NN	LD
distributions	NNS	distribution
.	SENT	.
.	SENT	.
Limiting	VBG	Limit
values	NNS	value
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
LD	NN	LD
parameter	NN	parameter
distributions	NNS	distribution
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
are	VVP	be
relatively	RB	relatively
free	JJ	free
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
effect	NN	effect
of	IN	of
structural	JJ	structural
disorder	NN	disorder
,	,	,
define	VB	define
a	DT	a
range	NN	range
of	IN	of
angles	NNS	angle
at	IN	at
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=36 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
excitonic	JJ	excitonic
dipole	NN	dipole
moment	NN	moment
is	VVZ	be
oriented	VBN	orient
with	IN	with
<FORBIDDEN ID=58 ACTION=delete>
respect	NN	respect
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=58 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
surface	NN	surface
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
two-dimensional	JJ	two-dimensional
aggregate	NN	aggregate
of	IN	of
BChl	NN	BChl
molecules	NNS	molecule
.	SENT	.
.	SENT	.
Experiments	NNS	Experiment
on	IN	on
chlorosomes	NNS	chlorosome
of	IN	of
a	DT	a
triple	JJ	triple
mutant	NN	mutant
of	IN	of
Chlorobaculum	NN	Chlorobaculum
tepidum	NN	tepidum
show	VBP	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
mutant	JJ	mutant
chlorosomes	NNS	chlorosome
have	VHP	have
significantly	RB	significantly
less	RBR	less
inner	JJ	inner
structural	JJ	structural
disorder	NN	disorder
and	CC	and
higher	JJR	high
symmetry	NN	symmetry
,	,	,
compatible	JJ	compatible
with	IN	with
a	DT	a
model	NN	model
of	IN	of
well	RB	well
-	HYPH	-
ordered	VBN	order
concentric	JJ	concentric
cylinders	NNS	cylinder
.	SENT	.
.	SENT	.
Different	JJ	Different
values	NNS	value
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
transition	NN	transition
dipole	NN	dipole
moment	NN	moment
orientations	NNS	orientation
are	VVP	be
consistent	JJ	consistent
with	IN	with
a	DT	a
different	JJ	different
molecular	JJ	molecular
level	NN	level
organization	NN	organization
of	IN	of
BChl's	NNS	BChl'
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
mutant	JJ	mutant
and	CC	and
wild	JJ	wild
-	HYPH	-
type	NN	type
chlorosomes	NNS	chlorosome
.	SENT	.
.	SENT	.
BB-cat+ner-21498521/text	DOCUMENT	BB-cat+ner-21498521/text
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
lipid	NN	lipid
A	NN	A
from	IN	from
Vibrio	NP	Vibrio
fischeri	NP	fischeri
lipopolysaccharide	NN	lipopolysaccharide
:	COLUMN	:
a	DT	a
unique	JJ	unique
structure	NN	structure
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
bearing	VBG	bear
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
phosphoglycerol	NN	phosphoglycerol
moiety	NN	moiety
.	SENT	.
.	SENT	.
Vibrio	NP	Vibrio
fischeri	NP	fischeri
,	,	,
a	DT	a
bioluminescent	JJ	bioluminescent
marine	JJ	marine
bacterium	NN	bacterium
,	,	,
exists	VBZ	exist
in	IN	in
an	DT	an
exclusive	JJ	exclusive
symbiotic	JJ	symbiotic
relationship	NN	relationship
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Hawaiian	JJ	Hawaiian
bobtail	NN	bobtail
squid	NN	squid
,	,	,
Euprymna	NP	Euprymna
scolopes	NNS	scolope
,	,	,
whose	WP$	whose
light	JJ	light
organ	NN	organ
it	PP	it
colonizes	VBZ	colonize
.	SENT	.
.	SENT	.
Previously	RB	Previously
,	,	,
it	PP	it
has	VHZ	have
been	VVN	be
shown	VBN	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
lipopolysaccharide	NN	lipopolysaccharide
(	(	(
LPS	NN	LPS
)	)	)
or	CC	or
free	JJ	free
lipid	NN	lipid
A	NN	A
of	IN	of
V	NN	V
.	SENT	.
fischeri	NNS	fischeri
can	MD	can
trigger	VB	trigger
morphological	JJ	morphological
changes	NNS	change
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
juvenile	JJ	juvenile
squid's	NNS	squid'
light	NN	light
organ	NN	organ
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
occur	VBP	occur
upon	IN	upon
colonization	NN	colonization
.	SENT	.
.	SENT	.
To	TO	To
investigate	VB	investigate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
structural	JJ	structural
features	NNS	feature
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
might	MD	might
be	VV	be
responsible	JJ	responsible
for	IN	for
this	DT	this
phenomenon	NN	phenomenon
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
lipid	NN	lipid
A	NN	A
from	IN	from
V	NN	V
.	SENT	.
fischeri	``	fischeri
ES114	NN	ES114
LPS	NN	LPS
was	VVD	be
isolated	VBN	isolate
and	CC	and
characterized	VBN	characterize
by	IN	by
multistage	JJ	multistage
mass	NN	mass
spectrometry	NN	spectrometry
(MS(n))	NN	(MS(n))
.	SENT	.
.	SENT	.
A	DT	A
microheterogeneous	JJ	microheterogeneous
mixture	NN	mixture
of	IN	of
mono	AFX	mono
-	HYPH	-
and	CC	and
diphosphorylated	VBN	diphosphorylate
diglucosamine	NN	diglucosamine
disaccharides	NNS	disaccharide
was	VVD	be
observed	VBN	observe
with	IN	with
variable	JJ	variable
states	NNS	state
of	IN	of
acylation	NN	acylation
ranging	VBG	range
from	IN	from
tetra	AFX	tetra
-	HYPH	-
to	TO	to
octaacylated	VBN	octaacylate
forms	NNS	form
.	SENT	.
.	SENT	.
All	DT	All
lipid	NN	lipid
A	NN	A
species	NNS	specie
,	,	,
however	RB	however
,	,	,
contained	VBD	contain
a	DT	a
set	NN	set
of	IN	of
conserved	VBN	conserve
primary	JJ	primary
acyl	NN	acyl
chains	NNS	chain
consisting	VBG	consist
of	IN	of
an	DT	an
N-linked	JJ	N-linked
C14	NN	C14
:	COLUMN	:
0(3	CD	0(3
-	HYPH	-
OH	NN	OH
)	)	)
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
2-position	NN	2-position
,	,	,
an	DT	an
unusual	JJ	unusual
N-linked	JJ	N-linked
C14	NN	C14
:	COLUMN	:
1(3	CD	1(3
-	HYPH	-
OH	NN	OH
)	)	)
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
2'	NN	2'
-	HYPH	-
position	NN	position
,	,	,
and	CC	and
two	CD	two
O-linked	JJ	O-linked
C12	NN	C12
:	COLUMN	:
0(3	CD	0(3
-	HYPH	-
OH	NN	OH
)	)	)
fatty	JJ	fatty
acids	NNS	acid
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
3- and	JJ	3-_and
3'	JJ	3'
-	HYPH	-
positions	NNS	position
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
fatty	JJ	fatty
acids	NNS	acid
found	VBN	find
in	IN	in
secondary	JJ	secondary
acylation	NN	acylation
were	VVD	be
considerably	RB	considerably
<FORBIDDEN ID=82 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
variable	JJ	variable
,	,	,
with	IN	with
either	CC	either
a	DT	a
C12	NN	C12
:	COLUMN	:
0	CD	0
or	CC	or
C16	NN	C16
:	COLUMN	:
1	CD	1
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
2-position	NN	2-position
,	,	,
C14	NN	C14
:	COLUMN	:
0	CD	0
or	CC	or
C14	NN	C14
:	COLUMN	:
0(3	CD	0(3
-	HYPH	-
OH	NN	OH
)	)	)
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
2'	NN	2'
-	HYPH	-
position	NN	position
,	,	,
and	CC	and
C12	NN	C12
:	COLUMN	:
0	CD	0
or	CC	or
no	DT	no
substituent	NN	substituent
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
3'	JJ	3'
-	HYPH	-
position	NN	position
.	SENT	.
.	SENT	.
Most	JJS	Most
surprising	NN	surprising
was	VVD	be
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
an	DT	an
unusual	JJ	unusual
set	NN	set
of	IN	of
modifications	NNS	modification
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
secondary	JJ	secondary
acylation	NN	acylation
site	NN	site
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
3-position	NN	3-position
consisting	VBG	consist
of	IN	of
phosphoglycerol	NN	phosphoglycerol
(	(	(
GroP	NN	GroP
)	)	)
,	,	,
lysophosphatidic	JJ	lysophosphatidic
acid	NN	acid
(	(	(
GroP	NN	GroP
bearing	NN	bearing
C12	NN	C12
:	COLUMN	:
0	CD	0
,	,	,
C16	NN	C16
:	COLUMN	:
0	CD	0
,	,	,
or	CC	or
C16	NN	C16
:	COLUMN	:
1	LS	1
)	)	)
,	,	,
or	CC	or
phosphatidic	JJ	phosphatidic
acid	NN	acid
(	(	(
GroP	NN	GroP
bearing	VBG	bear
either	CC	either
C16	NN	C16
:	COLUMN	:
0	CD	0
+	JJ	+
C12	NN	C12
:	COLUMN	:
0	CD	0
or	CC	or
C16	NN	C16
:	COLUMN	:
0	CD	0
+	JJ	+
C16	NN	C16
:	COLUMN	:
1	LS	1
)	)	)
.	SENT	.
.	SENT	.
Given	VBN	Give
their	PP$	their
unusual	JJ	unusual
nature	NN	nature
,	,	,
it	PP	it
is	VVZ	be
possible	JJ	possible
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
these	DT	these
features	NNS	feature
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
V	NP	V
.	SENT	.
fischeri	``	fischeri
lipid	NN	lipid
A	NN	A
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
underlie	VB	underlie
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
ability	NN	ability
of	IN	of
E	NN	E
.	SENT	.
scolopes	NNS	scolope
to	TO	to
recognize	VB	recognize
its	PP$	its
symbiotic	JJ	symbiotic
partner	NN	partner
.	SENT	.
.	SENT	.
BB-cat+ner-21511409/text	DOCUMENT	BB-cat+ner-21511409/text
Molecular	JJ	Molecular
epidemiology	NN	epidemiology
of	IN	of
Pasteurella	NP	Pasteurella
multocida	NP	multocida
in	IN	in
dairy	NN	dairy
and	CC	and
beef	NN	beef
calves	NNS	calf
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
molecular	JJ	molecular
epidemiology	NN	epidemiology
of	IN	of
Pasteurella	NP	Pasteurella
multocida	NP	multocida
has	VHZ	have
rarely	RB	rarely
been	VVN	be
studied	VBN	study
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
farm	NN	farm
level	NN	level
in	IN	in
cattle	NNS	cattle
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
aim	NN	aim
of	IN	of
this	DT	this
study	NN	study
was	VVD	be
to	TO	to
determine	VB	determine
whether	IN	whether
single	JJ	single
or	CC	or
multiple	JJ	multiple
strains	NNS	strain
of	IN	of
P	NN	P
.	SENT	.
multocida	NN	multocida
tend	VBP	tend
to	TO	to
exist	VB	exist
within	IN	within
farms	NNS	farm
.	SENT	.
.	SENT	.
Molecular	JJ	Molecular
characterisation	NN	characterisation
was	VVD	be
carried	VBN	carry
out	RP	out
on	IN	on
isolates	NNS	isolate
obtained	VBN	obtain
from	IN	from
nasal	JJ	nasal
swabs	NNS	swab
from	IN	from
105	CD	105
calves	NNS	calf
from	IN	from
32	CD	32
randomly	RB	randomly
selected	VBN	select
beef	NN	beef
and	CC	and
dairy	NN	dairy
farms	NNS	farm
located	JJ	located
throughout	IN	throughout
Scotland	NP	Scotland
,	,	,
and	CC	and
from	IN	from
131	CD	131
calves	NNS	calf
from	IN	from
20	CD	20
farms	NNS	farm
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Mayenne	NP	Mayenne
region	NN	region
of	IN	of
France	NP	France
,	,	,
where	WRB	where
sampling	NN	sampling
occurred	VBD	occur
<FORBIDDEN ID=27 ACTION=delete>
<FORBIDDEN ID=26 ACTION=delete>
in	IN	in
response	NN	response
to	TO	to
</FORBIDDEN ID=26 ACTION=delete>
</FORBIDDEN ID=27 ACTION=delete>
respiratory	JJ	respiratory
disease	NN	disease
outbreaks	NNS	outbreak
.	SENT	.
.	SENT	.
P	NN	P
.	SENT	.
multocida	JJ	multocida
isolates	NNS	isolate
were	VVD	be
characterised	VBN	characterise
by	IN	by
random	NN	random
-	HYPH	-
amplified	VBN	amplify
polymorphic	JJ	polymorphic
DNA	NN	DNA
(	(	(
RAPD	NN	RAPD
)	)	)
typing	NN	typing
and	CC	and
pulsed	JJ	pulsed
-	HYPH	-
field	NN	field
gel	NN	gel
electrophoresis	NN	electrophoresis
(	(	(
PFGE	NN	PFGE
)	)	)
using	VBG	use
restriction	NN	restriction
enzyme	NN	enzyme
ApaI	NN	ApaI
.	SENT	.
.	SENT	.
In	IN	In
addition	NN	addition
,	,	,
isolates	VBZ	isolate
representative	NN	representative
of	IN	of
each	DT	each
farm	NN	farm
/	SYM	/
RAPD	NN	RAPD
profile	NN	profile
combination	NN	combination
were	VVD	be
typed	VBN	type
by	IN	by
multilocus	JJ	multilocus
sequence	NN	sequence
typing	NN	typing
(	(	(
MLST	NN	MLST
)	)	)
.	SENT	.
.	SENT	.
Among	IN	Among
105	CD	105
Scottish	JJ	Scottish
isolates	NNS	isolate
,	,	,
15	CD	15
RAPD	NN	RAPD
profiles	NNS	profile
were	VVD	be
distinguished	VBN	distinguish
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
majority	NN	majority
of	IN	of
farms	NNS	farm
(	(	(
27/32	CD	27/32
)	)	)
had	VHD	have
indistinguishable	JJ	indistinguishable
profiles	NNS	profile
in	IN	in
all	DT	all
positive	JJ	positive
animals	NNS	animal
.	SENT	.
.	SENT	.
Five	CD	Five
farms	NNS	farm
had	VHD	have
two	CD	two
profiles	NNS	profile
.	SENT	.
.	SENT	.
Among	IN	Among
140	CD	140
French	JJ	French
isolates	NNS	isolate
,	,	,
23	CD	23
RAPD	NN	RAPD
profiles	NNS	profile
were	VVD	be
distinguished	VBN	distinguish
.	SENT	.
.	SENT	.
<FORBIDDEN ID=82 ACTION=delete>
More	JJR	More
</FORBIDDEN ID=82 ACTION=delete>
within	IN	within
-	HYPH	-
farm	NN	farm
heterogeneity	NN	heterogeneity
was	VVD	be
observed	VBN	observe
although	IN	although
10/20	CD	10/20
farms	NNS	farm
had	VHD	have
just	RB	just
one	CD	one
profile	NN	profile
(	(	(
E4	NN	E4
)	)	)
in	IN	in
sampled	VBN	sample
calves	NNS	calf
.	SENT	.
.	SENT	.
Profile	NN	Profile
E4	NN	E4
accounted	VBD	account
for	IN	for
60%	CD	60%
(	(	(
84/140	CD	84/140
)	)	)
of	IN	of
French	JJ	French
isolates	NNS	isolate
.	SENT	.
.	SENT	.
PFGE	NN	PFGE
was	VVD	be
<FORBIDDEN ID=82 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
discriminatory	JJ	discriminatory
than	IN	than
RAPD	NN	RAPD
but	CC	but
confirmed	VBD	confirm
results	NNS	result
with	IN	with
<FORBIDDEN ID=58 ACTION=delete>
respect	NN	respect
to	TO	to
</FORBIDDEN ID=58 ACTION=delete>
within	IN	within
farm	NN	farm
homogeneity	NN	homogeneity
or	CC	or
heterogeneity	NN	heterogeneity
of	IN	of
strains	NNS	strain
,	,	,
whereas	IN	whereas
MLST	NN	MLST
was	VVD	be
not	RB	not
discriminatory	JJ	discriminatory
enough	RB	enough
for	IN	for
farm	NN	farm
level	NN	level
epidemiology	NN	epidemiology
.	SENT	.
.	SENT	.
As	IN	As
in	IN	in
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
host	NN	host
species	NNS	specie
,	,	,
either	CC	either
several	JJ	several
strains	NNS	strain
or	CC	or
one	CD	one
dominant	JJ	dominant
strain	NN	strain
of	IN	of
P	NN	P
.	SENT	.
multocida	NN	multocida
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
exist	VB	exist
within	IN	within
farms	NNS	farm
,	,	,
with	IN	with
evidence	NN	evidence
for	IN	for
a	DT	a
role	NN	role
of	IN	of
management	NN	management
factors	NNS	factor
<FORBIDDEN ID=17 ACTION=delete>
such	JJ	such
</FORBIDDEN ID=17 ACTION=delete>
as	IN	as
movements	NNS	movement
onto	IN	onto
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
farm	NN	farm
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
number	NN	number
of	IN	of
strains	NNS	strain
detected	VBN	detect
.	SENT	.
.	SENT	.
BB-cat+ner-21543877/text	DOCUMENT	BB-cat+ner-21543877/text
Cloning	NN	Cloning
,	,	,
expression	NN	expression
,	,	,
purification	NN	purification
,	,	,
crystallization	NN	crystallization
and	CC	and
X-ray	NN	X-ray
crystallographic	JJ	crystallographic
analysis	NN	analysis
of	IN	of
Rv3168	NN	Rv3168
from	IN	from
Mycobacterium	NN	Mycobacterium
tuberculosis	NN	tuberculosis
H37Rv	NN	H37Rv
.	SENT	.
.	SENT	.
Tuberculosis	NN	Tuberculosis
is	VVZ	be
a	DT	a
widespread	JJ	widespread
and	CC	and
deadly	JJ	deadly
infectious	JJ	infectious
disease	NN	disease
,	,	,
with	IN	with
one	CD	one
third	NN	third
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
human	JJ	human
population	NN	population
already	RB	already
being	VVG	be
infected	VBN	infect
.	SENT	.
.	SENT	.
Aminoglycoside	NN	Aminoglycoside
antibiotics	NNS	antibiotic
have	VHP	have
become	VBN	become
less	RBR	less
effective	JJ	effective
in	IN	in
recent	JJ	recent
years	NNS	year
<FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
owing	VBG	owe
to	TO	to
</FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
antibiotic	JJ	antibiotic
resistance	NN	resistance
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
arises	VBZ	arise
primarily	RB	primarily
through	IN	through
enzymatic	JJ	enzymatic
modification	NN	modification
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
antibiotics	NNS	antibiotic
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
gene	NN	gene
product	NN	product
Rv3168	NN	Rv3168
,	,	,
a	DT	a
putative	JJ	putative
aminoglycoside	NN	aminoglycoside
phosphotransferase	NN	phosphotransferase
(	(	(
APH	NN	APH
)	)	)
,	,	,
from	IN	from
Mycobacterium	NN	Mycobacterium
tuberculosis	NN	tuberculosis
was	VVD	be
crystallized	VBN	crystallize
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
using	VBG	use
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
sitting	VBG	sit
-	HYPH	-
drop	NN	drop
vapour	NN	vapour
-	HYPH	-
diffusion	NN	diffusion
method	NN	method
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
0.2	CD	0.2
M	NN	M
calcium	NN	calcium
acetate	NN	acetate
,	,	,
0.1	CD	0.1
M	NN	M
Tris	NN	Tris
-	HYPH	-
HCl	NN	HCl
pH	NN	pH
7.0	CD	7.0
and	CC	and
20%	CD	20%
PEG	NN	PEG
3000	CD	3000
at	IN	at
295	CD	295
K	NN	K
.	SENT	.
.	SENT	.
X-ray	NN	X-ray
diffraction	NN	diffraction
data	NNS	datum
were	VVD	be
collected	VBN	collect
to	TO	to
a	DT	a
maximum	NN	maximum
resolution	NN	resolution
of	IN	of
1.67	CD	1.67
Å	NN	Å
on	IN	on
a	DT	a
synchrotron	NN	synchrotron
beamline	NN	beamline
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
crystal	NN	crystal
belonged	VBD	belong
to	TO	to
space	VB	space
group	NN	group
P2(1)2(1)2(1)	NN	P2(1)2(1)2(1)
,	,	,
with	IN	with
unit	NN	unit
-	HYPH	-
cell	NN	cell
<FORBIDDEN ID=1 ACTION=split SPLIT_AFTER=0>
parameters	NNS	parameter
a	DT	a
</FORBIDDEN ID=1 ACTION=split SPLIT_AFTER=0>
=	JJ	=
56.74	CD	56.74
,	,	,
b	NN	b
=	SYM	=
62.37	CD	62.37
,	,	,
c	NN	c
=	SYM	=
103.61	CD	103.61
Å	NN	Å
.	SENT	.
.	SENT	.
With	IN	With
one	CD	one
molecule	NN	molecule
per	IN	per
asymmetric	JJ	asymmetric
unit	NN	unit
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
crystal	JJ	crystal
volume	NN	volume
per	IN	per
unit	NN	unit
protein	NN	protein
weight	NN	weight
(V(M))	NN	(V(M))
is	VVZ	be
2.91	CD	2.91
Å(3)	NN	Å(3)
Da	NN	Da
(	(	(
-1	CD	-1
)	)	)
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
structure	NN	structure
was	VVD	be
solved	VBN	solve
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
single	JJ	single
-	HYPH	-
wavelength	NN	wavelength
anomalous	JJ	anomalous
dispersion	NN	dispersion
method	NN	method
and	CC	and
refinement	NN	refinement
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
selenomethionine	NN	selenomethionine
structure	NN	structure
is	VVZ	be
in	IN	in
progress	NN	progress
.	SENT	.
.	SENT	.
BB-cat+ner-21695078/text	DOCUMENT	BB-cat+ner-21695078/text
Enhanced	VBN	Enhance
virulence	NN	virulence
of	IN	of
Chlamydia	NN	Chlamydia
muridarum	NN	muridarum
respiratory	JJ	respiratory
infections	NNS	infection
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
absence	NN	absence
of	IN	of
TLR2	NN	TLR2
activation	NN	activation
.	SENT	.
.	SENT	.
Chlamydia	NN	Chlamydia
trachomatis	NN	trachomatis
is	VVZ	be
a	DT	a
common	JJ	common
sexually	RB	sexually
transmitted	VBN	transmit
pathogen	NN	pathogen
and	CC	and
is	VVZ	be
associated	VBN	associate
with	IN	with
infant	NN	infant
pneumonia	NN	pneumonia
.	SENT	.
.	SENT	.
Data	NNS	Datum
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
female	JJ	female
mouse	NN	mouse
model	NN	model
of	IN	of
genital	JJ	genital
tract	NN	tract
chlamydia	NN	chlamydia
infection	NN	infection
suggests	VBZ	suggest
a	DT	a
requirement	NN	requirement
for	IN	for
TLR2	NN	TLR2
-	HYPH	-
dependent	JJ	dependent
signaling	NN	signaling
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
induction	NN	induction
of	IN	of
inflammation	NN	inflammation
and	CC	and
oviduct	NN	oviduct
pathology	NN	pathology
.	SENT	.
.	SENT	.
We	PP	We
hypothesized	VBD	hypothesize
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
role	NN	role
of	IN	of
TLR2	NN	TLR2
in	IN	in
moderating	VBG	moderate
mucosal	JJ	mucosal
inflammation	NN	inflammation
is	VVZ	be
site	NN	site
specific	JJ	specific
.	SENT	.
.	SENT	.
<FORBIDDEN ID=27 ACTION=delete>
<FORBIDDEN ID=26 ACTION=delete>
In	IN	In
order	NN	order
to	TO	to
</FORBIDDEN ID=26 ACTION=delete>
</FORBIDDEN ID=27 ACTION=delete>
investigate	VB	investigate
this	DT	this
,	,	,
we	PP	we
infected	VBD	infect
mice	NNS	mouse
via	IN	via
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
intranasal	JJ	intranasal
route	NN	route
with	IN	with
C	NN	C
.	SENT	.
muridarum	NN	muridarum
and	CC	and
observed	VBD	observe
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
absence	NN	absence
of	IN	of
TLR2	NN	TLR2
activation	NN	activation
,	,	,
mice	NNS	mouse
had	VHD	have
<FORBIDDEN ID=82 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
severe	JJ	severe
disease	NN	disease
,	,	,
higher	JJR	high
lung	NN	lung
cytokine	NN	cytokine
levels	NNS	level
,	,	,
and	CC	and
an	DT	an
exaggerated	JJ	exaggerated
influx	NN	influx
of	IN	of
neutrophils	NNS	neutrophil
and	CC	and
T-cells	NNS	T-cell
into	IN	into
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
lungs	NNS	lung
.	SENT	.
.	SENT	.
This	DT	This
could	MD	could
not	RB	not
be	VV	be
explained	VBN	explain
by	IN	by
impaired	JJ	impaired
bacterial	JJ	bacterial
clearance	NN	clearance
as	IN	as
TLR2	NN	TLR2
-	HYPH	-
deficient	JJ	deficient
mice	NNS	mouse
cleared	VBD	clear
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
infection	NN	infection
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
similar	JJ	similar
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
controls	NNS	control
.	SENT	.
.	SENT	.
These	DT	These
data	NNS	datum
suggest	VBP	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
TLR2	NN	TLR2
has	VHZ	have
an	DT	an
anti	AFX	anti
-	HYPH	-
inflammatory	JJ	inflammatory
function	NN	function
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
lung	NN	lung
during	IN	during
Chlamydia	NN	Chlamydia
infection	NN	infection
,	,	,
and	CC	and
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
role	NN	role
of	IN	of
TLR2	NN	TLR2
in	IN	in
mucosal	JJ	mucosal
inflammation	NN	inflammation
varies	VBZ	vary
at	IN	at
different	JJ	different
mucosal	JJ	mucosal
surfaces	NNS	surface
.	SENT	.
.	SENT	.
BB-cat+ner-21894542/text	DOCUMENT	BB-cat+ner-21894542/text
Iron	NN	Iron
transport	NN	transport
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
genus	NN	genus
Marinobacter	NP	Marinobacter
.	SENT	.
.	SENT	.
Marinobacter	NP	Marinobacter
belong	VBP	belong
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
class	NN	class
of	IN	of
Gammaproteobacteria	NNS	Gammaproteobacteria
and	CC	and
these	DT	these
motile	NN	motile
,	,	,
halophilic	JJ	halophilic
or	CC	or
halotolerent	JJ	halotolerent
bacteria	NNS	bacteria
are	VVP	be
widely	RB	widely
distributed	VBN	distribute
throughout	IN	throughout
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
world's	NNS	world'
oceans	NNS	ocean
having	VHG	have
been	VVN	be
isolated	VBN	isolate
from	IN	from
a	DT	a
wide	JJ	wide
<FORBIDDEN ID=57 ACTION=delete>
variety	NN	variety
of	IN	of
</FORBIDDEN ID=57 ACTION=delete>
marine	JJ	marine
environments	NNS	environment
.	SENT	.
.	SENT	.
They	PP	They
have	VHP	have
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
been	VVN	be
identified	VBN	identify
as	IN	as
members	NNS	member
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bacterial	JJ	bacterial
flora	NN	flora
associated	VBN	associate
with	IN	with
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
marine	JJ	marine
organisms	NNS	organism
.	SENT	.
.	SENT	.
Here	RB	Here
,	,	,
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
using	VBG	use
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
combination	NN	combination
of	IN	of
natural	JJ	natural
products	NNS	product
chemistry	NN	chemistry
and	CC	and
genomic	JJ	genomic
analysis	NN	analysis
,	,	,
we	PP	we
assess	VBP	assess
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
nature	NN	nature
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
siderophores	NNS	siderophore
produced	VBN	produce
by	IN	by
this	DT	this
genus	NN	genus
and	CC	and
their	PP$	their
potential	JJ	potential
relationship	NN	relationship
to	TO	to
phylogeny	NN	phylogeny
and	CC	and
lifestyle	NN	lifestyle
/	SYM	/
ecological	JJ	ecological
niche	NN	niche
of	IN	of
this	DT	this
diverse	JJ	diverse
group	NN	group
of	IN	of
organisms	NNS	organism
.	SENT	.
.	SENT	.
Our	PP$	Our
analysis	NN	analysis
shows	VBZ	show
a	DT	a
wide	JJ	wide
level	NN	level
of	IN	of
diversity	NN	diversity
in	IN	in
siderophore	NN	siderophore
based	JJ	based
iron	NN	iron
uptake	NN	uptake
systems	NNS	system
among	IN	among
this	DT	this
genus	NN	genus
with	IN	with
three	CD	three
general	JJ	general
strategies	NNS	strategy
:	COLUMN	:
(	(	(
1	LS	1
)	)	)
production	NN	production
and	CC	and
utilization	NN	utilization
of	IN	of
native	JJ	native
siderophores	NNS	siderophore
<FORBIDDEN ID=27 ACTION=delete>
<FORBIDDEN ID=26 ACTION=delete>
in	IN	in
addition	NN	addition
to	TO	to
</FORBIDDEN ID=26 ACTION=delete>
</FORBIDDEN ID=27 ACTION=delete>
utilization	NN	utilization
of	IN	of
a	DT	a
<FORBIDDEN ID=57 ACTION=delete>
variety	NN	variety
of	IN	of
</FORBIDDEN ID=57 ACTION=delete>
exogenous	JJ	exogenous
ones	NNS	one
,	,	,
(	(	(
2	LS	2
)	)	)
production	NN	production
and	CC	and
utilization	NN	utilization
of	IN	of
native	JJ	native
siderophores	NNS	siderophore
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
,	,	,
(	(	(
3	LS	3
)	)	)
lack	NN	lack
of	IN	of
siderophore	NN	siderophore
production	NN	production
but	CC	but
utilization	NN	utilization
of	IN	of
exogenous	JJ	exogenous
ones	NNS	one
.	SENT	.
.	SENT	.
They	PP	They
all	DT	all
share	VBP	share
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
at	IN	at
<FORBIDDEN ID=18 ACTION=delete>
least	JJS	least
</FORBIDDEN ID=18 ACTION=delete>
one	CD	one
siderophore	NN	siderophore
-	HYPH	-
independent	JJ	independent
iron	NN	iron
uptake	NN	uptake
ABC	NN	ABC
transport	NN	transport
systems	NNS	system
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
FbpABC	NP	FbpABC
iron	NN	iron
metal	NN	metal
type	NN	type
and	CC	and
lack	VBP	lack
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
ability	NN	ability
for	IN	for
direct	JJ	direct
transport	NN	transport
of	IN	of
ferrous	JJ	ferrous
iron	NN	iron
.	SENT	.
.	SENT	.
Siderophore	NN	Siderophore
production	NN	production
and	CC	and
utilization	NN	utilization
can	MD	can
be	VV	be
correlated	VBN	correlate
with	IN	with
phylogeny	NN	phylogeny
and	CC	and
thus	RB	thus
it	PP	it
forms	VBZ	form
a	DT	a
type	NN	type
of	IN	of
chemotaxonomic	JJ	chemotaxonomic
marker	NN	marker
for	IN	for
this	DT	this
genus	NN	genus
.	SENT	.
.	SENT	.
BB-cat+ner-21917915/text	DOCUMENT	BB-cat+ner-21917915/text
Structural	JJ	Structural
basis	NN	basis
for	IN	for
hemoglobin	NN	hemoglobin
capture	NN	capture
by	IN	by
Staphylococcus	FW	Staphylococcus
aureus	FW	aureus
cell	NN	cell
-	HYPH	-
surface	NN	surface
protein	NN	protein
,	,	,
IsdH	NN	IsdH
.	SENT	.
.	SENT	.
Pathogens	NNS	Pathogen
must	MD	must
steal	VB	steal
iron	NN	iron
from	IN	from
their	PP$	their
hosts	NNS	host
to	TO	to
establish	VB	establish
infection	NN	infection
.	SENT	.
.	SENT	.
In	IN	In
mammals	NNS	mammal
,	,	,
hemoglobin	NN	hemoglobin
(	(	(
Hb	NN	Hb
)	)	)
represents	VBZ	represent
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
largest	JJS	large
reservoir	NN	reservoir
of	IN	of
iron	NN	iron
,	,	,
and	CC	and
pathogens	NNS	pathogen
express	VBP	express
Hb-binding	JJ	Hb-binding
proteins	NNS	protein
to	TO	to
access	VB	access
this	DT	this
source	NN	source
.	SENT	.
.	SENT	.
Here	RB	Here
,	,	,
we	PP	we
show	VBP	show
how	WRB	how
<FORBIDDEN ID=55 ACTION=delete>
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
one	CD	one
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=55 ACTION=delete>
the	DT	the
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
commonest	NN	commonest
and	CC	and
most	RBS	most
significant	JJ	significant
human	JJ	human
pathogens	NNS	pathogen
,	,	,
Staphylococcus	NP	Staphylococcus
aureus	NP	aureus
,	,	,
captures	NNS	capture
Hb	VBP	Hb
as	IN	as
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
first	JJ	first
step	NN	step
of	IN	of
an	DT	an
iron	NN	iron
-	HYPH	-
scavenging	VBG	scavenge
pathway	NN	pathway
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
x-ray	NN	x-ray
crystal	NN	crystal
structure	NN	structure
of	IN	of
Hb	NN	Hb
bound	VBD	bind
to	TO	to
a	DT	a
domain	NN	domain
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Isd	NN	Isd
(	(	(
iron	NN	iron
-	HYPH	-
regulated	VBN	regulate
surface	NN	surface
determinant	NN	determinant
)	)	)
protein	NN	protein
,	,	,
IsdH	NN	IsdH
,	,	,
is	VVZ	be
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
first	JJ	first
structure	NN	structure
of	IN	of
a	DT	a
Hb	NN	Hb
capture	NN	capture
complex	NN	complex
to	TO	to
be	VV	be
determined	VBN	determine
.	SENT	.
.	SENT	.
Surface	NN	Surface
mutations	NNS	mutation
in	IN	in
Hb	NN	Hb
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
reduce	VBP	reduce
<FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
binding	VBG	bind
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Hb-receptor	NN	Hb-receptor
limit	VBP	limit
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
capacity	NN	capacity
of	IN	of
S	NN	S
.	SENT	.
aureus	NN	aureus
to	TO	to
utilize	VB	utilize
Hb	NN	Hb
as	IN	as
an	DT	an
iron	NN	iron
source	NN	source
,	,	,
suggesting	VBG	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
Hb	NN	Hb
sequence	NN	sequence
is	VVZ	be
a	DT	a
factor	NN	factor
in	IN	in
host	NN	host
susceptibility	NN	susceptibility
to	TO	to
infection	NN	infection
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
demonstration	NN	demonstration
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
pathogens	NNS	pathogen
make	VBP	make
highly	RB	highly
specific	JJ	specific
recognition	NN	recognition
complexes	NNS	complex
with	IN	with
Hb	NN	Hb
raises	VBZ	raise
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
possibility	NN	possibility
of	IN	of
developing	VBG	develop
inhibitors	NNS	inhibitor
of	IN	of
Hb	NN	Hb
binding	NN	binding
as	IN	as
antibacterial	JJ	antibacterial
agents	NNS	agent
.	SENT	.
.	SENT	.
BB-cat+ner-21924022/text	DOCUMENT	BB-cat+ner-21924022/text
[	(	[
Value	NN	Value
of	IN	of
protein	NN	protein
array	NN	array
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
diagnosis	NN	diagnosis
of	IN	of
Helicobactor	NN	Helicobactor
pylori	NN	pylori
infection	NN	infection
in	IN	in
children	NNS	child
]	)	]
.	SENT	.
.	SENT	.
To	TO	To
study	VB	study
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
value	NN	value
of	IN	of
multiple	JJ	multiple
Helicobacter	NN	Helicobacter
pylori	NN	pylori
(	(	(
H	NN	H
.	NN	.
pylori	NN	pylori
)	)	)
antibody	NN	antibody
detection	NN	detection
by	IN	by
protein	NN	protein
array	NN	array
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
diagnosis	NN	diagnosis
of	IN	of
H	NN	H
.	SYM	.
pylori	NN	pylori
infection	NN	infection
in	IN	in
children	NNS	child
.	SENT	.
.	SENT	.
Biopsy	NN	Biopsy
specimens	NNS	specimen
obtained	VBN	obtain
by	IN	by
gastroscopy	NN	gastroscopy
from	IN	from
120	CD	120
children	NNS	child
with	IN	with
digestive	JJ	digestive
system	NN	system
symptoms	NNS	symptom
were	VVD	be
detected	VBN	detect
by	IN	by
rapid	JJ	rapid
urease	NN	urease
test	NN	test
(	(	(
RUT	NN	RUT
)	)	)
and	CC	and
modified	VBN	modify
Giemsa	NP	Giemsa
staining	NN	staining
.	SENT	.
.	SENT	.
Positivity	NN	Positivity
in	IN	in
<FORBIDDEN ID=30 ACTION=delete>
both	CC	both
</FORBIDDEN ID=30 ACTION=delete>
RUT	NN	RUT
and	CC	and
Giemsa	NP	Giemsa
staining	NN	staining
was	VVD	be
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
"	``	"
gold	NN	gold
criterion	NN	criterion
"	''	"
of	IN	of
H	NN	H
.	SYM	.
pylori	NN	pylori
infection	NN	infection
.	SENT	.
.	SENT	.
Serum	NN	Serum
samples	NNS	sample
of	IN	of
these	DT	these
patients	NNS	patient
were	VVD	be
obtained	VBN	obtain
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
antibodies	NNS	antibody
against	IN	against
cytotoxin	NN	cytotoxin
associated	VBN	associate
gene	NN	gene
A	NN	A
protein	NN	protein
(	(	(
CagA	NN	CagA
)	)	)
,	,	,
vacuolating	VBG	vacuolate
toxin	NN	toxin
A	NN	A
(	(	(
VacA	NN	VacA
)	)	)
,	,	,
urease	NN	urease
,	,	,
heat	NN	heat
shock	NN	shock
protein	NN	protein
60	CD	60
(	(	(
Hsp60	NN	Hsp60
)	)	)
and	CC	and
RdxA	NN	RdxA
(	(	(
nitroreductase	NN	nitroreductase
)	)	)
were	VVD	be
detected	VBN	detect
by	IN	by
protein	NN	protein
array	NN	array
technique	NN	technique
.	SENT	.
.	SENT	.
H	NN	H
.	SYM	.
pylori	NN	pylori
infection	NN	infection
was	VVD	be
identified	VBN	identify
<FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
according	VBG	accord
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
"	``	"
gold	NN	gold
criterion	NN	criterion
"	''	"
in	IN	in
60	CD	60
children	NNS	child
.	SENT	.
.	SENT	.
Compared	VBN	Compare
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
"	``	"
gold	NN	gold
criterion	NN	criterion
"	''	"
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
goodness	NN	goodness
of	IN	of
fit	NN	fit
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
coefficient	NN	coefficient
of	IN	of
contingency	NN	contingency
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
diagnosis	NN	diagnosis
of	IN	of
H	NN	H
.	SYM	.
pylori	NN	pylori
infection	NN	infection
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
following	VBG	follow
four	CD	four
groups	NNS	group
antibody	NN	antibody
detection	NN	detection
were	VVD	be
all	RB	all
statistically	RB	statistically
significant	JJ	significant
(	(	(
PINF	NN	PINF
0.001	CD	0.001
)	)	)
:	COLUMN	:
anti	AFX	anti
-	HYPH	-
Ure	NN	Ure
antibody	NN	antibody
alone	RB	alone
,	,	,
anti	AFX	anti
-	HYPH	-
Ure	NN	Ure
antibody	NN	antibody
combined	VBN	combine
with	IN	with
anti	AFX	anti
-	HYPH	-
CagA	NN	CagA
antibody	NN	antibody
,	,	,
anti	AFX	anti
-	HYPH	-
Ure	NN	Ure
antibody	NN	antibody
combined	VBN	combine
with	IN	with
anti	AFX	anti
-	HYPH	-
VacA	NN	VacA
antibody	NN	antibody
and	CC	and
anti	AFX	anti
-	HYPH	-
Ure	NN	Ure
antibody	NN	antibody
combined	VBN	combine
with	IN	with
anti	AFX	anti
-	HYPH	-
CagA	NN	CagA
and	CC	and
anti	AFX	anti
-	HYPH	-
VacA	NN	VacA
antibody	NN	antibody
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
sensitivity	NN	sensitivity
,	,	,
specificity	NN	specificity
and	CC	and
accuracy	NN	accuracy
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
detection	NN	detection
of	IN	of
anti	AFX	anti
-	HYPH	-
Ure	NN	Ure
antibody	NN	antibody
combined	VBN	combine
with	IN	with
anti	AFX	anti
-	HYPH	-
CagA	NN	CagA
antibody	NN	antibody
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
diagnosis	NN	diagnosis
of	IN	of
H	NN	H
.	SYM	.
pylori	NN	pylori
infection	NN	infection
were	VVD	be
81.7	CD	81.7
%	NN	%
,	,	,
91.7	CD	91.7
%	NN	%
and	CC	and
86.7	CD	86.7
%	NN	%
,	,	,
respectively	RB	respectively
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
antibody	NN	antibody
detection	NN	detection
showed	VBD	show
a	DT	a
high	JJ	high
positive	JJ	positive
predictive	JJ	predictive
value	NN	value
(	(	(
90.7	CD	90.7
%	NN	%
)	)	)
and	CC	and
a	DT	a
high	JJ	high
negative	JJ	negative
predictive	JJ	predictive
value	NN	value
(	(	(
83.3	CD	83.3
%	NN	%
)	)	)
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
antibody	NN	antibody
detection	NN	detection
by	IN	by
protein	NN	protein
array	NN	array
,	,	,
especially	RB	especially
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
detection	NN	detection
of	IN	of
anti	AFX	anti
-	HYPH	-
Ure	NN	Ure
antibody	NN	antibody
combined	VBN	combine
with	IN	with
anti	AFX	anti
-	HYPH	-
CagA	NN	CagA
antibody	NN	antibody
,	,	,
is	VVZ	be
valuable	JJ	valuable
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
diagnosis	NN	diagnosis
of	IN	of
H	NN	H
.	SYM	.
pylori	NN	pylori
infection	NN	infection
.	SENT	.
.	SENT	.
BB-cat+ner-21989983/text	DOCUMENT	BB-cat+ner-21989983/text
Insights	NNS	Insight
into	IN	into
Acinetobacter	NN	Acinetobacter
baumannii	NN	baumannii
pathogenicity	NN	pathogenicity
.	SENT	.
.	SENT	.
Acinetobacter	NN	Acinetobacter
spp	NN	spp
.	SENT	.
have	VHP	have
justifiably	RB	justifiably
received	VBN	receive
significant	JJ	significant
attention	NN	attention
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
public	JJ	public
,	,	,
scientific	JJ	scientific
,	,	,
and	CC	and
medical	JJ	medical
communities	NNS	community
.	SENT	.
.	SENT	.
Over	IN	Over
recent	JJ	recent
years	NNS	year
,	,	,
Acinetobacter	NP	Acinetobacter
,	,	,
particularly	RB	particularly
Acinetobacter	NN	Acinetobacter
baumannii	NN	baumannii
,	,	,
has	VHZ	have
become	VBN	become
a	DT	a
"	``	"
red-alert	JJ	red-alert
"	''	"
human	JJ	human
pathogen	NN	pathogen
,	,	,
primarily	RB	primarily
because	IN	because
of	IN	of
its	PP$	its
exceptional	JJ	exceptional
ability	NN	ability
to	TO	to
develop	VB	develop
resistance	NN	resistance
to	TO	to
all	DT	all
currently	RB	currently
available	JJ	available
antibiotics	NNS	antibiotic
.	SENT	.
.	SENT	.
This	DT	This
characteristic	NN	characteristic
is	VVZ	be
compounded	VBN	compound
by	IN	by
its	PP$	its
unique	JJ	unique
abilities	NNS	ability
to	TO	to
survive	VB	survive
in	IN	in
a	DT	a
diverse	JJ	diverse
range	NN	range
of	IN	of
environments	NNS	environment
,	,	,
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
including	VBG	include
those	DT	those
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
within	IN	within
healthcare	NN	healthcare
institutions	NNS	institution
,	,	,
<FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
leading	VBG	lead
to	TO	to
</FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
problematic	JJ	problematic
outbreaks	NNS	outbreak
.	SENT	.
.	SENT	.
Historically	RB	Historically
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
virulence	NN	virulence
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
organism	NN	organism
has	VHZ	have
been	VVN	be
questioned	VBN	question
,	,	,
but	CC	but
recent	JJ	recent
clinical	JJ	clinical
reports	NNS	report
suggest	VBP	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
Acinetobacter	NN	Acinetobacter
can	MD	can
cause	VB	cause
serious	JJ	serious
,	,	,
life	NN	life
-	HYPH	-
threatening	VBG	threaten
infections	NNS	infection
.	SENT	.
.	SENT	.
Furthermore	RB	Furthermore
,	,	,
its	PP$	its
metabolic	JJ	metabolic
adaptability	NN	adaptability
gives	VBZ	give
it	PP	it
a	DT	a
selective	JJ	selective
advantage	NN	advantage
in	IN	in
harsh	JJ	harsh
hospital	NN	hospital
environments	NNS	environment
.	SENT	.
.	SENT	.
This	DT	This
review	NN	review
focuses	VBZ	focus
on	IN	on
current	JJ	current
understanding	NN	understanding
of	IN	of
A	NN	A
.	SENT	.
baumannii	NN	baumannii
pathogenesis	NN	pathogenesis
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
model	NN	model
systems	NNS	system
used	VBN	use
to	TO	to
study	VB	study
this	DT	this
interesting	JJ	interesting
organism	NN	organism
.	SENT	.
.	SENT	.
BB-cat+ner-22203552/text	DOCUMENT	BB-cat+ner-22203552/text
Characterization	NN	Characterization
and	CC	and
screening	NN	screening
of	IN	of
plant	NN	plant
probiotic	JJ	probiotic
traits	NNS	trait
of	IN	of
bacteria	NNS	bacteria
isolated	VBN	isolate
from	IN	from
rice	NN	rice
seeds	NNS	seed
cultivated	VBN	cultivate
in	IN	in
Argentina	NP	Argentina
.	SENT	.
.	SENT	.
<FORBIDDEN ID=28 ACTION=delete>
Many	JJ	Many
</FORBIDDEN ID=28 ACTION=delete>
seeds	NNS	seed
carry	VBP	carry
endophytes	NNS	endophyte
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
ensure	VBP	ensure
good	JJ	good
chances	NNS	chance
of	IN	of
seedling	VBG	seedle
colonization	NN	colonization
.	SENT	.
.	SENT	.
In	IN	In
this	DT	this
work	NN	work
,	,	,
we	PP	we
have	VHP	have
studied	VBN	study
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
seed	NN	seed
-	HYPH	-
borne	VBN	bear
bacterial	JJ	bacterial
flora	NN	flora
of	IN	of
rice	NN	rice
varieties	NNS	variety
cultivated	VBN	cultivate
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
northeast	NN	northeast
of	IN	of
Argentina	NP	Argentina
.	SENT	.
.	SENT	.
Surface	NN	Surface
-	HYPH	-
sterilized	VBN	sterilize
husked	VBN	husk
seeds	NNS	seed
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
rice	NN	rice
cultivars	NNS	cultivar
CT6919	NN	CT6919
,	,	,
El	NP	El
Paso	NP	Paso
144	CD	144
,	,	,
CAMBA	NN	CAMBA
,	,	,
and	CC	and
IRGA	NN	IRGA
417	CD	417
contained	VBD	contain
an	DT	an
average	NN	average
of	IN	of
5×10(6)	CD	5×10(6)
CFU	NN	CFU
/	SYM	/
g	NN	g
of	IN	of
mesophilic	JJ	mesophilic
and	CC	and
copiotrophic	JJ	copiotrophic
bacteria	NNS	bacteria
.	SENT	.
.	SENT	.
Microbiological	JJ	Microbiological
,	,	,
physiological	JJ	physiological
,	,	,
and	CC	and
molecular	JJ	molecular
characterization	NN	characterization
of	IN	of
a	DT	a
set	NN	set
of	IN	of
39	CD	39
fast	RB	fast
-	HYPH	-
growing	VBG	grow
isolates	NNS	isolate
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
CT6919	NN	CT6919
seeds	NNS	seed
revealed	VBD	reveal
an	DT	an
important	JJ	important
diversity	NN	diversity
of	IN	of
seed	NN	seed
-	HYPH	-
borne	VBN	bear
mesophiles	NNS	mesophile
and	CC	and
potential	JJ	potential
plant	NN	plant
probiotic	JJ	probiotic
activities	NNS	activity
,	,	,
including	VBG	include
diazotrophy	NN	diazotrophy
and	CC	and
antagonism	NN	antagonism
of	IN	of
fungal	JJ	fungal
pathogens	NNS	pathogen
.	SENT	.
.	SENT	.
In	IN	In
fact	NN	fact
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
seed	NN	seed
-	HYPH	-
borne	VBN	bear
bacterial	JJ	bacterial
flora	NN	flora
protected	VBD	protect
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
rice	NN	rice
seedlings	NNS	seedling
against	IN	against
Curvularia	NP	Curvularia
sp	NN	sp
.	SENT	.
infection	NN	infection
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
root	NN	root
colonization	NN	colonization
pattern	NN	pattern
of	IN	of
2	CD	2
Pantoea	NP	Pantoea
isolates	NNS	isolate
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
seeds	NNS	seed
was	VVD	be
studied	VBN	study
by	IN	by
fluorescence	NN	fluorescence
microscopy	NN	microscopy
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
inoculated	VBN	inoculate
axenic	JJ	axenic
rice	NN	rice
seedlings	NNS	seedling
.	SENT	.
.	SENT	.
<FORBIDDEN ID=30 ACTION=delete>
Both	DT	Both
</FORBIDDEN ID=30 ACTION=delete>
isolates	NNS	isolate
strongly	RB	strongly
colonized	VBD	colonize
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
site	NN	site
of	IN	of
emergence	NN	emergence
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
lateral	JJ	lateral
roots	NNS	root
and	CC	and
lenticels	NNS	lenticel
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
<FORBIDDEN ID=123 ACTION=delete>
</FORBIDDEN ID=36 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
represent	VB	represent
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
entry	NN	entry
sites	NNS	site
for	IN	for
endophytic	JJ	endophytic
spreading	NN	spreading
.	SENT	.
.	SENT	.
These	DT	These
findings	NNS	finding
suggest	VBP	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
rice	NN	rice
plants	NNS	plant
allow	VBP	allow
grain	NN	grain
colonization	NN	colonization
by	IN	by
bacterial	JJ	bacterial
species	NNS	specie
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
<FORBIDDEN ID=123 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
act	VB	act
as	IN	as
natural	JJ	natural
biofertilizers	NNS	biofertilizer
and	CC	and
bioprotectives	NNS	bioprotective
<FORBIDDEN ID=45 ACTION=delete>
early	RB	early
</FORBIDDEN ID=45 ACTION=delete>
from	IN	from
seed	NN	seed
germination	NN	germination
.	SENT	.
.	SENT	.
BB-cat+ner-22537874/text	DOCUMENT	BB-cat+ner-22537874/text
Mutational	JJ	Mutational
analysis	NN	analysis
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
N-terminal	JJ	N-terminal
domain	NN	domain
of	IN	of
UreR	NN	UreR
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
positive	JJ	positive
transcriptional	JJ	transcriptional
regulator	NN	regulator
of	IN	of
urease	NN	urease
gene	NN	gene
expression	NN	expression
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Escherichia	FW	Escherichia
coli	FW	coli
plasmid	NN	plasmid
-	HYPH	-
encoded	VBN	encode
urease	NN	urease
,	,	,
a	DT	a
virulence	NN	virulence
factor	NN	factor
in	IN	in
human	JJ	human
and	CC	and
animal	JJ	animal
infections	NNS	infection
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
urinary	JJ	urinary
and	CC	and
gastroduodenal	JJ	gastroduodenal
tracts	NNS	tract
,	,	,
is	VVZ	be
induced	VBN	induce
when	WRB	when
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
substrate	NN	substrate
urea	NN	urea
is	VVZ	be
present	JJ	present
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
growth	NN	growth
medium	NN	medium
.	SENT	.
.	SENT	.
Urea	NN	Urea
-	HYPH	-
dependent	JJ	dependent
urease	NN	urease
expression	NN	expression
is	VVZ	be
mediated	VBN	mediate
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
transcriptional	JJ	transcriptional
level	NN	level
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
AraC	NN	AraC
-	HYPH	-
like	JJ	like
activator	NN	activator
UreR	NN	UreR
.	SENT	.
.	SENT	.
Previous	JJ	Previous
work	NN	work
has	VHZ	have
shown	VBN	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
a	DT	a
peptide	NN	peptide
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
representing	VBG	represent
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
N-terminal	JJ	N-terminal
194	CD	194
amino	JJ	amino
-	HYPH	-
acid	NN	acid
residues	NNS	residue
of	IN	of
UreR	NN	UreR
binds	VBZ	bind
urea	NN	urea
at	IN	at
a	DT	a
single	JJ	single
site	NN	site
,	,	,
full	JJ	full
-	HYPH	-
length	NN	length
UreR	NN	UreR
forms	VBZ	form
an	DT	an
oligomer	NN	oligomer
,	,	,
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
oligomerization	NN	oligomerization
motif	NN	motif
is	VVZ	be
thought	VBN	think
to	TO	to
reside	VB	reside
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
N-terminal	JJ	N-terminal
portion	NN	portion
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
molecule	NN	molecule
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
C-terminal	JJ	C-terminal
domain	NN	domain
of	IN	of
UreR	NN	UreR
contains	VBZ	contain
two	CD	two
helix	NN	helix
-	HYPH	-
turn	NN	turn
-	HYPH	-
helix	NN	helix
motifs	NNS	motif
presumed	VBN	presume
to	TO	to
be	VV	be
necessary	JJ	necessary
for	IN	for
DNA	NN	DNA
binding	NN	binding
.	SENT	.
.	SENT	.
In	IN	In
this	DT	this
study	NN	study
,	,	,
we	PP	we
exploited	VBD	exploit
mutational	JJ	mutational
analyses	NNS	analysis
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
N-terminal	JJ	N-terminal
domain	NN	domain
of	IN	of
UreR	NN	UreR
to	TO	to
determine	VB	determine
if	IN	if
this	DT	this
domain	NN	domain
dimerizes	VBZ	dimerize
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
similar	JJ	similar
to	TO	to
<FORBIDDEN ID=22 ACTION=delete>
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
AraC	NN	AraC
family	NN	family
members	NNS	member
.	SENT	.
.	SENT	.
UreR	NN	UreR
mutants	NNS	mutant
were	VVD	be
analyzed	VBN	analyze
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
ability	NN	ability
to	TO	to
activate	VB	activate
transcription	NN	transcription
of	IN	of
lacZ	NN	lacZ
from	IN	from
an	DT	an
ureDp	NN	ureDp
-	HYPH	-
lacZ	NN	lacZ
transcriptional	JJ	transcriptional
fusion	NN	fusion
.	SENT	.
.	SENT	.
A	DT	A
construct	NN	construct
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
encoding	VBG	encode
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
N-terminal	JJ	N-terminal
194	CD	194
amino	NN	amino
acids	NNS	acid
of	IN	of
UreR	NN	UreR
,	,	,
eluted	VBD	elute
as	IN	as
an	DT	an
oligomer	NN	oligomer
by	IN	by
gel	NN	gel
filtration	NN	filtration
and	CC	and
had	VHD	have
a	DT	a
dominant	JJ	dominant
negative	JJ	negative
phenotype	NN	phenotype
over	IN	over
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
wild	JJ	wild
-	HYPH	-
type	NN	type
ureR	NN	ureR
allele	NN	allele
.	SENT	.
.	SENT	.
We	PP	We
hypothesize	VBP	hypothesize
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
this	DT	this
dominant	JJ	dominant
negative	JJ	negative
phenotype	NN	phenotype
results	VBZ	result
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
formation	NN	formation
of	IN	of
inactive	JJ	inactive
heterodimers	NNS	heterodimer
between	IN	between
wild	JJ	wild
-	HYPH	-
type	NN	type
and	CC	and
truncated	VBN	truncate
UreR	NN	UreR
.	SENT	.
.	SENT	.
Dominant	JJ	Dominant
negative	JJ	negative
analysis	NN	analysis
and	CC	and
cross	AFX	cross
-	HYPH	-
linking	VBG	link
assays	NNS	assay
demonstrated	VBD	demonstrate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
E	NN	E
.	SENT	.
coli	NP	coli
UreR	NP	UreR
is	VVZ	be
active	JJ	active
as	IN	as
a	DT	a
dimer	NN	dimer
and	CC	and
dimerization	NN	dimerization
occurs	VBZ	occur
within	IN	within
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
first	JJ	first
180	CD	180
residues	NNS	residue
.	SENT	.
.	SENT	.
BB-cat+ner-22834551/text	DOCUMENT	BB-cat+ner-22834551/text
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
effect	NN	effect
of	IN	of
Artemisia	NN	Artemisia
annua	NN	annua
on	IN	on
broiler	NN	broiler
performance	NN	performance
,	,	,
on	IN	on
intestinal	JJ	intestinal
microbiota	NN	microbiota
and	CC	and
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
course	NN	course
of	IN	of
a	DT	a
Clostridium	NN	Clostridium
perfringens	NNS	perfringen
infection	NN	infection
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
applying	VBG	apply
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
necrotic	JJ	necrotic
enteritis	NN	enteritis
disease	NN	disease
model	NN	model
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
aerial	JJ	aerial
parts	NNS	part
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
plant	NN	plant
Artemisia	NN	Artemisia
annua	NN	annua
contain	VBP	contain
essential	JJ	essential
oils	NNS	oil
having	VHG	have
antimicrobial	JJ	antimicrobial
properties	NNS	property
against	IN	against
Clostridium	NN	Clostridium
perfringens	NNS	perfringen
Type	NN	Type
A	NN	A
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
causal	JJ	causal
agent	NN	agent
for	IN	for
necrotic	JJ	necrotic
enteritis	NN	enteritis
in	IN	in
broilers	NNS	broiler
.	SENT	.
.	SENT	.
In	IN	In
two	CD	two
experiments	NNS	experiment
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
influence	NN	influence
of	IN	of
increasing	VBG	increase
dietary	JJ	dietary
concentrations	NNS	concentration
of	IN	of
dried	VBN	dry
A	NN	A
.	SENT	.
annua	NN	annua
leaves	NNS	leaf
(	(	(
0	CD	0
,	,	,
5	CD	5
,	,	,
10	CD	10
and	CC	and
20	CD	20
g	NN	g
/	SYM	/
kg	NN	kg
)	)	)
and	CC	and
n-hexane	JJ	n-hexane
extract	NN	extract
from	IN	from
fresh	JJ	fresh
A	NN	A
.	SENT	.
annua	NN	annua
leaves	NNS	leaf
(	(	(
0	CD	0
,	,	,
125	CD	125
,	,	,
250	CD	250
and	CC	and
500	CD	500
mg	NN	mg
/	SYM	/
kg	NN	kg
)	)	)
on	IN	on
broiler	NN	broiler
performance	NN	performance
was	VVD	be
investigated	VBN	investigate
.	SENT	.
.	SENT	.
Dried	VBN	Dry
plant	NN	plant
material	NN	material
decreased	VBD	decrease
feed	NN	feed
intake	NN	intake
and	CC	and
body	NN	body
weight	NN	weight
in	IN	in
a	DT	a
dose	NN	dose
-	HYPH	-
dependent	JJ	dependent
manner	NN	manner
,	,	,
and	CC	and
10	CD	10
and	CC	and
20	CD	20
g	NN	g
/	SYM	/
kg	NN	kg
diet	NN	diet
tended	VBD	tend
to	TO	to
improve	VB	improve
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
feed	NN	feed
conversion	NN	conversion
ratio	NN	ratio
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
n-hexane	JJ	n-hexane
extract	NN	extract
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
reduced	VBD	reduce
feed	NN	feed
intake	NN	intake
,	,	,
but	CC	but
broiler	NN	broiler
weight	NN	weight
tended	VBD	tend
to	TO	to
decrease	VB	decrease
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
highest	JJS	high
dietary	JJ	dietary
concentration	NN	concentration
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
feed	NN	feed
conversion	NN	conversion
ratio	NN	ratio
tended	VBD	tend
to	TO	to
improve	VB	improve
when	WRB	when
birds	NNS	bird
received	VBD	receive
250	CD	250
and	CC	and
500	CD	500
mg	NN	mg
/	SYM	/
kg	NN	kg
n-hexane	NN	n-hexane
extract	NN	extract
.	SENT	.
.	SENT	.
In	IN	In
a	DT	a
third	JJ	third
experiment	NN	experiment
,	,	,
a	DT	a
necrotic	JJ	necrotic
enteritis	NN	enteritis
disease	NN	disease
model	NN	model
was	VVD	be
applied	VBN	apply
to	TO	to
investigate	VB	investigate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
effect	NN	effect
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
dietary	JJ	dietary
addition	NN	addition
of	IN	of
dried	VBN	dry
A	NN	A
.	SENT	.
annua	NN	annua
leaves	NNS	leaf
(	(	(
10	CD	10
g	NN	g
/	SYM	/
kg	NN	kg
on	IN	on
top	NN	top
)	)	)
or	CC	or
n-hexane	JJ	n-hexane
extract	NN	extract
of	IN	of
A	NN	A
.	SENT	.
annua	NN	annua
(	(	(
250	CD	250
mg	NN	mg
/	SYM	/
kg	NN	kg
)	)	)
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
severity	NN	severity
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
disease	NN	disease
in	IN	in
broilers	NNS	broiler
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
addition	NN	addition
of	IN	of
n-hexane	JJ	n-hexane
extract	NN	extract
reduced	VBD	reduce
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
intestinal	JJ	intestinal
C	NN	C
.	SENT	.
perfringens	NNS	perfringen
numbers	NNS	number
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
severity	NN	severity
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
disease	NN	disease
-	HYPH	-
related	VBN	relate
small	JJ	small
intestinal	JJ	intestinal
lesions	NNS	lesion
.	SENT	.
.	SENT	.
Over	IN	Over
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
infection	NN	infection
period	NN	period
from	IN	from
day	NN	day
17	CD	17
to	TO	to
day	NN	day
27	CD	27
,	,	,
birds	NNS	bird
supplemented	VBN	supplement
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
n-hexane	NN	n-hexane
extract	NN	extract
gained	VBD	gain
<FORBIDDEN ID=82 ACTION=delete>
more	JJR	more
</FORBIDDEN ID=82 ACTION=delete>
weight	NN	weight
than	IN	than
<FORBIDDEN ID=30 ACTION=delete>
both	CC	both
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=30 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
challenged	VBN	challenge
control	NN	control
birds	NNS	bird
and	CC	and
birds	NNS	bird
receiving	VBG	receive
dried	VBN	dry
plant	NN	plant
material	NN	material
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
results	NNS	result
indicate	VBP	indicate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
n-hexane	NN	n-hexane
extracts	NNS	extract
derived	VBN	derive
from	IN	from
A	NN	A
.	SENT	.
annua	NN	annua
can	MD	can
modulate	VB	modulate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
course	NN	course
of	IN	of
necrotic	JJ	necrotic
enteritis	NN	enteritis
and	CC	and
compensate	NN	compensate
to	TO	to
a	DT	a
<FORBIDDEN ID=87 ACTION=delete>
certain	JJ	certain
</FORBIDDEN ID=87 ACTION=delete>
extent	NN	extent
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
disease	NN	disease
-	HYPH	-
associated	VBN	associate
weight	NN	weight
losses	NNS	loss
.	SENT	.
.	SENT	.
BB-cat+ner-23645023/text	DOCUMENT	BB-cat+ner-23645023/text
Taibaiella	NP	Taibaiella
smilacinae	JJ	smilacinae
gen	NN	gen
.	SENT	.
nov	NN	nov
.	NN	.
,	,	,
sp	NN	sp
.	SENT	.
nov	NN	nov
.	NN	.
,	,	,
an	DT	an
endophytic	JJ	endophytic
member	NN	member
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
family	NN	family
Chitinophagaceae	NP	Chitinophagaceae
isolated	VBN	isolate
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
stem	NN	stem
of	IN	of
Smilacina	NP	Smilacina
japonica	NP	japonica
,	,	,
and	CC	and
emended	VBD	emend
description	NN	description
of	IN	of
Flavihumibacter	NN	Flavihumibacter
petaseus	NN	petaseus
.	SENT	.
.	SENT	.
A	DT	A
light	NN	light
-	HYPH	-
yellow	NN	yellow
-	HYPH	-
coloured	VBN	colour
bacterium	NN	bacterium
,	,	,
designated	VBN	designate
strain	NN	strain
PTJT	NN	PTJT
-5	CD	-5
(	(	(
T	NN	T
)	)	)
,	,	,
was	VVD	be
isolated	VBN	isolate
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
stem	NN	stem
of	IN	of
Smilacina	NP	Smilacina
japonica	NP	japonica
A	NP	A
.	SENT	.
.	SENT	.
Gray	NN	Gray
collected	VBN	collect
from	IN	from
Taibai	NP	Taibai
Mountain	NP	Mountain
in	IN	in
Shaanxi	NP	Shaanxi
Province	NP	Province
,	,	,
north	RB	north
-	HYPH	-
west	JJ	west
China	NP	China
,	,	,
and	CC	and
was	VVD	be
subjected	VBN	subject
to	TO	to
a	DT	a
taxonomic	JJ	taxonomic
study	NN	study
by	IN	by
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
using	VBG	use
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
polyphasic	JJ	polyphasic
approach	NN	approach
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
novel	JJ	novel
isolate	NN	isolate
grew	VBD	grow
optimally	RB	optimally
at	IN	at
25-28	CD	25-28
°C	NN	°C
and	CC	and
pH	NN	pH
6.0-7.0	CD	6.0-7.0
.	SENT	.
.	SENT	.
Flexirubin	NN	Flexirubin
-	HYPH	-
type	NN	type
pigments	NNS	pigment
were	VVD	be
produced	VBN	produce
.	SENT	.
.	SENT	.
Cells	NNS	Cell
were	VVD	be
Gram	NN	Gram
-	HYPH	-
reaction	NN	reaction
-	HYPH	-
negative	JJ	negative
,	,	,
strictly	RB	strictly
aerobic	JJ	aerobic
,	,	,
rod-shaped	JJ	rod-shaped
and	CC	and
non-motile	JJ	non-motile
.	SENT	.
.	SENT	.
Phylogenetic	JJ	Phylogenetic
analysis	NN	analysis
based	VBN	base
on	IN	on
16S	NN	16S
rRNA	NN	rRNA
gene	NN	gene
sequences	NNS	sequence
showed	VBD	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
strain	NN	strain
PTJT	NN	PTJT
-5	CD	-5
(	(	(
T	NN	T
)	)	)
was	VVD	be
a	DT	a
member	NN	member
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
phylum	NN	phylum
Bacteroidetes	NNS	Bacteroidete
,	,	,
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
exhibiting	VBG	exhibit
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
highest	JJS	high
sequence	NN	sequence
similarity	NN	similarity
to	TO	to
Lacibacter	NP	Lacibacter
cauensis	VBZ	cauensi
NJ	NP	NJ
-8	CD	-8
(	(	(
T	NN	T
)	)	)
(	(	(
87.7	CD	87.7
 %	NN	_%
)	)	)
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
major	JJ	major
cellular	JJ	cellular
fatty	JJ	fatty
acids	NNS	acid
were	VVD	be
iso-C15 	NN	iso-C15_
:	COLUMN	:
 0	CD	_0
,	,	,
iso-C15 	NN	iso-C15_
:	COLUMN	:
 1	CD	_1
G	NN	G
,	,	,
iso-C17 	NN	iso-C17_
:	COLUMN	:
 0	CD	_0
and	CC	and
iso-C17 	NN	iso-C17_
:	COLUMN	:
 0	CD	_0
3-OH	NN	3-OH
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
<FORBIDDEN ID=156 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
only	JJ	only
</FORBIDDEN ID=156 ACTION=delete>
polyamine	NN	polyamine
was	VVD	be
homospermidine	NN	homospermidine
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
major	JJ	major
polar	JJ	polar
lipid	NN	lipid
was	VVD	be
phosphatidylethanolamine	NN	phosphatidylethanolamine
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
<FORBIDDEN ID=156 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
only	JJ	only
</FORBIDDEN ID=156 ACTION=delete>
respiratory	JJ	respiratory
quinone	NN	quinone
was	VVD	be
MK	NN	MK
-7	CD	-7
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
DNA	NN	DNA
G+C	NN	G+C
content	NN	content
was	VVD	be
40.3	CD	40.3
mol%	NN	mol%
.	SENT	.
.	SENT	.
Based	VBN	Base
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
phenotypic	JJ	phenotypic
,	,	,
phylogenetic	JJ	phylogenetic
and	CC	and
genotypic	JJ	genotypic
data	NNS	datum
,	,	,
strain	NN	strain
PTJT	NN	PTJT
-5	CD	-5
(	(	(
T	NN	T
)	)	)
is	VVZ	be
considered	VBN	consider
to	TO	to
represent	VB	represent
a	DT	a
novel	JJ	novel
species	NNS	specie
of	IN	of
a	DT	a
<FORBIDDEN ID=38 ACTION=delete>
<FORBIDDEN ID=37 ACTION=delete>
new	JJ	new
</FORBIDDEN ID=37 ACTION=delete>
</FORBIDDEN ID=38 ACTION=delete>
genus	NN	genus
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
family	NN	family
Chitinophagaceae	NP	Chitinophagaceae
,	,	,
for	IN	for
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=36 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
name	NN	name
Taibaiella	NP	Taibaiella
smilacinae	JJ	smilacinae
gen	NN	gen
.	SENT	.
nov	NN	nov
.	NN	.
,	,	,
sp	NN	sp
.	SENT	.
nov	NN	nov
.	SENT	.
is	VVZ	be
proposed	VBN	propose
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
type	NN	type
strain	NN	strain
of	IN	of
Taibaiella	NP	Taibaiella
smilacinae	NN	smilacinae
is	VVZ	be
PTJT	NN	PTJT
-5	CD	-5
(	(	(
T	NN	T
)	)	)
(	(	(
 = CCTCC	NP	_=_CCTCC
AB	NP	AB
2013017(T) = KCTC	NP	2013017(T)_=_KCTC
32316(T))	NP	32316(T))
.	SENT	.
.	SENT	.
An	DT	An
emended	VBN	emend
description	NN	description
of	IN	of
Flavihumibacter	NN	Flavihumibacter
petaseus	NN	petaseus
is	VVZ	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
proposed	VBN	propose
.	SENT	.
.	SENT	.
BB-cat+ner-23702192/text	DOCUMENT	BB-cat+ner-23702192/text
Clinical	JJ	Clinical
factors	NNS	factor
associated	VBN	associate
with	IN	with
development	NN	development
of	IN	of
severe	JJ	severe
-	HYPH	-
complicated	VBN	complicate
Clostridium	NN	Clostridium
difficile	NN	difficile
infection	NN	infection
.	SENT	.
.	SENT	.
Clostridium	NN	Clostridium
difficile	JJ	difficile
infection	NN	infection
(	(	(
CDI	NN	CDI
)	)	)
can	MD	can
cause	VB	cause
life	NN	life
-	HYPH	-
threatening	VBG	threaten
complications	NNS	complication
.	SENT	.
.	SENT	.
Severe	NN	Severe
-	HYPH	-
complicated	VBN	complicate
CDI	NN	CDI
is	VVZ	be
characterized	VBN	characterize
by	IN	by
hypotension	NN	hypotension
,	,	,
shock	NN	shock
,	,	,
sepsis	NN	sepsis
,	,	,
ileus	NN	ileus
,	,	,
megacolon	NN	megacolon
,	,	,
and	CC	and
colon	NN	colon
perforation	NN	perforation
.	SENT	.
.	SENT	.
We	PP	We
created	VBD	create
a	DT	a
model	NN	model
to	TO	to
identify	VB	identify
clinical	JJ	clinical
factors	NNS	factor
associated	VBN	associate
with	IN	with
severe	JJ	severe
-	HYPH	-
complicated	VBN	complicate
CDI	NP	CDI
.	SENT	.
.	SENT	.
We	PP	We
analyzed	VBD	analyze
data	NNS	datum
from	IN	from
1446	CD	1446
inpatient	NN	inpatient
cases	NNS	case
of	IN	of
CDI	NN	CDI
(	(	(
48.6	CD	48.6
%	NN	%
female	NN	female
;	COLUMN	;
median	JJ	median
age	NN	age
,	,	,
62.5	CD	62.5
years	NNS	year
;	COLUMN	;
range	NN	range
,	,	,
0.1-103.7	CD	0.1-103.7
years	NNS	year
)	)	)
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Mayo	NP	Mayo
Clinic	NP	Clinic
from	IN	from
<FORBIDDEN ID=124 ACTION=delete>
June	NP	June
</FORBIDDEN ID=124 ACTION=delete>
28	CD	28
,	,	,
2007	CD	2007
,	,	,
to	TO	to
<FORBIDDEN ID=124 ACTION=delete>
June	NP	June
</FORBIDDEN ID=124 ACTION=delete>
25	CD	25
,	,	,
2010	CD	2010
.	SENT	.
.	SENT	.
Patients	NNS	Patient
with	IN	with
severe	JJ	severe
-	HYPH	-
complicated	VBN	complicate
CDI	NN	CDI
(	(	(
n =	NN	n =
487	CD	487
)	)	)
were	VVD	be
identified	VBN	identify
as	IN	as
those	DT	those
who	WP	who
required	VBD	require
admission	NN	admission
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
intensive	JJ	intensive
care	NN	care
unit	NN	unit
or	CC	or
colectomy	NN	colectomy
,	,	,
or	CC	or
died	VBD	die
,	,	,
within	IN	within
30	CD	30
days	NNS	day
of	IN	of
CDI	NN	CDI
diagnosis	NN	diagnosis
.	SENT	.
.	SENT	.
Logistic	JJ	Logistic
regression	NN	regression
models	NNS	model
were	VVD	be
used	VBN	use
to	TO	to
identify	VB	identify
variables	NNS	variable
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
were	VVD	be
independently	RB	independently
associated	VBN	associate
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
occurrence	NN	occurrence
of	IN	of
severe	JJ	severe
-	HYPH	-
complicated	VBN	complicate
CDI	NN	CDI
in	IN	in
2	CD	2
cohorts	NNS	cohort
.	SENT	.
.	SENT	.
One	CD	One
cohort	NN	cohort
comprised	VBD	comprise
all	DT	all
hospitalized	VBN	hospitalize
patients	NNS	patient
;	COLUMN	;
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=22 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
comprised	VBD	comprise
a	DT	a
subset	NN	subset
of	IN	of
these	DT	these
inpatients	NNS	inpatient
who	WP	who
were	VVD	be
residents	NNS	resident
of	IN	of
Olmsted	NP	Olmsted
County	NP	County
,	,	,
Minnesota	NP	Minnesota
to	TO	to
assess	VB	assess
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
association	NN	association
of	IN	of
comorbid	JJ	comorbid
conditions	NNS	condition
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
development	NN	development
of	IN	of
severe	JJ	severe
-	HYPH	-
complicated	VBN	complicate
infection	NN	infection
in	IN	in
a	DT	a
population	NN	population
-	HYPH	-
based	VBN	base
cohort	JJ	cohort
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
linear	JJ	linear
combinations	NNS	combination
of	IN	of
variables	NNS	variable
identified	VBN	identify
by	IN	by
using	VBG	use
logistic	JJ	logistic
regression	NN	regression
models	NNS	model
provided	VBD	provide
scores	NNS	score
to	TO	to
predict	VB	predict
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
risk	NN	risk
of	IN	of
developing	VBG	develop
severe	JJ	severe
-	HYPH	-
complicated	VBN	complicate
CDI	NP	CDI
.	SENT	.
.	SENT	.
In	IN	In
a	DT	a
multivariable	JJ	multivariable
model	NN	model
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
included	VBD	include
all	DT	all
inpatients	NNS	inpatient
,	,	,
increasing	VBG	increase
age	NN	age
,	,	,
leukocyte	NN	leukocyte
count	NN	count
SUP15 × 10(9)	NN	SUP15 × 10(9)
/	SYM	/
L	NN	L
,	,	,
increase	NN	increase
in	IN	in
serum	NN	serum
level	NN	level
of	IN	of
creatinine	NN	creatinine
SUP	SYM	SUP
1.5	CD	1.5
-	HYPH	-
fold	RB	fold
from	IN	from
baseline	NN	baseline
,	,	,
and	CC	and
use	NN	use
of	IN	of
proton	NN	proton
pump	NN	pump
inhibitors	NNS	inhibitor
or	CC	or
narcotic	JJ	narcotic
medications	NNS	medication
were	VVD	be
independently	RB	independently
associated	VBN	associate
with	IN	with
severe	JJ	severe
-	HYPH	-
complicated	VBN	complicate
CDI	NP	CDI
.	SENT	.
.	SENT	.
In	IN	In
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
secondary	JJ	secondary
analysis	NN	analysis
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
included	VBD	include
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
patients	NNS	patient
from	IN	from
Olmsted	NP	Olmsted
County	NP	County
,	,	,
comorbid	JJ	comorbid
conditions	NNS	condition
were	VVD	be
not	RB	not
significantly	RB	significantly
associated	VBN	associate
with	IN	with
severe	JJ	severe
-	HYPH	-
complicated	VBN	complicate
CDI	NP	CDI
.	SENT	.
.	SENT	.
Older	JJR	Old
age	NN	age
,	,	,
high	JJ	high
numbers	NNS	number
of	IN	of
leukocytes	NNS	leukocyte
in	IN	in
blood	NN	blood
samples	NNS	sample
,	,	,
an	DT	an
increased	VBN	increase
serum	NN	serum
level	NN	level
of	IN	of
creatinine	NN	creatinine
,	,	,
gastric	JJ	gastric
acid	NN	acid
suppression	NN	suppression
,	,	,
and	CC	and
use	NN	use
of	IN	of
narcotic	JJ	narcotic
medications	NNS	medication
were	VVD	be
independently	RB	independently
associated	VBN	associate
with	IN	with
development	NN	development
of	IN	of
severe	JJ	severe
-	HYPH	-
complicated	VBN	complicate
CDI	NN	CDI
in	IN	in
hospitalized	VBN	hospitalize
patients	NNS	patient
.	SENT	.
.	SENT	.
<FORBIDDEN ID=45 ACTION=delete>
Early	RB	Early
</FORBIDDEN ID=45 ACTION=delete>
aggressive	JJ	aggressive
monitoring	NN	monitoring
and	CC	and
intervention	NN	intervention
could	MD	could
improve	VB	improve
outcomes	NNS	outcome
.	SENT	.
.	SENT	.
BB-cat+ner-23704121/text	DOCUMENT	BB-cat+ner-23704121/text
Is	VBZ	Be
fidaxomicin	NN	fidaxomicin
<FORBIDDEN ID=3 ACTION=split SPLIT_AFTER=0>
worth	JJ	worth
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=3 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cost	NN	cost
?	SENT	?
.	SENT	.
An	DT	An
economic	JJ	economic
analysis	NN	analysis
.	SENT	.
.	SENT	.
In	IN	In
<FORBIDDEN ID=123 ACTION=delete>
May	NP	May
</FORBIDDEN ID=123 ACTION=delete>
2011	CD	2011
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Food	NP	Food
and	CC	and
Drug	NP	Drug
Administration	NP	Administration
approved	VBD	approve
fidaxomicin	NN	fidaxomicin
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
treatment	NN	treatment
of	IN	of
Clostridium	NN	Clostridium
difficile	JJ	difficile
infection	NN	infection
(	(	(
CDI	NN	CDI
)	)	)
.	SENT	.
.	SENT	.
It	PP	It
has	VHZ	have
been	VVN	be
found	VBN	find
to	TO	to
be	VV	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
noninferior	JJ	noninferior
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
vancomycin	NN	vancomycin
;	COLUMN	;
however	RB	however
,	,	,
its	PP$	its
cost	NN	cost
-	HYPH	-
effectiveness	NN	effectiveness
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
treatment	NN	treatment
of	IN	of
CDI	NN	CDI
remains	VBZ	remain
undetermined	JJ	undetermined
.	SENT	.
.	SENT	.
We	PP	We
developed	VBD	develop
a	DT	a
decision	NN	decision
analytic	JJ	analytic
simulation	NN	simulation
model	NN	model
to	TO	to
determine	VB	determine
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
economic	JJ	economic
value	NN	value
of	IN	of
fidaxomicin	NN	fidaxomicin
for	IN	for
CDI	NN	CDI
treatment	NN	treatment
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
third	JJ	third
-	HYPH	-
party	NN	party
payer	NN	payer
perspective	NN	perspective
.	SENT	.
.	SENT	.
We	PP	We
looked	VBD	look
at	IN	at
CDI	NP	CDI
treatment	NN	treatment
in	IN	in
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
these	DT	these
3	CD	3
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
cases	NNS	case
:	COLUMN	:
(	(	(
1	LS	1
)	)	)
no	DT	no
fidaxomicin	NN	fidaxomicin
,	,	,
(	(	(
2	LS	2
)	)	)
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
fidaxomicin	NN	fidaxomicin
,	,	,
and	CC	and
(	(	(
3	LS	3
)	)	)
fidaxomicin	NN	fidaxomicin
based	VBN	base
on	IN	on
strain	NN	strain
typing	NN	typing
results	NNS	result
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
incremental	JJ	incremental
cost	NN	cost
-	HYPH	-
effectiveness	NN	effectiveness
ratio	NN	ratio
for	IN	for
fidaxomicin	NN	fidaxomicin
based	VBN	base
on	IN	on
screening	VBG	screen
given	VBN	give
current	JJ	current
conditions	NNS	condition
was	VVD	be
SUP$	$	SUP$
43.7	CD	43.7
million	CD	million
per	IN	per
quality	NN	quality
-	HYPH	-
adjusted	VBN	adjust
life	NN	life
-	HYPH	-
year	NN	year
and	CC	and
using	VBG	use
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
fidaxomicin	NN	fidaxomicin
was	VVD	be
dominated	VBN	dominate
(	(	(
ie	FW	ie
,	,	,
<FORBIDDEN ID=82 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
costly	JJ	costly
and	CC	and
less	RBR	less
effective	JJ	effective
)	)	)
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=22 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
2	CD	2
treatment	NN	treatment
strategies	NNS	strategy
explored	VBN	explore
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
fidaxomicin	NN	fidaxomicin
strategy	NN	strategy
tended	VBD	tend
to	TO	to
remain	VB	remain
dominated	JJ	dominated
,	,	,
<FORBIDDEN ID=157 ACTION=delete>
even	RB	even
</FORBIDDEN ID=157 ACTION=delete>
at	IN	at
lower	JJR	low
costs	NNS	cost
.	SENT	.
.	SENT	.
With	IN	With
approximately	RB	approximately
50%	CD	50%
of	IN	of
CDI	NN	CDI
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
due	JJ	due
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
NAP1	NN	NAP1
/	SYM	/
BI	NN	BI
/	SYM	/
027	CD	027
strain	NN	strain
,	,	,
a	DT	a
course	NN	course
of	IN	of
fidaxomicin	NN	fidaxomicin
would	MD	would
need	VB	need
to	TO	to
cost	VB	cost
≤$150	CD	≤$150
to	TO	to
be	VV	be
cost	AFX	cost
-	HYPH	-
effective	JJ	effective
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
treatment	NN	treatment
of	IN	of
all	DT	all
CDI	NP	CDI
cases	NNS	case
and	CC	and
between	IN	between
$160	CD	$160
and	CC	and
$400	CD	$400
to	TO	to
be	VV	be
cost	AFX	cost
-	HYPH	-
effective	JJ	effective
for	IN	for
those	DT	those
with	IN	with
a	DT	a
non-NAP1	NN	non-NAP1
/	SYM	/
BI	NN	BI
/	SYM	/
027	CD	027
strain	NN	strain
(	(	(
ie	FW	ie
,	,	,
treatment	NN	treatment
based	VBN	base
on	IN	on
strain	NN	strain
typing	NN	typing
)	)	)
.	SENT	.
.	SENT	.
Given	VBN	Give
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
current	JJ	current
cost	NN	cost
and	CC	and
NAP1	NN	NAP1
/	SYM	/
BI	NN	BI
/	SYM	/
027	CD	027
accounting	NN	accounting
for	IN	for
approximately	RB	approximately
50%	CD	50%
of	IN	of
isolates	NNS	isolate
,	,	,
using	VBG	use
fidaxomicin	NN	fidaxomicin
as	IN	as
a	DT	a
first	JJ	first
-	HYPH	-
line	NN	line
treatment	NN	treatment
for	IN	for
CDI	NP	CDI
is	VVZ	be
not	RB	not
cost	NN	cost
-	HYPH	-
effective	JJ	effective
.	SENT	.
.	SENT	.
However	RB	However
,	,	,
typing	NN	typing
and	CC	and
treatment	NN	treatment
with	IN	with
fidaxomicin	NN	fidaxomicin
based	VBN	base
on	IN	on
strain	NN	strain
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
be	VV	be
<FORBIDDEN ID=82 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
promising	JJ	promising
depending	VBG	depend
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
costs	NNS	cost
of	IN	of
fidaxomicin	NN	fidaxomicin
.	SENT	.
.	SENT	.
BB-cat+ner-23855904/text	DOCUMENT	BB-cat+ner-23855904/text
Widespread	JJ	Widespread
acquisition	NN	acquisition
of	IN	of
antimicrobial	JJ	antimicrobial
resistance	NN	resistance
among	IN	among
Campylobacter	NP	Campylobacter
isolates	NNS	isolate
from	IN	from
UK	NP	UK
retail	JJ	retail
poultry	NN	poultry
and	CC	and
evidence	NN	evidence
for	IN	for
clonal	JJ	clonal
expansion	NN	expansion
of	IN	of
resistant	JJ	resistant
lineages	NNS	lineage
.	SENT	.
.	SENT	.
Antimicrobial	JJ	Antimicrobial
resistance	NN	resistance
is	VVZ	be
increasing	VBG	increase
among	IN	among
clinical	JJ	clinical
Campylobacter	NP	Campylobacter
cases	NNS	case
and	CC	and
is	VVZ	be
common	JJ	common
among	IN	among
isolates	NNS	isolate
from	IN	from
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
sources	NNS	source
,	,	,
specifically	RB	specifically
retail	JJ	retail
poultry - a	NN	poultry_-_a
major	JJ	major
source	NN	source
of	IN	of
human	JJ	human
infection	NN	infection
.	SENT	.
.	SENT	.
In	IN	In
this	DT	this
<FORBIDDEN ID=0 ACTION=split SPLIT_AFTER=0>
study	NN	study
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=0 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
antimicrobial	JJ	antimicrobial
susceptibility	NN	susceptibility
of	IN	of
isolates	NNS	isolate
from	IN	from
a	DT	a
UK	NN	UK
-	HYPH	-
wide	JJ	wide
survey	NN	survey
of	IN	of
Campylobacter	NP	Campylobacter
in	IN	in
retail	JJ	retail
poultry	NN	poultry
in	IN	in
2001	CD	2001
and	CC	and
2004-5	CD	2004-5
was	VVD	be
investigated	VBN	investigate
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
occurrence	NN	occurrence
of	IN	of
phenotypes	NNS	phenotype
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
resistant	JJ	resistant
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
tetracycline	NN	tetracycline
,	,	,
quinolones	NNS	quinolone
(	(	(
ciprofloxacin	NN	ciprofloxacin
and	CC	and
naladixic	JJ	naladixic
acid	NN	acid
)	)	)
,	,	,
erythromycin	NN	erythromycin
,	,	,
chloramphenicol	NN	chloramphenicol
and	CC	and
aminoglycosides	NNS	aminoglycoside
was	VVD	be
quantified	VBN	quantify
.	SENT	.
.	SENT	.
This	DT	This
was	VVD	be
compared	VBN	compare
with	IN	with
a	DT	a
phylogeny	NN	phylogeny
for	IN	for
these	DT	these
isolates	NNS	isolate
based	VBN	base
upon	IN	upon
Multi	NP	Multi
Locus	NP	Locus
Sequence	NN	Sequence
Typing	NN	Typing
(	(	(
MLST	NN	MLST
)	)	)
to	TO	to
investigate	VB	investigate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
pattern	NN	pattern
of	IN	of
antimicrobial	JJ	antimicrobial
resistance	NN	resistance
acquisition	NN	acquisition
.	SENT	.
.	SENT	.
Antimicrobial	JJ	Antimicrobial
resistance	NN	resistance
was	VVD	be
present	JJ	present
in	IN	in
all	DT	all
lineage	NN	lineage
clusters	NNS	cluster
,	,	,
but	CC	but
statistical	JJ	statistical
testing	NN	testing
showed	VBD	show
a	DT	a
non-random	JJ	non-random
distribution	NN	distribution
.	SENT	.
.	SENT	.
Erythromycin	NN	Erythromycin
resistance	NN	resistance
was	VVD	be
associated	VBN	associate
with	IN	with
Campylobacter	NP	Campylobacter
coli	NP	coli
.	SENT	.
.	SENT	.
For	IN	For
all	DT	all
antimicrobials	NNS	antimicrobial
tested	VBN	test
,	,	,
resistant	JJ	resistant
isolates	NNS	isolate
were	VVD	be
distributed	VBN	distribute
among	IN	among
relatively	RB	relatively
distant	JJ	distant
lineages	NNS	lineage
indicative	JJ	indicative
of	IN	of
widespread	JJ	widespread
acquisition	NN	acquisition
.	SENT	.
.	SENT	.
There	EX	There
was	VVD	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
evidence	NN	evidence
of	IN	of
clustering	NN	clustering
of	IN	of
resistance	NN	resistance
phenotypes	NNS	phenotype
within	IN	within
lineages	NNS	lineage
;	COLUMN	;
indicative	JJ	indicative
of	IN	of
local	JJ	local
expansion	NN	expansion
of	IN	of
resistant	JJ	resistant
strains	NNS	strain
.	SENT	.
.	SENT	.
These	DT	These
results	NNS	result
are	VVP	be
consistent	JJ	consistent
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
widespread	JJ	widespread
acquisition	NN	acquisition
of	IN	of
antimicrobial	JJ	antimicrobial
resistance	NN	resistance
among	IN	among
chicken	NN	chicken
associated	VBN	associate
Campylobacter	NP	Campylobacter
isolates	NNS	isolate
,	,	,
either	CC	either
through	IN	through
mutation	NN	mutation
or	CC	or
horizontal	JJ	horizontal
gene	NN	gene
transfer	NN	transfer
,	,	,
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
expansion	NN	expansion
of	IN	of
these	DT	these
lineages	NNS	lineage
as	IN	as
a	DT	a
proportion	NN	proportion
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
population	NN	population
.	SENT	.
.	SENT	.
As	IN	As
Campylobacter	NP	Campylobacter
are	VVP	be
not	RB	not
known	VBN	know
to	TO	to
multiply	VB	multiply
outside	JJ	outside
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
host	NN	host
and	CC	and
long	JJ	long
-	HYPH	-
term	NN	term
carriage	NN	carriage
in	IN	in
humans	NNS	human
is	VVZ	be
extremely	RB	extremely
infrequent	JJ	infrequent
in	IN	in
industrialized	JJ	industrialized
countries	NNS	country
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
most	RBS	most
likely	JJ	likely
location	NN	location
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
proliferation	NN	proliferation
of	IN	of
resistant	JJ	resistant
lineages	NNS	lineage
is	VVZ	be
in	IN	in
farmed	JJ	farmed
chickens	NNS	chicken
.	SENT	.
.	SENT	.
BB-cat+ner-23902156/text	DOCUMENT	BB-cat+ner-23902156/text
Isolation	NN	Isolation
,	,	,
expression	NN	expression
and	CC	and
characterization	NN	characterization
of	IN	of
a	DT	a
minor	JJ	minor
allergen	NN	allergen
from	IN	from
Penicillium	NP	Penicillium
crustosum	NN	crustosum
.	SENT	.
.	SENT	.
A	DT	A
ribosomal	JJ	ribosomal
P1	NN	P1
protein	NN	protein
,	,	,
Pen	NP	Pen
b	VBP	b
26	CD	26
from	IN	from
Penicillium	NP	Penicillium
brevicompactum	NN	brevicompactum
,	,	,
was	VVD	be
previously	RB	previously
identified	VBN	identify
as	IN	as
a	DT	a
major	JJ	major
allergen	NN	allergen
.	SENT	.
.	SENT	.
A	DT	A
homolog	NN	homolog
protein	NN	protein
was	VVD	be
isolated	VBN	isolate
and	CC	and
characterized	VBN	characterize
from	IN	from
Penicillium	NP	Penicillium
crustosum	NN	crustosum
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
is	VVZ	be
not	RB	not
known	VBN	know
to	TO	to
be	VV	be
allergenic	JJ	allergenic
mold	NN	mold
.	SENT	.
.	SENT	.
A	DT	A
cDNA	NN	cDNA
library	NN	library
of	IN	of
P	NN	P
.	SENT	.
 crustosum	NN	 crustosum
was	VVD	be
constructed	VBN	construct
and	CC	and
screened	VBN	screen
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
using	VBG	use
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
probe	NN	probe
based	VBN	base
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
DNA	NN	DNA
sequence	NN	sequence
of	IN	of
Pen	NP	Pen
b	NN	b
26	CD	26
.	SENT	.
.	SENT	.
A	DT	A
positive	JJ	positive
clone	NN	clone
was	VVD	be
isolated	VBN	isolate
,	,	,
expressed	VBN	express
in	IN	in
Escherichia	NP	Escherichia
coli	NP	coli
,	,	,
purified	VBN	purify
and	CC	and
characterized	VBN	characterize
by	IN	by
comparing	VBG	compare
its	PP$	its
immunological	JJ	immunological
and	CC	and
physical	JJ	physical
properties	NNS	property
to	TO	to
Pen	NP	Pen
b	NN	b
26	CD	26
.	SENT	.
.	SENT	.
It	PP	It
was	VVD	be
designated	VBN	designate
as	IN	as
Pen	NP	Pen
cr	NN	cr
26	CD	26
and	CC	and
had	VHD	have
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
a	DT	a
321	CD	321
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
nt	NN	nt
ORF	NN	ORF
<FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
corresponding	VBG	correspond
to	TO	to
</FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
107	CD	107
amino	NN	amino
acids	NNS	acid
with	IN	with
a	DT	a
MW	NN	MW
of	IN	of
11 kDa	NN	11_kDa
.	SENT	.
.	SENT	.
Pen	IN	Pen
cr	NN	cr
26	CD	26
had	VHD	have
strong	JJ	strong
sequence	NN	sequence
homology	NN	homology
to	TO	to
Pen	NP	Pen
b	NN	b
26	CD	26
(	(	(
92%	CD	92%
for	IN	for
nucleotides	NNS	nucleotide
and	CC	and
86%	CD	86%
for	IN	for
amino	JJ	amino
acids	NNS	acid
)	)	)
and	CC	and
its	PP$	its
physical	JJ	physical
and	CC	and
predicted	VBN	predict
structural	JJ	structural
properties	NNS	property
were	VVD	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
similar	JJ	similar
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
latter	JJ	latter
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
level	NN	level
of	IN	of
expression	NN	expression
of	IN	of
Pen	NP	Pen
cr	NN	cr
26	CD	26
was	VVD	be
<FORBIDDEN ID=83 ACTION=delete>
much	RB	much
</FORBIDDEN ID=83 ACTION=delete>
lower	JJR	low
than	IN	than
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	DT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
of	IN	of
Pen	NP	Pen
b	NN	b
26	CD	26
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=16 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
same	JJ	same
</FORBIDDEN ID=16 ACTION=delete>
expression	NN	expression
vector	NN	vector
.	SENT	.
.	SENT	.
<FORBIDDEN ID=30 ACTION=delete>
Both	DT	Both
</FORBIDDEN ID=30 ACTION=delete>
proteins	NNS	protein
were	VVD	be
recognized	VBN	recognize
equally	RB	equally
well	RB	well
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
IgG	NN	IgG
class	NN	class
specific	JJ	specific
antibodies	NNS	antibody
,	,	,
but	CC	but
Pen	NP	Pen
cr	NN	cr
26	CD	26
was	VVD	be
poorly	RB	poorly
recognized	VBN	recognize
by	IN	by
Penicillium	NN	Penicillium
-	HYPH	-
sensitive	JJ	sensitive
atopic	JJ	atopic
sera	NNS	serum
(	(	(
IgE	NN	IgE
)	)	)
,	,	,
suggesting	VBG	suggest
striking	JJ	striking
antigenic	JJ	antigenic
difference	NN	difference
in	IN	in
IgE	NN	IgE
epitopes	NNS	epitope
,	,	,
<FORBIDDEN ID=71 ACTION=delete>
i.e.	FW	i.e.
</FORBIDDEN ID=71 ACTION=delete>
,	,	,
87%	CD	87%
were	VVD	be
positive	JJ	positive
for	IN	for
Pen	NP	Pen
b	NN	b
26	CD	26
while	IN	while
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
23%	CD	23%
were	VVD	be
positive	JJ	positive
for	IN	for
Pen	NP	Pen
cr	NN	cr
26	CD	26
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
allergenicity	NN	allergenicity
of	IN	of
Pen	NP	Pen
cr	NN	cr
26	CD	26
seems	VBZ	seem
to	TO	to
be	VV	be
minor	JJ	minor
in	IN	in
nature	NN	nature
and	CC	and
it	PP	it
could	MD	could
be	VV	be
a	DT	a
hypoallergenic	JJ	hypoallergenic
variant	NN	variant
of	IN	of
Pen	NP	Pen
b	NN	b
26	CD	26
.	SENT	.
.	SENT	.
BB-cat+ner-23908036/text	DOCUMENT	BB-cat+ner-23908036/text
Preliminary	JJ	Preliminary
X-ray	NN	X-ray
crystallographic	JJ	crystallographic
analysis	NN	analysis
of	IN	of
β	AFX	β
-	HYPH	-
carbonic	JJ	carbonic
anhydrase	NN	anhydrase
psCA3	NN	psCA3
from	IN	from
Pseudomonas	NP	Pseudomonas
aeruginosa	NN	aeruginosa
.	SENT	.
.	SENT	.
Pseudomonas	NN	Pseudomonas
aeruginosa	NN	aeruginosa
is	VVZ	be
a	DT	a
Gram	NN	Gram
-	HYPH	-
negative	JJ	negative
bacterium	NN	bacterium
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
causes	VBZ	cause
life	NN	life
-	HYPH	-
threatening	VBG	threaten
infections	NNS	infection
in	IN	in
susceptible	JJ	susceptible
individuals	NNS	individual
and	CC	and
is	VVZ	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
resistant	JJ	resistant
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
most	RBS	most
clinically	RB	clinically
available	JJ	available
antimicrobials	NNS	antimicrobial
.	SENT	.
.	SENT	.
Genomic	JJ	Genomic
and	CC	and
proteomic	JJ	proteomic
studies	NNS	study
have	VHP	have
identified	VBN	identify
three	CD	three
genes	NNS	gene
,	,	,
pa0102	NN	pa0102
,	,	,
pa2053	NN	pa2053
and	CC	and
pa4676	NN	pa4676
,	,	,
in	IN	in
P	NN	P
.	SENT	.
aeruginosa	NN	aeruginosa
PAO1	NN	PAO1
encoding	VBG	encode
three	CD	three
functional	JJ	functional
β	AFX	β
-	HYPH	-
carbonic	JJ	carbonic
anhydrases	NNS	anhydras
(	(	(
β	AFX	β
-	HYPH	-
CAs	NNS	CA
)	)	)
:	COLUMN	:
psCA1	NN	psCA1
,	,	,
psCA2	NN	psCA2
and	CC	and
psCA3	NN	psCA3
,	,	,
respectively	RB	respectively
.	SENT	.
.	SENT	.
These	DT	These
β	AFX	β
-	HYPH	-
CAs	NNS	CA
could	MD	could
serve	VB	serve
as	IN	as
novel	JJ	novel
antimicrobial	JJ	antimicrobial
drug	NN	drug
targets	NNS	target
for	IN	for
this	DT	this
pathogen	NN	pathogen
.	SENT	.
.	SENT	.
X-ray	NN	X-ray
crystallographic	JJ	crystallographic
structural	JJ	structural
studies	NNS	study
have	VHP	have
been	VVN	be
initiated	VBN	initiate
to	TO	to
characterize	VB	characterize
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
structure	NN	structure
and	CC	and
function	NN	function
of	IN	of
these	DT	these
proteins	NNS	protein
.	SENT	.
.	SENT	.
This	DT	This
communication	NN	communication
describes	VBZ	describe
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
production	NN	production
of	IN	of
two	CD	two
crystal	JJ	crystal
forms	NNS	form
(	(	(
A	NN	A
and	CC	and
B	NN	B
)	)	)
of	IN	of
β	AFX	β
-	HYPH	-
CA	NN	CA
psCA3	NN	psCA3
.	SENT	.
.	SENT	.
Form	NN	Form
A	NN	A
diffracted	VBN	diffract
to	TO	to
a	DT	a
resolution	NN	resolution
of	IN	of
2.9	CD	2.9
Å	NN	Å
;	COLUMN	;
it	PP	it
belonged	VBD	belong
to	TO	to
space	VB	space
group	NN	group
P212121	NN	P212121
,	,	,
with	IN	with
unit	NN	unit
-	HYPH	-
cell	NN	cell
<FORBIDDEN ID=1 ACTION=split SPLIT_AFTER=0>
parameters	NNS	parameter
a	DT	a
</FORBIDDEN ID=1 ACTION=split SPLIT_AFTER=0>
=	JJ	=
81.9	CD	81.9
,	,	,
b	NN	b
=	SYM	=
84.9	CD	84.9
,	,	,
c	NN	c
=	SYM	=
124.2	CD	124.2
Å	NN	Å
,	,	,
and	CC	and
had	VHD	have
a	DT	a
calculated	VBN	calculate
Matthews	NP	Matthews
coefficient	NN	coefficient
of	IN	of
2.23	CD	2.23
Å³	NP	Å³
Da⁻¹	NP	Da⁻¹
assuming	VBG	assume
four	CD	four
molecules	NNS	molecule
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
crystallographic	JJ	crystallographic
asymmetric	JJ	asymmetric
unit	NN	unit
.	SENT	.
.	SENT	.
Form	NN	Form
B	NN	B
diffracted	VBD	diffract
to	TO	to
a	DT	a
resolution	NN	resolution
of	IN	of
3.0	CD	3.0
Å	NN	Å
;	COLUMN	;
it	PP	it
belonged	VBD	belong
to	TO	to
space	VB	space
group	NN	group
P21212	NN	P21212
,	,	,
with	IN	with
unit	NN	unit
-	HYPH	-
cell	NN	cell
<FORBIDDEN ID=1 ACTION=split SPLIT_AFTER=0>
parameters	NNS	parameter
a	DT	a
</FORBIDDEN ID=1 ACTION=split SPLIT_AFTER=0>
=	JJ	=
69.9	CD	69.9
,	,	,
b	NN	b
=	SYM	=
77.7	CD	77.7
,	,	,
c	NN	c
=	SYM	=
88.5	CD	88.5
Å	NN	Å
,	,	,
and	CC	and
had	VHD	have
a	DT	a
calculated	VBN	calculate
Matthews	NP	Matthews
coefficient	NN	coefficient
of	IN	of
2.48	CD	2.48
Å³	NP	Å³
Da⁻¹	NP	Da⁻¹
assuming	VBG	assume
two	CD	two
molecules	NNS	molecule
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
crystallographic	JJ	crystallographic
asymmetric	JJ	asymmetric
unit	NN	unit
.	SENT	.
.	SENT	.
Preliminary	JJ	Preliminary
molecular	JJ	molecular
-	HYPH	-
replacement	NN	replacement
solutions	NNS	solution
have	VHP	have
been	VVN	be
determined	VBN	determine
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
PHENIX	NN	PHENIX
AutoMR	NN	AutoMR
wizard	NN	wizard
and	CC	and
refinement	NN	refinement
of	IN	of
<FORBIDDEN ID=30 ACTION=delete>
both	DT	both
</FORBIDDEN ID=30 ACTION=delete>
crystal	JJ	crystal
forms	NNS	form
is	VVZ	be
currently	RB	currently
in	IN	in
progress	NN	progress
.	SENT	.
.	SENT	.
BB-cat+ner-24198224/text	DOCUMENT	BB-cat+ner-24198224/text
A	DT	A
large	JJ	large
outbreak	NN	outbreak
of	IN	of
Salmonella	NP	Salmonella
Paratyphi	NP	Paratyphi
A	NP	A
infection	NN	infection
among	IN	among
israeli	JJ	israeli
travelers	NNS	traveler
to	TO	to
Nepal	NP	Nepal
.	SENT	.
.	SENT	.
In	IN	In
Asia	NP	Asia
,	,	,
Salmonella	NP	Salmonella
Paratyphi	NP	Paratyphi
A	NP	A
is	VVZ	be
an	DT	an
emerging	VBG	emerge
infection	NN	infection
,	,	,
and	CC	and
travelers	NNS	traveler
are	VVP	be
increasingly	RB	increasingly
at	IN	at
risk	NN	risk
.	SENT	.
.	SENT	.
During	IN	During
October	NP	October
2009-November	NP	2009-November
2009	CD	2009
,	,	,
an	DT	an
outbreak	NN	outbreak
in	IN	in
S	NN	S
.	SENT	.
.	SENT	.
Paratyphi	NP	Paratyphi
A	NP	A
infection	NN	infection
was	VVD	be
noted	VBN	note
in	IN	in
Israeli	JJ	Israeli
travelers	NNS	traveler
returning	VBG	return
from	IN	from
Nepal	NP	Nepal
.	SENT	.
.	SENT	.
An	DT	An
outbreak	JJ	outbreak
investigation	NN	investigation
included	VBD	include
a	DT	a
standardized	JJ	standardized
exposure	NN	exposure
questionnaire	NN	questionnaire
admitted	VBN	admit
to	TO	to
all	DT	all
patients	NNS	patient
and	CC	and
medical	JJ	medical
chart	NN	chart
abstraction	NN	abstraction
.	SENT	.
.	SENT	.
Isolates	NNS	Isolate
were	VVD	be
tested	VBN	test
for	IN	for
antimicrobial	JJ	antimicrobial
susceptibility	NN	susceptibility
and	CC	and
pulsed	JJ	pulsed
-	HYPH	-
field	NN	field
gel	NN	gel
electrophoresis	NN	electrophoresis
(	(	(
PFGE	NN	PFGE
)	)	)
.	SENT	.
.	SENT	.
During	IN	During
1	CD	1
October	NP	October
2009-30	CD	2009-30
November	NP	November
2009	CD	2009
,	,	,
37	CD	37
Israeli	JJ	Israeli
travelers	NNS	traveler
returning	VBG	return
from	IN	from
Nepal	NP	Nepal
were	VVD	be
diagnosed	VBN	diagnose
with	IN	with
S	NN	S
.	SENT	.
.	SENT	.
<FORBIDDEN ID=2 ACTION=split SPLIT_AFTER=0>
Paratyphi	NP	Paratyphi
A	DT	A
</FORBIDDEN ID=2 ACTION=split SPLIT_AFTER=0>
bacteremia	NN	bacteremia
.	SENT	.
.	SENT	.
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
All	DT	All
37	CD	37
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
case	NN	case
isolates	NNS	isolate
had	VHD	have
an	DT	an
identical	JJ	identical
pattern	NN	pattern
on	IN	on
PFGE	NN	PFGE
,	,	,
and	CC	and
all	DT	all
were	VVD	be
nalidixic	JJ	nalidixic
acid	NN	acid
resistant	JJ	resistant
.	SENT	.
.	SENT	.
<FORBIDDEN ID=156 ACTION=delete>
Only	RB	Only
</FORBIDDEN ID=156 ACTION=delete>
1	CD	1
food	NN	food
venue	NN	venue
was	VVD	be
frequented	VBN	frequent
by	IN	by
all	PDT	all
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
outbreak	JJ	outbreak
cases	NNS	case
,	,	,
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
largest	JJS	large
number	NN	number
of	IN	of
exposures	NNS	exposure
occurring	VBG	occur
around	IN	around
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Jewish	NP	Jewish
<FORBIDDEN ID=38 ACTION=delete>
<FORBIDDEN ID=37 ACTION=delete>
New	NP	New
</FORBIDDEN ID=37 ACTION=delete>
</FORBIDDEN ID=38 ACTION=delete>
Year	NP	Year
.	SENT	.
.	SENT	.
All	DT	All
patients	NNS	patient
recovered	VBD	recover
without	IN	without
complications	NNS	complication
.	SENT	.
.	SENT	.
Time	NN	Time
to	TO	to
defervescence	NN	defervescence
in	IN	in
17	CD	17
patients	NNS	patient
treated	VBN	treat
with	IN	with
ceftriaxone	NN	ceftriaxone
and	CC	and
azithromycin	NN	azithromycin
combination	NN	combination
was	VVD	be
3.2	CD	3.2
days	NNS	day
(	(	(
±	NN	±
1.7	CD	1.7
)	)	)
,	,	,
whereas	IN	whereas
in	IN	in
13	CD	13
cases	NNS	case
treated	VBN	treat
with	IN	with
ceftriaxone	NN	ceftriaxone
monotherapy	NN	monotherapy
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
time	NN	time
to	TO	to
defervescence	NN	defervescence
was	VVD	be
6.6	CD	6.6
days	NNS	day
(	(	(
±	NN	±
1.8	CD	1.8
;	COLUMN	;
P	NN	P
INF	SYM	INF
.	SENT	.
001	CD	001
)	)	)
.	SENT	.
.	SENT	.
A	DT	A
point	NN	point
-	HYPH	-
source	NN	source
,	,	,
"	''	"
Paratyphoid	NP	Paratyphoid
Mary	NP	Mary
"	''	"
-	HYPH	-
like	JJ	like
outbreak	NN	outbreak
was	VVD	be
identified	VBN	identify
among	IN	among
Israeli	JJ	Israeli
travelers	NNS	traveler
to	TO	to
Nepal	NP	Nepal
.	SENT	.
.	SENT	.
Combination	NN	Combination
Ceftriaxone	NN	Ceftriaxone
-	HYPH	-
Azithromycin	NN	Azithromycin
therapy	NN	therapy
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
provide	VB	provide
a	DT	a
therapeutic	JJ	therapeutic
advantage	NN	advantage
over	IN	over
monotherapy	NN	monotherapy
,	,	,
and	CC	and
merits	VBZ	merit
<FORBIDDEN ID=79 ACTION=delete>
further	JJ	further
</FORBIDDEN ID=79 ACTION=delete>
clinical	JJ	clinical
trials	NNS	trial
.	SENT	.
.	SENT	.
BB-cat+ner-24251551/text	DOCUMENT	BB-cat+ner-24251551/text
Structure	NN	Structure
of	IN	of
MurNAc	NN	MurNAc
6-phosphate	NN	6-phosphate
hydrolase	NN	hydrolase
(	(	(
MurQ	NN	MurQ
)	)	)
from	IN	from
Haemophilus	NP	Haemophilus
influenzae	VBP	influenzae
with	IN	with
a	DT	a
bound	VBN	bind
inhibitor	NN	inhibitor
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
breakdown	NN	breakdown
and	CC	and
recycling	NN	recycling
of	IN	of
peptidoglycan	NN	peptidoglycan
,	,	,
an	DT	an
essential	JJ	essential
polymeric	JJ	polymeric
cell	NN	cell
structure	NN	structure
,	,	,
occur	VBP	occur
in	IN	in
a	DT	a
number	NN	number
of	IN	of
bacterial	JJ	bacterial
species	NNS	specie
.	SENT	.
.	SENT	.
A	DT	A
key	JJ	key
enzyme	NN	enzyme
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
recycling	VBG	recycle
pathway	NN	pathway
of	IN	of
<FORBIDDEN ID=55 ACTION=delete>
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
one	CD	one
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=55 ACTION=delete>
the	DT	the
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
components	NNS	component
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
peptidoglycan	NN	peptidoglycan
layer	NN	layer
,	,	,
N-acetylmuramic	JJ	N-acetylmuramic
acid	NN	acid
(	(	(
MurNAc	NN	MurNAc
)	)	)
,	,	,
is	VVZ	be
MurNAc	JJ	MurNAc
6-phosphate	NN	6-phosphate
hydrolase	NN	hydrolase
(	(	(
MurQ	NN	MurQ
)	)	)
.	SENT	.
.	SENT	.
This	DT	This
enzyme	NN	enzyme
catalyzes	VBZ	catalyze
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cofactor	NN	cofactor
-	HYPH	-
independent	JJ	independent
cleavage	NN	cleavage
of	IN	of
a	DT	a
relatively	RB	relatively
nonlabile	JJ	nonlabile
ether	NN	ether
bond	NN	bond
and	CC	and
presents	VBZ	present
an	DT	an
interesting	JJ	interesting
target	NN	target
for	IN	for
mechanistic	JJ	mechanistic
studies	NNS	study
.	SENT	.
.	SENT	.
Open	JJ	Open
chain	NN	chain
product	NN	product
and	CC	and
substrate	NN	substrate
analogues	NNS	analogue
were	VVD	be
synthesized	VBN	synthesize
and	CC	and
tested	VBN	test
as	IN	as
competitive	JJ	competitive
inhibitors	NNS	inhibitor
(	(	(
K(is)	NN	K(is)
values	NNS	value
of	IN	of
1.1	CD	1.1
±	NN	±
0.3	CD	0.3
and	CC	and
0.23	CD	0.23
±	HYPH	±
0.02	CD	0.02
mM	NN	mM
,	,	,
respectively	RB	respectively
)	)	)
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MurNAc	NP	MurNAc
6P	NN	6P
hydrolase	NN	hydrolase
from	IN	from
Escherichia	FW	Escherichia
coli	FW	coli
(	(	(
MurQ	NN	MurQ
-	HYPH	-
EC	NN	EC
)	)	)
.	SENT	.
.	SENT	.
To	TO	To
identify	VB	identify
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
roles	NNS	role
of	IN	of
active	JJ	active
site	NN	site
residues	NNS	residue
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
are	VVP	be
important	JJ	important
for	IN	for
catalysis	NN	catalysis
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
substrate	NN	substrate
analogue	NN	analogue
was	VVD	be
cocrystallized	VBN	cocrystallize
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MurNAc	NP	MurNAc
6P	NN	6P
hydrolase	NN	hydrolase
from	IN	from
Haemophilus	NP	Haemophilus
influenzae	NP	influenzae
(	(	(
MurQ	NN	MurQ
-	HYPH	-
HI	NN	HI
)	)	)
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
was	VVD	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
amenable	JJ	amenable
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
crystallographic	JJ	crystallographic
studies	NNS	study
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cocrystal	JJ	cocrystal
structure	NN	structure
of	IN	of
MurQ	NN	MurQ
-	HYPH	-
HI	NN	HI
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
substrate	NN	substrate
analogue	NN	analogue
showed	VBD	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
Glu89	NN	Glu89
was	VVD	be
located	VBN	locate
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
proximity	NN	proximity
of	IN	of
<FORBIDDEN ID=30 ACTION=delete>
both	CC	both
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=30 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
C2	NN	C2
atom	NN	atom
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
oxygen	NN	oxygen
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
C3	NN	C3
position	NN	position
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bound	VBN	bind
inhibitor	NN	inhibitor
and	CC	and
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
no	DT	no
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
potential	JJ	potential
acid	NN	acid
/	SYM	/
base	NN	base
residue	NN	residue
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
could	MD	could
act	VB	act
as	IN	as
an	DT	an
active	JJ	active
site	NN	site
acid	NN	acid
/	SYM	/
base	NN	base
was	VVD	be
located	VBN	locate
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
vicinity	NN	vicinity
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
conserved	VBN	conserve
residues	NNS	residue
Glu120	NN	Glu120
and	CC	and
Lys239	NN	Lys239
were	VVD	be
found	VBN	find
within	IN	within
hydrogen	NN	hydrogen
bonding	VBG	bond
distance	NN	distance
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
C5	NN	C5
hydroxyl	NN	hydroxyl
group	NN	group
and	CC	and
C6	NN	C6
phosphate	NN	phosphate
group	NN	group
,	,	,
suggesting	VBG	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
they	PP	they
play	VBP	play
a	DT	a
role	NN	role
in	IN	in
substrate	NN	substrate
binding	NN	binding
and	CC	and
ring	NN	ring
opening	NN	opening
.	SENT	.
.	SENT	.
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
Combining	VBG	Combine
these	DT	these
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
results	NNS	result
with	IN	with
previous	JJ	previous
biochemical	JJ	biochemical
data	NNS	datum
,	,	,
we	PP	we
propose	VBP	propose
a	DT	a
one-base	JJ	one-base
mechanism	NN	mechanism
of	IN	of
action	NN	action
in	IN	in
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
Glu89	NN	Glu89
functions	VBZ	function
to	TO	to
<FORBIDDEN ID=30 ACTION=delete>
both	CC	both
</FORBIDDEN ID=30 ACTION=delete>
deprotonate	NN	deprotonate
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
C2	NN	C2
position	NN	position
and	CC	and
assist	NN	assist
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
departure	NN	departure
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
lactyl	NN	lactyl
ether	NN	ether
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
C3	NN	C3
position	NN	position
.	SENT	.
.	SENT	.
This	DT	This
<FORBIDDEN ID=16 ACTION=delete>
same	JJ	same
</FORBIDDEN ID=16 ACTION=delete>
residue	NN	residue
would	MD	would
serve	VB	serve
to	TO	to
deprotonate	VB	deprotonate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
incoming	JJ	incoming
water	NN	water
and	CC	and
reprotonate	VB	reprotonate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
enolate	NN	enolate
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
second	JJ	second
half	NN	half
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
catalytic	JJ	catalytic
cycle	NN	cycle
.	SENT	.
.	SENT	.
BB-cat+ner-24361838/text	DOCUMENT	BB-cat+ner-24361838/text
Evaluation	NN	Evaluation
of	IN	of
a	DT	a
lytic	JJ	lytic
bacteriophage	NN	bacteriophage
,	,	,
Φ	NN	Φ
st1	NN	st1
,	,	,
for	IN	for
biocontrol	NN	biocontrol
of	IN	of
Salmonella	NP	Salmonella
enterica	NP	enterica
serovar	NP	serovar
Typhimurium	NP	Typhimurium
in	IN	in
chickens	NNS	chicken
.	SENT	.
.	SENT	.
In	IN	In
this	DT	this
study	NN	study
,	,	,
a	DT	a
Salmonella	NP	Salmonella
Typhimurium	NP	Typhimurium
lytic	JJ	lytic
bacteriophage	NN	bacteriophage
,	,	,
Φ	NN	Φ
st1	NN	st1
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
was	VVD	be
isolated	VBN	isolate
from	IN	from
chicken	NN	chicken
faecal	JJ	faecal
material	NN	material
,	,	,
was	VVD	be
evaluated	VBN	evaluate
as	IN	as
a	DT	a
candidate	NN	candidate
for	IN	for
biocontrol	NN	biocontrol
of	IN	of
Salmonella	NP	Salmonella
in	IN	in
chickens	NNS	chicken
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
morphology	NN	morphology
of	IN	of
Φ	NN	Φ
st1	NN	st1
showed	VBD	show
strong	JJ	strong
resemblance	NN	resemblance
to	TO	to
members	NNS	member
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Siphoviridae	NP	Siphoviridae
family	NN	family
.	SENT	.
.	SENT	.
Φ	NN	Φ
st1	NN	st1
was	VVD	be
observed	VBN	observe
to	TO	to
be	VV	be
a	DT	a
DNA	NN	DNA
phage	NN	phage
with	IN	with
an	DT	an
estimated	VBN	estimate
genome	NN	genome
size	NN	size
of	IN	of
121	CD	121
kbp	NN	kbp
.	SENT	.
.	SENT	.
It	PP	It
was	VVD	be
found	VBN	find
to	TO	to
be	VV	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
able	JJ	able
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
infect	VB	infect
S	NN	S
.	SENT	.
.	SENT	.
Typhimurium	NN	Typhimurium
and	CC	and
S	NN	S
.	SENT	.
.	SENT	.
Hadar	NP	Hadar
,	,	,
with	IN	with
a	DT	a
stronger	JJR	strong
lytic	JJ	lytic
activity	NN	activity
against	IN	against
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
former	JJ	former
.	SENT	.
.	SENT	.
Subsequent	JJ	Subsequent
characterisation	NN	characterisation
of	IN	of
Φ	NN	Φ
st1	NN	st1
against	IN	against
S	NN	S
.	SENT	.
.	SENT	.
Typhimurium	NN	Typhimurium
showed	VBD	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
Φ	NN	Φ
st1	NN	st1
has	VHZ	have
a	DT	a
latent	JJ	latent
period	NN	period
of	IN	of
40	CD	40
min	NN	min
with	IN	with
an	DT	an
average	JJ	average
burst	NN	burst
size	NN	size
of	IN	of
22	CD	22
particles	NNS	particle
per	IN	per
infective	JJ	infective
centre	NN	centre
.	SENT	.
.	SENT	.
Approximately	RB	Approximately
86.1	CD	86.1
%	NN	%
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
phage	NN	phage
adsorbed	VBN	adsorb
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
host	NN	host
cells	NNS	cell
within	IN	within
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
initial	JJ	initial
5	CD	5
min	NN	min
of	IN	of
infection	NN	infection
.	SENT	.
.	SENT	.
At	IN	At
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
optimum	JJ	optimum
multiplicity	NN	multiplicity
of	IN	of
infection	NN	infection
(	(	(
MOI	NN	MOI
)	)	)
(	(	(
0.1	CD	0.1
)	)	)
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
highest	JJS	high
reduction	NN	reduction
rate	NN	rate
of	IN	of
S	NN	S
.	SENT	.
.	SENT	.
Typhimurium	NN	Typhimurium
(	(	(
6.6	CD	6.6
log₁₀	NN	log₁₀
CFU	NN	CFU
/	SYM	/
ml	NN	ml
)	)	)
and	CC	and
increment	NN	increment
in	IN	in
phage	NN	phage
titre	NN	titre
(	(	(
3.8	CD	3.8
log₁₀	NN	log₁₀
PFU	NN	PFU
/	SYM	/
ml	NN	ml
)	)	)
was	VVD	be
observed	VBN	observe
.	SENT	.
.	SENT	.
Φ	NN	Φ
st1	NN	st1
produced	VBD	produce
adsorption	NN	adsorption
rates	NNS	rate
of	IN	of
88.4-92.2	CD	88.4-92.2
%	NN	%
at	IN	at
pH	NN	pH
7-9	CD	7-9
and	CC	and
demonstrated	VBD	demonstrate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
highest	JJS	high
bacteria	NN	bacteria
reduction	NN	reduction
(	(	(
6.6	CD	6.6
log₁₀	NN	log₁₀
CFU	NN	CFU
/	SYM	/
ml	NN	ml
)	)	)
at	IN	at
pH9	NN	pH9
.	SENT	.
.	SENT	.
Φ	NN	Φ
st1	NN	st1
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
showed	VBD	show
an	DT	an
insignificant	JJ	insignificant
different	JJ	different
(	(	(
PSUP	NN	PSUP
0.05	CD	0.05
)	)	)
reduction	NN	reduction
rate	NN	rate
of	IN	of
host	NN	host
cells	NNS	cell
at	IN	at
37	CD	37
°C	NN	°C
(	(	(
6.4	CD	6.4
log₁₀	NN	log₁₀
CFU	NN	CFU
/	SYM	/
ml	NN	ml
)	)	)
and	CC	and
42	CD	42
°C	NN	°C
(	(	(
6.0	CD	6.0
log₁₀	NN	log₁₀
CFU	NN	CFU
/	SYM	/
ml	NN	ml
)	)	)
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
in vivo	NN	in_vivo
study	NN	study
using	VBG	use
Φ	NN	Φ
st1	NN	st1
showed	VBD	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
intracloacal	JJ	intracloacal
inoculation	NN	inoculation
of	IN	of
~10¹²	NN	~10¹²
PFU	NN	PFU
/	SYM	/
ml	NN	ml
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
phage	NN	phage
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
chickens	NNS	chicken
challenged	VBD	challenge
with	IN	with
~10¹⁰	NN	~10¹⁰
CFU	NN	CFU
/	SYM	/
ml	NN	ml
of	IN	of
S	NN	S
.	SENT	.
.	SENT	.
Typhimurium	NP	Typhimurium
was	VVD	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
able	JJ	able
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
reduce	VB	reduce
(	(	(
PINF	NN	PINF
0.05	CD	0.05
)	)	)
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
S	NN	S
.	SENT	.
.	SENT	.
Typhimurium	NP	Typhimurium
<FORBIDDEN ID=82 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
rapidly	RB	rapidly
than	IN	than
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
untreated	JJ	untreated
group	NN	group
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Salmonella	NP	Salmonella
count	NN	count
reduced	VBD	reduce
to	TO	to
2.9	CD	2.9
log₁₀	NN	log₁₀
CFU	NN	CFU
/	SYM	/
ml	NN	ml
within	IN	within
6h	NN	6h
of	IN	of
post	AFX	post
-	HYPH	-
challenge	NN	challenge
and	CC	and
S	NN	S
.	SENT	.
.	SENT	.
Typhimurium	NN	Typhimurium
was	VVD	be
not	RB	not
detected	VBN	detect
at	IN	at
and	CC	and
after	IN	after
24h	NN	24h
of	IN	of
post	AFX	post
-	HYPH	-
challenge	NN	challenge
.	SENT	.
.	SENT	.
Reduction	NN	Reduction
of	IN	of
Salmonella	NP	Salmonella
count	NN	count
in	IN	in
visceral	JJ	visceral
organs	NNS	organ
was	VVD	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
observed	VBN	observe
at	IN	at
6h	CD	6h
post	AFX	post
-	HYPH	-
challenge	NN	challenge
.	SENT	.
.	SENT	.
Approximately	RB	Approximately
1.6	CD	1.6
log₁₀	NN	log₁₀
FU	NN	FU
/	SYM	/
ml	NN	ml
Φ	SYM	Φ
st1	NN	st1
was	VVD	be
found	VBN	find
to	TO	to
persist	VB	persist
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
caecal	JJ	caecal
wall	NN	wall
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
chicks	NNS	chick
at	IN	at
72	CD	72
h	NN	h
of	IN	of
post	AFX	post
-	HYPH	-
challenge	NN	challenge
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
present	JJ	present
study	NN	study
indicated	VBD	indicate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
Φ	NN	Φ
st1	NN	st1
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
serve	VB	serve
as	IN	as
a	DT	a
potential	JJ	potential
biocontrol	NN	biocontrol
agent	NN	agent
to	TO	to
reduce	VB	reduce
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Salmonella	NP	Salmonella
count	NN	count
in	IN	in
caecal	JJ	caecal
content	NN	content
of	IN	of
chickens	NNS	chicken
.	SENT	.
.	SENT	.
BB-cat+ner-24389148/text	DOCUMENT	BB-cat+ner-24389148/text
Molecular	JJ	Molecular
determinants	NNS	determinant
for	IN	for
a	DT	a
cardiovascular	JJ	cardiovascular
collapse	NN	collapse
in	IN	in
anthrax	NN	anthrax
.	SENT	.
.	SENT	.
Bacillus	NN	Bacillus
anthracis	NN	anthracis
releases	VBZ	release
two	CD	two
bipartite	JJ	bipartite
proteins	NNS	protein
,	,	,
lethal	JJ	lethal
toxin	NN	toxin
and	CC	and
edema	NN	edema
factor	NN	factor
,	,	,
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
contribute	VBP	contribute
significantly	RB	significantly
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
progression	NN	progression
of	IN	of
anthrax	NN	anthrax
-	HYPH	-
associated	VBN	associate
shock	NN	shock
.	SENT	.
.	SENT	.
As	IN	As
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
blocking	VBG	block
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
anthrax	NN	anthrax
toxins	NNS	toxin
prevents	VBZ	prevent
disease	NN	disease
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
toxins	NNS	toxin
are	VVP	be
considered	VBN	consider
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
main	JJ	main
virulence	NN	virulence
factors	NNS	factor
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bacterium	NN	bacterium
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
anthrax	NN	anthrax
bacterium	NN	bacterium
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
anthrax	NN	anthrax
toxins	NNS	toxin
trigger	VBP	trigger
multi	AFX	multi
-	HYPH	-
organ	NN	organ
failure	NN	failure
associated	VBN	associate
with	IN	with
enhanced	VBN	enhance
vascular	JJ	vascular
permeability	NN	permeability
,	,	,
hemorrhage	NN	hemorrhage
and	CC	and
cardiac	JJ	cardiac
dysfunction	NN	dysfunction
in	IN	in
animal	NN	animal
challenge	NN	challenge
models	NNS	model
.	SENT	.
.	SENT	.
A	DT	A
recent	JJ	recent
study	NN	study
using	VBG	use
mice	NNS	mouse
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
either	CC	either
lacked	VBD	lack
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
anthrax	NN	anthrax
toxin	NN	toxin
receptor	NN	receptor
in	IN	in
specific	JJ	specific
cells	NNS	cell
and	CC	and
corresponding	VBG	correspond
mice	NNS	mouse
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
expressing	VBG	express
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
receptor	NN	receptor
in	IN	in
specific	JJ	specific
cell	NN	cell
types	NNS	type
demonstrated	VBD	demonstrate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
cardiovascular	JJ	cardiovascular
cells	NNS	cell
are	VVP	be
critical	JJ	critical
for	IN	for
disease	NN	disease
mediated	VBN	mediate
by	IN	by
anthrax	NN	anthrax
lethal	JJ	lethal
toxin	NN	toxin
.	SENT	.
.	SENT	.
These	DT	These
studies	NNS	study
are	VVP	be
consistent	JJ	consistent
with	IN	with
involvement	NN	involvement
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cardiovascular	JJ	cardiovascular
system	NN	system
,	,	,
and	CC	and
with	IN	with
an	DT	an
increase	NN	increase
of	IN	of
cardiac	JJ	cardiac
failure	NN	failure
markers	NNS	marker
observed	VBN	observe
in	IN	in
human	JJ	human
anthrax	NN	anthrax
and	CC	and
in	IN	in
animal	NN	animal
models	NNS	model
using	VBG	use
B	NN	B
.	SENT	.
anthracis	NN	anthracis
and	CC	and
anthrax	NN	anthrax
toxins	NNS	toxin
.	SENT	.
.	SENT	.
This	DT	This
review	NN	review
discusses	VBZ	discuss
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
current	JJ	current
state	NN	state
of	IN	of
knowledge	NN	knowledge
<FORBIDDEN ID=150 ACTION=delete>
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
regarding	VBG	regard
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=150 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
pathophysiology	NN	pathophysiology
of	IN	of
anthrax	NN	anthrax
and	CC	and
tries	VBZ	try
to	TO	to
provide	VB	provide
a	DT	a
mechanistic	JJ	mechanistic
model	NN	model
and	CC	and
molecular	JJ	molecular
determinants	NNS	determinant
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
circulatory	JJ	circulatory
shock	NN	shock
in	IN	in
anthrax	NN	anthrax
.	SENT	.
.	SENT	.
BB-cat+ner-24584903/text	DOCUMENT	BB-cat+ner-24584903/text
On	IN	On
destabilization	NN	destabilization
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Fenna	NP	Fenna
-	HYPH	-
Matthews	NP	Matthews
-	HYPH	-
Olson	NP	Olson
complex	NN	complex
of	IN	of
Chlorobaculum	NN	Chlorobaculum
tepidum	NN	tepidum
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Fenna	NP	Fenna
-	HYPH	-
Matthews	NP	Matthews
-	HYPH	-
Olson	NP	Olson
(	(	(
FMO	NN	FMO
)	)	)
complex	NN	complex
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
green	JJ	green
sulfur	NN	sulfur
bacterium	NN	bacterium
Chlorobaculum	NN	Chlorobaculum
tepidum	NN	tepidum
was	VVD	be
studied	VBN	study
with	IN	with
<FORBIDDEN ID=58 ACTION=delete>
respect	NN	respect
to	TO	to
</FORBIDDEN ID=58 ACTION=delete>
its	PP$	its
stability	NN	stability
.	SENT	.
.	SENT	.
We	PP	We
provide	VBP	provide
a	DT	a
critical	JJ	critical
assessment	NN	assessment
of	IN	of
published	VBN	publish
and	CC	and
recently	RB	recently
measured	VBN	measure
optical	JJ	optical
spectra	NNS	spectrum
.	SENT	.
.	SENT	.
FMO	NN	FMO
complexes	NNS	complex
were	VVD	be
found	VBN	find
to	TO	to
destabilize	VB	destabilize
over	IN	over
time	NN	time
producing	VBG	produce
spectral	JJ	spectral
shifts	NNS	shift
,	,	,
with	IN	with
destabilized	JJ	destabilized
samples	NNS	sample
having	VHG	have
significantly	RB	significantly
higher	JJR	high
hole	NN	hole
-	HYPH	-
burning	VBG	burn
efficiencies	NNS	efficiency
;	COLUMN	;
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
indicating	VBG	indicate
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
remodeled	VBN	remodel
protein	NN	protein
energy	NN	energy
landscape	NN	landscape
.	SENT	.
.	SENT	.
Observed	VBN	Observe
correlated	VBD	correlate
peak	JJ	peak
shifts	NNS	shift
near	IN	near
825	CD	825
and	CC	and
815 nm	CD	815 nm
suggest	VBP	suggest
possible	JJ	possible
correlated	VBN	correlate
(	(	(
protein	NN	protein
)	)	)
fluctuations	NNS	fluctuation
.	SENT	.
.	SENT	.
It	PP	It
is	VVZ	be
proposed	VBN	propose
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
value	NN	value
of	IN	of
35 cm	NN	35 cm
(	(	(
-1	NN	-1
)	)	)
widely	RB	widely
used	VBN	use
for	IN	for
reorganization	NN	reorganization
energy	NN	energy
(	(	(
E	NN	E
λ	NN	λ
)	)	)
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
has	VHZ	have
important	JJ	important
implications	NNS	implication
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
contributions	NNS	contribution
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
coherence	NN	coherence
rate	NN	rate
(	(	(
Kreisbeck	NP	Kreisbeck
and	CC	and
Kramer	NP	Kramer
3	CD	3
:	COLUMN	:
2828-2833	CD	2828-2833
,	,	,
2012	CD	2012
)	)	)
,	,	,
in	IN	in
<FORBIDDEN ID=54 ACTION=delete>
various	JJ	various
</FORBIDDEN ID=54 ACTION=delete>
modeling	NN	modeling
studies	NNS	study
of	IN	of
two-dimensional	JJ	two-dimensional
electronic	JJ	electronic
spectra	NNS	spectrum
is	VVZ	be
overestimated	VBN	overestimate
.	SENT	.
.	SENT	.
We	PP	We
demonstrate	VBP	demonstrate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
value	NN	value
of	IN	of
E	NN	E
λ	NN	λ
is	VVZ	be
most	RBS	most
likely	JJ	likely
about	IN	about
15-22	CD	15-22
 cm	NN	 cm
(	(	(
-1	CD	-1
)	)	)
and	CC	and
suggest	VBP	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
spectra	NNS	spectrum
reported	VBN	report
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
literature	NN	literature
(	(	(
often	RB	often
measured	VBN	measure
on	IN	on
different	JJ	different
FMO	NN	FMO
samples	NNS	sample
)	)	)
exhibit	VBP	exhibit
varied	JJ	varied
peak	JJ	peak
positions	NNS	position
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
due	JJ	due
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
different	JJ	different
purification	NN	purification
/	SYM	/
isolation	NN	isolation
procedures	NNS	procedure
or	CC	or
destabilization	NN	destabilization
effects	NNS	effect
.	SENT	.
.	SENT	.
BB-cat+ner-24678646/text	DOCUMENT	BB-cat+ner-24678646/text
Natural	JJ	Natural
history	NN	history
of	IN	of
colonization	NN	colonization
with	IN	with
methicillin	NN	methicillin
-	HYPH	-
resistant	JJ	resistant
Staphylococcus	NN	Staphylococcus
aureus	NN	aureus
(	(	(
MRSA	NN	MRSA
)	)	)
and	CC	and
vancomycin	NN	vancomycin
-	HYPH	-
resistant	JJ	resistant
Enterococcus	NN	Enterococcus
(	(	(
VRE	NN	VRE
)	)	)
:	COLUMN	:
a	DT	a
systematic	JJ	systematic
review	NN	review
.	SENT	.
.	SENT	.
No	DT	No
published	VBN	publish
systematic	JJ	systematic
reviews	NNS	review
have	VHP	have
assessed	VBN	assess
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
natural	JJ	natural
history	NN	history
of	IN	of
colonization	NN	colonization
with	IN	with
methicillin	NN	methicillin
-	HYPH	-
resistant	JJ	resistant
Staphylococcus	NN	Staphylococcus
aureus	NN	aureus
(	(	(
MRSA	NN	MRSA
)	)	)
or	CC	or
vancomycin	NN	vancomycin
-	HYPH	-
resistant	JJ	resistant
Enterococcus	NN	Enterococcus
(	(	(
VRE	NN	VRE
)	)	)
.	SENT	.
.	SENT	.
Time	NN	Time
to	TO	to
clearance	NN	clearance
of	IN	of
colonization	NN	colonization
has	VHZ	have
important	JJ	important
implications	NNS	implication
for	IN	for
patient	NN	patient
care	NN	care
and	CC	and
infection	NN	infection
control	NN	control
policy	NN	policy
.	SENT	.
.	SENT	.
We	PP	We
performed	VBD	perform
parallel	JJ	parallel
searches	NNS	search
in	IN	in
OVID	NN	OVID
Medline	NN	Medline
for	IN	for
studies	NNS	study
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
reported	VBD	report
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
time	NN	time
to	TO	to
<FORBIDDEN ID=106 ACTION=delete>
documented	VBN	document
</FORBIDDEN ID=106 ACTION=delete>
clearance	NN	clearance
of	IN	of
MRSA	NN	MRSA
and	CC	and
VRE	NN	VRE
colonization	NN	colonization
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
absence	NN	absence
of	IN	of
treatment	NN	treatment
,	,	,
published	VBN	publish
between	IN	between
<FORBIDDEN ID=119 ACTION=delete>
January	NP	January
</FORBIDDEN ID=119 ACTION=delete>
1990	CD	1990
and	CC	and
<FORBIDDEN ID=125 ACTION=delete>
July	NP	July
</FORBIDDEN ID=125 ACTION=delete>
2012	CD	2012
.	SENT	.
.	SENT	.
For	IN	For
MRSA	NN	MRSA
,	,	,
we	PP	we
screened	VBD	screen
982	CD	982
articles	NNS	article
,	,	,
identified	VBD	identify
16	CD	16
eligible	JJ	eligible
studies	NNS	study
(	(	(
13	CD	13
observational	JJ	observational
studies	NNS	study
and	CC	and
3	CD	3
randomized	VBN	randomize
controlled	VBN	control
trials	NNS	trial
)	)	)
,	,	,
for	IN	for
a	DT	a
total	NN	total
of	IN	of
1	CD	1
,	,	,
804	CD	804
non-duplicated	JJ	non-duplicated
subjects	NNS	subject
.	SENT	.
.	SENT	.
For	IN	For
VRE	NN	VRE
,	,	,
we	PP	we
screened	VBD	screen
284	CD	284
articles	NNS	article
,	,	,
identified	VBD	identify
13	CD	13
eligible	JJ	eligible
studies	NNS	study
(	(	(
12	CD	12
observational	JJ	observational
studies	NNS	study
and	CC	and
1	CD	1
randomized	VBD	randomize
controlled	VBN	control
trial	NN	trial
)	)	)
,	,	,
for	IN	for
a	DT	a
total	NN	total
of	IN	of
1	CD	1
,	,	,
936	CD	936
non-duplicated	JJ	non-duplicated
subjects	NNS	subject
.	SENT	.
.	SENT	.
Studies	NNS	Study
reported	VBD	report
varying	VBG	vary
definitions	NNS	definition
of	IN	of
clearance	NN	clearance
of	IN	of
colonization	NN	colonization
;	COLUMN	;
no	DT	no
study	NN	study
reported	VBD	report
time	NN	time
of	IN	of
initial	JJ	initial
colonization	NN	colonization
.	SENT	.
.	SENT	.
Studies	NNS	Study
varied	VBD	vary
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
frequency	NN	frequency
of	IN	of
sampling	NN	sampling
,	,	,
assays	NNS	assay
used	VBN	use
for	IN	for
sampling	NN	sampling
,	,	,
and	CC	and
follow-up	JJ	follow-up
period	NN	period
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
median	JJ	median
duration	NN	duration
of	IN	of
total	JJ	total
follow-up	NN	follow-up
was	VVD	be
38 weeks	NNS	38 week
for	IN	for
MRSA	NN	MRSA
and	CC	and
25 weeks	NNS	25 week
for	IN	for
VRE	NN	VRE
.	SENT	.
.	SENT	.
Based	VBN	Base
on	IN	on
pooled	JJ	pooled
analyses	NNS	analysis
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
model	NN	model
-	HYPH	-
estimated	VBN	estimate
median	JJ	median
time	NN	time
to	TO	to
clearance	NN	clearance
was	VVD	be
88 weeks	NNS	88 week
after	IN	after
<FORBIDDEN ID=106 ACTION=delete>
documented	VBN	document
</FORBIDDEN ID=106 ACTION=delete>
colonization	NN	colonization
for	IN	for
MRSA	NN	MRSA
-	HYPH	-
colonized	VBN	colonize
patients	NNS	patient
and	CC	and
26 weeks	NNS	26 week
for	IN	for
VRE	NN	VRE
-	HYPH	-
colonized	VBN	colonize
patients	NNS	patient
.	SENT	.
.	SENT	.
In	IN	In
a	DT	a
secondary	JJ	secondary
analysis	NN	analysis
,	,	,
clearance	NN	clearance
rates	NNS	rate
for	IN	for
MRSA	NN	MRSA
and	CC	and
VRE	NN	VRE
were	VVD	be
compared	VBN	compare
by	IN	by
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
restricting	VBG	restrict
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
duration	NN	duration
of	IN	of
follow-up	NN	follow-up
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MRSA	NN	MRSA
studies	NNS	study
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
maximum	NN	maximum
observed	VBN	observe
time	NN	time
point	NN	point
for	IN	for
VRE	NN	VRE
studies	NNS	study
(	(	(
43 weeks	NNS	43 week
)	)	)
.	SENT	.
.	SENT	.
With	IN	With
this	DT	this
restriction	NN	restriction
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
model	NN	model
-	HYPH	-
fitted	VBN	fit
median	NN	median
time	NN	time
to	TO	to
<FORBIDDEN ID=106 ACTION=delete>
documented	VBN	document
</FORBIDDEN ID=106 ACTION=delete>
clearance	NN	clearance
for	IN	for
MRSA	NN	MRSA
would	MD	would
occur	VB	occur
at	IN	at
41 weeks	NNS	41 week
after	IN	after
<FORBIDDEN ID=106 ACTION=delete>
documented	VBN	document
</FORBIDDEN ID=106 ACTION=delete>
colonization	NN	colonization
,	,	,
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
demonstrating	VBG	demonstrate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
sensitivity	NN	sensitivity
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
pooled	VBN	pool
estimate	NN	estimate
to	TO	to
length	NN	length
of	IN	of
study	NN	study
follow-up	NN	follow-up
.	SENT	.
.	SENT	.
Few	JJ	Few
available	JJ	available
studies	NNS	study
report	VBP	report
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
natural	JJ	natural
history	NN	history
of	IN	of
MRSA	NN	MRSA
and	CC	and
VRE	NN	VRE
colonization	NN	colonization
.	SENT	.
.	SENT	.
Lack	NN	Lack
of	IN	of
a	DT	a
consistent	JJ	consistent
definition	NN	definition
of	IN	of
clearance	NN	clearance
,	,	,
uncertainty	NN	uncertainty
<FORBIDDEN ID=150 ACTION=delete>
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
regarding	VBG	regard
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=150 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
time	NN	time
of	IN	of
initial	JJ	initial
colonization	NN	colonization
,	,	,
variation	NN	variation
in	IN	in
frequency	NN	frequency
of	IN	of
sampling	NN	sampling
for	IN	for
persistent	JJ	persistent
colonization	NN	colonization
,	,	,
assays	NNS	assay
employed	VBN	employ
and	CC	and
variation	NN	variation
in	IN	in
duration	NN	duration
of	IN	of
follow-up	NN	follow-up
are	VVP	be
limitations	NNS	limitation
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
existing	VBG	exist
published	VBN	publish
literature	NN	literature
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
heterogeneity	NN	heterogeneity
of	IN	of
study	NN	study
characteristics	NNS	characteristic
limits	VBZ	limit
interpretation	NN	interpretation
of	IN	of
pooled	JJ	pooled
estimates	NNS	estimate
of	IN	of
time	NN	time
to	TO	to
clearance	NN	clearance
,	,	,
however	RB	however
,	,	,
studies	NNS	study
included	VBN	include
in	IN	in
this	DT	this
review	NN	review
suggest	VBP	suggest
an	DT	an
increase	NN	increase
in	IN	in
<FORBIDDEN ID=106 ACTION=delete>
documented	VBN	document
</FORBIDDEN ID=106 ACTION=delete>
clearance	NN	clearance
over	IN	over
time	NN	time
,	,	,
a	DT	a
result	NN	result
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
is	VVZ	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
sensitive	JJ	sensitive
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
duration	NN	duration
of	IN	of
follow-up	NN	follow-up
.	SENT	.
.	SENT	.
BB-cat+ner-24739626/text	DOCUMENT	BB-cat+ner-24739626/text
Comparative	JJ	Comparative
transcriptomics	NNS	transcriptomic
of	IN	of
two	CD	two
environmentally	RB	environmentally
relevant	JJ	relevant
cyanobacteria	NNS	cyanobacteria
reveals	VBZ	reveal
unexpected	JJ	unexpected
transcriptome	NN	transcriptome
diversity	NN	diversity
.	SENT	.
.	SENT	.
Prochlorococcus	NP	Prochlorococcus
is	VVZ	be
a	DT	a
genus	NN	genus
of	IN	of
abundant	JJ	abundant
and	CC	and
ecologically	RB	ecologically
important	JJ	important
marine	JJ	marine
cyanobacteria	NNS	cyanobacteria
.	SENT	.
.	SENT	.
Here	RB	Here
,	,	,
we	PP	we
present	VBP	present
a	DT	a
comprehensive	JJ	comprehensive
comparison	NN	comparison
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
structure	NN	structure
and	CC	and
composition	NN	composition
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
transcriptomes	NNS	transcriptome
of	IN	of
two	CD	two
Prochlorococcus	NP	Prochlorococcus
strains	NNS	strain
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
,	,	,
despite	IN	despite
their	PP$	their
similarities	NNS	similarity
,	,	,
have	VHP	have
adapted	VBN	adapt
their	PP$	their
gene	NN	gene
pool	NN	pool
to	TO	to
specific	JJ	specific
environmental	JJ	environmental
constraints	NNS	constraint
.	SENT	.
.	SENT	.
We	PP	We
present	VBP	present
genome	NN	genome
-	HYPH	-
wide	JJ	wide
maps	NNS	map
of	IN	of
transcriptional	JJ	transcriptional
start	NN	start
sites	NNS	site
(	(	(
TSS	NN	TSS
)	)	)
for	IN	for
<FORBIDDEN ID=30 ACTION=delete>
both	DT	both
</FORBIDDEN ID=30 ACTION=delete>
organisms	NNS	organism
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
are	VVP	be
representatives	NNS	representative
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
two	CD	two
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
most	RBS	most
diverse	JJ	diverse
clades	NNS	clade
within	IN	within
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
two	CD	two
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
major	JJ	major
ecotypes	NNS	ecotype
adapted	VBN	adapt
to	TO	to
high	JJ	high
-	HYPH	-
and	CC	and
low-light	JJ	low-light
conditions	NNS	condition
,	,	,
respectively	RB	respectively
.	SENT	.
.	SENT	.
Our	PP$	Our
data	NNS	datum
suggest	VBP	suggest
antisense	JJ	antisense
transcription	NN	transcription
for	IN	for
three	CD	three
-	HYPH	-
quarters	NNS	quarter
of	IN	of
all	DT	all
genes	NNS	gene
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
is	VVZ	be
substantially	RB	substantially
<FORBIDDEN ID=82 ACTION=delete>
more	JJR	more
</FORBIDDEN ID=82 ACTION=delete>
than	IN	than
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	DT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
observed	VBN	observe
in	IN	in
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
bacteria	NNS	bacteria
.	SENT	.
.	SENT	.
We	PP	We
discovered	VBD	discover
hundreds	NNS	hundred
of	IN	of
TSS	NN	TSS
within	IN	within
genes	NNS	gene
,	,	,
most	RBS	most
notably	RB	notably
within	IN	within
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
16	CD	16
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
29	CD	29
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
prochlorosin	NN	prochlorosin
genes	NNS	gene
,	,	,
in	IN	in
strain	NN	strain
MIT9313	NN	MIT9313
.	SENT	.
.	SENT	.
A	DT	A
direct	JJ	direct
comparison	NN	comparison
revealed	VBD	reveal
very	RB	very
little	JJ	little
conservation	NN	conservation
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
location	NN	location
of	IN	of
TSS	NN	TSS
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
nature	NN	nature
of	IN	of
non-coding	JJ	non-coding
transcripts	NNS	transcript
between	IN	between
<FORBIDDEN ID=30 ACTION=delete>
both	DT	both
</FORBIDDEN ID=30 ACTION=delete>
strains	NNS	strain
.	SENT	.
.	SENT	.
We	PP	We
detected	VBD	detect
extremely	RB	extremely
short	JJ	short
5'	JJ	5'
untranslated	JJ	untranslated
regions	NNS	region
with	IN	with
a	DT	a
median	JJ	median
length	NN	length
of	IN	of
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
27	CD	27
and	CC	and
29	CD	29
nt	NN	nt
for	IN	for
MED4	NN	MED4
and	CC	and
MIT9313	NN	MIT9313
,	,	,
respectively	RB	respectively
,	,	,
and	CC	and
for	IN	for
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
8%	CD	8%
of	IN	of
all	DT	all
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
protein	NN	protein
-	HYPH	-
coding	VBG	cod
<FORBIDDEN ID=1 ACTION=split SPLIT_AFTER=0>
genes	NNS	gene
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=1 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
median	JJ	median
distance	NN	distance
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
start	NN	start
codon	NN	codon
is	VVZ	be
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
10	CD	10
nt	NN	nt
or	CC	or
<FORBIDDEN ID=157 ACTION=delete>
even	RB	even
</FORBIDDEN ID=157 ACTION=delete>
shorter	JJR	short
.	SENT	.
.	SENT	.
These	DT	These
findings	NNS	finding
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
absence	NN	absence
of	IN	of
an	DT	an
obvious	JJ	obvious
Shine	NN	Shine
-	HYPH	-
Dalgarno	NN	Dalgarno
motif	NN	motif
suggest	VBP	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
leaderless	JJ	leaderless
translation	NN	translation
and	CC	and
ribosomal	JJ	ribosomal
protein	NN	protein
S1	NN	S1
-	HYPH	-
dependent	JJ	dependent
translation	NN	translation
constitute	VBP	constitute
alternative	JJ	alternative
mechanisms	NNS	mechanism
for	IN	for
translation	NN	translation
initiation	NN	initiation
in	IN	in
Prochlorococcus	NP	Prochlorococcus
.	SENT	.
.	SENT	.
We	PP	We
conclude	VBP	conclude
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
genome	NN	genome
-	HYPH	-
wide	JJ	wide
antisense	JJ	antisense
transcription	NN	transcription
is	VVZ	be
a	DT	a
major	JJ	major
component	NN	component
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
transcriptional	JJ	transcriptional
output	NN	output
from	IN	from
these	DT	these
relatively	RB	relatively
small	JJ	small
genomes	NNS	genome
and	CC	and
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
a	DT	a
hitherto	RB	hitherto
unrecognized	JJ	unrecognized
high	JJ	high
degree	NN	degree
of	IN	of
complexity	NN	complexity
and	CC	and
variability	NN	variability
of	IN	of
gene	NN	gene
expression	NN	expression
exists	VBZ	exist
in	IN	in
their	PP$	their
transcriptional	JJ	transcriptional
architecture	NN	architecture
.	SENT	.
.	SENT	.
BB-cat+ner-24794581/text	DOCUMENT	BB-cat+ner-24794581/text
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
warm	JJ	warm
temperature	NN	temperature
acclimation	NN	acclimation
protein	NN	protein
(	(	(
Wap65	NN	Wap65
)	)	)
has	VHZ	have
an	DT	an
important	JJ	important
role	NN	role
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
inflammatory	JJ	inflammatory
response	NN	response
of	IN	of
turbot	NN	turbot
(	(	(
Scophthalmus	NN	Scophthalmus
maximus	NN	maximus
)	)	)
.	SENT	.
.	SENT	.
Wap65	NN	Wap65
is	VVZ	be
a	DT	a
molecule	NN	molecule
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
similar	JJ	similar
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
mammalian	JJ	mammalian
hemopexin	NN	hemopexin
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
is	VVZ	be
a	DT	a
serum	NN	serum
glycoprotein	NN	glycoprotein
produced	VBN	produce
mainly	RB	mainly
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
liver	NN	liver
with	IN	with
high	JJ	high
affinity	NN	affinity
to	TO	to
heme	NN	heme
.	SENT	.
.	SENT	.
Its	PP$	Its
primary	JJ	primary
role	NN	role
is	VVZ	be
participating	VBG	participate
in	IN	in
iron	NN	iron
metabolism	NN	metabolism
scavenging	NN	scavenging
heme	NN	heme
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
is	VVZ	be
released	VBN	release
into	IN	into
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
plasma	NN	plasma
and	CC	and
transporting	VBG	transport
it	PP	it
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
liver	NN	liver
.	SENT	.
.	SENT	.
It	PP	It
has	VHZ	have
been	VVN	be
reported	VBN	report
an	DT	an
important	JJ	important
role	NN	role
of	IN	of
hemopexin	NN	hemopexin
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
inflammation	NN	inflammation
as	IN	as
an	DT	an
acute	JJ	acute
-	HYPH	-
phase	NN	phase
protein	NN	protein
and	CC	and
its	PP$	its
production	NN	production
is	VVZ	be
up-regulated	VBN	up-regulate
by	IN	by
pro-inflammatory	JJ	pro-inflammatory
cytokines	NNS	cytokine
.	SENT	.
.	SENT	.
There	EX	There
are	VVP	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
some	DT	some
evidences	NNS	evidence
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
suggesting	VBG	suggest
this	DT	this
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
immune	JJ	immune
-	HYPH	-
induction	NN	induction
in	IN	in
fish	NN	fish
Wap65	NN	Wap65
genes	NNS	gene
.	SENT	.
.	SENT	.
Most	JJS	Most
teleost	NN	teleost
species	NNS	specie
presents	VBZ	present
two	CD	two
Wap65	NN	Wap65
genes	NNS	gene
but	CC	but
their	PP$	their
physiological	JJ	physiological
functions	NNS	function
have	VHP	have
not	RB	not
been	VVN	be
completely	RB	completely
elucidated	VBN	elucidate
;	COLUMN	;
in	IN	in
fact	NN	fact
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
transcriptional	JJ	transcriptional
patterns	NNS	pattern
of	IN	of
Wap65	NN	Wap65
genes	NNS	gene
to	TO	to
stimulatory	JJ	stimulatory
treatments	NNS	treatment
are	VVP	be
variable	JJ	variable
and	CC	and
contradictory	JJ	contradictory
.	SENT	.
.	SENT	.
In	IN	In
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
present	JJ	present
study	NN	study
two	CD	two
Wap65	NN	Wap65
genes	NNS	gene
,	,	,
Wap	NN	Wap
65-1	CD	65-1
and	CC	and
Wap	NN	Wap
65-2	CD	65-2
,	,	,
have	VHP	have
been	VVN	be
characterized	VBN	characterize
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
first	JJ	first
time	NN	time
in	IN	in
turbot	NN	turbot
(	(	(
Scophthalmus	NN	Scophthalmus
maximus	NN	maximus
)	)	)
.	SENT	.
.	SENT	.
Their	PP$	Their
constitutive	JJ	constitutive
expression	NN	expression
and	CC	and
differential	JJ	differential
modulation	NN	modulation
by	IN	by
thermal	JJ	thermal
treatments	NNS	treatment
,	,	,
immune	JJ	immune
challenges	NNS	challenge
(	(	(
bacterial	JJ	bacterial
and	CC	and
viral	JJ	viral
)	)	)
,	,	,
as	RB	as
well	RB	well
as	IN	as
iron	NN	iron
supplementation	NN	supplementation
,	,	,
have	VHP	have
been	VVN	be
investigated	VBN	investigate
.	SENT	.
.	SENT	.
<FORBIDDEN ID=30 ACTION=delete>
Both	DT	Both
</FORBIDDEN ID=30 ACTION=delete>
genes	NNS	gene
were	VVD	be
mainly	RB	mainly
expressed	VBN	express
in	IN	in
liver	NN	liver
,	,	,
but	CC	but
they	PP	they
were	VVD	be
detected	VBN	detect
in	IN	in
all	DT	all
tested	VBN	test
tissues	NNS	tissue
.	SENT	.
.	SENT	.
Whereas	IN	Whereas
Wap	NN	Wap
65-1	CD	65-1
and	CC	and
Wap	NN	Wap
65-2	CD	65-2
were	VVD	be
up-regulated	VBN	up-regulate
by	IN	by
temperature	NN	temperature
rise	NN	rise
and	CC	and
bacterial	JJ	bacterial
challenge	NN	challenge
,	,	,
VHSV	NN	VHSV
infection	NN	infection
inhibited	VBD	inhibit
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
expression	NN	expression
of	IN	of
<FORBIDDEN ID=30 ACTION=delete>
both	DT	both
</FORBIDDEN ID=30 ACTION=delete>
genes	NNS	gene
.	SENT	.
.	SENT	.
Moreover	RB	Moreover
,	,	,
iron	NN	iron
-	HYPH	-
dextran	NN	dextran
administration	NN	administration
induced	VBD	induce
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=156 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
overexpression	NN	overexpression
of	IN	of
Wap	NP	Wap
65-1	CD	65-1
.	SENT	.
.	SENT	.
Interestingly	RB	Interestingly
,	,	,
these	DT	these
induction	NN	induction
were	VVD	be
observed	VBN	observe
in	IN	in
head	NN	head
kidney	NN	kidney
buy	VBP	buy
not	RB	not
in	IN	in
liver	NN	liver
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
effect	NN	effect
of	IN	of
Wap65	NN	Wap65
protein	NN	protein
purified	VBN	purify
from	IN	from
turbot	NN	turbot
serum	NN	serum
by	IN	by
hemin	NN	hemin
-	HYPH	-
agarose	NN	agarose
affinity	NN	affinity
chromatography	NN	chromatography
was	VVD	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
studied	VBN	study
to	TO	to
demonstrate	VB	demonstrate
a	DT	a
possible	JJ	possible
anti	AFX	anti
-	HYPH	-
inflammatory	JJ	inflammatory
role	NN	role
,	,	,
analyzing	VBG	analyze
its	PP$	its
inhibitory	JJ	inhibitory
effect	NN	effect
on	IN	on
leucocytes	NNS	leucocyte
migration	NN	migration
induced	VBN	induce
by	IN	by
zymosan	NN	zymosan
injection	NN	injection
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
peritoneal	JJ	peritoneal
cavity	NN	cavity
.	SENT	.
.	SENT	.
BB-cat+ner-24831788/text	DOCUMENT	BB-cat+ner-24831788/text
Evaluation	NN	Evaluation
of	IN	of
impermeant	NN	impermeant
,	,	,
DNA	NN	DNA
-	HYPH	-
binding	VBG	bind
dye	NN	dye
fluorescence	NN	fluorescence
as	IN	as
a	DT	a
real	JJ	real
-	HYPH	-
time	NN	time
readout	NN	readout
of	IN	of
eukaryotic	JJ	eukaryotic
cell	NN	cell
toxicity	NN	toxicity
in	IN	in
a	DT	a
high	JJ	high
throughput	NN	throughput
screening	VBG	screen
format	NN	format
.	SENT	.
.	SENT	.
Interpretation	NN	Interpretation
of	IN	of
high	JJ	high
throughput	NN	throughput
screening	NN	screening
(	(	(
HTS	NN	HTS
)	)	)
data	NNS	datum
in	IN	in
cell	NN	cell
-	HYPH	-
based	VBN	base
assays	NNS	assay
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
be	VV	be
confounded	VBN	confound
by	IN	by
cytotoxic	JJ	cytotoxic
properties	NNS	property
of	IN	of
screening	NN	screening
compounds	NNS	compound
.	SENT	.
.	SENT	.
<FORBIDDEN ID=162 ACTION=delete>
Therefore	RB	Therefore
</FORBIDDEN ID=162 ACTION=delete>
,	,	,
assessing	VBG	assess
cell	NN	cell
toxicity	NN	toxicity
in	IN	in
real	JJ	real
time	NN	time
during	IN	during
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
HTS	NN	HTS
process	NN	process
itself	PP	itself
would	MD	would
be	VV	be
highly	RB	highly
advantageous	JJ	advantageous
.	SENT	.
.	SENT	.
Here	RB	Here
,	,	,
we	PP	we
investigate	VBP	investigate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
potential	NN	potential
of	IN	of
putatively	RB	putatively
impermeant	JJ	impermeant
,	,	,
fluorescent	JJ	fluorescent
,	,	,
DNA	NN	DNA
-	HYPH	-
binding	VBG	bind
dyes	NNS	dye
to	TO	to
give	VB	give
cell	NN	cell
toxicity	NN	toxicity
readout	NN	readout
during	IN	during
HTS	NN	HTS
.	SENT	.
.	SENT	.
Amongst	IN	Amongst
19	CD	19
DNA	NN	DNA
-	HYPH	-
binding	VBG	bind
dyes	NNS	dye
examined	VBN	examine
,	,	,
three	CD	three
classes	NNS	class
were	VVD	be
identified	VBN	identify
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
were	VVD	be
(	(	(
1	CD	1
)	)	)
permeant	JJ	permeant
,	,	,
(	(	(
2	LS	2
)	)	)
cytotoxic	JJ	cytotoxic
,	,	,
or	CC	or
(	(	(
3	LS	3
)	)	)
neither	CC	neither
permeant	JJ	permeant
nor	CC	nor
cytotoxic	JJ	cytotoxic
during	IN	during
3-day	JJ	3-day
incubation	NN	incubation
with	IN	with
a	DT	a
macrophage	NN	macrophage
cell	NN	cell
line	NN	line
.	SENT	.
.	SENT	.
In	IN	In
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
last	JJ	last
class	NN	class
,	,	,
four	CD	four
dyes	NNS	dye
(	(	(
SYTOX	NP	SYTOX
Green	NP	Green
,	,	,
CellTox	NP	CellTox
Green	NP	Green
,	,	,
GelGreen	NP	GelGreen
,	,	,
and	CC	and
EvaGreen	NN	EvaGreen
)	)	)
gave	VBD	give
highly	RB	highly
robust	JJ	robust
cytotoxicity	NN	cytotoxicity
data	NNS	datum
in	IN	in
384-well	JJ	384-well
screening	NN	screening
plates	NNS	plate
.	SENT	.
.	SENT	.
As	IN	As
proof	NN	proof
of	IN	of
principle	NN	principle
,	,	,
successful	JJ	successful
combination	NN	combination
with	IN	with
a	DT	a
luminescence	NN	luminescence
-	HYPH	-
based	VBN	base
assay	NN	assay
in	IN	in
HTS	NN	HTS
format	NN	format
was	VVD	be
demonstrated	VBN	demonstrate
.	SENT	.
.	SENT	.
Here	RB	Here
,	,	,
<FORBIDDEN ID=30 ACTION=delete>
both	DT	both
</FORBIDDEN ID=30 ACTION=delete>
intracellular	JJ	intracellular
growth	NN	growth
of	IN	of
Legionella	NN	Legionella
pneumophila	NN	pneumophila
(	(	(
luminescence	NN	luminescence
)	)	)
and	CC	and
host	NN	host
cell	NN	cell
viability	NN	viability
(	(	(
SYTOX	NN	SYTOX
Green	NN	Green
exclusion	NN	exclusion
)	)	)
were	VVD	be
assayed	VBN	assay
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=16 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
same	JJ	same
</FORBIDDEN ID=16 ACTION=delete>
screening	NN	screening
well	RB	well
.	SENT	.
.	SENT	.
Incorporation	NN	Incorporation
of	IN	of
membrane	NN	membrane
-	HYPH	-
impermeant	NN	impermeant
,	,	,
DNA	NN	DNA
-	HYPH	-
binding	VBG	bind
,	,	,
fluorescent	JJ	fluorescent
dyes	NNS	dye
in	IN	in
HTS	NN	HTS
assays	NNS	assay
should	MD	should
prove	VB	prove
useful	JJ	useful
by	IN	by
allowing	VBG	allow
evaluation	NN	evaluation
of	IN	of
cytotoxicity	NN	cytotoxicity
in	IN	in
real	JJ	real
time	NN	time
,	,	,
eliminating	VBG	eliminate
reagent	NN	reagent
addition	NN	addition
steps	NNS	step
and	CC	and
effort	NN	effort
associated	VBN	associate
with	IN	with
endpoint	NN	endpoint
cell	NN	cell
viability	NN	viability
analysis	NN	analysis
,	,	,
and	CC	and
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
reducing	VBG	reduce
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
need	NN	need
for	IN	for
follow-up	JJ	follow-up
cytotoxicity	NN	cytotoxicity
screening	NN	screening
.	SENT	.
.	SENT	.
BB-cat+ner-24865686/text	DOCUMENT	BB-cat+ner-24865686/text
Mycobacterium	NN	Mycobacterium
tuberculosis	NN	tuberculosis
isolates	NNS	isolate
from	IN	from
single	JJ	single
outpatient	NN	outpatient
clinic	NN	clinic
in	IN	in
Panama	NP	Panama
City	NP	City
exhibit	VBP	exhibit
wide	JJ	wide
genetic	JJ	genetic
diversity	NN	diversity
.	SENT	.
.	SENT	.
Understanding	VBG	Understand
Mycobacterium	NN	Mycobacterium
tuberculosis	NN	tuberculosis
biodiversity	NN	biodiversity
and	CC	and
transmission	NN	transmission
is	VVZ	be
significant	JJ	significant
for	IN	for
tuberculosis	NN	tuberculosis
control	NN	control
.	SENT	.
.	SENT	.
This	DT	This
short	JJ	short
report	NN	report
aimed	VBN	aim
to	TO	to
determine	VB	determine
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
genetic	JJ	genetic
diversity	NN	diversity
of	IN	of
M	NN	M
.	SENT	.
tuberculosis	NN	tuberculosis
isolates	NNS	isolate
from	IN	from
an	DT	an
outpatient	NN	outpatient
clinic	NN	clinic
in	IN	in
Panama	NP	Panama
City	NP	City
.	SENT	.
.	SENT	.
A	DT	A
total	NN	total
of	IN	of
62	CD	62
M	NN	M
.	SENT	.
tuberculosis	NN	tuberculosis
isolates	NNS	isolate
were	VVD	be
genotyped	VBN	genotype
by	IN	by
12	CD	12
loci	NNS	locus
mycobacterial	JJ	mycobacterial
interspersed	JJ	interspersed
repetitive	JJ	repetitive
units	NNS	unit
-	HYPH	-
variable	JJ	variable
number	NN	number
of	IN	of
tandem	JJ	tandem
repeats	NNS	repeat
(	(	(
MIRU	NN	MIRU
-	HYPH	-
VNTR	NN	VNTR
)	)	)
and	CC	and
Spoligotyping	NN	Spoligotyping
.	SENT	.
.	SENT	.
Forty	CD	Forty
-	HYPH	-
five	CD	five
(	(	(
72.6	CD	72.6
%	NN	%
)	)	)
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
isolates	NNS	isolate
showed	VBD	show
unique	JJ	unique
MIRU	NN	MIRU
-	HYPH	-
VNTR	NN	VNTR
genotypes	NNS	genotype
,	,	,
and	CC	and
13	CD	13
(	(	(
21%	CD	21%
)	)	)
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
isolates	NNS	isolate
were	VVD	be
grouped	VBN	group
into	IN	into
four	CD	four
clusters	NNS	cluster
.	SENT	.
.	SENT	.
Four	CD	Four
isolates	NNS	isolate
showed	VBD	show
polyclonal	JJ	polyclonal
MIRU	NN	MIRU
-	HYPH	-
VNTR	NN	VNTR
genotypes	NNS	genotype
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MIRU	NN	MIRU
-	HYPH	-
VNTR	NN	VNTR
Hunter	NP	Hunter
-	HYPH	-
Gaston	NP	Gaston
discriminatory	JJ	discriminatory
index	NN	index
reached	VBD	reach
0.988	CD	0.988
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Spoligotyping	NN	Spoligotyping
analysis	NN	analysis
revealed	VBD	reveal
16	CD	16
M	NN	M
.	SENT	.
tuberculosis	NN	tuberculosis
families	NNS	family
,	,	,
including	VBG	include
Latin	NP	Latin
American	NP	American
-	HYPH	-
Mediterranean	NP	Mediterranean
,	,	,
Harlem	NP	Harlem
,	,	,
and	CC	and
Beijing	NP	Beijing
.	SENT	.
.	SENT	.
These	DT	These
findings	NNS	finding
suggest	VBP	suggest
a	DT	a
wide	JJ	wide
genetic	JJ	genetic
diversity	NN	diversity
of	IN	of
M	NN	M
.	SENT	.
tuberculosis	NN	tuberculosis
isolates	NNS	isolate
at	IN	at
one	CD	one
outpatient	NN	outpatient
clinic	NN	clinic
.	SENT	.
.	SENT	.
A	DT	A
detailed	JJ	detailed
molecular	JJ	molecular
epidemiology	NN	epidemiology
survey	NN	survey
is	VVZ	be
now	RB	now
warranted	VBN	warrant
,	,	,
especially	RB	especially
following	VBG	follow
second	JJ	second
massive	JJ	massive
immigration	NN	immigration
for	IN	for
local	JJ	local
Panama	NP	Panama
Canal	NP	Canal
expansion	NN	expansion
activities	NNS	activity
.	SENT	.
.	SENT	.
BB-cat+ner-24874563/text	DOCUMENT	BB-cat+ner-24874563/text
Methylocella	NN	Methylocella
:	COLUMN	:
a	DT	a
gourmand	NN	gourmand
among	IN	among
methanotrophs	NNS	methanotroph
.	SENT	.
.	SENT	.
A	DT	A
recent	JJ	recent
article	NN	article
in	IN	in
Nature	NP	Nature
describes	VBZ	describe
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
ability	NN	ability
of	IN	of
Methylocella	NN	Methylocella
silvestris	NN	silvestris
to	TO	to
grow	VB	grow
simultaneously	RB	simultaneously
on	IN	on
methane	NN	methane
and	CC	and
longer	JJR	long
chain	NN	chain
alkanes	NNS	alkane
,	,	,
something	NN	something
never	RB	never
before	RB	before
observed	VBN	observe
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
microbial	JJ	microbial
world	NN	world
.	SENT	.
.	SENT	.
It	PP	It
adds	VBZ	add
to	TO	to
a	DT	a
growing	VBG	grow
list	NN	list
of	IN	of
unique	JJ	unique
metabolic	JJ	metabolic
traits	NNS	trait
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
distinguish	VBP	distinguish
Methylocella	NN	Methylocella
from	IN	from
any	DT	any
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
bacterium	NN	bacterium
.	SENT	.
.	SENT	.
BB-cat+ner-25046729/text	DOCUMENT	BB-cat+ner-25046729/text
Wolbachia	NP	Wolbachia
endosymbionts	NNS	endosymbiont
and	CC	and
human	JJ	human
disease	NN	disease
control	NN	control
.	SENT	.
.	SENT	.
Most	RBS	Most
human	JJ	human
filarial	JJ	filarial
nematode	NN	nematode
parasites	NNS	parasite
and	CC	and
arthropods	NNS	arthropod
are	VVP	be
hosts	NNS	host
for	IN	for
a	DT	a
bacterial	JJ	bacterial
endosymbiont	NN	endosymbiont
,	,	,
Wolbachia	NP	Wolbachia
.	SENT	.
.	SENT	.
In	IN	In
filaria	NN	filaria
,	,	,
Wolbachia	NP	Wolbachia
are	VVP	be
required	VBN	require
for	IN	for
normal	JJ	normal
development	NN	development
,	,	,
fertility	NN	fertility
and	CC	and
survival	NN	survival
,	,	,
whereas	IN	whereas
in	IN	in
arthropods	NNS	arthropod
,	,	,
they	PP	they
are	VVP	be
largely	RB	largely
parasitic	JJ	parasitic
and	CC	and
can	MD	can
influence	VB	influence
development	NN	development
and	CC	and
reproduction	NN	reproduction
,	,	,
but	CC	but
are	VVP	be
<FORBIDDEN ID=161 ACTION=delete>
generally	RB	generally
</FORBIDDEN ID=161 ACTION=delete>
not	RB	not
required	VBN	require
for	IN	for
host	NN	host
survival	NN	survival
.	SENT	.
.	SENT	.
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
Due	JJ	Due
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
their	PP$	their
obligate	JJ	obligate
nature	NN	nature
in	IN	in
filarial	JJ	filarial
parasites	NNS	parasite
,	,	,
Wolbachia	NP	Wolbachia
have	VHP	have
been	VVN	be
a	DT	a
target	NN	target
for	IN	for
drug	NN	drug
discovery	NN	discovery
initiatives	NNS	initiative
using	VBG	use
several	JJ	several
approaches	NNS	approach
including	VBG	include
diversity	NN	diversity
and	CC	and
focused	VBD	focus
library	NN	library
screening	NN	screening
and	CC	and
genomic	JJ	genomic
sequence	NN	sequence
analysis	NN	analysis
.	SENT	.
.	SENT	.
In	FW	In
vitro	FW	vitro
and	CC	and
in vivo	FW	in_vivo
anti	AFX	anti
-	HYPH	-
Wolbachia	NP	Wolbachia
antibiotic	JJ	antibiotic
treatments	NNS	treatment
have	VHP	have
been	VVN	be
shown	VBN	show
to	TO	to
have	VH	have
adulticidal	JJ	adulticidal
activity	NN	activity
,	,	,
a	DT	a
long	JJ	long
sought	VBN	seek
goal	NN	goal
of	IN	of
filarial	JJ	filarial
parasite	NN	parasite
drug	NN	drug
discovery	NN	discovery
.	SENT	.
.	SENT	.
In	IN	In
mosquitoes	NNS	mosquito
,	,	,
it	PP	it
has	VHZ	have
been	VVN	be
shown	VBN	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
Wolbachia	NP	Wolbachia
can	MD	can
inhibit	VB	inhibit
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
transmission	NN	transmission
of	IN	of
<FORBIDDEN ID=87 ACTION=delete>
certain	JJ	certain
</FORBIDDEN ID=87 ACTION=delete>
viruses	NNS	virus
,	,	,
<FORBIDDEN ID=17 ACTION=delete>
such	JJ	such
</FORBIDDEN ID=17 ACTION=delete>
as	IN	as
Dengue	NP	Dengue
,	,	,
Chikungunya	NP	Chikungunya
,	,	,
Yellow	NP	Yellow
Fever	NP	Fever
,	,	,
West	NP	West
Nile	NP	Nile
,	,	,
as	RB	as
well	RB	well
as	IN	as
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
infectivity	NN	infectivity
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
malaria	NN	malaria
-	HYPH	-
causing	VBG	cause
protozoan	NN	protozoan
,	,	,
Plasmodium	NN	Plasmodium
and	CC	and
filarial	JJ	filarial
nematodes	NNS	nematode
.	SENT	.
.	SENT	.
Furthermore	RB	Furthermore
,	,	,
Wolbachia	NP	Wolbachia
can	MD	can
cause	VB	cause
a	DT	a
form	NN	form
of	IN	of
conditional	JJ	conditional
sterility	NN	sterility
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
can	MD	can
be	VV	be
used	VBN	use
to	TO	to
suppress	VB	suppress
populations	NNS	population
of	IN	of
mosquitoes	NNS	mosquito
and	CC	and
additional	JJ	additional
medically	RB	medically
important	JJ	important
insects	NNS	insect
.	SENT	.
.	SENT	.
Thus	RB	Thus
Wolbachia	NP	Wolbachia
,	,	,
a	DT	a
pandemic	JJ	pandemic
endosymbiont	NN	endosymbiont
offers	VBZ	offer
great	JJ	great
potential	NN	potential
for	IN	for
elimination	NN	elimination
of	IN	of
a	DT	a
wide	JJ	wide
-	HYPH	-
<FORBIDDEN ID=57 ACTION=delete>
variety	NN	variety
of	IN	of
</FORBIDDEN ID=57 ACTION=delete>
devastating	VBG	devastate
human	JJ	human
diseases	NNS	disease
.	SENT	.
.	SENT	.
BB-cat+ner-25098305/text	DOCUMENT	BB-cat+ner-25098305/text
Surveillance	NN	Surveillance
for	IN	for
upper	JJ	upper
respiratory	JJ	respiratory
tract	NN	tract
disease	NN	disease
and	CC	and
Mycoplasma	NN	Mycoplasma
in	IN	in
free	JJ	free
-	HYPH	-
ranging	VBG	range
gopher	NN	gopher
tortoises	NNS	tortoise
(	(	(
Gopherus	NP	Gopherus
polyphemus	NN	polyphemus
)	)	)
in	IN	in
Georgia	NP	Georgia
,	,	,
USA	NP	USA
.	SENT	.
.	SENT	.
<FORBIDDEN ID=92 ACTION=delete>
<FORBIDDEN ID=91 ACTION=delete>
Abstract	NP	Abstract
</FORBIDDEN ID=91 ACTION=delete>
</FORBIDDEN ID=92 ACTION=delete>
Upper	NP	Upper
respiratory	JJ	respiratory
tract	NN	tract
disease	NN	disease
(	(	(
URTD	NN	URTD
)	)	)
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
gopher	NN	gopher
tortoise	NN	tortoise
(	(	(
Gopherus	NP	Gopherus
polyphemus	NN	polyphemus
)	)	)
is	VVZ	be
highly	RB	highly
contagious	JJ	contagious
and	CC	and
has	VHZ	have
been	VVN	be
implicated	VBN	implicate
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
reduction	NN	reduction
of	IN	of
populations	NNS	population
throughout	IN	throughout
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
range	NN	range
.	SENT	.
.	SENT	.
With	IN	With
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
exception	NN	exception
of	IN	of
a	DT	a
few	JJ	few
limited	JJ	limited
studies	NNS	study
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
prevalence	NN	prevalence
of	IN	of
URTD	NN	URTD
in	IN	in
Georgia	NP	Georgia
,	,	,
USA	NP	USA
tortoise	NN	tortoise
populations	NNS	population
is	VVZ	be
poorly	RB	poorly
known	VBN	know
.	SENT	.
.	SENT	.
We	PP	We
found	VBD	find
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
exposure	NN	exposure
to	TO	to
Mycoplasma	NN	Mycoplasma
agassizii	NN	agassizii
and	CC	and
Mycoplasma	NN	Mycoplasma
testudineum	NN	testudineum
,	,	,
associated	VBN	associate
with	IN	with
URTD	NN	URTD
,	,	,
varied	VBD	vary
geographically	RB	geographically
among	IN	among
11	CD	11
Georgia	NP	Georgia
tortoise	NN	tortoise
populations	NNS	population
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
prevalence	NN	prevalence
of	IN	of
antibodies	NNS	antibody
to	TO	to
M	NN	M
.	SENT	.
agassizii	NN	agassizii
in	IN	in
individual	JJ	individual
populations	NNS	population
was	VVD	be
either	CC	either
very	RB	very
low	JJ	low
(	(	(
0-3	CD	0-3
%	NN	%
,	,	,
n=7	NN	n=7
populations	NNS	population
)	)	)
or	CC	or
very	RB	very
high	JJ	high
(	(	(
96-100	CD	96-100
%	NN	%
,	,	,
n=4	NN	n=4
populations	NNS	population
)	)	)
,	,	,
whereas	IN	whereas
there	EX	there
was	VVD	be
variation	NN	variation
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
prevalence	NN	prevalence
of	IN	of
antibodies	NNS	antibody
to	TO	to
M	NN	M
.	SENT	.
testudineum	NN	testudineum
among	IN	among
populations	NNS	population
(	(	(
20-61	CD	20-61
%	NN	%
,	,	,
n=10	NN	n=10
)	)	)
with	IN	with
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
one	CD	one
site	NN	site
being	VVG	be
negative	JJ	negative
.	SENT	.
.	SENT	.
Five	CD	Five
sites	NNS	site
had	VHD	have
tortoises	NNS	tortoise
with	IN	with
antibodies	NNS	antibody
to	TO	to
<FORBIDDEN ID=30 ACTION=delete>
both	DT	both
</FORBIDDEN ID=30 ACTION=delete>
pathogens	NNS	pathogen
,	,	,
and	CC	and
these	DT	these
were	VVD	be
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=156 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
only	JJ	only
</FORBIDDEN ID=156 ACTION=delete>
sites	NNS	site
where	WRB	where
we	PP	we
observed	VBD	observe
tortoises	NNS	tortoise
with	IN	with
clinical	JJ	clinical
signs	NNS	sign
consistent	JJ	consistent
with	IN	with
URTD	NN	URTD
.	SENT	.
.	SENT	.
We	PP	We
did	VBD	do
not	RB	not
find	VB	find
tortoises	NNS	tortoise
with	IN	with
clinical	JJ	clinical
signs	NNS	sign
of	IN	of
URTD	NN	URTD
at	IN	at
sites	NNS	site
with	IN	with
tortoises	NNS	tortoise
with	IN	with
antibodies	NNS	antibody
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
to	TO	to
M	NN	M
.	SENT	.
testudineum	NN	testudineum
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
provides	VBZ	provide
evidence	NN	evidence
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
this	DT	this
organism	NN	organism
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
be	VV	be
of	IN	of
limited	JJ	limited
pathogenicity	NN	pathogenicity
for	IN	for
gopher	NN	gopher
tortoises	NNS	tortoise
.	SENT	.
.	SENT	.
Collectively	RB	Collectively
,	,	,
these	DT	these
data	NNS	datum
indicate	VBP	indicate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=30 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
both	DT	both
</FORBIDDEN ID=30 ACTION=delete>
M	NN	M
.	SENT	.
agassizii	NN	agassizii
and	CC	and
M	NN	M
.	SENT	.
testudineum	NN	testudineum
are	VVP	be
present	JJ	present
in	IN	in
Georgia	NP	Georgia
populations	NNS	population
of	IN	of
gopher	NN	gopher
tortoises	NNS	tortoise
and	CC	and
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
clinical	JJ	clinical
disease	NN	disease
is	VVZ	be
apparent	JJ	apparent
in	IN	in
populations	NNS	population
where	WRB	where
<FORBIDDEN ID=30 ACTION=delete>
both	DT	both
</FORBIDDEN ID=30 ACTION=delete>
pathogens	NNS	pathogen
are	VVP	be
present	JJ	present
.	SENT	.
.	SENT	.
Additional	JJ	Additional
research	NN	research
is	VVZ	be
needed	VBN	need
to	TO	to
better	RBR	well
understand	VB	understand
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
role	NN	role
of	IN	of
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
these	DT	these
two	CD	two
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
pathogens	NNS	pathogen
,	,	,
and	CC	and
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
potential	JJ	potential
pathogens	NNS	pathogen
,	,	,
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
overall	JJ	overall
health	NN	health
of	IN	of
tortoise	NN	tortoise
populations	NNS	population
,	,	,
especially	RB	especially
if	IN	if
future	JJ	future
conservation	NN	conservation
efforts	NNS	effort
involve	VBP	involve
translocation	NN	translocation
of	IN	of
tortoises	NNS	tortoise
.	SENT	.
.	SENT	.
BB-cat+ner-25114119/text	DOCUMENT	BB-cat+ner-25114119/text
Characterization	NN	Characterization
of	IN	of
a	DT	a
lipopolysaccharide	NN	lipopolysaccharide
-	HYPH	-
targeted	VBN	target
monoclonal	JJ	monoclonal
antibody	NN	antibody
and	CC	and
its	PP$	its
variable	JJ	variable
fragments	NNS	fragment
as	IN	as
candidates	NNS	candidate
for	IN	for
prophylaxis	NN	prophylaxis
against	IN	against
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
obligate	JJ	obligate
intracellular	JJ	intracellular
bacterial	JJ	bacterial
pathogen	NN	pathogen
Coxiella	NP	Coxiella
burnetii	NP	burnetii
.	SENT	.
.	SENT	.
Our	PP$	Our
previous	JJ	previous
study	NN	study
demonstrated	VBD	demonstrate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
treatment	NN	treatment
of	IN	of
Coxiella	NP	Coxiella
burnetii	NNS	burnetii
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
phase	NN	phase
I	CD	I
lipopolysaccharide	NN	lipopolysaccharide
(	(	(
PI	NN	PI
-	HYPH	-
LPS	NN	LPS
)	)	)
-	HYPH	-
targeted	VBN	target
monoclonal	JJ	monoclonal
antibody	NN	antibody
(	(	(
MAb	NN	MAb
)	)	)
<FORBIDDEN ID=165 ACTION=delete>
1E4	NN	1E4
significantly	RB	significantly
</FORBIDDEN ID=165 ACTION=delete>
inhibited	VBD	inhibit
C	NN	C
.	SENT	.
burnetii	NN	burnetii
infection	NN	infection
in	IN	in
mice	NNS	mouse
,	,	,
suggesting	VBG	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
1E4	NN	1E4
is	VVZ	be
a	DT	a
protective	JJ	protective
MAb	NN	MAb
.	SENT	.
.	SENT	.
To	TO	To
determine	VB	determine
whether	IN	whether
passive	JJ	passive
transfer	NN	transfer
of	IN	of
antibodies	NNS	antibody
(	(	(
Abs	NNS	Ab
)	)	)
can	MD	can
provide	VB	provide
protection	NN	protection
against	IN	against
C	NN	C
.	SENT	.
burnetii	JJ	burnetii
natural	JJ	natural
infection	NN	infection
,	,	,
we	PP	we
examined	VBD	examine
if	IN	if
passive	JJ	passive
transfer	NN	transfer
of	IN	of
1E4	NN	1E4
would	MD	would
protect	VB	protect
SCID	NN	SCID
mice	NNS	mouse
against	IN	against
C	NN	C
.	SENT	.
burnetii	NN	burnetii
aerosol	NN	aerosol
infection	NN	infection
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
results	NNS	result
indicated	VBD	indicate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
1E4	NN	1E4
conferred	VBD	confer
significant	JJ	significant
protection	NN	protection
against	IN	against
aerosolized	VBN	aerosolize
C	NN	C
.	SENT	.
burnetii	NN	burnetii
,	,	,
suggesting	VBG	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
1E4	NN	1E4
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
be	VV	be
useful	JJ	useful
for	IN	for
preventing	VBG	prevent
C	NN	C
.	SENT	.
burnetii	JJ	burnetii
natural	JJ	natural
infection	NN	infection
.	SENT	.
.	SENT	.
To	TO	To
<FORBIDDEN ID=79 ACTION=delete>
further	RB	further
</FORBIDDEN ID=79 ACTION=delete>
understand	VB	understand
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
mechanisms	NNS	mechanism
of	IN	of
1E4	NN	1E4
-	HYPH	-
mediated	VBN	mediate
protection	NN	protection
and	CC	and
to	TO	to
test	VB	test
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
possibility	NN	possibility
of	IN	of
using	VBG	use
humanized	JJ	humanized
1E4	NN	1E4
to	TO	to
prevent	VB	prevent
C	NN	C
.	SENT	.
burnetii	NN	burnetii
infection	NN	infection
,	,	,
we	PP	we
examined	VBD	examine
whether	IN	whether
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Fab	NP	Fab
fragment	NN	fragment
of	IN	of
1E4	NN	1E4
(	(	(
Fab1E4	NN	Fab1E4
)	)	)
,	,	,
a	DT	a
recombinant	JJ	recombinant
murine	JJ	murine
single	JJ	single
-	HYPH	-
chain	NN	chain
variable	JJ	variable
fragment	NN	fragment
(	(	(
muscFv1E4	NN	muscFv1E4
)	)	)
,	,	,
and	CC	and
a	DT	a
humanized	JJ	humanized
single	JJ	single
-	HYPH	-
chain	NN	chain
variable	JJ	variable
fragment	NN	fragment
(	(	(
huscFv1E4	NN	huscFv1E4
)	)	)
retained	VBD	retain
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
ability	NN	ability
of	IN	of
1E4	NN	1E4
to	TO	to
inhibit	VB	inhibit
C	NN	C
.	SENT	.
burnetii	NN	burnetii
infection	NN	infection
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
results	NNS	result
indicated	VBD	indicate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
Fab1E4	NN	Fab1E4
,	,	,
muscFv1E4	NN	muscFv1E4
,	,	,
and	CC	and
huscFv1E4	NN	huscFv1E4
were	VVD	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
able	JJ	able
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
inhibit	VB	inhibit
C	NN	C
.	SENT	.
burnetii	NN	burnetii
infection	NN	infection
in	IN	in
mice	NNS	mouse
but	CC	but
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	DT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
their	PP$	their
ability	NN	ability
to	TO	to
inhibit	VB	inhibit
C	NN	C
.	SENT	.
burnetii	NN	burnetii
infection	NN	infection
was	VVD	be
lower	JJR	low
than	IN	than
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	DT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
of	IN	of
1E4	NN	1E4
.	SENT	.
.	SENT	.
In	IN	In
addition	NN	addition
,	,	,
treatment	NN	treatment
of	IN	of
C	NN	C
.	SENT	.
burnetii	NN	burnetii
with	IN	with
Fab1E4	NN	Fab1E4
,	,	,
muscFv1E4	NN	muscFv1E4
,	,	,
or	CC	or
huscFv1E4	NN	huscFv1E4
can	MD	can
block	VB	block
C	NN	C
.	SENT	.
burnetii	NN	burnetii
infection	NN	infection
of	IN	of
macrophages	NNS	macrophage
.	SENT	.
.	SENT	.
Interestingly	RB	Interestingly
,	,	,
treatment	NN	treatment
of	IN	of
C	NN	C
.	SENT	.
burnetii	NN	burnetii
with	IN	with
huscFv1E4	NN	huscFv1E4
can	MD	can
significantly	RB	significantly
reduce	VB	reduce
C	NN	C
.	SENT	.
burnetii	NN	burnetii
infectivity	NN	infectivity
in	IN	in
human	JJ	human
macrophages	NNS	macrophage
.	SENT	.
.	SENT	.
This	DT	This
report	NN	report
provides	VBZ	provide
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
first	JJ	first
evidence	NN	evidence
to	TO	to
demonstrate	VB	demonstrate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
humanized	JJ	humanized
variable	JJ	variable
fragments	NNS	fragment
of	IN	of
an	DT	an
LPS	NN	LPS
-	HYPH	-
specific	JJ	specific
MAb	NN	MAb
can	MD	can
neutralize	VB	neutralize
C	NN	C
.	SENT	.
burnetii	NN	burnetii
infection	NN	infection
and	CC	and
appears	VBZ	appear
to	TO	to
be	VV	be
a	DT	a
promising	JJ	promising
step	NN	step
toward	IN	toward
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
potential	JJ	potential
use	NN	use
of	IN	of
a	DT	a
humanized	JJ	humanized
MAb	NN	MAb
as	IN	as
emergency	NN	emergency
prophylaxis	NN	prophylaxis
against	IN	against
C	NN	C
.	SENT	.
burnetii	NN	burnetii
exposure	NN	exposure
.	SENT	.
.	SENT	.
BB-cat+ner-25179651/text	DOCUMENT	BB-cat+ner-25179651/text
Emergence	NN	Emergence
and	CC	and
prevention	NN	prevention
measures	NNS	measure
for	IN	for
multidrug	JJ	multidrug
resistant	JJ	resistant
Pseudomonas	NN	Pseudomonas
aeruginosa	NN	aeruginosa
in	IN	in
catheter	NN	catheter
-	HYPH	-
associated	VBN	associate
urinary	JJ	urinary
tract	NN	tract
infection	NN	infection
in	IN	in
spinal	JJ	spinal
cord	NN	cord
injury	NN	injury
patients	NNS	patient
.	SENT	.
.	SENT	.
To	TO	To
evaluate	VB	evaluate
measures	NNS	measure
for	IN	for
preventing	VBG	prevent
multidrug	JJ	multidrug
resistant	JJ	resistant
Pseudomonas	NN	Pseudomonas
aeruginosa	NN	aeruginosa
(	(	(
MDRP	NN	MDRP
)	)	)
in	IN	in
catheter	NN	catheter
-	HYPH	-
associated	VBN	associate
urinary	JJ	urinary
tract	NN	tract
infection	NN	infection
(	(	(
CAUTI	NN	CAUTI
)	)	)
in	IN	in
spinal	JJ	spinal
cord	NN	cord
injury	NN	injury
patients	NNS	patient
.	SENT	.
.	SENT	.
Spinal	NP	Spinal
Cord	NP	Cord
Injury	NP	Injury
Unit	NP	Unit
of	IN	of
Hyogo	NP	Hyogo
Prefectural	NP	Prefectural
Hyogo	NP	Hyogo
Prefectural	NP	Prefectural
Rehabilitation	NP	Rehabilitation
Center	NP	Center
,	,	,
Kobe	NP	Kobe
,	,	,
Japan	NP	Japan
.	SENT	.
.	SENT	.
We	PP	We
defined	VBD	define
MDRP	NN	MDRP
as	IN	as
resistance	NN	resistance
to	TO	to
amikacin	NN	amikacin
,	,	,
imipenem	NN	imipenem
and	CC	and
levofloxacin	NN	levofloxacin
.	SENT	.
.	SENT	.
We	PP	We
had	VHD	have
eight	CD	eight
cases	NNS	case
of	IN	of
MDRP	NN	MDRP
-	HYPH	-
causing	VBG	cause
CAUTI	NN	CAUTI
in	IN	in
hospitalized	VBN	hospitalize
neurogenic	JJ	neurogenic
bladder	NN	bladder
patients	NNS	patient
caused	VBN	cause
by	IN	by
spinal	JJ	spinal
cord	NN	cord
injury	NN	injury
in	IN	in
2	CD	2
months	NNS	month
.	SENT	.
.	SENT	.
Pulse	NN	Pulse
-	HYPH	-
field	NN	field
gel	NN	gel
electrophoresis	NN	electrophoresis
(	(	(
PFGE	NN	PFGE
)	)	)
was	VVD	be
performed	VBN	perform
for	IN	for
epidemiological	JJ	epidemiological
studies	NNS	study
.	SENT	.
.	SENT	.
We	PP	We
assessed	VBD	assess
prevention	NN	prevention
measures	NNS	measure
against	IN	against
MDRP	NN	MDRP
emergence	NN	emergence
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
2nd	JJ	2nd
month	NN	month
,	,	,
<FORBIDDEN ID=17 ACTION=delete>
such	JJ	such
</FORBIDDEN ID=17 ACTION=delete>
as	IN	as
surveillance	NN	surveillance
of	IN	of
CAUTI	NN	CAUTI
and	CC	and
infection	NN	infection
control	NN	control
,	,	,
and	CC	and
evaluated	VBD	evaluate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
outcomes	NNS	outcome
of	IN	of
these	DT	these
measures	NNS	measure
over	IN	over
a	DT	a
total	NN	total
of	IN	of
8	CD	8
months	NNS	month
.	SENT	.
.	SENT	.
Our	PP$	Our
PFGE	NN	PFGE
results	NNS	result
showed	VBD	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
these	DT	these
eight	CD	eight
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
MDRP	NN	MDRP
isolates	NNS	isolate
could	MD	could
be	VV	be
considered	VBN	consider
as	RB	as
closely	RB	closely
related	JJ	related
strains	NNS	strain
.	SENT	.
.	SENT	.
We	PP	We
concluded	VBD	conclude
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
this	DT	this
was	VVD	be
an	DT	an
MDRP	NN	MDRP
outbreak	NN	outbreak
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
was	VVD	be
causing	VBG	cause
CAUTI	NN	CAUTI
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
isolated	VBN	isolate
ratio	NN	ratio
of	IN	of
MDRP	NN	MDRP
began	VBD	begin
to	TO	to
decrease	VB	decrease
over	IN	over
4	CD	4
months	NNS	month
of	IN	of
surveillance	NN	surveillance
and	CC	and
significantly	RB	significantly
decreased	VBD	decrease
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
4th	JJ	4th
quarter	NN	quarter
(	(	(
7th	JJ	7th
and	CC	and
8th	JJ	8th
months	NNS	month
)	)	)
compared	VBN	compare
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
1st	JJ	1st
quarter	NN	quarter
(	(	(
1st	CD	1st
and	CC	and
2nd	CD	2nd
months	NNS	month
)	)	)
(	(	(
P=	NN	P=
0.021	CD	0.021
)	)	)
<FORBIDDEN ID=157 ACTION=delete>
even	RB	even
</FORBIDDEN ID=157 ACTION=delete>
though	IN	though
urinary	JJ	urinary
tract	NN	tract
device	NN	device
<FORBIDDEN ID=165 ACTION=delete>
usage	NN	usage
significantly	RB	significantly
</FORBIDDEN ID=165 ACTION=delete>
increased	VBD	increase
over	IN	over
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=16 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
same	JJ	same
</FORBIDDEN ID=16 ACTION=delete>
period	NN	period
(	(	(
PINF	NN	PINF
0.001	CD	0.001
)	)	)
.	SENT	.
.	SENT	.
We	PP	We
experienced	VBD	experience
an	DT	an
outbreak	NN	outbreak
of	IN	of
emergent	JJ	emergent
MDRP	NN	MDRP
causing	VBG	cause
CAUTI	NN	CAUTI
in	IN	in
neurogenic	JJ	neurogenic
bladder	NN	bladder
patients	NNS	patient
with	IN	with
spinal	JJ	spinal
cord	NN	cord
injury	NN	injury
.	SENT	.
.	SENT	.
Our	PP$	Our
preventive	JJ	preventive
measures	NNS	measure
for	IN	for
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
isolating	VBG	isolate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
outbreak	NN	outbreak
,	,	,
including	VBG	include
surveillance	NN	surveillance
,	,	,
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
have	VH	have
led	VBN	lead
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
decrease	NN	decrease
we	PP	we
observed	VBD	observe
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
ratio	NN	ratio
of	IN	of
MDRP	NN	MDRP
isolated	VBN	isolate
.	SENT	.
.	SENT	.
BB-cat+ner-25204345/text	DOCUMENT	BB-cat+ner-25204345/text
Association	NN	Association
of	IN	of
mutation	NN	mutation
patterns	NNS	pattern
in	IN	in
GyrA	NN	GyrA
and	CC	and
ParC	NN	ParC
genes	NNS	gene
with	IN	with
quinolone	NN	quinolone
resistance	NN	resistance
levels	NNS	level
in	IN	in
lactic	JJ	lactic
acid	NN	acid
bacteria	NNS	bacteria
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
quinolone	NN	quinolone
resistance	NN	resistance
of	IN	of
19	CD	19
lactic	JJ	lactic
acid	NN	acid
bacterial	JJ	bacterial
strains	NNS	strain
<FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
belonging	VBG	belong
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
genera	NN	genera
Enterococcus	NN	Enterococcus
and	CC	and
Lactobacillus	NN	Lactobacillus
isolated	VBN	isolate
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
natural	JJ	natural
fermented	VBN	ferment
koumiss	NN	koumiss
and	CC	and
yoghurt	NN	yoghurt
were	VVD	be
investigated	VBN	investigate
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
objective	NN	objective
of	IN	of
this	DT	this
study	NN	study
was	VVD	be
to	TO	to
determine	VB	determine
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
quinolone	NN	quinolone
resistance	NN	resistance
levels	NNS	level
and	CC	and
to	TO	to
explore	VB	explore
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
association	NN	association
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
resistance	NN	resistance
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
mutation	NN	mutation
patterns	NNS	pattern
in	IN	in
gyrA	NN	gyrA
and	CC	and
parC	NN	parC
genes	NNS	gene
,	,	,
as	IN	as
is	VVZ	be
currently	RB	currently
recommended	VBN	recommend
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Food	NP	Food
and	CC	and
Agriculture	NP	Agriculture
Organization	NP	Organization
/	NP	/
World	NP	World
Health	NP	Health
Organization	NP	Organization
Joint	NP	Joint
Expert	NP	Expert
Committee	NP	Committee
in	IN	in
Guidelines	NP	Guidelines
for	IN	for
Evaluation	NN	Evaluation
of	IN	of
Probiotics	NNS	Probiotic
in	IN	in
Food	NN	Food
for	IN	for
probiotic	JJ	probiotic
lactic	JJ	lactic
acid	NN	acid
bacteria	NNS	bacteria
drug	NN	drug
resistance	NN	resistance
in	IN	in
2001	CD	2001
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Oxford	NP	Oxford
Cup	NP	Cup
method	NN	method
and	CC	and
double	JJ	double
-	HYPH	-
tube	NN	tube
dilution	NN	dilution
method	NN	method
were	VVD	be
used	VBN	use
to	TO	to
determine	VB	determine
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
quinolone	NN	quinolone
resistance	NN	resistance
levels	NNS	level
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
isolated	VBN	isolate
strains	NNS	strain
.	SENT	.
.	SENT	.
<FORBIDDEN ID=161 ACTION=delete>
Generally	RB	Generally
</FORBIDDEN ID=161 ACTION=delete>
,	,	,
all	DT	all
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
19	CD	19
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
strains	NNS	strain
showed	VBD	show
resistance	NN	resistance
towards	IN	towards
norfloxacin	NN	norfloxacin
and	CC	and
ciprofloxacin	NN	ciprofloxacin
when	WRB	when
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Oxford	NP	Oxford
cup	NN	cup
method	NN	method
was	VVD	be
used	VBN	use
,	,	,
whereas	IN	whereas
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
incidence	NN	incidence
was	VVD	be
lower	JJR	low
(	(	(
to	TO	to
norfloxacin	NN	norfloxacin
89.5	CD	89.5
%	NN	%
and	CC	and
to	TO	to
ciprofloxacin	NN	ciprofloxacin
68.4	CD	68.4
%	NN	%
)	)	)
when	WRB	when
minimum	JJ	minimum
inhibitory	JJ	inhibitory
concentration	NN	concentration
breakpoints	NNS	breakpoint
(	(	(
CLSI	NN	CLSI
M100	NN	M100
-	HYPH	-
S23	NN	S23
)	)	)
were	VVD	be
tested	VBN	test
.	SENT	.
.	SENT	.
Furthermore	RB	Furthermore
,	,	,
gene	NN	gene
sequencing	NN	sequencing
was	VVD	be
conducted	VBN	conduct
on	IN	on
gyrA	NN	gyrA
and	CC	and
parC	NN	parC
of	IN	of
topoisomerase	NN	topoisomerase
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
II	CD	II
of	IN	of
these	DT	these
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
isolated	VBN	isolate
strains	NNS	strain
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
genetic	JJ	genetic
basis	NN	basis
for	IN	for
quinolone	NN	quinolone
resistance	NN	resistance
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
be	VV	be
closely	RB	closely
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
related	JJ	related
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
mutations	NNS	mutation
in	IN	in
gyrA	NN	gyrA
genes	NNS	gene
as	IN	as
there	EX	there
were	VVD	be
10	CD	10
mutation	NN	mutation
sites	NNS	site
in	IN	in
amino	JJ	amino
-	HYPH	-
acid	NN	acid
sequences	NNS	sequence
encoded	VBN	encode
by	IN	by
gyrA	NN	gyrA
genes	NNS	gene
in	IN	in
10	CD	10
quinolone	NN	quinolone
resistance	NN	resistance
strains	NNS	strain
and	CC	and
14	CD	14
mutation	NN	mutation
sites	NNS	site
in	IN	in
Enterococcus	NP	Enterococcus
durans	NNS	duran
HZ28	NN	HZ28
,	,	,
whereas	IN	whereas
no	DT	no
typical	JJ	typical
mutations	NNS	mutation
were	VVD	be
detected	VBN	detect
in	IN	in
parC	NN	parC
genes	NNS	gene
.	SENT	.
.	SENT	.
BB-cat+ner-25562320/text	DOCUMENT	BB-cat+ner-25562320/text
Annexin1	NN	Annexin1
regulates	VBZ	regulate
DC	NN	DC
efferocytosis	NN	efferocytosis
and	CC	and
cross	AFX	cross
-	HYPH	-
presentation	NN	presentation
during	IN	during
Mycobacterium	NN	Mycobacterium
tuberculosis	NN	tuberculosis
infection	NN	infection
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
phagocytosis	NN	phagocytosis
of	IN	of
apoptotic	JJ	apoptotic
cells	NNS	cell
and	CC	and
associated	VBN	associate
vesicles	NNS	vesicle
(	(	(
efferocytosis	NN	efferocytosis
)	)	)
by	IN	by
DCs	NNS	DC
is	VVZ	be
an	DT	an
important	JJ	important
mechanism	NN	mechanism
for	IN	for
<FORBIDDEN ID=30 ACTION=delete>
both	CC	both
</FORBIDDEN ID=30 ACTION=delete>
self	NN	self
tolerance	NN	tolerance
and	CC	and
host	NN	host
defense	NN	defense
.	SENT	.
.	SENT	.
Although	IN	Although
some	DT	some
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
engulfment	NN	engulfment
ligands	NNS	ligand
involved	VBN	involve
in	IN	in
efferocytosis	NN	efferocytosis
have	VHP	have
been	VVN	be
identified	VBN	identify
and	CC	and
studied	VBN	study
in vitro	FW	in_vitro
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
contributions	NNS	contribution
of	IN	of
these	DT	these
ligands	NNS	ligand
in vivo	RB	in_vivo
remain	VBP	remain
ill	RB	ill
defined	VBN	define
.	SENT	.
.	SENT	.
Here	RB	Here
,	,	,
we	PP	we
determined	VBD	determine
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
during	IN	during
Mycobacterium	NN	Mycobacterium
tuberculosis	NN	tuberculosis
(	(	(
Mtb	NN	Mtb
)	)	)
infection	NN	infection
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
engulfment	NN	engulfment
ligand	NN	ligand
annexin1	NN	annexin1
is	VVZ	be
an	DT	an
important	JJ	important
mediator	NN	mediator
in	IN	in
DC	NNS	DC
cross	AFX	cross
-	HYPH	-
presentation	NN	presentation
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
increases	VBZ	increase
efferocytosis	NN	efferocytosis
in	IN	in
DCs	NNS	DC
and	CC	and
intrinsically	RB	intrinsically
enhances	VBZ	enhance
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
capacity	NN	capacity
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
DC	NN	DC
antigen	NN	antigen
-	HYPH	-
presenting	VBG	present
machinery	NN	machinery
.	SENT	.
.	SENT	.
Annexin1	NN	Annexin1
-	HYPH	-
deficient	JJ	deficient
mice	NNS	mouse
were	VVD	be
highly	RB	highly
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
susceptible	JJ	susceptible
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
Mtb	NN	Mtb
infection	NN	infection
and	CC	and
showed	VBD	show
an	DT	an
impaired	JJ	impaired
Mtb	NN	Mtb
antigen	NN	antigen
-	HYPH	-
specific	JJ	specific
CD8+	JJ	CD8+
T	NN	T
cell	NN	cell
response	NN	response
.	SENT	.
.	SENT	.
Importantly	RB	Importantly
,	,	,
annexin1	NN	annexin1
expression	NN	expression
was	VVD	be
greatly	RB	greatly
downregulated	VBN	downregulate
in	IN	in
Mtb-infected	JJ	Mtb-infected
human	JJ	human
blood	NN	blood
monocyte	NN	monocyte
-	HYPH	-
derived	VBN	derive
DCs	NNS	DC
,	,	,
indicating	VBG	indicate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
reduction	NN	reduction
of	IN	of
annexin1	NN	annexin1
is	VVZ	be
a	DT	a
critical	JJ	critical
mechanism	NN	mechanism
for	IN	for
immune	JJ	immune
evasion	NN	evasion
by	IN	by
Mtb	NN	Mtb
.	SENT	.
.	SENT	.
Collectively	RB	Collectively
,	,	,
these	DT	these
data	NNS	datum
indicate	VBP	indicate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
annexin1	NN	annexin1
is	VVZ	be
essential	JJ	essential
<FORBIDDEN ID=27 ACTION=delete>
<FORBIDDEN ID=26 ACTION=delete>
in	IN	in
immunity	NN	immunity
to	TO	to
</FORBIDDEN ID=26 ACTION=delete>
</FORBIDDEN ID=27 ACTION=delete>
Mtb	NN	Mtb
infection	NN	infection
and	CC	and
mediates	VBZ	mediate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
power	NN	power
of	IN	of
DC	NN	DC
efferocytosis	NN	efferocytosis
and	CC	and
cross	AFX	cross
-	HYPH	-
presentation	NN	presentation
.	SENT	.
.	SENT	.
BB-cat+ner-25607366/text	DOCUMENT	BB-cat+ner-25607366/text
Biocontainment	NN	Biocontainment
of	IN	of
genetically	RB	genetically
modified	VBN	modify
organisms	NNS	organism
by	IN	by
synthetic	JJ	synthetic
protein	NN	protein
design	NN	design
.	SENT	.
.	SENT	.
Genetically	RB	Genetically
modified	VBN	modify
organisms	NNS	organism
(	(	(
GMOs	NNS	GMO
)	)	)
are	VVP	be
increasingly	RB	increasingly
deployed	VBN	deploy
at	IN	at
large	JJ	large
scales	NNS	scale
and	CC	and
in	IN	in
open	JJ	open
environments	NNS	environment
.	SENT	.
.	SENT	.
Genetic	JJ	Genetic
biocontainment	NN	biocontainment
strategies	NNS	strategy
are	VVP	be
needed	VBN	need
to	TO	to
prevent	VB	prevent
unintended	JJ	unintended
proliferation	NN	proliferation
of	IN	of
GMOs	NNS	GMO
in	IN	in
natural	JJ	natural
ecosystems	NNS	ecosystem
.	SENT	.
.	SENT	.
Existing	VBG	Exist
biocontainment	NN	biocontainment
methods	NNS	method
are	VVP	be
insufficient	JJ	insufficient
because	IN	because
they	PP	they
impose	VBP	impose
evolutionary	JJ	evolutionary
pressure	NN	pressure
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
organism	NN	organism
to	TO	to
eject	VB	eject
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
safeguard	NN	safeguard
by	IN	by
spontaneous	JJ	spontaneous
mutagenesis	NN	mutagenesis
or	CC	or
horizontal	JJ	horizontal
gene	NN	gene
transfer	NN	transfer
,	,	,
or	CC	or
because	IN	because
they	PP	they
can	MD	can
be	VV	be
circumvented	VBN	circumvent
by	IN	by
environmentally	RB	environmentally
available	JJ	available
compounds	NNS	compound
.	SENT	.
.	SENT	.
Here	RB	Here
we	PP	we
computationally	RB	computationally
redesign	VBP	redesign
essential	JJ	essential
enzymes	NNS	enzyme
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
first	JJ	first
organism	NN	organism
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
possessing	VBG	possess
an	DT	an
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
altered	JJ	altered
genetic	JJ	genetic
code	NN	code
(	(	(
Escherichia	FW	Escherichia
coli	FW	coli
strain	NN	strain
C321	NN	C321
.	SENT	.
.	SENT	.
ΔA	NN	ΔA
)	)	)
to	TO	to
confer	VB	confer
metabolic	JJ	metabolic
dependence	NN	dependence
on	IN	on
non-standard	JJ	non-standard
amino	JJ	amino
acids	NNS	acid
for	IN	for
survival	NN	survival
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
resulting	VBG	result
GMOs	NNS	GMO
cannot	MD	cannot
metabolically	RB	metabolically
bypass	VB	bypass
their	PP$	their
biocontainment	NN	biocontainment
mechanisms	NNS	mechanism
using	VBG	use
known	JJ	known
environmental	JJ	environmental
compounds	NNS	compound
,	,	,
and	CC	and
they	PP	they
exhibit	VBP	exhibit
unprecedented	JJ	unprecedented
resistance	NN	resistance
to	TO	to
evolutionary	JJ	evolutionary
escape	NN	escape
through	IN	through
mutagenesis	NN	mutagenesis
and	CC	and
horizontal	JJ	horizontal
gene	NN	gene
transfer	NN	transfer
.	SENT	.
.	SENT	.
This	DT	This
work	NN	work
provides	VBZ	provide
a	DT	a
foundation	NN	foundation
for	IN	for
safer	JJR	safe
GMOs	NNS	GMO
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
are	VVP	be
isolated	VBN	isolate
from	IN	from
natural	JJ	natural
ecosystems	NNS	ecosystem
by	IN	by
a	DT	a
reliance	NN	reliance
on	IN	on
synthetic	JJ	synthetic
metabolites	NNS	metabolite
.	SENT	.
.	SENT	.
BB-cat+ner-25634638/text	DOCUMENT	BB-cat+ner-25634638/text
Real	JJ	Real
-	HYPH	-
time	NN	time
monitoring	NN	monitoring
of	IN	of
hydrogen	NN	hydrogen
cyanide	NN	cyanide
(	(	(
HCN	NN	HCN
)	)	)
and	CC	and
ammonia	NN	ammonia
(	(	(
NH₃	NN	NH₃
)	)	)
emitted	VBN	emit
by	IN	by
Pseudomonas	NN	Pseudomonas
aeruginosa	NN	aeruginosa
.	SENT	.
.	SENT	.
We	PP	We
present	VBP	present
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
real	JJ	real
-	HYPH	-
time	NN	time
monitoring	NN	monitoring
of	IN	of
hydrogen	NN	hydrogen
cyanide	NN	cyanide
(	(	(
HCN	NN	HCN
)	)	)
production	NN	production
from	IN	from
Pseudomonas	NP	Pseudomonas
aeruginosa	NN	aeruginosa
(	(	(
P	NN	P
.	SENT	.
aeruginosa	NN	aeruginosa
)	)	)
strains	NNS	strain
in vitro	FW	in_vitro
,	,	,
using	VBG	use
laser	NN	laser
-	HYPH	-
based	VBN	base
photoacoustic	JJ	photoacoustic
spectroscopy	NN	spectroscopy
.	SENT	.
.	SENT	.
Simultaneously	RB	Simultaneously
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
production	NN	production
of	IN	of
ammonia	NN	ammonia
(	(	(
NH3	NN	NH3
)	)	)
was	VVD	be
measured	VBN	measure
,	,	,
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
influence	NN	influence
of	IN	of
different	JJ	different
factors	NNS	factor
(	(	(
<FORBIDDEN ID=67 ACTION=delete>
e.g.	FW	e.g.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=67 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
medium	NN	medium
,	,	,
temperature	NN	temperature
and	CC	and
antibiotics	NNS	antibiotic
treatment	NN	treatment
)	)	)
was	VVD	be
assessed	VBN	assess
.	SENT	.
.	SENT	.
<FORBIDDEN ID=30 ACTION=delete>
Both	DT	Both
</FORBIDDEN ID=30 ACTION=delete>
reference	NN	reference
strains	NNS	strain
and	CC	and
clinical	JJ	clinical
isolates	NNS	isolate
of	IN	of
patients	NNS	patient
with	IN	with
CF	NN	CF
were	VVD	be
studied	VBN	study
,	,	,
and	CC	and
compared	VBN	compare
to	TO	to
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
pathogens	NNS	pathogen
commonly	RB	commonly
present	JJ	present
in	IN	in
lungs	NNS	lung
/	SYM	/
airways	NNS	airway
of	IN	of
CF	NN	CF
patients	NNS	patient
.	SENT	.
.	SENT	.
Hydrogen	NN	Hydrogen
cyanide	NN	cyanide
production	NN	production
starts	VBZ	start
to	TO	to
rise	VB	rise
as	RB	as
soon	RB	soon
as	IN	as
P	NN	P
.	SENT	.
aeruginosa	NN	aeruginosa
bacteria	NNS	bacteria
reach	VBP	reach
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
stationary	JJ	stationary
phase	NN	phase
(	(	(
(	(	(
9.0-9.5	CD	9.0-9.5
)	)	)
×	VBP	×
10(9)	CD	10(9)
colony	NN	colony
forming	VBG	form
units	NNS	unit
,	,	,
CFUs	NNS	CFU
)	)	)
,	,	,
up	RB	up
to	TO	to
concentrations	NNS	concentration
of	IN	of
14.5	CD	14.5
microliters	NNS	microliter
per	IN	per
hour	NN	hour
(	(	(
µl h	NN	µl_h
(	(	(
-1	CD	-1
)	)	)
)	)	)
.	SENT	.
.	SENT	.
Different	JJ	Different
strains	NNS	strain
of	IN	of
P	NN	P
.	SENT	.
aeruginosa	NN	aeruginosa
produced	VBD	produce
HCN	NN	HCN
to	TO	to
varying	VBG	vary
degrees	NNS	degree
,	,	,
and	CC	and
addition	NN	addition
of	IN	of
tobramycin	NN	tobramycin
strongly	RB	strongly
reduced	VBD	reduce
HCN	NN	HCN
production	NN	production
within	IN	within
2 h	NN	2_h
from	IN	from
application	NN	application
.	SENT	.
.	SENT	.
Burkholderia	NN	Burkholderia
cepacia	NN	cepacia
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
produced	VBD	produce
HCN	NN	HCN
(	(	(
up	RB	up
to	TO	to
0.35	CD	0.35
µl h	NN	µl_h
(	(	(
-1	NN	-1
)	)	)
in	IN	in
9.0	CD	9.0
 	NN	_
×	NN	×
 10(9) CFU)	NN	_10(9)_CFU)
while	IN	while
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
pathogens	NNS	pathogen
(	(	(
Aspergillus	NP	Aspergillus
fumigatus	NP	fumigatus
,	,	,
Stenotrophomonas	NP	Stenotrophomonas
maltophilia	NN	maltophilia
,	,	,
Mycobacterium	NN	Mycobacterium
abscessus	NN	abscessus
)	)	)
did	VBD	do
not	RB	not
produce	VB	produce
detectable	JJ	detectable
levels	NNS	level
.	SENT	.
.	SENT	.
Our	PP$	Our
study	NN	study
reveals	VBZ	reveal
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
first	JJ	first
<FORBIDDEN ID=0 ACTION=split SPLIT_AFTER=0>
time	NN	time
a	DT	a
</FORBIDDEN ID=0 ACTION=split SPLIT_AFTER=0>
broad	JJ	broad
overview	NN	overview
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
dynamics	NNS	dynamic
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
HCN	NN	HCN
production	NN	production
in vitro	FW	in_vitro
.	SENT	.
.	SENT	.
BB-cat+ner-25644009/text	DOCUMENT	BB-cat+ner-25644009/text
Comparative	JJ	Comparative
genome	NN	genome
sequencing	NN	sequencing
of	IN	of
Rickettsia	NP	Rickettsia
rickettsii	NN	rickettsii
strains	NNS	strain
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
differ	VBP	differ
in	IN	in
virulence	NN	virulence
.	SENT	.
.	SENT	.
Rickettsia	NP	Rickettsia
rickettsii	NN	rickettsii
is	VVZ	be
an	DT	an
obligate	JJ	obligate
intracellular	JJ	intracellular
pathogen	NN	pathogen
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
is	VVZ	be
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
causative	JJ	causative
agent	NN	agent
of	IN	of
Rocky	NP	Rocky
Mountain	NP	Mountain
spotted	VBD	spot
fever	NN	fever
.	SENT	.
.	SENT	.
Strains	NNS	Strain
of	IN	of
R	NN	R
.	SENT	.
rickettsii	NNS	rickettsii
differ	VBP	differ
dramatically	RB	dramatically
in	IN	in
virulence	NN	virulence
.	SENT	.
.	SENT	.
In	IN	In
a	DT	a
guinea	NN	guinea
pig	NN	pig
model	NN	model
of	IN	of
infection	NN	infection
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
severity	NN	severity
of	IN	of
disease	NN	disease
as	IN	as
assessed	VBN	assess
by	IN	by
fever	NN	fever
response	NN	response
varies	VBZ	vary
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
most	RBS	most
virulent	JJ	virulent
,	,	,
Sheila	NP	Sheila
Smith	NP	Smith
,	,	,
to	TO	to
Iowa	NP	Iowa
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
causes	VBZ	cause
no	DT	no
fever	NN	fever
.	SENT	.
.	SENT	.
To	TO	To
identify	VB	identify
potential	JJ	potential
determinants	NNS	determinant
of	IN	of
virulence	NN	virulence
in	IN	in
R	NN	R
.	SENT	.
rickettsii	NN	rickettsii
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
genomes	NNS	genome
of	IN	of
two	CD	two
additional	JJ	additional
strains	NNS	strain
were	VVD	be
sequenced	VBN	sequence
for	IN	for
comparison	NN	comparison
to	TO	to
known	VBN	know
sequences	NNS	sequence
(	(	(
comparative	JJ	comparative
genome	NN	genome
sequencing	NN	sequencing
[CGS]	NN	[CGS]
)	)	)
.	SENT	.
.	SENT	.
R	NN	R
.	SENT	.
rickettsii	NN	rickettsii
Morgan	NP	Morgan
and	CC	and
R	NP	R
strains	NNS	strain
were	VVD	be
compared	VBN	compare
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
avirulent	JJ	avirulent
R	NN	R
.	SENT	.
rickettsii	NN	rickettsii
Iowa	NP	Iowa
and	CC	and
virulent	JJ	virulent
R	NN	R
.	SENT	.
rickettsii	NN	rickettsii
Sheila	NP	Sheila
Smith	NP	Smith
strains	NNS	strain
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Montana	NP	Montana
strains	VBZ	strain
Sheila	NP	Sheila
Smith	NP	Smith
and	CC	and
R	NN	R
were	VVD	be
found	VBN	find
to	TO	to
be	VV	be
highly	RB	highly
similar	JJ	similar
while	IN	while
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
eastern	JJ	eastern
strains	NNS	strain
Iowa	NP	Iowa
and	CC	and
Morgan	NP	Morgan
were	VVD	be
most	RBS	most
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
similar	JJ	similar
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
each	DT	each
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
.	SENT	.
.	SENT	.
A	DT	A
major	JJ	major
surface	NN	surface
antigen	NN	antigen
,	,	,
rickettsial	JJ	rickettsial
outer	JJ	outer
membrane	NN	membrane
protein	NN	protein
A	NN	A
(	(	(
rOmpA	NN	rOmpA
)	)	)
,	,	,
is	VVZ	be
severely	RB	severely
truncated	VBN	truncate
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Iowa	NP	Iowa
strain	NN	strain
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
region	NN	region
of	IN	of
ompA	NN	ompA
containing	VBG	contain
13	CD	13
tandem	JJ	tandem
repeats	NNS	repeat
was	VVD	be
sequenced	VBN	sequence
,	,	,
revealing	VBG	reveal
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
seven	CD	seven
shared	VBN	share
SNPs	NNS	SNP
(	(	(
four	CD	four
nonsynonymous	JJ	nonsynonymous
)	)	)
for	IN	for
R	NN	R
and	CC	and
Morgan	NP	Morgan
strains	NNS	strain
compared	VBN	compare
to	TO	to
Sheila	NP	Sheila
Smith	NP	Smith
,	,	,
with	IN	with
an	DT	an
additional	JJ	additional
17	CD	17
SNPs	NNS	SNP
identified	VBN	identify
in	IN	in
Morgan	NP	Morgan
.	SENT	.
.	SENT	.
<FORBIDDEN ID=29 ACTION=delete>
Another	DT	Another
</FORBIDDEN ID=29 ACTION=delete>
major	JJ	major
surface	NN	surface
antigen	NN	antigen
and	CC	and
autotransporter	NN	autotransporter
,	,	,
rOmpB	NN	rOmpB
,	,	,
exhibits	VBZ	exhibit
a	DT	a
defect	NN	defect
in	IN	in
processing	NN	processing
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Iowa	NP	Iowa
strain	NN	strain
<FORBIDDEN ID=17 ACTION=delete>
such	IN	such
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=17 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
beta	NN	beta
fragment	NN	fragment
is	VVZ	be
not	RB	not
cleaved	VBN	cleave
.	SENT	.
.	SENT	.
Sequence	NN	Sequence
analysis	NN	analysis
of	IN	of
ompB	NN	ompB
reveals	VBZ	reveal
identical	JJ	identical
sequences	NNS	sequence
between	IN	between
Iowa	NP	Iowa
and	CC	and
Morgan	NP	Morgan
strains	NNS	strain
and	CC	and
between	IN	between
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
R	NP	R
and	CC	and
Sheila	NP	Sheila
Smith	NP	Smith
strains	NNS	strain
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
number	NN	number
of	IN	of
SNPs	NNS	SNP
and	CC	and
insertions	NNS	insertion
/	SYM	/
deletions	NNS	deletion
between	IN	between
sequences	NNS	sequence
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
two	CD	two
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
Montana	NP	Montana
strains	NNS	strain
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
two	CD	two
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
eastern	JJ	eastern
strains	NNS	strain
is	VVZ	be
low	JJ	low
,	,	,
thus	RB	thus
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
narrowing	VBG	narrow
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
field	NN	field
of	IN	of
possible	JJ	possible
virulence	NN	virulence
factors	NNS	factor
.	SENT	.
.	SENT	.
BB-cat+ner-26155675/text	DOCUMENT	BB-cat+ner-26155675/text
Production	NN	Production
of	IN	of
a	DT	a
cellulase	NN	cellulase
-	HYPH	-
free	JJ	free
alkaline	NN	alkaline
xylanase	NN	xylanase
from	IN	from
Bacillus	NN	Bacillus
pumilus	NN	pumilus
MTCC	NN	MTCC
5015	CD	5015
by	IN	by
submerged	JJ	submerged
fermentation	NN	fermentation
and	CC	and
its	PP$	its
application	NN	application
in	IN	in
biobleaching	NN	biobleaching
.	SENT	.
.	SENT	.
Here	RB	Here
,	,	,
we	PP	we
described	VBD	describe
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
production	NN	production
of	IN	of
a	DT	a
cellulase	NN	cellulase
-	HYPH	-
free	JJ	free
alkaline	NN	alkaline
xylanase	NN	xylanase
from	IN	from
Bacillus	NN	Bacillus
pumilus	NN	pumilus
MTCC	NN	MTCC
5015	CD	5015
by	IN	by
submerged	JJ	submerged
fermentation	NN	fermentation
and	CC	and
its	PP$	its
application	NN	application
in	IN	in
biobleaching	NN	biobleaching
.	SENT	.
.	SENT	.
<FORBIDDEN ID=54 ACTION=delete>
Various	JJ	Various
</FORBIDDEN ID=54 ACTION=delete>
process	NN	process
parameters	NNS	parameter
affecting	VBG	affect
xylanase	NN	xylanase
production	NN	production
by	IN	by
B	NN	B
.	SENT	.
pumilus	NN	pumilus
were	VVD	be
optimized	VBN	optimize
by	IN	by
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
adopting	VBG	adopt
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
Plackett	NP	Plackett
-	HYPH	-
Burman	NP	Burman
design	NN	design
(	(	(
PBD	NN	PBD
)	)	)
as	RB	as
well	RB	well
as	IN	as
Response	NN	Response
surface	NN	surface
methodology	NN	methodology
(	(	(
RSM	NN	RSM
)	)	)
.	SENT	.
.	SENT	.
These	DT	These
statistical	JJ	statistical
methods	NNS	method
aid	NN	aid
in	IN	in
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
improving	VBG	improve
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
enzyme	NN	enzyme
yield	NN	yield
by	IN	by
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
analysing	VBG	analyse
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
individual	JJ	individual
crucial	JJ	crucial
components	NNS	component
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
medium	NN	medium
.	SENT	.
.	SENT	.
Maximum	JJ	Maximum
production	NN	production
was	VVD	be
obtained	VBN	obtain
with	IN	with
4%	NN	4%
yeast	NN	yeast
extract	NN	extract
,	,	,
0.08	CD	0.08
%	NN	%
magnesium	NN	magnesium
sulphate	NN	sulphate
,	,	,
30	CD	30
h	NN	h
of	IN	of
inoculum	NN	inoculum
age	NN	age
,	,	,
incubation	NN	incubation
temperature	NN	temperature
of	IN	of
33.5	CD	33.5
degrees	NNS	degree
C	NN	C
and	CC	and
pH	NN	pH
9.0	CD	9.0
.	SENT	.
.	SENT	.
Under	IN	Under
optimized	VBN	optimize
conditions	NNS	condition
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
xylanase	NN	xylanase
activity	NN	activity
was	VVD	be
372	CD	372
IU	NN	IU
/	SYM	/
ml	NN	ml
.	SENT	.
.	SENT	.
Media	NP	Media
engineering	NN	engineering
improved	VBD	improve
a	DT	a
5-fold	JJ	5-fold
increase	NN	increase
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
enzyme	NN	enzyme
production	NN	production
.	SENT	.
.	SENT	.
Scanning	NN	Scanning
electron	NN	electron
microscopy	NN	microscopy
(	(	(
SEM	NN	SEM
)	)	)
showed	VBD	show
significant	JJ	significant
changes	NNS	change
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
surface	NN	surface
of	IN	of
xylanase	NN	xylanase
treated	VBN	treat
pulps	NNS	pulp
as	IN	as
a	DT	a
result	NN	result
of	IN	of
xylan	NN	xylan
hydrolysis	NN	hydrolysis
.	SENT	.
.	SENT	.
Increased	VBN	Increase
roughness	NN	roughness
of	IN	of
paper	NN	paper
carton	NN	carton
fibres	NNS	fibre
was	VVD	be
apparent	JJ	apparent
in	IN	in
scanning	VBG	scan
electron	NN	electron
micrograph	NNS	micrograph
due	IN	due
to	TO	to
opening	NN	opening
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
micro	NN	micro
fibrils	NNS	fibril
present	JJ	present
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
surface	NN	surface
by	IN	by
xylanase	NN	xylanase
action	NN	action
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
untreated	JJ	untreated
pulp	NN	pulp
did	VBD	do
not	RB	not
show	VB	show
any	DT	any
<FORBIDDEN ID=17 ACTION=delete>
such	JJ	such
</FORBIDDEN ID=17 ACTION=delete>
change	NN	change
.	SENT	.
.	SENT	.
These	DT	These
results	NNS	result
demonstrated	VBD	demonstrate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
B	NN	B
.	SENT	.
pumilus	NN	pumilus
MTCC	NN	MTCC
5015	CD	5015
xylanase	NN	xylanase
was	VVD	be
effective	JJ	effective
in	IN	in
bio-bleaching	NN	bio-bleaching
of	IN	of
paper	NN	paper
carton	NN	carton
.	SENT	.
.	SENT	.
BB-cat+ner-2617654/text	DOCUMENT	BB-cat+ner-2617654/text
Carriage	NN	Carriage
of	IN	of
Haemophilus	NP	Haemophilus
influenzae	NNS	influenzae
in	IN	in
healthy	JJ	healthy
Gambian	JJ	Gambian
children	NNS	child
.	SENT	.
1240	CD	1240
throat	JJ	throat
samples	NNS	sample
were	VVD	be
processed	VBN	process
during	IN	during
different	JJ	different
seasons	NNS	season
in	IN	in
11	CD	11
different	JJ	different
communities	NNS	community
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Gambia	NP	Gambia
(	(	(
West	NP	West
Africa	NP	Africa
)	)	)
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
carriage	NN	carriage
rate	NN	rate
for	IN	for
Haemophilus	NP	Haemophilus
influenzae	VBP	influenzae
type	NN	type
b	NN	b
ranged	VBD	range
from	IN	from
0	CD	0
to	TO	to
33%	CD	33%
,	,	,
but	CC	but
often	RB	often
attained	VBN	attain
10%	CD	10%
<FORBIDDEN ID=21 ACTION=delete>
or	CC	or
<FORBIDDEN ID=82 ACTION=delete>
more	JJR	more
</FORBIDDEN ID=21 ACTION=delete>
</FORBIDDEN ID=82 ACTION=delete>
,	,	,
higher	JJR	high
than	IN	than
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	DT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
reported	VBN	report
from	IN	from
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
open	JJ	open
communities	NNS	community
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
duration	NN	duration
of	IN	of
carriage	NN	carriage
was	VVD	be
short	JJ	short
(	(	(
less	JJR	less
than	IN	than
3	CD	3
months	NNS	month
)	)	)
and	CC	and
H	NN	H
.	VBD	.
influenzae	JJ	influenzae
b	NN	b
was	VVD	be
found	VBN	find
in	IN	in
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=156 ACTION=delete>
10%	CD	10%
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
carriers	NNS	carrier
isolated	VBN	isolate
during	IN	during
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
previous	JJ	previous
or	CC	or
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
following	JJ	following
survey	NN	survey
.	SENT	.
.	SENT	.
Children	NNS	Child
less	JJR	less
than	IN	than
5	CD	5
years	NNS	year
old	JJ	old
carried	VBN	carry
H	NN	H
.	VBD	.
influenzae	JJ	influenzae
b	NN	b
in	IN	in
their	PP$	their
<FORBIDDEN ID=165 ACTION=delete>
throat	NN	throat
significantly	RB	significantly
<FORBIDDEN ID=82 ACTION=delete>
</FORBIDDEN ID=165 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
often	RB	often
than	IN	than
children	NNS	child
older	JJR	old
than	IN	than
14	CD	14
years	NNS	year
(	(	(
P	NN	P
less	JJR	less
than	IN	than
0.05	CD	0.05
)	)	)
.	SENT	.
.	SENT	.
A	DT	A
high	JJ	high
carriage	NN	carriage
rate	NN	rate
did	VBD	do
not	RB	not
correlate	VB	correlate
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
wet	JJ	wet
or	CC	or
dry	JJ	dry
season	NN	season
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
carriage	NN	carriage
rate	NN	rate
of	IN	of
children	NNS	child
in	IN	in
rural	JJ	rural
areas	NNS	area
was	VVD	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
similar	JJ	similar
to	TO	to
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
that	DT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
of	IN	of
children	NNS	child
in	IN	in
urban	JJ	urban
areas	NNS	area
.	SENT	.
.	SENT	.
Children	NNS	Child
in	IN	in
day-care	JJ	day-care
centres	NNS	centre
or	CC	or
nurseries	NNS	nursery
had	VHD	have
a	DT	a
surprisingly	RB	surprisingly
low	JJ	low
carriage	NN	carriage
rate	NN	rate
(	(	(
2%	NN	2%
)	)	)
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
carriage	NN	carriage
rate	NN	rate
of	IN	of
H	NN	H
.	SYM	.
influenzae	NN	influenzae
b	NN	b
was	VVD	be
compared	VBN	compare
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
H	NN	H
.	VBD	.
influenzae	JJ	influenzae
subspecies	NNS	subspecy
in	IN	in
a	DT	a
random	JJ	random
sample	NN	sample
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
revealed	VBD	reveal
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
H	NN	H
.	VBD	.
influenzae	NN	influenzae
subspecies	NNS	subspecy
was	VVD	be
found	VBN	find
in	IN	in
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
90%	CD	90%
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
children	NNS	child
under	IN	under
5	CD	5
years	NNS	year
old	JJ	old
.	SENT	.
.	SENT	.
Encapsulated	VBN	Encapsulate
strains	NNS	strain
of	IN	of
H	NN	H
.	NN	.
influenzae	NNS	influenzae
were	VVD	be
found	VBN	find
in	IN	in
25%	NN	25%
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=16 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
same	JJ	same
</FORBIDDEN ID=16 ACTION=delete>
sample	NN	sample
,	,	,
two-thirds	NNS	two-third
of	IN	of
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
were	VVD	be
not	RB	not
type	NN	type
b	NN	b
.	SENT	.
.	SENT	.
All	DT	All
capsule	NN	capsule
types	NNS	type
were	VVD	be
represented	VBN	represent
.	SENT	.
.	SENT	.
No	DT	No
meningitis	NN	meningitis
cases	NNS	case
occurred	VBD	occur
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
survey	NN	survey
populations	NNS	population
.	SENT	.
.	SENT	.
We	PP	We
conclude	VBP	conclude
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
prevalence	NN	prevalence
of	IN	of
H	NN	H
.	SYM	.
influenzae	NN	influenzae
b	NN	b
in	IN	in
open	JJ	open
Gambian	JJ	Gambian
communities	NNS	community
is	VVZ	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
similar	JJ	similar
to	TO	to
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
that	DT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
in	IN	in
closed	VBN	close
communities	NNS	community
elsewhere	RB	elsewhere
,	,	,
but	CC	but
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
kinetics	NNS	kinetic
are	VVP	be
different	JJ	different
from	IN	from
those	DT	those
in	IN	in
closed	JJ	closed
communities	NNS	community
,	,	,
as	IN	as
persistence	NN	persistence
of	IN	of
infection	NN	infection
in	IN	in
Gambian	JJ	Gambian
children	NNS	child
is	VVZ	be
short	JJ	short
-	HYPH	-
lived	VBN	live
.	SENT	.
.	SENT	.
BB-cat+ner-2696427/text	DOCUMENT	BB-cat+ner-2696427/text
Presence	NN	Presence
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
fish	NN	fish
pathogen	NN	pathogen
Vibrio	NN	Vibrio
salmonicida	NN	salmonicida
in	IN	in
fish	NN	fish
farm	NN	farm
sediments	NNS	sediment
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
persistence	NN	persistence
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
fish	NN	fish
pathogen	NN	pathogen
Vibrio	NN	Vibrio
salmonicida	NN	salmonicida
in	IN	in
fish	NN	fish
farm	NN	farm
sediments	NNS	sediment
was	VVD	be
studied	VBN	study
by	IN	by
use	NN	use
of	IN	of
fluorescent	JJ	fluorescent
-	HYPH	-
antibody	NN	antibody
techniques	NNS	technique
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
specificities	NNS	specificity
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
monoclonal	JJ	monoclonal
antibodies	NNS	antibody
and	CC	and
polyclonal	JJ	polyclonal
rabbit	NN	rabbit
serum	NN	serum
used	VBN	use
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
study	NN	study
were	VVD	be
tested	VBN	test
against	IN	against
a	DT	a
number	NN	number
of	IN	of
Vibrio	NP	Vibrio
strains	NNS	strain
,	,	,
including	VBG	include
4	CD	4
isolates	NNS	isolate
from	IN	from
intestinal	JJ	intestinal
tracts	NNS	tract
of	IN	of
healthy	JJ	healthy
fish	NNS	fish
and	CC	and
98	CD	98
isolates	NNS	isolate
from	IN	from
sediments	NNS	sediment
.	SENT	.
.	SENT	.
V	NN	V
.	SENT	.
salmonicida	NN	salmonicida
was	VVD	be
detected	VBN	detect
in	IN	in
sediment	NN	sediment
samples	NNS	sample
from	IN	from
diseased	JJ	diseased
farms	NNS	farm
several	JJ	several
months	NNS	month
after	IN	after
an	DT	an
outbreak	NN	outbreak
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
disease	NN	disease
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bacterium	NN	bacterium
was	VVD	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
detected	VBN	detect
in	IN	in
a	DT	a
sediment	NN	sediment
sample	NN	sample
from	IN	from
a	DT	a
disease	NN	disease
-	HYPH	-
free	JJ	free
fish	NN	fish
farm	NN	farm
.	SENT	.
.	SENT	.
No	DT	No
V	NN	V
.	SENT	.
salmonicida	NN	salmonicida
could	MD	could
be	VV	be
detected	VBN	detect
in	IN	in
sediments	NNS	sediment
not	RB	not
influenced	VBN	influence
by	IN	by
fish	NN	fish
farming	NN	farming
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
number	NN	number
of	IN	of
positive	JJ	positive
samples	NNS	sample
was	VVD	be
<FORBIDDEN ID=161 ACTION=delete>
generally	RB	generally
</FORBIDDEN ID=161 ACTION=delete>
higher	JJR	high
with	IN	with
application	NN	application
of	IN	of
rabbit	NN	rabbit
serum	NN	serum
as	IN	as
opposed	VBN	oppose
to	TO	to
use	VB	use
of	IN	of
monoclonal	JJ	monoclonal
antibodies	NNS	antibody
,	,	,
indicating	VBG	indicate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
rabbit	NN	rabbit
serum	NN	serum
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
cross	VB	cross
-	HYPH	-
react	VB	react
with	IN	with
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
bacteria	NNS	bacteria
.	SENT	.
.	SENT	.
BB-cat+ner-3015879/text	DOCUMENT	BB-cat+ner-3015879/text
Construction	NN	Construction
of	IN	of
a	DT	a
host	NN	host
-	HYPH	-
vector	NN	vector
system	NN	system
in	IN	in
Candida	NP	Candida
maltosa	NN	maltosa
by	IN	by
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
using	VBG	use
an	DT	an
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
ARS	NN	ARS
site	NN	site
isolated	VBN	isolate
from	IN	from
its	PP$	its
genome	NN	genome
.	SENT	.
.	SENT	.
To	TO	To
construct	VB	construct
a	DT	a
host	NN	host
-	HYPH	-
vector	NN	vector
system	NN	system
in	IN	in
an	DT	an
n-alkane	NN	n-alkane
-	HYPH	-
assimilating	VBG	assimilate
yeast	NN	yeast
,	,	,
Candida	NP	Candida
maltosa	NP	maltosa
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
isolation	NN	isolation
of	IN	of
an	DT	an
ARS	NN	ARS
site	NN	site
from	IN	from
its	PP$	its
genome	NN	genome
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
replicates	VBZ	replicate
autonomously	RB	autonomously
in	IN	in
C	NN	C
.	SENT	.
maltosa	NN	maltosa
was	VVD	be
attempted	VBN	attempt
.	SENT	.
.	SENT	.
Leu	NN	Leu
-	HYPH	-
mutants	NNS	mutant
of	IN	of
C	NN	C
.	SENT	.
maltosa	NN	maltosa
were	VVD	be
transformed	VBN	transform
with	IN	with
a	DT	a
gene	NN	gene
library	NN	library
prepared	VBN	prepare
by	IN	by
using	VBG	use
YEp13	NN	YEp13
(	(	(
LEU2+	NN	LEU2+
)	)	)
as	IN	as
a	DT	a
vector	NN	vector
,	,	,
and	CC	and
Leu+	JJ	Leu+
transformants	NNS	transformant
were	VVD	be
obtained	VBN	obtain
at	IN	at
a	DT	a
high	JJ	high
frequency	NN	frequency
.	SENT	.
.	SENT	.
A	DT	A
plasmid	NN	plasmid
named	VBN	name
pCS1	NN	pCS1
was	VVD	be
isolated	VBN	isolate
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
recipient	JJ	recipient
cells	NNS	cell
.	SENT	.
pCS1	NN	pCS1
contained	VBD	contain
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
a	DT	a
6.3	CD	6.3
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
-	HYPH	-
kilobase	NN	kilobase
(	(	(
kb	NN	kb
)	)	)
fragment	NN	fragment
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
C	NN	C
.	SENT	.
maltosa	NN	maltosa
genome	NN	genome
,	,	,
and	CC	and
a	DT	a
3.8-kb	JJ	3.8-kb
fragment	NN	fragment
with	IN	with
ARS	NN	ARS
activity	NN	activity
was	VVD	be
subcloned	VBN	subclone
and	CC	and
designated	VBN	designate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
TRA	NN	TRA
(	(	(
transformation	NN	transformation
ability	NN	ability
)	)	)
region	NN	region
.	SENT	.
.	SENT	.
Vectors	NNS	Vector
(	(	(
pTRA1	NN	pTRA1
and	CC	and
pTRA11	NN	pTRA11
)	)	)
for	IN	for
C	NN	C
.	SENT	.
maltosa	NN	maltosa
J288	NN	J288
were	VVD	be
constructed	VBN	construct
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
contained	VBD	contain
this	DT	this
3.8-kb	JJ	3.8-kb
fragment	NN	fragment
,	,	,
pBR322	NN	pBR322
,	,	,
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
LEU2	NN	LEU2
gene	NN	gene
of	IN	of
Saccharomyces	NP	Saccharomyces
cerevisiae	NP	cerevisiae
.	SENT	.
.	SENT	.
Transformation	NN	Transformation
of	IN	of
C	NN	C
.	SENT	.
maltosa	NN	maltosa
J288	NN	J288
with	IN	with
these	DT	these
plasmids	NNS	plasmid
was	VVD	be
successful	JJ	successful
by	IN	by
<FORBIDDEN ID=30 ACTION=delete>
both	CC	both
</FORBIDDEN ID=30 ACTION=delete>
spheroplast	NN	spheroplast
and	CC	and
lithium	NN	lithium
acetate	NN	acetate
methods	NNS	method
.	SENT	.
.	SENT	.
Southern	NN	Southern
blot	NN	blot
analysis	NN	analysis
suggested	VBD	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
copy	NN	copy
number	NN	number
of	IN	of
pTRA1	NN	pTRA1
in	IN	in
C	NN	C
.	SENT	.
maltosa	NN	maltosa
was	VVD	be
between	IN	between
10	CD	10
and	CC	and
20	CD	20
,	,	,
and	CC	and
it	PP	it
was	VVD	be
stably	RB	stably
maintained	VBN	maintain
during	IN	during
growth	NN	growth
without	IN	without
selective	JJ	selective
pressure	NN	pressure
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
medium	NN	medium
.	SENT	.
.	SENT	.
It	PP	It
was	VVD	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
found	VBN	find
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
these	DT	these
vectors	NNS	vector
could	MD	could
transform	VB	transform
S	NN	S
.	SENT	.
cerevisiae	FW	cerevisiae
leu2- to	JJ	leu2-_to
LEU2+	NN	LEU2+
,	,	,
suggesting	VBG	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
TRA	NN	TRA
region	NN	region
contained	VBD	contain
an	DT	an
ARS	NN	ARS
site(s)	NNS	site(s)
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
was	VVD	be
specific	JJ	specific
not	RB	not
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
for	IN	for
C	NN	C
.	SENT	.
maltosa	NN	maltosa
but	CC	but
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
for	IN	for
S	NN	S
.	SENT	.
cerevisiae	FW	cerevisiae
.	SENT	.
.	SENT	.
BB-cat+ner-3074181/text	DOCUMENT	BB-cat+ner-3074181/text
[	(	[
Experimental	JJ	Experimental
and	CC	and
clinical	JJ	clinical
studies	NNS	study
of	IN	of
flomoxef	NN	flomoxef
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
field	NN	field
of	IN	of
obstetrics	NNS	obstetric
and	CC	and
gynecology	NN	gynecology
.	SENT	.
.	SENT	.
Representative	JJ	Representative
Committee	NP	Committee
Members	NP	Members
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Research	NP	Research
Team	NP	Team
for	IN	for
Infections	NPS	Infection
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Field	NP	Field
of	IN	of
Obstetrics	NP	Obstetrics
and	CC	and
Gynecology	NP	Gynecology
]	)	]
.	SENT	.
.	SENT	.
Flomoxef	NN	Flomoxef
(	(	(
FMOX	NN	FMOX
)	)	)
has	VHZ	have
a	DT	a
broad	JJ	broad
antibacterial	JJ	antibacterial
spectrum	NN	spectrum
against	IN	against
Gram	NN	Gram
-	HYPH	-
positive	JJ	positive
and	CC	and
Gram	NN	Gram
-	HYPH	-
negative	JJ	negative
bacteria	NNS	bacteria
;	COLUMN	;
especially	RB	especially
its	PP$	its
potent	JJ	potent
antibacterial	JJ	antibacterial
activity	NN	activity
against	IN	against
Staphylococcus	FW	Staphylococcus
aureus	FW	aureus
is	VVZ	be
a	DT	a
significant	JJ	significant
advantage	NN	advantage
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
<FORBIDDEN ID=123 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
not	RB	not
be	VV	be
found	VBN	find
with	IN	with
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
cephem	NN	cephem
compounds	NNS	compound
.	SENT	.
.	SENT	.
In	IN	In
our	PP$	our
determination	NN	determination
of	IN	of
its	PP$	its
antibacterial	JJ	antibacterial
potency	NN	potency
against	IN	against
<FORBIDDEN ID=54 ACTION=delete>
various	JJ	various
</FORBIDDEN ID=54 ACTION=delete>
clinical	JJ	clinical
isolates	NNS	isolate
obtained	VBN	obtain
from	IN	from
clinical	JJ	clinical
materials	NNS	material
(	(	(
amniotic	JJ	amniotic
fluid	NN	fluid
,	,	,
intrauterine	JJ	intrauterine
secretions	NNS	secretion
,	,	,
exudates	NNS	exudate
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
pelvic	JJ	pelvic
dead	JJ	dead
space	NN	space
)	)	)
of	IN	of
patients	NNS	patient
with	IN	with
<FORBIDDEN ID=54 ACTION=delete>
various	JJ	various
</FORBIDDEN ID=54 ACTION=delete>
infections	NNS	infection
,	,	,
we	PP	we
obtained	VBD	obtain
results	NNS	result
representing	VBG	represent
specific	JJ	specific
features	NNS	feature
of	IN	of
this	DT	this
drug	NN	drug
.	SENT	.
.	SENT	.
From	IN	From
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
results	NNS	result
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
drug	NN	drug
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
be	VV	be
expected	VBN	expect
to	TO	to
produce	VB	produce
an	DT	an
excellent	JJ	excellent
effect	NN	effect
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
treatment	NN	treatment
of	IN	of
<FORBIDDEN ID=54 ACTION=delete>
various	JJ	various
</FORBIDDEN ID=54 ACTION=delete>
infections	NNS	infection
.	SENT	.
.	SENT	.
Our	PP$	Our
study	NN	study
on	IN	on
drug	NN	drug
concentrations	NNS	concentration
in	IN	in
body	NN	body
fluids	NNS	fluid
and	CC	and
genital	JJ	genital
tissues	NNS	tissue
demonstrated	VBD	demonstrate
a	DT	a
good	JJ	good
transfer	NN	transfer
of	IN	of
this	DT	this
drug	NN	drug
into	IN	into
<FORBIDDEN ID=54 ACTION=delete>
various	JJ	various
</FORBIDDEN ID=54 ACTION=delete>
tissues	NNS	tissue
;	COLUMN	;
in	IN	in
every	DT	every
tissue	NN	tissue
examined	VBN	examine
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
drug	NN	drug
administered	VBN	administer
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
usual	JJ	usual
method	NN	method
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
usual	JJ	usual
dose	NN	dose
yielded	VBD	yield
a	DT	a
concentration	NN	concentration
exceeding	VBG	exceed
MIC	NN	MIC
for	IN	for
principal	JJ	principal
pathogens	NNS	pathogen
,	,	,
thus	RB	thus
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
promising	VBG	promise
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
good	JJ	good
clinical	JJ	clinical
response	NN	response
.	SENT	.
.	SENT	.
Indeed	RB	Indeed
a	DT	a
high	JJ	high
clinical	JJ	clinical
efficacy	NN	efficacy
rate	NN	rate
of	IN	of
90.1	CD	90.1
%	NN	%
(	(	(
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
good	JJ	good
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
very	RB	very
good	JJ	good
responses	NNS	response
)	)	)
was	VVD	be
obtained	VBN	obtain
in	IN	in
a	DT	a
clinical	JJ	clinical
trial	NN	trial
involving	VBG	involve
222	CD	222
cases	NNS	case
.	SENT	.
.	SENT	.
Administration	NN	Administration
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
drug	NN	drug
in	IN	in
2	CD	2
g	NN	g
quantity	NN	quantity
daily	RB	daily
produced	VBD	produce
a	DT	a
high	JJ	high
response	NN	response
rate	NN	rate
of	IN	of
92.8	CD	92.8
%	NN	%
.	SENT	.
.	SENT	.
It	PP	It
was	VVD	be
especially	RB	especially
noteworthy	JJ	noteworthy
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
a	DT	a
good	JJ	good
response	NN	response
was	VVD	be
obtained	VBN	obtain
in	IN	in
30	CD	30
of	IN	of
32	CD	32
cases	NNS	case
(	(	(
93.8	CD	93.8
%	NN	%
)	)	)
in	IN	in
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
<FORBIDDEN ID=22 ACTION=delete>
</FORBIDDEN ID=36 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
cephem	NN	cephem
compounds	NNS	compound
had	VHD	have
failed	VBN	fail
.	SENT	.
.	SENT	.
In	IN	In
evaluation	NN	evaluation
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bacteriological	JJ	bacteriological
effect	NN	effect
,	,	,
furthermore	RB	furthermore
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
drug	NN	drug
showed	VBD	show
an	DT	an
excellent	JJ	excellent
rate	NN	rate
of	IN	of
bacterial	JJ	bacterial
elimination	NN	elimination
.	SENT	.
.	SENT	.
In	IN	In
conclusion	NN	conclusion
,	,	,
this	DT	this
drug	NN	drug
is	VVZ	be
expected	VBN	expect
to	TO	to
be	VV	be
greatly	RB	greatly
useful	JJ	useful
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
light	NN	light
of	IN	of
its	PP$	its
good	JJ	good
transfer	NN	transfer
into	IN	into
genital	JJ	genital
tissues	NNS	tissue
and	CC	and
its	PP$	its
strong	JJ	strong
antibacterial	JJ	antibacterial
activities	NNS	activity
against	IN	against
Gram	NN	Gram
-	HYPH	-
positive	JJ	positive
cocci	NNS	coccus
,	,	,
Gram	NN	Gram
-	HYPH	-
negative	JJ	negative
bacteria	NNS	bacteria
and	CC	and
anaerobes	NNS	anaerobe
as	RB	as
well	RB	well
as	IN	as
against	IN	against
multiple	JJ	multiple
bacterial	JJ	bacterial
infections	NNS	infection
predominating	VBG	predominate
among	IN	among
women	NNS	woman
with	IN	with
genital	JJ	genital
infections	NNS	infection
.	SENT	.
.	SENT	.
BB-cat+ner-351567/text	DOCUMENT	BB-cat+ner-351567/text
A	DT	A
cell	NN	cell
-	HYPH	-
free	JJ	free
system	NN	system
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
replication	NN	replication
fo	NN	fo
bacteriophage	NN	bacteriophage
M	NN	M
-13	CD	-13
duplex	NN	duplex
DNA	NN	DNA
.	SENT	.
.	SENT	.
Cell	NN	Cell
-	HYPH	-
free	JJ	free
extracts	NNS	extract
from	IN	from
M	NN	M
-13	CD	-13
am5	NN	am5
infected	JJ	infected
Escherichia	FW	Escherichia
coli	FW	coli
cells	NNS	cell
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
are	VVP	be
highly	RB	highly
concentrated	VBN	concentrate
on	IN	on
cellophane	NN	cellophane
membrane	NN	membrane
disks	NNS	disk
replicate	VBP	replicate
efficiently	RB	efficiently
endogenous	JJ	endogenous
M	NN	M
-13	CD	-13
duplex	NN	duplex
DNA	NN	DNA
.	SENT	.
.	SENT	.
If	IN	If
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
reaction	NN	reaction
is	VVZ	be
carried	VBN	carry
out	RP	out
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
bromodeoxyuridine	NN	bromodeoxyuridine
triphosphate	NN	triphosphate
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
majority	NN	majority
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
label	NN	label
is	VVZ	be
found	VBN	find
in	IN	in
two	CD	two
classes	NNS	class
of	IN	of
hybrid	NN	hybrid
DNA	NN	DNA
molecules	NNS	molecule
in	IN	in
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
either	CC	either
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
viral	JJ	viral
or	CC	or
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
complementary	JJ	complementary
strand	NN	strand
is	VVZ	be
newly	RB	newly
synthesized	VBN	synthesize
.	SENT	.
.	SENT	.
A	DT	A
minor	JJ	minor
portion	NN	portion
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
label	NN	label
is	VVZ	be
incorporated	VBN	incorporate
into	IN	into
fully	RB	fully
synthetic	JJ	synthetic
duplex	NN	duplex
DNA	NN	DNA
.	SENT	.
.	SENT	.
DNA	NN	DNA
synthesis	NN	synthesis
requires	VBZ	require
ATP	NN	ATP
and	CC	and
is	VVZ	be
inhibited	VBN	inhibit
by	IN	by
nalidixic	JJ	nalidixic
acid	NN	acid
,	,	,
novobiocin	NN	novobiocin
,	,	,
and	CC	and
arabinosylnucleoside	NN	arabinosylnucleoside
triphosphates	NNS	triphosphate
.	SENT	.
.	SENT	.
Rifampicin	NN	Rifampicin
blocks	VBZ	block
preferentially	RB	preferentially
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
synthesis	NN	synthesis
of	IN	of
molecules	NNS	molecule
with	IN	with
labeled	VBN	label
complementary	JJ	complementary
strands	NNS	strand
.	SENT	.
.	SENT	.
A	DT	A
similar	JJ	similar
effect	NN	effect
is	VVZ	be
observed	VBN	observe
upon	IN	upon
addition	NN	addition
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
helix	NN	helix
-	HYPH	-
destabilising	VBG	destabilise
M	NN	M
-13	CD	-13
gene	NN	gene
V	NN	V
protein	NN	protein
.	SENT	.
.	SENT	.
In	IN	In
contrast	NN	contrast
,	,	,
addition	NN	addition
of	IN	of
E	NN	E
.	SENT	.
coli	NN	coli
helix	NN	helix
-	HYPH	-
destabilising	VBG	destabilise
protein	NN	protein
(	(	(
Eco	NN	Eco
HD	NN	HD
-	HYPH	-
protein	NN	protein
)	)	)
stimulates	VBZ	stimulate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
synthesis	NN	synthesis
of	IN	of
<FORBIDDEN ID=30 ACTION=delete>
both	DT	both
</FORBIDDEN ID=30 ACTION=delete>
types	NNS	type
of	IN	of
hybrid	NN	hybrid
DNA	NN	DNA
molecules	NNS	molecule
as	RB	as
well	RB	well
as	IN	as
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
formation	NN	formation
of	IN	of
fully	RB	fully
synthetic	JJ	synthetic
duplex	NN	duplex
DNA	NN	DNA
.	SENT	.
.	SENT	.
BB-cat+ner-3516874/text	DOCUMENT	BB-cat+ner-3516874/text
Identification	NN	Identification
of	IN	of
a	DT	a
nonfimbrial	JJ	nonfimbrial
adhesive	JJ	adhesive
factor	NN	factor
of	IN	of
an	DT	an
enterotoxigenic	JJ	enterotoxigenic
Escherichia	FW	Escherichia
coli	FW	coli
strain	NN	strain
.	SENT	.
.	SENT	.
An	DT	An
enterotoxigenic	JJ	enterotoxigenic
Escherichia	FW	Escherichia
coli	FW	coli
strain	NN	strain
(	(	(
strain	NN	strain
2230	CD	2230
)	)	)
,	,	,
isolated	VBN	isolate
from	IN	from
a	DT	a
patient	NN	patient
with	IN	with
acute	JJ	acute
infantile	JJ	infantile
diarrhea	NN	diarrhea
,	,	,
was	VVD	be
found	VBN	find
to	TO	to
adhere	VB	adhere
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
brush	JJ	brush
border	NN	border
of	IN	of
human	JJ	human
intestinal	JJ	intestinal
epithelial	JJ	epithelial
cells	NNS	cell
.	SENT	.
.	SENT	.
This	DT	This
strain	NN	strain
does	VBZ	do
not	RB	not
hemagglutinate	VB	hemagglutinate
human	JJ	human
,	,	,
bovine	JJ	bovine
,	,	,
chicken	NN	chicken
,	,	,
or	CC	or
guinea	NN	guinea
pig	NN	pig
erythrocytes	NNS	erythrocyte
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
adhesion	NN	adhesion
of	IN	of
E	NN	E
.	SENT	.
coli	NN	coli
2230	CD	2230
appears	VBZ	appear
to	TO	to
be	VV	be
mediated	VBN	mediate
by	IN	by
a	DT	a
nonfimbrial	JJ	nonfimbrial
bacterial	JJ	bacterial
surface	NN	surface
protein	NN	protein
of	IN	of
16	CD	16
,	,	,
000	CD	000
daltons	NNS	dalton
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
can	MD	can
be	VV	be
extracted	VBN	extract
by	IN	by
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
heating	VBG	heat
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bacteria	NNS	bacteria
at	IN	at
60	CD	60
degrees	NNS	degree
C	JJ	C
for	IN	for
20	CD	20
min	NN	min
.	SENT	.
.	SENT	.
This	DT	This
surface	NN	surface
protein	NN	protein
is	VVZ	be
implicated	VBN	implicate
as	IN	as
an	DT	an
adhesive	JJ	adhesive
factor	NN	factor
because	IN	because
pretreatment	NN	pretreatment
of	IN	of
enterocytes	NNS	enterocyte
with	IN	with
this	DT	this
protein	NN	protein
extract	NN	extract
completely	RB	completely
inhibits	VBZ	inhibit
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
adhesion	NN	adhesion
of	IN	of
E	NN	E
.	SENT	.
coli	NN	coli
2230	CD	2230
.	SENT	.
.	SENT	.
This	DT	This
adhesive	JJ	adhesive
factor	NN	factor
is	VVZ	be
serologically	RB	serologically
distinct	JJ	distinct
from	IN	from
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
adhesive	JJ	adhesive
factors	NNS	factor
found	VBN	find
in	IN	in
enterotoxigenic	JJ	enterotoxigenic
E	NN	E
.	SENT	.
coli	NN	coli
strains	NNS	strain
.	SENT	.
.	SENT	.
A	DT	A
plasmid	NN	plasmid
DNA	NN	DNA
of	IN	of
66	CD	66
megadaltons	NNS	megadalton
is	VVZ	be
involved	VBN	involve
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
synthesis	NN	synthesis
of	IN	of
this	DT	this
nonfimbrial	JJ	nonfimbrial
adhesive	JJ	adhesive
factor	NN	factor
.	SENT	.
.	SENT	.
BB-cat+ner-3544198/text	DOCUMENT	BB-cat+ner-3544198/text
Methods	NNS	Method
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
detection	NN	detection
of	IN	of
a	DT	a
specific	JJ	specific
Mycobacterium	NN	Mycobacterium
leprae	NN	leprae
antigen	NN	antigen
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
urine	NN	urine
of	IN	of
leprosy	JJ	leprosy
patients	NNS	patient
.	SENT	.
.	SENT	.
Two	CD	Two
methods	NNS	method
for	IN	for
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
detecting	VBG	detect
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
phenolic	JJ	phenolic
glycolipid	NN	glycolipid
,	,	,
PGL	NN	PGL
-1	NN	-1
,	,	,
a	DT	a
Mycobacterium	NP	Mycobacterium
leprae	NN	leprae
-	HYPH	-
specific	JJ	specific
molecule	NN	molecule
,	,	,
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
urine	NN	urine
of	IN	of
leprosy	JJ	leprosy
patients	NNS	patient
are	VVP	be
described	VBN	describe
.	SENT	.
.	SENT	.
<FORBIDDEN ID=30 ACTION=delete>
Both	DT	Both
</FORBIDDEN ID=30 ACTION=delete>
methods	NNS	method
rely	VBP	rely
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
100-fold	JJ	100-fold
preconcentration	NN	preconcentration
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
urine	NN	urine
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
can	MD	can
be	VV	be
accomplished	VBN	accomplish
by	IN	by
a	DT	a
single	JJ	single
-	HYPH	-
step	NN	step
ultrafiltration	NN	ultrafiltration
procedure	NN	procedure
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
equivalent	NN	equivalent
of	IN	of
approximately	RB	approximately
2.5	CD	2.5
micrograms	NNS	microgram
of	IN	of
PGL	NN	PGL
-1	NN	-1
/	SYM	/
ml	NN	ml
was	VVD	be
detected	VBN	detect
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
urine	NN	urine
of	IN	of
LL	NN	LL
patients	NNS	patient
with	IN	with
an	DT	an
inhibition	NN	inhibition
ELISA	NN	ELISA
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
second	JJ	second
method	NN	method
,	,	,
a	DT	a
direct	JJ	direct
dot-blot	NN	dot-blot
assay	NN	assay
on	IN	on
nitrocellulose	NN	nitrocellulose
paper	NN	paper
,	,	,
was	VVD	be
<FORBIDDEN ID=83 ACTION=delete>
much	RB	much
</FORBIDDEN ID=83 ACTION=delete>
simpler	JJR	simple
and	CC	and
<FORBIDDEN ID=82 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
sensitive	JJ	sensitive
.	SENT	.
.	SENT	.
As	RB	As
little	JJ	little
as	IN	as
3	CD	3
ng	NN	ng
of	IN	of
antigen	NN	antigen
was	VVD	be
detected	VBN	detect
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
dot-blot	NN	dot-blot
technique	NN	technique
.	SENT	.
.	SENT	.
PGL	NN	PGL
-1	NN	-1
was	VVD	be
detected	VBN	detect
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
urine	NN	urine
of	IN	of
LL	NN	LL
patients	NNS	patient
.	SENT	.
.	SENT	.
BB-cat+ner-4105033/text	DOCUMENT	BB-cat+ner-4105033/text
Interactions	NNS	Interaction
of	IN	of
alkaline	NN	alkaline
phosphatase	NN	phosphatase
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cell	NN	cell
wall	NN	wall
of	IN	of
Pseudomonas	NN	Pseudomonas
aeruginosa	NN	aeruginosa
.	SENT	.
.	SENT	.
Spheroplasts	NNS	Spheroplast
prepared	VBN	prepare
by	IN	by
lysozyme	NN	lysozyme
treatment	NN	treatment
of	IN	of
cells	NNS	cell
of	IN	of
Pseudomonas	NN	Pseudomonas
aeruginosa	NN	aeruginosa
,	,	,
suspended	VBN	suspend
in	IN	in
20%	JJ	20%
sucrose	NN	sucrose
or	CC	or
0.2	CD	0.2
m	NN	m
MgCl(2)	NN	MgCl(2)
,	,	,
were	VVD	be
examined	VBN	examine
in	IN	in
detail	NN	detail
.	SENT	.
.	SENT	.
Preparation	NN	Preparation
of	IN	of
spheroplasts	NNS	spheroplast
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
0.2	CD	0.2
m	NN	m
Mg(2+)	NN	Mg(2+)
released	VBD	release
periplasmic	JJ	periplasmic
alkaline	NN	alkaline
phosphatase	NN	phosphatase
,	,	,
whereas	IN	whereas
preparation	NN	preparation
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
20%	JJ	20%
sucrose	NN	sucrose
did	VBD	do
not	RB	not
,	,	,
<FORBIDDEN ID=157 ACTION=delete>
even	RB	even
</FORBIDDEN ID=157 ACTION=delete>
though	IN	though
untreated	JJ	untreated
cells	NNS	cell
released	VBD	release
phosphatase	NN	phosphatase
when	WRB	when
suspended	VBN	suspend
in	IN	in
sucrose	NN	sucrose
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
absence	NN	absence
of	IN	of
lysozyme	NN	lysozyme
.	SENT	.
.	SENT	.
Biochemical	JJ	Biochemical
characterizations	NNS	characterization
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
sucrose	NN	sucrose
-	HYPH	-
lysozyme	NN	lysozyme
preparations	NNS	preparation
indicated	VBD	indicate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
lysozyme	NN	lysozyme
mediated	VBD	mediate
a	DT	a
reassociation	NN	reassociation
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
released	VBN	release
phosphatase	NN	phosphatase
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
spheroplasts	NNS	spheroplast
.	SENT	.
.	SENT	.
In	IN	In
addition	NN	addition
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
enzyme	NN	enzyme
released	VBN	release
from	IN	from
whole	JJ	whole
cells	NNS	cell
suspended	VBN	suspend
in	IN	in
20%	CD	20%
sucrose	NN	sucrose
(	(	(
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
represents	VBZ	represent
20	CD	20
to	TO	to
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
40%	CD	40%
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cell	NN	cell
-	HYPH	-
bound	VBN	bind
phosphatase	NN	phosphatase
)	)	)
reassociates	VBZ	reassociate
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cells	NNS	cell
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
lysozyme	NN	lysozyme
.	SENT	.
.	SENT	.
Electron	NN	Electron
microscopic	JJ	microscopic
examinations	NNS	examination
of	IN	of
<FORBIDDEN ID=54 ACTION=delete>
various	JJ	various
</FORBIDDEN ID=54 ACTION=delete>
preparations	NNS	preparation
revealed	VBD	reveal
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
phosphatase	NN	phosphatase
released	VBN	release
in	IN	in
sucrose	NN	sucrose
reassociated	VBN	reassociate
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
external	JJ	external
cell	NN	cell
wall	NN	wall
layers	NNS	layer
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
lysozyme	NN	lysozyme
,	,	,
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
sucrose	NN	sucrose
-	HYPH	-
lysozyme	NN	lysozyme
prepared	VBN	prepare
spheroplasts	NNS	spheroplast
did	VBD	do
not	RB	not
dissociate	VB	dissociate
phosphatase	NN	phosphatase
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
remained	VBD	remain
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
periplasm	NN	periplasm
of	IN	of
sucrose	NN	sucrose
-	HYPH	-
washed	VBN	wash
cells	NNS	cell
,	,	,
and	CC	and
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
phosphatase	NN	phosphatase
was	VVD	be
never	RB	never
observed	VBN	observe
to	TO	to
be	VV	be
associated	VBN	associate
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cytoplasmic	JJ	cytoplasmic
membrane	NN	membrane
.	SENT	.
.	SENT	.
A	DT	A
model	NN	model
to	TO	to
account	VB	account
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
binding	NN	binding
of	IN	of
P	NN	P
.	SENT	.
aeruginosa	NN	aeruginosa
alkaline	JJ	alkaline
phosphatase	NN	phosphatase
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
internal	JJ	internal
portion	NN	portion
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
tripartite	JJ	tripartite
layer	NN	layer
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cell	NN	cell
wall	NN	wall
rather	RB	rather
than	IN	than
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cytoplasmic	JJ	cytoplasmic
membrane	NN	membrane
or	CC	or
peptidoglycan	NN	peptidoglycan
layer	NN	layer
is	VVZ	be
presented	VBN	present
.	SENT	.
.	SENT	.
BB-cat+ner-4328756/text	DOCUMENT	BB-cat+ner-4328756/text
Biochemistry	NP	Biochemistry
of	IN	of
Coxiella	NP	Coxiella
burnetii	NP	burnetii
:	COLUMN	:
Embden	NP	Embden
-	HYPH	-
Meyerhof	NP	Meyerhof
pathway	NN	pathway
.	SENT	.
.	SENT	.
Purified	VBN	Purify
preparations	NNS	preparation
of	IN	of
Coxiella	NP	Coxiella
burnetii	NNS	burnetii
were	VVD	be
examined	VBN	examine
for	IN	for
enzymes	NNS	enzyme
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
glycolytic	JJ	glycolytic
pathway	NN	pathway
.	SENT	.
.	SENT	.
Glucose	NN	Glucose
-	HYPH	-
phosphate	NN	phosphate
isomerase	NN	isomerase
,	,	,
fructose	NN	fructose
-1	NN	-1
,	,	,
6-diphosphatase	NN	6-diphosphatase
,	,	,
aldolase	NN	aldolase
,	,	,
glyceraldehyde	NN	glyceraldehyde
-3	CD	-3
-	HYPH	-
phosphate	NN	phosphate
dehydrogenase	NN	dehydrogenase
,	,	,
and	CC	and
pyruvate	NN	pyruvate
kinase	NN	kinase
were	VVD	be
shown	VBN	show
to	TO	to
be	VV	be
present	JJ	present
in	IN	in
C	NN	C
.	SENT	.
burnetii	NN	burnetii
extracts	NNS	extract
.	SENT	.
.	SENT	.
Heat	NN	Heat
-	HYPH	-
killed	VBN	kill
C	NN	C
.	SENT	.
burnetii	NN	burnetii
purified	VBN	purify
with	IN	with
normal	JJ	normal
yolk	NN	yolk
sacs	NNS	sac
demonstrated	VBD	demonstrate
no	DT	no
activity	NN	activity
after	IN	after
disruption	NN	disruption
.	SENT	.
.	SENT	.
Aldolase	NN	Aldolase
was	VVD	be
shown	VBN	show
to	TO	to
be	VV	be
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
class	NN	class
II	CD	II
type	NN	type
by	IN	by
complete	JJ	complete
inhibition	NN	inhibition
of	IN	of
activity	NN	activity
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
8	CD	8
x	NN	x
10	CD	10
(	(	(
-3	CD	-3
)	)	)
m	NN	m
ethylenediaminetetraacetic	JJ	ethylenediaminetetraacetic
acid	NN	acid
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
host	NN	host
enzyme	NN	enzyme
activity	NN	activity
(	(	(
normal	JJ	normal
and	CC	and
infected	JJ	infected
yolk	NN	yolk
sacs	NNS	sac
)	)	)
was	VVD	be
not	RB	not
affected	VBN	affect
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=16 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
same	JJ	same
</FORBIDDEN ID=16 ACTION=delete>
treatment	NN	treatment
.	SENT	.
.	SENT	.
When	WRB	When
cellulose	NN	cellulose
acetate	NN	acetate
electrophoresis	NN	electrophoresis
was	VVD	be
performed	VBN	perform
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
extracts	NNS	extract
,	,	,
aldolase	NN	aldolase
from	IN	from
<FORBIDDEN ID=30 ACTION=delete>
both	CC	both
</FORBIDDEN ID=30 ACTION=delete>
normal	JJ	normal
and	CC	and
infected	JJ	infected
yolk	NN	yolk
sacs	NNS	sac
exhibited	VBD	exhibit
five	CD	five
isozyme	NN	isozyme
bands	NNS	band
,	,	,
whereas	IN	whereas
aldolase	NN	aldolase
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
C	NN	C
.	SENT	.
burnetii	NN	burnetii
extract	NN	extract
appeared	VBD	appear
as	IN	as
a	DT	a
single	JJ	single
band	NN	band
.	SENT	.
.	SENT	.
BB-cat+ner-4329237/text	DOCUMENT	BB-cat+ner-4329237/text
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
in vitro	NN	in_vitro
assay	NN	assay
of	IN	of
tuberculin	NN	tuberculin
hypersensitivity	NN	hypersensitivity
in	IN	in
Macaca	NP	Macaca
mulatta	NP	mulatta
sensitized	VBD	sensitize
with	IN	with
bacille	NN	bacille
Calmette	NP	Calmette
Guerin	NP	Guerin
cell	NN	cell
wall	NN	wall
vaccine	NN	vaccine
and-or	CC	and-or
infected	VBN	infect
with	IN	with
virulent	JJ	virulent
Mycobacterium	NN	Mycobacterium
tuberculosis	NN	tuberculosis
.	SENT	.
.	SENT	.
BB-cat+ner-448557/text	DOCUMENT	BB-cat+ner-448557/text
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
etiologic	JJ	etiologic
and	CC	and
epidemiologic	JJ	epidemiologic
spectrum	NN	spectrum
of	IN	of
bronchiolitis	NN	bronchiolitis
in	IN	in
pediatric	JJ	pediatric
practice	NN	practice
.	SENT	.
.	SENT	.
To	TO	To
develop	VB	develop
a	DT	a
broad	JJ	broad
understanding	NN	understanding
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
causes	NNS	cause
and	CC	and
patterns	NNS	pattern
of	IN	of
occurrence	NN	occurrence
of	IN	of
wheezing	VBG	wheeze
associated	VBN	associate
respiratory	JJ	respiratory
infections	NNS	infection
,	,	,
we	PP	we
analyzed	VBD	analyze
data	NNS	datum
from	IN	from
an	DT	an
11-year	JJ	11-year
study	NN	study
of	IN	of
acute	JJ	acute
lower	JJR	low
respiratory	JJ	respiratory
illness	NN	illness
in	IN	in
a	DT	a
pediatric	JJ	pediatric
practice	NN	practice
.	SENT	.
.	SENT	.
Although	IN	Although
half	NN	half
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
WARI	NP	WARI
occurred	VBD	occur
in	IN	in
children	NNS	child
less	JJR	less
than	IN	than
2	CD	2
years	NNS	year
of	IN	of
age	NN	age
,	,	,
wheezing	VBG	wheeze
continued	VBD	continue
to	TO	to
be	VV	be
observed	VBN	observe
in	IN	in
19%	CD	19%
of	IN	of
children	NNS	child
greater	JJR	great
than	IN	than
9	CD	9
years	NNS	year
of	IN	of
age	NN	age
who	WP	who
had	VHD	have
lower	JJR	low
respiratory	JJ	respiratory
illness	NN	illness
.	SENT	.
.	SENT	.
Males	NNS	Male
experienced	VBD	experience
LRI	NN	LRI
1.25	CD	1.25
times	NNS	time
<FORBIDDEN ID=82 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
often	RB	often
than	IN	than
did	VBD	do
females	NNS	female
;	COLUMN	;
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
relative	JJ	relative
risk	NN	risk
of	IN	of
males	NNS	male
for	IN	for
WARI	NN	WARI
was	VVD	be
1.35	CD	1.35
.	SENT	.
.	SENT	.
A	DT	A
nonbacterial	JJ	nonbacterial
pathogen	NN	pathogen
was	VVD	be
recovered	VBN	recover
from	IN	from
21%	CD	21%
of	IN	of
patients	NNS	patient
with	IN	with
WARI	NN	WARI
;	COLUMN	;
respiratory	JJ	respiratory
syncytial	JJ	syncytial
virus	NN	virus
,	,	,
parainfluenza	NN	parainfluenza
virus	NN	virus
types	NNS	type
1	CD	1
and	CC	and
3	CD	3
,	,	,
adenoviruses	NNS	adenovirus
,	,	,
and	CC	and
Mycoplasma	NN	Mycoplasma
pneumoniae	NNS	pneumoniae
accounted	VBD	account
for	IN	for
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
81%	CD	81%
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
isolates	NNS	isolate
.	SENT	.
.	SENT	.
Patient	NN	Patient
age	NN	age
influenced	VBD	influence
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
pattern	NN	pattern
of	IN	of
recovery	NN	recovery
of	IN	of
these	DT	these
agents	NNS	agent
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
most	RBS	most
common	JJ	common
cause	NN	cause
of	IN	of
WARI	NN	WARI
in	IN	in
children	NNS	child
under	IN	under
5	CD	5
years	NNS	year
of	IN	of
age	NN	age
was	VVD	be
RSV	NN	RSV
whereas	IN	whereas
Mycoplasma	NN	Mycoplasma
pneumoniae	NN	pneumoniae
was	VVD	be
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
most	RBS	most
frequent	JJ	frequent
isolate	NN	isolate
from	IN	from
school	NN	school
age	NN	age
children	NNS	child
with	IN	with
wheezing	VBG	wheeze
illness	NN	illness
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
data	NNS	datum
expand	VBP	expand
our	PP$	our
understanding	NN	understanding
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
causes	NNS	cause
of	IN	of
WARI	NN	WARI
and	CC	and
are	VVP	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
useful	JJ	useful
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
diagnosticians	NNS	diagnostician
and	CC	and
to	TO	to
researchers	NNS	researcher
interested	VBN	interest
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
control	NN	control
of	IN	of
lower	JJR	low
respiratory	JJ	respiratory
disease	NN	disease
.	SENT	.
.	SENT	.
BB-cat+ner-460951/text	DOCUMENT	BB-cat+ner-460951/text
Atypical	JJ	Atypical
mycobacteria	NNS	mycobacterium
causing	VBG	cause
non-pulmonary	JJ	non-pulmonary
disease	NN	disease
in	IN	in
Queensland	NP	Queensland
.	SENT	.
.	SENT	.
During	IN	During
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
period	NN	period
1971--7	CD	1971--7
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Tuberculosis	NP	Tuberculosis
Reference	NP	Reference
Laboratory	NP	Laboratory
in	IN	in
Queensland	NP	Queensland
dealt	VBD	deal
with	IN	with
52	CD	52
isolates	NNS	isolate
of	IN	of
atypical	JJ	atypical
mycobacteria	NNS	mycobacterium
made	VBN	make
from	IN	from
non-pulmonary	JJ	non-pulmonary
sites	NNS	site
under	IN	under
circumstances	NNS	circumstance
suggesting	VBG	suggest
complicity	NN	complicity
in	IN	in
disease	NN	disease
.	SENT	.
.	SENT	.
Twenty	CD	Twenty
-	HYPH	-
four	CD	four
isolates	NNS	isolate
<FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
belonging	VBG	belong
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MAIS	NN	MAIS
complex	NN	complex
were	VVD	be
associated	VBN	associate
with	IN	with
lymph	NN	lymph
node	NN	node
infections	NNS	infection
in	IN	in
children	NNS	child
.	SENT	.
.	SENT	.
Twelve	CD	Twelve
isolates	NNS	isolate
belonged	VBD	belong
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
M	NN	M
.	SENT	.
fortuitum	NN	fortuitum
-	HYPH	-
chelonei	NN	chelonei
complex	NN	complex
;	COLUMN	;
most	JJS	most
were	VVD	be
from	IN	from
superficial	JJ	superficial
abscesses	NNS	abscess
.	SENT	.
.	SENT	.
Five	CD	Five
cases	NNS	case
of	IN	of
M	NN	M
.	SENT	.
marinum	NN	marinum
infection	NN	infection
and	CC	and
8	CD	8
of	IN	of
M	NN	M
.	SENT	.
ulcerans	NNS	ulceran
disease	NN	disease
were	VVD	be
detected	VBN	detect
.	SENT	.
.	SENT	.
BB-cat+ner-47483/text	DOCUMENT	BB-cat+ner-47483/text
Ampicillin	NN	Ampicillin
-	HYPH	-
resistant	JJ	resistant
Haemophilus	NP	Haemophilus
influenzae	NN	influenzae
type	NN	type
B	NN	B
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
possessing	VBG	possess
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
TEM	NN	TEM
-	HYPH	-
type	NN	type
beta	SYM	beta
-	HYPH	-
lactamase	NN	lactamase
but	CC	but
little	JJ	little
permeability	NN	permeability
barrier	NN	barrier
to	TO	to
ampicillin	NN	ampicillin
.	SENT	.
.	SENT	.
Ampicillin	NN	Ampicillin
-	HYPH	-
resistant	JJ	resistant
Haemophilus	NP	Haemophilus
influenzae	NN	influenzae
type	NN	type
B	NN	B
have	VHP	have
been	VVN	be
reported	VBN	report
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
during	IN	during
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
past	JJ	past
year	NN	year
.	SENT	.
.	SENT	.
Five	CD	Five
clinical	JJ	clinical
isolates	NNS	isolate
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
U	NN	U
.	SENT	.
.	SENT	.
S	NN	S
.	SENT	.
and	CC	and
<FORBIDDEN ID=2 ACTION=split SPLIT_AFTER=0>
Germany	NP	Germany
all	DT	all
</FORBIDDEN ID=2 ACTION=split SPLIT_AFTER=0>
had	VHD	have
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
TEM	NN	TEM
-	HYPH	-
type	NN	type
beta	SYM	beta
-	HYPH	-
lactamase	NN	lactamase
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
is	VVZ	be
known	VBN	know
to	TO	to
be	VV	be
transferred	VBN	transfer
widely	RB	widely
among	IN	among
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
gram	NN	gram
-	HYPH	-
negative	JJ	negative
bacilli	NNS	bacilli
.	SENT	.
.	SENT	.
Unlike	IN	Unlike
those	DT	those
bacilli	NNS	bacilli
,	,	,
however	RB	however
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
H	NN	H
.	VBD	.
influenzae	JJ	influenzae
cell	NN	cell
had	VHD	have
very	RB	very
little	JJ	little
barrier	NN	barrier
to	TO	to
entry	NN	entry
of	IN	of
penicillins	NNS	penicillin
.	SENT	.
.	SENT	.
This	DT	This
greater	JJR	great
permeability	NN	permeability
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
H	NN	H
.	VBD	.
influenzae	JJ	influenzae
cell	NN	cell
to	TO	to
penicillins	NNS	penicillin
appeared	VBD	appear
to	TO	to
reduce	VB	reduce
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
protective	JJ	protective
effect	NN	effect
of	IN	of
its	PP$	its
beta	SYM	beta
-	HYPH	-
lactamase	NN	lactamase
,	,	,
in	IN	in
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	DT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
acquisition	NN	acquisition
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
TEM	NN	TEM
-	HYPH	-
type	NN	type
beta	SYM	beta
-	HYPH	-
lactamase	NN	lactamase
increased	VBN	increase
levels	NNS	level
of	IN	of
resistance	NN	resistance
to	TO	to
penicillins	NNS	penicillin
<FORBIDDEN ID=83 ACTION=delete>
much	RB	much
</FORBIDDEN ID=83 ACTION=delete>
less	JJR	less
for	IN	for
individual	JJ	individual
cells	NNS	cell
of	IN	of
H	NN	H
.	VBD	.
influenzae	JJ	influenzae
than	IN	than
for	IN	for
those	DT	those
of	IN	of
Escherichia	NP	Escherichia
coli	NP	coli
.	SENT	.
.	SENT	.
Large	JJ	Large
inocula	NN	inocula
of	IN	of
either	DT	either
species	NN	species
appeared	VBD	appear
highly	RB	highly
resistant	JJ	resistant
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
unusually	RB	unusually
low	JJ	low
level	NN	level
of	IN	of
resistance	NN	resistance
of	IN	of
individual	JJ	individual
cells	NNS	cell
of	IN	of
H	NN	H
.	VBD	.
influenzae	NN	influenzae
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
containing	VBG	contain
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
TEM	NN	TEM
-	HYPH	-
type	NN	type
beta	SYM	beta
-	HYPH	-
lactamase	NN	lactamase
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
have	VH	have
delayed	VBN	delay
their	PP$	their
emergence	NN	emergence
or	CC	or
recognition	NN	recognition
,	,	,
and	CC	and
has	VHZ	have
unresolved	VBN	unresolve
clinical	JJ	clinical
implications	NNS	implication
.	SENT	.
.	SENT	.
BB-cat+ner-5526468/text	DOCUMENT	BB-cat+ner-5526468/text
Vibrio	NP	Vibrio
fetus	VBZ	fetu
human	JJ	human
infection	NN	infection
-	HYPH	-
-	HYPH	-
isolation	NN	isolation
from	IN	from
a	DT	a
subacute	JJ	subacute
bacterial	JJ	bacterial
endocarditis	NN	endocarditis
case	NN	case
.	SENT	.
.	SENT	.
BB-cat+ner-607884/text	DOCUMENT	BB-cat+ner-607884/text
[	(	[
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
infections	NNS	infection
from	IN	from
"	``	"
Serratia	NP	Serratia
"	''	"
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Hospital	NP	Hospital
S	NP	S
.	SENT	.
.	SENT	.
Camillo	NP	Camillo
De	NP	De
Lellis	NP	Lellis
of	IN	of
Roma	NP	Roma
(	(	(
Italy	NP	Italy
)	)	)
(	(	(
author's	NNS	author'
transl)	NN	transl)
]	)	]
.	SENT	.
.	SENT	.
BB-cat+ner-6107735/text	DOCUMENT	BB-cat+ner-6107735/text
Recurrence	NN	Recurrence
of	IN	of
Pelecypod	NN	Pelecypod
-	HYPH	-
associated	VBN	associate
cholera	NN	cholera
in	IN	in
Sardinia	NP	Sardinia
.	SENT	.
.	SENT	.
From	IN	From
Oct	NP	Oct
.	SENT	.
30	CD	30
to	TO	to
Nov	NP	Nov
.	SENT	.
7	CD	7
,	,	,
1979	CD	1979
,	,	,
10	CD	10
people	NNS	people
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Sardinian	JJ	Sardinian
province	NN	province
of	IN	of
Cagliari	NP	Cagliari
had	VHD	have
onset	NN	onset
of	IN	of
bacteriologically	RB	bacteriologically
confirmed	VBN	confirm
cholera	NN	cholera
.	SENT	.
.	SENT	.
Two	CD	Two
symptom	NN	symptom
-	HYPH	-
free	JJ	free
excretors	NNS	excretor
of	IN	of
Vibrio	NP	Vibrio
cholerae	NP	cholerae
O	NP	O
:	COLUMN	:
1	CD	1
were	VVD	be
detected	VBN	detect
in	IN	in
household	NN	household
contacts	NNS	contact
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
patients	NNS	patient
.	SENT	.
.	SENT	.
There	EX	There
were	VVD	be
no	DT	no
deaths	NNS	death
.	SENT	.
.	SENT	.
All	DT	All
but	CC	but
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
1	CD	1
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
12	CD	12
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
people	NNS	people
with	IN	with
V	NN	V
.	SENT	.
cholerae	NN	cholerae
O	NP	O
:	COLUMN	:
1	CD	1
infection	NN	infection
gave	VBD	give
a	DT	a
history	NN	history
of	IN	of
recent	JJ	recent
consumption	NN	consumption
of	IN	of
marine	JJ	marine
bivalves	NNS	bivalve
known	VBN	know
locally	RB	locally
as	IN	as
arselle	NN	arselle
(	(	(
pelecypods	NNS	pelecypod
)	)	)
.	SENT	.
.	SENT	.
Triplicate	NP	Triplicate
matched	VBD	match
neighbourhood	NN	neighbourhood
controls	NNS	control
for	IN	for
each	DT	each
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
first	JJ	first
7	CD	7
cases	NNS	case
identified	VBN	identify
were	VVD	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
interviewed	VBN	interview
;	COLUMN	;
none	NN	none
had	VHD	have
recently	RB	recently
eaten	JJ	eaten
arselle	NN	arselle
.	SENT	.
.	SENT	.
V	NP	V
.	SENT	.
cholerae	NP	cholerae
O	NP	O
:	COLUMN	:
1	CD	1
was	VVD	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
recovered	VBN	recover
from	IN	from
samples	NNS	sample
of	IN	of
water	NN	water
and	CC	and
bivalves	NNS	bivalve
obtained	VBN	obtain
from	IN	from
a	DT	a
lagoon	NN	lagoon
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
outskirts	NNS	outskirt
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
city	NN	city
of	IN	of
Cagliari	NP	Cagliari
.	SENT	.
.	SENT	.
Arselle	NP	Arselle
had	VHD	have
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
been	VVN	be
implicated	VBN	implicate
as	IN	as
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
vehicle	NN	vehicle
of	IN	of
transmission	NN	transmission
in	IN	in
1973	CD	1973
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
last	JJ	last
outbreak	NN	outbreak
of	IN	of
cholera	NN	cholera
in	IN	in
Sardinia	NP	Sardinia
.	SENT	.
.	SENT	.
It	PP	It
seems	VBZ	seem
unlikely	JJ	unlikely
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
cholera	NN	cholera
transmission	NN	transmission
had	VHD	have
persisted	VBN	persist
locally	RB	locally
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
interim	NN	interim
.	SENT	.
.	SENT	.
BB-cat+ner-6143890/text	DOCUMENT	BB-cat+ner-6143890/text
Rapid	JJ	Rapid
detection	NN	detection
with	IN	with
monoclonal	JJ	monoclonal
antibodies	NNS	antibody
of	IN	of
Chlamydia	NN	Chlamydia
trachomatis	NN	trachomatis
in	IN	in
urethral	JJ	urethral
smears	NNS	smear
and	CC	and
urine	NN	urine
sediments	NNS	sediment
.	SENT	.
.	SENT	.
BB-cat+ner-6631408/text	DOCUMENT	BB-cat+ner-6631408/text
Amino	NN	Amino
acid	NN	acid
requirements	NNS	requirement
of	IN	of
strains	NNS	strain
of	IN	of
Chlamydia	NN	Chlamydia
trachomatis	NN	trachomatis
and	CC	and
C	NN	C
.	SENT	.
psittaci	NNS	psittaci
growing	VBG	grow
in	IN	in
McCoy	NP	McCoy
cells	NNS	cell
:	COLUMN	:
relationship	NN	relationship
with	IN	with
clinical	JJ	clinical
syndrome	NN	syndrome
and	CC	and
host	NN	host
origin	NN	origin
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
effects	NNS	effect
of	IN	of
omission	NN	omission
of	IN	of
individual	JJ	individual
amino	JJ	amino
acids	NNS	acid
from	IN	from
growth	NN	growth
medium	NN	medium
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
multiplication	NN	multiplication
of	IN	of
a	DT	a
range	NN	range
of	IN	of
Chlamydia	NN	Chlamydia
trachomatis	NN	trachomatis
and	CC	and
C	NN	C
.	SENT	.
psittaci	NN	psittaci
strains	NNS	strain
in	IN	in
cycloheximide	NN	cycloheximide
-	HYPH	-
treated	VBN	treat
McCoy	NN	McCoy
cells	NNS	cell
have	VHP	have
been	VVN	be
assessed	VBN	assess
.	SENT	.
.	SENT	.
Differences	NNS	Difference
in	IN	in
requirements	NNS	requirement
were	VVD	be
revealed	VBN	reveal
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
for	IN	for
C	NN	C
.	SENT	.
trachomatis	NN	trachomatis
strains	NNS	strain
correlated	VBD	correlate
with	IN	with
clinical	JJ	clinical
syndrome	NN	syndrome
and	CC	and
for	IN	for
C	NN	C
.	SENT	.
psittaci	NNS	psittaci
with	IN	with
host	NN	host
origin	NN	origin
.	SENT	.
.	SENT	.
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
All	DT	All
11	CD	11
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
strains	NNS	strain
of	IN	of
C	NN	C
.	SENT	.
trachomatis	NN	trachomatis
examined	VBD	examine
showed	VBD	show
a	DT	a
requirement	NN	requirement
for	IN	for
addition	NN	addition
of	IN	of
histidine	NN	histidine
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
medium	NN	medium
;	COLUMN	;
this	DT	this
was	VVD	be
not	RB	not
shown	VBN	show
by	IN	by
any	DT	any
of	IN	of
four	CD	four
C	JJ	C
.	SENT	.
psittaci	NNS	psittaci
strains	NNS	strain
.	SENT	.
.	SENT	.
Among	IN	Among
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
strains	NNS	strain
of	IN	of
C	NN	C
.	SENT	.
trachomatis	NN	trachomatis
,	,	,
three	CD	three
from	IN	from
cases	NNS	case
of	IN	of
trachoma	NN	trachoma
,	,	,
representing	VBG	represent
serotypes	NNS	serotype
A	NN	A
,	,	,
B	NN	B
and	CC	and
C	NN	C
,	,	,
showed	VBD	show
a	DT	a
distinctive	JJ	distinctive
requirement	NN	requirement
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
addition	NN	addition
of	IN	of
tryptophan	NN	tryptophan
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
medium	NN	medium
,	,	,
whilst	IN	whilst
six	CD	six
strains	NNS	strain
of	IN	of
oculogenital	JJ	oculogenital
origin	NN	origin
,	,	,
representing	VBG	represent
serotypes	NNS	serotype
D-I	NN	D-I
,	,	,
exhibited	VBD	exhibit
no	DT	no
requirement	NN	requirement
for	IN	for
tryptophan	NN	tryptophan
or	CC	or
methionine	NN	methionine
;	COLUMN	;
a	DT	a
lymphogranuloma	NN	lymphogranuloma
venereum	NN	venereum
and	CC	and
a	DT	a
'fast	JJ	'fast
variant'	NN	variant'
<FORBIDDEN ID=0 ACTION=split SPLIT_AFTER=0>
strain	NN	strain
<FORBIDDEN ID=30 ACTION=delete>
both	DT	both
</FORBIDDEN ID=0 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=30 ACTION=delete>
showed	VBD	show
a	DT	a
requirement	NN	requirement
for	IN	for
methionine	NN	methionine
.	SENT	.
.	SENT	.
Of	IN	Of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
four	CD	four
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
C	NN	C
.	SENT	.
psittaci	NN	psittaci
strains	NNS	strain
from	IN	from
different	JJ	different
hosts	NNS	host
,	,	,
three	CD	three
showed	VBD	show
distinct	JJ	distinct
patterns	NNS	pattern
of	IN	of
amino	JJ	amino
acid	NN	acid
requirements	NNS	requirement
.	SENT	.
.	SENT	.
All	DT	All
chlamydiae	NNS	chlamydiae
required	VBD	require
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
addition	NN	addition
of	IN	of
valine	NN	valine
to	TO	to
medium	NN	medium
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
majority	NN	majority
required	VBD	require
leucine	NN	leucine
,	,	,
phenylalanine	NN	phenylalanine
and	CC	and
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
glutamine	NN	glutamine
.	SENT	.
.	SENT	.
BB-cat+ner-7867953/text	DOCUMENT	BB-cat+ner-7867953/text
Cloning	NN	Cloning
,	,	,
sequence	NN	sequence
and	CC	and
regulation	NN	regulation
of	IN	of
expression	NN	expression
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
lexA	NN	lexA
gene	NN	gene
of	IN	of
Aeromonas	NP	Aeromonas
hydrophila	NN	hydrophila
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
lexA	NN	lexA
gene	NN	gene
of	IN	of
Aeromonas	NP	Aeromonas
hydrophila	NN	hydrophila
(	(	(
Ah	NN	Ah
)	)	)
has	VHZ	have
been	VVN	be
isolated	VBN	isolate
by	IN	by
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
using	VBG	use
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
specific	JJ	specific
one-step	JJ	one-step
cloning	NN	cloning
system	NN	system
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Ah	NN	Ah
LexA	NN	LexA
repressor	NN	repressor
is	VVZ	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
able	JJ	able
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
block	VB	block
Escherichia	FW	Escherichia
coli	FW	coli
(	(	(
Ec	NN	Ec
)	)	)
SOS	NN	SOS
gene	NN	gene
expression	NN	expression
and	CC	and
is	VVZ	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
likely	JJ	likely
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
be	VV	be
cleaved	VBN	cleave
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
activated	VBN	activate
RecA	NN	RecA
protein	NN	protein
of	IN	of
this	DT	this
bacterial	JJ	bacterial
species	NNS	specie
after	IN	after
DNA	NN	DNA
damage	NN	damage
.	SENT	.
.	SENT	.
Ah	NN	Ah
lexA	NN	lexA
would	MD	would
encode	VB	encode
a	DT	a
protein	NN	protein
of	IN	of
207	CD	207
amino	NN	amino
acids	NNS	acid
(	(	(
aa	NN	aa
)	)	)
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
is	VVZ	be
75%	CD	75%
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
identical	JJ	identical
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
LexA	NN	LexA
repressor	NN	repressor
of	IN	of
Ec	NN	Ec
.	SENT	.
.	SENT	.
Two	CD	Two
Ec-like	JJ	Ec-like
SOS	NN	SOS
boxes	NNS	box
have	VHP	have
been	VVN	be
located	JJ	located
upstream	RB	upstream
from	IN	from
Ah	NN	Ah
lexA	NN	lexA
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
distance	NN	distance
between	IN	between
them	PP	them
<FORBIDDEN ID=6 ACTION=delete>
being	VVG	be
4	CD	4
</FORBIDDEN ID=6 ACTION=delete>
bp	NN	bp
,	,	,
whereas	IN	whereas
this	DT	this
<FORBIDDEN ID=16 ACTION=delete>
same	JJ	same
</FORBIDDEN ID=16 ACTION=delete>
distance	NN	distance
in	IN	in
Ec	NN	Ec
lexA	NN	lexA
is	VVZ	be
5	CD	5
bp	NN	bp
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
structure	NN	structure
and	CC	and
sequence	NN	sequence
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
DNA	NN	DNA
-	HYPH	-
binding	VBG	bind
domain	NN	domain
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
LexA	NP	LexA
repressor	NN	repressor
of	IN	of
Ec	NN	Ec
,	,	,
as	RB	as
well	RB	well
as	IN	as
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
region	NN	region
at	IN	at
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
its	PP$	its
hydrolysis	NN	hydrolysis
occurs	VBZ	occur
,	,	,
are	VVP	be
highly	RB	highly
conserved	VBN	conserve
in	IN	in
Ah	NP	Ah
LexA	NP	LexA
.	SENT	.
.	SENT	.
Moreover	RB	Moreover
,	,	,
a	DT	a
residue	NN	residue
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
region	NN	region
implicated	VBN	implicate
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
specific	JJ	specific
cleavage	NN	cleavage
reaction	NN	reaction
,	,	,
and	CC	and
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
is	VVZ	be
present	JJ	present
in	IN	in
all	DT	all
known	VBN	know
RecA	NN	RecA
-	HYPH	-
cleavable	JJ	cleavable
repressors	NNS	repressor
,	,	,
is	VVZ	be
changed	VBN	change
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Ah	NP	Ah
LexA	NP	LexA
.	SENT	.
.	SENT	.
Expression	NN	Expression
of	IN	of
Ah	NN	Ah
lexA	NN	lexA
is	VVZ	be
DNA	NN	DNA
-	HYPH	-
damage	NN	damage
inducible	JJ	inducible
in	IN	in
<FORBIDDEN ID=30 ACTION=delete>
both	CC	both
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=30 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Ah	NN	Ah
and	CC	and
Ec	NN	Ec
genetic	JJ	genetic
backgrounds	NNS	background
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=16 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
same	JJ	same
</FORBIDDEN ID=16 ACTION=delete>
extent	NN	extent
.	SENT	.
.	SENT	.
In	IN	In
contrast	NN	contrast
,	,	,
Ec	NN	Ec
lexA	NN	lexA
is	VVZ	be
poorly	RB	poorly
induced	VBN	induce
in	IN	in
DNA	NN	DNA
-	HYPH	-
injured	VBN	injure
Ah	NN	Ah
cells	NNS	cell
.	SENT	.
.	SENT	.
BB-cat+ner-7876637/text	DOCUMENT	BB-cat+ner-7876637/text
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
spread	NN	spread
of	IN	of
Vibrio	NP	Vibrio
cholerae	NP	cholerae
O139	NP	O139
in	IN	in
India	NP	India
.	SENT	.
.	SENT	.
BB-cat+ner-817056/text	DOCUMENT	BB-cat+ner-817056/text
Tissue	NN	Tissue
dispersion	NN	dispersion
,	,	,
cell	NN	cell
harvest	NN	harvest
and	CC	and
fluid	NN	fluid
suspension	NN	suspension
culture	NN	culture
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
use	NN	use
of	IN	of
bacterial	JJ	bacterial
neutral	JJ	neutral
protease	NN	protease
.	SENT	.
.	SENT	.
Bacterial	JJ	Bacterial
neutral	JJ	neutral
protease	NN	protease
of	IN	of
Bacillus	NN	Bacillus
polymyxa	NN	polymyxa
was	VVD	be
found	VBN	find
to	TO	to
disperse	VB	disperse
mammalian	JJ	mammalian
tissues	NNS	tissue
and	CC	and
cells	NNS	cell
.	SENT	.
.	SENT	.
Primary	JJ	Primary
cell	NN	cell
cultures	NNS	culture
were	VVD	be
obtained	VBN	obtain
from	IN	from
several	JJ	several
tissues	NNS	tissue
after	IN	after
treatments	NNS	treatment
with	IN	with
200	CD	200
to	TO	to
2	CD	2
,	,	,
000	CD	000
Kunitz	NP	Kunitz
unit	NN	unit
per	IN	per
ml	NN	ml
of	IN	of
this	DT	this
protease	NN	protease
in	IN	in
either	CC	either
a	DT	a
phosphate	NN	phosphate
buffer	NN	buffer
solution	NN	solution
,	,	,
a	DT	a
balanced	JJ	balanced
salt	NN	salt
solution	NN	solution
or	CC	or
a	DT	a
tissue	NN	tissue
culture	NN	culture
medium	NN	medium
supplemented	VBN	supplement
with	IN	with
serum	NN	serum
.	SENT	.
.	SENT	.
Monolayer	NN	Monolayer
cultures	NNS	culture
wither	CC	wither
in	IN	in
their	PP$	their
<FORBIDDEN ID=45 ACTION=delete>
early	JJ	early
</FORBIDDEN ID=45 ACTION=delete>
passage	NN	passage
levels	NNS	level
or	CC	or
of	IN	of
established	VBN	establish
strains	NNS	strain
were	VVD	be
harvested	VBN	harvest
by	IN	by
a	DT	a
treatment	NN	treatment
with	IN	with
this	DT	this
protease	NN	protease
,	,	,
and	CC	and
proliferated	VBD	proliferate
again	RB	again
in	IN	in
monolayer	NN	monolayer
after	IN	after
its	PP$	its
removal	NN	removal
.	SENT	.
.	SENT	.
A	DT	A
growing	VBG	grow
culture	NN	culture
of	IN	of
strain	NN	strain
L	NN	L
-929	CD	-929
was	VVD	be
kept	VBN	keep
in	IN	in
monodisperse	JJ	monodisperse
suspension	NN	suspension
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
this	DT	this
protease	NN	protease
.	SENT	.
.	SENT	.
<FORBIDDEN ID=27 ACTION=delete>
<FORBIDDEN ID=26 ACTION=delete>
In	IN	In
contrast	NN	contrast
to	TO	to
</FORBIDDEN ID=26 ACTION=delete>
</FORBIDDEN ID=27 ACTION=delete>
trypsin	NN	trypsin
,	,	,
this	DT	this
protease	NN	protease
was	VVD	be
found	VBN	find
active	JJ	active
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
serum	NN	serum
,	,	,
stable	JJ	stable
during	IN	during
incubation	NN	incubation
and	CC	and
scarcely	RB	scarcely
injured	VBN	injure
cells	NNS	cell
.	SENT	.
.	SENT	.
BB-cat+ner-8347510/text	DOCUMENT	BB-cat+ner-8347510/text
Arhodomonas	NP	Arhodomonas
aquaeolei	NP	aquaeolei
gen	NN	gen
.	SENT	.
nov	NN	nov
.	NN	.
,	,	,
sp	NN	sp
.	SENT	.
nov	NN	nov
.	NN	.
,	,	,
an	DT	an
aerobic	JJ	aerobic
,	,	,
halophilic	JJ	halophilic
bacterium	NN	bacterium
isolated	VBN	isolate
from	IN	from
a	DT	a
subterranean	JJ	subterranean
brine	NN	brine
.	SENT	.
.	SENT	.
Arhodomonas	NP	Arhodomonas
aquaeolei	NP	aquaeolei
gen	NN	gen
.	SENT	.
nov	NN	nov
.	NN	.
,	,	,
sp	NN	sp
.	SENT	.
nov	NN	nov
.	SENT	.
,	,	,
isolated	VBN	isolate
from	IN	from
a	DT	a
petroleum	NN	petroleum
reservoir	NN	reservoir
production	NN	production
fluid	NN	fluid
,	,	,
is	VVZ	be
described	VBN	describe
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
single	JJ	single
isolate	NN	isolate
was	VVD	be
an	DT	an
obligately	RB	obligately
halophilic	JJ	halophilic
,	,	,
aerobic	JJ	aerobic
,	,	,
gram	NN	gram
-	HYPH	-
negative	JJ	negative
,	,	,
oval	JJ	oval
rod-shaped	JJ	rod-shaped
bacterium	NN	bacterium
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
was	VVD	be
actively	RB	actively
motile	JJ	motile
by	IN	by
<FORBIDDEN ID=19 ACTION=delete>
means	NNS	mean
of	IN	of
</FORBIDDEN ID=19 ACTION=delete>
a	DT	a
single	JJ	single
polar	JJ	polar
flagellum	NN	flagellum
.	SENT	.
.	SENT	.
It	PP	It
was	VVD	be
catalase	NN	catalase
and	CC	and
oxidase	NN	oxidase
positive	JJ	positive
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
isolate	NN	isolate
had	VHD	have
a	DT	a
specific	JJ	specific
requirement	NN	requirement
for	IN	for
NaCl	NN	NaCl
;	COLUMN	;
growth	NN	growth
occurred	VBD	occur
at	IN	at
NaCl	NN	NaCl
concentrations	NNS	concentration
between	IN	between
6	CD	6
and	CC	and
20%	CD	20%
,	,	,
and	CC	and
optimal	JJ	optimal
growth	NN	growth
occurred	VBD	occur
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
15%	NN	15%
NaCl	NN	NaCl
.	SENT	.
.	SENT	.
This	DT	This
species	NN	species
metabolized	VBD	metabolize
primarily	RB	primarily
organic	JJ	organic
acids	NNS	acid
and	CC	and
required	VBD	require
biotin	NN	biotin
for	IN	for
growth	NN	growth
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
name	NN	name
Arhodomonas	NP	Arhodomonas
is	VVZ	be
proposed	VBN	propose
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=38 ACTION=delete>
<FORBIDDEN ID=37 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
new	JJ	new
</FORBIDDEN ID=37 ACTION=delete>
</FORBIDDEN ID=38 ACTION=delete>
genus	NN	genus
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
was	VVD	be
placed	VBN	place
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
gamma	NN	gamma
subclass	NN	subclass
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Proteobacteria	NP	Proteobacteria
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
basis	NN	basis
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
results	NNS	result
of	IN	of
a	DT	a
16S	NN	16S
rRNA	NN	rRNA
sequence	NN	sequence
analysis	NN	analysis
.	SENT	.
.	SENT	.
Although	IN	Although
A	NN	A
.	SENT	.
aquaeolei	NN	aquaeolei
is	VVZ	be
most	RBS	most
closely	RB	closely
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
related	JJ	related
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
purple	VB	purple
sulfur	NN	sulfur
bacteria	NNS	bacteria
(	(	(
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
genera	NN	genera
Ectothiorhodospira	NN	Ectothiorhodospira
and	CC	and
Chromatium	NN	Chromatium
)	)	)
,	,	,
it	PP	it
is	VVZ	be
not	RB	not
a	DT	a
phototrophic	JJ	phototrophic
microorganism	NN	microorganism
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
is	VVZ	be
consistent	JJ	consistent
with	IN	with
its	PP$	its
isolation	NN	isolation
from	IN	from
a	DT	a
subterranean	JJ	subterranean
environment	NN	environment
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
major	JJ	major
components	NNS	component
of	IN	of
its	PP$	its
cellular	JJ	cellular
fatty	JJ	fatty
acids	NNS	acid
were	VVD	be
C16	NN	C16
:	COLUMN	:
0	CD	0
,	,	,
C18	NN	C18
:	COLUMN	:
1	CD	1
,	,	,
C19	NN	C19
:	COLUMN	:
0	CD	0
,	,	,
C16	NN	C16
:	COLUMN	:
1	CD	1
,	,	,
and	CC	and
C18	NN	C18
:	COLUMN	:
0	CD	0
acids	NNS	acid
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
DNA	NN	DNA
base	NN	base
composition	NN	composition
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
type	NN	type
strain	NN	strain
is	VVZ	be
67	CD	67
mol%	NN	mol%
G+C	NN	G+C
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
type	NN	type
and	CC	and
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
strain	NN	strain
is	VVZ	be
strain	NN	strain
HA	NN	HA
-1	CD	-1
(	(	(
=	SYM	=
ATCC	NN	ATCC
49307	CD	49307
)	)	)
.	SENT	.
.	SENT	.
BB-cat+ner-8358765/text	DOCUMENT	BB-cat+ner-8358765/text
[	(	[
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
effect	NN	effect
of	IN	of
omeprazole	NN	omeprazole
on	IN	on
healing	NN	healing
of	IN	of
duodenal	JJ	duodenal
ulcers	NNS	ulcer
,	,	,
Helicobacter	NN	Helicobacter
pylori	NN	pylori
and	CC	and
gastritis	NN	gastritis
]	)	]
.	SENT	.
.	SENT	.
Losec	NN	Losec
(	(	(
omeprazole	NN	omeprazole
)	)	)
Astra	NP	Astra
Co	NP	Co
.	SENT	.
is	VVZ	be
a	DT	a
blocker	NN	blocker
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
proton	NN	proton
pump	NN	pump
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
parietal	JJ	parietal
cell	NN	cell
.	SENT	.
.	SENT	.
It	PP	It
inhibits	VBZ	inhibit
basal	JJ	basal
and	CC	and
stimulated	VBN	stimulate
HCl	NN	HCl
secretion	NN	secretion
.	SENT	.
.	SENT	.
It	PP	It
is	VVZ	be
used	VBN	use
for	IN	for
treatment	NN	treatment
of	IN	of
gastroduodenal	JJ	gastroduodenal
ulcers	NNS	ulcer
,	,	,
reflux	NN	reflux
oesophagitis	NN	oesophagitis
and	CC	and
Zollinger	NN	Zollinger
Ellison's	NNS	Ellison'
syndrome	NN	syndrome
.	SENT	.
.	SENT	.
In	IN	In
a	DT	a
group	NN	group
of	IN	of
17	CD	17
patients	NNS	patient
with	IN	with
duodenal	JJ	duodenal
<FORBIDDEN ID=1 ACTION=split SPLIT_AFTER=0>
ulcers	NNS	ulcer
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=1 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
authors	NNS	author
investigated	VBD	investigate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
effect	NN	effect
of	IN	of
omeprazole	NN	omeprazole
on	IN	on
(	(	(
1	LS	1
)	)	)
healing	NN	healing
of	IN	of
duodenal	JJ	duodenal
ulcers	NNS	ulcer
and	CC	and
bulbitis	NN	bulbitis
after	IN	after
2-4	CD	2-4
weeks	NNS	week
of	IN	of
therapy	NN	therapy
,	,	,
(	(	(
2	LS	2
)	)	)
elimination	NN	elimination
of	IN	of
Helicobacter	NN	Helicobacter
pylori	NN	pylori
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
antrum	NN	antrum
,	,	,
(	(	(
3	LS	3
)	)	)
chronic	JJ	chronic
antral	JJ	antral
gastritis	NN	gastritis
.	SENT	.
.	SENT	.
Ad	NN	Ad
1	CD	1
.	SENT	.
.	SENT	.
After	IN	After
two	CD	two
weeks	NNS	week
of	IN	of
<FORBIDDEN ID=0 ACTION=split SPLIT_AFTER=0>
treatment	NN	treatment
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=0 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
authors	NNS	author
found	VBD	find
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
5	CD	5
of	IN	of
17	CD	17
chronic	JJ	chronic
duodenal	JJ	duodenal
ulcers	NNS	ulcer
were	VVD	be
healed	VBN	heal
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
remainder	NN	remainder
substantial	JJ	substantial
regression	NN	regression
was	VVD	be
found	VBN	find
.	SENT	.
.	SENT	.
Four	CD	Four
-	HYPH	-
week	NN	week
treatment	NN	treatment
led	VBD	lead
to	TO	to
healing	NN	healing
of	IN	of
16	CD	16
from	IN	from
a	DT	a
total	NN	total
of	IN	of
17	CD	17
ulcers	NNS	ulcer
(	(	(
P	NN	P
INF	SYM	INF
0.001	CD	0.001
)	)	)
,	,	,
i	NN	i
.	SENT	.
e	NN	e
.	SENT	.
94%	CD	94%
.	SENT	.
.	SENT	.
In	IN	In
subjects	NNS	subject
with	IN	with
ulcers	NNS	ulcer
and	CC	and
bulbitis	NN	bulbitis
(	(	(
12	CD	12
patients	NNS	patient
)	)	)
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
ulcer	NN	ulcer
healed	VBD	heal
in	IN	in
11	CD	11
instances	NNS	instance
,	,	,
in	IN	in
7	CD	7
patients	NNS	patient
residual	JJ	residual
bulbitis	NN	bulbitis
persisted	VBD	persist
.	SENT	.
.	SENT	.
Ad	NN	Ad
2	CD	2
.	SENT	.
.	SENT	.
H	NN	H
.	SYM	.
pylori	NN	pylori
was	VVD	be
detected	VBN	detect
before	IN	before
treatment	NN	treatment
in	IN	in
16	CD	16
of	IN	of
17	CD	17
patients	NNS	patient
,	,	,
after	IN	after
treatment	NN	treatment
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
in	IN	in
5	CD	5
(	(	(
P	NN	P
INF	SYM	INF
0.001	CD	0.001
)	)	)
.	SENT	.
.	SENT	.
Ad	NN	Ad
3	CD	3
.	SENT	.
.	SENT	.
Chronic	JJ	Chronic
gastritis	NN	gastritis
was	VVD	be
recorded	VBN	record
before	IN	before
treatment	NN	treatment
in	IN	in
all	DT	all
patients	NNS	patient
.	SENT	.
.	SENT	.
Treatment	NN	Treatment
reduced	VBD	reduce
its	PP$	its
activity	NN	activity
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
H	NN	H
.	NN	.
pylori	NN	pylori
.	SENT	.
.	SENT	.
BB-cat+ner-8406892/text	DOCUMENT	BB-cat+ner-8406892/text
Virulence	NN	Virulence
determinants	NNS	determinant
in	IN	in
nontoxinogenic	JJ	nontoxinogenic
Escherichia	FW	Escherichia
coli	FW	coli
O157	NN	O157
strains	NNS	strain
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
cause	VBP	cause
infantile	JJ	infantile
diarrhea	NN	diarrhea
.	SENT	.
.	SENT	.
Ten	CD	Ten
sorbitol	NN	sorbitol
-	HYPH	-
fermenting	VBG	ferment
Escherichia	FW	Escherichia
coli	FW	coli
O157	NN	O157
strains	NNS	strain
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
cause	VBP	cause
infantile	JJ	infantile
diarrhea	NN	diarrhea
and	CC	and
are	VVP	be
positive	JJ	positive
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
fluorescence	NN	fluorescence
actin	NN	actin
staining	NN	staining
test	NN	test
were	VVD	be
determined	VBN	determine
to	TO	to
be	VV	be
negative	JJ	negative
for	IN	for
Shiga	NP	Shiga
-	HYPH	-
like	JJ	like
toxin	NN	toxin
(	(	(
SLT	NN	SLT
)	)	)
genes	NNS	gene
.	SENT	.
.	SENT	.
We	PP	We
amplified	VBD	amplify
their	PP$	their
complete	JJ	complete
eae	JJ	eae
genes	NNS	gene
,	,	,
contrasting	VBG	contrast
them	PP	them
with	IN	with
those	DT	those
of	IN	of
SLT	NN	SLT
-	HYPH	-
producing	VBG	produce
E	NN	E
.	SENT	.
coli	NN	coli
O157	NN	O157
by	IN	by
restriction	NN	restriction
fragment	NN	fragment
length	NN	length
polymorphism	NN	polymorphism
analysis	NN	analysis
and	CC	and
nucleotide	NN	nucleotide
sequence	NN	sequence
analysis	NN	analysis
of	IN	of
a	DT	a
400-bp	JJ	400-bp
stretch	NN	stretch
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
3'	JJ	3'
end	NN	end
of	IN	of
eae	NNS	eae
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
data	NNS	datum
substantiated	VBD	substantiate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
two	CD	two
eae	JJ	eae
genotypes	NNS	genotype
within	IN	within
serogroup	NN	serogroup
O157	NN	O157
,	,	,
one	CD	one
resembling	VBG	resemble
eae	NNS	eae
of	IN	of
enteropathogenic	JJ	enteropathogenic
E	NN	E
.	SENT	.
coli	NN	coli
(	(	(
EPEC	NN	EPEC
)	)	)
strain	NN	strain
E	NN	E
2348/69	CD	2348/69
,	,	,
found	VBN	find
in	IN	in
nontoxinogenic	JJ	nontoxinogenic
E	NN	E
.	SENT	.
coli	NN	coli
O157	NN	O157
strains	NNS	strain
,	,	,
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=22 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
resembling	VBG	resemble
eae	NNS	eae
of	IN	of
EHEC	NN	EHEC
strain	NN	strain
EDL	NN	EDL
933	CD	933
,	,	,
found	VBN	find
in	IN	in
toxinogenic	JJ	toxinogenic
E	NN	E
.	SENT	.
coli	NN	coli
O157	NN	O157
strains	NNS	strain
.	SENT	.
.	SENT	.
<FORBIDDEN ID=29 ACTION=delete>
Another	DT	Another
</FORBIDDEN ID=29 ACTION=delete>
EPEC	NN	EPEC
-	HYPH	-
specific	JJ	specific
virulence	NN	virulence
determinant	NN	determinant
was	VVD	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
shown	VBN	show
to	TO	to
be	VV	be
large	JJ	large
plasmids	NNS	plasmid
harboring	VBG	harbor
EPEC	NN	EPEC
adherence	NN	adherence
factor	NN	factor
sequences	NNS	sequence
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
SLT	NN	SLT
-	HYPH	-
negative	JJ	negative
E	NN	E
.	SENT	.
coli	NN	coli
O157	NN	O157
strains	NNS	strain
described	VBN	describe
here	RB	here
fall	VB	fall
under	IN	under
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
heading	NN	heading
of	IN	of
EPEC	NP	EPEC
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
serves	VBZ	serve
as	IN	as
an	DT	an
explanation	NN	explanation
for	IN	for
their	PP$	their
virulence	NN	virulence
in	IN	in
infants	NNS	infant
,	,	,
and	CC	and
represent	VBP	represent
a	DT	a
third	JJ	third
pathogroup	NN	pathogroup
within	IN	within
serogroup	NN	serogroup
O157	NN	O157
.	SENT	.
.	SENT	.
BB-cat+ner-8532424/text	DOCUMENT	BB-cat+ner-8532424/text
Respiratory	JJ	Respiratory
carriage	NN	carriage
of	IN	of
Kingella	NP	Kingella
kingae	NNS	kingae
among	IN	among
healthy	JJ	healthy
children	NNS	child
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
role	NN	role
of	IN	of
Kingella	NP	Kingella
kingae	NNS	kingae
as	IN	as
an	DT	an
invasive	JJ	invasive
pathogen	NN	pathogen
of	IN	of
young	JJ	young
children	NNS	child
is	VVZ	be
being	VVG	be
increasingly	RB	increasingly
recognized	VBN	recognize
,	,	,
but	CC	but
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
niche	NN	niche
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
organism	NN	organism
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
respiratory	JJ	respiratory
tract	NN	tract
and	CC	and
its	PP$	its
prevalence	NN	prevalence
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
normal	JJ	normal
flora	NN	flora
of	IN	of
children	NNS	child
remain	VBP	remain
unknown	JJ	unknown
.	SENT	.
.	SENT	.
To	TO	To
investigate	VB	investigate
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
these	DT	these
two	CD	two
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
aspects	NNS	aspect
throat	JJ	throat
and	CC	and
nasopharyngeal	JJ	nasopharyngeal
cultures	NNS	culture
were	VVD	be
obtained	VBN	obtain
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
every	DT	every
2	CD	2
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
weeks	NNS	week
from	IN	from
two	CD	two
cohorts	NNS	cohort
of	IN	of
children	NNS	child
,	,	,
ages	NNS	age
6	CD	6
to	TO	to
42	CD	42
months	NNS	month
on	IN	on
enrollment	NN	enrollment
,	,	,
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
attending	VBG	attend
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
day-care	JJ	day-care
center	NN	center
in	IN	in
southern	JJ	southern
Israel	NP	Israel
.	SENT	.
.	SENT	.
To	TO	To
determine	VB	determine
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
age-related	JJ	age-related
prevalence	NN	prevalence
of	IN	of
K	NN	K
.	SENT	.
kingae	NNS	kingae
,	,	,
throat	NN	throat
cultures	NNS	culture
were	VVD	be
obtained	VBN	obtain
from	IN	from
children	NNS	child
ages	NNS	age
6	CD	6
months	NNS	month
to	TO	to
14	CD	14
years	NNS	year
hospitalized	VBN	hospitalize
for	IN	for
elective	JJ	elective
surgery	NN	surgery
who	WP	who
had	VHD	have
not	RB	not
received	VBN	receive
antibiotics	NNS	antibiotic
during	IN	during
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
previous	JJ	previous
30	CD	30
days	NNS	day
and	CC	and
from	IN	from
healthy	JJ	healthy
infants	NNS	infant
younger	JJR	young
than	IN	than
6	CD	6
months	NNS	month
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
attending	VBG	attend
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
well	RB	well
-	HYPH	-
baby	NN	baby
-	HYPH	-
care	NN	care
clinic	NN	clinic
for	IN	for
routine	JJ	routine
vaccinations	NNS	vaccination
.	SENT	.
.	SENT	.
During	IN	During
an	DT	an
11-month	JJ	11-month
follow-up	NN	follow-up
109	CD	109
of	IN	of
624	CD	624
(	(	(
27.5	CD	27.5
%	NN	%
)	)	)
throat	NN	throat
cultures	NNS	culture
but	CC	but
none	NN	none
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
nasopharyngeal	JJ	nasopharyngeal
cultures	NNS	culture
obtained	VBN	obtain
from	IN	from
48	CD	48
day-care	JJ	day-care
center	NN	center
attendees	NNS	attendee
grew	VBD	grow
K	NN	K
.	SENT	.
kingae	NN	kingae
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
monthly	JJ	monthly
prevalence	NN	prevalence
of	IN	of
K	NN	K
.	SENT	.
kingae	NN	kingae
ranged	VBD	range
from	IN	from
6.1	CD	6.1
to	TO	to
34.6	CD	34.6
%	NN	%
with	IN	with
December	NP	December
and	CC	and
<FORBIDDEN ID=122 ACTION=delete>
April	NP	April
</FORBIDDEN ID=122 ACTION=delete>
peaks	NNS	peak
.	SENT	.
.	SENT	.
Overall	RB	Overall
35	CD	35
of	IN	of
48	CD	48
(	(	(
72.9	CD	72.9
%	NN	%
)	)	)
children	NNS	child
had	VHD	have
at	IN	at
<FORBIDDEN ID=18 ACTION=delete>
least	JJS	least
</FORBIDDEN ID=18 ACTION=delete>
one	CD	one
positive	JJ	positive
culture	NN	culture
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
organism	NN	organism
.	SENT	.
.	SENT	.
Among	IN	Among
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
27	CD	27
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
children	NNS	child
who	WP	who
had	VHD	have
SUP	SYM	SUP
or	CC	or
=	SYM	=
2	CD	2
positive	JJ	positive
cultures	NNS	culture
,	,	,
continuous	JJ	continuous
and	CC	and
intermittent	JJ	intermittent
patterns	NNS	pattern
of	IN	of
carriage	NN	carriage
were	VVD	be
observed	VBN	observe
.	SENT	.
.	SENT	.
None	NN	None
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
colonized	VBN	colonize
children	NNS	child
experienced	VBD	experience
an	DT	an
invasive	JJ	invasive
K	NN	K
.	SENT	.
kingae	NN	kingae
infection	NN	infection
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
prevalence	NN	prevalence
of	IN	of
pharyngeal	JJ	pharyngeal
carriage	NN	carriage
among	IN	among
surgical	JJ	surgical
patients	NNS	patient
was	VVD	be
8.0	CD	8.0
%	NN	%
,	,	,
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
organism	NN	organism
was	VVD	be
not	RB	not
isolated	VBN	isolate
from	IN	from
any	DT	any
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
infants	NNS	infant
younger	JJR	young
than	IN	than
6	CD	6
months	NNS	month
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
attending	VBG	attend
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
well	RB	well
-	HYPH	-
baby	NN	baby
-	HYPH	-
care	NN	care
clinic	NN	clinic
.	SENT	.
.	SENT	.
BB-cat+ner-8559802/text	DOCUMENT	BB-cat+ner-8559802/text
Construction	NN	Construction
of	IN	of
a	DT	a
cloning	NN	cloning
vector	NN	vector
from	IN	from
a	DT	a
naturally	RB	naturally
occurring	VBG	occur
plasmid	NN	plasmid
of	IN	of
Salmonella	NP	Salmonella
typhimurium	NP	typhimurium
.	SENT	.
.	SENT	.
A	DT	A
naturally	RB	naturally
occurring	VBG	occur
plasmid	NN	plasmid
isolated	VBN	isolate
from	IN	from
a	DT	a
drug	NN	drug
-	HYPH	-
resistant	JJ	resistant
strain	NN	strain
of	IN	of
Salmonella	NP	Salmonella
typhimurium	NP	typhimurium
(	(	(
993	CD	993
)	)	)
has	VHZ	have
been	VVN	be
used	VBN	use
to	TO	to
construct	VB	construct
a	DT	a
plasmid	NN	plasmid
vector	NN	vector
for	IN	for
cloning	NN	cloning
in	IN	in
a	DT	a
wild	JJ	wild
strain	NN	strain
of	IN	of
Salmonella	NP	Salmonella
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
strain	NN	strain
(	(	(
993	CD	993
)	)	)
contains	VBZ	contain
at	IN	at
<FORBIDDEN ID=18 ACTION=delete>
least	JJS	least
</FORBIDDEN ID=18 ACTION=delete>
two	CD	two
plasmids	NNS	plasmid
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
smaller	JJR	small
plasmid	NN	plasmid
(	(	(
9	CD	9
kb	NN	kb
)	)	)
contains	VBZ	contain
an	DT	an
ampicillin	NN	ampicillin
-	HYPH	-
resistant	JJ	resistant
marker	NN	marker
,	,	,
while	IN	while
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
larger	JJR	large
one	CD	one
(	(	(
25	CD	25
kb	NN	kb
)	)	)
is	VVZ	be
cryptic	JJ	cryptic
.	SENT	.
.	SENT	.
Physical	JJ	Physical
mapping	NN	mapping
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
9-kb	JJ	9-kb
plasmid	NN	plasmid
and	CC	and
construction	NN	construction
of	IN	of
a	DT	a
3.5-kb	JJ	3.5-kb
derivative	NN	derivative
have	VHP	have
been	VVN	be
carried	VBN	carry
out	RP	out
.	SENT	.
.	SENT	.
This	DT	This
plasmid	NN	plasmid
has	VHZ	have
been	VVN	be
used	VBN	use
for	IN	for
cloning	VBG	clone
in	IN	in
a	DT	a
restriction+modification+strain	NN	restriction+modification+strain
of	IN	of
S	NN	S
.	SENT	.
typhimurium	NN	typhimurium
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
using	VBG	use
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
conventional	JJ	conventional
calcium	NN	calcium
chloride	NN	chloride
method	NN	method
.	SENT	.
.	SENT	.
It	PP	It
exhibited	VBD	exhibit
better	JJR	good
efficiency	NN	efficiency
of	IN	of
transformation	NN	transformation
than	IN	than
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
commonly	RB	commonly
used	VBN	use
plasmids	NNS	plasmid
<FORBIDDEN ID=17 ACTION=delete>
such	JJ	such
</FORBIDDEN ID=17 ACTION=delete>
as	IN	as
pBR322	NN	pBR322
or	CC	or
its	PP$	its
derivatives	NNS	derivative
and	CC	and
transformants	NNS	transformant
were	VVD	be
found	VBN	find
to	TO	to
be	VV	be
stable	JJ	stable
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
absence	NN	absence
of	IN	of
antibiotic	JJ	antibiotic
selection	NN	selection
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
vector	NN	vector
is	VVZ	be
compatible	JJ	compatible
with	IN	with
pBR322	NN	pBR322
and	CC	and
can	MD	can
be	VV	be
used	VBN	use
to	TO	to
study	VB	study
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
expression	NN	expression
of	IN	of
cloned	VBN	clone
genes	NNS	gene
in	IN	in
minicells	NNS	minicell
.	SENT	.
.	SENT	.
BB-cat+ner-8607503/text	DOCUMENT	BB-cat+ner-8607503/text
Non-O1	JJ	Non-O1
Vibrio	NP	Vibrio
cholerae	NN	cholerae
bacteremia	NN	bacteremia
in	IN	in
patients	NNS	patient
with	IN	with
cirrhosis	NN	cirrhosis
:	COLUMN	:
5-yr	JJ	5-yr
experience	NN	experience
from	IN	from
a	DT	a
single	JJ	single
medical	JJ	medical
center	NN	center
.	SENT	.
.	SENT	.
To	TO	To
assess	VB	assess
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
clinical	JJ	clinical
features	NNS	feature
and	CC	and
susceptibility	NN	susceptibility
of	IN	of
cirrhotic	JJ	cirrhotic
patients	NNS	patient
to	TO	to
non-O1	JJ	non-O1
Vibrio	NP	Vibrio
cholerae	NN	cholerae
bacteremia	NN	bacteremia
and	CC	and
to	TO	to
provide	VB	provide
our	PP$	our
therapeutic	JJ	therapeutic
experiences	NNS	experience
in	IN	in
this	DT	this
rare	JJ	rare
and	CC	and
high	JJ	high
lethal	JJ	lethal
infection	NN	infection
.	SENT	.
.	SENT	.
Twenty	CD	Twenty
-	HYPH	-
eight	CD	eight
blood	NN	blood
culture	NN	culture
isolates	NNS	isolate
of	IN	of
non-O1	JJ	non-O1
V	NN	V
.	SENT	.
cholerae	NNS	cholerae
were	VVD	be
identified	VBN	identify
by	IN	by
our	PP$	our
clinical	JJ	clinical
microbiology	NN	microbiology
laboratory	NN	laboratory
between	IN	between
<FORBIDDEN ID=125 ACTION=delete>
July	NP	July
</FORBIDDEN ID=125 ACTION=delete>
1989	CD	1989
and	CC	and
<FORBIDDEN ID=124 ACTION=delete>
June	NP	June
</FORBIDDEN ID=124 ACTION=delete>
1994	CD	1994
.	SENT	.
.	SENT	.
Patients	NNS	Patient
with	IN	with
underlying	VBG	underlie
cirrhosis	NN	cirrhosis
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
aforementioned	JJ	aforementioned
bacteremia	NN	bacteremia
were	VVD	be
retrospectively	RB	retrospectively
reviewed	VBN	review
.	SENT	.
.	SENT	.
Twenty-one	CD	Twenty-one
cirrhotic	JJ	cirrhotic
patients	NNS	patient
(	(	(
16	CD	16
male	JJ	male
,	,	,
five	CD	five
female	JJ	female
;	COLUMN	;
mean	NN	mean
age	NN	age
,	,	,
50.9	CD	50.9
yr	NN	yr
;	COLUMN	;
range	NN	range
28-67	CD	28-67
yr	NN	yr
)	)	)
were	VVD	be
identified	VBN	identify
and	CC	and
classified	VBN	classify
as	IN	as
Child	NN	Child
B	NN	B
(	(	(
6	CD	6
cases	NNS	case
)	)	)
and	CC	and
Child	NN	Child
C	NN	C
(	(	(
15	CD	15
cases	NNS	case
)	)	)
.	SENT	.
.	SENT	.
Bacteremic	JJ	Bacteremic
episodes	NNS	episode
occurred	VBD	occur
most	RBS	most
often	RB	often
from	IN	from
<FORBIDDEN ID=121 ACTION=delete>
March	NP	March
</FORBIDDEN ID=121 ACTION=delete>
to	TO	to
September	NP	September
.	SENT	.
.	SENT	.
Seafood	NN	Seafood
ingestion	NN	ingestion
(	(	(
seven	CD	seven
cases	NNS	case
)	)	)
and	CC	and
seawater	NN	seawater
exposure	NN	exposure
(	(	(
two	CD	two
cases	NNS	case
)	)	)
were	VVD	be
risk	NN	risk
factors	NNS	factor
,	,	,
but	CC	but
nosocomial	JJ	nosocomial
infections	NNS	infection
were	VVD	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
noted	VBN	note
in	IN	in
six	CD	six
cases	NNS	case
.	SENT	.
.	SENT	.
Presenting	VBG	Present
symptoms	NNS	symptom
and	CC	and
signs	NNS	sign
included	VBD	include
ascites	NNS	ascite
(	(	(
95.2	CD	95.2
%	NN	%
)	)	)
,	,	,
fever	NN	fever
(	(	(
81%	CD	81%
)	)	)
,	,	,
abdominal	JJ	abdominal
pain	NN	pain
(	(	(
52.4	CD	52.4
%	NN	%
)	)	)
,	,	,
diarrhea	NN	diarrhea
(	(	(
33.3	CD	33.3
%	NN	%
)	)	)
,	,	,
and	CC	and
cellulitis	NN	cellulitis
with	IN	with
bullae	NN	bullae
formation	NN	formation
(	(	(
19%	CD	19%
)	)	)
.	SENT	.
.	SENT	.
Concurrent	JJ	Concurrent
spontaneous	JJ	spontaneous
bacterial	JJ	bacterial
peritonitis	NN	peritonitis
was	VVD	be
determined	VBN	determine
in	IN	in
10	CD	10
cases	NNS	case
,	,	,
seven	CD	seven
with	IN	with
positive	JJ	positive
ascites	NNS	ascite
cultures	NNS	culture
.	SENT	.
.	SENT	.
Antibiotic	JJ	Antibiotic
therapy	NN	therapy
(	(	(
either	CC	either
cephalothin	NN	cephalothin
with	IN	with
gentamicin	NN	gentamicin
or	CC	or
ceftriaxone	NN	ceftriaxone
alone	RB	alone
)	)	)
cured	VBN	cure
most	JJS	most
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bacteremic	JJ	bacteremic
episodes	NNS	episode
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
overall	JJ	overall
case	NN	case
-	HYPH	-
fatality	NN	fatality
rate	NN	rate
was	VVD	be
23.8	CD	23.8
%	NN	%
,	,	,
but	CC	but
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
75%	CD	75%
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
deaths	NNS	death
were	VVD	be
observed	VBN	observe
in	IN	in
patients	NNS	patient
with	IN	with
skin	NN	skin
manifestation	NN	manifestation
.	SENT	.
.	SENT	.
Patients	NNS	Patient
with	IN	with
decompensated	VBN	decompensate
cirrhosis	NN	cirrhosis
are	VVP	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
susceptible	JJ	susceptible
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
non-O1	JJ	non-O1
V	NN	V
.	SENT	.
cholerae	NN	cholerae
bacteremia	NN	bacteremia
and	CC	and
should	MD	should
not	RB	not
ingest	VB	ingest
raw	JJ	raw
seafood	NN	seafood
or	CC	or
expose	VB	expose
skin	NN	skin
wounds	NNS	wound
to	TO	to
salt	VB	salt
water	NN	water
.	SENT	.
.	SENT	.
A	DT	A
high	JJ	high
index	NN	index
of	IN	of
suspicion	NN	suspicion
and	CC	and
<FORBIDDEN ID=45 ACTION=delete>
early	JJ	early
</FORBIDDEN ID=45 ACTION=delete>
administration	NN	administration
of	IN	of
antibiotics	NNS	antibiotic
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
lower	VB	lower
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
mortality	NN	mortality
rate	NN	rate
.	SENT	.
.	SENT	.
BB-cat+ner-8698477/text	DOCUMENT	BB-cat+ner-8698477/text
Macrophages	NNS	Macrophage
exposed	VBN	expose
to	TO	to
Borrelia	NP	Borrelia
burgdorferi	NNS	burgdorferi
induce	VBP	induce
Lyme	NN	Lyme
arthritis	NN	arthritis
in	IN	in
hamsters	NNS	hamster
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
mechanism(s)	NN	mechanism(s)
by	IN	by
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
Lyme	NN	Lyme
arthritis	NN	arthritis
is	VVZ	be
induced	VBN	induce
has	VHZ	have
not	RB	not
been	VVN	be
elucidated	VBN	elucidate
.	SENT	.
.	SENT	.
In	IN	In
this	DT	this
study	NN	study
,	,	,
we	PP	we
showed	VBD	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
macrophages	NNS	macrophage
have	VHP	have
a	DT	a
direct	JJ	direct
,	,	,
effector	NN	effector
role	NN	role
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
pathogenesis	NN	pathogenesis
of	IN	of
Lyme	NN	Lyme
arthritis	NN	arthritis
.	SENT	.
.	SENT	.
Severe	JJ	Severe
destructive	JJ	destructive
arthritis	NN	arthritis
was	VVD	be
induced	VBN	induce
in	IN	in
recipients	NNS	recipient
of	IN	of
macrophages	NNS	macrophage
obtained	VBN	obtain
from	IN	from
Borrelia	NP	Borrelia
burgdorferi	AFX	burgdorferi
-	HYPH	-
vaccinated	VBN	vaccinate
and	CC	and
nonvaccinated	JJ	nonvaccinated
hamsters	NNS	hamster
exposed	VBN	expose
to	TO	to
Formalin	NN	Formalin
-	HYPH	-
inactivated	VBN	inactivate
B	NN	B
.	SENT	.
burgdorferi	FW	burgdorferi
in vitro	FW	in_vitro
and	CC	and
then	RB	then
challenged	VBD	challenge
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Lyme	NN	Lyme
spirochete	NN	spirochete
.	SENT	.
.	SENT	.
Swelling	NN	Swelling
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
hind	NN	hind
paws	NNS	paw
was	VVD	be
detected	VBN	detect
within	IN	within
8	CD	8
h	NN	h
of	IN	of
infection	NN	infection
,	,	,
increased	VBN	increase
rapidly	RB	rapidly
,	,	,
and	CC	and
peaked	VBD	peak
at	IN	at
21	CD	21
h	NN	h
.	SENT	.
.	SENT	.
This	DT	This
initial	JJ	initial
swelling	NN	swelling
decreased	VBD	decrease
,	,	,
and	CC	and
by	IN	by
day	NN	day
4	CD	4
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
</FORBIDDEN ID=156 ACTION=delete>
slight	JJ	slight
swelling	NN	swelling
was	VVD	be
detected	VBN	detect
.	SENT	.
.	SENT	.
Severe	JJ	Severe
swelling	NN	swelling
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
hind	NN	hind
paws	NNS	paw
was	VVD	be
detected	VBN	detect
8	CD	8
days	NNS	day
after	IN	after
infection	NN	infection
and	CC	and
increased	VBD	increase
rapidly	RB	rapidly
,	,	,
with	IN	with
peak	NN	peak
swelling	VBG	swell
occurring	VBG	occur
on	IN	on
day	NN	day
11	CD	11
.	SENT	.
.	SENT	.
Histopathologic	JJ	Histopathologic
examination	NN	examination
affirmed	VBD	affirm
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
macrophages	NNS	macrophage
exposed	VBN	expose
to	TO	to
Formalin	NN	Formalin
-	HYPH	-
inactivated	VBN	inactivate
spirochetes	NNS	spirochete
induced	VBD	induce
a	DT	a
severe	JJ	severe
destructive	JJ	destructive
Lyme	NN	Lyme
arthritis	NN	arthritis
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
onset	NN	onset
and	CC	and
severity	NN	severity
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
severe	JJ	severe
destructive	JJ	destructive
arthritis	NN	arthritis
were	VVD	be
dependent	JJ	dependent
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
number	NN	number
of	IN	of
macrophages	NNS	macrophage
transferred	VBN	transfer
.	SENT	.
.	SENT	.
By	IN	By
contrast	NN	contrast
,	,	,
macrophages	NNS	macrophage
not	RB	not
exposed	VBN	expose
to	TO	to
Formalin	NN	Formalin
-	HYPH	-
inactivated	VBN	inactivate
B	NN	B
.	SENT	.
burgdorferi	NNS	burgdorferi
failed	VBD	fail
to	TO	to
induce	VB	induce
severe	JJ	severe
destructive	JJ	destructive
arthritis	NN	arthritis
in	IN	in
recipients	NNS	recipient
after	IN	after
challenge	NN	challenge
with	IN	with
B	NN	B
.	SENT	.
burgdorferi	NN	burgdorferi
.	SENT	.
.	SENT	.
Similarly	RB	Similarly
,	,	,
severe	JJ	severe
destructive	JJ	destructive
arthritis	NN	arthritis
was	VVD	be
not	RB	not
detected	VBN	detect
in	IN	in
recipients	NNS	recipient
of	IN	of
macrophages	NNS	macrophage
injected	VBN	inject
with	IN	with
spirochetal	JJ	spirochetal
growth	NN	growth
medium	NN	medium
.	SENT	.
.	SENT	.
Our	PP$	Our
results	NNS	result
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
showed	VBD	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
transferred	VBN	transfer
macrophages	NNS	macrophage
could	MD	could
not	RB	not
protect	VB	protect
hamsters	NNS	hamster
from	IN	from
infection	NN	infection
with	IN	with
B	NN	B
.	SENT	.
burgdorferi	NN	burgdorferi
,	,	,
as	IN	as
spirochetes	NNS	spirochete
were	VVD	be
readily	RB	readily
recovered	VBN	recover
from	IN	from
their	PP$	their
tissues	NNS	tissue
when	WRB	when
cultured	VBN	culture
.	SENT	.
.	SENT	.
These	DT	These
findings	NNS	finding
demonstrate	VBP	demonstrate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
macrophages	NNS	macrophage
exposed	VBN	expose
to	TO	to
B	NN	B
.	SENT	.
burgdorferi	NNS	burgdorferi
are	VVP	be
directly	RB	directly
involved	VBN	involve
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
induction	NN	induction
of	IN	of
Lyme	NN	Lyme
arthritis	NN	arthritis
.	SENT	.
.	SENT	.
BB-cat+ner-8703935/text	DOCUMENT	BB-cat+ner-8703935/text
NMR	NN	NMR
analysis	NN	analysis
of	IN	of
site	NN	site
-	HYPH	-
specific	JJ	specific
ligand	NN	ligand
binding	NN	binding
in	IN	in
oligomeric	JJ	oligomeric
proteins	NNS	protein
.	SENT	.
.	SENT	.
Dynamic	JJ	Dynamic
studies	NNS	study
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
interaction	NN	interaction
of	IN	of
riboflavin	NN	riboflavin
synthase	NN	synthase
with	IN	with
trifluoromethyl	NN	trifluoromethyl
-	HYPH	-
substituted	VBN	substitute
intermediates	NNS	intermediate
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
binding	NN	binding
of	IN	of
small	JJ	small
ligands	NNS	ligand
to	TO	to
symmetrical	JJ	symmetrical
oligomeric	JJ	oligomeric
proteins	NNS	protein
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
lead	VB	lead
to	TO	to
a	DT	a
number	NN	number
of	IN	of
different	JJ	different
partially	RB	partially
ligated	VBN	ligate
intermediates	NNS	intermediate
but	CC	but
should	MD	should
<FORBIDDEN ID=160 ACTION=delete>
finally	RB	finally
</FORBIDDEN ID=160 ACTION=delete>
yield	VB	yield
a	DT	a
symmetrical	JJ	symmetrical
fully	RB	fully
ligated	VBN	ligate
enzyme	NN	enzyme
/	SYM	/
ligand	NN	ligand
complex	NN	complex
.	SENT	.
.	SENT	.
In	IN	In
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
case	NN	case
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
trimeric	JJ	trimeric
protein	NN	protein
,	,	,
riboflavin	NN	riboflavin
synthase	NN	synthase
,	,	,
some	DT	some
ligands	NNS	ligand
form	VBP	form
an	DT	an
unexpected	JJ	unexpected
protein	NN	protein
/	SYM	/
ligand	NN	ligand
complex	NN	complex
,	,	,
<FORBIDDEN ID=157 ACTION=delete>
even	RB	even
</FORBIDDEN ID=157 ACTION=delete>
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
a	DT	a
large	JJ	large
excess	NN	excess
of	IN	of
ligand	NN	ligand
.	SENT	.
.	SENT	.
Three	CD	Three
different	JJ	different
bound	JJ	bound
forms	NNS	form
were	VVD	be
observed	VBN	observe
by	IN	by
19F	NN	19F
NMR	NN	NMR
spectroscopy	NN	spectroscopy
,	,	,
and	CC	and
Scatchard	NN	Scatchard
-	HYPH	-
type	NN	type
analysis	NN	analysis
suggested	VBD	suggest
binding	VBG	bind
sites	NNS	site
of	IN	of
similar	JJ	similar
affinities	NNS	affinity
.	SENT	.
.	SENT	.
NOESY	NN	NOESY
analysis	NN	analysis
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
kinetic	JJ	kinetic
network	NN	network
revealed	VBD	reveal
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
three	CD	three
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
bound	VBN	bind
states	NNS	state
exchange	NN	exchange
with	IN	with
free	JJ	free
ligand	NN	ligand
,	,	,
but	CC	but
not	RB	not
with	IN	with
each	DT	each
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
,	,	,
thus	RB	thus
suggesting	VBG	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
trimeric	JJ	trimeric
enzyme	NN	enzyme
could	MD	could
be	VV	be
asymmetrical	JJ	asymmetrical
.	SENT	.
.	SENT	.
This	DT	This
information	NN	information
permits	VBZ	permit
appropriate	JJ	appropriate
precautions	NNS	precaution
to	TO	to
be	VV	be
taken	VBN	take
during	IN	during
X-ray	NN	X-ray
structure	NN	structure
analysis	NN	analysis
of	IN	of
riboflavin	NN	riboflavin
synthase	NN	synthase
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
is	VVZ	be
in	IN	in
progress	NN	progress
.	SENT	.
.	SENT	.
Quantitative	JJ	Quantitative
analysis	NN	analysis
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
NOESY	NN	NOESY
spectra	NNS	spectrum
yielded	VBD	yield
different	JJ	different
rate	NN	rate
constants	NNS	constant
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
different	JJ	different
binding	VBG	bind
sites	NNS	site
.	SENT	.
.	SENT	.
For	IN	For
comparison	NN	comparison
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
monomeric	JJ	monomeric
lumazine	NN	lumazine
protein	NN	protein
was	VVD	be
investigated	VBN	investigate
as	IN	as
an	DT	an
<FORBIDDEN ID=134 ACTION=delete>
<FORBIDDEN ID=133 ACTION=delete>
<FORBIDDEN ID=131 ACTION=delete>
example	NN	example
</FORBIDDEN ID=131 ACTION=delete>
</FORBIDDEN ID=133 ACTION=delete>
</FORBIDDEN ID=134 ACTION=delete>
of	IN	of
a	DT	a
case	NN	case
with	IN	with
simple	JJ	simple
two-site	JJ	two-site
exchange	NN	exchange
.	SENT	.
.	SENT	.
For	IN	For
<FORBIDDEN ID=17 ACTION=delete>
such	JJ	such
</FORBIDDEN ID=17 ACTION=delete>
systems	NNS	system
,	,	,
all	DT	all
kinetic	JJ	kinetic
parameters	NNS	parameter
including	VBG	include
kon	NN	kon
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
dissociation	NN	dissociation
constant	NN	constant
can	MD	can
be	VV	be
determined	VBN	determine
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
NOESY	NN	NOESY
spectrum	NN	spectrum
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
data	NNS	datum
show	VBP	show
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
NMR	NN	NMR
spectroscopy	NN	spectroscopy
can	MD	can
produce	VB	produce
qualitative	JJ	qualitative
and	CC	and
quantitative	JJ	quantitative
information	NN	information
in	IN	in
cases	NNS	case
of	IN	of
nonequivalent	JJ	nonequivalent
binding	VBG	bind
sites	NNS	site
in	IN	in
oligomeric	JJ	oligomeric
proteins	NNS	protein
if	IN	if
isolated	VBN	isolate
NMR	NN	NMR
signals	NNS	signal
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
different	JJ	different
forms	NNS	form
can	MD	can
be	VV	be
observed	VBN	observe
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
technique	NN	technique
is	VVZ	be
not	RB	not
limited	VBN	limit
to	TO	to
19F	NN	19F
as	IN	as
reporter	NN	reporter
nucleus	NN	nucleus
.	SENT	.
.	SENT	.
BB-cat+ner-8997164/text	DOCUMENT	BB-cat+ner-8997164/text
Gamma	NN	Gamma
/	SYM	/
delta	SYM	delta
T	NN	T
lymphocytes	NNS	lymphocyte
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
BCG	NN	BCG
granulomatous	JJ	granulomatous
lesions	NNS	lesion
.	SENT	.
.	SENT	.
Recent	JJ	Recent
studies	NNS	study
in	IN	in
man	NN	man
and	CC	and
animal	NN	animal
models	NNS	model
have	VHP	have
demonstrated	VBN	demonstrate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
TCR	NN	TCR
-	HYPH	-
gamma	SYM	gamma
delta	SYM	delta
-	HYPH	-
bearing	VBG	bear
T	NN	T
cells	NNS	cell
(	(	(
gamma	NN	gamma
delta	NN	delta
T	NN	T
cells	NNS	cell
)	)	)
are	VVP	be
activated	VBN	activate
by	IN	by
mycobacteria	NNS	mycobacterium
and	CC	and
accumulate	VBP	accumulate
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
sites	NNS	site
of	IN	of
mycobacterial	JJ	mycobacterial
infection	NN	infection
.	SENT	.
.	SENT	.
Although	IN	Although
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
function	NN	function
of	IN	of
gamma	NN	gamma
delta	NN	delta
T	NN	T
cells	NNS	cell
remains	VBZ	remain
unclear	JJ	unclear
,	,	,
some	DT	some
data	NNS	datum
suggest	VBP	suggest
a	DT	a
potential	JJ	potential
role	NN	role
for	IN	for
these	DT	these
cells	NNS	cell
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
granulomatous	JJ	granulomatous
immune	JJ	immune
response	NN	response
.	SENT	.
.	SENT	.
To	TO	To
address	VB	address
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
gamma	NN	gamma
delta	NN	delta
T	NN	T
cells	NNS	cell
within	IN	within
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
BCG	NN	BCG
granulomas	NNS	granuloma
,	,	,
we	PP	we
have	VHP	have
characterized	VBN	characterize
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
TCR	NN	TCR
phenotype	NN	phenotype
of	IN	of
T-lymphocytes	NNS	T-lymphocyte
present	JJ	present
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
BCG	NN	BCG
granulomatous	JJ	granulomatous
lesion	NN	lesion
immunohistochemically	RB	immunohistochemically
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
using	VBG	use
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
monoclonal	JJ	monoclonal
antibody	NN	antibody
to	TO	to
TCR	NN	TCR
delta	NN	delta
1	CD	1
and	CC	and
<FORBIDDEN ID=22 ACTION=delete>
others	NNS	other
</FORBIDDEN ID=22 ACTION=delete>
.	SENT	.
.	SENT	.
Fairly	RB	Fairly
large	JJ	large
numbers	NNS	number
of	IN	of
gamma	NN	gamma
delta	NN	delta
T	NN	T
cells	NNS	cell
were	VVD	be
located	JJ	located
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
periphery	NN	periphery
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
BCG	NN	BCG
granulomas	NNS	granuloma
without	IN	without
necrosis	NN	necrosis
and	CC	and
most	JJS	most
of	IN	of
them	PP	them
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
expressed	VBD	express
CD8	NN	CD8
.	SENT	.
.	SENT	.
However	RB	However
,	,	,
gamma	NN	gamma
delta	NN	delta
T	NN	T
cells	NNS	cell
were	VVD	be
rarely	RB	rarely
present	JJ	present
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
granulomas	NNS	granuloma
with	IN	with
central	JJ	central
caseous	JJ	caseous
necrosis	NN	necrosis
,	,	,
calcification	NN	calcification
and	CC	and
fibrotic	JJ	fibrotic
changes	NNS	change
.	SENT	.
.	SENT	.
With	IN	With
these	DT	these
results	NNS	result
,	,	,
it	PP	it
might	MD	might
be	VV	be
speculated	VBN	speculate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
CD8+	JJ	CD8+
gamma	NN	gamma
delta	NN	delta
T	NN	T
lymphocytes	NNS	lymphocyte
participate	VBP	participate
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
BCG	NN	BCG
granuloma	NN	granuloma
formation	NN	formation
mainly	RB	mainly
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=45 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
early	JJ	early
</FORBIDDEN ID=45 ACTION=delete>
stage	NN	stage
.	SENT	.
.	SENT	.
BB-cat+ner-9231420/text	DOCUMENT	BB-cat+ner-9231420/text
Neuraminidase	NN	Neuraminidase
(	(	(
sialidase	NN	sialidase
)	)	)
activity	NN	activity
of	IN	of
Haemophilus	NN	Haemophilus
parasuis	NN	parasuis
.	SENT	.
.	SENT	.
Neuraminidase	NN	Neuraminidase
(	(	(
sialidase	NN	sialidase
)	)	)
,	,	,
a	DT	a
potential	JJ	potential
virulence	NN	virulence
factor	NN	factor
in	IN	in
bacteria	NNS	bacteria
,	,	,
was	VVD	be
demonstrated	VBN	demonstrate
in	IN	in
Haemophilus	NP	Haemophilus
parasuis	NN	parasuis
,	,	,
an	DT	an
invasive	JJ	invasive
swine	NN	swine
pathogen	NN	pathogen
,	,	,
but	CC	but
not	RB	not
in	IN	in
four	CD	four
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
pathogens	NNS	pathogen
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Pasteurellaceae	NP	Pasteurellaceae
family	NN	family
:	COLUMN	:
H	NN	H
.	NN	.
influenzae	NNS	influenzae
,	,	,
H	NN	H
.	VBD	.
somnus	NN	somnus
,	,	,
H	NN	H
.	VBD	.
paragallinarum	NN	paragallinarum
,	,	,
or	CC	or
Actinobacillus	FW	Actinobacillus
pleuropneumoniae	FW	pleuropneumoniae
.	SENT	.
.	SENT	.
H	NN	H
.	SYM	.
parasuis	NN	parasuis
neuraminidase	NN	neuraminidase
had	VHD	have
an	DT	an
acidic	JJ	acidic
pH	NN	pH
optimum	NN	optimum
and	CC	and
a	DT	a
specificity	NN	specificity
for	IN	for
several	JJ	several
substrates	NNS	substrate
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
cleaved	VBN	cleave
by	IN	by
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
bacterial	JJ	bacterial
neuraminidases	NNS	neuraminidas
.	SENT	.
.	SENT	.
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
Similar	JJ	Similar
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
neuraminidase	NN	neuraminidase
of	IN	of
Pasteurella	NP	Pasteurella
multocida	NP	multocida
,	,	,
H	NP	H
.	VBD	.
parasuis	NN	parasuis
neuraminidase	NN	neuraminidase
was	VVD	be
cell	NN	cell
associated	JJ	associated
and	CC	and
did	VBD	do
not	RB	not
require	VB	require
divalent	JJ	divalent
cations	NNS	cation
for	IN	for
activity	NN	activity
.	SENT	.
.	SENT	.
Exogenous	JJ	Exogenous
sialic	JJ	sialic
acid	NN	acid
added	VBN	add
to	TO	to
growth	NN	growth
medium	NN	medium
of	IN	of
H	NN	H
.	SENT	.
parasuis	''	parasuis
was	VVD	be
cleared	VBN	clear
after	IN	after
a	DT	a
lag	NN	lag
of	IN	of
about	IN	about
10	CD	10
h	NN	h
and	CC	and
these	DT	these
cultures	NNS	culture
grew	VBD	grow
to	TO	to
a	DT	a
greater	JJR	great
final	JJ	final
density	NN	density
than	IN	than
cultures	NNS	culture
without	IN	without
added	VBN	add
sialic	JJ	sialic
acid	NN	acid
,	,	,
indicating	VBG	indicate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
exogenous	JJ	exogenous
sialic	JJ	sialic
acid	NN	acid
is	VVZ	be
metabolized	VBN	metabolize
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
role	NN	role
of	IN	of
sialidase	NN	sialidase
in	IN	in
providing	VBG	provide
nutrients	NNS	nutrient
to	TO	to
H	NN	H
.	SYM	.
parasuis	NN	parasuis
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
be	VV	be
an	DT	an
important	JJ	important
factor	NN	factor
in	IN	in
its	PP$	its
obligate	JJ	obligate
parasitism	NN	parasitism
.	SENT	.
.	SENT	.
BB-cat+ner-9255900/text	DOCUMENT	BB-cat+ner-9255900/text
Isolation	NN	Isolation
of	IN	of
Helicobacter	NN	Helicobacter
pullorum	NN	pullorum
from	IN	from
patients	NNS	patient
with	IN	with
enteritis	NN	enteritis
.	SENT	.
.	SENT	.
Helicobacter	NP	Helicobacter
pullorum	NN	pullorum
,	,	,
recently	RB	recently
described	VBN	describe
as	IN	as
sp	NN	sp
.	SENT	.
nov	NN	nov
.	NN	.
,	,	,
is	VVZ	be
commonly	RB	commonly
isolated	VBN	isolate
from	IN	from
asymptomatic	JJ	asymptomatic
poultry	NN	poultry
.	SENT	.
.	SENT	.
Two	CD	Two
cases	NNS	case
of	IN	of
human	JJ	human
enteritis	NN	enteritis
associated	VBN	associate
with	IN	with
H	NN	H
.	SYM	.
pullorum	NN	pullorum
,	,	,
<FORBIDDEN ID=55 ACTION=delete>
one	CD	one
of	IN	of
</FORBIDDEN ID=55 ACTION=delete>
them	PP	them
in	IN	in
an	DT	an
immunocompromised	JJ	immunocompromised
patient	NN	patient
,	,	,
are	VVP	be
reported	VBN	report
.	SENT	.
.	SENT	.
Problems	NNS	Problem
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
correct	JJ	correct
species	NN	species
identification	NN	identification
by	IN	by
<FORBIDDEN ID=19 ACTION=delete>
means	NNS	mean
of	IN	of
</FORBIDDEN ID=19 ACTION=delete>
phenotypic	JJ	phenotypic
and	CC	and
genotypic	JJ	genotypic
methods	NNS	method
are	VVP	be
discussed	VBN	discuss
and	CC	and
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
first	JJ	first
<FORBIDDEN ID=0 ACTION=split SPLIT_AFTER=0>
time	NN	time
a	DT	a
</FORBIDDEN ID=0 ACTION=split SPLIT_AFTER=0>
fatty	JJ	fatty
acid	NN	acid
pattern	NN	pattern
of	IN	of
Helicobacter	NN	Helicobacter
pullorum	NN	pullorum
is	VVZ	be
presented	VBN	present
.	SENT	.
.	SENT	.
BB-cat+ner-9521147/text	DOCUMENT	BB-cat+ner-9521147/text
Lipopolysaccharide	NN	Lipopolysaccharide
from	IN	from
nonvirulent	JJ	nonvirulent
Ara+	JJ	Ara+
Burkholderia	NN	Burkholderia
pseudomallei	NN	pseudomallei
isolates	NNS	isolate
is	VVZ	be
immunologically	RB	immunologically
indistinguishable	JJ	indistinguishable
from	IN	from
lipopolysaccharide	NN	lipopolysaccharide
from	IN	from
virulent	JJ	virulent
Ara	NP	Ara
-	HYPH	-
clinical	JJ	clinical
isolates	NNS	isolate
.	SENT	.
.	SENT	.
Different	JJ	Different
lines	NNS	line
of	IN	of
evidence	NN	evidence
suggest	VBP	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
a	DT	a
discrepancy	NN	discrepancy
between	IN	between
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
distribution	NN	distribution
of	IN	of
Burkholderia	NP	Burkholderia
(	(	(
Pseudomonas	NP	Pseudomonas
)	)	)
pseudomallei	NNS	pseudomallei
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
environment	NN	environment
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
distribution	NN	distribution
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
disease	NN	disease
melioidosis	NN	melioidosis
is	VVZ	be
attributable	JJ	attributable
,	,	,
at	IN	at
<FORBIDDEN ID=18 ACTION=delete>
least	JJS	least
</FORBIDDEN ID=18 ACTION=delete>
in	IN	in
part	NN	part
,	,	,
to	TO	to
phenotypic	JJ	phenotypic
differences	NNS	difference
between	IN	between
clinical	JJ	clinical
and	CC	and
some	DT	some
environmental	JJ	environmental
isolates	NNS	isolate
.	SENT	.
.	SENT	.
Two	CD	Two
antigenically	RB	antigenically
and	CC	and
biochemically	RB	biochemically
distinct	JJ	distinct
biotypes	NNS	biotype
have	VHP	have
been	VVN	be
described	VBN	describe
,	,	,
<FORBIDDEN ID=156 ACTION=delete>
only	RB	only
<FORBIDDEN ID=55 ACTION=delete>
</FORBIDDEN ID=156 ACTION=delete>
one	CD	one
of	IN	of
<FORBIDDEN ID=36 ACTION=delete>
</FORBIDDEN ID=55 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
is	VVZ	be
virulent	JJ	virulent
.	SENT	.
.	SENT	.
In	IN	In
this	DT	this
study	NN	study
,	,	,
lipopolysaccharides	NNS	lipopolysaccharide
(	(	(
LPSs	NNS	LPS
)	)	)
were	VVD	be
extracted	VBN	extract
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
proteinase	NN	proteinase
K	NN	K
digestion	NN	digestion
method	NN	method
from	IN	from
a	DT	a
total	NN	total
of	IN	of
214	CD	214
B	NN	B
.	SENT	.
pseudomallei	NN	pseudomallei
isolates	NNS	isolate
,	,	,
and	CC	and
their	PP$	their
immunoreactivities	NNS	immunoreactivity
with	IN	with
sera	NNS	serum
from	IN	from
patients	NNS	patient
with	IN	with
different	JJ	different
clinical	JJ	clinical
spectra	NNS	spectrum
and	CC	and
with	IN	with
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
infections	NNS	infection
were	VVD	be
evaluated	VBN	evaluate
.	SENT	.
.	SENT	.
With	IN	With
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
exception	NN	exception
of4	NN	of4
isolates	NNS	isolate
from	IN	from
a	DT	a
total	NN	total
of	IN	of
214	CD	214
tested	VBN	test
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
sodium	NN	sodium
dodecyl	NN	dodecyl
sulfate	NN	sulfate
-	HYPH	-
polyacrylamide	NN	polyacrylamide
gel	NN	gel
electrophoresis	NN	electrophoresis
silver	NN	silver
-	HYPH	-
staining	VBG	stain
profiles	NNS	profile
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
LPSs	NNS	LPS
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
two	CD	two
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
biotypes	NNS	biotype
showed	VBD	show
identical	JJ	identical
ladder	NN	ladder
patterns	NNS	pattern
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
were	VVD	be
typical	JJ	typical
for	IN	for
smooth	JJ	smooth
LPSs	NNS	LPS
from	IN	from
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
gram	NN	gram
-	HYPH	-
negative	JJ	negative
bacteria	NNS	bacteria
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
210	CD	210
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
isolates	NNS	isolate
with	IN	with
typical	JJ	typical
LPS	NN	LPS
patterns	NNS	pattern
(	(	(
119	CD	119
Ara	NP	Ara
-	HYPH	-
clinical	JJ	clinical
,	,	,
13	CD	13
Ara	NP	Ara
-	HYPH	-
soil	NN	soil
,	,	,
70	CD	70
Ara+	JJ	Ara+
soil	NN	soil
,	,	,
and	CC	and
8	CD	8
reference	NN	reference
National	NP	National
Type	NP	Type
Culture	NP	Culture
Collection	NP	Collection
strains	NNS	strain
)	)	)
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
exhibited	VBD	exhibit
similar	JJ	similar
immunoblot	NN	immunoblot
profiles	NNS	profile
against	IN	against
pooled	JJ	pooled
sera	NNS	serum
from	IN	from
patients	NNS	patient
with	IN	with
melioidosis	NN	melioidosis
and	CC	and
hyperimmune	JJ	hyperimmune
mouse	NN	mouse
sera	NNS	serum
.	SENT	.
.	SENT	.
Concordant	JJ	Concordant
findings	NNS	finding
were	VVD	be
noted	VBN	note
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
indirect	JJ	indirect
enzyme	NN	enzyme
-	HYPH	-
linked	VBN	link
immunosorbent	NN	immunosorbent
assay	NN	assay
with	IN	with
Ara	NN	Ara
-	HYPH	-
and	CC	and
Ara+	JJ	Ara+
LPSs	NNS	LPS
to	TO	to
coat	VB	coat
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
microtiter	NN	microtiter
plates	VBZ	plat
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
LPSs	NNS	LPS
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
different	JJ	different
B	NN	B
.	SENT	.
pseudomallei	NN	pseudomallei
biotypes	NNS	biotype
appear	VBP	appear
antigenically	RB	antigenically
indistinguishable	JJ	indistinguishable
.	SENT	.
.	SENT	.
It	PP	It
is	VVZ	be
,	,	,
<FORBIDDEN ID=162 ACTION=delete>
therefore	RB	therefore
</FORBIDDEN ID=162 ACTION=delete>
,	,	,
unlikely	JJ	unlikely
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
this	DT	this
component	NN	component
is	VVZ	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
related	JJ	related
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
virulence	NN	virulence
and	CC	and
pathogenicity	NN	pathogenicity
of	IN	of
B	NN	B
.	SENT	.
pseudomallei	NN	pseudomallei
.	SENT	.
.	SENT	.
BB-cat+ner-9526514/text	DOCUMENT	BB-cat+ner-9526514/text
A	DT	A
putative	JJ	putative
rolB	NN	rolB
gene	NN	gene
homologue	NN	homologue
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Agrobacterium	NP	Agrobacterium
rhizogenes	NNS	rhizogene
TR	NN	TR
-	HYPH	-
DNA	NN	DNA
has	VHZ	have
different	JJ	different
morphogenetic	JJ	morphogenetic
activity	NN	activity
in	IN	in
tobacco	NN	tobacco
than	IN	than
rolB	NN	rolB
.	SENT	.
.	SENT	.
Agrobacterium	NN	Agrobacterium
rhizogenes	NNS	rhizogene
strains	NNS	strain
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
agropine	NN	agropine
type	NN	type
harbor	VBP	harbor
on	IN	on
their	PP$	their
Ri-plasmid	JJ	Ri-plasmid
two	CD	two
T-DNAs	NNS	T-DNA
,	,	,
a	DT	a
left	JJ	left
TL	NN	TL
-	HYPH	-
DNA	NN	DNA
and	CC	and
a	DT	a
right	JJ	right
TR	NN	TR
-	HYPH	-
DNA	NN	DNA
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
rolB	NN	rolB
gene	NN	gene
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
TL	NN	TL
-	HYPH	-
DNA	NN	DNA
is	VVZ	be
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
major	JJ	major
factor	NN	factor
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
pathogenesis	NN	pathogenesis
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
hairy	JJ	hairy
-	HYPH	-
root	NN	root
disease	NN	disease
and	CC	and
its	PP$	its
constitutive	JJ	constitutive
expression	NN	expression
interfere	NN	interfere
profoundly	RB	profoundly
with	IN	with
plant	NN	plant
morphogenesis	NN	morphogenesis
.	SENT	.
.	SENT	.
We	PP	We
have	VHP	have
tested	VBN	test
whether	IN	whether
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
expression	NN	expression
of	IN	of
its	PP$	its
sequence	NN	sequence
related	JJ	related
putative	JJ	putative
homologue	NN	homologue
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
TR	NN	TR
-	HYPH	-
DNA	NN	DNA
(	(	(
rolBTR	NN	rolBTR
)	)	)
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
cause	VB	cause
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
bacterial	JJ	bacterial
virulence	NN	virulence
or	CC	or
affect	VB	affect
plant	NN	plant
development	NN	development
.	SENT	.
.	SENT	.
Unlike	IN	Unlike
rolB	NN	rolB
,	,	,
rolBTR	NN	rolBTR
is	VVZ	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
unable	JJ	unable
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
induce	VB	induce
root	NN	root
formation	NN	formation
on	IN	on
tobacco	NN	tobacco
leaf	NN	leaf
discs	NNS	disc
.	SENT	.
.	SENT	.
Tobacco	NP	Tobacco
plants	NNS	plant
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
expressing	VBG	express
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
chimeric	JJ	chimeric
35S	NN	35S
:	COLUMN	:
:	COLUMN	:
rolBTR	NN	rolBTR
gene	NN	gene
have	VHP	have
reduced	VBN	reduce
stature	NN	stature
,	,	,
off-shoots	NNS	off-shoot
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
stem	NN	stem
base	NN	base
and	CC	and
bent	NN	bent
and	CC	and
wrinkled	VBD	wrinkle
leaves	NNS	leaf
with	IN	with
epinastic	JJ	epinastic
growth	NN	growth
.	SENT	.
14	CD	14
N-terminal	JJ	N-terminal
amino	NN	amino
acids	NNS	acid
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
are	VVP	be
absent	JJ	absent
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
rolB	NN	rolB
protein	NN	protein
are	VVP	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
indispensable	JJ	indispensable
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
rolBTR	NN	rolBTR
protein	NN	protein
activity	NN	activity
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
characteristic	JJ	characteristic
tyrosine	NN	tyrosine
phosphatase	NN	phosphatase
super	NN	super
family	NN	family
motif	NN	motif
CX5R	NN	CX5R
is	VVZ	be
absent	JJ	absent
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
rolBTR	NN	rolBTR
protein	NN	protein
.	SENT	.
.	SENT	.
For	IN	For
<FORBIDDEN ID=0 ACTION=split SPLIT_AFTER=0>
rolB	NN	rolB
this	DT	this
</FORBIDDEN ID=0 ACTION=split SPLIT_AFTER=0>
motif	NN	motif
is	VVZ	be
possibly	RB	possibly
functionally	RB	functionally
relevant	JJ	relevant
.	SENT	.
.	SENT	.
We	PP	We
conclude	VBP	conclude
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
rolBTR	NN	rolBTR
gene	NN	gene
product	NN	product
has	VHZ	have
morphogenic	JJ	morphogenic
activity	NN	activity
but	CC	but
is	VVZ	be
not	RB	not
a	DT	a
functional	JJ	functional
homologue	NN	homologue
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
rolB	NN	rolB
protein	NN	protein
.	SENT	.
.	SENT	.
BB-cat+ner-9535771/text	DOCUMENT	BB-cat+ner-9535771/text
Order	NN	Order
of	IN	of
fusions	NNS	fusion
between	IN	between
bacterial	JJ	bacterial
and	CC	and
mammalian	JJ	mammalian
proteins	NNS	protein
can	MD	can
determine	VB	determine
solubility	NN	solubility
in	IN	in
Escherichia	NP	Escherichia
coli	NP	coli
.	SENT	.
.	SENT	.
We	PP	We
made	VBD	make
fusions	NNS	fusion
between	IN	between
Escherichia	FW	Escherichia
coli	FW	coli
maltose	NN	maltose
-	HYPH	-
binding	VBG	bind
protein	NN	protein
(	(	(
MBP	NN	MBP
)	)	)
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
mammalian	JJ	mammalian
aspartic	JJ	aspartic
proteinases	NNS	proteinas
pepsinogen	NN	pepsinogen
or	CC	or
procathepsin	NN	procathepsin
D	NN	D
.	SENT	.
.	SENT	.
When	WRB	When
MBP	NN	MBP
was	VVD	be
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
N-terminus	NN	N-terminus
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
fusions	NNS	fusion
were	VVD	be
soluble	JJ	soluble
in	IN	in
E	NN	E
.	SENT	.
coli	NN	coli
.	SENT	.
.	SENT	.
When	WRB	When
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
order	NN	order
was	VVD	be
reversed	VBN	reverse
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
chimeric	JJ	chimeric
proteins	NNS	protein
formed	VBD	form
inclusion	NN	inclusion
bodies	NNS	body
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
data	NNS	datum
suggest	VBP	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
solubility	NN	solubility
of	IN	of
fusion	NN	fusion
proteins	NNS	protein
is	VVZ	be
controlled	VBN	control
by	IN	by
whether	IN	whether
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
protein	NN	protein
domains	NNS	domain
emerging	VBG	emerge
first	RB	first
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
ribosome	NN	ribosome
normally	RB	normally
fold	RB	fold
into	IN	into
soluble	JJ	soluble
or	CC	or
insoluble	JJ	insoluble
states	NNS	state
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
soluble	JJ	soluble
MBP	NN	MBP
-	HYPH	-
aspartic	JJ	aspartic
proteinase	NN	proteinase
fusions	NNS	fusion
were	VVD	be
stable	JJ	stable
but	CC	but
proteolytically	RB	proteolytically
inactive	JJ	inactive
.	SENT	.
.	SENT	.
MBP	NN	MBP
-	HYPH	-
pepsinogen	NN	pepsinogen
,	,	,
however	RB	however
,	,	,
was	VVD	be
efficiently	RB	efficiently
renatured	VBN	renature
from	IN	from
8	CD	8
M	NN	M
urea	FW	urea
in vitro	FW	in_vitro
,	,	,
suggesting	VBG	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
E	NN	E
.	SENT	.
coli	NN	coli
cytoplasm	NN	cytoplasm
does	VBZ	do
not	RB	not
support	VB	support
folding	NN	folding
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
mammalian	JJ	mammalian
partner	NN	partner
protein	NN	protein
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
native	JJ	native
state	NN	state
.	SENT	.
.	SENT	.
Thus	RB	Thus
,	,	,
inclusion	NN	inclusion
body	NN	body
formation	NN	formation
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
be	VV	be
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
consequence	NN	consequence
,	,	,
rather	RB	rather
than	IN	than
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cause	NN	cause
,	,	,
of	IN	of
non-native	JJ	non-native
folding	NN	folding
in vivo	FW	in_vivo
,	,	,
and	CC	and
in	IN	in
E	NN	E
.	SENT	.
coli	JJ	coli
soluble	JJ	soluble
proteins	NNS	protein
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
fold	VB	fold
into	IN	into
states	NNS	state
different	JJ	different
from	IN	from
those	DT	those
reached	VBN	reach
in vitro	FW	in_vitro
.	SENT	.
.	SENT	.
BB-cat+ner-9553794/text	DOCUMENT	BB-cat+ner-9553794/text
Evaluation	NN	Evaluation
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
role	NN	role
of	IN	of
Carnobacterium	NN	Carnobacterium
piscicola	NN	piscicola
in	IN	in
spoilage	NN	spoilage
of	IN	of
vacuum	NN	vacuum
-	HYPH	-
and	CC	and
modified	VBN	modify
-	HYPH	-
atmosphere	NN	atmosphere
-	HYPH	-
packed	VBN	pack
cold	NN	cold
-	HYPH	-
smoked	VBN	smoke
salmon	NN	salmon
stored	VBN	store
at	IN	at
5	CD	5
degrees	NNS	degree
C	JJ	C
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
microflora	NN	microflora
on	IN	on
spoiled	VBN	spoil
cold	NN	cold
-	HYPH	-
smoked	VBN	smoke
salmon	NN	salmon
often	RB	often
consists	VBZ	consist
of	IN	of
a	DT	a
mixture	NN	mixture
of	IN	of
lactic	JJ	lactic
acid	NN	acid
bacteria	NNS	bacteria
(	(	(
LAB	NN	LAB
)	)	)
and	CC	and
Gram	NN	Gram
-	HYPH	-
negative	JJ	negative
bacteria	NNS	bacteria
.	SENT	.
.	SENT	.
To	TO	To
elucidate	VB	elucidate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
role	NN	role
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
different	JJ	different
groups	NNS	group
,	,	,
a	DT	a
storage	NN	storage
trial	NN	trial
was	VVD	be
carried	VBN	carry
out	RP	out
in	IN	in
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
nisin	NN	nisin
and	CC	and
CO2	NN	CO2
were	VVD	be
used	VBN	use
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
selective	JJ	selective
inhibition	NN	inhibition
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
two	CD	two
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
bacterial	JJ	bacterial
groups	NNS	group
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
shelf	NN	shelf
-	HYPH	-
life	NN	life
of	IN	of
vacuum	NN	vacuum
-	HYPH	-
packed	VBN	pack
cold	NN	cold
-	HYPH	-
smoked	VBN	smoke
salmon	NN	salmon
,	,	,
recorded	VBN	record
by	IN	by
sensory	JJ	sensory
evaluation	NN	evaluation
,	,	,
was	VVD	be
four	CD	four
weeks	NNS	week
at	IN	at
5	CD	5
degrees	NNS	degree
C	NN	C
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
microflora	NN	microflora
was	VVD	be
composed	VBN	compose
of	IN	of
LAB	NN	LAB
(	(	(
10(6)	CD	10(6)
-10	CD	-10
(	(	(
7	CD	7
)	)	)
cfu	NN	cfu
/	SYM	/
g	NN	g
)	)	)
with	IN	with
an	DT	an
associate	JJ	associate
Gram	NN	Gram
-	HYPH	-
negative	JJ	negative
flora	NN	flora
in	IN	in
varying	VBG	vary
levels	NNS	level
(	(	(
10(5)	CD	10(5)
-10	CD	-10
(	(	(
7	CD	7
)	)	)
cfu	NN	cfu
/	SYM	/
g	NN	g
)	)	)
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
addition	NN	addition
of	IN	of
nisin	NN	nisin
and	CC	and
/	SYM	/
or	CC	or
a	DT	a
CO2	NN	CO2
-	HYPH	-
atmosphere	NN	atmosphere
increased	VBD	increase
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
shelf	NN	shelf
-	HYPH	-
life	NN	life
to	TO	to
five	CD	five
or	CC	or
six	CD	six
weeks	NNS	week
and	CC	and
limited	VBD	limit
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
level	NN	level
of	IN	of
LAB	NN	LAB
to	TO	to
about	IN	about
10(4)	CD	10(4)
-10	CD	-10
(	(	(
6	CD	6
)	)	)
,	,	,
10(3)	CD	10(3)
-10	CD	-10
(	(	(
6	CD	6
)	)	)
and	CC	and
10(2)	CD	10(2)
-10	CD	-10
(	(	(
4	CD	4
)	)	)
cfu	NN	cfu
/	SYM	/
g	NN	g
,	,	,
respectively	RB	respectively
.	SENT	.
.	SENT	.
CO2	NN	CO2
-	HYPH	-
atmosphere	NN	atmosphere
+	SYM	+
/	SYM	/
-	HYPH	-
nisin	NN	nisin
inhibited	VBD	inhibit
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
growth	NN	growth
of	IN	of
Gram	NN	Gram
-	HYPH	-
negative	JJ	negative
bacteria	NNS	bacteria
,	,	,
whereas	IN	whereas
nisin	NN	nisin
had	VHD	have
no	DT	no
effect	NN	effect
on	IN	on
these	DT	these
in	IN	in
vacuum	NN	vacuum
packages	NNS	package
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Gram	NN	Gram
-	HYPH	-
negative	JJ	negative
flora	NN	flora
on	IN	on
vacuum	NN	vacuum
-	HYPH	-
packed	VBN	pack
salmon	NN	salmon
was	VVD	be
dominated	VBN	dominate
by	IN	by
a	DT	a
Vibrio	NP	Vibrio
sp	NN	sp
.	NN	.
,	,	,
resembling	VBG	resemble
V	NN	V
.	SENT	.
marinus	NN	marinus
,	,	,
Enterobacteriaceae	NP	Enterobacteriaceae
(	(	(
Enterobacter	NP	Enterobacter
agglomerans	NP	agglomerans
,	,	,
Serratia	NP	Serratia
liquefaciens	NP	liquefaciens
and	CC	and
Rahnella	NP	Rahnella
aquatilis	NP	aquatilis
)	)	)
and	CC	and
occasionally	RB	occasionally
Aeromonas	NP	Aeromonas
hydrophila	NN	hydrophila
.	SENT	.
.	SENT	.
Irrespective	JJ	Irrespective
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
addition	NN	addition
of	IN	of
nisin	NN	nisin
and	CC	and
/	SYM	/
or	CC	or
CO2	NN	CO2
-	HYPH	-
atmosphere	NN	atmosphere
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
LAB	NN	LAB
microflora	NN	microflora
was	VVD	be
dominated	VBN	dominate
by	IN	by
Carnobacterium	NP	Carnobacterium
piscicola	NN	piscicola
,	,	,
<FORBIDDEN ID=36 ACTION=delete>
which	WDT	which
</FORBIDDEN ID=36 ACTION=delete>
was	VVD	be
found	VBN	find
to	TO	to
account	VB	account
for	IN	for
87%	NN	87%
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
255	CD	255
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
LAB	NN	LAB
isolates	NNS	isolate
characterized	VBN	characterize
.	SENT	.
.	SENT	.
Whole	JJ	Whole
-	HYPH	-
cell	NN	cell
-	HYPH	-
protein	NN	protein
patterns	NNS	pattern
analysed	VBN	analyse
by	IN	by
SDS	NN	SDS
-	HYPH	-
PAGE	NN	PAGE
confirmed	VBD	confirm
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
Carnobacterium	NP	Carnobacterium
species	NNS	specie
identification	NN	identification
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
spoilage	NN	spoilage
potential	NN	potential
of	IN	of
C	NN	C
.	SENT	.
piscicola	NN	piscicola
isolates	NNS	isolate
was	VVD	be
<FORBIDDEN ID=79 ACTION=delete>
further	RBR	further
</FORBIDDEN ID=79 ACTION=delete>
studied	VBN	study
by	IN	by
inoculation	NN	inoculation
of	IN	of
approx	NN	approx
.	SENT	.
10(6)	CD	10(6)
cfu	NN	cfu
/	SYM	/
g	NN	g
in	IN	in
cold	NN	cold
-	HYPH	-
smoked	VBN	smoke
salmon	NN	salmon
stored	VBN	store
at	IN	at
5	CD	5
degrees	NNS	degree
C	JJ	C
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
salmon	NN	salmon
did	VBD	do
not	RB	not
spoil	VB	spoil
within	IN	within
4	CD	4
weeks	NNS	week
of	IN	of
storage	NN	storage
in	IN	in
vacuum	NN	vacuum
-	HYPH	-
or	CC	or
CO2	NN	CO2
-	HYPH	-
atmosphere	NN	atmosphere
,	,	,
and	CC	and
it	PP	it
is	VVZ	be
concluded	VBN	conclude
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
despite	IN	despite
high	JJ	high
levels	NNS	level
(	(	(
SUP	SYM	SUP
10(7)	CD	10(7)
cfu	NN	cfu
/	SYM	/
g	NN	g
)	)	)
of	IN	of
C	NN	C
.	SENT	.
piscicola	NN	piscicola
,	,	,
sensory	JJ	sensory
rejection	NN	rejection
was	VVD	be
caused	VBN	cause
by	IN	by
autolytic	JJ	autolytic
changes	NNS	change
.	SENT	.
.	SENT	.
This	DT	This
was	VVD	be
supported	VBN	support
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
development	NN	development
of	IN	of
soft	JJ	soft
texture	NN	texture
and	CC	and
sour	NN	sour
,	,	,
rancid	NN	rancid
and	CC	and
bitter	JJ	bitter
off-flavours	NNS	off-flavour
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
point	NN	point
of	IN	of
spoilage	NN	spoilage
,	,	,
irrespective	JJ	irrespective
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
length	NN	length
of	IN	of
shelf	NN	shelf
-	HYPH	-
life	NN	life
and	CC	and
low	JJ	low
or	CC	or
high	JJ	high
total	JJ	total
counts	NNS	count
of	IN	of
LAB	NN	LAB
and	CC	and
Gram	NN	Gram
-	HYPH	-
negative	JJ	negative
bacteria	NNS	bacteria
.	SENT	.
.	SENT	.
BB-cat+ner-9562874/text	DOCUMENT	BB-cat+ner-9562874/text
Enterobacteriaceae	NNS	Enterobacteriaceae
found	VBN	find
in	IN	in
high	JJ	high
numbers	NNS	number
in	IN	in
fish	NN	fish
,	,	,
minced	VBD	mince
meat	NN	meat
and	CC	and
pasteurised	VBD	pasteurise
milk	NN	milk
or	CC	or
cream	NN	cream
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
presence	NN	presence
of	IN	of
toxin	NN	toxin
encoding	VBG	encode
genes	NNS	gene
.	SENT	.
.	SENT	.
Enterobacteriaceae	NNS	Enterobacteriaceae
were	VVD	be
found	VBN	find
in	IN	in
high	JJ	high
numbers	NNS	number
after	IN	after
storage	NN	storage
at	IN	at
7	CD	7
degrees	NNS	degree
C	JJ	C
in	IN	in
6%	CD	6%
of	IN	of
consumers	NNS	consumer
packs	NNS	pack
of	IN	of
pasteurised	VBN	pasteurise
milk	NN	milk
or	CC	or
cream	NN	cream
,	,	,
in	IN	in
31%	CD	31%
of	IN	of
retailed	JJ	retailed
fish	NNS	fish
and	CC	and
in	IN	in
100%	CD	100%
of	IN	of
retail	JJ	retail
packs	NNS	pack
of	IN	of
minced	JJ	minced
meat	NN	meat
.	SENT	.
.	SENT	.
Seventy	CD	Seventy
two	CD	two
fresh	JJ	fresh
-	HYPH	-
water	NN	water
fishes	NNS	fish
,	,	,
40	CD	40
packs	NNS	pack
of	IN	of
minced	JJ	minced
meat	NN	meat
and	CC	and
430	CD	430
milk	NN	milk
packs	NNS	pack
were	VVD	be
sampled	VBN	sample
.	SENT	.
.	SENT	.
One	CD	One
hundred	CD	hundred
and	CC	and
eighty	CD	eighty
four	CD	four
isolates	NNS	isolate
were	VVD	be
randomly	RB	randomly
picked	VBN	pick
from	IN	from
Tryptone	NN	Tryptone
glucose	NN	glucose
extract	NN	extract
(	(	(
TGE	NN	TGE
)	)	)
agar	NN	agar
(	(	(
30	CD	30
degrees	NNS	degree
C	JJ	C
for	IN	for
3d	NN	3d
)	)	)
or	CC	or
Violet	VB	Violet
red	JJ	red
bile	NN	bile
glucose	NN	glucose
(	(	(
VRBG	NN	VRBG
)	)	)
agar	NN	agar
(	(	(
37	CD	37
degrees	NNS	degree
C	JJ	C
for	IN	for
1d	NN	1d
)	)	)
.	SENT	.
.	SENT	.
In	IN	In
minced	JJ	minced
meat	NN	meat
,	,	,
Serratia	NP	Serratia
liquefaciens	VBZ	liquefacien
,	,	,
Hafnia	NP	Hafnia
alvei	NP	alvei
,	,	,
Rahnella	NP	Rahnella
aquatilis	NPS	aquatili
were	VVD	be
frequently	RB	frequently
encountered	VBN	encounter
.	SENT	.
.	SENT	.
On	IN	On
fish	NNS	fish
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
most	RBS	most
frequently	RB	frequently
found	VBN	find
species	NNS	specie
were	VVD	be
R	NN	R
.	SENT	.
aquatilis	NN	aquatilis
,	,	,
and	CC	and
in	IN	in
milk	NN	milk
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
dominating	VBG	dominate
species	NNS	specie
were	VVD	be
S	NN	S
.	SENT	.
liquefaciens	NNS	liquefacien
,	,	,
H	NN	H
.	VBD	.
alvei	NN	alvei
and	CC	and
R	NN	R
.	SENT	.
aquatilis	NN	aquatilis
.	SENT	.
.	SENT	.
One	CD	One
to	TO	to
three	CD	three
isolates	NNS	isolate
of	IN	of
Citrobacter	NP	Citrobacter
freundii	NNS	freundii
were	VVD	be
found	VBN	find
in	IN	in
<FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
all	DT	all
three	CD	three
</FORBIDDEN ID=13 ACTION=split SPLIT_AFTER=0>
food	NN	food
categories	NNS	category
.	SENT	.
.	SENT	.
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
Using	VBG	Use
a	DT	a
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
polymerase	NN	polymerase
chain	NN	chain
reaction	NN	reaction
(	(	(
PCR	NN	PCR
)	)	)
technique	NN	technique
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
gene	NN	gene
of	IN	of
Escherichia	FW	Escherichia
coli	FW	coli
heat	NN	heat
-	HYPH	-
labile	JJ	labile
toxin	NN	toxin
(	(	(
lt	NN	lt
)	)	)
was	VVD	be
indicated	VBN	indicate
in	IN	in
one	CD	one
fish	NN	fish
isolate	NN	isolate
of	IN	of
R	NN	R
.	SENT	.
aquatilis	NN	aquatilis
whereas	IN	whereas
heat	NN	heat
-	HYPH	-
stable	JJ	stable
toxin	NN	toxin
genes	NNS	gene
(	(	(
s	NNS	s
.	SENT	.
t	NN	t
.	SENT	.
)	)	)
were	VVD	be
indicated	VBN	indicate
in	IN	in
four	CD	four
H	NN	H
.	VBD	.
alvei	NN	alvei
isolates	NNS	isolate
,	,	,
two	CD	two
originating	VBG	originate
from	IN	from
fish	NNS	fish
and	CC	and
two	CD	two
from	IN	from
minced	JJ	minced
meat	NN	meat
.	SENT	.
.	SENT	.
Positive	JJ	Positive
PCR	NN	PCR
-	HYPH	-
reaction	NN	reaction
for	IN	for
vero	NN	vero
cytotoxin	NN	cytotoxin
genes	NNS	gene
were	VVD	be
found	VBN	find
in	IN	in
one	CD	one
H	NN	H
.	SYM	.
alvei	NN	alvei
strain	NN	strain
originating	VBG	originate
from	IN	from
fish	NN	fish
(	(	(
vt1	NN	vt1
)	)	)
,	,	,
in	IN	in
two	CD	two
S	NN	S
.	SENT	.
liquefaciens	VBZ	liquefacien
strains	NNS	strain
from	IN	from
minced	VBN	mince
meat	NN	meat
(	(	(
vt2	NN	vt2
)	)	)
,	,	,
and	CC	and
in	IN	in
a	DT	a
C	NN	C
.	SENT	.
freundii	NN	freundii
reference	NN	reference
strain	NN	strain
.	SENT	.
.	SENT	.
<FORBIDDEN ID=55 ACTION=delete>
<FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
One	CD	One
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=55 ACTION=delete>
the	DT	the
</FORBIDDEN ID=10 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
st-positive	JJ	st-positive
H	NN	H
.	VBD	.
alvei	NN	alvei
strains	NNS	strain
from	IN	from
meat	NN	meat
harboured	VBD	harbour
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
eaeA	NN	eaeA
gene	NN	gene
involved	VBN	involve
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
attaching	VBG	attach
phenotype	NN	phenotype
of	IN	of
enteropathogenic	JJ	enteropathogenic
E	NN	E
.	SENT	.
coli	NN	coli
.	SENT	.
.	SENT	.
BB-cat+ner-9564489/text	DOCUMENT	BB-cat+ner-9564489/text
Gingivomandibular	JJ	Gingivomandibular
infection	NN	infection
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
due	JJ	due
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
Mycobacterium	NN	Mycobacterium
kansasii	NN	kansasii
in	IN	in
a	DT	a
patient	NN	patient
with	IN	with
AIDS	NP	AIDS
.	SENT	.
.	SENT	.
BB-cat+ner-9575437/text	DOCUMENT	BB-cat+ner-9575437/text
[	(	[
Comparative	JJ	Comparative
studies	NNS	study
on	IN	on
activities	NNS	activity
of	IN	of
antimicrobial	JJ	antimicrobial
agents	NNS	agent
against	IN	against
causative	JJ	causative
organisms	NNS	organism
isolated	VBN	isolate
from	IN	from
patients	NNS	patient
with	IN	with
urinary	JJ	urinary
tract	NN	tract
infections	NNS	infection
(	(	(
1996	CD	1996
)	)	)
.	SENT	.
.	SENT	.
I	PP	I
.	SENT	.
.	SENT	.
Susceptibility	NN	Susceptibility
distribution	NN	distribution
]	)	]
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
frequencies	NNS	frequency
of	IN	of
isolation	NN	isolation
and	CC	and
susceptibilities	NNS	susceptibility
to	TO	to
antimicrobial	JJ	antimicrobial
agents	NNS	agent
were	VVD	be
investigated	VBN	investigate
on	IN	on
680	CD	680
bacterial	JJ	bacterial
strains	NNS	strain
isolated	VBN	isolate
from	IN	from
patients	NNS	patient
with	IN	with
urinary	JJ	urinary
tract	NN	tract
infections	NNS	infection
(	(	(
UTIs	NNS	UTI
)	)	)
in	IN	in
10	CD	10
hospitals	NNS	hospital
during	IN	during
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
period	NN	period
of	IN	of
<FORBIDDEN ID=124 ACTION=delete>
June	NP	June
</FORBIDDEN ID=124 ACTION=delete>
1996	CD	1996
to	TO	to
<FORBIDDEN ID=123 ACTION=delete>
May	VB	May
</FORBIDDEN ID=123 ACTION=delete>
1997	CD	1997
.	SENT	.
.	SENT	.
Of	IN	Of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
above	JJ	above
bacterial	JJ	bacterial
isolates	NNS	isolate
,	,	,
Gram	NN	Gram
-	HYPH	-
positive	JJ	positive
bacteria	NNS	bacteria
accounted	VBD	account
for	IN	for
30.4	CD	30.4
%	NN	%
and	CC	and
a	DT	a
majority	NN	majority
of	IN	of
them	PP	them
were	VVD	be
Enterococcus	NP	Enterococcus
faecalis	NP	faecalis
.	SENT	.
.	SENT	.
Gram	NN	Gram
-	HYPH	-
negative	JJ	negative
bacteria	NNS	bacteria
accounted	VBD	account
for	IN	for
69.6	CD	69.6
%	NN	%
and	CC	and
most	JJS	most
of	IN	of
them	PP	them
were	VVD	be
Escherichia	NP	Escherichia
coli	NP	coli
.	SENT	.
.	SENT	.
Susceptabilities	NNS	Susceptability
of	IN	of
several	JJ	several
isolated	VBN	isolate
bacteria	NNS	bacteria
to	TO	to
antimicrobial	JJ	antimicrobial
agents	NNS	agent
were	VVD	be
as	RB	as
followed	VBN	follow
;	COLUMN	;
1	CD	1
.	SENT	.
.	SENT	.
Enterococcus	NP	Enterococcus
faecalis	NP	faecalis
Ampicillin	NP	Ampicillin
(	(	(
ABPC	NN	ABPC
)	)	)
showed	VBD	show
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
highest	JJS	high
activity	NN	activity
against	IN	against
E	NN	E
.	SENT	.
faecalis	NN	faecalis
isolated	VBN	isolate
from	IN	from
patients	NNS	patient
with	IN	with
UTIs	NNS	UTI
.	SENT	.
.	SENT	.
Its	PP$	Its
MIC90	NN	MIC90
was	VVD	be
1	CD	1
microgram	NN	microgram
/	SYM	/
ml	NN	ml
.	SENT	.
.	SENT	.
Imipenem	NN	Imipenem
(	(	(
IPM	NN	IPM
)	)	)
and	CC	and
vancomycin	NN	vancomycin
(	(	(
VCM	NN	VCM
)	)	)
were	VVD	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
active	JJ	active
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MIC90S	NN	MIC90S
of	IN	of
2	CD	2
micrograms	NNS	microgram
/	SYM	/
ml	NN	ml
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
<FORBIDDEN ID=22 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
others	NNS	other
</FORBIDDEN ID=22 ACTION=delete>
had	VHD	have
low	JJ	low
activities	NNS	activity
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MIC90S	NN	MIC90S
of	IN	of
16	CD	16
micrograms	NNS	microgram
/	SYM	/
ml	NN	ml
or	CC	or
above	RB	above
.	SENT	.
2	CD	2
.	SENT	.
.	SENT	.
Staphylococcus	FW	Staphylococcus
aureus	FW	aureus
including	VBG	include
MRSA	NN	MRSA
Arbekacin	NN	Arbekacin
(	(	(
ABK	NN	ABK
)	)	)
and	CC	and
VCM	NN	VCM
showed	VBD	show
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
highest	JJS	high
activities	NNS	activity
against	IN	against
<FORBIDDEN ID=30 ACTION=delete>
both	DT	both
</FORBIDDEN ID=30 ACTION=delete>
S	NN	S
.	SENT	.
aureus	NN	aureus
and	CC	and
MRSA	NN	MRSA
isolated	VBN	isolate
from	IN	from
patients	NNS	patient
with	IN	with
UTIs	NNS	UTI
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MIC90S	NN	MIC90S
of	IN	of
them	PP	them
were	VVD	be
1	CD	1
or	CC	or
2	CD	2
micrograms	NNS	microgram
/	SYM	/
ml	NN	ml
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
<FORBIDDEN ID=22 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
others	NNS	other
</FORBIDDEN ID=22 ACTION=delete>
except	IN	except
minocycline	NN	minocycline
(	(	(
MINO	NN	MINO
)	)	)
had	VHD	have
low	JJ	low
activities	NNS	activity
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MIC90S	NN	MIC90S
of	IN	of
32	CD	32
micrograms	NNS	microgram
/	SYM	/
ml	NN	ml
or	CC	or
above	RB	above
.	SENT	.
3	CD	3
.	SENT	.
.	SENT	.
Staphylococcus	NN	Staphylococcus
epidermidis	NN	epidermidis
ABK	NN	ABK
and	CC	and
VCM	NN	VCM
showed	VBD	show
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
strongest	JJS	strong
activities	NNS	activity
against	IN	against
S	NN	S
.	SENT	.
epidermis	NN	epidermis
isolated	VBN	isolate
from	IN	from
patients	NNS	patient
with	IN	with
UTIs	NNS	UTI
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MICs	NNS	MIC
for	IN	for
all	DT	all
strains	NNS	strain
were	VVD	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
equal	JJ	equal
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
or	CC	or
lower	JJR	low
than	IN	than
2	CD	2
micrograms	NNS	microgram
/	SYM	/
ml	NN	ml
.	SENT	.
.	SENT	.
Cefazolin	NN	Cefazolin
(	(	(
CEZ	NN	CEZ
)	)	)
,	,	,
cefotiam	NN	cefotiam
(	(	(
CTM	NN	CTM
)	)	)
and	CC	and
cefozopran	NN	cefozopran
(	(	(
CZOP	NN	CZOP
)	)	)
were	VVD	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
active	JJ	active
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MIC90S	NN	MIC90S
of	IN	of
4	CD	4
micrograms	NNS	microgram
/	SYM	/
ml	NN	ml
.	SENT	.
.	SENT	.
Compared	VBN	Compare
with	IN	with
antimicrobial	JJ	antimicrobial
activities	NNS	activity
of	IN	of
cephems	NNS	cephem
is	VVZ	be
1995	CD	1995
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MIC90S	NN	MIC90S
of	IN	of
them	PP	them
had	VHD	have
changed	VBN	change
into	IN	into
a	DT	a
better	JJR	good
state	NN	state
.	SENT	.
.	SENT	.
They	PP	They
ranged	VBD	range
from	IN	from
4	CD	4
micrograms	NNS	microgram
/	SYM	/
ml	NN	ml
16	CD	16
micrograms	NNS	microgram
/	SYM	/
ml	NN	ml
in	IN	in
1996	CD	1996
.	SENT	.
4	CD	4
.	SENT	.
.	SENT	.
Streptococcus	NP	Streptococcus
<FORBIDDEN ID=2 ACTION=split SPLIT_AFTER=0>
agalactiae	NP	agalactiae
All	DT	All
</FORBIDDEN ID=2 ACTION=split SPLIT_AFTER=0>
drugs	NNS	drug
except	IN	except
MINO	NN	MINO
were	VVD	be
active	JJ	active
against	IN	against
S	NN	S
.	SENT	.
agalactiae	FW	agalactiae
.	SENT	.
.	SENT	.
ABPC	NN	ABPC
,	,	,
CZOP	NN	CZOP
,	,	,
IPM	NN	IPM
,	,	,
and	CC	and
clarithromycin	NN	clarithromycin
(	(	(
CAM	NN	CAM
)	)	)
showed	VBD	show
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
highest	JJS	high
activities	NNS	activity
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MICs	NNS	MIC
for	IN	for
all	DT	all
strains	NNS	strain
were	VVD	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
equal	JJ	equal
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
or	CC	or
lower	JJR	low
than	IN	than
0.125	CD	0.125
micromilligrams	NNS	micromilligram
.	SENT	.
.	SENT	.
Tosufloxacin	NN	Tosufloxacin
(	(	(
TFLX	NN	TFLX
)	)	)
and	CC	and
VCM	NN	VCM
were	VVD	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
active	JJ	active
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MIC90S	NN	MIC90S
of	IN	of
0.5	CD	0.5
micromilligrams	NNS	micromilligram
.	SENT	.
5	CD	5
.	SENT	.
.	SENT	.
Citrobacter	NN	Citrobacter
freundii	NN	freundii
Gentamicin	NN	Gentamicin
(	(	(
GM	NN	GM
)	)	)
showed	VBD	show
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
highest	JJS	high
activity	NN	activity
against	IN	against
C	NN	C
.	SENT	.
freundii	NN	freundii
isolated	VBN	isolate
from	IN	from
patients	NNS	patient
with	IN	with
UTIs	NNS	UTI
.	SENT	.
.	SENT	.
Its	PP$	Its
MIC90	NN	MIC90
was	VVD	be
0.5	CD	0.5
micrograms	NNS	microgram
/	SYM	/
ml	NN	ml
.	SENT	.
.	SENT	.
IPM	NN	IPM
and	CC	and
amikacin	NN	amikacin
(	(	(
AMK	NN	AMK
)	)	)
were	VVD	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
active	JJ	active
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MIC90S	NN	MIC90S
of	IN	of
1	CD	1
microgram	NN	microgram
/	SYM	/
ml	NN	ml
and	CC	and
2	CD	2
micrograms	NNS	microgram
/	SYM	/
ml	NN	ml
,	,	,
respectively	RB	respectively
.	SENT	.
.	SENT	.
Cefpirome	NN	Cefpirome
(	(	(
CPR	NN	CPR
)	)	)
and	CC	and
CZOP	NN	CZOP
were	VVD	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
active	JJ	active
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MIC90S	NN	MIC90S
of	IN	of
8	CD	8
micrograms	NNS	microgram
/	SYM	/
ml	NN	ml
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MIC90S	NN	MIC90S
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
<FORBIDDEN ID=22 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
others	NNS	other
</FORBIDDEN ID=22 ACTION=delete>
were	VVD	be
16	CD	16
micrograms	NNS	microgram
/	SYM	/
ml	NN	ml
or	CC	or
above	RB	above
.	SENT	.
6	CD	6
.	SENT	.
.	SENT	.
Enterobacter	NN	Enterobacter
cloacae	NNS	cloaca
IPM	NN	IPM
showed	VBD	show
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
highest	JJS	high
activity	NN	activity
against	IN	against
E	NN	E
.	SENT	.
cloacae	NN	cloacae
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MICs	NNS	MIC
for	IN	for
all	DT	all
strains	NNS	strain
were	VVD	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
equal	JJ	equal
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
or	CC	or
lower	JJR	low
than	IN	than
0.5	CD	0.5
microgram	NN	microgram
/	SYM	/
ml	NN	ml
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MIC90S	NN	MIC90S
of	IN	of
ciprofloxacin	NN	ciprofloxacin
(	(	(
CPFX	NN	CPFX
)	)	)
and	CC	and
TFLX	NN	TFLX
were	VVD	be
1	CD	1
microgram	NN	microgram
/	SYM	/
ml	NN	ml
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MIC90	NN	MIC90
of	IN	of
AMK	NN	AMK
was	VVD	be
2	CD	2
micrograms	NNS	microgram
/	SYM	/
ml	NN	ml
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MIC90S	NN	MIC90S
of	IN	of
CZOP	NP	CZOP
,	,	,
GM	NP	GM
and	CC	and
ofloxacin	NN	ofloxacin
(	(	(
OFLX	NN	OFLX
)	)	)
were	VVD	be
4	CD	4
micrograms	NNS	microgram
/	SYM	/
ml	NN	ml
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MIC50S	NN	MIC50S
of	IN	of
cephems	NNS	cephem
except	IN	except
CEZ	NN	CEZ
,	,	,
cefmetazole	NN	cefmetazole
(	(	(
CMZ	NN	CMZ
)	)	)
and	CC	and
cefaclor	NN	cefaclor
(	(	(
CCL	NN	CCL
)	)	)
had	VHD	have
changed	VBN	change
into	IN	into
a	DT	a
better	JJR	good
state	NN	state
in	IN	in
1996	CD	1996
,	,	,
compared	VBN	compare
with	IN	with
those	DT	those
in	IN	in
1995	CD	1995
.	SENT	.
7	CD	7
.	SENT	.
.	SENT	.
Escherichia	FW	Escherichia
coli	FW	coli
All	DT	All
drugs	NNS	drug
except	IN	except
penicillins	NNS	penicillin
and	CC	and
MINO	NN	MINO
were	VVD	be
active	JJ	active
against	IN	against
E	NN	E
.	SENT	.
coli	NN	coli
.	SENT	.
.	SENT	.
Particularly	RB	Particularly
CPR	NN	CPR
,	,	,
CZOP	NN	CZOP
and	CC	and
IPM	NN	IPM
showed	VBD	show
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
highest	JJS	high
activities	NNS	activity
against	IN	against
E	NN	E
.	SENT	.
coli	NN	coli
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MIC90S	NN	MIC90S
of	IN	of
them	PP	them
were	VVD	be
0.125	CD	0.125
microgram	NN	microgram
/	SYM	/
ml	NN	ml
or	CC	or
below	IN	below
.	SENT	.
.	SENT	.
Among	IN	Among
E	NN	E
.	SENT	.
coli	NN	coli
strains	NNS	strain
,	,	,
those	DT	those
with	IN	with
low	JJ	low
susceptibilities	NNS	susceptibility
to	TO	to
cephems	NNS	cephem
except	IN	except
CEZ	NN	CEZ
,	,	,
cefoperazone	NN	cefoperazone
(	(	(
CPZ	NN	CPZ
)	)	)
,	,	,
latamoxef	NN	latamoxef
(	(	(
LMOX	NN	LMOX
)	)	)
and	CC	and
CCL	NN	CCL
have	VHP	have
increased	VBN	increase
in	IN	in
1996	CD	1996
,	,	,
compared	VBN	compare
with	IN	with
those	DT	those
in	IN	in
1995	CD	1995
.	SENT	.
8	CD	8
.	SENT	.
.	SENT	.
Klebsiella	NP	Klebsiella
pneumoniae	FW	pneumoniae
K	NP	K
.	SENT	.
pneumoniae	''	pneumoniae
was	VVD	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
susceptible	JJ	susceptible
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
all	DT	all
drugs	NNS	drug
except	IN	except
penicillins	NNS	penicillin
,	,	,
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MIC90S	NN	MIC90S
of	IN	of
2	CD	2
micrograms	NNS	microgram
/	SYM	/
ml	NN	ml
or	CC	or
below	IN	below
.	SENT	.
.	SENT	.
CPR	NN	CPR
had	VHD	have
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
strongest	JJS	strong
activity	NN	activity
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MICs	NNS	MIC
for	IN	for
all	DT	all
strains	NNS	strain
were	VVD	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
equal	JJ	equal
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
or	CC	or
lower	JJR	low
than	IN	than
0.25	CD	0.25
microgram	NN	microgram
/	SYM	/
ml	NN	ml
.	SENT	.
.	SENT	.
Flomoxef	NN	Flomoxef
(	(	(
FMOX	NN	FMOX
)	)	)
,	,	,
cefixime	NN	cefixime
(	(	(
CFIX	NN	CFIX
)	)	)
,	,	,
CZOP	NN	CZOP
and	CC	and
carumonam	NN	carumonam
(	(	(
CRMN	NN	CRMN
)	)	)
were	VVD	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
active	JJ	active
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MIC90S	NN	MIC90S
of	IN	of
0.125	CD	0.125
microgram	NN	microgram
/	SYM	/
ml	NN	ml
or	CC	or
below	IN	below
.	SENT	.
9	CD	9
.	SENT	.
.	SENT	.
Pseudomonas	NP	Pseudomonas
aeruginosa	IN	aeruginosa
All	DT	All
drugs	NNS	drug
except	IN	except
quinolones	NNS	quinolone
were	VVD	be
not	RB	not
so	RB	so
active	JJ	active
against	IN	against
P	NN	P
.	SENT	.
aeruginosa	NN	aeruginosa
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MIC90S	NN	MIC90S
were	VVD	be
32	CD	32
micrograms	NNS	microgram
/	SYM	/
ml	NN	ml
or	CC	or
above	RB	above
.	SENT	.
.	SENT	.
Quinolones	NNS	Quinolone
were	VVD	be
<FORBIDDEN ID=82 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
active	JJ	active
in	IN	in
1996	CD	1996
than	IN	than
1995	CD	1995
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MIC90S	NN	MIC90S
of	IN	of
them	PP	them
were	VVD	be
between	IN	between
4	CD	4
micrograms	NNS	microgram
/	SYM	/
ml	NN	ml
and	CC	and
8	CD	8
micrograms	NNS	microgram
/	SYM	/
ml	NN	ml
,	,	,
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
MIC50S	NN	MIC50S
of	IN	of
them	PP	them
were	VVD	be
between	IN	between
1	CD	1
microgram	NN	microgram
/	SYM	/
ml	NN	ml
and	CC	and
2	CD	2
micrograms	NNS	microgram
/	SYM	/
ml	NN	ml
.	SENT	.
10	CD	10
.	SENT	.
.	SENT	.
Serratia	NP	Serratia
marcescens	VBZ	marcescen
GM	NP	GM
showed	VBD	show
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
highest	JJS	high
activity	NN	activity
against	IN	against
S	NN	S
.	SENT	.
marcescens	NNS	marcescen
.	SENT	.
.	SENT	.
Its	PP$	Its
MIC90	NN	MIC90
was	VVD	be
1	CD	1
micro	NN	micro
.	SENT	.
BB-cat+ner-9643457/text	DOCUMENT	BB-cat+ner-9643457/text
Flow	NN	Flow
cytometric	JJ	cytometric
measurement	NN	measurement
of	IN	of
neutrophil	NN	neutrophil
alkaline	NN	alkaline
phosphatase	NN	phosphatase
before	IN	before
and	CC	and
during	IN	during
initiation	NN	initiation
of	IN	of
an	DT	an
induced	VBN	induce
Escherichia	FW	Escherichia
coli	FW	coli
mastitis	NN	mastitis
in	IN	in
cattle	NNS	cattle
.	SENT	.
.	SENT	.
In	IN	In
12	CD	12
healthy	JJ	healthy
cows	NNS	cow
,	,	,
neutrophil	NN	neutrophil
alkaline	NN	alkaline
phosphatase	NN	phosphatase
(	(	(
NAP	NN	NAP
)	)	)
activity	NN	activity
was	VVD	be
measured	VBN	measure
by	IN	by
flow	NN	flow
cytometer	NN	cytometer
before	IN	before
and	CC	and
during	IN	during
an	DT	an
experimentally	RB	experimentally
induced	VBN	induce
Escherichia	FW	Escherichia
coli	FW	coli
mastitis	NN	mastitis
,	,	,
to	TO	to
study	VB	study
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
role	NN	role
and	CC	and
increase	NN	increase
of	IN	of
NAP	NN	NAP
in	IN	in
Gram	NN	Gram
-	HYPH	-
negative	JJ	negative
bacterial	JJ	bacterial
infections	NNS	infection
.	SENT	.
.	SENT	.
Percentage	NN	Percentage
of	IN	of
neutrophils	NNS	neutrophil
containing	VBG	contain
alkaline	NN	alkaline
phosphatase	NN	phosphatase
and	CC	and
intensity	NN	intensity
of	IN	of
NAP	NN	NAP
activity	NN	activity
were	VVD	be
measured	VBN	measure
.	SENT	.
.	SENT	.
Preinfection	NN	Preinfection
percentage	NN	percentage
of	IN	of
neutrophils	NNS	neutrophil
with	IN	with
enzyme	NN	enzyme
activity	NN	activity
varied	VBD	vary
between	IN	between
64.0	CD	64.0
%	NN	%
and	CC	and
84.4	CD	84.4
%	NN	%
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
intensity	NN	intensity
of	IN	of
enzyme	NN	enzyme
activity	NN	activity
was	VVD	be
low	JJ	low
in	IN	in
all	DT	all
cows	NNS	cow
.	SENT	.
.	SENT	.
After	IN	After
induction	NN	induction
of	IN	of
infection	NN	infection
,	,	,
percentage	NN	percentage
of	IN	of
neutrophils	NNS	neutrophil
with	IN	with
enzyme	NN	enzyme
activity	NN	activity
showed	VBD	show
a	DT	a
significant	JJ	significant
decrease	NN	decrease
on	IN	on
day	NN	day
1	CD	1
followed	VBN	follow
by	IN	by
an	DT	an
significant	JJ	significant
increase	NN	increase
on	IN	on
day	NN	day
3	CD	3
.	SENT	.
.	SENT	.
NAP	NN	NAP
intensity	NN	intensity
increased	VBD	increase
significantly	RB	significantly
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
second	JJ	second
and	CC	and
third	JJ	third
day	NN	day
after	IN	after
infection	NN	infection
.	SENT	.
.	SENT	.
This	DT	This
increase	NN	increase
of	IN	of
intensity	NN	intensity
was	VVD	be
significantly	RB	significantly
,	,	,
positively	RB	positively
correlated	VBN	correlate
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
severity	NN	severity
of	IN	of
infection	NN	infection
.	SENT	.
.	SENT	.
From	IN	From
this	DT	this
study	NN	study
we	PP	we
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
conclude	VB	conclude
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
variation	NN	variation
<FORBIDDEN ID=27 ACTION=delete>
<FORBIDDEN ID=26 ACTION=delete>
in	IN	in
susceptibility	NN	susceptibility
to	TO	to
</FORBIDDEN ID=26 ACTION=delete>
</FORBIDDEN ID=27 ACTION=delete>
E	NN	E
.	SENT	.
coli	NN	coli
mastitis	NN	mastitis
could	MD	could
not	RB	not
be	VV	be
explained	VBN	explain
by	IN	by
preinfection	NN	preinfection
NAP	NN	NAP
levels	NNS	level
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
post	AFX	post
-	HYPH	-
infection	NN	infection
increase	NN	increase
of	IN	of
NAP	NN	NAP
activity	NN	activity
,	,	,
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	WDT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
was	VVD	be
found	VBN	find
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
following	VBG	follow
an	DT	an
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
induced	VBN	induce
infection	NN	infection
was	VVD	be
<FORBIDDEN ID=82 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
a	DT	a
result	NN	result
of	IN	of
increased	VBN	increase
enzyme	NN	enzyme
intensity	NN	intensity
per	IN	per
neutrophil	NN	neutrophil
,	,	,
then	RB	then
from	IN	from
an	DT	an
increase	NN	increase
of	IN	of
percentage	NN	percentage
neutrophils	NNS	neutrophil
with	IN	with
enzyme	NN	enzyme
activity	NN	activity
.	SENT	.
.	SENT	.
Furthermore	RB	Furthermore
,	,	,
a	DT	a
strong	JJ	strong
correlation	NN	correlation
was	VVD	be
found	VBN	find
between	IN	between
NAP	NN	NAP
intensity	NN	intensity
and	CC	and
severity	NN	severity
of	IN	of
inflammation	NN	inflammation
.	SENT	.
.	SENT	.
There	EX	There
was	VVD	be
evidence	NN	evidence
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
<FORBIDDEN ID=82 ACTION=delete>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
more	RBR	more
</FORBIDDEN ID=82 ACTION=delete>
severely	RB	severely
diseased	VBN	disease
animals	NNS	animal
showed	VBD	show
stronger	JJR	strong
NAP	NN	NAP
intensity	NN	intensity
increase	NN	increase
.	SENT	.
.	SENT	.
BB-cat+ner-9666962/text	DOCUMENT	BB-cat+ner-9666962/text
Effect	NN	Effect
of	IN	of
cytokine	NN	cytokine
modulation	NN	modulation
by	IN	by
thalidomide	NN	thalidomide
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
granulomatous	JJ	granulomatous
response	NN	response
in	IN	in
murine	JJ	murine
tuberculosis	NN	tuberculosis
.	SENT	.
.	SENT	.
Experimental	JJ	Experimental
murine	JJ	murine
tuberculosis	NN	tuberculosis
.	SENT	.
.	SENT	.
To	TO	To
evaluate	VB	evaluate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
effect	NN	effect
of	IN	of
cytokine	NN	cytokine
modulation	NN	modulation
by	IN	by
thalidomide	NN	thalidomide
on	IN	on
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
progression	NN	progression
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
lung	NN	lung
granulomatous	JJ	granulomatous
response	NN	response
following	VBG	follow
aerosol	NN	aerosol
tuberculosis	NN	tuberculosis
infection	NN	infection
in	IN	in
mice	NNS	mouse
.	SENT	.
.	SENT	.
Mice	NNS	Mouse
infected	VBN	infect
by	IN	by
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
respiratory	JJ	respiratory
route	NN	route
with	IN	with
200-500	CD	200-500
viable	JJ	viable
Mycobacterium	NN	Mycobacterium
tuberculosis	NN	tuberculosis
Erdman	NN	Erdman
were	VVD	be
treated	VBN	treat
with	IN	with
daily	JJ	daily
subcutaneous	JJ	subcutaneous
injections	NNS	injection
of	IN	of
thalidomide	NN	thalidomide
(	(	(
30	CD	30
mg	NN	mg
/	SYM	/
kg	NN	kg
)	)	)
or	CC	or
saline	NN	saline
for	IN	for
4	CD	4
weeks	NNS	week
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bacillary	JJ	bacillary
load	NN	load
,	,	,
granulomatous	JJ	granulomatous
response	NN	response
and	CC	and
cytokine	NN	cytokine
production	NN	production
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
lungs	NNS	lung
were	VVD	be
evaluated	VBN	evaluate
.	SENT	.
.	SENT	.
Aerosol	NP	Aerosol
M	NP	M
.	SENT	.
tuberculosis	NN	tuberculosis
infection	NN	infection
resulted	VBD	result
in	IN	in
a	DT	a
progressive	JJ	progressive
granulomatous	JJ	granulomatous
response	NN	response
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
lungs	NNS	lung
.	SENT	.
.	SENT	.
At	IN	At
28	CD	28
days	NNS	day
after	IN	after
infection	NN	infection
,	,	,
large	JJ	large
granulomata	NNS	granuloma
with	IN	with
central	JJ	central
necrosis	NN	necrosis
and	CC	and
no	DT	no
apoptosis	NN	apoptosis
were	VVD	be
observed	VBN	observe
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
infection	NN	infection
induced	VBD	induce
high	JJ	high
serum	NN	serum
and	CC	and
lung	NN	lung
cytokine	NN	cytokine
mRNA	NN	mRNA
levels	NNS	level
.	SENT	.
.	SENT	.
Thalidomide	NN	Thalidomide
treatment	NN	treatment
resulted	VBD	result
in	IN	in
a	DT	a
significant	JJ	significant
reduction	NN	reduction
in	IN	in
tumor	NN	tumor
necrosis	NN	necrosis
factor	NN	factor
-	HYPH	-
alpha	SYM	alpha
,	,	,
interleukin	NN	interleukin
6	CD	6
(	(	(
IL	NN	IL
-6	CD	-6
)	)	)
and	CC	and
IL	NN	IL
-10	CD	-10
protein	NN	protein
levels	NNS	level
(	(	(
blood	NN	blood
)	)	)
and	CC	and
mRNA	NN	mRNA
expression	NN	expression
(	(	(
lungs	NNS	lung
)	)	)
.	SENT	.
.	SENT	.
IL	NN	IL
-12	CD	-12
and	CC	and
interferon	NN	interferon
-	HYPH	-
gamma	SYM	gamma
were	VVD	be
unaffected	JJ	unaffected
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
lungs	NNS	lung
of	IN	of
thalidomide	NN	thalidomide
-	HYPH	-
treated	VBN	treat
mice	NNS	mouse
had	VHD	have
smaller	JJR	small
granulomata	NNS	granuloma
with	IN	with
apoptotic	JJ	apoptotic
cells	NNS	cell
and	CC	and
no	DT	no
necrosis	NN	necrosis
.	SENT	.
.	SENT	.
Thalidomide	NN	Thalidomide
treatment	NN	treatment
did	VBD	do
not	RB	not
change	VB	change
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bacillary	JJ	bacillary
load	NN	load
.	SENT	.
.	SENT	.
Thalidomide	NN	Thalidomide
immunomodulation	NN	immunomodulation
reduces	VBZ	reduce
inflammatory	JJ	inflammatory
cytokines	NNS	cytokine
and	CC	and
concomitant	JJ	concomitant
lung	NN	lung
pathology	NN	pathology
following	VBG	follow
acute	JJ	acute
aerosol	NN	aerosol
M	NN	M
.	SENT	.
tuberculosis	NN	tuberculosis
infection	NN	infection
,	,	,
without	IN	without
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
increasing	VBG	increase
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
bacillary	JJ	bacillary
load	NN	load
.	SENT	.
.	SENT	.
BB-cat+ner-9693738/text	DOCUMENT	BB-cat+ner-9693738/text
Maintenance	NN	Maintenance
energy	NN	energy
requirement	NN	requirement
:	COLUMN	:
what	WP	what
is	VVZ	be
required	VBN	require
for	IN	for
stasis	NN	stasis
survival	NN	survival
of	IN	of
Escherichia	FW	Escherichia
coli	FW	coli
?	SENT	?
.	SENT	.
Little	JJ	Little
is	VVZ	be
known	VBN	know
about	IN	about
how	WRB	how
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
energy	NN	energy
of	IN	of
maintenance	NN	maintenance
is	VVZ	be
generated	VBN	generate
in	IN	in
a	DT	a
cell	NN	cell
supporting	VBG	support
its	PP$	its
persistence	NN	persistence
solely	RB	solely
on	IN	on
endogenous	JJ	endogenous
carbon	NN	carbon
material	NN	material
,	,	,
and	CC	and
what	WP	what
this	DT	this
energy	NN	energy
is	VVZ	be
used	VBN	use
for	IN	for
.	SENT	.
.	SENT	.
However	RB	However
,	,	,
it	PP	it
is	VVZ	be
clear	JJ	clear
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
endogenous	JJ	endogenous
metabolism	NN	metabolism
of	IN	of
Escherichia	FW	Escherichia
coli	FW	coli
cells	NNS	cell
held	VBN	hold
in	IN	in
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
absence	NN	absence
of	IN	of
exogenous	JJ	exogenous
carbon	NN	carbon
includes	VBZ	include
de novo	NN	de_novo
protein	NN	protein
synthesis	NN	synthesis
,	,	,
and	CC	and
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
this	DT	this
synthesis	NN	synthesis
is	VVZ	be
required	VBN	require
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
maintenance	NN	maintenance
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
growth	NN	growth
-	HYPH	-
arrested	VBN	arrest
cell	NN	cell
.	SENT	.
.	SENT	.
Recent	JJ	Recent
findings	NNS	finding
suggest	VBP	suggest
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
several	JJ	several
genes	NNS	gene
/	SYM	/
proteins	NNS	protein
<FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
responding	VBG	respond
to	TO	to
</FORBIDDEN ID=14 ACTION=split SPLIT_AFTER=0>
carbon	NN	carbon
starvation	NN	starvation
are	VVP	be
themselves	PP	themselves
involved	VBN	involve
in	IN	in
reorganizing	VBG	reorganize
and	CC	and
modulating	VBG	modulate
catabolic	JJ	catabolic
flux	NN	flux
,	,	,
while	IN	while
<FORBIDDEN ID=22 ACTION=delete>
others	NNS	other
</FORBIDDEN ID=22 ACTION=delete>
form	VBP	form
an	DT	an
integral	JJ	integral
part	NN	part
of	IN	of
a	DT	a
defense	NN	defense
system	NN	system
aimed	VBN	aim
at	IN	at
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
avoiding	VBG	avoid
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
damaging	JJ	damaging
effects	NNS	effect
of	IN	of
ongoing	VBG	ongoe
respiratory	JJ	respiratory
activity	NN	activity
.	SENT	.
.	SENT	.
A	DT	A
significant	JJ	significant
fraction	NN	fraction
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
energy	NN	energy
of	IN	of
maintenance	NN	maintenance
is	VVZ	be
suggested	VBN	suggest
to	TO	to
be	VV	be
required	VBN	require
to	TO	to
prevent	VB	prevent
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
denaturation	NN	denaturation
and	CC	and
spontaneous	JJ	spontaneous
aging	NN	aging
of	IN	of
proteins	NNS	protein
during	IN	during
stasis	NN	stasis
.	SENT	.
.	SENT	.
BB-cat+ner-9745160/text	DOCUMENT	BB-cat+ner-9745160/text
<FORBIDDEN ID=38 ACTION=delete>
<FORBIDDEN ID=37 ACTION=delete>
New	JJ	New
</FORBIDDEN ID=37 ACTION=delete>
</FORBIDDEN ID=38 ACTION=delete>
one-week	JJ	one-week
,	,	,
low-dose	JJ	low-dose
triple	JJ	triple
therapy	NN	therapy
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
treatment	NN	treatment
of	IN	of
duodenal	JJ	duodenal
ulcer	NN	ulcer
with	IN	with
Helicobacter	NN	Helicobacter
pylori	NN	pylori
infection	NN	infection
.	SENT	.
.	SENT	.
Antimicrobial	JJ	Antimicrobial
therapy	NN	therapy
is	VVZ	be
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
recommended	VBN	recommend
treatment	NN	treatment
for	IN	for
duodenal	JJ	duodenal
ulcer	NN	ulcer
associated	VBN	associate
with	IN	with
Helicobacter	NN	Helicobacter
pylori	NN	pylori
infection	NN	infection
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
eradication	NN	eradication
of	IN	of
bismuth	NN	bismuth
-	HYPH	-
based	VBN	base
triple	JJ	triple
therapy	NN	therapy
with	IN	with
bismuth	JJ	bismuth
subcitrate	NN	subcitrate
,	,	,
metronidazole	NN	metronidazole
and	CC	and
amoxicillin	NN	amoxicillin
is	VVZ	be
limited	VBN	limit
by	IN	by
low	JJ	low
compliance	NN	compliance
,	,	,
drug	NN	drug
resistance	NN	resistance
and	CC	and
side	NN	side
-	HYPH	-
effects	NNS	effect
.	SENT	.
.	SENT	.
Two-week	JJ	Two-week
proton	NN	proton
pump	NN	pump
inhibitor	NN	inhibitor
(	(	(
PPI	NN	PPI
)	)	)
-	HYPH	-
based	VBN	base
triple	JJ	triple
therapy	NN	therapy
has	VHZ	have
a	DT	a
higher	JJR	high
eradication	NN	eradication
rate	NN	rate
but	CC	but
is	VVZ	be
costly	JJ	costly
.	SENT	.
.	SENT	.
This	DT	This
study	NN	study
was	VVD	be
designed	VBN	design
to	TO	to
compare	VB	compare
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
efficacy	NN	efficacy
,	,	,
patient	NN	patient
compliance	NN	compliance
and	CC	and
cost	NN	cost
of	IN	of
short	JJ	short
-	HYPH	-
term	NN	term
PPI	NN	PPI
-	HYPH	-
based	VBN	base
triple	JJ	triple
therapy	NN	therapy
with	IN	with
those	DT	those
of	IN	of
bismuth	NN	bismuth
-	HYPH	-
based	VBN	base
triple	JJ	triple
therapy	NN	therapy
.	SENT	.
.	SENT	.
Ninety	CD	Ninety
patients	NNS	patient
with	IN	with
active	JJ	active
duodenal	JJ	duodenal
ulcer	NN	ulcer
disease	NN	disease
and	CC	and
H	NN	H
pylori	NN	pylori
infection	NN	infection
,	,	,
proven	VBN	prove
with	IN	with
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
13C	NN	13C
-	HYPH	-
urea	NN	urea
breath	NN	breath
test	NN	test
and	CC	and
CLO	NN	CLO
test	NN	test
(	(	(
Campylobacter	NN	Campylobacter
-	HYPH	-
like	JJ	like
organism	NN	organism
test	NN	test
)	)	)
were	VVD	be
treated	VBN	treat
randomly	RB	randomly
in	IN	in
three	CD	three
therapeutic	JJ	therapeutic
groups	NNS	group
:	COLUMN	:
Group	NN	Group
A	NN	A
,	,	,
DeNol	NN	DeNol
120	CD	120
mg	NN	mg
,	,	,
amoxicillin	NN	amoxicillin
500	CD	500
mg	NN	mg
and	CC	and
metronidazole	NN	metronidazole
250	CD	250
mg	NN	mg
four	CD	four
<FORBIDDEN ID=1 ACTION=split SPLIT_AFTER=0>
times	NNS	time
a	DT	a
</FORBIDDEN ID=1 ACTION=split SPLIT_AFTER=0>
day	NN	day
orally	RB	orally
for	IN	for
14	CD	14
days	NNS	day
;	COLUMN	;
Group	NN	Group
B	NN	B
,	,	,
omeprazole	NN	omeprazole
20	CD	20
mg	NN	mg
plus	CC	plus
clarithromycin	NN	clarithromycin
500	CD	500
mg	NN	mg
twice	RB	twice
a	DT	a
day	NN	day
and	CC	and
amoxicillin	NN	amoxicillin
500	CD	500
mg	NN	mg
four	CD	four
<FORBIDDEN ID=1 ACTION=split SPLIT_AFTER=0>
times	NNS	time
a	DT	a
</FORBIDDEN ID=1 ACTION=split SPLIT_AFTER=0>
day	NN	day
for	IN	for
14	CD	14
days	NNS	day
;	COLUMN	;
Group	NN	Group
C	NN	C
,	,	,
omeprazole	NN	omeprazole
20	CD	20
mg	NN	mg
,	,	,
clarithromycin	NN	clarithromycin
250	CD	250
mg	NN	mg
and	CC	and
metronidazole	NN	metronidazole
500	CD	500
mg	NN	mg
twice	RB	twice
a	DT	a
day	NN	day
for	IN	for
seven	CD	seven
days	NNS	day
.	SENT	.
.	SENT	.
Nizatidine	NN	Nizatidine
150	CD	150
mg	NN	mg
twice	RB	twice
a	DT	a
day	NN	day
was	VVD	be
given	VBN	give
continuously	RB	continuously
<FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
following	VBG	follow
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=4 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
end	NN	end
of	IN	of
anti	AFX	anti
-	HYPH	-
H	NN	H
pylori	NN	pylori
therapy	NN	therapy
for	IN	for
each	DT	each
group	NN	group
.	SENT	.
.	SENT	.
Two	CD	Two
months	NNS	month
later	RB	later
,	,	,
endoscopy	NN	endoscopy
,	,	,
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
CLO	NP	CLO
test	NN	test
and	CC	and
13C	NN	13C
-	HYPH	-
urea	NN	urea
breath	NN	breath
test	NN	test
were	VVD	be
repeated	VBN	repeat
to	TO	to
assess	VB	assess
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
eradication	NN	eradication
rate	NN	rate
of	IN	of
H	NN	H
pylori	NN	pylori
and	CC	and
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
ulcer	NN	ulcer
-	HYPH	-
healing	VBG	heal
rate	NN	rate
.	SENT	.
.	SENT	.
Drug	NN	Drug
tolerance	NN	tolerance
was	VVD	be
evaluated	VBN	evaluate
by	IN	by
patients	NNS	patient
themselves	PP	themselves
by	IN	by
daily	JJ	daily
recording	NN	recording
of	IN	of
any	DT	any
side	NN	side
-	HYPH	-
effects	NNS	effect
.	SENT	.
.	SENT	.
Eighty	CD	Eighty
-	HYPH	-
four	CD	four
patients	NNS	patient
completed	VBD	complete
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
entire	JJ	entire
course	NN	course
of	IN	of
therapy	NN	therapy
and	CC	and
evaluation	NN	evaluation
for	IN	for
H	NN	H
pylori	NN	pylori
infection	NN	infection
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
H	NN	H
pylori	NN	pylori
eradication	NN	eradication
rates	NNS	rate
in	IN	in
Groups	NNS	Group
A	NN	A
,	,	,
B	NN	B
and	CC	and
C	NN	C
were	VVD	be
75%	CD	75%
(	(	(
21/28	CD	21/28
)	)	)
,	,	,
93%	CD	93%
(	(	(
26/28	CD	26/28
)	)	)
and	CC	and
89%	CD	89%
(	(	(
25/28	CD	25/28
)	)	)
,	,	,
respectively	RB	respectively
(	(	(
p	NN	p
=	SYM	=
0.466	CD	0.466
)	)	)
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
ulcer	NN	ulcer
healing	NN	healing
rate	NN	rate
was	VVD	be
86%	CD	86%
(	(	(
24/28	CD	24/28
)	)	)
in	IN	in
Group	NN	Group
A	NN	A
and	CC	and
89%	NN	89%
(	(	(
25/28	CD	25/28
)	)	)
in	IN	in
Groups	NNS	Group
B	NN	B
and	CC	and
C	NN	C
(	(	(
p	NN	p
=	SYM	=
0.764	CD	0.764
)	)	)
.	SENT	.
.	SENT	.
A	DT	A
total	NN	total
of	IN	of
74	CD	74
patients	NNS	patient
(	(	(
88%	NN	88%
)	)	)
were	VVD	be
free	JJ	free
from	IN	from
symptoms	NNS	symptom
at	IN	at
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
end	NN	end
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
triple	JJ	triple
therapy	NN	therapy
.	SENT	.
.	SENT	.
Symptom	NN	Symptom
relief	NN	relief
was	VVD	be
faster	JJR	fast
in	IN	in
patients	NNS	patient
with	IN	with
PPI	NN	PPI
-	HYPH	-
based	VBN	base
triple	JJ	triple
therapy	NN	therapy
(	(	(
Groups	NNS	Group
B	NN	B
and	CC	and
C	NN	C
)	)	)
(	(	(
days	NNS	day
3	CD	3
and	CC	and
4	CD	4
)	)	)
than	IN	than
for	IN	for
patients	NNS	patient
with	IN	with
bismuth	NN	bismuth
-	HYPH	-
based	VBN	base
triple	JJ	triple
therapy	NN	therapy
(	(	(
day	NN	day
5	CD	5
)	)	)
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
cost	NN	cost
of	IN	of
Group	NN	Group
C	NN	C
therapy	NN	therapy
was	VVD	be
lower	JJR	low
than	IN	than
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	DT	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
for	IN	for
Groups	NNS	Group
A	NN	A
and	CC	and
B	NN	B
.	SENT	.
.	SENT	.
There	EX	There
were	VVD	be
no	DT	no
major	JJ	major
side	NN	side
-	HYPH	-
effects	NNS	effect
in	IN	in
any	DT	any
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
patients	NNS	patient
.	SENT	.
.	SENT	.
One-week	JJ	One-week
triple	JJ	triple
therapy	NN	therapy
with	IN	with
omeprazole	NN	omeprazole
,	,	,
clarithromycin	NN	clarithromycin
and	CC	and
metronidazole	NN	metronidazole
is	VVZ	be
highly	RB	highly
effected	VBN	effect
for	IN	for
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
eradication	NN	eradication
of	IN	of
H	NN	H
pylori	NN	pylori
.	SENT	.
.	SENT	.
A	DT	A
therapeutic	JJ	therapeutic
regime	NN	regime
of	IN	of
one	CD	one
week's	NNS	week'
duration	NN	duration
with	IN	with
lower	JJR	low
cost	NN	cost
,	,	,
good	JJ	good
compliance	NN	compliance
and	CC	and
mild	JJ	mild
side	NN	side
-	HYPH	-
effects	NNS	effect
<FORBIDDEN ID=123 ACTION=delete>
may	MD	may
</FORBIDDEN ID=123 ACTION=delete>
offer	VB	offer
a	DT	a
good	JJ	good
choice	NN	choice
for	IN	for
treatment	NN	treatment
of	IN	of
duodenal	JJ	duodenal
ulcer	NN	ulcer
associated	VBN	associate
with	IN	with
H	NN	H
pylori	NN	pylori
infection	NN	infection
in	IN	in
clinical	JJ	clinical
practice	NN	practice
.	SENT	.
.	SENT	.
BB-cat+ner-9798026/text	DOCUMENT	BB-cat+ner-9798026/text
Previous	JJ	Previous
infection	NN	infection
with	IN	with
Helicobacter	NN	Helicobacter
pylori	NN	pylori
is	VVZ	be
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
primary	JJ	primary
determinant	NN	determinant
of	IN	of
spontaneous	JJ	spontaneous
gastric	JJ	gastric
hypoacidity	NN	hypoacidity
in	IN	in
human	JJ	human
immunodeficiency	NN	immunodeficiency
virus	NN	virus
-	HYPH	-
infected	VBN	infect
outpatients	NNS	outpatient
.	SENT	.
.	SENT	.
To	TO	To
investigate	VB	investigate
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
incidence	NN	incidence
and	CC	and
demographics	NNS	demographic
of	IN	of
gastric	JJ	gastric
hypoacidity	NN	hypoacidity
among	IN	among
persons	NNS	person
infected	VBN	infect
with	IN	with
human	JJ	human
immunodeficiency	NN	immunodeficiency
virus	NN	virus
(	(	(
HIV	NN	HIV
)	)	)
,	,	,
146	CD	146
asymptomatic	JJ	asymptomatic
subjects	NNS	subject
were	VVD	be
evaluated	VBN	evaluate
with	IN	with
use	NN	use
of	IN	of
a	DT	a
radiotelemetry	NN	radiotelemetry
device	NN	device
(	(	(
Heidelberg	NN	Heidelberg
capsule	NN	capsule
)	)	)
.	SENT	.
.	SENT	.
Gastric	JJ	Gastric
hypoacidity	NN	hypoacidity
(	(	(
minimum	JJ	minimum
gastric	JJ	gastric
pH	NN	pH
of	IN	of
SUP	SYM	SUP
or	CC	or
=	SYM	=
3	CD	3
)	)	)
occurred	VBD	occur
in	IN	in
24	CD	24
subjects	NNS	subject
(	(	(
17%	NN	17%
)	)	)
.	SENT	.
.	SENT	.
Demographic	JJ	Demographic
characteristics	NNS	characteristic
,	,	,
CD4	NN	CD4
cell	NN	cell
counts	NNS	count
,	,	,
and	CC	and
Helicobacter	NN	Helicobacter
pylori	NN	pylori
serological	JJ	serological
status	NN	status
were	VVD	be
evaluated	VBN	evaluate
for	IN	for
an	DT	an
association	NN	association
with	IN	with
gastric	JJ	gastric
pH	NN	pH
.	SENT	.
.	SENT	.
Subjects	NNS	Subject
with	IN	with
hypoacidity	NN	hypoacidity
were	VVD	be
<FORBIDDEN ID=82 ACTION=delete>
more	RBR	more
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
</FORBIDDEN ID=82 ACTION=delete>
likely	JJ	likely
to	TO	to
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
have	VH	have
positive	JJ	positive
H	NN	H
.	NN	.
pylori	NN	pylori
serology	NN	serology
than	IN	than
were	VVD	be
subjects	NNS	subject
without	IN	without
hypoacidity	NN	hypoacidity
(	(	(
15	CD	15
of	IN	of
24	CD	24
vs	NNS	v
.	SENT	.
23	CD	23
of	IN	of
74	CD	74
,	,	,
respectively	RB	respectively
;	COLUMN	;
P	NN	P
=	JJ	=
.	SENT	.
004	CD	004
)	)	)
.	SENT	.
.	SENT	.
Multivariate	JJ	Multivariate
analysis	NN	analysis
indicated	VBD	indicate
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
a	DT	a
positive	JJ	positive
H	NN	H
.	NN	.
pylori	NN	pylori
serology	NN	serology
was	VVD	be
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
most	RBS	most
significant	JJ	significant
predictor	NN	predictor
of	IN	of
hypoacidity	NN	hypoacidity
,	,	,
accounting	VBG	account
for	IN	for
an	DT	an
increase	NN	increase
in	IN	in
gastric	JJ	gastric
pH	NN	pH
of	IN	of
39%	NN	39%
.	SENT	.
.	SENT	.
A	DT	A
history	NN	history
of	IN	of
injection	NN	injection
drug	NN	drug
use	NN	use
,	,	,
heterosexual	JJ	heterosexual
transmission	NN	transmission
of	IN	of
HIV	NN	HIV
,	,	,
and	CC	and
male	JJ	male
gender	NN	gender
were	VVD	be
<FORBIDDEN ID=155 ACTION=delete>
also	RB	also
</FORBIDDEN ID=155 ACTION=delete>
associated	VBN	associate
with	IN	with
an	DT	an
elevated	JJ	elevated
gastric	JJ	gastric
pH	NN	pH
.	SENT	.
.	SENT	.
CD4	NN	CD4
cell	NN	cell
counts	NNS	count
did	VBD	do
not	RB	not
contribute	VB	contribute
to	TO	to
predictions	NNS	prediction
of	IN	of
gastric	JJ	gastric
pH	NN	pH
.	SENT	.
.	SENT	.
A	DT	A
history	NN	history
of	IN	of
H	NN	H
.	SYM	.
pylori	NN	pylori
infection	NN	infection
is	VVZ	be
relatively	RB	relatively
common	JJ	common
in	IN	in
HIV	NN	HIV
-	HYPH	-
positive	JJ	positive
black	JJ	black
and	CC	and
Hispanic	JJ	Hispanic
populations	NNS	population
and	CC	and
is	VVZ	be
a	DT	a
predictor	NN	predictor
of	IN	of
gastric	JJ	gastric
pH	NN	pH
.	SENT	.
.	SENT	.
BB-cat+ner-9864452/text	DOCUMENT	BB-cat+ner-9864452/text
Isolation	NN	Isolation
and	CC	and
properties	NNS	property
of	IN	of
extracellular	JJ	extracellular
alkaline	NN	alkaline
phosphatase	NN	phosphatase
from	IN	from
Bacillus	NN	Bacillus
intermedius	NN	intermedius
.	SENT	.
.	SENT	.
Alkaline	NN	Alkaline
phosphatase	NN	phosphatase
(	(	(
APase	NN	APase
)	)	)
was	VVD	be
isolated	VBN	isolate
from	IN	from
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
culture	NN	culture
liquid	NN	liquid
of	IN	of
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
streptomycin	NN	streptomycin
-	HYPH	-
resistant	JJ	resistant
strain	NN	strain
of	IN	of
Bacillus	NN	Bacillus
intermedius	NN	intermedius
S	NN	S
3-19	CD	3-19
and	CC	and
purified	VBN	purify
as	IN	as
a	DT	a
homogeneous	JJ	homogeneous
preparation	NN	preparation
by	IN	by
ion-exchange	NN	ion-exchange
chromatography	NN	chromatography
and	CC	and
FPLC	NN	FPLC
.	SENT	.
.	SENT	.
Electrophoresis	NN	Electrophoresis
and	CC	and
gel-filtration	NN	gel-filtration
revealed	VBD	reveal
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
active	JJ	active
enzyme	NN	enzyme
is	VVZ	be
a	DT	a
monomer	NN	monomer
with	IN	with
molecular	JJ	molecular
weight	NN	weight
of	IN	of
46-47	CD	46-47
kD	NN	kD
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
enzyme	NN	enzyme
possessed	VBD	possess
phosphomonoesterase	NN	phosphomonoesterase
and	CC	and
phosphodiesterase	NN	phosphodiesterase
activities	NNS	activity
with	IN	with
maximal	JJ	maximal
levels	NNS	level
at	IN	at
pH	NN	pH
9.5	CD	9.5
and	CC	and
55	CD	55
degreesC	NN	degreesC
and	CC	and
was	VVD	be
stable	JJ	stable
until	IN	until
60	CD	60
degreesC	NN	degreesC
at	IN	at
pH	NN	pH
8.0-10.0	CD	8.0-10.0
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
isolated	VBN	isolate
APase	NN	APase
exhibits	VBZ	exhibit
a	DT	a
broad	JJ	broad
specificity	NN	specificity
towards	IN	towards
a	DT	a
wide	JJ	wide
<FORBIDDEN ID=57 ACTION=delete>
variety	NN	variety
of	IN	of
</FORBIDDEN ID=57 ACTION=delete>
substrates	NNS	substrate
.	SENT	.
.	SENT	.
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
The	DT	The
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
effect	NN	effect
of	IN	of
divalent	JJ	divalent
metal	NN	metal
ions	NNS	ion
and	CC	and
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
reagents	NNS	reagent
on	IN	on
its	PP$	its
catalytic	JJ	catalytic
activities	NNS	activity
was	VVD	be
studied	VBN	study
.	SENT	.
.	SENT	.
It	PP	It
was	VVD	be
concluded	VBN	conclude
<FORBIDDEN ID=35 ACTION=delete>
<FORBIDDEN ID=31 ACTION=delete>
that	IN	that
</FORBIDDEN ID=31 ACTION=delete>
</FORBIDDEN ID=35 ACTION=delete>
alkaline	NN	alkaline
phosphatase	NN	phosphatase
of	IN	of
B	NN	B
.	SENT	.
intermedius	NN	intermedius
is	VVZ	be
<FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
similar	JJ	similar
to	TO	to
<FORBIDDEN ID=34 ACTION=delete>
<FORBIDDEN ID=33 ACTION=delete>
<FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=9 ACTION=split SPLIT_AFTER=0>
the	DT	the
</FORBIDDEN ID=32 ACTION=delete>
</FORBIDDEN ID=33 ACTION=delete>
</FORBIDDEN ID=34 ACTION=delete>
secreted	VBN	secrete
alkaline	NN	alkaline
phosphatases	NNS	phosphatas
from	IN	from
<FORBIDDEN ID=22 ACTION=delete>
other	JJ	other
</FORBIDDEN ID=22 ACTION=delete>
Bacillus	NN	Bacillus
species	NNS	specie
in	IN	in
its	PP$	its
physicochemical	JJ	physicochemical
and	CC	and
catalytic	JJ	catalytic
properties	NNS	property
.	SENT	.
.	SENT	.
